data_1fkr_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1fkr _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.1 p . . . . . 0 N--CA 1.503 2.19 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -124.07 154.96 39.18 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.4 t -124.86 112.76 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -114.31 90.97 3.47 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 97.9 m -69.78 154.84 41.43 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 119.008 -1.077 . . . . 0.0 112.425 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 58.9 mt -123.58 -52.01 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 CA-C-N 113.859 -1.519 . . . . 0.0 107.407 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 9' ' ' PRO . 38.9 t -122.03 80.66 42.99 Favored Pre-proline 0 N--CA 1.505 2.324 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.041 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 8' ' ' SER . 6.4 Cg_exo -36.96 166.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.812 2.341 . . . . 0.0 113.718 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -115.81 -172.68 16.99 Favored Glycine 0 N--CA 1.5 2.921 0 N-CA-C 105.75 -2.94 . . . . 0.0 105.75 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.492 ' CG ' ' H ' ' A' ' 12' ' ' GLY . 11.7 p-10 -44.73 -58.35 3.13 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 118.405 1.102 . . . . 0.0 111.173 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.492 ' H ' ' CG ' ' A' ' 11' ' ' ASP . . . 107.65 24.26 6.49 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 107.636 -2.186 . . . . 0.0 107.636 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 -128.83 -37.56 1.73 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 114.532 -0.834 . . . . 0.0 111.249 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.4 m -111.07 138.34 47.61 Favored 'General case' 0 N--CA 1.507 2.416 0 CA-C-O 121.833 0.825 . . . . 0.0 112.834 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.458 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 48.5 m-85 -133.07 173.78 5.48 Favored Pre-proline 0 N--CA 1.495 1.786 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -61.53 134.57 52.01 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 N-CA-C 110.09 -0.773 . . . . 0.0 110.09 164.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.428 ' CB ' ' HZ1' ' A' ' 17' ' ' LYS . 8.2 mtpm? -115.3 170.21 8.56 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.943 0.877 . . . . 0.0 110.484 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.9 mtm180 -73.64 97.01 2.56 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.198 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 122.84 18.98 3.1 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -115.82 170.1 8.72 Favored 'General case' 0 N--CA 1.504 2.245 0 CA-C-O 121.83 0.824 . . . . 0.0 110.116 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 95.4 m -125.1 110.33 14.01 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 114.481 -1.236 . . . . 0.0 107.915 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 27.5 m -69.76 149.29 48.13 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.16 -1.016 . . . . 0.0 110.074 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 93.3 t -125.17 97.8 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 101.14 -3.652 . . . . 0.0 101.14 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.8 m -121.13 151.26 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 48.3 t60 -130.24 116.55 18.54 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 104.675 -2.342 . . . . 0.0 104.675 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -134.01 179.33 6.31 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 123.044 1.402 . . . . 0.0 111.966 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.438 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 51.2 m -141.91 126.11 17.46 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 101.016 -3.698 . . . . 0.0 101.016 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -103.09 129.95 10.07 Favored Glycine 0 N--CA 1.5 2.93 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 39.5 ttm . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 179.954 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 66.4 t80 . . . . . 0 N--CA 1.495 1.819 0 N-CA-C 110.551 -0.166 . . . . 0.0 110.551 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -137.0 122.02 18.98 Favored 'General case' 0 N--CA 1.507 2.415 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.542 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -138.98 177.09 8.14 Favored 'General case' 0 N--CA 1.509 2.495 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.765 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 43.1 ttp -121.29 156.94 31.46 Favored 'General case' 0 N--CA 1.503 2.207 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.966 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.9 tp -90.95 120.32 31.86 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.15 12.71 30.8 Favored Glycine 0 N--CA 1.501 2.969 0 C-N-CA 121.059 -0.591 . . . . 0.0 114.04 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.475 ' O ' ' N ' ' A' ' 54' ' ' GLU . 59.3 tttp -128.24 45.81 2.7 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 118.349 1.074 . . . . 0.0 108.945 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' A' ' 52' ' ' LYS . 20.5 pt20 4.16 61.18 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 115.991 1.849 . . . . 0.0 115.991 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.475 ' N ' ' O ' ' A' ' 52' ' ' LYS . 6.8 mm-40 -102.98 -29.98 11.07 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 56' ' ' ILE . 13.0 m -114.87 155.76 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.426 ' O ' ' O ' ' A' ' 55' ' ' VAL . 17.0 pt -51.74 -179.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 C-N-CA 119.065 -1.054 . . . . 0.0 109.001 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.536 ' O ' ' N ' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -80.45 -58.59 3.05 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -28.3 -35.93 0.01 OUTLIER Glycine 0 N--CA 1.501 3.025 0 O-C-N 124.531 1.145 . . . . 0.0 111.53 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.536 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.9 OUTLIER -78.78 -75.72 0.22 Allowed 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 113.236 -1.482 . . . . 0.0 107.237 179.822 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 59' ' ' TRP . 71.1 tt0 -25.87 -55.01 0.06 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 125.839 1.962 . . . . 0.0 110.828 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -75.27 -54.7 6.66 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -51.04 -75.09 0.23 Allowed Glycine 0 N--CA 1.482 1.753 0 C-N-CA 119.564 -1.303 . . . . 0.0 111.168 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' A' ' 59' ' ' TRP . 28.9 t -41.58 -49.91 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 119.594 -0.842 . . . . 0.0 112.292 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.511 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -45.9 -60.59 2.16 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 124.056 1.884 . . . . 0.0 111.157 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -48.68 -11.28 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 109.416 -3.538 . . . . 0.0 109.195 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.511 ' H ' ' C ' ' A' ' 64' ' ' ALA . 49.8 mtm -99.82 160.64 14.15 Favored 'General case' 0 N--CA 1.517 2.887 0 C-N-CA 118.518 -1.273 . . . . 0.0 108.823 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 96.7 p -115.32 150.63 35.97 Favored 'General case' 0 N--CA 1.51 2.539 0 CA-C-O 122.584 1.183 . . . . 0.0 113.919 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 63.8 t -49.21 99.63 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 112.641 -2.072 . . . . 0.0 113.681 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 113.95 9.27 16.38 Favored Glycine 0 N--CA 1.499 2.834 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -107.8 154.14 21.96 Favored 'General case' 0 N--CA 1.506 2.33 0 CA-C-O 122.428 1.109 . . . . 0.0 111.164 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.0 ttp180 -131.46 140.12 49.52 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 112.83 -1.986 . . . . 0.0 107.224 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -148.44 177.58 9.33 Favored 'General case' 0 N--CA 1.502 2.158 0 CA-C-N 112.947 -1.933 . . . . 0.0 115.496 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -126.47 105.28 8.65 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 111.295 -2.684 . . . . 0.0 103.936 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.4 mt -99.77 152.57 19.96 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 93.7 m -124.57 119.81 30.15 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 25.7 mt -112.13 140.28 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.417 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 35.1 p -111.13 155.53 42.44 Favored Pre-proline 0 N--CA 1.506 2.343 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.185 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -37.85 -51.59 1.84 Allowed 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 122.189 1.926 . . . . 0.0 114.695 -175.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 18.0 p-10 -39.28 -41.28 0.87 Allowed 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 . . . . . 0 N--CA 1.493 1.694 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.312 -179.544 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 62.3 m . . . . . 0 N--CA 1.5 2.067 0 CA-C-O 118.794 -0.622 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 24.2 mt -111.1 151.76 27.73 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.4 t -134.12 125.29 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -120.29 139.81 52.18 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.178 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 27' ' ' THR . 5.1 p-10 -117.57 98.84 6.6 Favored 'General case' 0 N--CA 1.501 2.076 1 N-CA-C 97.338 -5.06 . . . . 0.0 97.338 178.902 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 16.5 t -108.51 153.62 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.355 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 -178.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -127.99 104.37 7.75 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 112.119 -2.309 . . . . 0.0 107.609 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 37.8 tp -75.49 121.45 22.37 Favored 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 102.556 -3.127 . . . . 0.0 102.556 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.3 mt -93.16 -57.86 2.49 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -157.96 173.81 16.2 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.605 0.717 . . . . 0.0 112.074 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 35.4 mt -117.59 143.19 46.36 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 . . . . . 0 N--CA 1.503 2.215 0 CA-C-O 116.286 -1.816 . . . . 0.0 110.007 179.885 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.9 p . . . . . 0 N--CA 1.502 2.153 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -122.92 156.39 34.77 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.4 t -125.44 114.84 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 108.039 -1.096 . . . . 0.0 108.039 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -115.22 90.02 3.24 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 90.5 m -69.83 155.67 40.2 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.048 -1.061 . . . . 0.0 112.488 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 59.0 mt -123.66 -51.59 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 CA-C-N 113.645 -1.616 . . . . 0.0 107.258 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.418 ' O ' ' O ' ' A' ' 9' ' ' PRO . 46.5 t -122.22 80.13 44.32 Favored Pre-proline 0 N--CA 1.506 2.328 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.283 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 8' ' ' SER . 6.4 Cg_exo -37.42 164.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.348 2.032 . . . . 0.0 112.808 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -123.51 -168.95 13.12 Favored Glycine 0 N--CA 1.498 2.826 0 N-CA-C 105.632 -2.987 . . . . 0.0 105.632 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 11' ' ' ASP . 12.3 p-10 -39.5 -62.93 0.62 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.747 -0.781 . . . . 0.0 112.575 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.58 15.25 21.44 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 105.838 -2.905 . . . . 0.0 105.838 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 30.4 mtm-85 -125.95 -39.4 2.11 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 113.307 -1.447 . . . . 0.0 112.774 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.1 m -108.2 137.14 46.68 Favored 'General case' 0 N--CA 1.507 2.395 0 CA-C-O 121.775 0.798 . . . . 0.0 112.763 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.445 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 57.0 m-85 -130.56 177.43 2.22 Favored Pre-proline 0 N--CA 1.496 1.859 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -69.57 146.77 62.37 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 N-CA-C 109.765 -0.898 . . . . 0.0 109.765 162.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -122.37 168.44 12.07 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 122.086 0.946 . . . . 0.0 110.248 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 19.1 ptt85 -72.61 126.58 30.22 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.648 -1.16 . . . . 0.0 108.677 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 111.38 -19.71 24.06 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.5 ' O ' ' SD ' ' A' ' 49' ' ' MET . 25.7 mt-30 -109.76 176.4 5.08 Favored 'General case' 0 N--CA 1.506 2.341 0 CA-C-O 121.766 0.793 . . . . 0.0 112.274 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 27.7 m -110.07 161.47 15.5 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 57.2 m -111.7 146.56 37.3 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 103.889 -2.634 . . . . 0.0 103.889 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 33.4 t -123.07 101.95 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 101.644 -3.465 . . . . 0.0 101.644 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 m -123.01 150.46 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 125.004 1.44 . . . . 0.0 114.324 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.403 ' ND1' ' C ' ' A' ' 25' ' ' HIS . 2.7 t-80 -130.61 113.77 14.62 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 103.598 -2.742 . . . . 0.0 103.598 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -131.21 176.63 8.11 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 123.184 1.468 . . . . 0.0 113.576 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 96.0 m -139.42 121.85 16.11 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 101.921 -3.363 . . . . 0.0 101.921 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -96.93 151.61 19.88 Favored Glycine 0 N--CA 1.498 2.824 0 C-N-CA 119.127 -1.511 . . . . 0.0 109.457 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 36.6 ttp . . . . . 0 N--CA 1.487 1.4 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 179.868 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 52.9 t80 . . . . . 0 N--CA 1.494 1.749 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.433 ' HZ1' ' CB ' ' A' ' 47' ' ' LYS . 9.1 mtmp? -143.08 125.29 15.45 Favored 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 118.745 -0.645 . . . . 0.0 111.695 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -137.53 171.94 13.71 Favored 'General case' 0 N--CA 1.515 2.795 0 CA-C-N 119.812 1.187 . . . . 0.0 114.158 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.5 ' SD ' ' O ' ' A' ' 20' ' ' GLN . 45.6 tpp -109.11 140.74 42.27 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 114.954 1.464 . . . . 0.0 114.954 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.8 tp -91.01 122.38 33.62 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 114.249 -1.341 . . . . 0.0 110.196 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.03 18.67 13.12 Favored Glycine 0 N--CA 1.5 2.9 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -122.57 -20.57 5.96 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-N 114.732 -0.734 . . . . 0.0 109.313 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.655 HE22 ' NH1' ' A' ' 57' ' ' ARG . 9.6 mm100 54.48 67.84 0.95 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -109.76 -35.3 6.22 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.3 m -106.15 156.47 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.4 pt -50.98 174.96 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 118.368 -1.333 . . . . 0.0 110.548 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.655 ' NH1' HE22 ' A' ' 53' ' ' GLN . 4.2 tpp180 -68.71 -64.93 0.77 Allowed 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.061 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -28.95 -35.03 0.01 OUTLIER Glycine 0 N--CA 1.498 2.817 0 O-C-N 124.722 1.264 . . . . 0.0 112.308 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.531 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.5 OUTLIER -76.68 -70.57 0.45 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 179.858 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -33.49 -55.81 0.43 Allowed 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 113.723 -1.58 . . . . 0.0 109.992 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -70.16 -53.8 15.65 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 113.431 -1.713 . . . . 0.0 107.353 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -56.24 -75.81 0.23 Allowed Glycine 0 N--CA 1.48 1.574 0 C-N-CA 119.558 -1.306 . . . . 0.0 111.544 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 59' ' ' TRP . 41.2 t -38.37 -48.98 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 C-N-CA 120.332 -0.547 . . . . 0.0 112.243 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.512 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -46.86 -59.93 2.75 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 124.198 1.951 . . . . 0.0 110.584 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -51.27 -9.18 0.06 Allowed 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 109.37 -3.559 . . . . 0.0 109.719 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.512 ' H ' ' C ' ' A' ' 64' ' ' ALA . 90.3 mtp -98.23 154.94 17.43 Favored 'General case' 0 N--CA 1.512 2.646 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 84.8 p -116.39 151.13 36.59 Favored 'General case' 0 N--CA 1.507 2.424 0 CA-C-O 122.691 1.234 . . . . 0.0 113.75 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 95.5 t -44.93 98.14 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-N 112.499 -2.137 . . . . 0.0 114.385 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.02 11.9 15.23 Favored Glycine 0 N--CA 1.498 2.796 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -109.99 151.73 26.77 Favored 'General case' 0 N--CA 1.508 2.441 0 CA-C-O 122.215 1.007 . . . . 0.0 111.012 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -132.21 141.98 49.26 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 113.459 -1.7 . . . . 0.0 107.815 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -149.53 179.68 7.78 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 112.979 -1.918 . . . . 0.0 116.143 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -127.1 105.8 8.83 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 102.678 -3.082 . . . . 0.0 102.678 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.9 mt -101.66 153.86 19.39 Favored 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 121.315 0.579 . . . . 0.0 109.587 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 87.3 m -125.46 126.5 45.03 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 31.8 mt -115.64 141.4 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.421 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 35.5 p -110.31 152.32 43.17 Favored Pre-proline 0 N--CA 1.498 1.948 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -40.78 -54.9 2.21 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 121.738 1.625 . . . . 0.0 112.513 -172.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 18.8 p30 -37.35 -35.96 0.13 Allowed 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.39 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 . . . . . 0 N--CA 1.494 1.726 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.185 -179.692 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 27.2 m . . . . . 0 N--CA 1.498 1.964 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 34.2 mt -118.33 156.56 28.7 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 58.9 t -137.15 130.11 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -123.29 155.91 36.31 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 122.058 0.932 . . . . 0.0 111.208 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -126.81 90.0 3.09 Favored 'General case' 0 N--CA 1.493 1.704 1 N-CA-C 98.977 -4.453 . . . . 0.0 98.977 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 13.1 t -104.55 150.84 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.594 0 N-CA-C 116.73 2.122 . . . . 0.0 116.73 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -128.39 98.08 4.94 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 112.595 -2.093 . . . . 0.0 106.838 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 49.1 tp -73.01 117.2 14.45 Favored 'General case' 0 N--CA 1.503 2.192 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.5 mt -83.92 -57.55 3.15 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 114.296 -1.32 . . . . 0.0 113.784 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 16.2 ttpp -168.91 -171.41 1.34 Allowed 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.271 -0.972 . . . . 0.0 108.733 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 22.9 mt -116.6 157.5 25.22 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 . . . . . 0 N--CA 1.506 2.328 0 CA-C-O 116.176 -1.869 . . . . 0.0 110.172 179.912 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 N--CA 1.502 2.139 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -120.86 155.38 34.25 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 43.4 t -126.08 122.44 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.478 ' N ' ' CD ' ' A' ' 5' ' ' GLU . 8.9 mp0 -120.4 93.48 4.06 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 96.4 m -69.71 156.36 39.1 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 118.675 -1.21 . . . . 0.0 112.079 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 70.3 mt -121.95 -55.13 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-N 113.882 -1.508 . . . . 0.0 107.484 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.43 ' O ' ' O ' ' A' ' 9' ' ' PRO . 33.1 t -123.74 82.78 54.49 Favored Pre-proline 0 N--CA 1.506 2.329 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.382 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.43 ' O ' ' O ' ' A' ' 8' ' ' SER . 3.9 Cg_exo -35.84 164.39 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.689 2.26 . . . . 0.0 113.606 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -113.78 -176.43 19.22 Favored Glycine 0 N--CA 1.499 2.894 0 N-CA-C 105.797 -2.921 . . . . 0.0 105.797 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.507 ' CG ' ' H ' ' A' ' 12' ' ' GLY . 11.2 p-10 -43.85 -59.03 2.44 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 118.352 1.076 . . . . 0.0 111.586 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.507 ' H ' ' CG ' ' A' ' 11' ' ' ASP . . . 109.18 25.81 5.43 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 107.737 -2.145 . . . . 0.0 107.737 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.5 mmm180 -132.42 -36.68 1.1 Allowed 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 114.671 -0.764 . . . . 0.0 111.415 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 45.6 m -111.31 128.84 56.08 Favored 'General case' 0 N--CA 1.507 2.379 0 CA-C-O 121.584 0.707 . . . . 0.0 112.687 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.413 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 37.6 m-85 -129.95 171.6 8.63 Favored Pre-proline 0 N--CA 1.497 1.92 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_exo -53.24 145.75 42.73 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 CA-C-N 119.588 0.888 . . . . 0.0 112.244 166.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -122.83 168.39 12.33 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 122.458 1.123 . . . . 0.0 111.175 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 42.9 mtp-105 -81.18 93.72 6.53 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 113.639 -1.619 . . . . 0.0 111.687 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.76 3.49 5.94 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 108.637 -1.785 . . . . 0.0 108.637 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -117.91 173.97 6.46 Favored 'General case' 0 N--CA 1.505 2.322 0 C-N-CA 120.254 -0.578 . . . . 0.0 109.567 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.7 m -110.0 164.8 12.27 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 31.6 m -117.22 128.38 55.04 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 33.3 t -108.5 111.48 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 101.106 -3.664 . . . . 0.0 101.106 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.1 m -125.88 155.06 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 125.007 1.442 . . . . 0.0 114.127 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -129.87 107.88 9.72 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 104.512 -2.403 . . . . 0.0 104.512 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -130.48 175.29 9.1 Favored 'General case' 0 N--CA 1.503 2.2 0 CA-C-O 122.923 1.344 . . . . 0.0 114.458 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 93.7 m -138.17 121.8 17.42 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 102.292 -3.225 . . . . 0.0 102.292 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -111.2 138.1 14.74 Favored Glycine 0 N--CA 1.503 3.124 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 21.9 tpp . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 -179.871 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 68.8 t80 . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 120.713 0.292 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -130.36 117.81 20.31 Favored 'General case' 0 N--CA 1.509 2.499 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -136.23 170.77 15.48 Favored 'General case' 0 N--CA 1.51 2.54 0 C-N-CA 119.732 -0.787 . . . . 0.0 112.313 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 40.3 ttm -118.64 154.96 31.82 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.2 tp -91.03 120.88 32.37 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.889 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.42 34.21 5.38 Favored Glycine 0 N--CA 1.499 2.864 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.049 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.484 ' O ' ' CB ' ' A' ' 53' ' ' GLN . 23.0 ttmm -129.93 -51.01 1.13 Allowed 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.484 ' CB ' ' O ' ' A' ' 52' ' ' LYS . 37.3 tt0 100.9 67.74 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.161 0 O-C-N 125.837 1.961 . . . . 0.0 109.592 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -110.24 -35.94 5.95 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.1 m -116.73 159.06 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.854 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 13.4 pt -56.51 179.97 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.527 ' O ' ' N ' ' A' ' 59' ' ' TRP . 34.8 ttt180 -74.48 -61.21 1.95 Allowed 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.92 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 57' ' ' ARG . . . -25.61 -39.32 0.01 OUTLIER Glycine 0 N--CA 1.501 2.988 0 O-C-N 124.986 1.428 . . . . 0.0 112.489 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.53 ' O ' ' N ' ' A' ' 63' ' ' VAL . 0.7 OUTLIER -73.26 -73.62 0.2 Allowed 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 179.721 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.484 ' OE1' ' N ' ' A' ' 61' ' ' GLU . 10.4 tm-20 -26.62 -55.7 0.08 Allowed 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 112.934 -1.939 . . . . 0.0 110.707 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.484 ' N ' ' OE1' ' A' ' 60' ' ' GLU . 50.3 tp10 -73.98 -54.96 6.76 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 112.927 -1.942 . . . . 0.0 106.23 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -52.16 -75.55 0.22 Allowed Glycine 0 N--CA 1.482 1.705 0 C-N-CA 119.617 -1.278 . . . . 0.0 110.961 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.53 ' N ' ' O ' ' A' ' 59' ' ' TRP . 30.8 t -40.92 -49.12 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 119.973 -0.691 . . . . 0.0 112.093 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.508 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -46.9 -59.01 3.37 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 124.012 1.863 . . . . 0.0 110.928 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -52.0 -8.04 0.06 Allowed 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 109.517 -3.492 . . . . 0.0 109.836 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.508 ' H ' ' C ' ' A' ' 64' ' ' ALA . 93.8 mtp -102.09 155.21 18.33 Favored 'General case' 0 N--CA 1.516 2.827 0 C-N-CA 119.036 -1.066 . . . . 0.0 108.242 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 90.4 p -114.94 150.11 36.24 Favored 'General case' 0 N--CA 1.511 2.582 0 CA-C-O 122.605 1.193 . . . . 0.0 113.211 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 87.2 t -43.84 96.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 112.594 -2.094 . . . . 0.0 113.246 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 113.06 11.89 13.12 Favored Glycine 0 N--CA 1.499 2.87 0 N-CA-C 108.735 -1.746 . . . . 0.0 108.735 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -103.66 143.93 32.12 Favored 'General case' 0 N--CA 1.503 2.209 0 C-N-CA 120.189 -0.605 . . . . 0.0 110.159 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 25.3 ttt85 -125.57 140.77 52.47 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -148.73 177.32 9.62 Favored 'General case' 0 N--CA 1.503 2.18 0 CA-C-N 113.046 -1.888 . . . . 0.0 116.048 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.45 ' CE ' ' OD1' ' A' ' 100' ' ' ASP . 4.6 tppp? -127.13 107.14 9.76 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 101.568 -3.493 . . . . 0.0 101.568 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.4 mt -103.58 152.85 21.25 Favored 'General case' 0 N--CA 1.503 2.207 0 C-N-CA 119.822 -0.751 . . . . 0.0 109.365 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 86.3 m -124.54 118.32 26.32 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 31.1 mt -111.76 141.92 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.425 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 41.7 p -107.78 156.68 37.64 Favored Pre-proline 0 N--CA 1.507 2.391 0 O-C-N 124.796 1.31 . . . . 0.0 109.373 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -36.18 -54.24 0.89 Allowed 'Trans proline' 0 C--N 1.316 -1.165 0 C-N-CA 121.986 1.791 . . . . 0.0 113.744 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 80' ' ' TYR . 1.7 p30 -45.36 -41.85 9.41 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.523 ' OH ' ' NH1' ' A' ' 57' ' ' ARG . 2.6 m-85 . . . . . 0 N--CA 1.493 1.695 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.304 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 58.0 m . . . . . 0 N--CA 1.503 2.198 0 CA-C-O 118.13 -0.938 . . . . 0.0 110.566 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 13.9 mt -107.36 157.05 18.26 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 120.514 1.506 . . . . 0.0 107.042 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.3 t -139.75 115.69 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -110.28 159.45 17.4 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 122.417 1.103 . . . . 0.0 110.241 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.45 ' OD1' ' CE ' ' A' ' 73' ' ' LYS . 54.9 m-20 -127.66 89.11 2.89 Favored 'General case' 0 N--CA 1.493 1.7 1 N-CA-C 98.575 -4.602 . . . . 0.0 98.575 179.314 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 12.2 t -103.1 148.83 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.699 0 N-CA-C 116.777 2.14 . . . . 0.0 116.777 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -127.92 96.75 4.58 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 112.701 -2.045 . . . . 0.0 107.419 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 51.6 tp -68.7 121.96 17.56 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.6 mt -89.39 -58.07 2.66 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.894 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -164.36 178.12 7.73 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.734 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 17.1 mt -115.1 168.97 9.46 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 . . . . . 0 N--CA 1.514 2.757 0 CA-C-O 115.862 -2.018 . . . . 0.0 107.414 179.604 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.4 p . . . . . 0 N--CA 1.501 2.101 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.525 ' N ' ' OE1' ' A' ' 3' ' ' GLN . 3.3 mp0 -115.52 159.24 21.48 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.8 t -124.66 123.11 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.025 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.47 ' CD ' ' N ' ' A' ' 5' ' ' GLU . 9.3 mp0 -125.42 89.96 3.14 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 88.1 m -69.71 155.25 40.8 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.76 -1.176 . . . . 0.0 113.765 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 57.6 mt -122.45 -53.29 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-N 113.352 -1.749 . . . . 0.0 107.84 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.419 ' O ' ' O ' ' A' ' 9' ' ' PRO . 29.3 m -122.84 80.69 49.54 Favored Pre-proline 0 N--CA 1.506 2.366 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.759 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.419 ' O ' ' O ' ' A' ' 8' ' ' SER . 12.6 Cg_exo -38.2 164.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.37 2.047 . . . . 0.0 112.262 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -120.38 -178.76 16.23 Favored Glycine 0 N--CA 1.5 2.945 0 N-CA-C 105.322 -3.111 . . . . 0.0 105.322 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.472 ' CG ' ' H ' ' A' ' 12' ' ' GLY . 13.1 p-10 -45.76 -58.08 3.76 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 118.404 1.102 . . . . 0.0 111.075 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.472 ' H ' ' CG ' ' A' ' 11' ' ' ASP . . . 108.62 6.88 30.48 Favored Glycine 0 N--CA 1.498 2.814 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -110.81 -31.14 7.28 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 114.584 -0.808 . . . . 0.0 111.685 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 96.8 m -112.03 134.13 53.77 Favored 'General case' 0 N--CA 1.504 2.242 0 CA-C-N 118.876 0.762 . . . . 0.0 113.0 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.451 ' N ' ' CD1' ' A' ' 15' ' ' PHE . 57.3 m-85 -131.31 177.24 2.33 Favored Pre-proline 0 N--CA 1.5 2.029 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -72.09 145.29 44.13 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 C-N-CA 120.729 0.953 . . . . 0.0 110.391 161.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -121.58 168.63 11.53 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-O 121.786 0.803 . . . . 0.0 109.236 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.3 130.15 41.8 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.565 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 109.67 -22.69 23.58 Favored Glycine 0 N--CA 1.499 2.838 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.334 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -105.71 178.42 4.57 Favored 'General case' 0 N--CA 1.506 2.371 0 CA-C-O 121.981 0.896 . . . . 0.0 111.747 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.1 m -113.26 161.46 17.17 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 64.5 m -112.48 148.0 35.35 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.9 t -121.91 104.94 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 103.296 -2.853 . . . . 0.0 103.296 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 m -121.69 149.81 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.347 0 N-CA-C 116.217 1.932 . . . . 0.0 116.217 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -128.49 117.5 21.43 Favored 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 104.429 -2.434 . . . . 0.0 104.429 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -134.3 174.09 10.9 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 123.072 1.415 . . . . 0.0 114.801 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 81.3 m -138.92 122.04 16.85 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 102.335 -3.209 . . . . 0.0 102.335 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -112.57 140.45 16.27 Favored Glycine 0 N--CA 1.503 3.165 0 C-N-CA 120.174 -1.012 . . . . 0.0 112.337 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 57.2 mtm . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 179.973 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 71.4 t80 . . . . . 0 N--CA 1.489 1.481 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 72.0 mttt -142.45 133.95 26.53 Favored 'General case' 0 N--CA 1.515 2.801 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -144.46 173.4 11.83 Favored 'General case' 0 N--CA 1.515 2.777 0 CA-C-N 119.265 0.939 . . . . 0.0 112.766 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 44.5 ttm -116.47 148.97 40.25 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.3 tp -90.99 120.26 31.84 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 114.365 -1.288 . . . . 0.0 109.23 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.35 18.56 18.77 Favored Glycine 0 N--CA 1.499 2.875 0 N-CA-C 107.757 -2.137 . . . . 0.0 107.757 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -121.06 -19.98 6.98 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 114.383 -0.908 . . . . 0.0 109.387 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 55.9 69.02 0.78 Allowed 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.396 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -110.03 -35.86 6.02 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.431 ' O ' ' O ' ' A' ' 56' ' ' ILE . 4.2 m -113.99 152.69 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.176 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.431 ' O ' ' O ' ' A' ' 55' ' ' VAL . 13.3 pt -49.46 179.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.857 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.559 ' O ' ' N ' ' A' ' 59' ' ' TRP . 19.5 ttm180 -75.94 -58.96 2.97 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -34.12 -27.2 0.01 OUTLIER Glycine 0 N--CA 1.494 2.538 0 O-C-N 123.944 0.777 . . . . 0.0 111.925 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.559 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -91.33 -73.98 0.52 Allowed 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.874 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -36.98 -50.48 0.88 Allowed 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 114.333 -1.303 . . . . 0.0 110.228 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.417 ' OE1' ' O ' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -71.99 -57.7 4.07 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 104.818 -2.29 . . . . 0.0 104.818 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -50.95 -82.2 0.04 OUTLIER Glycine 0 N--CA 1.48 1.57 0 C-N-CA 119.011 -1.566 . . . . 0.0 109.7 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.533 ' N ' ' O ' ' A' ' 59' ' ' TRP . 62.1 t -29.95 -48.01 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.517 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -44.89 -60.2 2.17 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 124.349 2.023 . . . . 0.0 110.672 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -47.86 -12.06 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 109.027 -3.715 . . . . 0.0 109.548 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.517 ' H ' ' C ' ' A' ' 64' ' ' ALA . 33.4 mmt -89.92 158.51 17.38 Favored 'General case' 0 N--CA 1.508 2.433 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 86.1 p -122.19 136.12 54.86 Favored 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 121.64 0.733 . . . . 0.0 110.077 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.3 t -35.42 97.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-N 114.303 -1.317 . . . . 0.0 113.405 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.73 5.77 13.6 Favored Glycine 0 N--CA 1.5 2.906 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -107.02 149.23 27.78 Favored 'General case' 0 N--CA 1.508 2.457 0 CA-C-O 122.163 0.982 . . . . 0.0 110.291 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.0 ttp180 -133.61 143.4 48.61 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 113.621 -1.627 . . . . 0.0 107.365 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -153.22 179.22 8.93 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 113.312 -1.767 . . . . 0.0 115.066 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -124.75 104.01 8.41 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 103.364 -2.828 . . . . 0.0 103.364 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.2 mt -100.21 145.45 28.04 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.3 m -113.32 123.27 49.72 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 104.628 -2.36 . . . . 0.0 104.628 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 33.9 mt -112.6 131.13 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.491 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.426 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 61.6 p -104.71 154.31 38.62 Favored Pre-proline 0 N--CA 1.5 2.068 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -36.53 -54.08 0.99 Allowed 'Trans proline' 0 C--N 1.314 -1.261 0 C-N-CA 122.113 1.875 . . . . 0.0 113.663 -173.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.527 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 6.5 p-10 -42.2 -36.16 1.13 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 . . . . . 0 N--CA 1.5 2.065 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -179.66 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 84.5 m . . . . . 0 N--CA 1.5 2.026 0 CA-C-O 118.889 -0.577 . . . . 0.0 111.369 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 21.4 mt -107.57 144.61 34.34 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 49.9 t -132.39 119.65 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -111.85 163.87 13.71 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 122.513 1.149 . . . . 0.0 108.942 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -129.28 89.94 2.93 Favored 'General case' 0 C--N 1.301 -1.523 1 N-CA-C 97.383 -5.043 . . . . 0.0 97.383 179.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 12.3 t -103.89 151.17 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.447 0 N-CA-C 114.671 1.359 . . . . 0.0 114.671 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -125.82 103.05 7.59 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 112.007 -2.361 . . . . 0.0 108.122 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 43.6 tp -75.21 118.55 18.26 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 102.66 -3.089 . . . . 0.0 102.66 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.5 mt -85.35 -56.53 3.48 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 113.828 -1.533 . . . . 0.0 112.297 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.409 ' HZ1' ' CB ' ' A' ' 105' ' ' LYS . 0.1 OUTLIER -172.43 -168.34 0.52 Allowed 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.047 -1.061 . . . . 0.0 111.22 -179.865 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 22.2 mt -115.77 156.28 26.3 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 . . . . . 0 N--CA 1.505 2.277 0 CA-C-O 116.233 -1.842 . . . . 0.0 109.844 179.865 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 N--CA 1.503 2.216 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -123.47 153.57 40.31 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 97.0 t -129.51 102.15 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -99.73 161.32 13.69 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 102.854 -3.017 . . . . 0.0 102.854 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 72.8 m -121.31 156.38 32.68 Favored 'General case' 0 N--CA 1.504 2.253 0 CA-C-O 121.987 0.899 . . . . 0.0 112.301 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 74.8 mt -124.72 -54.17 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 9' ' ' PRO . 28.2 t -124.99 83.18 60.48 Favored Pre-proline 0 N--CA 1.508 2.459 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.052 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 8' ' ' SER . 13.5 Cg_exo -37.28 160.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.155 1.903 . . . . 0.0 111.612 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.25 -171.75 14.28 Favored Glycine 0 N--CA 1.503 3.142 0 N-CA-C 107.496 -2.241 . . . . 0.0 107.496 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 12' ' ' GLY . 1.3 p30 -39.61 -51.64 2.24 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.817 -0.753 . . . . 0.0 112.508 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.51 ' N ' ' OD1' ' A' ' 11' ' ' ASP . . . 97.43 2.88 58.77 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 108.126 -1.99 . . . . 0.0 108.126 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 34.6 mtm-85 -119.8 -36.02 3.39 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.8 m -106.99 134.3 50.34 Favored 'General case' 0 N--CA 1.506 2.345 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 33.0 m-85 -130.61 175.14 3.89 Favored Pre-proline 0 N--CA 1.495 1.816 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -66.43 155.13 71.55 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 CA-C-N 119.82 0.971 . . . . 0.0 110.006 165.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -121.7 172.83 7.85 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-O 121.893 0.854 . . . . 0.0 109.635 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.41 HH11 ' CB ' ' A' ' 18' ' ' ARG . 44.3 mtm105 -77.99 96.27 5.02 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.673 -1.148 . . . . 0.0 109.92 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.71 12.55 3.66 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.194 -1.563 . . . . 0.0 109.194 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.494 ' O ' ' SD ' ' A' ' 49' ' ' MET . 15.8 mm100 -113.85 167.88 10.26 Favored 'General case' 0 N--CA 1.504 2.245 0 CA-C-O 121.893 0.854 . . . . 0.0 109.236 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 97.1 m -118.6 114.32 22.6 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 114.226 -1.352 . . . . 0.0 107.551 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 56.9 m -74.67 146.15 42.58 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 118.871 -1.132 . . . . 0.0 108.606 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 94.7 t -117.69 99.67 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 101.311 -3.589 . . . . 0.0 101.311 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.8 m -121.21 148.26 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 N-CA-C 114.946 1.462 . . . . 0.0 114.946 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -122.24 143.73 49.41 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 102.948 -2.982 . . . . 0.0 102.948 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -157.97 175.53 13.72 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 118.895 -1.122 . . . . 0.0 112.931 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 93.7 m -135.12 126.36 28.19 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 101.375 -3.565 . . . . 0.0 101.375 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.86 127.79 8.74 Favored Glycine 0 N--CA 1.502 3.065 0 C-N-CA 120.04 -1.076 . . . . 0.0 111.963 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 68.5 mtp . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.915 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 44.0 t80 . . . . . 0 N--CA 1.495 1.818 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -143.06 122.88 13.42 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.487 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -135.4 171.55 14.28 Favored 'General case' 0 N--CA 1.512 2.627 0 CA-C-N 119.457 1.026 . . . . 0.0 112.466 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.494 ' SD ' ' O ' ' A' ' 20' ' ' GLN . 44.3 tpp -111.53 144.53 40.61 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 114.867 -1.06 . . . . 0.0 112.212 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.4 tp -90.8 121.43 32.66 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.601 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 117.27 -19.0 11.93 Favored Glycine 0 N--CA 1.501 2.967 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.888 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.429 ' O ' ' OE1' ' A' ' 54' ' ' GLU . 41.6 tptt -112.8 36.48 3.45 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.404 ' C ' ' O ' ' A' ' 52' ' ' LYS . 39.1 tt0 10.23 71.23 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 O-C-N 125.345 1.653 . . . . 0.0 113.664 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.429 ' OE1' ' O ' ' A' ' 52' ' ' LYS . 5.0 mm-40 -92.8 -24.06 18.65 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 113.408 -1.724 . . . . 0.0 106.828 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.1 m -115.92 -177.26 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 16.5 pt -90.27 169.94 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.193 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.549 ' O ' ' N ' ' A' ' 59' ' ' TRP . 19.4 ttm-85 -55.11 -63.18 1.24 Allowed 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.334 -0.947 . . . . 0.0 110.702 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -27.13 -35.31 0.01 OUTLIER Glycine 0 N--CA 1.496 2.694 0 O-C-N 124.933 1.396 . . . . 0.0 111.977 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.549 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.9 OUTLIER -86.76 -71.35 0.56 Allowed 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 114.058 -1.071 . . . . 0.0 108.646 179.856 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.422 ' OE1' ' O ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -28.53 -57.73 0.13 Allowed 'General case' 0 N--CA 1.504 2.255 0 O-C-N 125.066 1.478 . . . . 0.0 110.325 -179.867 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -73.25 -52.58 13.5 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -49.31 -79.9 0.07 OUTLIER Glycine 0 N--CA 1.477 1.375 0 C-N-CA 119.419 -1.372 . . . . 0.0 110.96 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.522 ' N ' ' O ' ' A' ' 59' ' ' TRP . 35.6 t -39.45 -47.71 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 120.226 -0.589 . . . . 0.0 112.358 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.526 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -45.3 -60.11 2.31 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 124.146 1.927 . . . . 0.0 111.094 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -48.51 -11.2 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 109.386 -3.552 . . . . 0.0 109.661 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.526 ' H ' ' C ' ' A' ' 64' ' ' ALA . 86.0 mtp -97.94 156.47 16.6 Favored 'General case' 0 N--CA 1.513 2.704 0 C-N-CA 118.854 -1.138 . . . . 0.0 108.606 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 79.8 p -118.64 149.13 41.91 Favored 'General case' 0 N--CA 1.508 2.443 0 CA-C-O 122.539 1.162 . . . . 0.0 112.8 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 99.5 t -43.52 97.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-N 112.801 -1.999 . . . . 0.0 114.716 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.36 12.92 16.14 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -108.03 145.05 34.51 Favored 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.106 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 25.7 ttt85 -123.79 135.1 53.59 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 105.464 -2.051 . . . . 0.0 105.464 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -136.82 172.61 12.75 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 112.026 -2.352 . . . . 0.0 116.142 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -129.58 103.77 7.06 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 111.069 -2.787 . . . . 0.0 103.917 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.0 mp -100.69 149.47 23.75 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.889 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.6 m -121.09 104.51 9.83 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 21.3 mt -99.81 137.25 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.503 ' HG ' ' CG ' ' A' ' 79' ' ' ASP . 29.5 p -115.54 156.34 46.16 Favored Pre-proline 0 N--CA 1.501 2.123 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -35.97 -52.07 1.03 Allowed 'Trans proline' 0 C--N 1.314 -1.266 0 C-N-CA 121.937 1.758 . . . . 0.0 113.971 -175.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.503 ' CG ' ' HG ' ' A' ' 77' ' ' SER . 1.3 p30 -37.62 -38.64 0.28 Allowed 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 121.456 0.646 . . . . 0.0 112.301 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 . . . . . 0 N--CA 1.493 1.683 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.428 -179.812 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 91.2 m . . . . . 0 N--CA 1.5 2.066 0 CA-C-O 119.353 -0.355 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 18.4 mt -89.76 146.97 24.11 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 55.1 t -131.78 109.71 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -103.26 156.43 17.72 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 122.135 0.969 . . . . 0.0 109.211 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -127.07 93.68 3.82 Favored 'General case' 0 N--CA 1.493 1.679 1 N-CA-C 97.897 -4.853 . . . . 0.0 97.897 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.4 t -108.38 154.89 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.434 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -128.74 102.36 6.53 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 111.612 -2.54 . . . . 0.0 107.741 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 37.0 tp -72.24 125.63 27.81 Favored 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 103.065 -2.939 . . . . 0.0 103.065 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 16.5 mt -96.25 -55.4 2.96 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.42 ' CG ' ' H ' ' A' ' 106' ' ' LEU . 56.0 tttp -166.09 177.3 7.07 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.071 -1.052 . . . . 0.0 111.474 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.42 ' H ' ' CG ' ' A' ' 105' ' ' LYS . 24.4 mt -114.55 150.94 34.18 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 . . . . . 0 N--CA 1.505 2.299 0 CA-C-O 116.17 -1.871 . . . . 0.0 109.996 179.731 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.8 p . . . . . 0 N--CA 1.504 2.229 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.474 ' NE2' ' OE2' ' A' ' 5' ' ' GLU . 41.2 tt0 -121.26 157.77 29.57 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.5 t -122.65 115.42 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.474 ' OE2' ' NE2' ' A' ' 3' ' ' GLN . 94.4 mt-10 -117.11 94.69 4.67 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 69.0 m -69.92 155.88 39.91 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 114.806 1.409 . . . . 0.0 114.806 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 72.2 mt -122.57 -55.48 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 CA-C-N 113.031 -1.895 . . . . 0.0 107.387 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.423 ' O ' ' O ' ' A' ' 9' ' ' PRO . 34.7 t -121.99 81.96 43.27 Favored Pre-proline 0 N--CA 1.505 2.292 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.576 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 8' ' ' SER . 12.2 Cg_exo -38.4 164.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.165 1.91 . . . . 0.0 111.868 178.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.67 -172.39 15.02 Favored Glycine 0 N--CA 1.498 2.803 0 N-CA-C 104.916 -3.274 . . . . 0.0 104.916 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 11' ' ' ASP . 12.9 p-10 -39.72 -58.56 1.31 Allowed 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.434 -0.907 . . . . 0.0 112.8 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.32 23.27 9.11 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 105.081 -3.208 . . . . 0.0 105.081 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.02 -40.73 1.48 Allowed 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 113.757 -1.222 . . . . 0.0 111.545 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.4 m -108.62 136.46 48.19 Favored 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.454 ' N ' ' CD1' ' A' ' 15' ' ' PHE . 66.0 m-85 -131.65 176.75 2.65 Favored Pre-proline 0 N--CA 1.494 1.765 0 N-CA-C 105.195 -2.15 . . . . 0.0 105.195 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -70.7 149.18 60.5 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 CA-C-N 119.485 0.852 . . . . 0.0 111.194 164.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -121.78 173.38 7.51 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 122.289 1.043 . . . . 0.0 110.41 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.1 ttm180 -77.69 98.34 5.44 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 113.912 -1.494 . . . . 0.0 109.556 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.13 9.63 4.56 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -113.89 171.76 7.4 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 76.8 m -124.42 112.63 17.15 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.732 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.443 ' N ' ' O ' ' A' ' 48' ' ' PHE . 36.5 m -72.11 147.66 46.48 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.752 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.2 t -116.78 114.11 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 101.389 -3.56 . . . . 0.0 101.389 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -126.65 150.16 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.04 0 N-CA-C 119.404 3.112 . . . . 0.0 119.404 -178.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -133.48 142.85 48.46 Favored 'General case' 0 N--CA 1.506 2.33 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.468 ' CD1' ' N ' ' A' ' 26' ' ' TYR . 39.2 p90 -160.53 -179.38 7.6 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 118.474 -1.291 . . . . 0.0 113.53 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 91.5 m -140.73 122.84 15.67 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 101.657 -3.46 . . . . 0.0 101.657 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -102.26 147.69 17.34 Favored Glycine 0 N--CA 1.504 3.198 0 C-N-CA 119.999 -1.096 . . . . 0.0 110.377 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 13.4 tpp . . . . . 0 N--CA 1.496 1.832 0 C-N-CA 120.069 -0.652 . . . . 0.0 110.181 -179.84 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . 0.255 0.7 OUTLIER . . . . . 0 N--CA 1.495 1.786 0 CA-C-O 121.591 0.71 . . . . 0.0 109.954 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -134.98 123.96 24.13 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 113.5 -1.682 . . . . 0.0 107.259 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.443 ' O ' ' N ' ' A' ' 22' ' ' CYS . 22.1 p90 -135.41 -178.01 4.92 Favored 'General case' 0 N--CA 1.515 2.814 0 CA-C-N 120.579 1.536 . . . . 0.0 114.696 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 42.9 ttm -116.69 144.25 44.65 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-N 115.199 -0.909 . . . . 0.0 113.024 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.3 tp -90.89 120.98 32.35 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.626 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.82 -11.48 49.48 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.468 ' O ' ' N ' ' A' ' 54' ' ' GLU . 25.6 tptp -112.44 38.58 2.7 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.407 ' C ' ' O ' ' A' ' 52' ' ' LYS . 47.5 tt0 0.86 66.18 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 O-C-N 125.653 1.846 . . . . 0.0 112.958 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' A' ' 52' ' ' LYS . 39.2 tt0 -96.28 -26.08 15.54 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 112.731 -2.031 . . . . 0.0 107.199 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.437 ' O ' ' O ' ' A' ' 56' ' ' ILE . 4.9 m -124.32 152.54 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.465 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.174 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 55' ' ' VAL . 4.9 pt -45.89 177.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.408 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.54 ' O ' ' N ' ' A' ' 59' ' ' TRP . 30.5 ttp180 -79.25 -57.53 3.67 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-O 118.337 -0.84 . . . . 0.0 112.715 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -30.58 -32.73 0.01 OUTLIER Glycine 0 N--CA 1.503 3.11 0 CA-C-O 122.664 1.147 . . . . 0.0 111.427 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.54 ' N ' ' O ' ' A' ' 57' ' ' ARG . 2.4 m0 -90.06 -73.5 0.52 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 113.629 -1.286 . . . . 0.0 107.853 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -31.86 -54.61 0.28 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 124.792 1.308 . . . . 0.0 110.768 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -73.15 -51.64 17.12 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 113.977 -1.465 . . . . 0.0 107.614 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 65' ' ' GLN . . . -55.69 -82.44 0.05 OUTLIER Glycine 0 N--CA 1.479 1.54 0 N-CA-C 108.16 -1.976 . . . . 0.0 108.16 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' A' ' 59' ' ' TRP . 66.1 t -30.38 -45.1 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.44 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -51.11 -49.29 61.02 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 123.692 1.711 . . . . 0.0 109.569 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.481 ' N ' ' O ' ' A' ' 62' ' ' GLY . 6.0 tt0 -66.01 3.29 0.87 Allowed 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 110.202 -3.181 . . . . 0.0 110.892 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.44 ' H ' ' C ' ' A' ' 64' ' ' ALA . 48.4 ttm -109.51 156.19 20.42 Favored 'General case' 0 N--CA 1.51 2.531 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 99.7 p -115.32 151.41 34.64 Favored 'General case' 0 N--CA 1.509 2.502 0 CA-C-O 122.545 1.164 . . . . 0.0 112.694 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 95.5 t -46.34 99.51 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-N 112.804 -1.998 . . . . 0.0 114.581 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.66 3.69 28.59 Favored Glycine 0 N--CA 1.502 3.076 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -101.83 149.13 24.5 Favored 'General case' 0 N--CA 1.506 2.328 0 CA-C-O 121.988 0.899 . . . . 0.0 111.03 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.8 ttt85 -127.14 143.2 51.32 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 113.786 -1.552 . . . . 0.0 106.961 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -151.72 175.99 11.85 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 113.401 -1.727 . . . . 0.0 113.958 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.5 ttmp? -119.67 102.8 8.87 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 103.45 -2.796 . . . . 0.0 103.45 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.2 mt -96.26 149.69 21.39 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 97.1 m -119.47 116.53 26.3 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 104.486 -2.412 . . . . 0.0 104.486 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 53.5 mt -102.45 142.58 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.9 p -101.53 154.36 37.3 Favored Pre-proline 0 N--CA 1.501 2.083 0 O-C-N 124.985 1.428 . . . . 0.0 111.398 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -44.72 -41.89 14.8 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 C-N-CA 122.915 2.41 . . . . 0.0 117.695 -175.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -87.77 20.24 3.11 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 117.908 2.558 . . . . 0.0 117.908 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 . . . . . 0 N--CA 1.501 2.084 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.52 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 28.9 m . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 103.752 -2.684 . . . . 0.0 103.752 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 19.3 mt -106.48 150.19 26.33 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.1 t -132.14 104.32 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -96.89 166.97 11.37 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -127.5 85.92 2.42 Favored 'General case' 0 N--CA 1.491 1.598 1 N-CA-C 94.844 -5.984 . . . . 0.0 94.844 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.1 t -98.59 149.45 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.3 0 CA-C-O 122.759 1.266 . . . . 0.0 114.342 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -126.84 111.45 14.19 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 112.19 -2.277 . . . . 0.0 106.897 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 35.0 tp -79.49 113.72 17.86 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 101.125 -3.657 . . . . 0.0 101.125 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.3 mt -74.19 -57.78 3.73 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 118.684 -1.207 . . . . 0.0 111.49 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -175.32 -172.27 0.56 Allowed 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 118.32 -1.352 . . . . 0.0 109.619 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.1 mt -117.89 155.28 30.43 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 . . . . . 0 N--CA 1.512 2.645 0 CA-C-O 116.175 -1.869 . . . . 0.0 109.143 179.443 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.2 p . . . . . 0 N--CA 1.503 2.203 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -121.09 152.64 38.44 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 55.6 t -126.64 112.38 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.531 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.417 ' OE1' ' O ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -113.03 96.04 5.72 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 103.644 -2.725 . . . . 0.0 103.644 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.417 ' O ' ' OE1' ' A' ' 5' ' ' GLU . 87.1 m -69.87 156.58 38.86 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 118.56 -1.256 . . . . 0.0 112.494 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 71.7 mt -121.16 -55.09 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 CA-C-N 113.939 -1.482 . . . . 0.0 107.422 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.423 ' O ' ' O ' ' A' ' 9' ' ' PRO . 36.2 m -124.35 82.42 57.95 Favored Pre-proline 0 N--CA 1.507 2.407 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.742 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 8' ' ' SER . 3.4 Cg_exo -35.93 164.21 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.566 2.177 . . . . 0.0 113.434 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -114.84 -176.91 18.87 Favored Glycine 0 N--CA 1.501 3.023 0 N-CA-C 105.841 -2.903 . . . . 0.0 105.841 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.494 ' CG ' ' H ' ' A' ' 12' ' ' GLY . 11.6 p-10 -42.5 -58.48 2.24 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 118.174 0.987 . . . . 0.0 111.745 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.494 ' H ' ' CG ' ' A' ' 11' ' ' ASP . . . 109.33 24.63 5.85 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 107.738 -2.145 . . . . 0.0 107.738 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.3 mtm180 -133.53 -34.35 1.05 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 114.75 -0.725 . . . . 0.0 112.771 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.4 m -111.51 130.4 55.74 Favored 'General case' 0 N--CA 1.506 2.347 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 26.2 m-85 -130.31 173.35 5.9 Favored Pre-proline 0 N--CA 1.497 1.898 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -67.94 150.28 78.03 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 CA-C-N 119.997 1.035 . . . . 0.0 111.165 167.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -121.62 171.15 9.05 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-O 121.898 0.856 . . . . 0.0 110.911 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.2 ttt-85 -77.51 98.57 5.38 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.491 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.0 10.38 4.32 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -114.97 173.91 6.24 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.1 m -124.7 112.09 16.34 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 20.1 m -69.82 145.8 51.84 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.4 t -118.11 102.84 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 101.268 -3.605 . . . . 0.0 101.268 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.0 m -124.09 153.9 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.443 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 -131.19 116.87 18.25 Favored 'General case' 0 N--CA 1.507 2.405 0 N-CA-C 104.991 -2.226 . . . . 0.0 104.991 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -132.16 177.38 7.61 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 122.997 1.379 . . . . 0.0 114.451 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 87.3 m -136.32 124.4 22.95 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 101.218 -3.623 . . . . 0.0 101.218 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -107.99 116.18 4.73 Favored Glycine 0 N--CA 1.501 3.022 0 C-N-CA 120.337 -0.935 . . . . 0.0 111.415 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 69.2 mtp . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 179.93 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 63.6 t80 . . . . . 0 N--CA 1.497 1.882 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.5 mtmp? -143.61 117.11 9.13 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.875 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -137.14 167.3 21.81 Favored 'General case' 0 N--CA 1.511 2.602 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.638 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.5 ' SD ' ' O ' ' A' ' 50' ' ' LEU . 7.8 tmm? -117.46 144.6 44.87 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.97 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.5 ' O ' ' SD ' ' A' ' 49' ' ' MET . 44.0 tp -90.81 134.52 34.38 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 114.516 -1.22 . . . . 0.0 111.443 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 132.97 -34.42 2.46 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 54' ' ' GLU . 80.3 tttt -122.62 44.39 2.65 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 4.42 58.73 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 126.015 2.072 . . . . 0.0 114.072 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 52' ' ' LYS . 50.4 mt-10 -63.74 -17.58 63.17 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 114.526 -1.215 . . . . 0.0 109.757 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 56' ' ' ILE . 21.1 m -117.6 159.79 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.32 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.425 ' O ' ' O ' ' A' ' 55' ' ' VAL . 16.2 pt -51.55 178.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 C-N-CA 118.64 -1.224 . . . . 0.0 108.534 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.532 ' O ' ' N ' ' A' ' 59' ' ' TRP . 17.6 ttm180 -75.18 -59.14 2.88 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.152 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -28.52 -34.98 0.01 OUTLIER Glycine 0 N--CA 1.497 2.738 0 O-C-N 124.614 1.196 . . . . 0.0 112.26 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.532 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.6 OUTLIER -81.39 -73.61 0.37 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 179.761 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 59' ' ' TRP . 32.4 tt0 -22.4 -57.24 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 O-C-N 125.914 2.009 . . . . 0.0 111.426 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -78.11 -52.21 9.09 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 113.075 -1.875 . . . . 0.0 106.491 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -49.65 -74.17 0.3 Allowed Glycine 0 N--CA 1.48 1.604 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.095 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.497 ' N ' ' O ' ' A' ' 59' ' ' TRP . 25.6 t -44.13 -50.59 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 C-N-CA 119.317 -0.953 . . . . 0.0 111.745 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.509 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -44.19 -62.39 1.17 Allowed 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 123.989 1.852 . . . . 0.0 111.608 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -45.9 -13.98 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 109.429 -3.532 . . . . 0.0 109.3 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.509 ' H ' ' C ' ' A' ' 64' ' ' ALA . 20.2 mtm -98.36 158.23 15.71 Favored 'General case' 0 N--CA 1.514 2.733 0 C-N-CA 118.084 -1.446 . . . . 0.0 108.96 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 84.4 p -117.9 149.43 40.9 Favored 'General case' 0 N--CA 1.508 2.467 0 CA-C-O 122.558 1.17 . . . . 0.0 113.399 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 90.5 t -39.4 96.6 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 112.719 -2.037 . . . . 0.0 114.044 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.13 9.4 20.24 Favored Glycine 0 N--CA 1.5 2.919 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -103.0 141.6 35.52 Favored 'General case' 0 N--CA 1.502 2.168 0 CA-C-O 121.457 0.646 . . . . 0.0 110.355 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 24.7 ttt85 -125.34 141.13 52.25 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -149.65 176.13 10.93 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-N 113.064 -1.88 . . . . 0.0 115.853 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -127.61 105.01 8.19 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 103.851 -2.648 . . . . 0.0 103.851 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.9 mp -102.47 152.27 21.33 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.591 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 92.0 m -123.73 117.18 24.37 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 22.8 mt -108.63 141.72 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 CA-C-O 121.099 0.476 . . . . 0.0 109.858 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.435 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 33.4 p -114.65 155.34 46.24 Favored Pre-proline 0 N--CA 1.504 2.263 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.429 ' O ' ' N ' ' A' ' 80' ' ' TYR . 10.2 Cg_endo -37.68 -55.65 1.04 Allowed 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.683 1.588 . . . . 0.0 113.961 -175.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 14.7 p30 -34.04 -34.89 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.579 0.704 . . . . 0.0 112.567 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.429 ' N ' ' O ' ' A' ' 78' ' ' PRO . 6.9 m-85 . . . . . 0 N--CA 1.495 1.812 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.644 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 31.2 m . . . . . 0 N--CA 1.494 1.737 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 20.3 mt -110.19 153.33 24.91 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.7 t -138.11 123.59 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -118.86 155.03 31.95 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 122.119 0.961 . . . . 0.0 110.307 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -125.7 89.94 3.12 Favored 'General case' 0 N--CA 1.494 1.76 1 N-CA-C 97.424 -5.028 . . . . 0.0 97.424 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 9.9 t -102.93 151.29 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.483 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -128.59 100.9 5.93 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 111.832 -2.44 . . . . 0.0 108.284 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 45.9 tp -72.75 124.49 25.44 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 104.159 -2.534 . . . . 0.0 104.159 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.1 mt -91.56 -58.32 2.47 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 114.372 -1.285 . . . . 0.0 112.008 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 29.3 tttm -168.93 -175.4 2.34 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.007 -1.077 . . . . 0.0 110.418 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 17.9 mt -117.22 154.89 30.36 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 . . . . . 0 N--CA 1.505 2.313 0 CA-C-O 116.056 -1.926 . . . . 0.0 110.817 179.578 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.6 p . . . . . 0 N--CA 1.502 2.145 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -121.96 157.46 31.21 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.6 t -126.64 106.62 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -107.47 88.47 2.74 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 93.4 m -69.7 156.13 39.45 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.004 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.0 mt -122.76 -52.73 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-N 113.681 -1.599 . . . . 0.0 107.025 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.422 ' O ' ' O ' ' A' ' 9' ' ' PRO . 98.2 p -122.75 82.22 48.89 Favored Pre-proline 0 N--CA 1.505 2.302 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.462 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 8' ' ' SER . 7.8 Cg_exo -37.59 167.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.606 2.204 . . . . 0.0 113.234 178.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.16 -171.79 15.03 Favored Glycine 0 N--CA 1.503 3.132 0 N-CA-C 107.17 -2.372 . . . . 0.0 107.17 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.521 ' N ' ' OD1' ' A' ' 11' ' ' ASP . 13.9 p-10 -39.62 -61.09 0.86 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.576 -0.85 . . . . 0.0 112.897 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.17 17.88 12.08 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 106.126 -2.789 . . . . 0.0 106.126 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.9 mmt85 -127.41 -39.61 1.85 Allowed 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 114.006 -1.097 . . . . 0.0 111.925 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.1 m -108.29 133.7 52.15 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.435 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 32.8 m-85 -131.16 175.67 3.5 Favored Pre-proline 0 N--CA 1.496 1.855 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -72.58 140.81 33.46 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 CA-C-N 119.621 0.9 . . . . 0.0 109.988 163.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -121.23 174.08 6.92 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.714 0.769 . . . . 0.0 110.325 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 25.1 ttt85 -73.13 110.36 7.36 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.082 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.96 0.89 10.69 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -116.63 172.94 6.9 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 121.933 0.873 . . . . 0.0 110.628 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 97.0 m -125.25 117.67 24.32 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-N 113.975 -1.466 . . . . 0.0 108.234 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 55.8 m -69.58 150.55 46.96 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 77.0 t -122.71 101.48 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 102.945 -2.983 . . . . 0.0 102.945 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.3 m -121.64 149.19 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.498 0 N-CA-C 117.904 2.557 . . . . 0.0 117.904 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -124.68 111.92 16.16 Favored 'General case' 0 N--CA 1.507 2.378 0 N-CA-C 103.352 -2.833 . . . . 0.0 103.352 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.471 ' CD1' ' N ' ' A' ' 26' ' ' TYR . 19.8 p90 -129.89 168.32 16.81 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 123.485 1.612 . . . . 0.0 114.434 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 97.3 m -134.6 111.05 9.72 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 102.384 -3.191 . . . . 0.0 102.384 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.36 138.35 14.62 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.113 -1.518 . . . . 0.0 109.875 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 38.1 ttm . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 -179.834 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 61.9 t80 . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -135.43 125.45 25.93 Favored 'General case' 0 N--CA 1.507 2.386 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -136.62 175.35 9.69 Favored 'General case' 0 N--CA 1.508 2.472 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.903 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 41.9 ttm -113.97 149.92 34.58 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 59.3 tp -91.01 119.85 31.52 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 113.993 -1.458 . . . . 0.0 112.444 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.82 -1.41 61.4 Favored Glycine 0 N--CA 1.498 2.774 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.444 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.414 ' O ' ' C ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -118.56 41.29 3.02 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.747 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.414 ' C ' ' O ' ' A' ' 52' ' ' LYS . 85.2 mt-30 4.9 65.72 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 O-C-N 125.54 1.775 . . . . 0.0 113.944 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.44 ' O ' ' OE1' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -93.58 -36.47 12.38 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 103.394 -2.817 . . . . 0.0 103.394 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.43 ' O ' ' O ' ' A' ' 56' ' ' ILE . 27.9 m -115.21 154.18 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.43 ' O ' ' O ' ' A' ' 55' ' ' VAL . 5.0 pt -48.29 175.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 118.971 -1.091 . . . . 0.0 110.353 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.555 ' NH1' ' CE2' ' A' ' 80' ' ' TYR . 23.5 ttt180 -72.78 -59.84 2.52 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 118.354 -0.832 . . . . 0.0 110.864 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -27.37 -37.19 0.01 OUTLIER Glycine 0 N--CA 1.502 3.048 0 O-C-N 124.539 1.15 . . . . 0.0 111.695 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.533 ' N ' ' O ' ' A' ' 57' ' ' ARG . 1.0 OUTLIER -79.61 -75.6 0.24 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 -29.1 -55.11 0.13 Allowed 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 112.983 -1.917 . . . . 0.0 110.788 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.525 ' OE1' ' NH1' ' A' ' 57' ' ' ARG . 37.7 tt0 -72.91 -50.27 24.64 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -58.37 -75.62 0.25 Allowed Glycine 0 N--CA 1.477 1.376 0 C-N-CA 119.512 -1.327 . . . . 0.0 111.028 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.525 ' N ' ' O ' ' A' ' 59' ' ' TRP . 35.9 t -39.76 -50.37 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 C-N-CA 119.901 -0.719 . . . . 0.0 112.868 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.503 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -43.66 -62.17 1.18 Allowed 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 124.16 1.933 . . . . 0.0 111.642 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -44.92 -14.92 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 109.233 -3.622 . . . . 0.0 108.946 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.503 ' H ' ' C ' ' A' ' 64' ' ' ALA . 8.2 mtm -98.26 159.99 14.58 Favored 'General case' 0 N--CA 1.512 2.661 0 C-N-CA 118.467 -1.293 . . . . 0.0 107.895 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 77.7 p -117.63 150.43 39.04 Favored 'General case' 0 N--CA 1.507 2.415 0 CA-C-O 122.573 1.177 . . . . 0.0 112.937 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 96.2 t -44.03 103.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 112.711 -2.041 . . . . 0.0 114.471 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.64 8.16 21.23 Favored Glycine 0 N--CA 1.5 2.942 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -109.15 152.94 24.45 Favored 'General case' 0 N--CA 1.506 2.35 0 CA-C-O 122.311 1.053 . . . . 0.0 111.665 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 -131.26 140.61 49.85 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 113.17 -1.832 . . . . 0.0 107.367 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -146.7 178.58 8.2 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 112.527 -2.124 . . . . 0.0 115.879 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.42 ' HZ1' ' CB ' ' A' ' 73' ' ' LYS . 6.7 ttpm? -126.91 104.99 8.32 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 102.866 -3.013 . . . . 0.0 102.866 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.8 mt -98.85 153.61 18.65 Favored 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 120.169 -0.612 . . . . 0.0 109.505 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 84.8 m -123.92 119.45 29.65 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 35.7 mt -111.53 141.08 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.426 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 69.3 p -109.09 150.69 41.31 Favored Pre-proline 0 N--CA 1.501 2.12 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -41.56 -54.6 2.67 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.627 1.552 . . . . 0.0 112.517 -171.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.511 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 10.9 p-10 -40.06 -27.21 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.555 ' CE2' ' NH1' ' A' ' 57' ' ' ARG . 4.5 m-85 . . . . . 0 N--CA 1.499 1.976 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 59.3 m . . . . . 0 N--CA 1.5 2.031 0 CA-C-O 119.274 -0.393 . . . . 0.0 111.447 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 15.1 mt -113.19 163.76 14.37 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 58.2 t -136.32 132.06 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -123.28 145.9 48.32 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -121.65 94.42 4.31 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 100.715 -3.809 . . . . 0.0 100.715 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.9 t -109.09 152.86 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.45 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -126.02 98.16 5.39 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 112.169 -2.287 . . . . 0.0 106.827 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 47.9 tp -71.87 124.18 24.28 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 102.953 -2.98 . . . . 0.0 102.953 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.6 mt -92.93 -55.96 3.16 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.122 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -170.03 -168.28 0.73 Allowed 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.141 -1.024 . . . . 0.0 111.587 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 27.9 mt -115.82 156.17 26.55 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 . . . . . 0 N--CA 1.504 2.226 0 CA-C-O 116.195 -1.86 . . . . 0.0 109.564 179.882 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.6 p . . . . . 0 N--CA 1.501 2.112 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.407 HE21 ' CG ' ' A' ' 5' ' ' GLU . 39.8 tt0 -122.43 158.12 30.42 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.5 t -124.48 113.14 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.407 ' CG ' HE21 ' A' ' 3' ' ' GLN . 50.5 mt-10 -112.96 90.28 3.3 Favored 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 91.3 m -69.78 156.28 39.26 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 114.312 -1.313 . . . . 0.0 113.437 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 56.4 mt -121.87 -51.19 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 CA-C-N 113.808 -1.542 . . . . 0.0 107.45 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.675 ' HG ' ' NH1' ' A' ' 71' ' ' ARG . 67.7 m -122.98 80.17 50.74 Favored Pre-proline 0 N--CA 1.506 2.369 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.272 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -40.05 160.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.715 2.277 . . . . 0.0 112.791 178.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -125.44 -175.27 14.16 Favored Glycine 0 N--CA 1.5 2.938 0 N-CA-C 106.631 -2.588 . . . . 0.0 106.631 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 12' ' ' GLY . 1.1 p30 -39.78 -52.84 2.3 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.599 -0.841 . . . . 0.0 112.906 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.468 ' N ' ' OD1' ' A' ' 11' ' ' ASP . . . 90.75 14.5 58.03 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 106.689 -2.564 . . . . 0.0 106.689 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 45.6 mtm-85 -124.68 -33.81 2.93 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 113.604 -1.298 . . . . 0.0 112.274 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.5 m -107.86 125.55 51.59 Favored 'General case' 0 N--CA 1.501 2.086 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.954 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.448 ' N ' ' CD1' ' A' ' 15' ' ' PHE . 36.9 m-85 -125.01 175.46 3.02 Favored Pre-proline 0 N--CA 1.501 2.097 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -66.68 154.8 73.18 Favored 'Trans proline' 0 C--N 1.315 -1.224 0 N-CA-C 109.474 -1.01 . . . . 0.0 109.474 164.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -119.23 169.04 10.31 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-O 121.967 0.889 . . . . 0.0 110.277 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 56.6 mtt-85 -77.18 107.5 9.61 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.343 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.19 -12.93 8.0 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 108.65 -1.78 . . . . 0.0 108.65 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -108.16 166.55 10.65 Favored 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 19.2 m -110.73 125.64 53.72 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.508 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 33.1 m -74.64 142.42 44.54 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 70.7 t -116.77 96.75 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 102.731 -3.063 . . . . 0.0 102.731 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.0 m -118.23 148.49 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 O-C-N 124.751 1.282 . . . . 0.0 113.915 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 49.9 t60 -128.76 117.93 21.94 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 103.472 -2.788 . . . . 0.0 103.472 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -134.88 176.06 9.0 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 122.951 1.357 . . . . 0.0 111.426 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 74.8 m -128.84 116.56 19.63 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 100.728 -3.804 . . . . 0.0 100.728 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -95.51 131.07 10.53 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 104.85 -3.3 . . . . 0.0 104.85 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 43.2 ttm . . . . . 0 C--N 1.302 -1.464 0 N-CA-C 104.732 -2.322 . . . . 0.0 104.732 -179.859 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 55.3 t80 . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 120.766 0.317 . . . . 0.0 111.367 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -133.17 121.95 23.3 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -137.82 172.48 12.89 Favored 'General case' 0 N--CA 1.508 2.474 0 C-N-CA 119.448 -0.901 . . . . 0.0 111.27 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.6 ttt -112.9 150.07 32.3 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.487 0.66 . . . . 0.0 112.73 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.4 tp -90.58 121.0 32.13 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.113 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.57 -3.7 39.71 Favored Glycine 0 N--CA 1.5 2.951 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.998 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' A' ' 54' ' ' GLU . 19.2 ttmm -115.84 42.46 2.32 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.411 ' C ' ' O ' ' A' ' 52' ' ' LYS . 72.8 mt-30 0.76 63.48 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.044 0 O-C-N 125.706 1.879 . . . . 0.0 113.655 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 52' ' ' LYS . 1.9 tm-20 -101.4 -23.9 14.28 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 113.796 -1.547 . . . . 0.0 106.864 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.2 m -112.7 158.73 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.577 0 C-N-CA 119.856 -0.738 . . . . 0.0 109.269 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.5 pt -59.1 173.95 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.484 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.549 ' O ' ' N ' ' A' ' 59' ' ' TRP . 3.6 tpp180 -66.99 -60.22 2.82 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 118.564 -0.731 . . . . 0.0 109.891 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -24.59 -38.9 0.01 OUTLIER Glycine 0 N--CA 1.499 2.889 0 O-C-N 125.1 1.5 . . . . 0.0 111.498 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.549 ' N ' ' O ' ' A' ' 57' ' ' ARG . 2.0 m95 -82.37 -74.88 0.33 Allowed 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 112.816 -1.692 . . . . 0.0 110.447 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 59' ' ' TRP . 29.9 tt0 -24.32 -54.6 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 125.97 2.044 . . . . 0.0 111.33 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -77.88 -54.18 6.62 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -50.36 -75.41 0.21 Allowed Glycine 0 N--CA 1.481 1.671 0 C-N-CA 119.729 -1.225 . . . . 0.0 110.544 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.53 ' N ' ' O ' ' A' ' 59' ' ' TRP . 25.1 t -43.53 -48.06 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 119.218 -0.993 . . . . 0.0 112.011 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.508 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -45.34 -58.75 3.09 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 123.783 1.754 . . . . 0.0 111.37 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -50.44 -9.02 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 109.873 -3.33 . . . . 0.0 110.617 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.508 ' H ' ' C ' ' A' ' 64' ' ' ALA . 40.8 mtm -103.97 151.05 23.66 Favored 'General case' 0 N--CA 1.519 2.989 0 C-N-CA 118.824 -1.15 . . . . 0.0 109.993 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 61.7 p -115.58 148.07 40.01 Favored 'General case' 0 N--CA 1.509 2.525 0 CA-C-O 122.756 1.265 . . . . 0.0 114.006 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 60.5 t -38.94 109.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-N 112.478 -2.146 . . . . 0.0 114.871 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.49 -2.51 36.9 Favored Glycine 0 N--CA 1.501 2.985 0 C-N-CA 119.58 -1.295 . . . . 0.0 111.296 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -99.97 153.61 19.05 Favored 'General case' 0 N--CA 1.506 2.338 0 CA-C-O 122.344 1.068 . . . . 0.0 111.87 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.675 ' NH1' ' HG ' ' A' ' 8' ' ' SER . 31.1 ttp180 -131.7 143.82 50.54 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 113.137 -1.847 . . . . 0.0 107.209 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -151.98 176.78 11.14 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 116.574 2.064 . . . . 0.0 116.574 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -124.78 104.58 8.72 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 110.855 -2.884 . . . . 0.0 104.349 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.1 mt -96.83 150.06 21.15 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.7 m -121.1 103.39 8.98 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 37.5 mt -99.38 132.09 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.418 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 66.9 p -113.03 156.38 42.88 Favored Pre-proline 0 N--CA 1.501 2.094 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -34.32 -50.41 0.63 Allowed 'Trans proline' 0 C--N 1.314 -1.248 0 C-N-CA 122.231 1.954 . . . . 0.0 114.096 -176.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 80' ' ' TYR . 1.4 p30 -38.91 -41.12 0.72 Allowed 'General case' 0 N--CA 1.485 1.324 0 CA-C-O 121.837 0.827 . . . . 0.0 111.734 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.472 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 6.5 m-85 . . . . . 0 N--CA 1.494 1.749 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.838 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 97.5 m . . . . . 0 N--CA 1.497 1.875 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 20.6 mt -101.55 152.7 20.48 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.7 t -132.27 117.8 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.458 ' CE2' ' NE1' ' A' ' 59' ' ' TRP . 3.9 m-85 -109.32 160.06 16.47 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -128.61 88.27 2.71 Favored 'General case' 0 N--CA 1.497 1.892 1 N-CA-C 98.295 -4.705 . . . . 0.0 98.295 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.7 t -101.98 152.5 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.64 0 N-CA-C 117.495 2.406 . . . . 0.0 117.495 -178.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -129.25 104.88 7.78 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 112.3 -2.227 . . . . 0.0 106.755 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 36.8 tp -77.06 116.05 17.38 Favored 'General case' 0 N--CA 1.505 2.321 0 N-CA-C 101.888 -3.375 . . . . 0.0 101.888 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.7 mt -86.2 -61.99 1.62 Allowed 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 114.372 -1.285 . . . . 0.0 114.115 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 14.5 mmtt -157.16 -171.86 3.79 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.834 0.826 . . . . 0.0 111.351 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 21.4 mt -119.15 159.99 22.96 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 103.772 -2.677 . . . . 0.0 103.772 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 . . . . . 0 N--CA 1.508 2.445 0 CA-C-O 115.572 -2.156 . . . . 0.0 107.548 179.919 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.8 p . . . . . 0 N--CA 1.503 2.18 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.537 HE21 ' CG ' ' A' ' 5' ' ' GLU . 40.6 tt0 -121.99 156.01 34.36 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.8 t -125.5 118.13 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.537 ' CG ' HE21 ' A' ' 3' ' ' GLN . 6.1 mm-40 -121.84 94.52 4.34 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 92.5 m -69.82 157.28 37.67 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 76.3 mt -121.98 -55.47 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 CA-C-N 113.656 -1.611 . . . . 0.0 107.132 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.423 ' O ' ' O ' ' A' ' 9' ' ' PRO . 36.6 m -120.94 84.44 38.84 Favored Pre-proline 0 N--CA 1.504 2.234 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.331 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 8' ' ' SER . 0.5 OUTLIER -34.71 159.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.3 2.0 . . . . 0.0 112.15 177.025 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -124.47 -164.75 12.01 Favored Glycine 0 N--CA 1.501 3.02 0 N-CA-C 107.992 -2.043 . . . . 0.0 107.992 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.503 ' CG ' ' H ' ' A' ' 12' ' ' GLY . 1.2 p-10 -39.55 -67.54 0.22 Allowed 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 121.816 0.817 . . . . 0.0 112.348 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.503 ' H ' ' CG ' ' A' ' 11' ' ' ASP . . . 104.33 12.61 28.61 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 105.3 -3.12 . . . . 0.0 105.3 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -124.38 -45.67 1.94 Allowed 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 113.797 -1.201 . . . . 0.0 112.188 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 38.6 m -103.12 129.2 49.91 Favored 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -128.97 173.04 6.11 Favored Pre-proline 0 N--CA 1.499 1.982 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -67.85 132.09 25.73 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 CA-C-N 119.707 0.931 . . . . 0.0 112.663 166.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -120.23 165.07 15.3 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.8 ptm85 -66.12 134.29 52.49 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.69 -25.71 11.63 Favored Glycine 0 N--CA 1.498 2.777 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -106.89 173.0 6.51 Favored 'General case' 0 N--CA 1.508 2.444 0 CA-C-O 121.715 0.769 . . . . 0.0 112.99 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.7 m -115.29 121.05 41.7 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.723 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 30.6 m -69.29 152.62 44.79 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 97.6 t -130.11 102.78 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 101.763 -3.421 . . . . 0.0 101.763 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.7 m -120.72 152.66 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.374 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -129.13 113.82 15.56 Favored 'General case' 0 N--CA 1.506 2.349 0 N-CA-C 102.807 -3.035 . . . . 0.0 102.807 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.552 ' CD1' ' N ' ' A' ' 26' ' ' TYR . 33.0 p90 -132.25 175.91 8.85 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 122.974 1.369 . . . . 0.0 114.221 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.8 m -137.06 117.59 13.82 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 101.794 -3.41 . . . . 0.0 101.794 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -98.61 141.85 15.78 Favored Glycine 0 N--CA 1.501 3.003 0 C-N-CA 119.921 -1.133 . . . . 0.0 110.697 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 69.6 mmm . . . . . 0 C--N 1.303 -1.43 0 CA-C-N 113.387 -1.407 . . . . 0.0 107.613 -179.734 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 49.2 t80 . . . . . 0 N--CA 1.501 2.109 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -143.08 121.2 12.14 Favored 'General case' 0 N--CA 1.506 2.374 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -135.4 171.98 13.66 Favored 'General case' 0 N--CA 1.513 2.703 0 CA-C-N 118.988 0.813 . . . . 0.0 110.631 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 43.2 ttm -119.16 143.8 47.02 Favored 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.427 ' CD1' ' OE1' ' A' ' 60' ' ' GLU . 50.5 tp -91.17 134.88 34.18 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 113.986 -1.461 . . . . 0.0 110.646 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 126.73 -35.02 3.0 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 108.393 -1.883 . . . . 0.0 108.393 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 54' ' ' GLU . 80.0 tttt -123.76 43.14 3.05 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 114.585 -0.807 . . . . 0.0 109.176 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 12.53 49.27 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 125.602 1.814 . . . . 0.0 114.685 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 52' ' ' LYS . 96.1 mt-10 -49.2 -29.82 6.11 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.537 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.433 ' O ' ' O ' ' A' ' 56' ' ' ILE . 32.7 m -117.56 158.31 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.646 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 55' ' ' VAL . 23.9 pt -46.4 172.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 C-N-CA 118.753 -1.179 . . . . 0.0 111.323 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.546 ' O ' ' N ' ' A' ' 59' ' ' TRP . 20.7 ttm-85 -72.44 -61.06 1.93 Allowed 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 118.84 -0.6 . . . . 0.0 112.073 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -34.58 -28.22 0.01 OUTLIER Glycine 0 N--CA 1.499 2.835 0 CA-C-O 122.156 0.864 . . . . 0.0 111.761 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.546 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.6 OUTLIER -87.75 -74.76 0.44 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 179.804 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.427 ' OE1' ' CD1' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -32.86 -50.96 0.28 Allowed 'General case' 0 N--CA 1.501 2.077 0 CA-C-N 114.035 -1.439 . . . . 0.0 110.127 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -74.57 -54.36 7.64 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 113.743 -1.572 . . . . 0.0 107.042 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -53.71 -76.07 0.2 Allowed Glycine 0 N--CA 1.478 1.47 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' A' ' 59' ' ' TRP . 40.0 t -37.25 -45.41 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 CA-C-N 115.067 -0.566 . . . . 0.0 112.04 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.526 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -48.35 -56.07 9.08 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 123.78 1.752 . . . . 0.0 110.092 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -59.53 -0.51 0.17 Allowed 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 110.139 -3.21 . . . . 0.0 110.409 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.593 ' SD ' ' NE2' ' A' ' 70' ' ' GLN . 16.3 tpp -98.85 153.2 18.97 Favored 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 106.039 -1.838 . . . . 0.0 106.039 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 83.5 p -116.37 143.23 45.82 Favored 'General case' 0 N--CA 1.508 2.453 0 CA-C-O 122.289 1.042 . . . . 0.0 112.212 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.422 ' O ' ' OD1' ' A' ' 11' ' ' ASP . 96.7 t -41.9 98.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 113.315 -1.766 . . . . 0.0 114.622 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.71 7.1 22.52 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.593 ' NE2' ' SD ' ' A' ' 66' ' ' MET . 44.3 tt0 -105.13 149.09 26.17 Favored 'General case' 0 N--CA 1.51 2.545 0 C-N-CA 119.179 -1.008 . . . . 0.0 111.018 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 24.8 ttt85 -124.71 141.02 52.4 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 113.905 -1.498 . . . . 0.0 107.0 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -149.64 177.97 9.28 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 116.081 1.882 . . . . 0.0 116.081 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -127.09 104.83 8.19 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 102.457 -3.164 . . . . 0.0 102.457 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.6 mt -101.48 155.12 18.26 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 87.2 m -125.32 132.2 52.9 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 23.8 mt -118.99 138.85 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 CA-C-O 121.319 0.581 . . . . 0.0 110.651 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.426 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 76.9 p -111.11 151.45 43.07 Favored Pre-proline 0 N--CA 1.502 2.151 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.423 ' O ' ' N ' ' A' ' 80' ' ' TYR . 10.2 Cg_endo -39.41 -56.14 1.37 Allowed 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 121.859 1.706 . . . . 0.0 113.035 -172.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.531 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 3.9 p-10 -34.37 -34.34 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.442 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.423 ' N ' ' O ' ' A' ' 78' ' ' PRO . 4.8 m-85 . . . . . 0 N--CA 1.493 1.682 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.086 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 91.1 m . . . . . 0 N--CA 1.504 2.262 0 CA-C-O 119.157 -0.449 . . . . 0.0 110.85 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 29.0 mt -108.8 144.37 36.74 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 119.252 0.933 . . . . 0.0 108.718 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 43.7 t -128.73 127.2 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 N-CA-C 107.113 -1.439 . . . . 0.0 107.113 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -118.82 157.88 26.71 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 122.063 0.935 . . . . 0.0 111.958 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -127.07 94.16 3.94 Favored 'General case' 0 N--CA 1.494 1.762 1 N-CA-C 99.069 -4.419 . . . . 0.0 99.069 179.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 16.4 t -107.36 152.94 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.524 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -127.36 100.65 6.13 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 111.877 -2.42 . . . . 0.0 106.357 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 40.9 tp -73.76 125.06 27.26 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 102.624 -3.102 . . . . 0.0 102.624 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.0 mt -94.0 -59.74 1.91 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.79 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 11.8 ptmm? -157.2 -178.58 7.46 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.0 mt -114.23 71.29 0.75 Allowed 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 . . . . . 0 N--CA 1.502 2.159 0 CA-C-O 115.91 -1.995 . . . . 0.0 109.676 179.971 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 N--CA 1.503 2.18 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -121.99 154.01 37.78 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.2 t -126.51 114.03 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -114.83 109.53 18.3 Favored 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 96.2 m -83.75 153.71 23.99 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.744 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 56.0 mt -123.55 -50.58 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 CA-C-N 113.656 -1.611 . . . . 0.0 107.363 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.417 ' O ' ' O ' ' A' ' 9' ' ' PRO . 43.8 t -122.33 79.68 45.15 Favored Pre-proline 0 N--CA 1.507 2.406 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.634 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.417 ' O ' ' O ' ' A' ' 8' ' ' SER . 9.0 Cg_exo -37.56 166.27 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.863 2.375 . . . . 0.0 113.77 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.79 -167.42 12.92 Favored Glycine 0 N--CA 1.502 3.091 0 N-CA-C 105.304 -3.119 . . . . 0.0 105.304 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.52 ' CG ' ' H ' ' A' ' 12' ' ' GLY . 11.2 p-10 -46.97 -58.99 3.4 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 118.619 1.21 . . . . 0.0 110.798 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.52 ' H ' ' CG ' ' A' ' 11' ' ' ASP . . . 106.99 27.63 5.3 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 107.232 -2.347 . . . . 0.0 107.232 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 32.7 mtp85 -133.87 -35.0 0.98 Allowed 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 114.545 -0.828 . . . . 0.0 112.597 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.8 m -109.57 139.46 44.55 Favored 'General case' 0 N--CA 1.508 2.454 0 CA-C-O 121.807 0.813 . . . . 0.0 112.952 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 50.5 m-85 -131.77 177.43 2.25 Favored Pre-proline 0 N--CA 1.499 1.988 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -67.13 138.74 48.33 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 121.145 1.23 . . . . 0.0 110.813 164.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -119.94 162.24 19.53 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 122.351 1.072 . . . . 0.0 109.232 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 29.8 mtm180 -71.07 126.68 30.23 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 114.189 -1.369 . . . . 0.0 108.146 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.51 -24.22 9.86 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -110.8 176.95 4.83 Favored 'General case' 0 N--CA 1.507 2.406 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.901 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 92.4 m -108.42 166.98 10.36 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.2 m -113.14 149.47 33.55 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 102.513 -3.143 . . . . 0.0 102.513 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 60.4 t -123.49 101.93 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 103.109 -2.923 . . . . 0.0 103.109 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.3 m -120.69 149.52 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.574 0 N-CA-C 116.516 2.043 . . . . 0.0 116.516 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -127.8 114.74 17.64 Favored 'General case' 0 N--CA 1.507 2.383 0 N-CA-C 103.67 -2.715 . . . . 0.0 103.67 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.499 ' CD1' ' N ' ' A' ' 26' ' ' TYR . 33.9 p90 -131.96 175.68 9.02 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 122.977 1.37 . . . . 0.0 113.702 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 84.8 m -134.65 116.89 15.47 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 101.308 -3.59 . . . . 0.0 101.308 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -102.55 128.7 9.63 Favored Glycine 0 N--CA 1.5 2.935 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 46.8 ttm . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 -179.83 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 49.7 t80 . . . . . 0 N--CA 1.499 2.013 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.95 130.88 21.65 Favored 'General case' 0 N--CA 1.508 2.45 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.41 ' CD1' ' C ' ' A' ' 48' ' ' PHE . 13.5 p90 -143.28 166.72 23.96 Favored 'General case' 0 N--CA 1.514 2.732 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.904 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.495 ' SD ' ' O ' ' A' ' 50' ' ' LEU . 2.7 tmm? -115.11 149.04 38.19 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 115.103 1.519 . . . . 0.0 115.103 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.495 ' O ' ' SD ' ' A' ' 49' ' ' MET . 52.3 tp -90.6 121.03 32.17 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 113.343 -1.753 . . . . 0.0 112.19 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.69 -24.71 7.09 Favored Glycine 0 N--CA 1.499 2.838 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 53' ' ' GLN . 2.3 tppp? -113.37 36.84 3.4 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.413 ' C ' ' O ' ' A' ' 52' ' ' LYS . 83.3 mt-30 7.8 63.56 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 125.281 1.613 . . . . 0.0 114.165 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -82.89 -30.23 28.7 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.419 ' O ' ' O ' ' A' ' 56' ' ' ILE . 32.6 m -118.78 151.13 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.419 ' O ' ' O ' ' A' ' 55' ' ' VAL . 1.6 pt -46.9 -176.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.542 ' O ' ' N ' ' A' ' 59' ' ' TRP . 8.8 tpt180 -81.16 -61.01 2.08 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.124 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -35.8 -26.86 0.01 OUTLIER Glycine 0 N--CA 1.497 2.703 0 CA-C-O 122.196 0.887 . . . . 0.0 110.919 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.542 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.8 OUTLIER -91.85 -76.07 0.46 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.776 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -33.94 -51.48 0.41 Allowed 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 113.752 -1.567 . . . . 0.0 110.031 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -73.06 -54.47 8.46 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 113.218 -1.81 . . . . 0.0 106.574 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -55.07 -80.55 0.07 OUTLIER Glycine 0 N--CA 1.476 1.335 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.533 ' N ' ' O ' ' A' ' 59' ' ' TRP . 53.1 t -32.3 -48.45 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 112.675 0.621 . . . . 0.0 112.675 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.511 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -46.37 -60.52 2.28 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 124.262 1.982 . . . . 0.0 110.905 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -48.01 -12.19 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 108.948 -3.751 . . . . 0.0 108.856 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.511 ' H ' ' C ' ' A' ' 64' ' ' ALA . 21.0 mtp -97.7 159.64 14.8 Favored 'General case' 0 N--CA 1.512 2.655 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 80.4 p -117.08 156.88 26.82 Favored 'General case' 0 N--CA 1.509 2.498 0 CA-C-O 122.804 1.288 . . . . 0.0 113.716 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 62.5 t -49.55 97.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 112.037 -2.347 . . . . 0.0 114.858 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.11 5.2 25.28 Favored Glycine 0 N--CA 1.499 2.841 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.488 ' OE1' ' N ' ' A' ' 71' ' ' ARG . 0.9 OUTLIER -106.73 148.61 28.22 Favored 'General case' 0 N--CA 1.505 2.325 0 CA-C-O 122.099 0.952 . . . . 0.0 111.399 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.488 ' N ' ' OE1' ' A' ' 70' ' ' GLN . 18.9 ttp180 -127.58 140.64 51.98 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 113.516 -1.674 . . . . 0.0 110.089 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -144.8 178.83 7.72 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 112.605 -2.089 . . . . 0.0 115.662 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -126.78 105.0 8.36 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 110.933 -2.849 . . . . 0.0 103.585 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.8 mt -96.73 149.7 21.53 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 86.5 m -124.59 112.72 17.14 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.5 mt -105.19 143.83 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 CA-C-O 121.448 0.642 . . . . 0.0 110.908 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 36.8 p -110.02 150.79 41.91 Favored Pre-proline 0 N--CA 1.496 1.869 0 N-CA-C 105.604 -1.998 . . . . 0.0 105.604 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.524 ' O ' ' N ' ' A' ' 80' ' ' TYR . 19.3 Cg_endo -44.33 -55.71 3.02 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 121.967 1.778 . . . . 0.0 113.614 -171.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 12.8 p-10 -38.82 -17.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.524 ' N ' ' O ' ' A' ' 78' ' ' PRO . 4.8 m-85 . . . . . 0 N--CA 1.5 2.043 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 94.8 m . . . . . 0 N--CA 1.502 2.16 0 CA-C-O 118.872 -0.585 . . . . 0.0 110.812 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 32.6 mt -108.21 153.07 23.72 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 50.4 t -133.31 121.15 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -114.26 151.33 33.03 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -122.73 94.07 4.16 Favored 'General case' 0 N--CA 1.496 1.839 1 N-CA-C 98.937 -4.468 . . . . 0.0 98.937 179.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 17.2 t -107.78 150.53 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.425 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -179.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -126.67 102.48 7.09 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 112.39 -2.186 . . . . 0.0 106.843 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 43.6 tp -73.31 126.5 30.26 Favored 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 101.823 -3.399 . . . . 0.0 101.823 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.9 mt -93.51 -54.05 3.82 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.877 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.46 -172.13 0.88 Allowed 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 118.366 -1.334 . . . . 0.0 110.621 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 19.1 mt -118.24 152.97 34.7 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.426 ' OE1' ' OXT' ' A' ' 107' ' ' GLU . 9.7 tm-20 . . . . . 0 N--CA 1.501 2.095 0 CA-C-O 116.099 -1.905 . . . . 0.0 109.002 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.473 ' C ' ' NE2' ' A' ' 3' ' ' GLN . 11.8 p . . . . . 0 N--CA 1.502 2.143 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.483 ' N ' ' CD ' ' A' ' 3' ' ' GLN . 14.9 mp0 -121.57 156.05 33.71 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 42.2 t -126.5 106.55 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -108.38 87.45 2.5 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 98.9 m -69.66 157.82 36.53 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.017 -1.073 . . . . 0.0 111.674 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 64.1 mt -121.94 -53.93 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 CA-C-N 114.195 -1.366 . . . . 0.0 107.631 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.417 ' O ' ' O ' ' A' ' 9' ' ' PRO . 51.8 m -123.09 80.22 51.5 Favored Pre-proline 0 N--CA 1.507 2.378 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.49 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.417 ' O ' ' O ' ' A' ' 8' ' ' SER . 6.9 Cg_exo -36.95 166.66 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.866 2.377 . . . . 0.0 114.104 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.51 -176.7 17.99 Favored Glycine 0 N--CA 1.5 2.96 0 N-CA-C 105.063 -3.215 . . . . 0.0 105.063 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.52 ' CG ' ' H ' ' A' ' 12' ' ' GLY . 14.4 p-10 -43.04 -59.08 2.16 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 118.557 1.178 . . . . 0.0 111.735 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.52 ' H ' ' CG ' ' A' ' 11' ' ' ASP . . . 110.06 22.34 6.6 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 108.541 -1.824 . . . . 0.0 108.541 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 60.0 mtt-85 -133.67 -31.38 1.19 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 114.994 -0.603 . . . . 0.0 112.392 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.0 m -109.11 124.85 51.45 Favored 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.375 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.47 ' N ' ' CD1' ' A' ' 15' ' ' PHE . 23.1 m-85 -127.28 176.1 2.88 Favored Pre-proline 0 N--CA 1.501 2.101 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -73.8 139.33 27.51 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 CA-C-N 119.51 0.861 . . . . 0.0 110.177 163.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -120.63 167.07 12.82 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 121.765 0.793 . . . . 0.0 109.264 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 62.8 mtt180 -70.26 127.6 33.35 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.763 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.32 -25.61 9.14 Favored Glycine 0 N--CA 1.498 2.78 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.501 ' O ' ' SD ' ' A' ' 49' ' ' MET . 25.8 mt-30 -109.37 175.62 5.38 Favored 'General case' 0 N--CA 1.505 2.276 0 CA-C-O 121.713 0.768 . . . . 0.0 111.429 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.9 m -107.23 163.86 12.66 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 114.611 -1.177 . . . . 0.0 108.47 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 55.6 m -114.39 145.62 41.6 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 103.718 -2.697 . . . . 0.0 103.718 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 64.4 t -122.89 101.08 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 102.22 -3.252 . . . . 0.0 102.22 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.7 m -124.12 151.54 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -130.15 119.45 23.02 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 103.841 -2.651 . . . . 0.0 103.841 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 26' ' ' TYR . 35.4 p90 -135.22 172.55 12.84 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 123.072 1.415 . . . . 0.0 114.592 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 61.4 m -134.34 116.14 14.88 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 102.865 -3.013 . . . . 0.0 102.865 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.62 137.42 13.61 Favored Glycine 0 N--CA 1.5 2.92 0 C-N-CA 119.918 -1.134 . . . . 0.0 112.003 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 35.0 ttm . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 179.987 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 71.6 t80 . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -137.7 123.5 20.0 Favored 'General case' 0 N--CA 1.505 2.323 0 CA-C-O 118.863 -0.589 . . . . 0.0 110.952 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -136.8 168.04 20.3 Favored 'General case' 0 N--CA 1.513 2.696 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.501 ' SD ' ' O ' ' A' ' 20' ' ' GLN . 44.6 tpp -107.1 132.35 53.1 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 114.111 -1.404 . . . . 0.0 113.866 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.0 tp -90.88 122.42 33.56 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 114.483 -1.235 . . . . 0.0 110.707 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.73 18.48 10.72 Favored Glycine 0 N--CA 1.5 2.91 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.483 ' O ' ' CB ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -118.75 -53.12 2.31 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.483 ' CB ' ' O ' ' A' ' 52' ' ' LYS . 47.9 tt0 100.92 70.56 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.208 0 O-C-N 125.812 1.945 . . . . 0.0 108.049 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -109.39 -33.71 6.75 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 114.182 -1.372 . . . . 0.0 108.708 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.4 m -115.15 153.03 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.291 0 CA-C-O 121.287 0.565 . . . . 0.0 110.4 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.2 pt -51.08 177.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.094 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.544 ' O ' ' N ' ' A' ' 59' ' ' TRP . 8.7 tpt180 -70.52 -60.76 2.07 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 120.232 -0.587 . . . . 0.0 109.442 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -24.24 -38.88 0.01 OUTLIER Glycine 0 N--CA 1.501 2.98 0 O-C-N 125.122 1.514 . . . . 0.0 112.718 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.544 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.6 OUTLIER -82.66 -71.38 0.49 Allowed 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 179.828 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -28.77 -54.62 0.12 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 125.266 1.604 . . . . 0.0 110.939 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -76.67 -53.53 7.88 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -50.83 -75.54 0.21 Allowed Glycine 0 N--CA 1.478 1.465 0 C-N-CA 119.207 -1.473 . . . . 0.0 110.287 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 59' ' ' TRP . 35.2 t -42.03 -50.77 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 C-N-CA 119.471 -0.891 . . . . 0.0 112.42 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.514 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -45.0 -62.04 1.39 Allowed 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 123.893 1.806 . . . . 0.0 111.434 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -47.15 -12.91 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 109.606 -3.452 . . . . 0.0 109.176 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.514 ' H ' ' C ' ' A' ' 64' ' ' ALA . 6.6 mtm -99.63 157.27 16.58 Favored 'General case' 0 N--CA 1.512 2.657 0 C-N-CA 118.503 -1.279 . . . . 0.0 107.638 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 84.4 p -118.65 148.24 42.94 Favored 'General case' 0 N--CA 1.507 2.398 0 CA-C-O 122.458 1.123 . . . . 0.0 113.412 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 52.9 t -40.82 100.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-N 112.775 -2.011 . . . . 0.0 113.829 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.19 10.97 12.74 Favored Glycine 0 N--CA 1.5 2.963 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -107.2 146.45 31.38 Favored 'General case' 0 N--CA 1.505 2.297 0 CA-C-O 121.681 0.753 . . . . 0.0 111.05 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.1 mtp85 -126.26 139.56 53.22 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -149.42 177.07 10.03 Favored 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 116.58 2.067 . . . . 0.0 116.58 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -127.92 107.1 9.57 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 102.531 -3.137 . . . . 0.0 102.531 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.8 mt -104.47 153.31 21.28 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 90.3 m -124.01 124.96 43.7 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 104.613 -2.366 . . . . 0.0 104.613 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.1 mt -116.95 136.34 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.417 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 61.1 p -111.92 154.11 44.27 Favored Pre-proline 0 N--CA 1.505 2.292 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -34.36 -53.05 0.6 Allowed 'Trans proline' 0 C--N 1.315 -1.187 0 C-N-CA 122.1 1.867 . . . . 0.0 114.297 -174.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 80' ' ' TYR . 1.8 p30 -37.34 -39.65 0.3 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.503 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.452 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 5.0 m-85 . . . . . 0 N--CA 1.493 1.676 0 CA-C-N 114.965 -1.016 . . . . 0.0 112.022 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 88.1 m . . . . . 0 N--CA 1.5 2.033 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 27.8 mt -115.86 155.21 28.33 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.8 t -136.43 124.51 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -118.39 150.7 39.1 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 122.305 1.05 . . . . 0.0 111.057 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -124.09 93.59 3.97 Favored 'General case' 0 N--CA 1.493 1.706 1 N-CA-C 98.926 -4.472 . . . . 0.0 98.926 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 12.7 t -108.09 155.57 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.513 0 N-CA-C 117.033 2.234 . . . . 0.0 117.033 -179.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -129.2 103.33 6.89 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 111.574 -2.557 . . . . 0.0 108.143 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 39.5 tp -77.86 118.44 20.19 Favored 'General case' 0 N--CA 1.506 2.363 0 N-CA-C 102.722 -3.066 . . . . 0.0 102.722 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.1 mt -87.3 -55.63 3.72 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 113.845 -1.525 . . . . 0.0 112.518 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -171.69 -170.08 0.75 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.334 -0.946 . . . . 0.0 110.962 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 21.2 mt -117.65 156.28 28.45 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 . . . . . 0 N--CA 1.503 2.191 0 CA-C-O 116.822 -1.561 . . . . 0.0 108.974 179.83 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.9 p . . . . . 0 N--CA 1.501 2.117 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -123.68 154.88 38.77 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.7 t -125.14 118.99 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -120.21 96.86 5.33 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 92.1 m -69.83 156.12 39.52 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.031 -1.068 . . . . 0.0 113.077 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 74.0 mt -122.52 -55.55 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 CA-C-N 113.693 -1.594 . . . . 0.0 107.471 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.422 ' O ' ' O ' ' A' ' 9' ' ' PRO . 34.2 t -122.95 82.48 50.35 Favored Pre-proline 0 N--CA 1.506 2.344 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.515 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 8' ' ' SER . 5.2 Cg_exo -36.23 161.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.391 2.061 . . . . 0.0 112.731 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -118.32 -174.62 16.39 Favored Glycine 0 N--CA 1.5 2.904 0 N-CA-C 106.482 -2.647 . . . . 0.0 106.482 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 11' ' ' ASP . 13.0 p-10 -39.77 -60.39 1.0 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.492 -0.883 . . . . 0.0 112.916 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.06 18.74 12.91 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 105.599 -3.001 . . . . 0.0 105.599 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 54.8 mtt-85 -127.13 -40.32 1.85 Allowed 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 113.773 -1.213 . . . . 0.0 112.214 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.6 m -108.21 139.58 42.69 Favored 'General case' 0 N--CA 1.506 2.341 0 CA-C-O 121.968 0.89 . . . . 0.0 112.726 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 50.8 m-85 -131.79 177.46 2.23 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -62.19 155.09 58.55 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 N-CA-C 109.805 -0.883 . . . . 0.0 109.805 161.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -119.73 166.61 12.99 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.921 0.867 . . . . 0.0 108.923 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 59.2 mtt85 -81.18 95.07 6.8 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.559 -1.201 . . . . 0.0 109.178 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.07 3.7 4.8 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -113.61 173.02 6.62 Favored 'General case' 0 N--CA 1.506 2.35 0 C-N-CA 120.219 -0.593 . . . . 0.0 109.513 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 97.8 m -118.08 117.86 30.35 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.591 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 24.8 m -69.66 148.61 49.07 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 87.5 t -122.13 101.61 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 101.679 -3.452 . . . . 0.0 101.679 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.0 m -125.38 151.04 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -129.04 117.67 21.26 Favored 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.434 ' CD2' ' CD2' ' A' ' 99' ' ' PHE . 41.9 p90 -136.27 -179.13 5.49 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 96.2 m -137.02 118.73 15.02 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 105.006 -2.22 . . . . 0.0 105.006 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -102.91 124.85 8.29 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 120.905 -0.665 . . . . 0.0 112.057 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 48.9 mtm . . . . . 0 N--CA 1.499 1.991 0 CA-C-O 122.041 0.924 . . . . 0.0 110.524 179.944 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 47.9 t80 . . . . . 0 N--CA 1.494 1.762 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -137.79 122.71 18.94 Favored 'General case' 0 N--CA 1.506 2.369 0 CA-C-O 119.109 -0.472 . . . . 0.0 111.128 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -137.71 175.4 9.63 Favored 'General case' 0 N--CA 1.513 2.69 0 CA-C-N 119.412 1.006 . . . . 0.0 112.381 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 42.2 ttm -117.67 144.06 45.58 Favored 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.1 tp -91.09 124.25 35.18 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 114.295 -1.32 . . . . 0.0 111.812 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.18 -18.07 14.28 Favored Glycine 0 N--CA 1.501 3.026 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.874 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.41 ' O ' ' C ' ' A' ' 53' ' ' GLN . 53.9 tttm -118.98 39.32 3.57 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 120.949 -0.3 . . . . 0.0 110.372 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 52' ' ' LYS . 15.1 pt20 14.12 68.26 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 125.262 1.601 . . . . 0.0 114.587 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -91.39 -27.3 18.42 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 113.758 -1.564 . . . . 0.0 106.869 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.427 ' O ' ' O ' ' A' ' 56' ' ' ILE . 26.8 m -118.8 154.6 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.235 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.427 ' O ' ' O ' ' A' ' 55' ' ' VAL . 12.7 pt -49.43 175.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 C-N-CA 119.568 -0.853 . . . . 0.0 108.908 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.537 ' O ' ' N ' ' A' ' 59' ' ' TRP . 32.4 ttp180 -72.24 -56.31 5.74 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.199 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -25.35 -38.52 0.01 OUTLIER Glycine 0 N--CA 1.499 2.886 0 O-C-N 124.773 1.296 . . . . 0.0 112.188 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.537 ' N ' ' O ' ' A' ' 57' ' ' ARG . 1.4 m95 -82.02 -74.26 0.35 Allowed 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 112.919 -1.64 . . . . 0.0 108.386 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 59' ' ' TRP . 29.2 tt0 -24.18 -54.72 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 125.932 2.02 . . . . 0.0 111.174 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -77.85 -54.81 5.89 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -48.56 -75.97 0.17 Allowed Glycine 0 N--CA 1.482 1.702 0 C-N-CA 119.84 -1.172 . . . . 0.0 110.391 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.529 ' N ' ' O ' ' A' ' 59' ' ' TRP . 23.1 t -44.03 -48.7 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 119.298 -0.961 . . . . 0.0 111.837 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.518 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -46.36 -58.93 3.28 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 123.948 1.832 . . . . 0.0 111.341 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -51.05 -8.81 0.05 OUTLIER 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 109.68 -3.418 . . . . 0.0 109.887 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.518 ' H ' ' C ' ' A' ' 64' ' ' ALA . 93.4 mtp -102.73 158.62 16.12 Favored 'General case' 0 N--CA 1.513 2.723 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 88.3 p -118.51 153.83 33.53 Favored 'General case' 0 N--CA 1.509 2.525 0 CA-C-O 122.775 1.274 . . . . 0.0 113.677 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 86.7 t -49.18 97.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 112.608 -2.087 . . . . 0.0 113.568 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.19 12.95 12.73 Favored Glycine 0 N--CA 1.499 2.869 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -107.65 143.54 35.99 Favored 'General case' 0 N--CA 1.505 2.305 0 CA-C-O 121.368 0.604 . . . . 0.0 109.781 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 25.4 ttt85 -124.88 140.85 52.55 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -149.7 176.47 10.65 Favored 'General case' 0 N--CA 1.502 2.175 0 CA-C-N 113.316 -1.765 . . . . 0.0 115.452 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -125.75 103.8 8.01 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 104.117 -2.549 . . . . 0.0 104.117 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.1 mt -98.26 145.93 26.15 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 89.5 m -117.35 104.07 10.76 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 33.9 mt -102.3 134.27 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.972 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.438 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -112.99 157.39 40.81 Favored Pre-proline 0 N--CA 1.501 2.123 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -37.37 -53.22 1.38 Allowed 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 123.148 2.565 . . . . 0.0 114.881 -166.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.524 ' O ' ' NH2' ' A' ' 57' ' ' ARG . 13.1 p-10 -45.39 -36.63 4.4 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.491 ' CZ ' ' NE ' ' A' ' 57' ' ' ARG . 4.6 m-85 . . . . . 0 N--CA 1.498 1.931 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 93.3 m . . . . . 0 N--CA 1.496 1.839 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 23.8 mt -103.78 152.87 21.35 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 57.3 t -133.24 103.93 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.434 ' CD2' ' CD2' ' A' ' 26' ' ' TYR . 2.7 m-85 -96.85 158.64 15.33 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 118.163 -1.415 . . . . 0.0 108.437 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -123.57 88.03 2.85 Favored 'General case' 0 N--CA 1.491 1.607 1 N-CA-C 97.511 -4.996 . . . . 0.0 97.511 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.3 t -101.47 146.3 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.518 0 N-CA-C 116.626 2.084 . . . . 0.0 116.626 -178.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -123.54 104.57 9.13 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 112.541 -2.118 . . . . 0.0 106.076 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 35.8 tp -76.93 120.25 21.79 Favored 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 102.868 -3.012 . . . . 0.0 102.868 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.6 mt -87.16 -57.54 2.92 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 113.913 -1.494 . . . . 0.0 112.123 -179.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -170.27 -169.45 0.84 Allowed 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 119.502 -0.879 . . . . 0.0 111.455 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 22.0 mt -118.12 156.18 29.14 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 . . . . . 0 N--CA 1.504 2.266 0 CA-C-O 116.164 -1.874 . . . . 0.0 109.597 179.911 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.3 p . . . . . 0 N--CA 1.501 2.124 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -120.64 149.65 42.15 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.7 t -125.56 111.28 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -109.92 97.46 6.97 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 85.6 m -69.93 155.33 40.73 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 118.87 -1.132 . . . . 0.0 112.546 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 72.3 mt -123.31 -54.16 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 CA-C-N 113.493 -1.685 . . . . 0.0 107.123 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.431 ' O ' ' O ' ' A' ' 9' ' ' PRO . 43.2 m -123.66 83.16 53.91 Favored Pre-proline 0 N--CA 1.506 2.335 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.463 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 8' ' ' SER . 4.6 Cg_exo -35.92 163.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.51 2.14 . . . . 0.0 112.971 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.11 -172.08 15.15 Favored Glycine 0 N--CA 1.502 3.059 0 N-CA-C 107.872 -2.091 . . . . 0.0 107.872 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 12' ' ' GLY . 1.4 p30 -39.63 -51.69 2.25 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.867 -0.733 . . . . 0.0 112.701 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.526 ' N ' ' OD1' ' A' ' 11' ' ' ASP . . . 100.88 -1.13 55.21 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 62.9 mtt180 -118.3 -37.08 3.4 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.8 m -104.77 128.27 52.85 Favored 'General case' 0 N--CA 1.504 2.271 0 C-N-CA 119.828 -0.749 . . . . 0.0 111.757 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 27.4 m-85 -129.01 172.39 7.18 Favored Pre-proline 0 N--CA 1.502 2.145 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -63.41 128.88 23.64 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 CA-C-N 119.915 1.005 . . . . 0.0 110.504 167.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -118.0 167.58 11.32 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 122.279 1.038 . . . . 0.0 110.61 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.555 HH12 ' CD2' ' A' ' 50' ' ' LEU . 5.2 tpp180 -68.73 123.51 21.11 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.11 -1.405 . . . . 0.0 109.684 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.86 -19.39 18.49 Favored Glycine 0 N--CA 1.499 2.889 0 C-N-CA 120.336 -0.935 . . . . 0.0 110.845 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -112.17 178.13 4.41 Favored 'General case' 0 N--CA 1.507 2.414 0 CA-C-O 121.695 0.759 . . . . 0.0 112.57 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 42.1 m -111.07 166.96 10.63 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.3 m -118.48 147.25 43.82 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 67.9 t -122.96 100.55 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 101.71 -3.441 . . . . 0.0 101.71 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.2 m -120.47 145.86 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.325 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -121.49 141.59 50.88 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 102.517 -3.142 . . . . 0.0 102.517 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -160.39 176.97 11.06 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 118.487 -1.285 . . . . 0.0 112.263 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 97.4 m -136.97 121.89 18.85 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 101.368 -3.568 . . . . 0.0 101.368 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -110.41 113.24 3.48 Favored Glycine 0 N--CA 1.499 2.864 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 39.1 ttm . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 179.918 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 68.1 t80 . . . . . 0 N--CA 1.493 1.678 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -141.87 135.66 29.74 Favored 'General case' 0 N--CA 1.517 2.898 0 N-CA-C 114.822 1.415 . . . . 0.0 114.822 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -148.03 172.14 14.72 Favored 'General case' 0 N--CA 1.514 2.736 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 43.9 ttm -116.16 148.93 39.85 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.815 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.555 ' CD2' HH12 ' A' ' 18' ' ' ARG . 65.2 tp -90.77 119.37 30.94 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.966 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.19 35.22 4.55 Favored Glycine 0 N--CA 1.497 2.7 0 N-CA-C 108.591 -1.804 . . . . 0.0 108.591 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.488 ' O ' ' CB ' ' A' ' 53' ' ' GLN . 63.5 tttp -128.11 -54.16 1.29 Allowed 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.488 ' CB ' ' O ' ' A' ' 52' ' ' LYS . 63.7 tp60 100.56 66.21 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 O-C-N 125.757 1.91 . . . . 0.0 110.267 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -110.1 -36.64 5.79 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.422 ' O ' ' O ' ' A' ' 56' ' ' ILE . 11.5 m -118.73 152.43 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.737 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.422 ' O ' ' O ' ' A' ' 55' ' ' VAL . 3.8 pt -51.46 -174.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-N 114.176 -1.375 . . . . 0.0 110.043 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.539 ' O ' ' N ' ' A' ' 59' ' ' TRP . 45.2 ttm180 -84.58 -54.64 4.6 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 122.391 -0.193 . . . . 0.0 110.902 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -41.13 -20.57 0.04 OUTLIER Glycine 0 N--CA 1.492 2.422 0 C-N-CA 120.201 -1.0 . . . . 0.0 111.559 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.54 ' O ' ' N ' ' A' ' 63' ' ' VAL . 0.1 OUTLIER -92.25 -77.0 0.44 Allowed 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -35.76 -48.98 0.57 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.912 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -73.45 -54.63 7.82 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 105.739 -1.949 . . . . 0.0 105.739 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -53.68 -81.0 0.06 OUTLIER Glycine 0 N--CA 1.477 1.408 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.54 ' N ' ' O ' ' A' ' 59' ' ' TRP . 47.8 t -30.4 -46.83 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.512 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -46.02 -58.69 3.38 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 123.994 1.854 . . . . 0.0 110.177 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -50.12 -9.76 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 109.39 -3.55 . . . . 0.0 109.906 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.512 ' H ' ' C ' ' A' ' 64' ' ' ALA . 88.8 mtp -101.3 156.38 17.48 Favored 'General case' 0 N--CA 1.513 2.686 0 C-N-CA 119.102 -1.039 . . . . 0.0 108.528 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 83.0 p -115.97 148.93 39.57 Favored 'General case' 0 N--CA 1.506 2.335 0 CA-C-O 122.418 1.104 . . . . 0.0 113.003 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 90.6 t -41.57 94.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 112.846 -1.979 . . . . 0.0 113.962 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 113.28 16.92 7.98 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -108.17 144.08 36.09 Favored 'General case' 0 N--CA 1.507 2.379 0 C-N-CA 120.072 -0.651 . . . . 0.0 111.085 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 24.7 ttt85 -126.28 139.44 53.31 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -147.69 176.14 10.34 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-N 112.967 -1.924 . . . . 0.0 115.416 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -127.19 103.99 7.72 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 103.56 -2.756 . . . . 0.0 103.56 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.1 mp -97.78 146.03 25.8 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.161 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.3 m -119.34 107.15 13.03 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 104.505 -2.405 . . . . 0.0 104.505 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.4 mt -101.89 140.69 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.23 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.424 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 52.0 p -112.07 154.66 44.19 Favored Pre-proline 0 N--CA 1.504 2.229 0 CA-C-N 114.337 -1.302 . . . . 0.0 107.831 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -37.54 -54.77 1.15 Allowed 'Trans proline' 0 C--N 1.313 -1.316 0 C-N-CA 122.023 1.815 . . . . 0.0 113.836 -174.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.528 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 2.0 p-10 -34.12 -38.48 0.06 Allowed 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.895 -1.048 . . . . 0.0 113.095 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 . . . . . 0 N--CA 1.496 1.852 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.492 -179.584 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 66.3 m . . . . . 0 N--CA 1.498 1.946 0 CA-C-O 119.14 -0.457 . . . . 0.0 111.317 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 16.7 mt -101.54 143.3 31.71 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.8 t -131.6 112.65 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -106.25 163.3 12.92 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 122.519 1.152 . . . . 0.0 109.399 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -129.1 90.27 3.0 Favored 'General case' 0 N--CA 1.492 1.649 1 N-CA-C 98.222 -4.733 . . . . 0.0 98.222 179.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 16.1 t -105.68 151.43 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.51 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -127.13 103.35 7.39 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 111.806 -2.452 . . . . 0.0 107.979 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 42.4 tp -72.74 120.86 18.94 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 102.177 -3.268 . . . . 0.0 102.177 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 15.8 mt -90.22 -55.57 3.55 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.409 ' CG ' ' H ' ' A' ' 106' ' ' LEU . 80.8 tttt -165.29 175.54 9.12 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.045 -1.062 . . . . 0.0 111.483 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.429 ' O ' ' OE1' ' A' ' 107' ' ' GLU . 18.2 mt -117.26 146.31 43.38 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.429 ' OE1' ' O ' ' A' ' 106' ' ' LEU . 5.7 mm-40 . . . . . 0 N--CA 1.505 2.32 0 CA-C-O 116.087 -1.911 . . . . 0.0 109.9 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.5 p . . . . . 0 N--CA 1.504 2.253 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.518 ' NE2' ' N ' ' A' ' 4' ' ' VAL . 4.7 tm0? -117.87 149.7 40.42 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.518 ' N ' ' NE2' ' A' ' 3' ' ' GLN . 40.5 t -123.51 101.73 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.524 ' OE2' ' NZ ' ' A' ' 73' ' ' LYS . 39.1 tt0 -103.24 107.88 18.87 Favored 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 93.9 m -83.65 154.14 23.86 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 122.229 1.014 . . . . 0.0 112.51 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 56.3 mt -124.15 -50.29 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 CA-C-N 113.313 -1.767 . . . . 0.0 107.282 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 9' ' ' PRO . 48.1 t -122.14 79.97 43.63 Favored Pre-proline 0 N--CA 1.507 2.384 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.498 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 8' ' ' SER . 5.8 Cg_exo -37.3 165.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.735 2.29 . . . . 0.0 113.528 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.43 -169.83 13.52 Favored Glycine 0 N--CA 1.5 2.914 0 N-CA-C 106.234 -2.746 . . . . 0.0 106.234 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.521 ' N ' ' OD1' ' A' ' 11' ' ' ASP . 13.0 p-10 -39.76 -60.68 0.95 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.518 -0.873 . . . . 0.0 112.678 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.22 14.32 18.85 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 106.844 -2.502 . . . . 0.0 106.844 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 45.6 mtm180 -128.9 -36.32 1.8 Allowed 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 114.468 -0.866 . . . . 0.0 113.324 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 36.6 m -107.65 138.36 44.01 Favored 'General case' 0 N--CA 1.508 2.468 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.457 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 61.7 m-85 -130.91 176.25 3.03 Favored Pre-proline 0 N--CA 1.497 1.916 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -69.84 133.61 25.85 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 CA-C-N 119.63 0.904 . . . . 0.0 111.149 164.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.0 mtmp? -119.48 162.32 19.07 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 122.313 1.054 . . . . 0.0 108.653 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 58.4 mtt-85 -61.86 144.28 55.12 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 114.39 -1.277 . . . . 0.0 107.714 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 107.17 -31.31 8.25 Favored Glycine 0 N--CA 1.498 2.781 0 C-N-CA 119.564 -1.303 . . . . 0.0 110.589 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -109.33 176.86 4.93 Favored 'General case' 0 N--CA 1.506 2.369 0 CA-C-O 121.781 0.801 . . . . 0.0 112.881 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 63.7 m -114.71 124.82 52.77 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 114.387 -1.279 . . . . 0.0 109.828 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 22.3 m -69.53 152.14 45.17 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.2 t -128.07 106.49 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 102.117 -3.29 . . . . 0.0 102.117 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.0 m -125.52 148.32 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.423 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -122.82 140.41 52.96 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 101.856 -3.387 . . . . 0.0 101.856 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -160.13 174.73 13.85 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 117.696 -1.602 . . . . 0.0 113.674 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.5 m -136.64 118.84 15.53 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 104.57 -2.382 . . . . 0.0 104.57 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.64 135.33 12.45 Favored Glycine 0 N--CA 1.503 3.112 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 63.9 mtp . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 122.102 0.953 . . . . 0.0 110.233 -179.821 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 72.2 t80 . . . . . 0 N--CA 1.5 2.036 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -140.9 133.22 28.25 Favored 'General case' 0 N--CA 1.514 2.731 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -139.04 174.92 10.01 Favored 'General case' 0 N--CA 1.515 2.779 0 CA-C-N 119.508 1.049 . . . . 0.0 111.771 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 44.6 ttm -115.24 134.66 54.94 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.3 tp -91.02 139.1 31.08 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 113.496 -1.684 . . . . 0.0 109.82 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 127.99 -36.26 2.55 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.284 -1.527 . . . . 0.0 109.284 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.411 ' O ' ' C ' ' A' ' 53' ' ' GLN . 19.7 tptp -130.38 42.67 3.23 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 119.147 -0.454 . . . . 0.0 112.087 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.411 ' C ' ' O ' ' A' ' 52' ' ' LYS . 8.4 tt0 23.98 77.32 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 124.578 1.173 . . . . 0.0 112.991 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.417 ' O ' ' OE1' ' A' ' 54' ' ' GLU . 8.1 tm-20 -84.3 -27.2 27.98 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.436 ' O ' ' O ' ' A' ' 56' ' ' ILE . 16.3 m -119.4 154.44 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.439 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.588 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.436 ' O ' ' O ' ' A' ' 55' ' ' VAL . 3.1 pt -45.8 174.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 C-N-CA 118.653 -1.219 . . . . 0.0 111.913 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.54 ' O ' ' N ' ' A' ' 59' ' ' TRP . 5.0 tpt180 -71.01 -58.96 3.06 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.883 -1.053 . . . . 0.0 113.171 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -32.52 -30.53 0.01 OUTLIER Glycine 0 N--CA 1.5 2.947 0 CA-C-O 122.825 1.236 . . . . 0.0 111.531 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.54 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.8 OUTLIER -92.2 -76.2 0.46 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 112.924 -1.638 . . . . 0.0 109.557 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.514 ' OE1' ' NH1' ' A' ' 57' ' ' ARG . 3.8 tm-20 -32.02 -50.3 0.21 Allowed 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.1 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -73.65 -56.39 5.06 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -51.35 -77.55 0.13 Allowed Glycine 0 N--CA 1.481 1.637 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.526 ' N ' ' O ' ' A' ' 59' ' ' TRP . 40.2 t -36.05 -45.87 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.47 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -50.09 -53.48 26.92 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 123.715 1.721 . . . . 0.0 109.618 179.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -61.97 0.29 0.41 Allowed 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 110.399 -3.091 . . . . 0.0 110.692 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.47 ' H ' ' C ' ' A' ' 64' ' ' ALA . 50.8 ttm -110.09 151.8 26.77 Favored 'General case' 0 N--CA 1.51 2.534 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 80.4 p -115.85 153.57 31.26 Favored 'General case' 0 N--CA 1.509 2.512 0 CA-C-O 122.832 1.301 . . . . 0.0 113.922 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 79.6 t -45.23 98.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-N 112.324 -2.216 . . . . 0.0 114.967 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.46 10.5 21.63 Favored Glycine 0 N--CA 1.498 2.795 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -108.58 152.13 25.18 Favored 'General case' 0 N--CA 1.509 2.517 0 CA-C-O 122.384 1.088 . . . . 0.0 111.249 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 -131.83 141.25 49.38 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 113.027 -1.897 . . . . 0.0 108.357 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -148.07 177.91 8.98 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 112.888 -1.96 . . . . 0.0 114.223 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.524 ' NZ ' ' OE2' ' A' ' 5' ' ' GLU . 6.3 ttpm? -122.8 103.55 8.71 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 102.986 -2.968 . . . . 0.0 102.986 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.7 mt -96.49 145.06 26.02 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 90.7 m -117.45 107.62 14.54 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 104.349 -2.463 . . . . 0.0 104.349 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 35.8 mt -101.55 140.05 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.665 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.425 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -114.24 160.42 32.76 Favored Pre-proline 0 N--CA 1.497 1.887 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -45.09 -52.69 6.11 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.39 2.06 . . . . 0.0 112.736 -172.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.439 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 24.5 p30 -39.66 -29.85 0.06 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 . . . . . 0 N--CA 1.501 2.106 0 N-CA-C 115.089 1.515 . . . . 0.0 115.089 -179.524 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 25.5 m . . . . . 0 N--CA 1.495 1.817 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 29.7 mt -109.17 151.65 26.19 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 104.929 -2.248 . . . . 0.0 104.929 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.4 t -134.81 102.7 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -96.49 163.38 13.07 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 117.83 -1.548 . . . . 0.0 107.812 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -125.41 87.7 2.74 Favored 'General case' 0 N--CA 1.492 1.633 1 N-CA-C 95.559 -5.719 . . . . 0.0 95.559 179.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 16.8 t -100.07 147.98 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.423 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -127.18 103.75 7.59 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 112.463 -2.153 . . . . 0.0 107.538 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 37.5 tp -74.39 114.37 12.68 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 102.866 -3.013 . . . . 0.0 102.866 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.1 mt -77.11 -53.97 7.11 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.187 -179.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 9.0 mtpt -174.5 -167.21 0.3 Allowed 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.64 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 22.5 mt -117.53 154.28 31.74 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 . . . . . 0 N--CA 1.501 2.123 0 CA-C-O 116.156 -1.878 . . . . 0.0 108.528 179.84 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.4 p . . . . . 0 N--CA 1.502 2.162 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -122.3 154.7 37.25 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 57.2 t -126.52 109.11 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 CA-C-N 115.197 -0.91 . . . . 0.0 108.567 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -109.9 96.0 5.96 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 89.7 m -69.89 156.33 39.24 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 118.813 -1.155 . . . . 0.0 113.106 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 69.1 mt -122.49 -54.72 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-N 113.361 -1.745 . . . . 0.0 107.356 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.416 ' O ' ' O ' ' A' ' 9' ' ' PRO . 48.6 m -123.85 82.43 55.26 Favored Pre-proline 0 N--CA 1.506 2.372 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.574 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.416 ' O ' ' O ' ' A' ' 8' ' ' SER . 5.3 Cg_exo -36.36 163.91 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.447 2.098 . . . . 0.0 113.176 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -118.02 -172.51 15.77 Favored Glycine 0 N--CA 1.5 2.961 0 N-CA-C 104.88 -3.288 . . . . 0.0 104.88 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.495 ' CG ' ' H ' ' A' ' 12' ' ' GLY . 10.6 p-10 -45.88 -58.46 3.51 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 118.635 1.218 . . . . 0.0 111.108 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.495 ' H ' ' CG ' ' A' ' 11' ' ' ASP . . . 106.5 27.02 5.68 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 107.246 -2.341 . . . . 0.0 107.246 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 57.7 mtt85 -132.39 -35.32 1.17 Allowed 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 114.457 -0.871 . . . . 0.0 111.871 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.8 m -111.28 136.8 49.86 Favored 'General case' 0 N--CA 1.506 2.326 0 CA-C-O 121.703 0.763 . . . . 0.0 112.848 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.448 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 59.0 m-85 -132.14 176.11 3.16 Favored Pre-proline 0 N--CA 1.496 1.851 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -70.91 140.24 37.92 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 CA-C-N 119.508 0.86 . . . . 0.0 111.484 163.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -122.74 169.95 10.55 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 121.716 0.77 . . . . 0.0 109.009 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.1 mtp-105 -70.23 126.34 29.37 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.078 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.42 -19.3 13.04 Favored Glycine 0 N--CA 1.498 2.775 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -108.56 174.12 6.02 Favored 'General case' 0 N--CA 1.504 2.225 0 CA-C-O 121.847 0.832 . . . . 0.0 111.391 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 42.5 m -118.82 129.93 55.49 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 114.039 -1.437 . . . . 0.0 107.753 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 59.3 m -78.75 149.45 32.69 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.5 t -121.85 101.6 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 103.12 -2.918 . . . . 0.0 103.12 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.0 m -121.59 150.69 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.49 0 N-CA-C 117.248 2.314 . . . . 0.0 117.248 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -123.31 107.04 11.22 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 179.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -127.59 170.15 12.95 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-O 123.237 1.494 . . . . 0.0 114.589 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 98.1 m -139.29 119.5 13.68 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 102.754 -3.054 . . . . 0.0 102.754 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.53 137.63 14.23 Favored Glycine 0 N--CA 1.501 3.001 0 C-N-CA 120.073 -1.06 . . . . 0.0 110.995 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 40.5 ttm . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 -179.964 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 67.2 t80 . . . . . 0 N--CA 1.5 2.041 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.49 116.29 14.03 Favored 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -132.92 172.63 12.35 Favored 'General case' 0 N--CA 1.512 2.63 0 C-N-CA 119.797 -0.761 . . . . 0.0 111.298 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.9 ttm -119.89 153.65 35.55 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.4 tp -90.93 125.27 35.72 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.822 -1.535 . . . . 0.0 110.491 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.18 -24.57 7.33 Favored Glycine 0 N--CA 1.501 2.983 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 54' ' ' GLU . 52.8 tttp -116.11 39.35 3.1 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' ' 52' ' ' LYS . 86.5 mt-30 1.49 61.77 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 125.794 1.934 . . . . 0.0 114.384 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 52' ' ' LYS . 43.7 tt0 -75.21 -23.38 57.61 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 113.715 -1.584 . . . . 0.0 107.406 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.5 m -113.15 -178.45 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 18.6 pt -90.26 167.04 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 C-N-CA 118.998 -1.081 . . . . 0.0 110.868 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.531 ' O ' ' N ' ' A' ' 59' ' ' TRP . 0.7 OUTLIER -45.69 -70.22 0.11 Allowed 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 114.311 -1.313 . . . . 0.0 111.138 -179.774 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -26.47 -36.66 0.01 OUTLIER Glycine 0 N--CA 1.496 2.654 0 O-C-N 125.175 1.547 . . . . 0.0 112.799 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.531 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.8 OUTLIER -83.59 -68.36 0.72 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.819 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.463 ' OE1' ' N ' ' A' ' 61' ' ' GLU . 10.1 tm-20 -33.73 -53.45 0.44 Allowed 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 113.934 -1.485 . . . . 0.0 110.721 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.503 ' OE2' ' NE2' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -73.71 -57.42 4.0 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 104.777 -2.305 . . . . 0.0 104.777 179.707 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -46.46 -78.57 0.08 OUTLIER Glycine 0 N--CA 1.485 1.963 0 C-N-CA 119.554 -1.307 . . . . 0.0 111.061 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 59' ' ' TRP . 32.3 t -39.63 -47.32 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 114.948 -0.626 . . . . 0.0 111.932 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.424 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -50.1 -51.27 44.32 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 123.265 1.507 . . . . 0.0 110.499 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.503 ' NE2' ' OE2' ' A' ' 61' ' ' GLU . 7.3 tt0 -65.94 2.98 0.9 Allowed 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 111.216 -2.72 . . . . 0.0 111.507 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.424 ' H ' ' C ' ' A' ' 64' ' ' ALA . 60.0 ttm -106.61 151.99 24.32 Favored 'General case' 0 N--CA 1.509 2.493 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 179.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 92.0 p -116.49 151.98 35.0 Favored 'General case' 0 N--CA 1.51 2.566 0 CA-C-O 122.69 1.233 . . . . 0.0 113.541 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 86.0 t -45.0 97.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 112.597 -2.092 . . . . 0.0 114.755 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.35 8.42 23.27 Favored Glycine 0 N--CA 1.5 2.937 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -105.4 145.31 30.97 Favored 'General case' 0 N--CA 1.506 2.361 0 CA-C-O 121.648 0.737 . . . . 0.0 111.566 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.9 ttt85 -126.17 141.45 51.93 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.261 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -149.54 177.52 9.66 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 113.007 -1.906 . . . . 0.0 115.507 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -127.03 105.14 8.39 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 103.07 -2.937 . . . . 0.0 103.07 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.1 mp -101.67 151.55 21.89 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 119.766 -0.774 . . . . 0.0 109.882 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 86.3 m -121.61 121.73 38.05 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 25.6 mt -111.41 139.92 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.429 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 66.8 p -113.87 154.35 45.92 Favored Pre-proline 0 N--CA 1.503 2.22 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -37.55 -54.11 1.28 Allowed 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 121.784 1.656 . . . . 0.0 113.192 -174.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.52 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 0.9 OUTLIER -34.66 -35.87 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.445 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 . . . . . 0 N--CA 1.495 1.795 0 CA-C-N 114.685 -1.143 . . . . 0.0 112.049 -179.768 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 68.9 m . . . . . 0 N--CA 1.498 1.96 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 31.5 mt -116.82 149.59 39.74 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.6 t -132.37 123.03 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -115.77 157.13 24.8 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 122.023 0.916 . . . . 0.0 110.166 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -127.72 90.82 3.17 Favored 'General case' 0 N--CA 1.493 1.689 1 N-CA-C 99.194 -4.372 . . . . 0.0 99.194 179.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.4 t -105.32 151.34 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.54 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -127.92 98.09 5.03 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 112.327 -2.215 . . . . 0.0 107.838 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 56.0 tp -69.87 119.44 14.1 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 11.4 mt -82.35 -55.97 4.18 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 113.902 -1.499 . . . . 0.0 110.639 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -173.95 -168.09 0.39 Allowed 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 114.71 -1.132 . . . . 0.0 111.065 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 25.7 mt -114.82 160.02 19.94 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 . . . . . 0 N--CA 1.504 2.251 0 CA-C-O 116.241 -1.838 . . . . 0.0 108.236 179.705 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.503 2.217 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -124.31 151.89 43.74 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.0 t -123.09 115.79 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -117.78 97.67 5.96 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.664 ' HG1' ' NE2' ' A' ' 70' ' ' GLN . 94.7 m -69.75 156.52 38.87 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.154 -1.018 . . . . 0.0 112.734 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.1 mt -121.38 -58.52 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.531 ' CB ' ' NH1' ' A' ' 71' ' ' ARG . 48.3 m -121.64 84.6 43.07 Favored Pre-proline 0 N--CA 1.501 2.086 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.877 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 8' ' ' SER . 6.8 Cg_exo -36.23 163.79 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.397 2.065 . . . . 0.0 113.264 178.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.2 -173.63 14.7 Favored Glycine 0 N--CA 1.499 2.885 0 N-CA-C 105.555 -3.018 . . . . 0.0 105.555 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 11' ' ' ASP . 13.0 p-10 -39.71 -59.87 1.08 Allowed 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.809 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.15 20.06 11.76 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 105.356 -3.098 . . . . 0.0 105.356 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 46.4 mtm180 -128.21 -38.5 1.78 Allowed 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 113.699 -1.251 . . . . 0.0 112.733 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.0 m -108.18 135.29 49.77 Favored 'General case' 0 N--CA 1.505 2.315 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.441 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 67.6 m-85 -130.94 177.16 2.37 Favored Pre-proline 0 N--CA 1.495 1.796 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -66.22 153.27 78.7 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 CA-C-N 119.408 0.824 . . . . 0.0 110.806 160.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -122.65 170.88 9.58 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 121.759 0.79 . . . . 0.0 109.361 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 42.4 mtp-105 -78.22 96.63 5.27 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.096 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.73 10.56 3.92 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -114.74 172.09 7.25 Favored 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 74.7 m -121.86 112.27 18.13 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.25 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 22.5 m -69.54 147.35 50.92 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.758 0.789 . . . . 0.0 109.518 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.1 t -123.09 112.31 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 101.592 -3.484 . . . . 0.0 101.592 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.0 m -122.44 151.62 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -120.38 99.21 6.44 Favored 'General case' 0 N--CA 1.508 2.463 0 CA-C-N 112.71 -2.041 . . . . 0.0 106.473 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.41 ' CD2' ' CD2' ' A' ' 99' ' ' PHE . 28.0 p90 -132.29 173.8 10.89 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.6 m -134.7 117.92 16.56 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 102.628 -3.101 . . . . 0.0 102.628 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.57 120.8 6.73 Favored Glycine 0 N--CA 1.503 3.157 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 37.4 tpp . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -179.659 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 69.3 t80 . . . . . 0 N--CA 1.486 1.372 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -133.05 143.9 49.67 Favored 'General case' 0 N--CA 1.514 2.753 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -149.07 174.64 12.1 Favored 'General case' 0 N--CA 1.504 2.242 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.156 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 41.6 ttm -118.04 142.74 47.06 Favored 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.3 tp -91.02 120.63 32.16 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.953 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.08 24.18 9.95 Favored Glycine 0 N--CA 1.5 2.903 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.48 ' O ' ' CB ' ' A' ' 53' ' ' GLN . 15.6 tppt? -125.29 -55.94 1.54 Allowed 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.48 ' CB ' ' O ' ' A' ' 52' ' ' LYS . 46.3 tt0 100.81 68.85 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 O-C-N 126.0 2.063 . . . . 0.0 108.29 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -109.12 -36.24 6.11 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 113.939 -1.482 . . . . 0.0 107.459 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.415 ' O ' ' O ' ' A' ' 56' ' ' ILE . 15.8 m -111.05 151.77 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.415 ' O ' ' O ' ' A' ' 55' ' ' VAL . 15.7 pt -48.48 174.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 C-N-CA 118.276 -1.37 . . . . 0.0 111.038 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.544 ' O ' ' N ' ' A' ' 59' ' ' TRP . 46.5 ttm180 -69.59 -63.28 1.1 Allowed 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -28.78 -34.73 0.01 OUTLIER Glycine 0 N--CA 1.499 2.837 0 O-C-N 124.472 1.107 . . . . 0.0 112.356 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.544 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.5 OUTLIER -81.42 -74.53 0.33 Allowed 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 113.177 -1.511 . . . . 0.0 107.553 179.877 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.518 ' OE1' ' N ' ' A' ' 61' ' ' GLU . 10.9 tm-20 -33.86 -51.37 0.4 Allowed 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.742 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.518 ' N ' ' OE1' ' A' ' 60' ' ' GLU . 17.7 tp10 -72.7 -55.48 6.73 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 112.544 -2.116 . . . . 0.0 108.095 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -55.29 -72.74 0.51 Allowed Glycine 0 N--CA 1.477 1.408 0 C-N-CA 119.246 -1.454 . . . . 0.0 110.17 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.498 ' N ' ' O ' ' A' ' 59' ' ' TRP . 40.6 t -39.56 -49.56 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 120.126 -0.629 . . . . 0.0 112.308 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.509 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -47.22 -62.09 1.58 Allowed 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 124.037 1.875 . . . . 0.0 110.139 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -48.43 -12.7 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 109.654 -3.43 . . . . 0.0 108.764 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.509 ' H ' ' C ' ' A' ' 64' ' ' ALA . 52.1 ttp -108.95 156.01 20.21 Favored 'General case' 0 N--CA 1.509 2.479 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.4 p -110.94 161.76 15.52 Favored 'General case' 0 N--CA 1.509 2.519 0 N-CA-C 116.338 1.977 . . . . 0.0 116.338 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 86.2 t -56.32 102.58 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-N 110.727 -2.942 . . . . 0.0 113.482 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.56 6.61 23.27 Favored Glycine 0 N--CA 1.499 2.867 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.664 ' NE2' ' HG1' ' A' ' 6' ' ' THR . 41.8 tt0 -107.12 148.86 28.29 Favored 'General case' 0 N--CA 1.504 2.27 0 CA-C-O 122.097 0.951 . . . . 0.0 110.29 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.531 ' NH1' ' CB ' ' A' ' 8' ' ' SER . 34.8 mtm-85 -122.35 128.35 50.89 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 113.577 -1.647 . . . . 0.0 107.977 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -134.91 172.02 13.58 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -124.57 103.17 8.0 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 102.766 -3.05 . . . . 0.0 102.766 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.8 mt -98.46 146.93 25.25 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.1 m -117.52 111.06 18.73 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 102.473 -3.158 . . . . 0.0 102.473 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 27.2 mt -109.41 137.79 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-O 121.462 0.649 . . . . 0.0 111.53 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.431 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 27.1 p -104.63 152.51 39.44 Favored Pre-proline 0 N--CA 1.504 2.27 0 CA-C-N 113.804 -1.543 . . . . 0.0 110.082 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -47.86 -38.83 31.2 Favored 'Trans proline' 0 N--CA 1.488 1.177 0 C-N-CA 122.574 2.183 . . . . 0.0 113.332 -173.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.521 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 7.0 p-10 -48.81 -40.44 29.22 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.101 -0.64 . . . . 0.0 110.943 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.7 m-30 . . . . . 0 N--CA 1.49 1.527 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.884 -179.745 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 87.3 m . . . . . 0 N--CA 1.494 1.727 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 20.7 mt -97.75 147.19 24.63 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 103.893 -2.632 . . . . 0.0 103.893 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 56.5 t -132.71 124.11 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.432 ' CD2' ' NE1' ' A' ' 59' ' ' TRP . 2.0 m-85 -115.5 167.82 10.55 Favored 'General case' 0 N--CA 1.507 2.387 0 CA-C-O 123.264 1.507 . . . . 0.0 110.477 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -130.28 88.7 2.68 Favored 'General case' 0 N--CA 1.49 1.544 1 N-CA-C 98.222 -4.733 . . . . 0.0 98.222 179.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.5 t -100.95 151.46 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.442 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 -179.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 72.8 tt0 -127.27 97.36 4.88 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 112.377 -2.192 . . . . 0.0 106.806 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 43.8 tp -68.25 122.72 18.92 Favored 'General case' 0 N--CA 1.506 2.373 0 C-N-CA 115.591 -2.444 . . . . 0.0 104.936 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 11.4 mt -85.42 -62.29 1.56 Allowed 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.92 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.461 ' CG ' ' H ' ' A' ' 106' ' ' LEU . 34.1 ttpt -170.77 -175.24 1.76 Allowed 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 118.892 -1.123 . . . . 0.0 109.826 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.461 ' H ' ' CG ' ' A' ' 105' ' ' LYS . 24.2 mt -108.94 156.31 19.86 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 . . . . . 0 N--CA 1.504 2.271 0 CA-C-O 116.037 -1.935 . . . . 0.0 109.686 179.955 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.2 p . . . . . 0 N--CA 1.502 2.167 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -119.51 151.25 38.9 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 86.6 t -129.41 98.11 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.142 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -102.0 117.16 34.23 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 104.879 -2.267 . . . . 0.0 104.879 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 92.8 m -91.7 154.86 18.71 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 122.054 0.93 . . . . 0.0 111.729 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 62.5 mt -123.53 -51.11 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 9' ' ' PRO . 33.8 m -121.46 81.26 38.79 Favored Pre-proline 0 N--CA 1.509 2.516 0 C-N-CA 120.271 -0.572 . . . . 0.0 112.038 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 8' ' ' SER . 5.3 Cg_exo -37.33 164.75 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.373 2.049 . . . . 0.0 112.578 178.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.11 -171.97 14.37 Favored Glycine 0 N--CA 1.5 2.926 0 N-CA-C 107.048 -2.421 . . . . 0.0 107.048 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 12' ' ' GLY . 1.1 p30 -39.55 -52.29 2.18 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.707 -0.797 . . . . 0.0 112.689 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.476 ' N ' ' OD1' ' A' ' 11' ' ' ASP . . . 100.51 5.14 54.45 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 108.44 -1.864 . . . . 0.0 108.44 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 32.3 mtp85 -121.45 -35.76 3.2 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 42.4 m -107.7 138.43 43.94 Favored 'General case' 0 N--CA 1.509 2.488 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.452 ' N ' ' CD1' ' A' ' 15' ' ' PHE . 35.0 m-85 -133.09 175.41 3.73 Favored Pre-proline 0 N--CA 1.498 1.952 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -66.27 145.63 78.58 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 CA-C-N 119.769 0.953 . . . . 0.0 109.967 165.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -118.96 169.89 9.5 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 122.373 1.083 . . . . 0.0 111.969 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 25.3 ttt85 -79.2 103.18 8.96 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 113.805 -1.543 . . . . 0.0 109.89 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.44 -10.09 6.49 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 108.353 -1.899 . . . . 0.0 108.353 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -114.93 176.1 5.2 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 89.2 m -112.62 163.2 14.81 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 2.2 m -114.27 143.26 45.14 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 104.613 -2.366 . . . . 0.0 104.613 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.8 t -117.72 102.5 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 103.397 -2.816 . . . . 0.0 103.397 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.8 m -122.46 152.0 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.363 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 -129.63 128.12 41.98 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 102.721 -3.066 . . . . 0.0 102.721 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -139.77 176.23 8.91 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 115.335 1.605 . . . . 0.0 115.335 -179.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 91.7 m -132.87 121.55 23.08 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 103.246 -2.872 . . . . 0.0 103.246 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.84 123.15 7.55 Favored Glycine 0 N--CA 1.503 3.138 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 45.3 ttp . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.704 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 65.5 t80 . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm -131.48 119.92 22.25 Favored 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -138.83 170.94 15.09 Favored 'General case' 0 N--CA 1.513 2.688 0 C-N-CA 119.306 -0.958 . . . . 0.0 112.402 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 43.1 ttm -115.75 154.6 29.29 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.1 tp -90.92 120.71 32.15 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.86 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.89 12.84 48.66 Favored Glycine 0 N--CA 1.499 2.84 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.303 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.427 ' O ' ' OE2' ' A' ' 54' ' ' GLU . 59.3 tttm -121.85 23.06 10.24 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 23.5 69.4 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 114.617 -1.174 . . . . 0.0 113.782 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.427 ' OE2' ' O ' ' A' ' 52' ' ' LYS . 66.6 mm-40 -106.28 -35.86 7.04 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 56' ' ' ILE . 18.6 m -116.59 152.56 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 CA-C-O 121.513 0.673 . . . . 0.0 110.543 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.425 ' O ' ' O ' ' A' ' 55' ' ' VAL . 4.8 pt -48.98 177.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.706 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.541 ' O ' ' N ' ' A' ' 59' ' ' TRP . 18.2 ttm180 -71.4 -61.01 1.93 Allowed 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -24.05 -39.16 0.01 OUTLIER Glycine 0 N--CA 1.495 2.622 0 O-C-N 124.929 1.393 . . . . 0.0 112.497 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.541 ' N ' ' O ' ' A' ' 57' ' ' ARG . 1.1 m95 -83.01 -70.01 0.59 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.412 ' OE1' ' O ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -30.4 -59.82 0.19 Allowed 'General case' 0 N--CA 1.504 2.243 0 O-C-N 124.95 1.406 . . . . 0.0 110.05 -179.899 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -67.72 -52.66 35.03 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -49.77 -89.11 0.01 OUTLIER Glycine 0 N--CA 1.478 1.451 0 CA-C-N 114.363 -1.29 . . . . 0.0 111.282 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' A' ' 59' ' ' TRP . 40.0 t -31.76 -48.43 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.523 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -46.32 -59.79 2.72 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 124.169 1.937 . . . . 0.0 110.648 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -48.18 -11.77 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 109.305 -3.588 . . . . 0.0 109.276 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.523 ' H ' ' C ' ' A' ' 64' ' ' ALA . 85.2 mtp -97.53 156.12 16.65 Favored 'General case' 0 N--CA 1.513 2.691 0 C-N-CA 118.753 -1.179 . . . . 0.0 108.123 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 70' ' ' GLN . 73.1 p -120.11 147.66 44.58 Favored 'General case' 0 N--CA 1.51 2.544 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 59.1 t -36.8 96.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 CA-C-N 113.131 -1.849 . . . . 0.0 114.139 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.05 13.75 16.99 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 108.539 -1.824 . . . . 0.0 108.539 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 67' ' ' SER . 44.6 tt0 -109.68 138.17 46.43 Favored 'General case' 0 N--CA 1.503 2.225 0 CA-C-O 121.602 0.715 . . . . 0.0 109.795 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -126.83 138.99 53.42 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -144.43 178.01 8.24 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-N 112.006 -2.361 . . . . 0.0 114.6 -179.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.5 ttmp? -124.55 104.22 8.59 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 111.406 -2.634 . . . . 0.0 104.021 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.3 mp -100.42 146.0 27.54 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 119.676 -0.81 . . . . 0.0 108.878 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 90.2 m -121.72 104.47 9.62 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.4 HD13 ' H ' ' A' ' 76' ' ' ILE . 2.7 mp -95.41 141.71 14.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.206 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.3 p -112.97 153.59 45.2 Favored Pre-proline 0 N--CA 1.503 2.204 0 CA-C-N 114.631 -1.168 . . . . 0.0 108.011 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -40.25 -47.13 4.2 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.01 1.807 . . . . 0.0 112.964 -172.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.526 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 4.0 p-10 -43.88 -35.3 1.92 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 . . . . . 0 N--CA 1.498 1.937 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.644 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 93.0 m . . . . . 0 N--CA 1.497 1.907 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 22.2 mt -113.35 157.91 21.25 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 53.4 t -135.28 98.39 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -93.36 155.42 17.4 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -122.66 89.99 3.21 Favored 'General case' 0 N--CA 1.491 1.606 1 N-CA-C 95.466 -5.753 . . . . 0.0 95.466 179.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 12.5 t -100.7 148.32 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 C-N-CA 118.817 -1.153 . . . . 0.0 113.793 -178.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -124.94 109.12 12.61 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 112.429 -2.169 . . . . 0.0 107.49 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 55.5 tp -79.68 116.73 20.04 Favored 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 102.396 -3.187 . . . . 0.0 102.396 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.479 ' O ' ' NZ ' ' A' ' 105' ' ' LYS . 15.4 mt -88.13 -54.57 4.15 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -178.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.479 ' NZ ' ' O ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -164.58 177.82 7.81 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.326 -179.722 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 28.6 mt -118.07 153.58 33.5 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 . . . . . 0 N--CA 1.503 2.206 0 CA-C-O 115.733 -2.08 . . . . 0.0 108.63 179.849 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.466 ' C ' ' NE2' ' A' ' 3' ' ' GLN . 9.2 p . . . . . 0 N--CA 1.502 2.155 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.478 ' N ' ' CD ' ' A' ' 3' ' ' GLN . 16.0 mp0 -121.59 148.11 44.95 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 59.6 t -124.66 109.36 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.026 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -109.98 97.03 6.62 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 88.6 m -69.91 156.72 38.67 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 118.961 -1.095 . . . . 0.0 112.643 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -121.84 -54.77 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-N 113.569 -1.65 . . . . 0.0 107.213 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.422 ' O ' ' O ' ' A' ' 9' ' ' PRO . 37.0 t -124.1 82.66 56.46 Favored Pre-proline 0 N--CA 1.506 2.345 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.821 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 8' ' ' SER . 2.0 Cg_exo -35.84 161.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.336 2.024 . . . . 0.0 112.574 178.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.52 -171.25 14.74 Favored Glycine 0 N--CA 1.502 3.036 0 N-CA-C 107.426 -2.269 . . . . 0.0 107.426 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 68' ' ' VAL . 0.7 OUTLIER -39.92 -65.18 0.42 Allowed 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.589 0.709 . . . . 0.0 112.351 -179.969 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.95 16.16 16.14 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 105.809 -2.916 . . . . 0.0 105.809 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.0 mtp85 -125.47 -44.18 1.86 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 114.028 -1.086 . . . . 0.0 111.963 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.0 m -103.96 133.23 49.27 Favored 'General case' 0 N--CA 1.504 2.247 0 CA-C-O 121.522 0.677 . . . . 0.0 112.085 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.43 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 41.9 m-85 -130.97 175.21 3.86 Favored Pre-proline 0 N--CA 1.501 2.085 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -71.44 150.66 58.4 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 N-CA-C 109.485 -1.006 . . . . 0.0 109.485 164.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -120.24 172.39 7.82 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-O 121.929 0.871 . . . . 0.0 110.84 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 19.6 ttp180 -81.23 96.67 7.33 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.382 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.16 -1.24 5.77 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 108.597 -1.801 . . . . 0.0 108.597 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.5 ' O ' ' SD ' ' A' ' 49' ' ' MET . 82.0 mt-30 -114.63 172.56 6.95 Favored 'General case' 0 N--CA 1.503 2.209 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.2 m -108.67 153.08 23.93 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.3 m -111.27 141.5 44.72 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 104.972 -2.233 . . . . 0.0 104.972 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.6 t -118.8 109.16 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 100.689 -3.819 . . . . 0.0 100.689 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.4 m -124.36 155.46 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 125.751 1.907 . . . . 0.0 113.058 -179.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 -130.76 107.3 9.05 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 104.197 -2.52 . . . . 0.0 104.197 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.419 ' CD2' ' CD2' ' A' ' 99' ' ' PHE . 27.2 p90 -132.59 177.29 7.73 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 95.9 m -137.49 116.41 12.36 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 111.444 -2.616 . . . . 0.0 104.959 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -111.5 114.5 3.65 Favored Glycine 0 N--CA 1.501 2.992 0 N-CA-C 107.642 -2.183 . . . . 0.0 107.642 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 38.9 ttm . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 -179.859 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 56.9 t80 . . . . . 0 N--CA 1.497 1.904 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 31.9 mtmm -142.51 122.89 13.94 Favored 'General case' 0 N--CA 1.504 2.247 0 CA-C-O 118.782 -0.628 . . . . 0.0 110.667 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -133.17 167.07 21.02 Favored 'General case' 0 N--CA 1.513 2.678 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.5 ' SD ' ' O ' ' A' ' 20' ' ' GLN . 47.3 tpp -107.37 129.39 54.92 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 113.492 -1.685 . . . . 0.0 111.824 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.7 tp -90.66 146.39 24.07 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.157 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 129.51 -42.28 1.44 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 107.317 -2.313 . . . . 0.0 107.317 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 54' ' ' GLU . 6.2 tmtt? -120.39 43.57 2.69 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 3.63 58.65 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.094 0 O-C-N 125.64 1.838 . . . . 0.0 114.807 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.534 ' N ' ' O ' ' A' ' 52' ' ' LYS . 11.3 pt-20 -64.01 -6.29 6.01 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 118.759 -1.176 . . . . 0.0 110.738 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 56' ' ' ILE . 33.7 m -116.38 158.94 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.425 ' O ' ' O ' ' A' ' 55' ' ' VAL . 17.3 pt -49.31 174.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 C-N-CA 117.83 -1.548 . . . . 0.0 110.118 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.541 ' O ' ' N ' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -70.55 -60.53 2.21 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 57' ' ' ARG . . . -20.52 -44.17 0.01 OUTLIER Glycine 0 N--CA 1.502 3.046 0 O-C-N 125.407 1.692 . . . . 0.0 112.495 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.541 ' N ' ' O ' ' A' ' 57' ' ' ARG . 1.5 m95 -73.99 -75.78 0.15 Allowed 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 111.668 -2.266 . . . . 0.0 108.813 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 59' ' ' TRP . 4.1 tm-20 -22.54 -55.66 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 126.303 2.252 . . . . 0.0 110.898 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -78.72 -53.07 7.52 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 113.219 -1.81 . . . . 0.0 106.592 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -51.35 -73.24 0.4 Allowed Glycine 0 N--CA 1.482 1.709 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.526 ' N ' ' O ' ' A' ' 59' ' ' TRP . 24.9 t -44.14 -49.76 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 119.258 -0.977 . . . . 0.0 111.503 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.518 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -45.22 -61.88 1.48 Allowed 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 123.864 1.793 . . . . 0.0 111.181 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -46.63 -13.63 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 109.913 -3.312 . . . . 0.0 109.244 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.518 ' H ' ' C ' ' A' ' 64' ' ' ALA . 41.9 mtm -103.32 154.8 18.99 Favored 'General case' 0 N--CA 1.513 2.717 0 C-N-CA 118.847 -1.141 . . . . 0.0 109.098 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 82.7 p -116.41 153.59 31.79 Favored 'General case' 0 N--CA 1.505 2.286 0 CA-C-O 122.624 1.202 . . . . 0.0 113.428 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.417 ' O ' ' OD1' ' A' ' 11' ' ' ASP . 85.8 t -43.07 95.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 112.416 -2.175 . . . . 0.0 114.388 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.04 16.42 7.88 Favored Glycine 0 N--CA 1.497 2.759 0 N-CA-C 108.816 -1.714 . . . . 0.0 108.816 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -108.38 142.81 38.17 Favored 'General case' 0 N--CA 1.506 2.356 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.741 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 24.2 ttt85 -126.72 141.65 51.78 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -149.46 177.4 9.74 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 116.334 1.976 . . . . 0.0 116.334 -179.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -127.81 104.5 7.86 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 103.326 -2.842 . . . . 0.0 103.326 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.2 mp -101.8 146.65 27.5 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 119.606 -0.838 . . . . 0.0 109.194 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 73.2 m -117.05 104.0 10.81 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 102.309 -3.219 . . . . 0.0 102.309 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 21.4 mt -102.86 138.73 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.14 163.7 20.62 Favored Pre-proline 0 N--CA 1.503 2.219 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.865 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -37.74 -50.94 1.87 Allowed 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 122.561 2.174 . . . . 0.0 113.184 -175.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 80' ' ' TYR . 1.7 p30 -44.24 -42.72 6.76 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 120.191 -0.603 . . . . 0.0 111.608 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.476 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 6.8 m-85 . . . . . 0 N--CA 1.496 1.846 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.674 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 99.9 m . . . . . 0 N--CA 1.506 2.343 0 CA-C-O 118.324 -0.846 . . . . 0.0 110.544 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.8 mt -96.72 152.61 18.5 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.5 t -134.78 115.12 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.419 ' CD2' ' CD2' ' A' ' 26' ' ' TYR . 2.0 m-85 -108.15 163.09 13.46 Favored 'General case' 0 N--CA 1.504 2.232 0 CA-C-O 122.968 1.366 . . . . 0.0 109.477 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -128.78 90.03 2.98 Favored 'General case' 0 N--CA 1.492 1.664 1 N-CA-C 98.186 -4.746 . . . . 0.0 98.186 179.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.3 t -102.21 148.31 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.558 0 N-CA-C 116.89 2.181 . . . . 0.0 116.89 -178.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -129.72 99.7 5.23 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 112.922 -1.944 . . . . 0.0 108.626 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 50.4 tp -73.28 119.39 17.45 Favored 'General case' 0 N--CA 1.504 2.253 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.2 mt -85.66 -60.07 2.13 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.643 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.432 ' CG ' ' H ' ' A' ' 106' ' ' LEU . 60.4 tttm -168.72 -175.89 2.57 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.813 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.432 ' H ' ' CG ' ' A' ' 105' ' ' LYS . 20.9 mt -109.03 160.6 15.91 Favored 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 . . . . . 0 N--CA 1.503 2.216 0 CA-C-O 115.827 -2.035 . . . . 0.0 109.4 179.838 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.503 2.223 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -121.87 154.53 36.96 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.6 t -126.98 114.12 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-N 112.929 -1.941 . . . . 0.0 109.3 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.528 ' OE2' ' NZ ' ' A' ' 73' ' ' LYS . 37.7 tt0 -118.06 101.52 8.31 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 42.0 m -70.04 150.73 46.32 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 118.938 -1.105 . . . . 0.0 113.623 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 77.2 mt -110.99 -55.35 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.9 t -129.65 90.78 42.57 Favored Pre-proline 0 N--CA 1.504 2.232 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.235 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -37.75 165.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 122.189 1.926 . . . . 0.0 112.54 174.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.6 -113.78 2.47 Favored Glycine 0 N--CA 1.5 2.938 0 N-CA-C 106.344 -2.702 . . . . 0.0 106.344 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.531 ' CG ' ' H ' ' A' ' 12' ' ' GLY . 9.8 p-10 -100.61 -62.5 1.23 Allowed 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.531 ' H ' ' CG ' ' A' ' 11' ' ' ASP . . . 104.88 28.05 5.76 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 42.4 mtp-105 -133.61 -39.0 0.9 Allowed 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.4 m -107.53 131.3 54.48 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.425 0.631 . . . . 0.0 112.279 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.461 ' N ' ' CD1' ' A' ' 15' ' ' PHE . 23.1 m-85 -129.73 174.18 4.89 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -71.48 139.15 33.94 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 CA-C-N 119.857 0.985 . . . . 0.0 111.801 166.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -120.07 171.98 8.08 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 122.205 1.003 . . . . 0.0 111.271 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.9 ttt85 -71.28 104.31 3.1 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.189 -1.369 . . . . 0.0 111.588 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.33 8.84 5.77 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -121.97 174.15 7.08 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 57.5 m -119.44 114.56 22.5 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.544 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 58.5 m -69.26 153.28 43.9 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 24.6 t -128.06 102.46 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 103.677 -2.712 . . . . 0.0 103.677 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.9 m -122.48 149.66 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.465 0 N-CA-C 116.662 2.097 . . . . 0.0 116.662 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -128.35 112.19 14.17 Favored 'General case' 0 N--CA 1.51 2.528 0 N-CA-C 103.996 -2.594 . . . . 0.0 103.996 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' A' ' 26' ' ' TYR . 36.1 p90 -133.7 -175.07 3.7 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 90.8 m -140.17 123.25 16.72 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 102.06 -3.311 . . . . 0.0 102.06 179.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -114.41 125.09 6.68 Favored Glycine 0 N--CA 1.507 3.392 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.8 tmm? . . . . . 0 N--CA 1.493 1.692 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -179.874 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 59.0 t80 . . . . . 0 N--CA 1.497 1.89 0 CA-C-O 119.73 -0.176 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 31.2 mttm -145.08 137.4 25.95 Favored 'General case' 0 N--CA 1.512 2.659 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -136.45 165.72 25.15 Favored 'General case' 0 N--CA 1.516 2.85 0 CA-C-N 119.972 1.26 . . . . 0.0 110.85 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 47.8 ttp -117.15 86.84 2.58 Favored 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 116.867 2.173 . . . . 0.0 116.867 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.4 tp -32.14 125.12 0.29 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 124.215 0.947 . . . . 0.0 112.867 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 129.48 -30.77 3.55 Favored Glycine 0 N--CA 1.499 2.84 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.48 ' O ' ' N ' ' A' ' 54' ' ' GLU . 80.1 tttt -121.03 43.76 2.7 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 52' ' ' LYS . 46.0 tt0 3.19 62.68 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.163 0 O-C-N 126.031 2.082 . . . . 0.0 113.306 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' A' ' 52' ' ' LYS . 43.8 tt0 -72.36 -24.77 61.32 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 113.541 -1.663 . . . . 0.0 106.686 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.4 m -113.8 156.5 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.818 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.7 pt -60.2 172.69 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 118.153 -1.419 . . . . 0.0 110.03 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.559 ' O ' ' N ' ' A' ' 59' ' ' TRP . 24.2 ttt85 -65.56 -59.99 3.39 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 118.214 -0.898 . . . . 0.0 112.624 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -28.13 -34.91 0.01 OUTLIER Glycine 0 N--CA 1.506 3.336 0 CA-C-O 122.916 1.287 . . . . 0.0 111.444 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.559 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.5 OUTLIER -83.01 -79.84 0.18 Allowed 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 112.24 -1.98 . . . . 0.0 107.746 179.829 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -28.48 -49.39 0.07 Allowed 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 113.347 -1.752 . . . . 0.0 110.692 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -77.33 -54.54 6.34 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -52.64 -74.95 0.25 Allowed Glycine 0 N--CA 1.482 1.752 0 N-CA-C 108.553 -1.819 . . . . 0.0 108.553 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.518 ' N ' ' O ' ' A' ' 59' ' ' TRP . 25.9 t -38.32 -45.47 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.612 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.8 -44.2 66.45 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 122.799 1.285 . . . . 0.0 109.445 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.443 ' N ' ' O ' ' A' ' 62' ' ' GLY . 6.7 tt0 -74.6 8.79 2.1 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 111.966 -2.379 . . . . 0.0 111.463 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 94.4 mtp -116.61 149.66 39.34 Favored 'General case' 0 N--CA 1.507 2.389 0 N-CA-C 104.664 -2.347 . . . . 0.0 104.664 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 80.3 p -116.52 153.87 31.4 Favored 'General case' 0 N--CA 1.51 2.571 0 CA-C-O 122.934 1.349 . . . . 0.0 113.899 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 63.0 t -43.03 100.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 112.04 -2.345 . . . . 0.0 116.15 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.26 4.52 28.97 Favored Glycine 0 N--CA 1.5 2.909 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.401 ' OE1' ' C ' ' A' ' 70' ' ' GLN . 0.8 OUTLIER -110.17 145.16 37.72 Favored 'General case' 0 N--CA 1.507 2.42 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.977 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -128.16 145.48 51.01 Favored 'General case' 0 N--CA 1.508 2.435 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.611 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -144.11 -177.72 5.59 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-N 112.776 -2.011 . . . . 0.0 115.538 -179.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.528 ' NZ ' ' OE2' ' A' ' 5' ' ' GLU . 6.6 ttpm? -125.49 106.79 10.04 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 101.767 -3.42 . . . . 0.0 101.767 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.1 mt -101.25 143.54 31.2 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 59.0 m -115.17 117.01 29.31 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 102.021 -3.326 . . . . 0.0 102.021 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 30.0 mt -110.82 142.4 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.422 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 32.7 p -114.31 158.32 40.09 Favored Pre-proline 0 N--CA 1.506 2.341 0 CA-C-N 114.427 -1.26 . . . . 0.0 108.141 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -35.0 -55.31 0.57 Allowed 'Trans proline' 0 C--N 1.315 -1.202 0 C-N-CA 121.871 1.714 . . . . 0.0 113.852 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.524 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 3.9 p-10 -42.15 -41.97 2.84 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.332 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.486 ' CE2' ' NE ' ' A' ' 57' ' ' ARG . 7.5 m-85 . . . . . 0 N--CA 1.499 1.984 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 29.5 m . . . . . 0 N--CA 1.499 1.998 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.2 mt -115.13 155.75 26.52 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 59.0 t -139.43 97.72 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -92.07 167.04 12.36 Favored 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 117.586 -1.646 . . . . 0.0 108.992 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -130.04 86.87 2.45 Favored 'General case' 0 N--CA 1.493 1.678 1 N-CA-C 97.387 -5.042 . . . . 0.0 97.387 178.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.7 t -100.8 149.82 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 -178.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -125.81 101.58 6.91 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 112.04 -2.345 . . . . 0.0 107.406 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 50.4 tp -74.83 113.8 12.53 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 103.35 -2.833 . . . . 0.0 103.35 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 9.3 mt -76.71 -55.19 5.72 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 113.315 -1.766 . . . . 0.0 111.479 -179.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -176.24 -168.18 0.25 Allowed 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 118.622 -1.231 . . . . 0.0 110.423 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.4 mt -115.21 150.25 36.42 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 . . . . . 0 N--CA 1.502 2.132 0 CA-C-O 115.79 -2.052 . . . . 0.0 109.24 179.892 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.622 ' N ' ' CE1' ' A' ' 80' ' ' TYR . . . . . . . . 0 N--CA 1.487 2.06 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.1 p -116.82 150.17 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -124.07 154.96 39.18 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.4 t -124.86 112.76 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -114.31 90.97 3.47 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 97.9 m -69.78 154.84 41.43 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 119.008 -1.077 . . . . 0.0 112.425 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 58.9 mt -123.58 -52.01 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 CA-C-N 113.859 -1.519 . . . . 0.0 107.407 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 9' ' ' PRO . 38.9 t -122.03 80.66 42.99 Favored Pre-proline 0 N--CA 1.505 2.324 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.041 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 8' ' ' SER . 6.4 Cg_exo -36.96 166.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.812 2.341 . . . . 0.0 113.718 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -115.81 -172.68 16.99 Favored Glycine 0 N--CA 1.5 2.921 0 N-CA-C 105.75 -2.94 . . . . 0.0 105.75 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.492 ' CG ' ' H ' ' A' ' 12' ' ' GLY . 11.7 p-10 -44.73 -58.35 3.13 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 118.405 1.102 . . . . 0.0 111.173 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.492 ' H ' ' CG ' ' A' ' 11' ' ' ASP . . . 107.65 24.26 6.49 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 107.636 -2.186 . . . . 0.0 107.636 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 -128.83 -37.56 1.73 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 114.532 -0.834 . . . . 0.0 111.249 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.4 m -111.07 138.34 47.61 Favored 'General case' 0 N--CA 1.507 2.416 0 CA-C-O 121.833 0.825 . . . . 0.0 112.834 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.458 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 48.5 m-85 -133.07 173.78 5.48 Favored Pre-proline 0 N--CA 1.495 1.786 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -61.53 134.57 52.01 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 N-CA-C 110.09 -0.773 . . . . 0.0 110.09 164.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.428 ' HZ1' ' CB ' ' A' ' 17' ' ' LYS . 8.2 mtpm? -115.3 170.21 8.56 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.943 0.877 . . . . 0.0 110.484 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.9 mtm180 -73.64 97.01 2.56 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.198 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 122.84 18.98 3.1 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -115.82 170.1 8.72 Favored 'General case' 0 N--CA 1.504 2.245 0 CA-C-O 121.83 0.824 . . . . 0.0 110.116 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 95.4 m -125.1 110.33 14.01 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 114.481 -1.236 . . . . 0.0 107.915 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 27.5 m -69.76 149.29 48.13 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.16 -1.016 . . . . 0.0 110.074 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 93.3 t -125.17 97.8 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 101.14 -3.652 . . . . 0.0 101.14 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.8 m -121.13 151.26 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 48.3 t60 -130.24 116.55 18.54 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 104.675 -2.342 . . . . 0.0 104.675 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.424 ' O ' ' OG ' ' A' ' 39' ' ' SER . 41.8 p90 -134.01 179.33 6.31 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 123.044 1.402 . . . . 0.0 111.966 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.438 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 51.2 m -141.91 126.11 17.46 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 101.016 -3.698 . . . . 0.0 101.016 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -103.09 129.95 10.07 Favored Glycine 0 N--CA 1.5 2.93 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 39.5 ttm -129.59 170.54 13.63 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 30.4 mt -116.02 173.51 6.53 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -29.34 -61.76 0.13 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 125.053 1.47 . . . . 0.0 113.719 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -160.61 41.2 0.17 Allowed 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 114.628 -1.169 . . . . 0.0 109.641 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -119.36 -79.23 0.61 Allowed Glycine 0 N--CA 1.502 3.085 0 C-N-CA 119.274 -1.441 . . . . 0.0 113.763 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.47 -167.7 1.96 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -90.81 139.4 30.77 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.004 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.467 ' CD2' ' CG ' ' A' ' 37' ' ' ASP . 8.8 p90 -126.04 -38.13 2.2 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 112.968 -1.924 . . . . 0.0 107.303 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.467 ' CG ' ' CD2' ' A' ' 36' ' ' PHE . 43.5 m-20 -128.81 87.16 2.53 Favored 'General case' 0 N--CA 1.506 2.357 0 CA-C-N 115.086 -0.961 . . . . 0.0 113.511 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 51.7 m -107.08 163.46 12.97 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.579 ' O ' ' N ' ' A' ' 41' ' ' ASP . 96.0 p -123.2 51.62 1.44 Allowed 'General case' 0 N--CA 1.503 2.184 0 CA-C-O 118.885 -0.579 . . . . 0.0 110.281 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -28.64 73.68 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 126.472 2.358 . . . . 0.0 112.838 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.579 ' N ' ' O ' ' A' ' 39' ' ' SER . 7.5 t70 -18.98 -58.23 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.025 0 CA-C-N 110.505 -3.043 . . . . 0.0 113.046 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.406 ' C ' ' O ' ' A' ' 41' ' ' ASP . 41.0 ttt-85 -19.58 -45.33 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 O-C-N 125.414 1.696 . . . . 0.0 113.479 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.498 ' N ' ' O ' ' A' ' 41' ' ' ASP . 75.2 m-20 -108.67 58.06 0.61 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.21 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.66 ' NZ ' ' HZ3' ' A' ' 47' ' ' LYS . 38.4 ttpt 56.33 127.08 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.495 0 CA-C-N 114.145 -1.389 . . . . 0.0 112.266 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' A' ' 44' ' ' LYS . 23.1 Cg_exo -42.48 -157.59 0.0 OUTLIER 'Trans proline' 0 N--CA 1.488 1.181 0 C-N-CA 122.489 2.126 . . . . 0.0 116.011 168.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -111.03 144.69 39.75 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 112.858 -1.974 . . . . 0.0 110.551 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.66 ' HZ3' ' NZ ' ' A' ' 44' ' ' LYS . 34.4 mtmm -137.0 122.02 18.98 Favored 'General case' 0 N--CA 1.507 2.415 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.542 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -138.98 177.09 8.14 Favored 'General case' 0 N--CA 1.509 2.495 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.765 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 43.1 ttp -121.29 156.94 31.46 Favored 'General case' 0 N--CA 1.503 2.207 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.966 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.9 tp -90.95 120.32 31.86 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.15 12.71 30.8 Favored Glycine 0 N--CA 1.501 2.969 0 C-N-CA 121.059 -0.591 . . . . 0.0 114.04 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.475 ' O ' ' N ' ' A' ' 54' ' ' GLU . 59.3 tttp -128.24 45.81 2.7 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 118.349 1.074 . . . . 0.0 108.945 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' A' ' 52' ' ' LYS . 20.5 pt20 4.16 61.18 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 115.991 1.849 . . . . 0.0 115.991 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.475 ' N ' ' O ' ' A' ' 52' ' ' LYS . 6.8 mm-40 -102.98 -29.98 11.07 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 56' ' ' ILE . 13.0 m -114.87 155.76 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.426 ' O ' ' O ' ' A' ' 55' ' ' VAL . 17.0 pt -51.74 -179.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 C-N-CA 119.065 -1.054 . . . . 0.0 109.001 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.536 ' O ' ' N ' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -80.45 -58.59 3.05 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -28.3 -35.93 0.01 OUTLIER Glycine 0 N--CA 1.501 3.025 0 O-C-N 124.531 1.145 . . . . 0.0 111.53 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.536 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.9 OUTLIER -78.78 -75.72 0.22 Allowed 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 113.236 -1.482 . . . . 0.0 107.237 179.822 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 59' ' ' TRP . 71.1 tt0 -25.87 -55.01 0.06 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 125.839 1.962 . . . . 0.0 110.828 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -75.27 -54.7 6.66 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -51.04 -75.09 0.23 Allowed Glycine 0 N--CA 1.482 1.753 0 C-N-CA 119.564 -1.303 . . . . 0.0 111.168 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' A' ' 59' ' ' TRP . 28.9 t -41.58 -49.91 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 119.594 -0.842 . . . . 0.0 112.292 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.511 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -45.9 -60.59 2.16 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 124.056 1.884 . . . . 0.0 111.157 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -48.68 -11.28 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 109.416 -3.538 . . . . 0.0 109.195 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.511 ' H ' ' C ' ' A' ' 64' ' ' ALA . 49.8 mtm -99.82 160.64 14.15 Favored 'General case' 0 N--CA 1.517 2.887 0 C-N-CA 118.518 -1.273 . . . . 0.0 108.823 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 96.7 p -115.32 150.63 35.97 Favored 'General case' 0 N--CA 1.51 2.539 0 CA-C-O 122.584 1.183 . . . . 0.0 113.919 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 63.8 t -49.21 99.63 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 112.641 -2.072 . . . . 0.0 113.681 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 113.95 9.27 16.38 Favored Glycine 0 N--CA 1.499 2.834 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -107.8 154.14 21.96 Favored 'General case' 0 N--CA 1.506 2.33 0 CA-C-O 122.428 1.109 . . . . 0.0 111.164 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.0 ttp180 -131.46 140.12 49.52 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 112.83 -1.986 . . . . 0.0 107.224 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -148.44 177.58 9.33 Favored 'General case' 0 N--CA 1.502 2.158 0 CA-C-N 112.947 -1.933 . . . . 0.0 115.496 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -126.47 105.28 8.65 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 111.295 -2.684 . . . . 0.0 103.936 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.4 mt -99.77 152.57 19.96 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 93.7 m -124.57 119.81 30.15 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 25.7 mt -112.13 140.28 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.417 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 35.1 p -111.13 155.53 42.44 Favored Pre-proline 0 N--CA 1.506 2.343 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.185 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -37.85 -51.59 1.84 Allowed 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 122.189 1.926 . . . . 0.0 114.695 -175.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 18.0 p-10 -39.28 -41.28 0.87 Allowed 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.622 ' CE1' ' N ' ' A' ' 1' ' ' GLY . 3.1 m-85 -100.79 -50.85 3.73 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.312 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -37.13 -91.9 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 114.827 1.418 . . . . 0.0 114.827 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -125.24 13.06 8.28 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.613 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 110.78 -104.71 1.8 Allowed Glycine 0 N--CA 1.502 3.098 0 N-CA-C 111.953 -0.459 . . . . 0.0 111.953 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -126.45 -52.23 1.49 Allowed 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 121.384 0.611 . . . . 0.0 109.931 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 97.5 m -113.06 158.5 20.25 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.897 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -130.34 -129.97 3.16 Favored Glycine 0 N--CA 1.5 2.955 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 91' ' ' ILE . 21.9 m80 -112.33 161.36 26.47 Favored Pre-proline 0 N--CA 1.502 2.173 0 CA-C-N 114.632 -0.784 . . . . 0.0 109.237 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -94.21 34.28 0.19 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.818 2.346 . . . . 0.0 108.602 164.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -130.89 -52.96 0.1 OUTLIER Glycine 0 N--CA 1.5 2.947 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.772 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.9 mt -116.8 -47.28 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.321 0 CA-C-O 121.937 0.875 . . . . 0.0 109.027 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.496 ' O ' ' N ' ' A' ' 87' ' ' HIS . 23.0 mm -114.17 77.02 3.77 Favored Pre-proline 0 N--CA 1.508 2.44 0 CA-C-N 113.94 -1.482 . . . . 0.0 113.316 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_exo -35.72 158.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.695 2.263 . . . . 0.0 110.468 162.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.407 ' O ' ' C ' ' A' ' 94' ' ' HIS . 57.5 Cg_endo -58.02 168.14 3.78 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 121.664 1.576 . . . . 0.0 110.051 177.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.407 ' C ' ' O ' ' A' ' 93' ' ' PRO . 90.5 m-70 9.64 60.02 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.237 0 O-C-N 125.572 1.795 . . . . 0.0 114.682 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -118.26 80.47 1.53 Allowed 'General case' 0 N--CA 1.5 2.068 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.22 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 62.3 m -29.36 145.09 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.067 0 O-C-N 124.886 1.366 . . . . 0.0 110.944 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 24.2 mt -111.1 151.76 27.73 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.4 t -134.12 125.29 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -120.29 139.81 52.18 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.178 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 27' ' ' THR . 5.1 p-10 -117.57 98.84 6.6 Favored 'General case' 0 N--CA 1.501 2.076 1 N-CA-C 97.338 -5.06 . . . . 0.0 97.338 178.902 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 16.5 t -108.51 153.62 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.355 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 -178.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -127.99 104.37 7.75 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 112.119 -2.309 . . . . 0.0 107.609 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 37.8 tp -75.49 121.45 22.37 Favored 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 102.556 -3.127 . . . . 0.0 102.556 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.3 mt -93.16 -57.86 2.49 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -157.96 173.81 16.2 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.605 0.717 . . . . 0.0 112.074 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 35.4 mt -117.59 143.19 46.36 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 . . . . . 0 N--CA 1.503 2.215 0 CA-C-O 116.286 -1.816 . . . . 0.0 110.007 179.885 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.406 ' O ' ' OG ' ' A' ' 77' ' ' SER . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.9 p -116.88 150.13 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -122.92 156.39 34.77 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.4 t -125.44 114.84 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 108.039 -1.096 . . . . 0.0 108.039 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -115.22 90.02 3.24 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 90.5 m -69.83 155.67 40.2 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.048 -1.061 . . . . 0.0 112.488 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 59.0 mt -123.66 -51.59 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 CA-C-N 113.645 -1.616 . . . . 0.0 107.258 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.418 ' O ' ' O ' ' A' ' 9' ' ' PRO . 46.5 t -122.22 80.13 44.32 Favored Pre-proline 0 N--CA 1.506 2.328 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.283 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 8' ' ' SER . 6.4 Cg_exo -37.42 164.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.348 2.032 . . . . 0.0 112.808 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -123.51 -168.95 13.12 Favored Glycine 0 N--CA 1.498 2.826 0 N-CA-C 105.632 -2.987 . . . . 0.0 105.632 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 11' ' ' ASP . 12.3 p-10 -39.5 -62.93 0.62 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.747 -0.781 . . . . 0.0 112.575 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.58 15.25 21.44 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 105.838 -2.905 . . . . 0.0 105.838 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 30.4 mtm-85 -125.95 -39.4 2.11 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 113.307 -1.447 . . . . 0.0 112.774 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.1 m -108.2 137.14 46.68 Favored 'General case' 0 N--CA 1.507 2.395 0 CA-C-O 121.775 0.798 . . . . 0.0 112.763 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.445 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 57.0 m-85 -130.56 177.43 2.22 Favored Pre-proline 0 N--CA 1.496 1.859 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -69.57 146.77 62.37 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 N-CA-C 109.765 -0.898 . . . . 0.0 109.765 162.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -122.37 168.44 12.07 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 122.086 0.946 . . . . 0.0 110.248 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 19.1 ptt85 -72.61 126.58 30.22 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.648 -1.16 . . . . 0.0 108.677 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 111.38 -19.71 24.06 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.5 ' O ' ' SD ' ' A' ' 49' ' ' MET . 25.7 mt-30 -109.76 176.4 5.08 Favored 'General case' 0 N--CA 1.506 2.341 0 CA-C-O 121.766 0.793 . . . . 0.0 112.274 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 27.7 m -110.07 161.47 15.5 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 57.2 m -111.7 146.56 37.3 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 103.889 -2.634 . . . . 0.0 103.889 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 33.4 t -123.07 101.95 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 101.644 -3.465 . . . . 0.0 101.644 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 m -123.01 150.46 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 125.004 1.44 . . . . 0.0 114.324 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.403 ' ND1' ' C ' ' A' ' 25' ' ' HIS . 2.7 t-80 -130.61 113.77 14.62 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 103.598 -2.742 . . . . 0.0 103.598 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -131.21 176.63 8.11 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 123.184 1.468 . . . . 0.0 113.576 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 96.0 m -139.42 121.85 16.11 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 101.921 -3.363 . . . . 0.0 101.921 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 37' ' ' ASP . . . -96.93 151.61 19.88 Favored Glycine 0 N--CA 1.498 2.824 0 C-N-CA 119.127 -1.511 . . . . 0.0 109.457 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 36.6 ttp -145.97 169.36 18.78 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 46.6 mt -118.79 174.66 6.15 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 105.534 -2.025 . . . . 0.0 105.534 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -29.09 -61.12 0.13 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 124.989 1.431 . . . . 0.0 113.447 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 32' ' ' ASP . 2.7 p30 -160.29 44.34 0.21 Allowed 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.041 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -115.9 -84.04 1.1 Allowed Glycine 0 N--CA 1.499 2.856 0 C-N-CA 119.044 -1.551 . . . . 0.0 113.802 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.92 -164.43 1.19 Allowed 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 112.503 -1.848 . . . . 0.0 113.11 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -90.41 140.43 29.72 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 122.512 1.148 . . . . 0.0 109.672 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -125.93 -35.78 2.44 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 112.888 -1.96 . . . . 0.0 107.475 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' A' ' 28' ' ' GLY . 33.6 t0 -127.07 104.59 8.07 Favored 'General case' 0 N--CA 1.513 2.693 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.038 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 52.6 m -119.77 175.28 5.95 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 104.459 -2.422 . . . . 0.0 104.459 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 76.7 p -107.54 56.73 0.63 Allowed 'General case' 0 N--CA 1.502 2.175 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.549 ' O ' ' N ' ' A' ' 42' ' ' ARG . 20.5 ttp85 -29.41 -67.95 0.08 Allowed 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 113.483 -1.689 . . . . 0.0 113.163 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -19.04 71.94 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 115.733 1.753 . . . . 0.0 115.733 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.549 ' N ' ' O ' ' A' ' 40' ' ' ARG . 12.8 mmt180 -32.04 -73.25 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 123.98 0.8 . . . . 0.0 112.87 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -20.95 -74.23 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 125.194 1.559 . . . . 0.0 114.131 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -134.25 141.24 38.57 Favored Pre-proline 0 N--CA 1.501 2.079 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -59.28 -159.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.218 0 C-N-CA 121.452 1.435 . . . . 0.0 113.387 -177.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -82.17 146.78 29.37 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 114.306 -1.316 . . . . 0.0 112.881 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.433 ' CB ' ' HZ1' ' A' ' 47' ' ' LYS . 9.1 mtmp? -143.08 125.29 15.45 Favored 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 118.745 -0.645 . . . . 0.0 111.695 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -137.53 171.94 13.71 Favored 'General case' 0 N--CA 1.515 2.795 0 CA-C-N 119.812 1.187 . . . . 0.0 114.158 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.5 ' SD ' ' O ' ' A' ' 20' ' ' GLN . 45.6 tpp -109.11 140.74 42.27 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 114.954 1.464 . . . . 0.0 114.954 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.8 tp -91.01 122.38 33.62 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 114.249 -1.341 . . . . 0.0 110.196 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.03 18.67 13.12 Favored Glycine 0 N--CA 1.5 2.9 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -122.57 -20.57 5.96 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-N 114.732 -0.734 . . . . 0.0 109.313 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.655 HE22 ' NH1' ' A' ' 57' ' ' ARG . 9.6 mm100 54.48 67.84 0.95 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -109.76 -35.3 6.22 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.3 m -106.15 156.47 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.4 pt -50.98 174.96 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 118.368 -1.333 . . . . 0.0 110.548 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.655 ' NH1' HE22 ' A' ' 53' ' ' GLN . 4.2 tpp180 -68.71 -64.93 0.77 Allowed 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.061 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -28.95 -35.03 0.01 OUTLIER Glycine 0 N--CA 1.498 2.817 0 O-C-N 124.722 1.264 . . . . 0.0 112.308 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.531 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.5 OUTLIER -76.68 -70.57 0.45 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 179.858 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -33.49 -55.81 0.43 Allowed 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 113.723 -1.58 . . . . 0.0 109.992 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -70.16 -53.8 15.65 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 113.431 -1.713 . . . . 0.0 107.353 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -56.24 -75.81 0.23 Allowed Glycine 0 N--CA 1.48 1.574 0 C-N-CA 119.558 -1.306 . . . . 0.0 111.544 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 59' ' ' TRP . 41.2 t -38.37 -48.98 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 C-N-CA 120.332 -0.547 . . . . 0.0 112.243 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.512 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -46.86 -59.93 2.75 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 124.198 1.951 . . . . 0.0 110.584 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -51.27 -9.18 0.06 Allowed 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 109.37 -3.559 . . . . 0.0 109.719 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.512 ' H ' ' C ' ' A' ' 64' ' ' ALA . 90.3 mtp -98.23 154.94 17.43 Favored 'General case' 0 N--CA 1.512 2.646 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 84.8 p -116.39 151.13 36.59 Favored 'General case' 0 N--CA 1.507 2.424 0 CA-C-O 122.691 1.234 . . . . 0.0 113.75 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 95.5 t -44.93 98.14 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-N 112.499 -2.137 . . . . 0.0 114.385 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.02 11.9 15.23 Favored Glycine 0 N--CA 1.498 2.796 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -109.99 151.73 26.77 Favored 'General case' 0 N--CA 1.508 2.441 0 CA-C-O 122.215 1.007 . . . . 0.0 111.012 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -132.21 141.98 49.26 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 113.459 -1.7 . . . . 0.0 107.815 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -149.53 179.68 7.78 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 112.979 -1.918 . . . . 0.0 116.143 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -127.1 105.8 8.83 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 102.678 -3.082 . . . . 0.0 102.678 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.9 mt -101.66 153.86 19.39 Favored 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 121.315 0.579 . . . . 0.0 109.587 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 87.3 m -125.46 126.5 45.03 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 31.8 mt -115.64 141.4 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.421 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 35.5 p -110.31 152.32 43.17 Favored Pre-proline 0 N--CA 1.498 1.948 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.401 ' O ' ' N ' ' A' ' 81' ' ' ALA . 11.5 Cg_endo -40.78 -54.9 2.21 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 121.738 1.625 . . . . 0.0 112.513 -172.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 18.8 p30 -37.35 -35.96 0.13 Allowed 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.39 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -100.83 -16.78 17.16 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.185 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 83' ' ' GLY . . . -102.43 159.75 15.15 Favored 'General case' 0 N--CA 1.505 2.278 0 C-N-CA 119.688 -0.805 . . . . 0.0 108.965 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -1.37 62.37 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 125.93 2.019 . . . . 0.0 115.81 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 81' ' ' ALA . . . -5.05 -69.59 0.01 OUTLIER Glycine 0 N--CA 1.501 2.989 0 O-C-N 125.329 1.643 . . . . 0.0 115.653 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -122.34 -65.78 1.08 Allowed 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 97.5 m -121.7 137.25 54.83 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.61 -62.2 0.1 Allowed Glycine 0 N--CA 1.501 2.997 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -122.5 156.19 61.46 Favored Pre-proline 0 N--CA 1.505 2.289 0 CA-C-N 115.311 -0.444 . . . . 0.0 109.854 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -60.86 -69.9 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 122.023 1.815 . . . . 0.0 114.899 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -123.45 52.62 0.77 Allowed Glycine 0 N--CA 1.506 3.32 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.95 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.2 mt -130.58 -49.16 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 37.6 mm -113.47 90.08 16.65 Favored Pre-proline 0 N--CA 1.503 2.176 0 CA-C-N 111.783 -2.462 . . . . 0.0 111.772 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -52.23 158.97 4.63 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 N-CA-C 106.809 -2.035 . . . . 0.0 106.809 161.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -46.86 172.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 121.99 1.794 . . . . 0.0 113.068 -177.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 19.6 m80 9.55 75.58 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 116.528 2.047 . . . . 0.0 116.528 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -116.49 157.26 25.49 Favored 'General case' 0 N--CA 1.505 2.314 0 CA-C-O 121.112 0.482 . . . . 0.0 109.812 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 27.2 m -91.23 138.75 31.35 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 34.2 mt -118.33 156.56 28.7 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 58.9 t -137.15 130.11 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -123.29 155.91 36.31 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 122.058 0.932 . . . . 0.0 111.208 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -126.81 90.0 3.09 Favored 'General case' 0 N--CA 1.493 1.704 1 N-CA-C 98.977 -4.453 . . . . 0.0 98.977 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 13.1 t -104.55 150.84 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.594 0 N-CA-C 116.73 2.122 . . . . 0.0 116.73 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -128.39 98.08 4.94 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 112.595 -2.093 . . . . 0.0 106.838 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 49.1 tp -73.01 117.2 14.45 Favored 'General case' 0 N--CA 1.503 2.192 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.5 mt -83.92 -57.55 3.15 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 114.296 -1.32 . . . . 0.0 113.784 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 16.2 ttpp -168.91 -171.41 1.34 Allowed 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.271 -0.972 . . . . 0.0 108.733 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 22.9 mt -116.6 157.5 25.22 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 . . . . . 0 N--CA 1.506 2.328 0 CA-C-O 116.176 -1.869 . . . . 0.0 110.172 179.912 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 110.014 -1.235 . . . . 0.0 110.014 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.2 p -119.34 150.39 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -120.86 155.38 34.25 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 43.4 t -126.08 122.44 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.478 ' N ' ' CD ' ' A' ' 5' ' ' GLU . 8.9 mp0 -120.4 93.48 4.06 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 96.4 m -69.71 156.36 39.1 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 118.675 -1.21 . . . . 0.0 112.079 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 70.3 mt -121.95 -55.13 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-N 113.882 -1.508 . . . . 0.0 107.484 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.43 ' O ' ' O ' ' A' ' 9' ' ' PRO . 33.1 t -123.74 82.78 54.49 Favored Pre-proline 0 N--CA 1.506 2.329 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.382 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.43 ' O ' ' O ' ' A' ' 8' ' ' SER . 3.9 Cg_exo -35.84 164.39 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.689 2.26 . . . . 0.0 113.606 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -113.78 -176.43 19.22 Favored Glycine 0 N--CA 1.499 2.894 0 N-CA-C 105.797 -2.921 . . . . 0.0 105.797 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.507 ' CG ' ' H ' ' A' ' 12' ' ' GLY . 11.2 p-10 -43.85 -59.03 2.44 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 118.352 1.076 . . . . 0.0 111.586 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.507 ' H ' ' CG ' ' A' ' 11' ' ' ASP . . . 109.18 25.81 5.43 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 107.737 -2.145 . . . . 0.0 107.737 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.5 mmm180 -132.42 -36.68 1.1 Allowed 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 114.671 -0.764 . . . . 0.0 111.415 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 45.6 m -111.31 128.84 56.08 Favored 'General case' 0 N--CA 1.507 2.379 0 CA-C-O 121.584 0.707 . . . . 0.0 112.687 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.413 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 37.6 m-85 -129.95 171.6 8.63 Favored Pre-proline 0 N--CA 1.497 1.92 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_exo -53.24 145.75 42.73 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 CA-C-N 119.588 0.888 . . . . 0.0 112.244 166.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -122.83 168.39 12.33 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 122.458 1.123 . . . . 0.0 111.175 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 42.9 mtp-105 -81.18 93.72 6.53 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 113.639 -1.619 . . . . 0.0 111.687 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.76 3.49 5.94 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 108.637 -1.785 . . . . 0.0 108.637 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -117.91 173.97 6.46 Favored 'General case' 0 N--CA 1.505 2.322 0 C-N-CA 120.254 -0.578 . . . . 0.0 109.567 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.7 m -110.0 164.8 12.27 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 31.6 m -117.22 128.38 55.04 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 33.3 t -108.5 111.48 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 101.106 -3.664 . . . . 0.0 101.106 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.1 m -125.88 155.06 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 125.007 1.442 . . . . 0.0 114.127 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -129.87 107.88 9.72 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 104.512 -2.403 . . . . 0.0 104.512 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -130.48 175.29 9.1 Favored 'General case' 0 N--CA 1.503 2.2 0 CA-C-O 122.923 1.344 . . . . 0.0 114.458 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 93.7 m -138.17 121.8 17.42 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 102.292 -3.225 . . . . 0.0 102.292 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -111.2 138.1 14.74 Favored Glycine 0 N--CA 1.503 3.124 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.443 ' SD ' ' C ' ' A' ' 34' ' ' LYS . 21.9 tpp -140.68 -179.83 6.27 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.1 mt -120.02 161.77 20.38 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -24.62 -58.68 0.05 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 125.335 1.647 . . . . 0.0 113.852 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 32' ' ' ASP . 3.0 p30 -160.17 42.17 0.19 Allowed 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.825 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -120.8 -80.27 0.59 Allowed Glycine 0 N--CA 1.5 2.946 0 C-N-CA 119.3 -1.429 . . . . 0.0 113.433 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.443 ' C ' ' SD ' ' A' ' 29' ' ' MET . 11.2 pttp -161.25 -166.49 1.56 Allowed 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.87 130.04 36.86 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 113.598 -1.637 . . . . 0.0 107.942 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.532 ' CD2' ' OD2' ' A' ' 37' ' ' ASP . 3.0 p90 -122.82 -35.75 2.99 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.011 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.532 ' OD2' ' CD2' ' A' ' 36' ' ' PHE . 45.6 m-20 -141.1 109.23 5.78 Favored 'General case' 0 N--CA 1.51 2.552 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 54.8 m -121.04 176.53 5.53 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 105.534 -2.025 . . . . 0.0 105.534 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.525 ' O ' ' N ' ' A' ' 41' ' ' ASP . 50.5 p -111.65 49.94 0.87 Allowed 'General case' 0 N--CA 1.505 2.307 0 CA-C-O 122.469 1.128 . . . . 0.0 108.484 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -29.48 -26.44 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 112.594 -2.094 . . . . 0.0 115.365 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 39' ' ' SER . 9.6 t70 -83.08 53.45 2.46 Favored 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 118.964 -1.094 . . . . 0.0 111.97 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -36.97 -34.76 0.08 Allowed 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.862 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.483 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 18.4 p30 -95.46 66.35 2.8 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.129 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.483 ' CB ' ' O ' ' A' ' 43' ' ' ASN . 64.4 tttm 119.84 77.45 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.388 0 O-C-N 126.396 2.31 . . . . 0.0 106.43 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' A' ' 44' ' ' LYS . 34.5 Cg_exo -43.84 -156.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.231 0 C-N-CA 124.071 3.181 . . . . 0.0 116.038 178.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -94.69 138.11 32.95 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 113.21 -1.814 . . . . 0.0 110.903 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -130.36 117.81 20.31 Favored 'General case' 0 N--CA 1.509 2.499 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -136.23 170.77 15.48 Favored 'General case' 0 N--CA 1.51 2.54 0 C-N-CA 119.732 -0.787 . . . . 0.0 112.313 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 40.3 ttm -118.64 154.96 31.82 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.2 tp -91.03 120.88 32.37 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.889 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.42 34.21 5.38 Favored Glycine 0 N--CA 1.499 2.864 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.049 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.484 ' O ' ' CB ' ' A' ' 53' ' ' GLN . 23.0 ttmm -129.93 -51.01 1.13 Allowed 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.484 ' CB ' ' O ' ' A' ' 52' ' ' LYS . 37.3 tt0 100.9 67.74 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.161 0 O-C-N 125.837 1.961 . . . . 0.0 109.592 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -110.24 -35.94 5.95 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.1 m -116.73 159.06 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.854 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 13.4 pt -56.51 179.97 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.527 ' O ' ' N ' ' A' ' 59' ' ' TRP . 34.8 ttt180 -74.48 -61.21 1.95 Allowed 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.92 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 57' ' ' ARG . . . -25.61 -39.32 0.01 OUTLIER Glycine 0 N--CA 1.501 2.988 0 O-C-N 124.986 1.428 . . . . 0.0 112.489 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.53 ' O ' ' N ' ' A' ' 63' ' ' VAL . 0.7 OUTLIER -73.26 -73.62 0.2 Allowed 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 179.721 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.484 ' OE1' ' N ' ' A' ' 61' ' ' GLU . 10.4 tm-20 -26.62 -55.7 0.08 Allowed 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 112.934 -1.939 . . . . 0.0 110.707 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.484 ' N ' ' OE1' ' A' ' 60' ' ' GLU . 50.3 tp10 -73.98 -54.96 6.76 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 112.927 -1.942 . . . . 0.0 106.23 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -52.16 -75.55 0.22 Allowed Glycine 0 N--CA 1.482 1.705 0 C-N-CA 119.617 -1.278 . . . . 0.0 110.961 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.53 ' N ' ' O ' ' A' ' 59' ' ' TRP . 30.8 t -40.92 -49.12 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 119.973 -0.691 . . . . 0.0 112.093 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.508 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -46.9 -59.01 3.37 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 124.012 1.863 . . . . 0.0 110.928 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -52.0 -8.04 0.06 Allowed 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 109.517 -3.492 . . . . 0.0 109.836 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.508 ' H ' ' C ' ' A' ' 64' ' ' ALA . 93.8 mtp -102.09 155.21 18.33 Favored 'General case' 0 N--CA 1.516 2.827 0 C-N-CA 119.036 -1.066 . . . . 0.0 108.242 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 90.4 p -114.94 150.11 36.24 Favored 'General case' 0 N--CA 1.511 2.582 0 CA-C-O 122.605 1.193 . . . . 0.0 113.211 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 87.2 t -43.84 96.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 112.594 -2.094 . . . . 0.0 113.246 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 113.06 11.89 13.12 Favored Glycine 0 N--CA 1.499 2.87 0 N-CA-C 108.735 -1.746 . . . . 0.0 108.735 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -103.66 143.93 32.12 Favored 'General case' 0 N--CA 1.503 2.209 0 C-N-CA 120.189 -0.605 . . . . 0.0 110.159 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 25.3 ttt85 -125.57 140.77 52.47 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -148.73 177.32 9.62 Favored 'General case' 0 N--CA 1.503 2.18 0 CA-C-N 113.046 -1.888 . . . . 0.0 116.048 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.45 ' CE ' ' OD1' ' A' ' 100' ' ' ASP . 4.6 tppp? -127.13 107.14 9.76 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 101.568 -3.493 . . . . 0.0 101.568 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.4 mt -103.58 152.85 21.25 Favored 'General case' 0 N--CA 1.503 2.207 0 C-N-CA 119.822 -0.751 . . . . 0.0 109.365 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 86.3 m -124.54 118.32 26.32 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 31.1 mt -111.76 141.92 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.425 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 41.7 p -107.78 156.68 37.64 Favored Pre-proline 0 N--CA 1.507 2.391 0 O-C-N 124.796 1.31 . . . . 0.0 109.373 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -36.18 -54.24 0.89 Allowed 'Trans proline' 0 C--N 1.316 -1.165 0 C-N-CA 121.986 1.791 . . . . 0.0 113.744 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 80' ' ' TYR . 1.7 p30 -45.36 -41.85 9.41 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.523 ' OH ' ' NH1' ' A' ' 57' ' ' ARG . 2.6 m-85 -102.1 17.71 22.6 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.304 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -122.85 -97.13 0.45 Allowed 'General case' 0 N--CA 1.508 2.447 0 CA-C-N 118.758 0.708 . . . . 0.0 111.783 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -121.41 -58.17 1.79 Allowed 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 120.848 0.356 . . . . 0.0 110.072 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 117.97 -152.13 17.69 Favored Glycine 0 N--CA 1.5 2.918 0 N-CA-C 108.028 -2.029 . . . . 0.0 108.028 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -107.5 28.99 7.59 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 89.9 m -130.0 57.53 1.69 Allowed 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -119.97 -166.62 13.3 Favored Glycine 0 N--CA 1.5 2.926 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.424 ' O ' ' O ' ' A' ' 91' ' ' ILE . 75.9 t60 -112.1 143.06 28.02 Favored Pre-proline 0 N--CA 1.502 2.164 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.68 150.63 45.39 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 N-CA-C 108.873 -1.241 . . . . 0.0 108.873 176.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 108.16 -47.13 1.08 Allowed Glycine 0 N--CA 1.5 2.901 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.9 mt -112.96 -56.6 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.424 ' O ' ' O ' ' A' ' 87' ' ' HIS . 20.4 mm -120.75 85.78 39.77 Favored Pre-proline 0 N--CA 1.508 2.459 0 CA-C-N 113.722 -1.581 . . . . 0.0 112.578 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -74.27 165.19 32.44 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.19 1.926 . . . . 0.0 107.326 170.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 94' ' ' HIS . 54.2 Cg_endo -55.85 172.59 0.52 Allowed 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.202 1.935 . . . . 0.0 110.81 178.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.4 ' C ' ' O ' ' A' ' 93' ' ' PRO . 90.9 m-70 9.52 61.32 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.23 0 O-C-N 125.619 1.824 . . . . 0.0 114.781 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -119.92 76.02 1.13 Allowed 'General case' 0 N--CA 1.501 2.116 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.49 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 58.0 m -29.42 142.4 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.198 0 O-C-N 124.761 1.288 . . . . 0.0 110.566 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 13.9 mt -107.36 157.05 18.26 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 120.514 1.506 . . . . 0.0 107.042 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.3 t -139.75 115.69 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -110.28 159.45 17.4 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 122.417 1.103 . . . . 0.0 110.241 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.45 ' OD1' ' CE ' ' A' ' 73' ' ' LYS . 54.9 m-20 -127.66 89.11 2.89 Favored 'General case' 0 N--CA 1.493 1.7 1 N-CA-C 98.575 -4.602 . . . . 0.0 98.575 179.314 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 12.2 t -103.1 148.83 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.699 0 N-CA-C 116.777 2.14 . . . . 0.0 116.777 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -127.92 96.75 4.58 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 112.701 -2.045 . . . . 0.0 107.419 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 51.6 tp -68.7 121.96 17.56 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.6 mt -89.39 -58.07 2.66 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.894 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -164.36 178.12 7.73 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.734 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 17.1 mt -115.1 168.97 9.46 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 . . . . . 0 N--CA 1.514 2.757 0 CA-C-O 115.862 -2.018 . . . . 0.0 107.414 179.604 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.4 p -115.3 138.95 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 3' ' ' GLN . 3.3 mp0 -115.52 159.24 21.48 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.8 t -124.66 123.11 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.025 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.47 ' N ' ' CD ' ' A' ' 5' ' ' GLU . 9.3 mp0 -125.42 89.96 3.14 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 88.1 m -69.71 155.25 40.8 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.76 -1.176 . . . . 0.0 113.765 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 57.6 mt -122.45 -53.29 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-N 113.352 -1.749 . . . . 0.0 107.84 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.419 ' O ' ' O ' ' A' ' 9' ' ' PRO . 29.3 m -122.84 80.69 49.54 Favored Pre-proline 0 N--CA 1.506 2.366 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.759 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.419 ' O ' ' O ' ' A' ' 8' ' ' SER . 12.6 Cg_exo -38.2 164.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.37 2.047 . . . . 0.0 112.262 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -120.38 -178.76 16.23 Favored Glycine 0 N--CA 1.5 2.945 0 N-CA-C 105.322 -3.111 . . . . 0.0 105.322 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.472 ' CG ' ' H ' ' A' ' 12' ' ' GLY . 13.1 p-10 -45.76 -58.08 3.76 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 118.404 1.102 . . . . 0.0 111.075 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.472 ' H ' ' CG ' ' A' ' 11' ' ' ASP . . . 108.62 6.88 30.48 Favored Glycine 0 N--CA 1.498 2.814 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -110.81 -31.14 7.28 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 114.584 -0.808 . . . . 0.0 111.685 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 96.8 m -112.03 134.13 53.77 Favored 'General case' 0 N--CA 1.504 2.242 0 CA-C-N 118.876 0.762 . . . . 0.0 113.0 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 57.3 m-85 -131.31 177.24 2.33 Favored Pre-proline 0 N--CA 1.5 2.029 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -72.09 145.29 44.13 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 C-N-CA 120.729 0.953 . . . . 0.0 110.391 161.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -121.58 168.63 11.53 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-O 121.786 0.803 . . . . 0.0 109.236 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.3 130.15 41.8 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.565 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 109.67 -22.69 23.58 Favored Glycine 0 N--CA 1.499 2.838 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.334 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -105.71 178.42 4.57 Favored 'General case' 0 N--CA 1.506 2.371 0 CA-C-O 121.981 0.896 . . . . 0.0 111.747 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.1 m -113.26 161.46 17.17 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 64.5 m -112.48 148.0 35.35 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.9 t -121.91 104.94 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 103.296 -2.853 . . . . 0.0 103.296 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 m -121.69 149.81 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.347 0 N-CA-C 116.217 1.932 . . . . 0.0 116.217 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -128.49 117.5 21.43 Favored 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 104.429 -2.434 . . . . 0.0 104.429 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -134.3 174.09 10.9 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 123.072 1.415 . . . . 0.0 114.801 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 81.3 m -138.92 122.04 16.85 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 102.335 -3.209 . . . . 0.0 102.335 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -112.57 140.45 16.27 Favored Glycine 0 N--CA 1.503 3.165 0 C-N-CA 120.174 -1.012 . . . . 0.0 112.337 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 57.2 mtm -137.85 175.37 9.65 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 29.0 mt -117.64 173.22 6.85 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -34.61 -62.9 0.33 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 124.564 1.165 . . . . 0.0 113.292 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -160.61 42.03 0.17 Allowed 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 114.508 -1.224 . . . . 0.0 109.25 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -117.82 -78.24 0.63 Allowed Glycine 0 N--CA 1.503 3.103 0 C-N-CA 119.283 -1.437 . . . . 0.0 113.721 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.53 -169.21 2.36 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -90.94 138.09 31.86 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 114.289 -1.323 . . . . 0.0 108.53 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.534 ' CD2' ' OD1' ' A' ' 37' ' ' ASP . 5.0 p90 -127.47 -39.7 1.84 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 113.192 -1.822 . . . . 0.0 106.152 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.534 ' OD1' ' CD2' ' A' ' 36' ' ' PHE . 1.0 OUTLIER -132.08 74.52 1.59 Allowed 'General case' 0 N--CA 1.507 2.403 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.3 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 68.8 m -110.64 113.33 25.85 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 56.7 p -108.8 51.41 0.74 Allowed 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -29.79 -46.66 0.06 Allowed 'General case' 0 N--CA 1.5 2.068 0 O-C-N 124.312 1.008 . . . . 0.0 112.782 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -19.12 86.3 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.3 mmm180 -77.9 -54.18 6.61 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.523 ' C ' HD21 ' A' ' 43' ' ' ASN . 0.6 OUTLIER -40.12 -64.26 0.52 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 179.778 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -122.66 79.84 48.07 Favored Pre-proline 0 N--CA 1.505 2.299 0 CA-C-N 115.051 -0.977 . . . . 0.0 112.112 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -55.29 -154.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 123.51 2.807 . . . . 0.0 115.102 -177.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -103.44 147.98 26.47 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 111.835 -2.438 . . . . 0.0 110.034 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 72.0 mttt -142.45 133.95 26.53 Favored 'General case' 0 N--CA 1.515 2.801 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -144.46 173.4 11.83 Favored 'General case' 0 N--CA 1.515 2.777 0 CA-C-N 119.265 0.939 . . . . 0.0 112.766 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 44.5 ttm -116.47 148.97 40.25 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.3 tp -90.99 120.26 31.84 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 114.365 -1.288 . . . . 0.0 109.23 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.35 18.56 18.77 Favored Glycine 0 N--CA 1.499 2.875 0 N-CA-C 107.757 -2.137 . . . . 0.0 107.757 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -121.06 -19.98 6.98 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 114.383 -0.908 . . . . 0.0 109.387 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 55.9 69.02 0.78 Allowed 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.396 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -110.03 -35.86 6.02 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.431 ' O ' ' O ' ' A' ' 56' ' ' ILE . 4.2 m -113.99 152.69 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.176 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.501 ' CG2' ' CE1' ' A' ' 82' ' ' TYR . 13.3 pt -49.46 179.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.857 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.559 ' O ' ' N ' ' A' ' 59' ' ' TRP . 19.5 ttm180 -75.94 -58.96 2.97 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -34.12 -27.2 0.01 OUTLIER Glycine 0 N--CA 1.494 2.538 0 O-C-N 123.944 0.777 . . . . 0.0 111.925 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.559 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -91.33 -73.98 0.52 Allowed 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.874 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -36.98 -50.48 0.88 Allowed 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 114.333 -1.303 . . . . 0.0 110.228 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.417 ' O ' ' OE1' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -71.99 -57.7 4.07 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 104.818 -2.29 . . . . 0.0 104.818 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -50.95 -82.2 0.04 OUTLIER Glycine 0 N--CA 1.48 1.57 0 C-N-CA 119.011 -1.566 . . . . 0.0 109.7 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.533 ' N ' ' O ' ' A' ' 59' ' ' TRP . 62.1 t -29.95 -48.01 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.517 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -44.89 -60.2 2.17 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 124.349 2.023 . . . . 0.0 110.672 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -47.86 -12.06 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 109.027 -3.715 . . . . 0.0 109.548 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.517 ' H ' ' C ' ' A' ' 64' ' ' ALA . 33.4 mmt -89.92 158.51 17.38 Favored 'General case' 0 N--CA 1.508 2.433 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 86.1 p -122.19 136.12 54.86 Favored 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 121.64 0.733 . . . . 0.0 110.077 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.3 t -35.42 97.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-N 114.303 -1.317 . . . . 0.0 113.405 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.73 5.77 13.6 Favored Glycine 0 N--CA 1.5 2.906 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -107.02 149.23 27.78 Favored 'General case' 0 N--CA 1.508 2.457 0 CA-C-O 122.163 0.982 . . . . 0.0 110.291 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.0 ttp180 -133.61 143.4 48.61 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 113.621 -1.627 . . . . 0.0 107.365 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -153.22 179.22 8.93 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 113.312 -1.767 . . . . 0.0 115.066 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -124.75 104.01 8.41 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 103.364 -2.828 . . . . 0.0 103.364 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.2 mt -100.21 145.45 28.04 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.3 m -113.32 123.27 49.72 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 104.628 -2.36 . . . . 0.0 104.628 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 33.9 mt -112.6 131.13 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.491 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.426 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 61.6 p -104.71 154.31 38.62 Favored Pre-proline 0 N--CA 1.5 2.068 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -36.53 -54.08 0.99 Allowed 'Trans proline' 0 C--N 1.314 -1.261 0 C-N-CA 122.113 1.875 . . . . 0.0 113.663 -173.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.527 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 6.5 p-10 -42.2 -36.16 1.13 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -106.85 23.2 14.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -130.67 -87.03 0.5 Allowed 'General case' 0 N--CA 1.506 2.34 0 CA-C-O 122.017 0.913 . . . . 0.0 112.415 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.501 ' CE1' ' CG2' ' A' ' 56' ' ' ILE . 43.6 m-85 -138.05 -45.91 0.52 Allowed 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.495 ' O ' ' CB ' ' A' ' 84' ' ' ALA . . . 1.54 128.9 0.0 OUTLIER Glycine 0 N--CA 1.496 2.687 0 CA-C-N 112.285 -2.234 . . . . 0.0 116.97 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.495 ' CB ' ' O ' ' A' ' 83' ' ' GLY . . . 120.59 -47.55 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 O-C-N 126.229 1.782 . . . . 0.0 110.468 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.445 ' O ' ' O ' ' A' ' 86' ' ' GLY . 87.5 m -117.96 -57.56 2.09 Favored 'General case' 0 N--CA 1.505 2.288 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 85' ' ' THR . . . 42.72 -176.47 0.01 OUTLIER Glycine 0 N--CA 1.493 2.488 0 CA-C-O 122.149 0.861 . . . . 0.0 113.251 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.492 ' N ' ' O ' ' A' ' 91' ' ' ILE . 18.4 m80 -115.38 153.48 47.56 Favored Pre-proline 0 N--CA 1.504 2.251 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -90.22 37.26 0.34 Allowed 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 122.072 1.848 . . . . 0.0 108.562 170.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -132.37 -50.66 0.09 OUTLIER Glycine 0 N--CA 1.499 2.862 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.57 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.3 mt -115.88 -50.92 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 CA-C-O 122.124 0.964 . . . . 0.0 109.779 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.492 ' O ' ' N ' ' A' ' 87' ' ' HIS . 23.0 mm -117.45 88.23 27.93 Favored Pre-proline 0 N--CA 1.51 2.555 0 CA-C-N 113.57 -1.65 . . . . 0.0 113.042 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -60.87 -175.44 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.016 1.811 . . . . 0.0 109.239 169.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -61.41 166.98 10.34 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.041 1.827 . . . . 0.0 110.593 178.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.445 ' CG ' ' O ' ' A' ' 94' ' ' HIS . 25.4 p-80 9.43 68.43 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.247 0 O-C-N 125.385 1.678 . . . . 0.0 115.097 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -116.27 74.36 0.9 Allowed 'General case' 0 N--CA 1.501 2.117 0 CA-C-O 120.747 0.308 . . . . 0.0 110.457 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 84.5 m -29.31 134.29 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.026 0 O-C-N 124.811 1.319 . . . . 0.0 111.369 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 21.4 mt -107.57 144.61 34.34 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 49.9 t -132.39 119.65 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -111.85 163.87 13.71 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 122.513 1.149 . . . . 0.0 108.942 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -129.28 89.94 2.93 Favored 'General case' 0 C--N 1.301 -1.523 1 N-CA-C 97.383 -5.043 . . . . 0.0 97.383 179.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 12.3 t -103.89 151.17 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.447 0 N-CA-C 114.671 1.359 . . . . 0.0 114.671 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -125.82 103.05 7.59 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 112.007 -2.361 . . . . 0.0 108.122 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 43.6 tp -75.21 118.55 18.26 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 102.66 -3.089 . . . . 0.0 102.66 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.5 mt -85.35 -56.53 3.48 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 113.828 -1.533 . . . . 0.0 112.297 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.409 ' HZ1' ' CB ' ' A' ' 105' ' ' LYS . 0.1 OUTLIER -172.43 -168.34 0.52 Allowed 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.047 -1.061 . . . . 0.0 111.22 -179.865 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 22.2 mt -115.77 156.28 26.3 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 . . . . . 0 N--CA 1.505 2.277 0 CA-C-O 116.233 -1.842 . . . . 0.0 109.844 179.865 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.8 p -114.04 147.65 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -123.47 153.57 40.31 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 97.0 t -129.51 102.15 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -99.73 161.32 13.69 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 102.854 -3.017 . . . . 0.0 102.854 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 72.8 m -121.31 156.38 32.68 Favored 'General case' 0 N--CA 1.504 2.253 0 CA-C-O 121.987 0.899 . . . . 0.0 112.301 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 74.8 mt -124.72 -54.17 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 9' ' ' PRO . 28.2 t -124.99 83.18 60.48 Favored Pre-proline 0 N--CA 1.508 2.459 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.052 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 8' ' ' SER . 13.5 Cg_exo -37.28 160.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.155 1.903 . . . . 0.0 111.612 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.25 -171.75 14.28 Favored Glycine 0 N--CA 1.503 3.142 0 N-CA-C 107.496 -2.241 . . . . 0.0 107.496 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 12' ' ' GLY . 1.3 p30 -39.61 -51.64 2.24 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.817 -0.753 . . . . 0.0 112.508 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.51 ' N ' ' OD1' ' A' ' 11' ' ' ASP . . . 97.43 2.88 58.77 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 108.126 -1.99 . . . . 0.0 108.126 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 34.6 mtm-85 -119.8 -36.02 3.39 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.8 m -106.99 134.3 50.34 Favored 'General case' 0 N--CA 1.506 2.345 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 33.0 m-85 -130.61 175.14 3.89 Favored Pre-proline 0 N--CA 1.495 1.816 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -66.43 155.13 71.55 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 CA-C-N 119.82 0.971 . . . . 0.0 110.006 165.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -121.7 172.83 7.85 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-O 121.893 0.854 . . . . 0.0 109.635 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.41 HH11 ' CB ' ' A' ' 18' ' ' ARG . 44.3 mtm105 -77.99 96.27 5.02 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.673 -1.148 . . . . 0.0 109.92 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.71 12.55 3.66 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.194 -1.563 . . . . 0.0 109.194 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.494 ' O ' ' SD ' ' A' ' 49' ' ' MET . 15.8 mm100 -113.85 167.88 10.26 Favored 'General case' 0 N--CA 1.504 2.245 0 CA-C-O 121.893 0.854 . . . . 0.0 109.236 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 97.1 m -118.6 114.32 22.6 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 114.226 -1.352 . . . . 0.0 107.551 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 56.9 m -74.67 146.15 42.58 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 118.871 -1.132 . . . . 0.0 108.606 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 94.7 t -117.69 99.67 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 101.311 -3.589 . . . . 0.0 101.311 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.8 m -121.21 148.26 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 N-CA-C 114.946 1.462 . . . . 0.0 114.946 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -122.24 143.73 49.41 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 102.948 -2.982 . . . . 0.0 102.948 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -157.97 175.53 13.72 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 118.895 -1.122 . . . . 0.0 112.931 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 93.7 m -135.12 126.36 28.19 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 101.375 -3.565 . . . . 0.0 101.375 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.86 127.79 8.74 Favored Glycine 0 N--CA 1.502 3.065 0 C-N-CA 120.04 -1.076 . . . . 0.0 111.963 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 68.5 mtp -128.77 176.93 7.43 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 30.8 mt -123.78 -169.21 1.91 Allowed 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.01 22.86 3.02 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.747 0.784 . . . . 0.0 109.889 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 33' ' ' GLY . 1.2 p30 -131.43 -48.64 0.98 Allowed 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.85 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.529 ' N ' ' OD1' ' A' ' 32' ' ' ASP . . . 118.42 33.56 1.2 Allowed Glycine 0 N--CA 1.501 3.032 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.122 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.402 ' O ' ' C ' ' A' ' 35' ' ' LYS . 55.9 mmtt -118.3 70.5 0.81 Allowed 'General case' 0 N--CA 1.504 2.238 0 CA-C-N 117.311 0.556 . . . . 0.0 110.506 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 34' ' ' LYS . 22.0 pttp -19.33 137.04 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.285 0 O-C-N 125.108 1.505 . . . . 0.0 114.065 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.532 ' CD2' ' OD1' ' A' ' 37' ' ' ASP . 2.3 p90 -130.49 -34.06 1.61 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 113.653 -1.612 . . . . 0.0 108.58 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.532 ' OD1' ' CD2' ' A' ' 36' ' ' PHE . 1.0 OUTLIER -134.7 89.29 2.52 Favored 'General case' 0 N--CA 1.511 2.619 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 51.1 m -113.69 135.14 54.25 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.6 p -127.16 57.04 1.49 Allowed 'General case' 0 N--CA 1.509 2.523 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 20.1 ttp85 -130.11 77.14 1.77 Allowed 'General case' 0 N--CA 1.502 2.157 0 CA-C-O 121.29 0.567 . . . . 0.0 111.165 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -90.59 -93.86 0.13 Allowed 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.515 ' C ' HD21 ' A' ' 43' ' ' ASN . 0.0 OUTLIER -92.61 -121.48 0.08 Allowed 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.515 HD21 ' C ' ' A' ' 42' ' ' ARG . 3.0 m120 -111.69 26.14 10.94 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-N 113.934 -1.485 . . . . 0.0 110.268 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.442 ' O ' ' O ' ' A' ' 45' ' ' PRO . 20.4 pttp -127.01 64.26 59.74 Favored Pre-proline 0 N--CA 1.503 2.222 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.442 ' O ' ' O ' ' A' ' 44' ' ' LYS . 20.0 Cg_endo -45.6 -158.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 121.96 1.773 . . . . 0.0 114.162 170.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -91.46 148.85 22.01 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 114.331 -1.304 . . . . 0.0 114.205 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -143.06 122.88 13.42 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.487 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -135.4 171.55 14.28 Favored 'General case' 0 N--CA 1.512 2.627 0 CA-C-N 119.457 1.026 . . . . 0.0 112.466 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.494 ' SD ' ' O ' ' A' ' 20' ' ' GLN . 44.3 tpp -111.53 144.53 40.61 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 114.867 -1.06 . . . . 0.0 112.212 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.4 tp -90.8 121.43 32.66 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.601 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 117.27 -19.0 11.93 Favored Glycine 0 N--CA 1.501 2.967 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.888 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.429 ' O ' ' OE1' ' A' ' 54' ' ' GLU . 41.6 tptt -112.8 36.48 3.45 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.404 ' C ' ' O ' ' A' ' 52' ' ' LYS . 39.1 tt0 10.23 71.23 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 O-C-N 125.345 1.653 . . . . 0.0 113.664 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.429 ' OE1' ' O ' ' A' ' 52' ' ' LYS . 5.0 mm-40 -92.8 -24.06 18.65 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 113.408 -1.724 . . . . 0.0 106.828 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.1 m -115.92 -177.26 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 16.5 pt -90.27 169.94 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.193 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.549 ' O ' ' N ' ' A' ' 59' ' ' TRP . 19.4 ttm-85 -55.11 -63.18 1.24 Allowed 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.334 -0.947 . . . . 0.0 110.702 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -27.13 -35.31 0.01 OUTLIER Glycine 0 N--CA 1.496 2.694 0 O-C-N 124.933 1.396 . . . . 0.0 111.977 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.549 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.9 OUTLIER -86.76 -71.35 0.56 Allowed 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 114.058 -1.071 . . . . 0.0 108.646 179.856 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.422 ' O ' ' OE1' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -28.53 -57.73 0.13 Allowed 'General case' 0 N--CA 1.504 2.255 0 O-C-N 125.066 1.478 . . . . 0.0 110.325 -179.867 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -73.25 -52.58 13.5 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -49.31 -79.9 0.07 OUTLIER Glycine 0 N--CA 1.477 1.375 0 C-N-CA 119.419 -1.372 . . . . 0.0 110.96 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.522 ' N ' ' O ' ' A' ' 59' ' ' TRP . 35.6 t -39.45 -47.71 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 120.226 -0.589 . . . . 0.0 112.358 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.526 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -45.3 -60.11 2.31 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 124.146 1.927 . . . . 0.0 111.094 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -48.51 -11.2 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 109.386 -3.552 . . . . 0.0 109.661 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.526 ' H ' ' C ' ' A' ' 64' ' ' ALA . 86.0 mtp -97.94 156.47 16.6 Favored 'General case' 0 N--CA 1.513 2.704 0 C-N-CA 118.854 -1.138 . . . . 0.0 108.606 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 79.8 p -118.64 149.13 41.91 Favored 'General case' 0 N--CA 1.508 2.443 0 CA-C-O 122.539 1.162 . . . . 0.0 112.8 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 99.5 t -43.52 97.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-N 112.801 -1.999 . . . . 0.0 114.716 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.36 12.92 16.14 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -108.03 145.05 34.51 Favored 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.106 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 25.7 ttt85 -123.79 135.1 53.59 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 105.464 -2.051 . . . . 0.0 105.464 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -136.82 172.61 12.75 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 112.026 -2.352 . . . . 0.0 116.142 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -129.58 103.77 7.06 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 111.069 -2.787 . . . . 0.0 103.917 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.0 mp -100.69 149.47 23.75 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.889 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.6 m -121.09 104.51 9.83 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 21.3 mt -99.81 137.25 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.503 ' HG ' ' CG ' ' A' ' 79' ' ' ASP . 29.5 p -115.54 156.34 46.16 Favored Pre-proline 0 N--CA 1.501 2.123 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.413 ' O ' ' O ' ' A' ' 81' ' ' ALA . 7.6 Cg_endo -35.97 -52.07 1.03 Allowed 'Trans proline' 0 C--N 1.314 -1.266 0 C-N-CA 121.937 1.758 . . . . 0.0 113.971 -175.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.503 ' CG ' ' HG ' ' A' ' 77' ' ' SER . 1.3 p30 -37.62 -38.64 0.28 Allowed 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 121.456 0.646 . . . . 0.0 112.301 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -104.02 -27.98 11.8 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.428 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.492 ' O ' ' N ' ' A' ' 83' ' ' GLY . . . -97.37 165.47 12.0 Favored 'General case' 0 N--CA 1.506 2.337 0 C-N-CA 119.299 -0.96 . . . . 0.0 109.171 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -5.44 -57.87 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 126.618 2.449 . . . . 0.0 114.873 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 81' ' ' ALA . . . 124.44 163.13 11.61 Favored Glycine 0 N--CA 1.5 2.938 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.142 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -12.3 -85.85 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 116.169 1.914 . . . . 0.0 116.169 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 92.8 m -125.34 94.27 4.1 Favored 'General case' 0 N--CA 1.501 2.108 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.127 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -112.63 -54.25 0.47 Allowed Glycine 0 N--CA 1.501 3.008 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.216 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -122.94 62.92 19.62 Favored Pre-proline 0 N--CA 1.506 2.352 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -44.87 126.82 7.81 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 121.326 1.351 . . . . 0.0 109.916 172.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 118.25 -40.23 2.36 Favored Glycine 0 N--CA 1.501 3.026 0 N-CA-C 108.597 -1.801 . . . . 0.0 108.597 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.8 mt -108.93 -51.22 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 23.7 mm -118.32 85.28 24.91 Favored Pre-proline 0 N--CA 1.502 2.128 0 CA-C-N 112.105 -2.316 . . . . 0.0 110.54 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -60.68 164.35 13.75 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 N-CA-C 107.223 -1.876 . . . . 0.0 107.223 177.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.41 ' O ' ' C ' ' A' ' 94' ' ' HIS . 16.3 Cg_endo -44.57 167.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 121.43 1.42 . . . . 0.0 110.178 177.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.41 ' C ' ' O ' ' A' ' 93' ' ' PRO . 20.4 m80 9.67 63.71 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 O-C-N 125.714 1.884 . . . . 0.0 114.73 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -115.65 71.35 0.77 Allowed 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.091 0.472 . . . . 0.0 110.031 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 91.2 m -29.34 125.17 0.13 Allowed 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 113.99 -1.459 . . . . 0.0 110.905 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 18.4 mt -89.76 146.97 24.11 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 55.1 t -131.78 109.71 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -103.26 156.43 17.72 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 122.135 0.969 . . . . 0.0 109.211 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -127.07 93.68 3.82 Favored 'General case' 0 N--CA 1.493 1.679 1 N-CA-C 97.897 -4.853 . . . . 0.0 97.897 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.4 t -108.38 154.89 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.434 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -128.74 102.36 6.53 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 111.612 -2.54 . . . . 0.0 107.741 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 37.0 tp -72.24 125.63 27.81 Favored 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 103.065 -2.939 . . . . 0.0 103.065 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 16.5 mt -96.25 -55.4 2.96 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.42 ' CG ' ' H ' ' A' ' 106' ' ' LEU . 56.0 tttp -166.09 177.3 7.07 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.071 -1.052 . . . . 0.0 111.474 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.42 ' H ' ' CG ' ' A' ' 105' ' ' LYS . 24.4 mt -114.55 150.94 34.18 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 . . . . . 0 N--CA 1.505 2.299 0 CA-C-O 116.17 -1.871 . . . . 0.0 109.996 179.731 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.231 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.8 p -110.22 143.84 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.474 ' NE2' ' OE2' ' A' ' 5' ' ' GLU . 41.2 tt0 -121.26 157.77 29.57 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.5 t -122.65 115.42 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.474 ' OE2' ' NE2' ' A' ' 3' ' ' GLN . 94.4 mt-10 -117.11 94.69 4.67 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 69.0 m -69.92 155.88 39.91 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 114.806 1.409 . . . . 0.0 114.806 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 72.2 mt -122.57 -55.48 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 CA-C-N 113.031 -1.895 . . . . 0.0 107.387 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.423 ' O ' ' O ' ' A' ' 9' ' ' PRO . 34.7 t -121.99 81.96 43.27 Favored Pre-proline 0 N--CA 1.505 2.292 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.576 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 8' ' ' SER . 12.2 Cg_exo -38.4 164.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.165 1.91 . . . . 0.0 111.868 178.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.67 -172.39 15.02 Favored Glycine 0 N--CA 1.498 2.803 0 N-CA-C 104.916 -3.274 . . . . 0.0 104.916 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.524 ' N ' ' OD1' ' A' ' 11' ' ' ASP . 12.9 p-10 -39.72 -58.56 1.31 Allowed 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.434 -0.907 . . . . 0.0 112.8 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.32 23.27 9.11 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 105.081 -3.208 . . . . 0.0 105.081 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.02 -40.73 1.48 Allowed 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 113.757 -1.222 . . . . 0.0 111.545 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.4 m -108.62 136.46 48.19 Favored 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.454 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 66.0 m-85 -131.65 176.75 2.65 Favored Pre-proline 0 N--CA 1.494 1.765 0 N-CA-C 105.195 -2.15 . . . . 0.0 105.195 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -70.7 149.18 60.5 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 CA-C-N 119.485 0.852 . . . . 0.0 111.194 164.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -121.78 173.38 7.51 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 122.289 1.043 . . . . 0.0 110.41 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.1 ttm180 -77.69 98.34 5.44 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 113.912 -1.494 . . . . 0.0 109.556 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.13 9.63 4.56 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -113.89 171.76 7.4 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 76.8 m -124.42 112.63 17.15 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.732 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.443 ' N ' ' O ' ' A' ' 48' ' ' PHE . 36.5 m -72.11 147.66 46.48 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.752 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.2 t -116.78 114.11 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 101.389 -3.56 . . . . 0.0 101.389 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -126.65 150.16 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.04 0 N-CA-C 119.404 3.112 . . . . 0.0 119.404 -178.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.608 ' CE1' ' HG ' ' A' ' 39' ' ' SER . 84.1 t60 -133.48 142.85 48.46 Favored 'General case' 0 N--CA 1.506 2.33 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.515 ' CZ ' ' O ' ' A' ' 38' ' ' SER . 39.2 p90 -160.53 -179.38 7.6 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 118.474 -1.291 . . . . 0.0 113.53 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 91.5 m -140.73 122.84 15.67 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 101.657 -3.46 . . . . 0.0 101.657 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -102.26 147.69 17.34 Favored Glycine 0 N--CA 1.504 3.198 0 C-N-CA 119.999 -1.096 . . . . 0.0 110.377 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.435 ' SD ' ' C ' ' A' ' 34' ' ' LYS . 13.4 tpp -147.36 170.35 17.51 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 120.069 -0.652 . . . . 0.0 110.181 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.404 ' O ' ' C ' ' A' ' 31' ' ' GLU . 31.3 mt -115.04 149.2 37.84 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' A' ' 31' ' ' GLU . 3.6 pm0 -20.64 -51.87 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -160.29 43.11 0.19 Allowed 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 118.732 -1.187 . . . . 0.0 110.408 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -121.44 -81.51 0.62 Allowed Glycine 0 N--CA 1.499 2.88 0 C-N-CA 119.439 -1.362 . . . . 0.0 112.859 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.604 ' HZ1' ' CB ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -160.96 -163.71 1.08 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 113.972 -1.114 . . . . 0.0 113.516 -179.395 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -90.37 133.26 35.1 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.432 ' O ' ' OD1' ' A' ' 37' ' ' ASP . 55.6 p90 -108.21 -34.84 6.72 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 103.769 -2.678 . . . . 0.0 103.769 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 36' ' ' PHE . 0.7 OUTLIER -147.89 150.16 33.58 Favored 'General case' 0 N--CA 1.508 2.437 0 CA-C-O 122.132 0.967 . . . . 0.0 112.738 179.755 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.515 ' O ' ' CZ ' ' A' ' 26' ' ' TYR . 52.1 m -130.34 -159.83 0.99 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.608 ' HG ' ' CE1' ' A' ' 25' ' ' HIS . 28.3 p -113.09 -82.94 0.6 Allowed 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 20.7 ttp85 -29.96 -37.47 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.127 0 CA-C-O 122.037 0.922 . . . . 0.0 112.301 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 39' ' ' SER . 64.1 t0 -18.78 -57.19 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 116.418 2.007 . . . . 0.0 116.418 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.511 ' C ' HD21 ' A' ' 43' ' ' ASN . 62.7 mtt180 -90.86 -107.71 0.09 Allowed 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.511 HD21 ' C ' ' A' ' 42' ' ' ARG . 3.4 m120 -110.88 65.3 0.61 Allowed 'General case' 0 N--CA 1.506 2.341 0 N-CA-C 114.93 1.455 . . . . 0.0 114.93 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.457 ' CB ' ' O ' ' A' ' 43' ' ' ASN . 75.7 mmtt 94.45 172.13 0.03 OUTLIER Pre-proline 0 N--CA 1.508 2.448 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -58.27 -158.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.245 0 CA-C-N 120.588 1.246 . . . . 0.0 114.254 177.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . 0.255 0.7 OUTLIER -117.08 129.03 55.73 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 112.093 -2.321 . . . . 0.0 109.954 -179.502 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -134.98 123.96 24.13 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 113.5 -1.682 . . . . 0.0 107.259 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.443 ' O ' ' N ' ' A' ' 22' ' ' CYS . 22.1 p90 -135.41 -178.01 4.92 Favored 'General case' 0 N--CA 1.515 2.814 0 CA-C-N 120.579 1.536 . . . . 0.0 114.696 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 42.9 ttm -116.69 144.25 44.65 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-N 115.199 -0.909 . . . . 0.0 113.024 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.3 tp -90.89 120.98 32.35 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.626 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.82 -11.48 49.48 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.468 ' O ' ' N ' ' A' ' 54' ' ' GLU . 25.6 tptp -112.44 38.58 2.7 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.407 ' C ' ' O ' ' A' ' 52' ' ' LYS . 47.5 tt0 0.86 66.18 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 O-C-N 125.653 1.846 . . . . 0.0 112.958 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' A' ' 52' ' ' LYS . 39.2 tt0 -96.28 -26.08 15.54 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 112.731 -2.031 . . . . 0.0 107.199 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.437 ' O ' ' O ' ' A' ' 56' ' ' ILE . 4.9 m -124.32 152.54 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.465 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.174 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 55' ' ' VAL . 4.9 pt -45.89 177.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.408 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.54 ' O ' ' N ' ' A' ' 59' ' ' TRP . 30.5 ttp180 -79.25 -57.53 3.67 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-O 118.337 -0.84 . . . . 0.0 112.715 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -30.58 -32.73 0.01 OUTLIER Glycine 0 N--CA 1.503 3.11 0 CA-C-O 122.664 1.147 . . . . 0.0 111.427 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.54 ' N ' ' O ' ' A' ' 57' ' ' ARG . 2.4 m0 -90.06 -73.5 0.52 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 113.629 -1.286 . . . . 0.0 107.853 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -31.86 -54.61 0.28 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 124.792 1.308 . . . . 0.0 110.768 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -73.15 -51.64 17.12 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 113.977 -1.465 . . . . 0.0 107.614 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 65' ' ' GLN . . . -55.69 -82.44 0.05 OUTLIER Glycine 0 N--CA 1.479 1.54 0 N-CA-C 108.16 -1.976 . . . . 0.0 108.16 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' A' ' 59' ' ' TRP . 66.1 t -30.38 -45.1 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.44 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -51.11 -49.29 61.02 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 123.692 1.711 . . . . 0.0 109.569 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.481 ' N ' ' O ' ' A' ' 62' ' ' GLY . 6.0 tt0 -66.01 3.29 0.87 Allowed 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 110.202 -3.181 . . . . 0.0 110.892 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.44 ' H ' ' C ' ' A' ' 64' ' ' ALA . 48.4 ttm -109.51 156.19 20.42 Favored 'General case' 0 N--CA 1.51 2.531 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 99.7 p -115.32 151.41 34.64 Favored 'General case' 0 N--CA 1.509 2.502 0 CA-C-O 122.545 1.164 . . . . 0.0 112.694 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 95.5 t -46.34 99.51 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-N 112.804 -1.998 . . . . 0.0 114.581 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.66 3.69 28.59 Favored Glycine 0 N--CA 1.502 3.076 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -101.83 149.13 24.5 Favored 'General case' 0 N--CA 1.506 2.328 0 CA-C-O 121.988 0.899 . . . . 0.0 111.03 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.8 ttt85 -127.14 143.2 51.32 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 113.786 -1.552 . . . . 0.0 106.961 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -151.72 175.99 11.85 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 113.401 -1.727 . . . . 0.0 113.958 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.5 ttmp? -119.67 102.8 8.87 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 103.45 -2.796 . . . . 0.0 103.45 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.2 mt -96.26 149.69 21.39 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 97.1 m -119.47 116.53 26.3 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 104.486 -2.412 . . . . 0.0 104.486 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 53.5 mt -102.45 142.58 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.9 p -101.53 154.36 37.3 Favored Pre-proline 0 N--CA 1.501 2.083 0 O-C-N 124.985 1.428 . . . . 0.0 111.398 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -44.72 -41.89 14.8 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 C-N-CA 122.915 2.41 . . . . 0.0 117.695 -175.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -87.77 20.24 3.11 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 117.908 2.558 . . . . 0.0 117.908 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -113.79 -38.39 4.27 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -115.35 -73.47 0.65 Allowed 'General case' 0 N--CA 1.503 2.192 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 8.9 m-30 -106.6 -92.84 0.39 Allowed 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 114.154 -1.384 . . . . 0.0 107.564 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 94' ' ' HIS . . . 107.94 -87.65 0.5 Allowed Glycine 0 N--CA 1.502 3.074 0 N-CA-C 115.051 0.78 . . . . 0.0 115.051 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -124.73 -28.84 3.49 Favored 'General case' 0 N--CA 1.503 2.185 0 CA-C-O 120.943 0.402 . . . . 0.0 111.433 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 91.3 m -99.55 67.83 1.54 Allowed 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.563 0.697 . . . . 0.0 110.544 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -112.83 -164.57 16.29 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 25.6 t-80 -115.6 82.71 10.32 Favored Pre-proline 0 N--CA 1.503 2.18 0 CA-C-O 118.865 -0.588 . . . . 0.0 111.416 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_exo -34.88 151.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 122.671 2.248 . . . . 0.0 111.433 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 107.38 -41.7 2.13 Favored Glycine 0 N--CA 1.5 2.959 0 N-CA-C 106.011 -2.836 . . . . 0.0 106.011 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.0 mm -119.53 -57.27 3.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 110.253 -2.974 . . . . 0.0 107.004 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 34.5 mm -118.93 87.57 33.99 Favored Pre-proline 0 N--CA 1.506 2.348 0 CA-C-N 113.354 -1.748 . . . . 0.0 111.086 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -69.64 162.66 41.16 Favored 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 122.448 2.099 . . . . 0.0 108.316 171.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -48.65 177.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.15 1.9 . . . . 0.0 112.176 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.52 ' N ' ' O ' ' A' ' 83' ' ' GLY . 24.5 m80 9.7 65.95 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 116.242 1.942 . . . . 0.0 116.242 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -115.62 138.33 51.18 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 28.9 m -90.73 136.94 32.74 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 103.752 -2.684 . . . . 0.0 103.752 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 19.3 mt -106.48 150.19 26.33 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.1 t -132.14 104.32 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -96.89 166.97 11.37 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -127.5 85.92 2.42 Favored 'General case' 0 N--CA 1.491 1.598 1 N-CA-C 94.844 -5.984 . . . . 0.0 94.844 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.1 t -98.59 149.45 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.3 0 CA-C-O 122.759 1.266 . . . . 0.0 114.342 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -126.84 111.45 14.19 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 112.19 -2.277 . . . . 0.0 106.897 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 35.0 tp -79.49 113.72 17.86 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 101.125 -3.657 . . . . 0.0 101.125 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.3 mt -74.19 -57.78 3.73 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 118.684 -1.207 . . . . 0.0 111.49 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -175.32 -172.27 0.56 Allowed 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 118.32 -1.352 . . . . 0.0 109.619 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.1 mt -117.89 155.28 30.43 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 . . . . . 0 N--CA 1.512 2.645 0 CA-C-O 116.175 -1.869 . . . . 0.0 109.143 179.443 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.2 p -113.63 150.08 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -121.09 152.64 38.44 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 55.6 t -126.64 112.38 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.531 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.417 ' OE1' ' O ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -113.03 96.04 5.72 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 103.644 -2.725 . . . . 0.0 103.644 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.417 ' O ' ' OE1' ' A' ' 5' ' ' GLU . 87.1 m -69.87 156.58 38.86 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 118.56 -1.256 . . . . 0.0 112.494 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 71.7 mt -121.16 -55.09 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 CA-C-N 113.939 -1.482 . . . . 0.0 107.422 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.423 ' O ' ' O ' ' A' ' 9' ' ' PRO . 36.2 m -124.35 82.42 57.95 Favored Pre-proline 0 N--CA 1.507 2.407 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.742 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 8' ' ' SER . 3.4 Cg_exo -35.93 164.21 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.566 2.177 . . . . 0.0 113.434 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -114.84 -176.91 18.87 Favored Glycine 0 N--CA 1.501 3.023 0 N-CA-C 105.841 -2.903 . . . . 0.0 105.841 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.494 ' CG ' ' H ' ' A' ' 12' ' ' GLY . 11.6 p-10 -42.5 -58.48 2.24 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 118.174 0.987 . . . . 0.0 111.745 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.494 ' H ' ' CG ' ' A' ' 11' ' ' ASP . . . 109.33 24.63 5.85 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 107.738 -2.145 . . . . 0.0 107.738 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.3 mtm180 -133.53 -34.35 1.05 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 114.75 -0.725 . . . . 0.0 112.771 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.4 m -111.51 130.4 55.74 Favored 'General case' 0 N--CA 1.506 2.347 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 26.2 m-85 -130.31 173.35 5.9 Favored Pre-proline 0 N--CA 1.497 1.898 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -67.94 150.28 78.03 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 CA-C-N 119.997 1.035 . . . . 0.0 111.165 167.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -121.62 171.15 9.05 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-O 121.898 0.856 . . . . 0.0 110.911 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.2 ttt-85 -77.51 98.57 5.38 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.491 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.0 10.38 4.32 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -114.97 173.91 6.24 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.1 m -124.7 112.09 16.34 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 20.1 m -69.82 145.8 51.84 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.4 t -118.11 102.84 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 101.268 -3.605 . . . . 0.0 101.268 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.0 m -124.09 153.9 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.443 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 -131.19 116.87 18.25 Favored 'General case' 0 N--CA 1.507 2.405 0 N-CA-C 104.991 -2.226 . . . . 0.0 104.991 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -132.16 177.38 7.61 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 122.997 1.379 . . . . 0.0 114.451 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 87.3 m -136.32 124.4 22.95 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 101.218 -3.623 . . . . 0.0 101.218 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -107.99 116.18 4.73 Favored Glycine 0 N--CA 1.501 3.022 0 C-N-CA 120.337 -0.935 . . . . 0.0 111.415 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 69.2 mtp -125.13 178.62 5.45 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 34.3 mt -123.18 172.17 8.79 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -29.66 -61.13 0.15 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 124.919 1.387 . . . . 0.0 113.637 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -160.5 42.84 0.18 Allowed 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.051 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -118.83 -79.93 0.67 Allowed Glycine 0 N--CA 1.5 2.946 0 C-N-CA 119.374 -1.393 . . . . 0.0 113.885 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -161.1 -168.73 2.13 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -91.11 133.9 34.96 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 113.963 -1.471 . . . . 0.0 109.957 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.531 ' CD2' ' OD1' ' A' ' 37' ' ' ASP . 4.9 p90 -123.77 -36.54 2.73 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.531 ' OD1' ' CD2' ' A' ' 36' ' ' PHE . 1.0 OUTLIER -132.55 74.77 1.59 Allowed 'General case' 0 N--CA 1.509 2.497 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.673 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 69.0 m -105.75 121.51 44.18 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 63.9 p -113.22 65.16 0.64 Allowed 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.043 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -116.22 -72.08 0.71 Allowed 'General case' 0 N--CA 1.503 2.216 0 CA-C-O 120.838 0.352 . . . . 0.0 110.803 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -91.11 11.71 22.32 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -91.15 -96.83 0.12 Allowed 'General case' 0 N--CA 1.503 2.223 0 C-N-CA 119.995 -0.682 . . . . 0.0 112.384 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.415 ' O ' ' O ' ' A' ' 44' ' ' LYS . 4.4 m120 -110.77 62.43 0.61 Allowed 'General case' 0 N--CA 1.504 2.256 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.72 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.415 ' O ' ' O ' ' A' ' 43' ' ' ASN . 48.8 mttm 52.29 -178.02 0.02 OUTLIER Pre-proline 0 N--CA 1.499 2.003 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -60.39 -161.35 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.559 0 CA-C-N 119.875 0.991 . . . . 0.0 111.52 174.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -123.3 159.23 29.24 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 113.671 -1.604 . . . . 0.0 112.891 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.5 mtmp? -143.61 117.11 9.13 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.875 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -137.14 167.3 21.81 Favored 'General case' 0 N--CA 1.511 2.602 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.638 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.5 ' SD ' ' O ' ' A' ' 50' ' ' LEU . 7.8 tmm? -117.46 144.6 44.87 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.97 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.5 ' O ' ' SD ' ' A' ' 49' ' ' MET . 44.0 tp -90.81 134.52 34.38 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 114.516 -1.22 . . . . 0.0 111.443 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 132.97 -34.42 2.46 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 54' ' ' GLU . 80.3 tttt -122.62 44.39 2.65 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 4.42 58.73 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 126.015 2.072 . . . . 0.0 114.072 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 52' ' ' LYS . 50.4 mt-10 -63.74 -17.58 63.17 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 114.526 -1.215 . . . . 0.0 109.757 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 56' ' ' ILE . 21.1 m -117.6 159.79 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.32 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.425 ' O ' ' O ' ' A' ' 55' ' ' VAL . 16.2 pt -51.55 178.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 C-N-CA 118.64 -1.224 . . . . 0.0 108.534 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.532 ' O ' ' N ' ' A' ' 59' ' ' TRP . 17.6 ttm180 -75.18 -59.14 2.88 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.152 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -28.52 -34.98 0.01 OUTLIER Glycine 0 N--CA 1.497 2.738 0 O-C-N 124.614 1.196 . . . . 0.0 112.26 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.532 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.6 OUTLIER -81.39 -73.61 0.37 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 179.761 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 59' ' ' TRP . 32.4 tt0 -22.4 -57.24 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 O-C-N 125.914 2.009 . . . . 0.0 111.426 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -78.11 -52.21 9.09 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 113.075 -1.875 . . . . 0.0 106.491 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -49.65 -74.17 0.3 Allowed Glycine 0 N--CA 1.48 1.604 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.095 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.497 ' N ' ' O ' ' A' ' 59' ' ' TRP . 25.6 t -44.13 -50.59 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 C-N-CA 119.317 -0.953 . . . . 0.0 111.745 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.509 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -44.19 -62.39 1.17 Allowed 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 123.989 1.852 . . . . 0.0 111.608 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -45.9 -13.98 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 109.429 -3.532 . . . . 0.0 109.3 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.509 ' H ' ' C ' ' A' ' 64' ' ' ALA . 20.2 mtm -98.36 158.23 15.71 Favored 'General case' 0 N--CA 1.514 2.733 0 C-N-CA 118.084 -1.446 . . . . 0.0 108.96 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 84.4 p -117.9 149.43 40.9 Favored 'General case' 0 N--CA 1.508 2.467 0 CA-C-O 122.558 1.17 . . . . 0.0 113.399 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 90.5 t -39.4 96.6 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 112.719 -2.037 . . . . 0.0 114.044 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.13 9.4 20.24 Favored Glycine 0 N--CA 1.5 2.919 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -103.0 141.6 35.52 Favored 'General case' 0 N--CA 1.502 2.168 0 CA-C-O 121.457 0.646 . . . . 0.0 110.355 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 24.7 ttt85 -125.34 141.13 52.25 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -149.65 176.13 10.93 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-N 113.064 -1.88 . . . . 0.0 115.853 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -127.61 105.01 8.19 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 103.851 -2.648 . . . . 0.0 103.851 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.9 mp -102.47 152.27 21.33 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.591 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 92.0 m -123.73 117.18 24.37 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 22.8 mt -108.63 141.72 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 CA-C-O 121.099 0.476 . . . . 0.0 109.858 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.435 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 33.4 p -114.65 155.34 46.24 Favored Pre-proline 0 N--CA 1.504 2.263 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.435 ' O ' ' N ' ' A' ' 81' ' ' ALA . 10.2 Cg_endo -37.68 -55.65 1.04 Allowed 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.683 1.588 . . . . 0.0 113.961 -175.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 14.7 p30 -34.04 -34.89 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.579 0.704 . . . . 0.0 112.567 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.429 ' N ' ' O ' ' A' ' 78' ' ' PRO . 6.9 m-85 -106.81 -20.29 13.38 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.644 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 78' ' ' PRO . . . -106.75 171.02 7.59 Favored 'General case' 0 N--CA 1.507 2.383 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.415 ' C ' ' O ' ' A' ' 81' ' ' ALA . 51.3 m-85 -7.99 -63.15 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.269 0 O-C-N 125.627 1.829 . . . . 0.0 114.704 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 115.15 -97.35 0.8 Allowed Glycine 0 N--CA 1.503 3.122 0 CA-C-N 115.776 -0.647 . . . . 0.0 113.901 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -127.71 -31.63 2.43 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 92.0 m -101.93 78.35 1.79 Allowed 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -111.01 -168.74 19.02 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 107.333 -2.307 . . . . 0.0 107.333 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.433 ' O ' ' O ' ' A' ' 91' ' ' ILE . 30.4 t-80 -111.86 135.84 21.2 Favored Pre-proline 0 N--CA 1.507 2.398 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -75.48 149.85 35.34 Favored 'Trans proline' 0 C--N 1.316 -1.18 0 C-N-CA 121.232 1.288 . . . . 0.0 109.666 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 107.04 -45.02 1.36 Allowed Glycine 0 N--CA 1.499 2.877 0 N-CA-C 108.257 -1.937 . . . . 0.0 108.257 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.4 mt -112.93 -53.78 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 87' ' ' HIS . 18.9 mm -118.99 86.02 30.5 Favored Pre-proline 0 N--CA 1.508 2.457 0 CA-C-N 113.689 -1.596 . . . . 0.0 111.908 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -65.0 161.51 36.56 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 N-CA-C 106.875 -2.01 . . . . 0.0 106.875 173.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -52.07 170.27 0.24 Allowed 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 121.918 1.745 . . . . 0.0 111.384 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 9.59 66.82 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 116.034 1.865 . . . . 0.0 116.034 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -116.85 152.7 33.91 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 31.2 m -91.02 143.26 26.89 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 20.3 mt -110.19 153.33 24.91 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.7 t -138.11 123.59 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -118.86 155.03 31.95 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 122.119 0.961 . . . . 0.0 110.307 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -125.7 89.94 3.12 Favored 'General case' 0 N--CA 1.494 1.76 1 N-CA-C 97.424 -5.028 . . . . 0.0 97.424 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 9.9 t -102.93 151.29 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.483 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -128.59 100.9 5.93 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 111.832 -2.44 . . . . 0.0 108.284 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 45.9 tp -72.75 124.49 25.44 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 104.159 -2.534 . . . . 0.0 104.159 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.1 mt -91.56 -58.32 2.47 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 114.372 -1.285 . . . . 0.0 112.008 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 29.3 tttm -168.93 -175.4 2.34 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.007 -1.077 . . . . 0.0 110.418 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 17.9 mt -117.22 154.89 30.36 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 . . . . . 0 N--CA 1.505 2.313 0 CA-C-O 116.056 -1.926 . . . . 0.0 110.817 179.578 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.6 p -117.58 150.26 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -121.96 157.46 31.21 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.6 t -126.64 106.62 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -107.47 88.47 2.74 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 93.4 m -69.7 156.13 39.45 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.004 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.0 mt -122.76 -52.73 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-N 113.681 -1.599 . . . . 0.0 107.025 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.422 ' O ' ' O ' ' A' ' 9' ' ' PRO . 98.2 p -122.75 82.22 48.89 Favored Pre-proline 0 N--CA 1.505 2.302 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.462 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 8' ' ' SER . 7.8 Cg_exo -37.59 167.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.606 2.204 . . . . 0.0 113.234 178.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.16 -171.79 15.03 Favored Glycine 0 N--CA 1.503 3.132 0 N-CA-C 107.17 -2.372 . . . . 0.0 107.17 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.521 ' N ' ' OD1' ' A' ' 11' ' ' ASP . 13.9 p-10 -39.62 -61.09 0.86 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.576 -0.85 . . . . 0.0 112.897 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.17 17.88 12.08 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 106.126 -2.789 . . . . 0.0 106.126 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.9 mmt85 -127.41 -39.61 1.85 Allowed 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 114.006 -1.097 . . . . 0.0 111.925 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.1 m -108.29 133.7 52.15 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.435 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 32.8 m-85 -131.16 175.67 3.5 Favored Pre-proline 0 N--CA 1.496 1.855 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -72.58 140.81 33.46 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 CA-C-N 119.621 0.9 . . . . 0.0 109.988 163.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -121.23 174.08 6.92 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.714 0.769 . . . . 0.0 110.325 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 25.1 ttt85 -73.13 110.36 7.36 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.082 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.96 0.89 10.69 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -116.63 172.94 6.9 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 121.933 0.873 . . . . 0.0 110.628 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 97.0 m -125.25 117.67 24.32 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-N 113.975 -1.466 . . . . 0.0 108.234 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 55.8 m -69.58 150.55 46.96 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 77.0 t -122.71 101.48 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 102.945 -2.983 . . . . 0.0 102.945 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.3 m -121.64 149.19 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.498 0 N-CA-C 117.904 2.557 . . . . 0.0 117.904 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -124.68 111.92 16.16 Favored 'General case' 0 N--CA 1.507 2.378 0 N-CA-C 103.352 -2.833 . . . . 0.0 103.352 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.471 ' CD1' ' N ' ' A' ' 26' ' ' TYR . 19.8 p90 -129.89 168.32 16.81 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 123.485 1.612 . . . . 0.0 114.434 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 97.3 m -134.6 111.05 9.72 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 102.384 -3.191 . . . . 0.0 102.384 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 37' ' ' ASP . . . -89.36 138.35 14.62 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.113 -1.518 . . . . 0.0 109.875 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 38.1 ttm -131.22 175.67 8.92 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 32.9 mt -116.61 -167.63 1.32 Allowed 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -89.18 24.61 2.1 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 33' ' ' GLY . 1.2 p30 -132.47 -48.24 0.9 Allowed 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.601 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.526 ' N ' ' OD1' ' A' ' 32' ' ' ASP . . . 120.92 31.53 1.19 Allowed Glycine 0 N--CA 1.501 3.032 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.621 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 35' ' ' LYS . 25.8 mmtp -118.93 81.55 1.72 Allowed 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 118.581 -0.723 . . . . 0.0 110.252 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.405 ' C ' ' O ' ' A' ' 34' ' ' LYS . 21.6 pttp -19.29 133.67 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.531 0 O-C-N 125.078 1.486 . . . . 0.0 113.211 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.527 ' CD2' ' OD1' ' A' ' 37' ' ' ASP . 0.6 OUTLIER -136.02 -31.07 0.93 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 113.906 -1.497 . . . . 0.0 110.195 -179.582 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.527 ' OD1' ' CD2' ' A' ' 36' ' ' PHE . 0.9 OUTLIER -132.08 92.83 3.17 Favored 'General case' 0 N--CA 1.516 2.853 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -179.737 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 52.6 m -108.66 173.57 6.26 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.574 ' O ' ' N ' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -116.13 78.21 1.17 Allowed 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.539 ' O ' ' N ' ' A' ' 42' ' ' ARG . 9.9 mmm180 -28.58 57.37 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.39 0 O-C-N 126.88 2.612 . . . . 0.0 117.687 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.574 ' N ' ' O ' ' A' ' 39' ' ' SER . 36.9 t70 -27.21 71.72 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 112.877 -1.965 . . . . 0.0 115.265 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.539 ' N ' ' O ' ' A' ' 40' ' ' ARG . 43.8 ttp180 -90.78 -63.16 1.31 Allowed 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.717 HD21 ' H ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -110.4 -81.93 0.58 Allowed 'General case' 0 N--CA 1.5 2.034 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.478 179.899 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.692 ' H ' ' ND2' ' A' ' 43' ' ' ASN . 18.3 ptpt -125.94 152.41 72.8 Favored Pre-proline 0 N--CA 1.504 2.265 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 44' ' ' LYS . 20.1 Cg_endo -46.72 -160.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 123.102 2.534 . . . . 0.0 117.117 -175.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -94.6 143.91 26.03 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 113.592 -1.64 . . . . 0.0 110.077 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.523 ' HZ2' ' CD ' ' A' ' 44' ' ' LYS . 56.7 mttp -135.43 125.45 25.93 Favored 'General case' 0 N--CA 1.507 2.386 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -136.62 175.35 9.69 Favored 'General case' 0 N--CA 1.508 2.472 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.903 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 41.9 ttm -113.97 149.92 34.58 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 59.3 tp -91.01 119.85 31.52 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 113.993 -1.458 . . . . 0.0 112.444 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.82 -1.41 61.4 Favored Glycine 0 N--CA 1.498 2.774 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.444 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.414 ' O ' ' C ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -118.56 41.29 3.02 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.747 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.414 ' C ' ' O ' ' A' ' 52' ' ' LYS . 85.2 mt-30 4.9 65.72 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 O-C-N 125.54 1.775 . . . . 0.0 113.944 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.44 ' O ' ' OE1' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -93.58 -36.47 12.38 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 103.394 -2.817 . . . . 0.0 103.394 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.43 ' O ' ' O ' ' A' ' 56' ' ' ILE . 27.9 m -115.21 154.18 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.43 ' O ' ' O ' ' A' ' 55' ' ' VAL . 5.0 pt -48.29 175.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 118.971 -1.091 . . . . 0.0 110.353 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.555 ' NH1' ' CE2' ' A' ' 80' ' ' TYR . 23.5 ttt180 -72.78 -59.84 2.52 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 118.354 -0.832 . . . . 0.0 110.864 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -27.37 -37.19 0.01 OUTLIER Glycine 0 N--CA 1.502 3.048 0 O-C-N 124.539 1.15 . . . . 0.0 111.695 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.533 ' N ' ' O ' ' A' ' 57' ' ' ARG . 1.0 OUTLIER -79.61 -75.6 0.24 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 -29.1 -55.11 0.13 Allowed 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 112.983 -1.917 . . . . 0.0 110.788 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.525 ' OE1' ' NH1' ' A' ' 57' ' ' ARG . 37.7 tt0 -72.91 -50.27 24.64 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -58.37 -75.62 0.25 Allowed Glycine 0 N--CA 1.477 1.376 0 C-N-CA 119.512 -1.327 . . . . 0.0 111.028 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.525 ' N ' ' O ' ' A' ' 59' ' ' TRP . 35.9 t -39.76 -50.37 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 C-N-CA 119.901 -0.719 . . . . 0.0 112.868 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.503 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -43.66 -62.17 1.18 Allowed 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 124.16 1.933 . . . . 0.0 111.642 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -44.92 -14.92 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 109.233 -3.622 . . . . 0.0 108.946 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.503 ' H ' ' C ' ' A' ' 64' ' ' ALA . 8.2 mtm -98.26 159.99 14.58 Favored 'General case' 0 N--CA 1.512 2.661 0 C-N-CA 118.467 -1.293 . . . . 0.0 107.895 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 77.7 p -117.63 150.43 39.04 Favored 'General case' 0 N--CA 1.507 2.415 0 CA-C-O 122.573 1.177 . . . . 0.0 112.937 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 96.2 t -44.03 103.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 112.711 -2.041 . . . . 0.0 114.471 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.64 8.16 21.23 Favored Glycine 0 N--CA 1.5 2.942 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -109.15 152.94 24.45 Favored 'General case' 0 N--CA 1.506 2.35 0 CA-C-O 122.311 1.053 . . . . 0.0 111.665 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 -131.26 140.61 49.85 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 113.17 -1.832 . . . . 0.0 107.367 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -146.7 178.58 8.2 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 112.527 -2.124 . . . . 0.0 115.879 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.42 ' HZ1' ' CB ' ' A' ' 73' ' ' LYS . 6.7 ttpm? -126.91 104.99 8.32 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 102.866 -3.013 . . . . 0.0 102.866 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.8 mt -98.85 153.61 18.65 Favored 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 120.169 -0.612 . . . . 0.0 109.505 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 84.8 m -123.92 119.45 29.65 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 35.7 mt -111.53 141.08 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.426 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 69.3 p -109.09 150.69 41.31 Favored Pre-proline 0 N--CA 1.501 2.12 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -41.56 -54.6 2.67 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.627 1.552 . . . . 0.0 112.517 -171.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.511 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 10.9 p-10 -40.06 -27.21 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.555 ' CE2' ' NH1' ' A' ' 57' ' ' ARG . 4.5 m-85 -103.54 24.87 10.42 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -171.03 -83.39 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 116.819 2.155 . . . . 0.0 116.819 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.401 ' O ' ' C ' ' A' ' 83' ' ' GLY . 6.4 m-30 -109.7 56.49 0.62 Allowed 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 113.72 -1.582 . . . . 0.0 110.939 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 82' ' ' TYR . . . -6.02 -114.55 0.0 OUTLIER Glycine 0 N--CA 1.503 3.113 0 O-C-N 125.505 1.753 . . . . 0.0 115.102 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -123.05 47.74 1.92 Allowed 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.432 ' O ' ' O ' ' A' ' 86' ' ' GLY . 94.2 m -124.03 -54.85 1.71 Allowed 'General case' 0 N--CA 1.5 2.059 0 CA-C-N 114.255 -1.339 . . . . 0.0 110.808 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 85' ' ' THR . . . 42.47 -171.21 0.01 OUTLIER Glycine 0 N--CA 1.493 2.459 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.716 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.448 ' N ' ' O ' ' A' ' 91' ' ' ILE . 22.1 m80 -116.22 159.62 38.95 Favored Pre-proline 0 N--CA 1.505 2.297 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -86.58 87.78 0.76 Allowed 'Trans proline' 0 C--N 1.314 -1.252 0 C-N-CA 122.808 2.339 . . . . 0.0 111.757 171.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 134.84 -32.1 2.64 Favored Glycine 0 N--CA 1.504 3.231 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.402 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.9 mt -105.7 -62.83 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.448 ' O ' ' N ' ' A' ' 87' ' ' HIS . 2.7 mp -121.97 87.11 46.89 Favored Pre-proline 0 N--CA 1.508 2.46 0 CA-C-N 114.592 -1.186 . . . . 0.0 109.766 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -54.16 -175.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.092 1.861 . . . . 0.0 108.989 167.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.24 168.16 5.16 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 121.951 1.767 . . . . 0.0 110.799 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 41.1 m170 9.46 63.4 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.205 0 O-C-N 125.371 1.669 . . . . 0.0 115.235 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.404 ' O ' ' O ' ' A' ' 96' ' ' THR . . . -119.09 74.82 1.0 Allowed 'General case' 0 N--CA 1.503 2.209 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.159 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.404 ' O ' ' O ' ' A' ' 95' ' ' ALA . 59.3 m -29.51 148.72 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 114.447 -1.252 . . . . 0.0 111.447 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 15.1 mt -113.19 163.76 14.37 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 58.2 t -136.32 132.06 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -123.28 145.9 48.32 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -121.65 94.42 4.31 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 100.715 -3.809 . . . . 0.0 100.715 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.9 t -109.09 152.86 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.45 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -126.02 98.16 5.39 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 112.169 -2.287 . . . . 0.0 106.827 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 47.9 tp -71.87 124.18 24.28 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 102.953 -2.98 . . . . 0.0 102.953 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.6 mt -92.93 -55.96 3.16 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.122 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -170.03 -168.28 0.73 Allowed 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.141 -1.024 . . . . 0.0 111.587 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 27.9 mt -115.82 156.17 26.55 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 . . . . . 0 N--CA 1.504 2.226 0 CA-C-O 116.195 -1.86 . . . . 0.0 109.564 179.882 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.6 p -105.88 147.62 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.407 HE21 ' CG ' ' A' ' 5' ' ' GLU . 39.8 tt0 -122.43 158.12 30.42 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.5 t -124.48 113.14 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.407 ' CG ' HE21 ' A' ' 3' ' ' GLN . 50.5 mt-10 -112.96 90.28 3.3 Favored 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 91.3 m -69.78 156.28 39.26 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 114.312 -1.313 . . . . 0.0 113.437 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 56.4 mt -121.87 -51.19 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 CA-C-N 113.808 -1.542 . . . . 0.0 107.45 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.675 ' HG ' ' NH1' ' A' ' 71' ' ' ARG . 67.7 m -122.98 80.17 50.74 Favored Pre-proline 0 N--CA 1.506 2.369 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.272 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -40.05 160.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.715 2.277 . . . . 0.0 112.791 178.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -125.44 -175.27 14.16 Favored Glycine 0 N--CA 1.5 2.938 0 N-CA-C 106.631 -2.588 . . . . 0.0 106.631 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 12' ' ' GLY . 1.1 p30 -39.78 -52.84 2.3 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.599 -0.841 . . . . 0.0 112.906 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.468 ' N ' ' OD1' ' A' ' 11' ' ' ASP . . . 90.75 14.5 58.03 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 106.689 -2.564 . . . . 0.0 106.689 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 45.6 mtm-85 -124.68 -33.81 2.93 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 113.604 -1.298 . . . . 0.0 112.274 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.5 m -107.86 125.55 51.59 Favored 'General case' 0 N--CA 1.501 2.086 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.954 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.448 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 36.9 m-85 -125.01 175.46 3.02 Favored Pre-proline 0 N--CA 1.501 2.097 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -66.68 154.8 73.18 Favored 'Trans proline' 0 C--N 1.315 -1.224 0 N-CA-C 109.474 -1.01 . . . . 0.0 109.474 164.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -119.23 169.04 10.31 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-O 121.967 0.889 . . . . 0.0 110.277 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 56.6 mtt-85 -77.18 107.5 9.61 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.343 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.19 -12.93 8.0 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 108.65 -1.78 . . . . 0.0 108.65 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -108.16 166.55 10.65 Favored 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 19.2 m -110.73 125.64 53.72 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.508 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 33.1 m -74.64 142.42 44.54 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 70.7 t -116.77 96.75 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 102.731 -3.063 . . . . 0.0 102.731 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.0 m -118.23 148.49 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 O-C-N 124.751 1.282 . . . . 0.0 113.915 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 49.9 t60 -128.76 117.93 21.94 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 103.472 -2.788 . . . . 0.0 103.472 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -134.88 176.06 9.0 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 122.951 1.357 . . . . 0.0 111.426 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 74.8 m -128.84 116.56 19.63 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 100.728 -3.804 . . . . 0.0 100.728 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -95.51 131.07 10.53 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 104.85 -3.3 . . . . 0.0 104.85 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 43.2 ttm -134.49 170.13 16.22 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 104.732 -2.322 . . . . 0.0 104.732 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.7 mt -111.76 -175.41 2.69 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 104.004 -2.591 . . . . 0.0 104.004 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -35.58 -62.67 0.39 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 124.26 0.975 . . . . 0.0 113.445 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 58.0 p-10 -161.15 44.01 0.17 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.383 -1.327 . . . . 0.0 109.28 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -117.68 -75.45 0.53 Allowed Glycine 0 N--CA 1.509 3.526 0 C-N-CA 119.164 -1.493 . . . . 0.0 115.608 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.09 -160.49 0.91 Allowed 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 119.421 -0.912 . . . . 0.0 112.977 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -89.99 142.96 27.2 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.524 ' CE2' ' OD2' ' A' ' 37' ' ' ASP . 1.9 p90 -135.36 -32.24 0.94 Allowed 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 112.818 -1.992 . . . . 0.0 108.076 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.524 ' OD2' ' CE2' ' A' ' 36' ' ' PHE . 9.6 m-20 -136.46 26.38 3.14 Favored 'General case' 0 N--CA 1.525 3.318 0 N-CA-C 117.806 2.521 . . . . 0.0 117.806 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 37' ' ' ASP . 48.7 m -43.32 168.22 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 114.86 -1.063 . . . . 0.0 110.285 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 90.7 p -105.18 48.89 0.82 Allowed 'General case' 0 N--CA 1.504 2.251 0 CA-C-O 120.9 0.381 . . . . 0.0 110.439 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -126.63 53.89 1.63 Allowed 'General case' 0 N--CA 1.505 2.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.366 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -90.53 -68.56 0.78 Allowed 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 119.666 -0.813 . . . . 0.0 113.05 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -91.27 -107.55 0.1 Allowed 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -110.42 -44.38 3.72 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 45' ' ' PRO . 6.4 mmmm -106.6 160.55 25.85 Favored Pre-proline 0 N--CA 1.507 2.422 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.26 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 44' ' ' LYS . 43.1 Cg_endo -52.9 -158.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.316 -1.156 0 C-N-CA 121.86 1.707 . . . . 0.0 111.446 175.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -94.81 135.46 36.28 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 114.228 -1.351 . . . . 0.0 111.367 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -133.17 121.95 23.3 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -137.82 172.48 12.89 Favored 'General case' 0 N--CA 1.508 2.474 0 C-N-CA 119.448 -0.901 . . . . 0.0 111.27 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.6 ttt -112.9 150.07 32.3 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.487 0.66 . . . . 0.0 112.73 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.4 tp -90.58 121.0 32.13 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.113 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.57 -3.7 39.71 Favored Glycine 0 N--CA 1.5 2.951 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.998 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' A' ' 54' ' ' GLU . 19.2 ttmm -115.84 42.46 2.32 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.411 ' C ' ' O ' ' A' ' 52' ' ' LYS . 72.8 mt-30 0.76 63.48 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.044 0 O-C-N 125.706 1.879 . . . . 0.0 113.655 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 52' ' ' LYS . 1.9 tm-20 -101.4 -23.9 14.28 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 113.796 -1.547 . . . . 0.0 106.864 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.2 m -112.7 158.73 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.577 0 C-N-CA 119.856 -0.738 . . . . 0.0 109.269 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.5 pt -59.1 173.95 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.484 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.549 ' O ' ' N ' ' A' ' 59' ' ' TRP . 3.6 tpp180 -66.99 -60.22 2.82 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 118.564 -0.731 . . . . 0.0 109.891 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -24.59 -38.9 0.01 OUTLIER Glycine 0 N--CA 1.499 2.889 0 O-C-N 125.1 1.5 . . . . 0.0 111.498 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.549 ' N ' ' O ' ' A' ' 57' ' ' ARG . 2.0 m95 -82.37 -74.88 0.33 Allowed 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 112.816 -1.692 . . . . 0.0 110.447 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 59' ' ' TRP . 29.9 tt0 -24.32 -54.6 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 125.97 2.044 . . . . 0.0 111.33 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -77.88 -54.18 6.62 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -50.36 -75.41 0.21 Allowed Glycine 0 N--CA 1.481 1.671 0 C-N-CA 119.729 -1.225 . . . . 0.0 110.544 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.53 ' N ' ' O ' ' A' ' 59' ' ' TRP . 25.1 t -43.53 -48.06 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 119.218 -0.993 . . . . 0.0 112.011 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.508 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -45.34 -58.75 3.09 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 123.783 1.754 . . . . 0.0 111.37 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -50.44 -9.02 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 109.873 -3.33 . . . . 0.0 110.617 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.508 ' H ' ' C ' ' A' ' 64' ' ' ALA . 40.8 mtm -103.97 151.05 23.66 Favored 'General case' 0 N--CA 1.519 2.989 0 C-N-CA 118.824 -1.15 . . . . 0.0 109.993 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 61.7 p -115.58 148.07 40.01 Favored 'General case' 0 N--CA 1.509 2.525 0 CA-C-O 122.756 1.265 . . . . 0.0 114.006 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 60.5 t -38.94 109.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-N 112.478 -2.146 . . . . 0.0 114.871 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.49 -2.51 36.9 Favored Glycine 0 N--CA 1.501 2.985 0 C-N-CA 119.58 -1.295 . . . . 0.0 111.296 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -99.97 153.61 19.05 Favored 'General case' 0 N--CA 1.506 2.338 0 CA-C-O 122.344 1.068 . . . . 0.0 111.87 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.675 ' NH1' ' HG ' ' A' ' 8' ' ' SER . 31.1 ttp180 -131.7 143.82 50.54 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 113.137 -1.847 . . . . 0.0 107.209 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -151.98 176.78 11.14 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 116.574 2.064 . . . . 0.0 116.574 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -124.78 104.58 8.72 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 110.855 -2.884 . . . . 0.0 104.349 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.1 mt -96.83 150.06 21.15 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.7 m -121.1 103.39 8.98 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 37.5 mt -99.38 132.09 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.418 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 66.9 p -113.03 156.38 42.88 Favored Pre-proline 0 N--CA 1.501 2.094 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -34.32 -50.41 0.63 Allowed 'Trans proline' 0 C--N 1.314 -1.248 0 C-N-CA 122.231 1.954 . . . . 0.0 114.096 -176.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 80' ' ' TYR . 1.4 p30 -38.91 -41.12 0.72 Allowed 'General case' 0 N--CA 1.485 1.324 0 CA-C-O 121.837 0.827 . . . . 0.0 111.734 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.472 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 6.5 m-85 -105.78 -44.08 4.73 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.838 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.534 ' O ' ' N ' ' A' ' 83' ' ' GLY . . . -74.81 161.87 29.19 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.464 ' O ' ' N ' ' A' ' 84' ' ' ALA . 58.6 m-85 -0.56 62.49 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 126.709 2.505 . . . . 0.0 114.755 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 81' ' ' ALA . . . 13.9 -74.36 0.0 OUTLIER Glycine 0 N--CA 1.497 2.757 0 CA-C-N 113.711 -1.586 . . . . 0.0 115.635 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 82' ' ' TYR . . . -128.77 -62.97 0.99 Allowed 'General case' 0 N--CA 1.506 2.362 0 CA-C-N 117.429 0.615 . . . . 0.0 111.816 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 85.2 m -115.36 151.2 35.09 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -131.63 -103.7 0.94 Allowed Glycine 0 N--CA 1.5 2.959 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.534 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -127.64 78.8 74.43 Favored Pre-proline 0 N--CA 1.5 2.068 0 CA-C-N 114.738 -0.731 . . . . 0.0 110.377 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -30.46 112.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 123.139 2.559 . . . . 0.0 112.827 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 128.03 -31.3 3.71 Favored Glycine 0 N--CA 1.499 2.835 0 N-CA-C 108.517 -1.833 . . . . 0.0 108.517 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.4 mt -111.27 -49.89 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.288 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 23.9 mm -116.39 84.67 14.88 Favored Pre-proline 0 N--CA 1.508 2.429 0 CA-C-N 113.226 -1.806 . . . . 0.0 112.059 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -48.05 158.31 0.91 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.438 2.092 . . . . 0.0 109.449 174.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.526 ' O ' ' CD2' ' A' ' 94' ' ' HIS . 83.8 Cg_endo -62.09 82.25 0.1 OUTLIER 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 123.055 2.503 . . . . 0.0 113.573 178.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.526 ' CD2' ' O ' ' A' ' 93' ' ' PRO . 74.3 m-70 107.13 71.99 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.343 0 O-C-N 125.685 1.865 . . . . 0.0 113.714 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -120.12 145.54 46.82 Favored 'General case' 0 N--CA 1.506 2.326 0 CA-C-O 121.652 0.739 . . . . 0.0 110.856 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 97.5 m -91.21 126.15 36.21 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 20.6 mt -101.55 152.7 20.48 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.7 t -132.27 117.8 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.458 ' CE2' ' NE1' ' A' ' 59' ' ' TRP . 3.9 m-85 -109.32 160.06 16.47 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -128.61 88.27 2.71 Favored 'General case' 0 N--CA 1.497 1.892 1 N-CA-C 98.295 -4.705 . . . . 0.0 98.295 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.7 t -101.98 152.5 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.64 0 N-CA-C 117.495 2.406 . . . . 0.0 117.495 -178.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -129.25 104.88 7.78 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 112.3 -2.227 . . . . 0.0 106.755 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 36.8 tp -77.06 116.05 17.38 Favored 'General case' 0 N--CA 1.505 2.321 0 N-CA-C 101.888 -3.375 . . . . 0.0 101.888 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.7 mt -86.2 -61.99 1.62 Allowed 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 114.372 -1.285 . . . . 0.0 114.115 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 14.5 mmtt -157.16 -171.86 3.79 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.834 0.826 . . . . 0.0 111.351 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 21.4 mt -119.15 159.99 22.96 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 103.772 -2.677 . . . . 0.0 103.772 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 . . . . . 0 N--CA 1.508 2.445 0 CA-C-O 115.572 -2.156 . . . . 0.0 107.548 179.919 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.994 -1.243 . . . . 0.0 109.994 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.8 p -112.02 150.17 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.537 HE21 ' CG ' ' A' ' 5' ' ' GLU . 40.6 tt0 -121.99 156.01 34.36 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.8 t -125.5 118.13 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.537 ' CG ' HE21 ' A' ' 3' ' ' GLN . 6.1 mm-40 -121.84 94.52 4.34 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 92.5 m -69.82 157.28 37.67 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 76.3 mt -121.98 -55.47 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 CA-C-N 113.656 -1.611 . . . . 0.0 107.132 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.423 ' O ' ' O ' ' A' ' 9' ' ' PRO . 36.6 m -120.94 84.44 38.84 Favored Pre-proline 0 N--CA 1.504 2.234 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.331 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 8' ' ' SER . 0.5 OUTLIER -34.71 159.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.3 2.0 . . . . 0.0 112.15 177.025 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -124.47 -164.75 12.01 Favored Glycine 0 N--CA 1.501 3.02 0 N-CA-C 107.992 -2.043 . . . . 0.0 107.992 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.503 ' CG ' ' H ' ' A' ' 12' ' ' GLY . 1.2 p-10 -39.55 -67.54 0.22 Allowed 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 121.816 0.817 . . . . 0.0 112.348 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.503 ' H ' ' CG ' ' A' ' 11' ' ' ASP . . . 104.33 12.61 28.61 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 105.3 -3.12 . . . . 0.0 105.3 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -124.38 -45.67 1.94 Allowed 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 113.797 -1.201 . . . . 0.0 112.188 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 38.6 m -103.12 129.2 49.91 Favored 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -128.97 173.04 6.11 Favored Pre-proline 0 N--CA 1.499 1.982 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -67.85 132.09 25.73 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 CA-C-N 119.707 0.931 . . . . 0.0 112.663 166.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -120.23 165.07 15.3 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.8 ptm85 -66.12 134.29 52.49 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.69 -25.71 11.63 Favored Glycine 0 N--CA 1.498 2.777 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -106.89 173.0 6.51 Favored 'General case' 0 N--CA 1.508 2.444 0 CA-C-O 121.715 0.769 . . . . 0.0 112.99 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.7 m -115.29 121.05 41.7 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.723 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 30.6 m -69.29 152.62 44.79 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 97.6 t -130.11 102.78 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 101.763 -3.421 . . . . 0.0 101.763 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.7 m -120.72 152.66 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.374 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -129.13 113.82 15.56 Favored 'General case' 0 N--CA 1.506 2.349 0 N-CA-C 102.807 -3.035 . . . . 0.0 102.807 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.552 ' CD1' ' N ' ' A' ' 26' ' ' TYR . 33.0 p90 -132.25 175.91 8.85 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 122.974 1.369 . . . . 0.0 114.221 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.8 m -137.06 117.59 13.82 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 101.794 -3.41 . . . . 0.0 101.794 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 37' ' ' ASP . . . -98.61 141.85 15.78 Favored Glycine 0 N--CA 1.501 3.003 0 C-N-CA 119.921 -1.133 . . . . 0.0 110.697 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.475 ' O ' ' O ' ' A' ' 30' ' ' LEU . 69.6 mmm -149.04 95.38 2.39 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 113.387 -1.407 . . . . 0.0 107.613 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.475 ' O ' ' O ' ' A' ' 29' ' ' MET . 23.6 mt -19.87 -113.78 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.307 0 O-C-N 125.487 1.742 . . . . 0.0 113.203 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -91.6 -69.55 0.73 Allowed 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 102.156 -3.276 . . . . 0.0 102.156 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 48.5 p-10 -162.16 33.42 0.12 Allowed 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 113.236 -1.802 . . . . 0.0 109.481 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -118.74 -68.75 0.33 Allowed Glycine 0 N--CA 1.51 3.605 0 N-CA-C 118.965 2.346 . . . . 0.0 118.965 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.91 172.44 8.19 Favored 'General case' 0 N--CA 1.509 2.517 0 CA-C-O 122.162 0.982 . . . . 0.0 113.566 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.2 mmtm -91.02 129.67 37.0 Favored 'General case' 0 N--CA 1.489 1.489 1 N-CA-C 99.68 -4.193 . . . . 0.0 99.68 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.534 ' CE2' ' OD2' ' A' ' 37' ' ' ASP . 1.2 p90 -125.19 -28.15 3.43 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.534 ' OD2' ' CE2' ' A' ' 36' ' ' PHE . 35.6 m-20 -139.43 85.61 2.06 Favored 'General case' 0 N--CA 1.506 2.373 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.3 m -112.31 160.56 17.55 Favored 'General case' 0 N--CA 1.505 2.282 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.71 ' HG ' ' H ' ' A' ' 40' ' ' ARG . 77.3 p -129.79 -52.95 1.15 Allowed 'General case' 0 N--CA 1.504 2.261 0 CA-C-O 121.617 0.722 . . . . 0.0 112.449 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.71 ' H ' ' HG ' ' A' ' 39' ' ' SER . 20.8 ttm-85 -28.88 -56.01 0.13 Allowed 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -19.28 -74.63 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 125.001 1.438 . . . . 0.0 114.792 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.578 ' O ' ' N ' ' A' ' 44' ' ' LYS . 1.3 mmp_? -91.31 60.52 4.2 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-O 118.688 -0.672 . . . . 0.0 109.67 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.483 HD21 ' C ' ' A' ' 42' ' ' ARG . 0.1 OUTLIER -8.75 58.91 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.353 0 N-CA-C 116.967 2.21 . . . . 0.0 116.967 -179.733 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.578 ' N ' ' O ' ' A' ' 42' ' ' ARG . 47.1 mmtm -147.72 78.46 9.87 Favored Pre-proline 0 C--N 1.298 -1.647 0 CA-C-N 112.731 -2.031 . . . . 0.0 106.783 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.445 ' O ' ' O ' ' A' ' 44' ' ' LYS . 51.0 Cg_exo -43.76 -170.01 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 122.96 2.44 . . . . 0.0 116.88 -172.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -111.55 159.09 18.45 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 114.329 -1.305 . . . . 0.0 114.443 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -143.08 121.2 12.14 Favored 'General case' 0 N--CA 1.506 2.374 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -135.4 171.98 13.66 Favored 'General case' 0 N--CA 1.513 2.703 0 CA-C-N 118.988 0.813 . . . . 0.0 110.631 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 43.2 ttm -119.16 143.8 47.02 Favored 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.427 ' CD1' ' OE1' ' A' ' 60' ' ' GLU . 50.5 tp -91.17 134.88 34.18 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 113.986 -1.461 . . . . 0.0 110.646 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 126.73 -35.02 3.0 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 108.393 -1.883 . . . . 0.0 108.393 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 54' ' ' GLU . 80.0 tttt -123.76 43.14 3.05 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 114.585 -0.807 . . . . 0.0 109.176 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 12.53 49.27 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 125.602 1.814 . . . . 0.0 114.685 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 52' ' ' LYS . 96.1 mt-10 -49.2 -29.82 6.11 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.537 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.433 ' O ' ' O ' ' A' ' 56' ' ' ILE . 32.7 m -117.56 158.31 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.646 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 55' ' ' VAL . 23.9 pt -46.4 172.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 C-N-CA 118.753 -1.179 . . . . 0.0 111.323 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.546 ' O ' ' N ' ' A' ' 59' ' ' TRP . 20.7 ttm-85 -72.44 -61.06 1.93 Allowed 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 118.84 -0.6 . . . . 0.0 112.073 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -34.58 -28.22 0.01 OUTLIER Glycine 0 N--CA 1.499 2.835 0 CA-C-O 122.156 0.864 . . . . 0.0 111.761 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.546 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.6 OUTLIER -87.75 -74.76 0.44 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 179.804 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.427 ' OE1' ' CD1' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -32.86 -50.96 0.28 Allowed 'General case' 0 N--CA 1.501 2.077 0 CA-C-N 114.035 -1.439 . . . . 0.0 110.127 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -74.57 -54.36 7.64 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 113.743 -1.572 . . . . 0.0 107.042 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -53.71 -76.07 0.2 Allowed Glycine 0 N--CA 1.478 1.47 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' A' ' 59' ' ' TRP . 40.0 t -37.25 -45.41 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 CA-C-N 115.067 -0.566 . . . . 0.0 112.04 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.526 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -48.35 -56.07 9.08 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 123.78 1.752 . . . . 0.0 110.092 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -59.53 -0.51 0.17 Allowed 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 110.139 -3.21 . . . . 0.0 110.409 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.593 ' SD ' ' NE2' ' A' ' 70' ' ' GLN . 16.3 tpp -98.85 153.2 18.97 Favored 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 106.039 -1.838 . . . . 0.0 106.039 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 83.5 p -116.37 143.23 45.82 Favored 'General case' 0 N--CA 1.508 2.453 0 CA-C-O 122.289 1.042 . . . . 0.0 112.212 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.422 ' O ' ' OD1' ' A' ' 11' ' ' ASP . 96.7 t -41.9 98.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 113.315 -1.766 . . . . 0.0 114.622 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.71 7.1 22.52 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.593 ' NE2' ' SD ' ' A' ' 66' ' ' MET . 44.3 tt0 -105.13 149.09 26.17 Favored 'General case' 0 N--CA 1.51 2.545 0 C-N-CA 119.179 -1.008 . . . . 0.0 111.018 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 24.8 ttt85 -124.71 141.02 52.4 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 113.905 -1.498 . . . . 0.0 107.0 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -149.64 177.97 9.28 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 116.081 1.882 . . . . 0.0 116.081 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -127.09 104.83 8.19 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 102.457 -3.164 . . . . 0.0 102.457 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.6 mt -101.48 155.12 18.26 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 87.2 m -125.32 132.2 52.9 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 23.8 mt -118.99 138.85 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 CA-C-O 121.319 0.581 . . . . 0.0 110.651 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.426 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 76.9 p -111.11 151.45 43.07 Favored Pre-proline 0 N--CA 1.502 2.151 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.423 ' O ' ' N ' ' A' ' 80' ' ' TYR . 10.2 Cg_endo -39.41 -56.14 1.37 Allowed 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 121.859 1.706 . . . . 0.0 113.035 -172.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.531 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 3.9 p-10 -34.37 -34.34 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.442 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.423 ' N ' ' O ' ' A' ' 78' ' ' PRO . 4.8 m-85 -102.87 -50.29 3.57 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.086 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 83' ' ' GLY . . . -59.61 172.65 0.66 Allowed 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 117.437 -1.705 . . . . 0.0 108.912 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.401 ' C ' ' O ' ' A' ' 81' ' ' ALA . 67.6 m-85 -10.49 -52.07 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 125.994 2.059 . . . . 0.0 115.529 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 81' ' ' ALA . . . 123.99 -154.64 17.71 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 106.412 -2.675 . . . . 0.0 106.412 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -104.89 39.56 1.68 Allowed 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 87.1 m -128.31 58.65 1.53 Allowed 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 113.732 -1.576 . . . . 0.0 109.001 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -113.73 -175.98 19.16 Favored Glycine 0 N--CA 1.499 2.867 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -116.35 146.89 38.38 Favored Pre-proline 0 N--CA 1.503 2.219 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -74.22 46.56 1.39 Allowed 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 121.469 1.446 . . . . 0.0 110.806 174.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -129.21 -51.74 0.11 Allowed Glycine 0 N--CA 1.5 2.914 0 N-CA-C 110.026 -1.229 . . . . 0.0 110.026 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.6 mt -114.6 -54.33 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 23.0 mm -117.7 89.83 34.16 Favored Pre-proline 0 N--CA 1.504 2.246 0 CA-C-N 112.733 -2.03 . . . . 0.0 111.539 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.411 ' CB ' ' CD ' ' A' ' 93' ' ' PRO . 18.0 Cg_exo -71.68 -171.12 0.6 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.217 1.945 . . . . 0.0 107.572 168.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.411 ' CD ' ' CB ' ' A' ' 92' ' ' PRO . 49.9 Cg_exo -62.01 171.01 5.4 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.294 1.996 . . . . 0.0 110.049 175.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 16.0 m80 9.67 68.12 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 O-C-N 125.387 1.679 . . . . 0.0 115.045 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -116.88 74.2 0.9 Allowed 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.704 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 91.1 m -29.4 134.35 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.262 0 O-C-N 124.913 1.383 . . . . 0.0 110.85 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 29.0 mt -108.8 144.37 36.74 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 119.252 0.933 . . . . 0.0 108.718 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 43.7 t -128.73 127.2 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 N-CA-C 107.113 -1.439 . . . . 0.0 107.113 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -118.82 157.88 26.71 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 122.063 0.935 . . . . 0.0 111.958 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -127.07 94.16 3.94 Favored 'General case' 0 N--CA 1.494 1.762 1 N-CA-C 99.069 -4.419 . . . . 0.0 99.069 179.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 16.4 t -107.36 152.94 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.524 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -127.36 100.65 6.13 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 111.877 -2.42 . . . . 0.0 106.357 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 40.9 tp -73.76 125.06 27.26 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 102.624 -3.102 . . . . 0.0 102.624 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.0 mt -94.0 -59.74 1.91 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.79 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 11.8 ptmm? -157.2 -178.58 7.46 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.0 mt -114.23 71.29 0.75 Allowed 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 . . . . . 0 N--CA 1.502 2.159 0 CA-C-O 115.91 -1.995 . . . . 0.0 109.676 179.971 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.469 ' N ' ' OG ' ' A' ' 77' ' ' SER . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.1 p -113.23 145.31 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -121.99 154.01 37.78 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.2 t -126.51 114.03 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -114.83 109.53 18.3 Favored 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 96.2 m -83.75 153.71 23.99 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.744 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 56.0 mt -123.55 -50.58 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 CA-C-N 113.656 -1.611 . . . . 0.0 107.363 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.417 ' O ' ' O ' ' A' ' 9' ' ' PRO . 43.8 t -122.33 79.68 45.15 Favored Pre-proline 0 N--CA 1.507 2.406 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.634 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.417 ' O ' ' O ' ' A' ' 8' ' ' SER . 9.0 Cg_exo -37.56 166.27 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.863 2.375 . . . . 0.0 113.77 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.79 -167.42 12.92 Favored Glycine 0 N--CA 1.502 3.091 0 N-CA-C 105.304 -3.119 . . . . 0.0 105.304 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.52 ' CG ' ' H ' ' A' ' 12' ' ' GLY . 11.2 p-10 -46.97 -58.99 3.4 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 118.619 1.21 . . . . 0.0 110.798 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.52 ' H ' ' CG ' ' A' ' 11' ' ' ASP . . . 106.99 27.63 5.3 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 107.232 -2.347 . . . . 0.0 107.232 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 32.7 mtp85 -133.87 -35.0 0.98 Allowed 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 114.545 -0.828 . . . . 0.0 112.597 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.8 m -109.57 139.46 44.55 Favored 'General case' 0 N--CA 1.508 2.454 0 CA-C-O 121.807 0.813 . . . . 0.0 112.952 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 50.5 m-85 -131.77 177.43 2.25 Favored Pre-proline 0 N--CA 1.499 1.988 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -67.13 138.74 48.33 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 121.145 1.23 . . . . 0.0 110.813 164.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -119.94 162.24 19.53 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 122.351 1.072 . . . . 0.0 109.232 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 29.8 mtm180 -71.07 126.68 30.23 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 114.189 -1.369 . . . . 0.0 108.146 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.51 -24.22 9.86 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -110.8 176.95 4.83 Favored 'General case' 0 N--CA 1.507 2.406 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.901 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 92.4 m -108.42 166.98 10.36 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.2 m -113.14 149.47 33.55 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 102.513 -3.143 . . . . 0.0 102.513 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 60.4 t -123.49 101.93 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 103.109 -2.923 . . . . 0.0 103.109 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.3 m -120.69 149.52 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.574 0 N-CA-C 116.516 2.043 . . . . 0.0 116.516 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.709 ' HD1' ' HG ' ' A' ' 39' ' ' SER . 36.8 t60 -127.8 114.74 17.64 Favored 'General case' 0 N--CA 1.507 2.383 0 N-CA-C 103.67 -2.715 . . . . 0.0 103.67 179.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.499 ' CD1' ' N ' ' A' ' 26' ' ' TYR . 33.9 p90 -131.96 175.68 9.02 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 122.977 1.37 . . . . 0.0 113.702 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 84.8 m -134.65 116.89 15.47 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 101.308 -3.59 . . . . 0.0 101.308 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 37' ' ' ASP . . . -102.55 128.7 9.63 Favored Glycine 0 N--CA 1.5 2.935 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 46.8 ttm -132.81 175.51 9.28 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 37.6 mt -115.84 170.36 8.53 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -33.77 -59.36 0.41 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 124.31 1.006 . . . . 0.0 112.706 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 57.6 p-10 -158.05 46.8 0.35 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.168 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -118.31 -79.21 0.65 Allowed Glycine 0 N--CA 1.501 2.99 0 C-N-CA 119.436 -1.364 . . . . 0.0 113.241 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -160.54 -163.01 1.02 Allowed 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 119.569 -0.852 . . . . 0.0 113.196 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -88.89 124.14 33.92 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 103.993 -2.595 . . . . 0.0 103.993 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.456 ' O ' ' CB ' ' A' ' 37' ' ' ASP . 0.9 OUTLIER -121.81 20.1 10.93 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.41 -179.547 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.456 ' CB ' ' O ' ' A' ' 36' ' ' PHE . 3.4 m-20 158.97 104.19 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.355 0 O-C-N 124.716 1.26 . . . . 0.0 111.917 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.2 m -118.5 169.41 9.8 Favored 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.709 ' HG ' ' HD1' ' A' ' 25' ' ' HIS . 98.5 p -114.91 45.86 1.52 Allowed 'General case' 0 N--CA 1.507 2.395 0 CA-C-N 116.209 -0.451 . . . . 0.0 112.071 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.3 tpt85 -126.26 65.02 1.23 Allowed 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -90.81 -88.75 0.17 Allowed 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.874 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.506 ' C ' HD21 ' A' ' 43' ' ' ASN . 18.0 ttp180 -92.12 -108.5 0.1 Allowed 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.714 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.506 HD21 ' C ' ' A' ' 42' ' ' ARG . 3.3 m120 -111.09 -39.86 4.64 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -100.49 154.25 37.29 Favored Pre-proline 0 N--CA 1.51 2.548 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -75.14 -158.48 0.08 OUTLIER 'Trans proline' 0 N--CA 1.49 1.276 0 C-N-CA 123.066 2.511 . . . . 0.0 113.812 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -97.12 150.34 20.96 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 114.211 -1.359 . . . . 0.0 114.417 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.95 130.88 21.65 Favored 'General case' 0 N--CA 1.508 2.45 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.41 ' CD1' ' C ' ' A' ' 48' ' ' PHE . 13.5 p90 -143.28 166.72 23.96 Favored 'General case' 0 N--CA 1.514 2.732 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.904 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.495 ' SD ' ' O ' ' A' ' 50' ' ' LEU . 2.7 tmm? -115.11 149.04 38.19 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 115.103 1.519 . . . . 0.0 115.103 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.495 ' O ' ' SD ' ' A' ' 49' ' ' MET . 52.3 tp -90.6 121.03 32.17 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 113.343 -1.753 . . . . 0.0 112.19 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.69 -24.71 7.09 Favored Glycine 0 N--CA 1.499 2.838 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 53' ' ' GLN . 2.3 tppp? -113.37 36.84 3.4 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.413 ' C ' ' O ' ' A' ' 52' ' ' LYS . 83.3 mt-30 7.8 63.56 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 125.281 1.613 . . . . 0.0 114.165 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -82.89 -30.23 28.7 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.419 ' O ' ' O ' ' A' ' 56' ' ' ILE . 32.6 m -118.78 151.13 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.419 ' O ' ' O ' ' A' ' 55' ' ' VAL . 1.6 pt -46.9 -176.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.542 ' O ' ' N ' ' A' ' 59' ' ' TRP . 8.8 tpt180 -81.16 -61.01 2.08 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.124 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -35.8 -26.86 0.01 OUTLIER Glycine 0 N--CA 1.497 2.703 0 CA-C-O 122.196 0.887 . . . . 0.0 110.919 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.542 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.8 OUTLIER -91.85 -76.07 0.46 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.776 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -33.94 -51.48 0.41 Allowed 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 113.752 -1.567 . . . . 0.0 110.031 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -73.06 -54.47 8.46 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 113.218 -1.81 . . . . 0.0 106.574 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -55.07 -80.55 0.07 OUTLIER Glycine 0 N--CA 1.476 1.335 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.533 ' N ' ' O ' ' A' ' 59' ' ' TRP . 53.1 t -32.3 -48.45 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 112.675 0.621 . . . . 0.0 112.675 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.511 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -46.37 -60.52 2.28 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 124.262 1.982 . . . . 0.0 110.905 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -48.01 -12.19 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 108.948 -3.751 . . . . 0.0 108.856 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.511 ' H ' ' C ' ' A' ' 64' ' ' ALA . 21.0 mtp -97.7 159.64 14.8 Favored 'General case' 0 N--CA 1.512 2.655 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 80.4 p -117.08 156.88 26.82 Favored 'General case' 0 N--CA 1.509 2.498 0 CA-C-O 122.804 1.288 . . . . 0.0 113.716 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 62.5 t -49.55 97.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 112.037 -2.347 . . . . 0.0 114.858 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.11 5.2 25.28 Favored Glycine 0 N--CA 1.499 2.841 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.488 ' OE1' ' N ' ' A' ' 71' ' ' ARG . 0.9 OUTLIER -106.73 148.61 28.22 Favored 'General case' 0 N--CA 1.505 2.325 0 CA-C-O 122.099 0.952 . . . . 0.0 111.399 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.488 ' N ' ' OE1' ' A' ' 70' ' ' GLN . 18.9 ttp180 -127.58 140.64 51.98 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 113.516 -1.674 . . . . 0.0 110.089 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -144.8 178.83 7.72 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 112.605 -2.089 . . . . 0.0 115.662 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -126.78 105.0 8.36 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 110.933 -2.849 . . . . 0.0 103.585 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.8 mt -96.73 149.7 21.53 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 86.5 m -124.59 112.72 17.14 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.5 mt -105.19 143.83 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 CA-C-O 121.448 0.642 . . . . 0.0 110.908 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.469 ' OG ' ' N ' ' A' ' 1' ' ' GLY . 36.8 p -110.02 150.79 41.91 Favored Pre-proline 0 N--CA 1.496 1.869 0 N-CA-C 105.604 -1.998 . . . . 0.0 105.604 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.524 ' O ' ' N ' ' A' ' 80' ' ' TYR . 19.3 Cg_endo -44.33 -55.71 3.02 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 121.967 1.778 . . . . 0.0 113.614 -171.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 12.8 p-10 -38.82 -17.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.524 ' N ' ' O ' ' A' ' 78' ' ' PRO . 4.8 m-85 -106.45 -31.87 8.36 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -111.05 -73.04 0.69 Allowed 'General case' 0 N--CA 1.506 2.373 0 N-CA-C 116.968 2.21 . . . . 0.0 116.968 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 13.0 m-30 -108.95 -85.97 0.52 Allowed 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 112.675 -2.057 . . . . 0.0 114.452 -179.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.71 68.67 1.33 Allowed Glycine 0 N--CA 1.495 2.616 0 N-CA-C 108.01 -2.036 . . . . 0.0 108.01 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 33.53 71.5 0.1 Allowed 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.683 0.754 . . . . 0.0 112.275 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 94.5 m -116.44 -44.88 2.84 Favored 'General case' 0 N--CA 1.503 2.22 0 CA-C-N 114.383 -1.28 . . . . 0.0 113.825 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -110.27 -54.95 0.54 Allowed Glycine 0 N--CA 1.508 3.44 0 C-N-CA 120.225 -0.988 . . . . 0.0 111.286 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.527 ' O ' ' ND1' ' A' ' 87' ' ' HIS . 33.4 p80 19.39 70.94 0.23 Allowed Pre-proline 0 N--CA 1.493 1.678 0 N-CA-C 117.685 2.476 . . . . 0.0 117.685 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -84.32 23.41 0.84 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 121.637 1.558 . . . . 0.0 108.273 164.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 87' ' ' HIS . . . 108.49 44.74 1.12 Allowed Glycine 0 N--CA 1.501 2.972 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.8 mt -136.52 -50.41 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.267 0 CA-C-O 122.625 1.202 . . . . 0.0 108.825 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 17.9 mm -112.73 59.64 0.61 Allowed Pre-proline 0 N--CA 1.5 2.047 0 CA-C-N 111.463 -2.608 . . . . 0.0 110.552 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -52.15 169.42 0.3 Allowed 'Trans proline' 0 C--N 1.311 -1.423 0 N-CA-C 107.938 -1.601 . . . . 0.0 107.938 -178.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -38.95 155.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 121.566 1.511 . . . . 0.0 111.808 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.434 ' CG ' ' O ' ' A' ' 94' ' ' HIS . 20.3 p-80 9.5 71.65 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.215 0 O-C-N 125.658 1.849 . . . . 0.0 114.713 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -114.52 75.46 0.93 Allowed 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 120.95 0.405 . . . . 0.0 110.511 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 94.8 m -29.24 139.2 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 CA-C-N 114.108 -1.405 . . . . 0.0 110.812 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 32.6 mt -108.21 153.07 23.72 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 50.4 t -133.31 121.15 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -114.26 151.33 33.03 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -122.73 94.07 4.16 Favored 'General case' 0 N--CA 1.496 1.839 1 N-CA-C 98.937 -4.468 . . . . 0.0 98.937 179.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 17.2 t -107.78 150.53 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.425 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -179.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -126.67 102.48 7.09 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 112.39 -2.186 . . . . 0.0 106.843 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 43.6 tp -73.31 126.5 30.26 Favored 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 101.823 -3.399 . . . . 0.0 101.823 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.9 mt -93.51 -54.05 3.82 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.877 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.46 -172.13 0.88 Allowed 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 118.366 -1.334 . . . . 0.0 110.621 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 19.1 mt -118.24 152.97 34.7 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.426 ' OE1' ' OXT' ' A' ' 107' ' ' GLU . 9.7 tm-20 . . . . . 0 N--CA 1.501 2.095 0 CA-C-O 116.099 -1.905 . . . . 0.0 109.002 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.473 ' C ' ' NE2' ' A' ' 3' ' ' GLN . 11.8 p -114.2 150.09 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.483 ' CD ' ' N ' ' A' ' 3' ' ' GLN . 14.9 mp0 -121.57 156.05 33.71 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 42.2 t -126.5 106.55 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -108.38 87.45 2.5 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 98.9 m -69.66 157.82 36.53 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.017 -1.073 . . . . 0.0 111.674 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 64.1 mt -121.94 -53.93 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 CA-C-N 114.195 -1.366 . . . . 0.0 107.631 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.417 ' O ' ' O ' ' A' ' 9' ' ' PRO . 51.8 m -123.09 80.22 51.5 Favored Pre-proline 0 N--CA 1.507 2.378 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.49 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.417 ' O ' ' O ' ' A' ' 8' ' ' SER . 6.9 Cg_exo -36.95 166.66 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.866 2.377 . . . . 0.0 114.104 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.51 -176.7 17.99 Favored Glycine 0 N--CA 1.5 2.96 0 N-CA-C 105.063 -3.215 . . . . 0.0 105.063 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.52 ' CG ' ' H ' ' A' ' 12' ' ' GLY . 14.4 p-10 -43.04 -59.08 2.16 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 118.557 1.178 . . . . 0.0 111.735 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.52 ' H ' ' CG ' ' A' ' 11' ' ' ASP . . . 110.06 22.34 6.6 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 108.541 -1.824 . . . . 0.0 108.541 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 60.0 mtt-85 -133.67 -31.38 1.19 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 114.994 -0.603 . . . . 0.0 112.392 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.0 m -109.11 124.85 51.45 Favored 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.375 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 23.1 m-85 -127.28 176.1 2.88 Favored Pre-proline 0 N--CA 1.501 2.101 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -73.8 139.33 27.51 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 CA-C-N 119.51 0.861 . . . . 0.0 110.177 163.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -120.63 167.07 12.82 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 121.765 0.793 . . . . 0.0 109.264 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 62.8 mtt180 -70.26 127.6 33.35 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.763 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.32 -25.61 9.14 Favored Glycine 0 N--CA 1.498 2.78 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.501 ' O ' ' SD ' ' A' ' 49' ' ' MET . 25.8 mt-30 -109.37 175.62 5.38 Favored 'General case' 0 N--CA 1.505 2.276 0 CA-C-O 121.713 0.768 . . . . 0.0 111.429 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.9 m -107.23 163.86 12.66 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 114.611 -1.177 . . . . 0.0 108.47 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 55.6 m -114.39 145.62 41.6 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 103.718 -2.697 . . . . 0.0 103.718 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 64.4 t -122.89 101.08 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 102.22 -3.252 . . . . 0.0 102.22 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.7 m -124.12 151.54 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.641 ' HD1' ' HG ' ' A' ' 39' ' ' SER . 43.4 t60 -130.15 119.45 23.02 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 103.841 -2.651 . . . . 0.0 103.841 179.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 26' ' ' TYR . 35.4 p90 -135.22 172.55 12.84 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 123.072 1.415 . . . . 0.0 114.592 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 61.4 m -134.34 116.14 14.88 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 102.865 -3.013 . . . . 0.0 102.865 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.62 137.42 13.61 Favored Glycine 0 N--CA 1.5 2.92 0 C-N-CA 119.918 -1.134 . . . . 0.0 112.003 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 35.0 ttm -134.16 175.33 9.58 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.3 mt -116.12 -173.33 2.34 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -90.16 21.38 3.78 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 121.569 0.7 . . . . 0.0 111.019 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.5 -44.81 1.82 Allowed 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 128.14 23.19 1.3 Allowed Glycine 0 N--CA 1.502 3.07 0 CA-C-O 118.501 -1.166 . . . . 0.0 115.52 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -118.7 152.81 35.43 Favored 'General case' 0 N--CA 1.502 2.174 0 CA-C-N 119.2 1.5 . . . . 0.0 107.488 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.38 139.66 30.51 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 122.379 1.085 . . . . 0.0 109.442 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.424 ' CG ' ' N ' ' A' ' 37' ' ' ASP . 6.3 p90 -126.44 -38.76 2.08 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 113.434 -1.712 . . . . 0.0 106.83 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.424 ' N ' ' CG ' ' A' ' 36' ' ' PHE . 0.9 OUTLIER -141.25 94.45 2.7 Favored 'General case' 0 N--CA 1.508 2.467 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -179.772 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 52.7 m -114.92 167.38 10.84 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.641 ' HG ' ' HD1' ' A' ' 25' ' ' HIS . 76.8 p -120.76 53.52 1.12 Allowed 'General case' 0 N--CA 1.506 2.344 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.524 ' O ' ' N ' ' A' ' 42' ' ' ARG . 33.1 mtm-85 -118.04 -72.51 0.68 Allowed 'General case' 0 N--CA 1.504 2.236 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 41' ' ' ASP . 64.5 t0 -34.1 -30.85 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 122.719 1.247 . . . . 0.0 110.908 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 44' ' ' LYS . 17.9 ttm180 -90.63 71.74 6.79 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 112.467 -2.151 . . . . 0.0 106.474 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -9.24 -50.68 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 CA-C-N 112.754 -2.021 . . . . 0.0 115.33 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 42' ' ' ARG . 94.1 mttt -95.98 136.38 22.21 Favored Pre-proline 0 N--CA 1.5 2.039 0 N-CA-C 106.6 -1.629 . . . . 0.0 106.6 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.427 ' O ' ' O ' ' A' ' 44' ' ' LYS . 49.2 Cg_exo -44.16 -161.95 0.0 OUTLIER 'Trans proline' 0 C--N 1.316 -1.135 0 C-N-CA 121.774 1.649 . . . . 0.0 115.479 171.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -113.73 146.77 39.36 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 113.283 -1.781 . . . . 0.0 110.433 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -137.7 123.5 20.0 Favored 'General case' 0 N--CA 1.505 2.323 0 CA-C-O 118.863 -0.589 . . . . 0.0 110.952 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -136.8 168.04 20.3 Favored 'General case' 0 N--CA 1.513 2.696 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.501 ' SD ' ' O ' ' A' ' 20' ' ' GLN . 44.6 tpp -107.1 132.35 53.1 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 114.111 -1.404 . . . . 0.0 113.866 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.0 tp -90.88 122.42 33.56 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 114.483 -1.235 . . . . 0.0 110.707 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.73 18.48 10.72 Favored Glycine 0 N--CA 1.5 2.91 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.483 ' O ' ' CB ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -118.75 -53.12 2.31 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.483 ' CB ' ' O ' ' A' ' 52' ' ' LYS . 47.9 tt0 100.92 70.56 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.208 0 O-C-N 125.812 1.945 . . . . 0.0 108.049 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -109.39 -33.71 6.75 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 114.182 -1.372 . . . . 0.0 108.708 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.4 m -115.15 153.03 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.291 0 CA-C-O 121.287 0.565 . . . . 0.0 110.4 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.57 ' CG2' ' CE1' ' A' ' 82' ' ' TYR . 14.2 pt -51.08 177.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.094 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.544 ' O ' ' N ' ' A' ' 59' ' ' TRP . 8.7 tpt180 -70.52 -60.76 2.07 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 120.232 -0.587 . . . . 0.0 109.442 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -24.24 -38.88 0.01 OUTLIER Glycine 0 N--CA 1.501 2.98 0 O-C-N 125.122 1.514 . . . . 0.0 112.718 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.544 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.6 OUTLIER -82.66 -71.38 0.49 Allowed 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 179.828 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -28.77 -54.62 0.12 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 125.266 1.604 . . . . 0.0 110.939 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -76.67 -53.53 7.88 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -50.83 -75.54 0.21 Allowed Glycine 0 N--CA 1.478 1.465 0 C-N-CA 119.207 -1.473 . . . . 0.0 110.287 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 59' ' ' TRP . 35.2 t -42.03 -50.77 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 C-N-CA 119.471 -0.891 . . . . 0.0 112.42 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.514 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -45.0 -62.04 1.39 Allowed 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 123.893 1.806 . . . . 0.0 111.434 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -47.15 -12.91 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 109.606 -3.452 . . . . 0.0 109.176 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.514 ' H ' ' C ' ' A' ' 64' ' ' ALA . 6.6 mtm -99.63 157.27 16.58 Favored 'General case' 0 N--CA 1.512 2.657 0 C-N-CA 118.503 -1.279 . . . . 0.0 107.638 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 84.4 p -118.65 148.24 42.94 Favored 'General case' 0 N--CA 1.507 2.398 0 CA-C-O 122.458 1.123 . . . . 0.0 113.412 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 52.9 t -40.82 100.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-N 112.775 -2.011 . . . . 0.0 113.829 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.19 10.97 12.74 Favored Glycine 0 N--CA 1.5 2.963 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -107.2 146.45 31.38 Favored 'General case' 0 N--CA 1.505 2.297 0 CA-C-O 121.681 0.753 . . . . 0.0 111.05 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.1 mtp85 -126.26 139.56 53.22 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -149.42 177.07 10.03 Favored 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 116.58 2.067 . . . . 0.0 116.58 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -127.92 107.1 9.57 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 102.531 -3.137 . . . . 0.0 102.531 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.8 mt -104.47 153.31 21.28 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 90.3 m -124.01 124.96 43.7 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 104.613 -2.366 . . . . 0.0 104.613 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.1 mt -116.95 136.34 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.417 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 61.1 p -111.92 154.11 44.27 Favored Pre-proline 0 N--CA 1.505 2.292 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -34.36 -53.05 0.6 Allowed 'Trans proline' 0 C--N 1.315 -1.187 0 C-N-CA 122.1 1.867 . . . . 0.0 114.297 -174.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 80' ' ' TYR . 1.8 p30 -37.34 -39.65 0.3 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.503 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.452 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 5.0 m-85 -102.11 -39.69 7.16 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 114.965 -1.016 . . . . 0.0 112.022 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.58 -125.27 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 118.094 -1.442 . . . . 0.0 108.87 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.57 ' CE1' ' CG2' ' A' ' 56' ' ' ILE . 19.0 m-85 -116.63 85.95 2.41 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -106.55 42.54 1.89 Allowed Glycine 0 N--CA 1.502 3.055 0 C-N-CA 119.475 -1.345 . . . . 0.0 112.008 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -145.82 -82.56 0.14 Allowed 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 119.946 -0.702 . . . . 0.0 112.524 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 96.7 m -128.9 90.76 3.09 Favored 'General case' 0 N--CA 1.504 2.229 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.503 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -106.79 -143.42 11.21 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.534 ' N ' ' O ' ' A' ' 91' ' ' ILE . 22.3 m80 -104.25 149.13 36.97 Favored Pre-proline 0 N--CA 1.505 2.316 0 CA-C-O 119.47 -0.3 . . . . 0.0 110.565 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -90.5 34.96 0.32 Allowed 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 122.012 1.808 . . . . 0.0 109.29 172.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -134.68 -49.48 0.08 OUTLIER Glycine 0 N--CA 1.5 2.907 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.866 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.1 mt -114.44 -54.4 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.287 0 CA-C-O 122.45 1.119 . . . . 0.0 109.84 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.534 ' O ' ' N ' ' A' ' 87' ' ' HIS . 16.6 mm -110.72 85.2 4.68 Favored Pre-proline 0 N--CA 1.505 2.301 0 CA-C-N 112.95 -1.932 . . . . 0.0 112.092 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.427 ' O ' ' O ' ' A' ' 93' ' ' PRO . 20.3 Cg_endo -86.39 159.14 9.58 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 N-CA-C 107.626 -1.721 . . . . 0.0 107.626 171.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.427 ' O ' ' O ' ' A' ' 92' ' ' PRO . 15.0 Cg_endo -42.84 174.21 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.299 0 C-N-CA 122.654 2.236 . . . . 0.0 114.416 -175.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.401 ' C ' ' O ' ' A' ' 93' ' ' PRO . 35.9 m170 9.87 61.61 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.403 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -124.15 78.63 1.66 Allowed 'General case' 0 N--CA 1.503 2.198 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.399 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 88.1 m -29.41 141.87 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 O-C-N 124.552 1.158 . . . . 0.0 112.119 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 27.8 mt -115.86 155.21 28.33 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.8 t -136.43 124.51 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -118.39 150.7 39.1 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 122.305 1.05 . . . . 0.0 111.057 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -124.09 93.59 3.97 Favored 'General case' 0 N--CA 1.493 1.706 1 N-CA-C 98.926 -4.472 . . . . 0.0 98.926 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 12.7 t -108.09 155.57 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.513 0 N-CA-C 117.033 2.234 . . . . 0.0 117.033 -179.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -129.2 103.33 6.89 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 111.574 -2.557 . . . . 0.0 108.143 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 39.5 tp -77.86 118.44 20.19 Favored 'General case' 0 N--CA 1.506 2.363 0 N-CA-C 102.722 -3.066 . . . . 0.0 102.722 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.1 mt -87.3 -55.63 3.72 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 113.845 -1.525 . . . . 0.0 112.518 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -171.69 -170.08 0.75 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.334 -0.946 . . . . 0.0 110.962 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 21.2 mt -117.65 156.28 28.45 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 . . . . . 0 N--CA 1.503 2.191 0 CA-C-O 116.822 -1.561 . . . . 0.0 108.974 179.83 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.9 p -116.12 150.26 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -123.68 154.88 38.77 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.7 t -125.14 118.99 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -120.21 96.86 5.33 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 92.1 m -69.83 156.12 39.52 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.031 -1.068 . . . . 0.0 113.077 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 74.0 mt -122.52 -55.55 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 CA-C-N 113.693 -1.594 . . . . 0.0 107.471 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.422 ' O ' ' O ' ' A' ' 9' ' ' PRO . 34.2 t -122.95 82.48 50.35 Favored Pre-proline 0 N--CA 1.506 2.344 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.515 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 8' ' ' SER . 5.2 Cg_exo -36.23 161.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.391 2.061 . . . . 0.0 112.731 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -118.32 -174.62 16.39 Favored Glycine 0 N--CA 1.5 2.904 0 N-CA-C 106.482 -2.647 . . . . 0.0 106.482 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.525 ' N ' ' OD1' ' A' ' 11' ' ' ASP . 13.0 p-10 -39.77 -60.39 1.0 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.492 -0.883 . . . . 0.0 112.916 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.06 18.74 12.91 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 105.599 -3.001 . . . . 0.0 105.599 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 54.8 mtt-85 -127.13 -40.32 1.85 Allowed 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 113.773 -1.213 . . . . 0.0 112.214 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.6 m -108.21 139.58 42.69 Favored 'General case' 0 N--CA 1.506 2.341 0 CA-C-O 121.968 0.89 . . . . 0.0 112.726 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 50.8 m-85 -131.79 177.46 2.23 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -62.19 155.09 58.55 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 N-CA-C 109.805 -0.883 . . . . 0.0 109.805 161.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -119.73 166.61 12.99 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.921 0.867 . . . . 0.0 108.923 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 59.2 mtt85 -81.18 95.07 6.8 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.559 -1.201 . . . . 0.0 109.178 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.07 3.7 4.8 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -113.61 173.02 6.62 Favored 'General case' 0 N--CA 1.506 2.35 0 C-N-CA 120.219 -0.593 . . . . 0.0 109.513 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 97.8 m -118.08 117.86 30.35 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.591 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 24.8 m -69.66 148.61 49.07 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 87.5 t -122.13 101.61 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 101.679 -3.452 . . . . 0.0 101.679 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.0 m -125.38 151.04 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -129.04 117.67 21.26 Favored 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.434 ' CD2' ' CD2' ' A' ' 99' ' ' PHE . 41.9 p90 -136.27 -179.13 5.49 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 96.2 m -137.02 118.73 15.02 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 105.006 -2.22 . . . . 0.0 105.006 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -102.91 124.85 8.29 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 120.905 -0.665 . . . . 0.0 112.057 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 48.9 mtm -134.28 -177.43 4.58 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 122.041 0.924 . . . . 0.0 110.524 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 12.2 mt -120.43 -173.26 2.54 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.357 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.541 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 9.5 pm0 -90.18 22.62 3.21 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.826 0.822 . . . . 0.0 109.332 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 33' ' ' GLY . 1.5 p30 -126.57 -46.01 1.61 Allowed 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 114.126 -1.397 . . . . 0.0 107.318 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.519 ' N ' ' OD1' ' A' ' 32' ' ' ASP . . . 124.79 29.88 1.01 Allowed Glycine 0 N--CA 1.503 3.117 0 N-CA-C 116.67 1.428 . . . . 0.0 116.67 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -117.5 144.37 45.13 Favored 'General case' 0 N--CA 1.506 2.328 0 CA-C-N 119.802 1.801 . . . . 0.0 107.953 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -91.06 135.44 33.75 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.417 ' O ' ' OD1' ' A' ' 37' ' ' ASP . 35.8 p90 -122.81 -36.43 2.89 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 36' ' ' PHE . 73.9 m-20 -139.86 125.33 19.11 Favored 'General case' 0 N--CA 1.517 2.917 0 CA-C-O 121.496 0.665 . . . . 0.0 111.763 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 52.4 m -130.56 162.49 29.16 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 82.3 p -104.22 35.98 2.52 Favored 'General case' 0 N--CA 1.505 2.323 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.016 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 18.1 ttp180 -130.14 56.62 1.74 Allowed 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -91.03 -69.61 0.72 Allowed 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 62.1 mtt85 -90.99 -102.33 0.1 Allowed 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -110.66 -53.14 2.72 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -110.37 153.78 43.27 Favored Pre-proline 0 N--CA 1.508 2.453 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.737 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -55.19 -158.62 0.01 OUTLIER 'Trans proline' 0 N--CA 1.488 1.186 0 C-N-CA 122.437 2.092 . . . . 0.0 114.349 -177.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -91.15 142.42 27.76 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 114.236 -1.347 . . . . 0.0 112.962 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -137.79 122.71 18.94 Favored 'General case' 0 N--CA 1.506 2.369 0 CA-C-O 119.109 -0.472 . . . . 0.0 111.128 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -137.71 175.4 9.63 Favored 'General case' 0 N--CA 1.513 2.69 0 CA-C-N 119.412 1.006 . . . . 0.0 112.381 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 42.2 ttm -117.67 144.06 45.58 Favored 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.1 tp -91.09 124.25 35.18 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 114.295 -1.32 . . . . 0.0 111.812 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.18 -18.07 14.28 Favored Glycine 0 N--CA 1.501 3.026 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.874 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.41 ' O ' ' C ' ' A' ' 53' ' ' GLN . 53.9 tttm -118.98 39.32 3.57 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 120.949 -0.3 . . . . 0.0 110.372 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 52' ' ' LYS . 15.1 pt20 14.12 68.26 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 125.262 1.601 . . . . 0.0 114.587 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -91.39 -27.3 18.42 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 113.758 -1.564 . . . . 0.0 106.869 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.427 ' O ' ' O ' ' A' ' 56' ' ' ILE . 26.8 m -118.8 154.6 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.235 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.427 ' O ' ' O ' ' A' ' 55' ' ' VAL . 12.7 pt -49.43 175.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 C-N-CA 119.568 -0.853 . . . . 0.0 108.908 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.537 ' O ' ' N ' ' A' ' 59' ' ' TRP . 32.4 ttp180 -72.24 -56.31 5.74 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.199 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -25.35 -38.52 0.01 OUTLIER Glycine 0 N--CA 1.499 2.886 0 O-C-N 124.773 1.296 . . . . 0.0 112.188 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.537 ' N ' ' O ' ' A' ' 57' ' ' ARG . 1.4 m95 -82.02 -74.26 0.35 Allowed 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 112.919 -1.64 . . . . 0.0 108.386 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 59' ' ' TRP . 29.2 tt0 -24.18 -54.72 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 125.932 2.02 . . . . 0.0 111.174 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -77.85 -54.81 5.89 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -48.56 -75.97 0.17 Allowed Glycine 0 N--CA 1.482 1.702 0 C-N-CA 119.84 -1.172 . . . . 0.0 110.391 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.529 ' N ' ' O ' ' A' ' 59' ' ' TRP . 23.1 t -44.03 -48.7 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 119.298 -0.961 . . . . 0.0 111.837 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.518 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -46.36 -58.93 3.28 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 123.948 1.832 . . . . 0.0 111.341 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -51.05 -8.81 0.05 OUTLIER 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 109.68 -3.418 . . . . 0.0 109.887 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.518 ' H ' ' C ' ' A' ' 64' ' ' ALA . 93.4 mtp -102.73 158.62 16.12 Favored 'General case' 0 N--CA 1.513 2.723 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 88.3 p -118.51 153.83 33.53 Favored 'General case' 0 N--CA 1.509 2.525 0 CA-C-O 122.775 1.274 . . . . 0.0 113.677 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 86.7 t -49.18 97.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 112.608 -2.087 . . . . 0.0 113.568 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.19 12.95 12.73 Favored Glycine 0 N--CA 1.499 2.869 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -107.65 143.54 35.99 Favored 'General case' 0 N--CA 1.505 2.305 0 CA-C-O 121.368 0.604 . . . . 0.0 109.781 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 25.4 ttt85 -124.88 140.85 52.55 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -149.7 176.47 10.65 Favored 'General case' 0 N--CA 1.502 2.175 0 CA-C-N 113.316 -1.765 . . . . 0.0 115.452 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -125.75 103.8 8.01 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 104.117 -2.549 . . . . 0.0 104.117 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.1 mt -98.26 145.93 26.15 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 89.5 m -117.35 104.07 10.76 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 33.9 mt -102.3 134.27 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.972 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.438 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -112.99 157.39 40.81 Favored Pre-proline 0 N--CA 1.501 2.123 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -37.37 -53.22 1.38 Allowed 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 123.148 2.565 . . . . 0.0 114.881 -166.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.524 ' O ' ' NH2' ' A' ' 57' ' ' ARG . 13.1 p-10 -45.39 -36.63 4.4 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.491 ' CZ ' ' NE ' ' A' ' 57' ' ' ARG . 4.6 m-85 -102.09 4.52 39.76 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.524 ' O ' ' CD1' ' A' ' 82' ' ' TYR . . . -124.67 -81.91 0.64 Allowed 'General case' 0 N--CA 1.507 2.394 0 CA-C-O 122.021 0.915 . . . . 0.0 110.613 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.524 ' CD1' ' O ' ' A' ' 81' ' ' ALA . 28.9 m-85 -141.96 111.69 6.69 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 113.924 -1.489 . . . . 0.0 111.069 -179.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 84' ' ' ALA . . . -88.38 179.03 46.31 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 105.164 -3.174 . . . . 0.0 105.164 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.499 ' N ' ' NE2' ' A' ' 94' ' ' HIS . . . 40.23 -162.41 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 CA-C-N 118.159 0.979 . . . . 0.0 111.026 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 92.3 m -108.88 145.35 35.48 Favored 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -130.07 -71.31 0.12 Allowed Glycine 0 N--CA 1.501 2.991 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.076 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.525 ' C ' ' H ' ' A' ' 89' ' ' GLY . 15.7 m80 -120.87 96.99 48.53 Favored Pre-proline 0 N--CA 1.505 2.281 0 CA-C-O 118.094 -0.955 . . . . 0.0 110.546 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -76.97 32.59 0.42 Allowed 'Trans proline' 0 C--N 1.315 -1.204 0 C-N-CA 121.115 1.21 . . . . 0.0 111.243 -172.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.525 ' H ' ' C ' ' A' ' 87' ' ' HIS . . . -128.36 -38.55 0.37 Allowed Glycine 0 N--CA 1.496 2.645 0 N-CA-C 108.144 -1.982 . . . . 0.0 108.144 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.7 mt -104.23 -54.91 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.427 ' O ' ' O ' ' A' ' 87' ' ' HIS . 1.5 mp -114.41 98.8 49.9 Favored Pre-proline 0 N--CA 1.503 2.203 0 CA-C-N 113.12 -1.855 . . . . 0.0 109.259 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -55.31 -179.36 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 122.05 1.833 . . . . 0.0 108.758 162.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -73.9 163.47 36.89 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 121.674 1.583 . . . . 0.0 111.43 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.499 ' NE2' ' N ' ' A' ' 84' ' ' ALA . 38.7 m170 9.31 70.32 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 115.677 1.732 . . . . 0.0 115.677 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -116.1 155.81 27.51 Favored 'General case' 0 N--CA 1.503 2.216 0 CA-C-O 121.68 0.752 . . . . 0.0 111.001 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 93.3 m -91.25 131.22 36.91 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 114.416 -1.265 . . . . 0.0 108.467 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 23.8 mt -103.78 152.87 21.35 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 57.3 t -133.24 103.93 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.434 ' CD2' ' CD2' ' A' ' 26' ' ' TYR . 2.7 m-85 -96.85 158.64 15.33 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 118.163 -1.415 . . . . 0.0 108.437 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -123.57 88.03 2.85 Favored 'General case' 0 N--CA 1.491 1.607 1 N-CA-C 97.511 -4.996 . . . . 0.0 97.511 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.3 t -101.47 146.3 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.518 0 N-CA-C 116.626 2.084 . . . . 0.0 116.626 -178.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -123.54 104.57 9.13 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 112.541 -2.118 . . . . 0.0 106.076 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 35.8 tp -76.93 120.25 21.79 Favored 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 102.868 -3.012 . . . . 0.0 102.868 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.6 mt -87.16 -57.54 2.92 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 113.913 -1.494 . . . . 0.0 112.123 -179.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -170.27 -169.45 0.84 Allowed 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 119.502 -0.879 . . . . 0.0 111.455 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 22.0 mt -118.12 156.18 29.14 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 . . . . . 0 N--CA 1.504 2.266 0 CA-C-O 116.164 -1.874 . . . . 0.0 109.597 179.911 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.473 ' N ' ' OD2' ' A' ' 79' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.3 p -114.44 150.06 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -120.64 149.65 42.15 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.7 t -125.56 111.28 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -109.92 97.46 6.97 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 85.6 m -69.93 155.33 40.73 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 118.87 -1.132 . . . . 0.0 112.546 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 72.3 mt -123.31 -54.16 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 CA-C-N 113.493 -1.685 . . . . 0.0 107.123 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.431 ' O ' ' O ' ' A' ' 9' ' ' PRO . 43.2 m -123.66 83.16 53.91 Favored Pre-proline 0 N--CA 1.506 2.335 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.463 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 8' ' ' SER . 4.6 Cg_exo -35.92 163.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.51 2.14 . . . . 0.0 112.971 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.11 -172.08 15.15 Favored Glycine 0 N--CA 1.502 3.059 0 N-CA-C 107.872 -2.091 . . . . 0.0 107.872 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 12' ' ' GLY . 1.4 p30 -39.63 -51.69 2.25 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.867 -0.733 . . . . 0.0 112.701 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.526 ' N ' ' OD1' ' A' ' 11' ' ' ASP . . . 100.88 -1.13 55.21 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 62.9 mtt180 -118.3 -37.08 3.4 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.8 m -104.77 128.27 52.85 Favored 'General case' 0 N--CA 1.504 2.271 0 C-N-CA 119.828 -0.749 . . . . 0.0 111.757 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 27.4 m-85 -129.01 172.39 7.18 Favored Pre-proline 0 N--CA 1.502 2.145 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -63.41 128.88 23.64 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 CA-C-N 119.915 1.005 . . . . 0.0 110.504 167.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -118.0 167.58 11.32 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 122.279 1.038 . . . . 0.0 110.61 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.555 HH12 ' CD2' ' A' ' 50' ' ' LEU . 5.2 tpp180 -68.73 123.51 21.11 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.11 -1.405 . . . . 0.0 109.684 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.86 -19.39 18.49 Favored Glycine 0 N--CA 1.499 2.889 0 C-N-CA 120.336 -0.935 . . . . 0.0 110.845 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -112.17 178.13 4.41 Favored 'General case' 0 N--CA 1.507 2.414 0 CA-C-O 121.695 0.759 . . . . 0.0 112.57 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 42.1 m -111.07 166.96 10.63 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.3 m -118.48 147.25 43.82 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 67.9 t -122.96 100.55 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 101.71 -3.441 . . . . 0.0 101.71 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.2 m -120.47 145.86 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.325 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.525 ' CE1' ' OD2' ' A' ' 41' ' ' ASP . 1.6 t60 -121.49 141.59 50.88 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 102.517 -3.142 . . . . 0.0 102.517 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -160.39 176.97 11.06 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 118.487 -1.285 . . . . 0.0 112.263 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 97.4 m -136.97 121.89 18.85 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 101.368 -3.568 . . . . 0.0 101.368 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -110.41 113.24 3.48 Favored Glycine 0 N--CA 1.499 2.864 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 39.1 ttm -122.56 173.97 7.36 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 21.1 mt -119.03 -174.81 2.78 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -90.19 26.54 1.87 Allowed 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 122.219 1.009 . . . . 0.0 108.606 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 33' ' ' GLY . 1.4 p30 -130.67 -50.09 1.06 Allowed 'General case' 0 N--CA 1.502 2.132 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.649 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.521 ' N ' ' OD1' ' A' ' 32' ' ' ASP . . . 119.36 24.5 2.91 Favored Glycine 0 N--CA 1.505 3.25 0 N-CA-C 114.618 0.607 . . . . 0.0 114.618 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.407 ' O ' ' C ' ' A' ' 35' ' ' LYS . 2.1 mptp? -113.73 67.96 0.68 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 117.944 0.872 . . . . 0.0 111.646 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 34' ' ' LYS . 60.2 pttt -19.64 135.0 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.369 0 O-C-N 125.157 1.536 . . . . 0.0 113.452 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.528 ' CD2' ' OD2' ' A' ' 37' ' ' ASP . 2.5 p90 -131.8 -33.82 1.36 Allowed 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 113.675 -1.602 . . . . 0.0 108.577 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.528 ' OD2' ' CD2' ' A' ' 36' ' ' PHE . 62.1 m-20 -137.27 86.99 2.24 Favored 'General case' 0 N--CA 1.515 2.779 0 N-CA-C 118.587 2.81 . . . . 0.0 118.587 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.8 m -112.46 173.07 6.55 Favored 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 100.53 -3.878 . . . . 0.0 100.53 179.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 88.5 p -117.18 -133.31 0.33 Allowed 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 121.476 1.944 . . . . 0.0 109.719 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.426 ' O ' ' O ' ' A' ' 44' ' ' LYS . 26.0 ttt85 -131.18 78.08 1.81 Allowed 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 112.84 -1.982 . . . . 0.0 110.547 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.525 ' OD2' ' CE1' ' A' ' 25' ' ' HIS . 10.1 t70 -88.09 34.14 0.73 Allowed 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 118.003 -1.479 . . . . 0.0 108.486 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.407 ' H ' ' C ' ' A' ' 40' ' ' ARG . 21.4 ttm-85 -91.56 -60.91 1.76 Allowed 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.001 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.503 ' C ' HD21 ' A' ' 43' ' ' ASN . 0.5 OUTLIER -110.41 -66.12 1.1 Allowed 'General case' 0 N--CA 1.501 2.094 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.527 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' A' ' 40' ' ' ARG . 98.8 mttt -120.9 153.65 57.35 Favored Pre-proline 0 N--CA 1.507 2.417 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -87.84 -157.8 0.07 OUTLIER 'Trans proline' 0 C--N 1.314 -1.255 0 C-N-CA 123.284 2.656 . . . . 0.0 110.655 178.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -96.36 149.24 21.92 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 114.055 -1.429 . . . . 0.0 109.928 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -141.87 135.66 29.74 Favored 'General case' 0 N--CA 1.517 2.898 0 N-CA-C 114.822 1.415 . . . . 0.0 114.822 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -148.03 172.14 14.72 Favored 'General case' 0 N--CA 1.514 2.736 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 43.9 ttm -116.16 148.93 39.85 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.815 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.555 ' CD2' HH12 ' A' ' 18' ' ' ARG . 65.2 tp -90.77 119.37 30.94 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.966 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.19 35.22 4.55 Favored Glycine 0 N--CA 1.497 2.7 0 N-CA-C 108.591 -1.804 . . . . 0.0 108.591 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.488 ' O ' ' CB ' ' A' ' 53' ' ' GLN . 63.5 tttp -128.11 -54.16 1.29 Allowed 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.488 ' CB ' ' O ' ' A' ' 52' ' ' LYS . 63.7 tp60 100.56 66.21 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 O-C-N 125.757 1.91 . . . . 0.0 110.267 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -110.1 -36.64 5.79 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.422 ' O ' ' O ' ' A' ' 56' ' ' ILE . 11.5 m -118.73 152.43 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.737 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.422 ' O ' ' O ' ' A' ' 55' ' ' VAL . 3.8 pt -51.46 -174.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-N 114.176 -1.375 . . . . 0.0 110.043 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.539 ' O ' ' N ' ' A' ' 59' ' ' TRP . 45.2 ttm180 -84.58 -54.64 4.6 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 122.391 -0.193 . . . . 0.0 110.902 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -41.13 -20.57 0.04 OUTLIER Glycine 0 N--CA 1.492 2.422 0 C-N-CA 120.201 -1.0 . . . . 0.0 111.559 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.54 ' O ' ' N ' ' A' ' 63' ' ' VAL . 0.1 OUTLIER -92.25 -77.0 0.44 Allowed 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -35.76 -48.98 0.57 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.912 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -73.45 -54.63 7.82 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 105.739 -1.949 . . . . 0.0 105.739 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -53.68 -81.0 0.06 OUTLIER Glycine 0 N--CA 1.477 1.408 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.54 ' N ' ' O ' ' A' ' 59' ' ' TRP . 47.8 t -30.4 -46.83 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.512 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -46.02 -58.69 3.38 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 123.994 1.854 . . . . 0.0 110.177 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -50.12 -9.76 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 109.39 -3.55 . . . . 0.0 109.906 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.512 ' H ' ' C ' ' A' ' 64' ' ' ALA . 88.8 mtp -101.3 156.38 17.48 Favored 'General case' 0 N--CA 1.513 2.686 0 C-N-CA 119.102 -1.039 . . . . 0.0 108.528 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 83.0 p -115.97 148.93 39.57 Favored 'General case' 0 N--CA 1.506 2.335 0 CA-C-O 122.418 1.104 . . . . 0.0 113.003 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 90.6 t -41.57 94.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 112.846 -1.979 . . . . 0.0 113.962 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 113.28 16.92 7.98 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -108.17 144.08 36.09 Favored 'General case' 0 N--CA 1.507 2.379 0 C-N-CA 120.072 -0.651 . . . . 0.0 111.085 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 24.7 ttt85 -126.28 139.44 53.31 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -147.69 176.14 10.34 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-N 112.967 -1.924 . . . . 0.0 115.416 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -127.19 103.99 7.72 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 103.56 -2.756 . . . . 0.0 103.56 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.1 mp -97.78 146.03 25.8 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.161 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.3 m -119.34 107.15 13.03 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 104.505 -2.405 . . . . 0.0 104.505 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.4 mt -101.89 140.69 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.23 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.424 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 52.0 p -112.07 154.66 44.19 Favored Pre-proline 0 N--CA 1.504 2.229 0 CA-C-N 114.337 -1.302 . . . . 0.0 107.831 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -37.54 -54.77 1.15 Allowed 'Trans proline' 0 C--N 1.313 -1.316 0 C-N-CA 122.023 1.815 . . . . 0.0 113.836 -174.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.528 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 2.0 p-10 -34.12 -38.48 0.06 Allowed 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.895 -1.048 . . . . 0.0 113.095 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -104.55 -51.21 3.13 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.492 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -41.02 -92.01 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -121.18 -15.37 8.19 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 114.869 -1.059 . . . . 0.0 109.633 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 125.48 -172.09 17.43 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 107.843 -2.103 . . . . 0.0 107.843 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -107.46 25.26 11.67 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.435 ' O ' ' O ' ' A' ' 86' ' ' GLY . 63.8 m -129.59 43.86 3.06 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 85' ' ' THR . . . -42.99 174.06 0.01 OUTLIER Glycine 0 N--CA 1.49 2.289 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.697 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.525 ' N ' ' O ' ' A' ' 91' ' ' ILE . 73.2 t60 -115.33 145.3 34.0 Favored Pre-proline 0 N--CA 1.5 2.046 0 N-CA-C 104.592 -2.373 . . . . 0.0 104.592 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -72.41 149.32 50.21 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 N-CA-C 108.228 -1.489 . . . . 0.0 108.228 174.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 114.1 -54.73 0.55 Allowed Glycine 0 N--CA 1.5 2.966 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.8 mt -117.02 -62.14 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.392 0 CA-C-O 122.221 1.01 . . . . 0.0 109.38 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.525 ' O ' ' N ' ' A' ' 87' ' ' HIS . 32.4 mm -118.36 86.45 27.83 Favored Pre-proline 0 N--CA 1.506 2.358 0 CA-C-N 113.071 -1.877 . . . . 0.0 112.63 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -65.47 -175.61 0.45 Allowed 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 121.845 1.696 . . . . 0.0 108.037 172.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.407 ' O ' ' C ' ' A' ' 94' ' ' HIS . 89.2 Cg_exo -54.25 170.22 0.56 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.8 1.667 . . . . 0.0 110.015 174.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.412 ' O ' ' CG ' ' A' ' 94' ' ' HIS . 21.3 t-160 9.55 66.98 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.208 0 O-C-N 125.448 1.718 . . . . 0.0 115.097 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -119.35 65.23 0.79 Allowed 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 66.3 m -29.06 134.57 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 125.216 1.572 . . . . 0.0 111.317 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 16.7 mt -101.54 143.3 31.71 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.8 t -131.6 112.65 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -106.25 163.3 12.92 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 122.519 1.152 . . . . 0.0 109.399 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -129.1 90.27 3.0 Favored 'General case' 0 N--CA 1.492 1.649 1 N-CA-C 98.222 -4.733 . . . . 0.0 98.222 179.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 16.1 t -105.68 151.43 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.51 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -127.13 103.35 7.39 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 111.806 -2.452 . . . . 0.0 107.979 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 42.4 tp -72.74 120.86 18.94 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 102.177 -3.268 . . . . 0.0 102.177 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 15.8 mt -90.22 -55.57 3.55 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.409 ' CG ' ' H ' ' A' ' 106' ' ' LEU . 80.8 tttt -165.29 175.54 9.12 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.045 -1.062 . . . . 0.0 111.483 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.429 ' O ' ' OE1' ' A' ' 107' ' ' GLU . 18.2 mt -117.26 146.31 43.38 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.429 ' OE1' ' O ' ' A' ' 106' ' ' LEU . 5.7 mm-40 . . . . . 0 N--CA 1.505 2.32 0 CA-C-O 116.087 -1.911 . . . . 0.0 109.9 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.628 ' N ' ' CE1' ' A' ' 80' ' ' TYR . . . . . . . . 0 N--CA 1.485 1.951 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.5 p -109.18 140.59 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.253 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.518 ' NE2' ' N ' ' A' ' 4' ' ' VAL . 4.7 tm0? -117.87 149.7 40.42 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.518 ' N ' ' NE2' ' A' ' 3' ' ' GLN . 40.5 t -123.51 101.73 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.524 ' OE2' ' NZ ' ' A' ' 73' ' ' LYS . 39.1 tt0 -103.24 107.88 18.87 Favored 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 93.9 m -83.65 154.14 23.86 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 122.229 1.014 . . . . 0.0 112.51 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 56.3 mt -124.15 -50.29 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 CA-C-N 113.313 -1.767 . . . . 0.0 107.282 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 9' ' ' PRO . 48.1 t -122.14 79.97 43.63 Favored Pre-proline 0 N--CA 1.507 2.384 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.498 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 8' ' ' SER . 5.8 Cg_exo -37.3 165.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.735 2.29 . . . . 0.0 113.528 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.43 -169.83 13.52 Favored Glycine 0 N--CA 1.5 2.914 0 N-CA-C 106.234 -2.746 . . . . 0.0 106.234 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.521 ' N ' ' OD1' ' A' ' 11' ' ' ASP . 13.0 p-10 -39.76 -60.68 0.95 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.518 -0.873 . . . . 0.0 112.678 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.22 14.32 18.85 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 106.844 -2.502 . . . . 0.0 106.844 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 45.6 mtm180 -128.9 -36.32 1.8 Allowed 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 114.468 -0.866 . . . . 0.0 113.324 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 36.6 m -107.65 138.36 44.01 Favored 'General case' 0 N--CA 1.508 2.468 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.457 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 61.7 m-85 -130.91 176.25 3.03 Favored Pre-proline 0 N--CA 1.497 1.916 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -69.84 133.61 25.85 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 CA-C-N 119.63 0.904 . . . . 0.0 111.149 164.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.0 mtmp? -119.48 162.32 19.07 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 122.313 1.054 . . . . 0.0 108.653 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 58.4 mtt-85 -61.86 144.28 55.12 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 114.39 -1.277 . . . . 0.0 107.714 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 107.17 -31.31 8.25 Favored Glycine 0 N--CA 1.498 2.781 0 C-N-CA 119.564 -1.303 . . . . 0.0 110.589 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -109.33 176.86 4.93 Favored 'General case' 0 N--CA 1.506 2.369 0 CA-C-O 121.781 0.801 . . . . 0.0 112.881 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 63.7 m -114.71 124.82 52.77 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 114.387 -1.279 . . . . 0.0 109.828 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 22.3 m -69.53 152.14 45.17 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.2 t -128.07 106.49 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 102.117 -3.29 . . . . 0.0 102.117 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.0 m -125.52 148.32 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.423 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.538 ' CE1' ' HG ' ' A' ' 39' ' ' SER . 78.9 t60 -122.82 140.41 52.96 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 101.856 -3.387 . . . . 0.0 101.856 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -160.13 174.73 13.85 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 117.696 -1.602 . . . . 0.0 113.674 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.5 m -136.64 118.84 15.53 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 104.57 -2.382 . . . . 0.0 104.57 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.64 135.33 12.45 Favored Glycine 0 N--CA 1.503 3.112 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 63.9 mtp -140.28 178.75 7.07 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 122.102 0.953 . . . . 0.0 110.233 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 24.6 mt -116.08 175.77 5.4 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -33.78 -63.5 0.26 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 124.934 1.396 . . . . 0.0 113.179 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -160.93 38.4 0.15 Allowed 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 114.369 -1.287 . . . . 0.0 109.447 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -119.25 -82.47 0.78 Allowed Glycine 0 N--CA 1.499 2.881 0 C-N-CA 118.684 -1.722 . . . . 0.0 114.896 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.24 174.1 10.91 Favored 'General case' 0 N--CA 1.505 2.292 0 N-CA-C 116.536 2.05 . . . . 0.0 116.536 -179.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -91.72 137.06 32.67 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 112.109 -2.314 . . . . 0.0 105.191 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -118.84 -33.97 4.07 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -141.76 107.6 5.14 Favored 'General case' 0 N--CA 1.511 2.607 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.7 m -120.39 168.08 11.67 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.538 ' HG ' ' CE1' ' A' ' 25' ' ' HIS . 68.3 p -118.32 63.18 0.76 Allowed 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 19.0 ttm180 -116.41 -70.46 0.79 Allowed 'General case' 0 N--CA 1.504 2.257 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.172 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -19.71 -61.03 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.387 0 O-C-N 125.18 1.55 . . . . 0.0 113.163 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.466 ' O ' ' N ' ' A' ' 44' ' ' LYS . 1.4 mmp_? -91.02 71.66 6.39 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 103.45 -2.796 . . . . 0.0 103.45 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.4 ' C ' ' O ' ' A' ' 42' ' ' ARG . 5.1 m120 -8.47 -57.13 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.13 0 O-C-N 126.239 2.212 . . . . 0.0 114.248 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.466 ' N ' ' O ' ' A' ' 42' ' ' ARG . 4.5 mptp? -52.08 158.71 1.69 Allowed Pre-proline 0 N--CA 1.495 1.781 0 C-N-CA 119.073 -1.051 . . . . 0.0 108.341 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.22 -162.02 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 121.663 1.575 . . . . 0.0 110.717 171.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -114.37 152.66 31.13 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-N 114.73 -1.123 . . . . 0.0 112.843 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -140.9 133.22 28.25 Favored 'General case' 0 N--CA 1.514 2.731 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -139.04 174.92 10.01 Favored 'General case' 0 N--CA 1.515 2.779 0 CA-C-N 119.508 1.049 . . . . 0.0 111.771 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 44.6 ttm -115.24 134.66 54.94 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.3 tp -91.02 139.1 31.08 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 113.496 -1.684 . . . . 0.0 109.82 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 127.99 -36.26 2.55 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.284 -1.527 . . . . 0.0 109.284 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.411 ' O ' ' C ' ' A' ' 53' ' ' GLN . 19.7 tptp -130.38 42.67 3.23 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 119.147 -0.454 . . . . 0.0 112.087 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.411 ' C ' ' O ' ' A' ' 52' ' ' LYS . 8.4 tt0 23.98 77.32 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 124.578 1.173 . . . . 0.0 112.991 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.417 ' O ' ' OE1' ' A' ' 54' ' ' GLU . 8.1 tm-20 -84.3 -27.2 27.98 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.436 ' O ' ' O ' ' A' ' 56' ' ' ILE . 16.3 m -119.4 154.44 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.439 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.588 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.436 ' O ' ' O ' ' A' ' 55' ' ' VAL . 3.1 pt -45.8 174.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 C-N-CA 118.653 -1.219 . . . . 0.0 111.913 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.54 ' O ' ' N ' ' A' ' 59' ' ' TRP . 5.0 tpt180 -71.01 -58.96 3.06 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.883 -1.053 . . . . 0.0 113.171 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -32.52 -30.53 0.01 OUTLIER Glycine 0 N--CA 1.5 2.947 0 CA-C-O 122.825 1.236 . . . . 0.0 111.531 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.54 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.8 OUTLIER -92.2 -76.2 0.46 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 112.924 -1.638 . . . . 0.0 109.557 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.514 ' OE1' ' NH1' ' A' ' 57' ' ' ARG . 3.8 tm-20 -32.02 -50.3 0.21 Allowed 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.1 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -73.65 -56.39 5.06 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -51.35 -77.55 0.13 Allowed Glycine 0 N--CA 1.481 1.637 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.526 ' N ' ' O ' ' A' ' 59' ' ' TRP . 40.2 t -36.05 -45.87 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.47 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -50.09 -53.48 26.92 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 123.715 1.721 . . . . 0.0 109.618 179.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -61.97 0.29 0.41 Allowed 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 110.399 -3.091 . . . . 0.0 110.692 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.47 ' H ' ' C ' ' A' ' 64' ' ' ALA . 50.8 ttm -110.09 151.8 26.77 Favored 'General case' 0 N--CA 1.51 2.534 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 80.4 p -115.85 153.57 31.26 Favored 'General case' 0 N--CA 1.509 2.512 0 CA-C-O 122.832 1.301 . . . . 0.0 113.922 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 79.6 t -45.23 98.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-N 112.324 -2.216 . . . . 0.0 114.967 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.46 10.5 21.63 Favored Glycine 0 N--CA 1.498 2.795 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -108.58 152.13 25.18 Favored 'General case' 0 N--CA 1.509 2.517 0 CA-C-O 122.384 1.088 . . . . 0.0 111.249 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 -131.83 141.25 49.38 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 113.027 -1.897 . . . . 0.0 108.357 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -148.07 177.91 8.98 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 112.888 -1.96 . . . . 0.0 114.223 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.524 ' NZ ' ' OE2' ' A' ' 5' ' ' GLU . 6.3 ttpm? -122.8 103.55 8.71 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 102.986 -2.968 . . . . 0.0 102.986 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.7 mt -96.49 145.06 26.02 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 90.7 m -117.45 107.62 14.54 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 104.349 -2.463 . . . . 0.0 104.349 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 35.8 mt -101.55 140.05 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.665 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.425 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -114.24 160.42 32.76 Favored Pre-proline 0 N--CA 1.497 1.887 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -45.09 -52.69 6.11 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.39 2.06 . . . . 0.0 112.736 -172.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.439 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 24.5 p30 -39.66 -29.85 0.06 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.628 ' CE1' ' N ' ' A' ' 1' ' ' GLY . 6.0 m-85 -105.52 18.67 21.85 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 115.089 1.515 . . . . 0.0 115.089 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -166.1 -84.09 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 7.9 m-30 -107.76 60.07 0.62 Allowed 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 114.419 -1.264 . . . . 0.0 111.355 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -8.9 -90.04 0.01 OUTLIER Glycine 0 N--CA 1.499 2.844 0 N-CA-C 116.697 1.439 . . . . 0.0 116.697 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -130.88 -55.95 1.05 Allowed 'General case' 0 N--CA 1.505 2.299 0 O-C-N 122.045 -0.679 . . . . 0.0 112.612 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 97.6 m -112.73 97.24 6.43 Favored 'General case' 0 N--CA 1.502 2.142 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.913 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -109.25 -83.01 1.43 Allowed Glycine 0 N--CA 1.501 2.988 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 29.1 t60 -144.19 75.62 15.35 Favored Pre-proline 0 N--CA 1.506 2.34 0 CA-C-N 118.033 0.916 . . . . 0.0 111.411 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -37.84 140.5 0.28 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.22 1.947 . . . . 0.0 110.796 177.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 113.92 -42.62 1.89 Allowed Glycine 0 N--CA 1.501 3.029 0 N-CA-C 107.491 -2.244 . . . . 0.0 107.491 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.6 mt -108.08 -52.84 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 37.6 mm -117.88 85.62 23.23 Favored Pre-proline 0 N--CA 1.502 2.151 0 CA-C-N 112.193 -2.276 . . . . 0.0 110.27 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -45.36 154.78 0.47 Allowed 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 122.234 1.956 . . . . 0.0 108.378 167.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -49.19 160.8 0.73 Allowed 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 121.657 1.571 . . . . 0.0 112.498 -174.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 8.9 p80 9.42 70.78 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 116.868 2.173 . . . . 0.0 116.868 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -111.96 154.67 24.92 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 25.5 m -91.12 140.42 29.83 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 29.7 mt -109.17 151.65 26.19 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 104.929 -2.248 . . . . 0.0 104.929 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.4 t -134.81 102.7 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -96.49 163.38 13.07 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 117.83 -1.548 . . . . 0.0 107.812 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -125.41 87.7 2.74 Favored 'General case' 0 N--CA 1.492 1.633 1 N-CA-C 95.559 -5.719 . . . . 0.0 95.559 179.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 16.8 t -100.07 147.98 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.423 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -127.18 103.75 7.59 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 112.463 -2.153 . . . . 0.0 107.538 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 37.5 tp -74.39 114.37 12.68 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 102.866 -3.013 . . . . 0.0 102.866 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.1 mt -77.11 -53.97 7.11 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.187 -179.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 9.0 mtpt -174.5 -167.21 0.3 Allowed 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.64 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 22.5 mt -117.53 154.28 31.74 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 . . . . . 0 N--CA 1.501 2.123 0 CA-C-O 116.156 -1.878 . . . . 0.0 108.528 179.84 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.353 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.4 p -110.88 150.26 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -122.3 154.7 37.25 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 57.2 t -126.52 109.11 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 CA-C-N 115.197 -0.91 . . . . 0.0 108.567 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -109.9 96.0 5.96 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 89.7 m -69.89 156.33 39.24 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 118.813 -1.155 . . . . 0.0 113.106 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 69.1 mt -122.49 -54.72 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-N 113.361 -1.745 . . . . 0.0 107.356 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.416 ' O ' ' O ' ' A' ' 9' ' ' PRO . 48.6 m -123.85 82.43 55.26 Favored Pre-proline 0 N--CA 1.506 2.372 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.574 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.416 ' O ' ' O ' ' A' ' 8' ' ' SER . 5.3 Cg_exo -36.36 163.91 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.447 2.098 . . . . 0.0 113.176 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -118.02 -172.51 15.77 Favored Glycine 0 N--CA 1.5 2.961 0 N-CA-C 104.88 -3.288 . . . . 0.0 104.88 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.495 ' CG ' ' H ' ' A' ' 12' ' ' GLY . 10.6 p-10 -45.88 -58.46 3.51 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 118.635 1.218 . . . . 0.0 111.108 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.495 ' H ' ' CG ' ' A' ' 11' ' ' ASP . . . 106.5 27.02 5.68 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 107.246 -2.341 . . . . 0.0 107.246 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 57.7 mtt85 -132.39 -35.32 1.17 Allowed 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 114.457 -0.871 . . . . 0.0 111.871 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.8 m -111.28 136.8 49.86 Favored 'General case' 0 N--CA 1.506 2.326 0 CA-C-O 121.703 0.763 . . . . 0.0 112.848 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.448 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 59.0 m-85 -132.14 176.11 3.16 Favored Pre-proline 0 N--CA 1.496 1.851 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -70.91 140.24 37.92 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 CA-C-N 119.508 0.86 . . . . 0.0 111.484 163.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -122.74 169.95 10.55 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 121.716 0.77 . . . . 0.0 109.009 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.1 mtp-105 -70.23 126.34 29.37 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.078 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.42 -19.3 13.04 Favored Glycine 0 N--CA 1.498 2.775 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -108.56 174.12 6.02 Favored 'General case' 0 N--CA 1.504 2.225 0 CA-C-O 121.847 0.832 . . . . 0.0 111.391 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 42.5 m -118.82 129.93 55.49 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 114.039 -1.437 . . . . 0.0 107.753 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 59.3 m -78.75 149.45 32.69 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.5 t -121.85 101.6 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 103.12 -2.918 . . . . 0.0 103.12 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.0 m -121.59 150.69 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.49 0 N-CA-C 117.248 2.314 . . . . 0.0 117.248 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.523 ' HD1' ' CG ' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -123.31 107.04 11.22 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 179.346 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -127.59 170.15 12.95 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-O 123.237 1.494 . . . . 0.0 114.589 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 98.1 m -139.29 119.5 13.68 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 102.754 -3.054 . . . . 0.0 102.754 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.53 137.63 14.23 Favored Glycine 0 N--CA 1.501 3.001 0 C-N-CA 120.073 -1.06 . . . . 0.0 110.995 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 40.5 ttm -136.05 168.54 19.18 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.1 mt -112.59 173.45 6.37 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 107.994 -1.114 . . . . 0.0 107.994 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.434 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -32.66 -63.33 0.21 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 124.792 1.308 . . . . 0.0 111.943 179.857 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.425 ' OD1' ' OE2' ' A' ' 31' ' ' GLU . 12.3 p-10 -160.29 42.69 0.19 Allowed 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.303 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -118.49 -80.22 0.7 Allowed Glycine 0 N--CA 1.5 2.938 0 C-N-CA 119.222 -1.466 . . . . 0.0 112.979 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.9 pttp -161.11 -168.01 1.94 Allowed 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -90.7 137.7 32.15 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.528 ' CE2' ' OD2' ' A' ' 37' ' ' ASP . 6.5 p90 -127.87 -38.31 1.86 Allowed 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 113.098 -1.865 . . . . 0.0 107.111 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.528 ' OD2' ' CE2' ' A' ' 36' ' ' PHE . 29.6 m-20 -129.88 80.78 1.98 Allowed 'General case' 0 N--CA 1.508 2.444 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 56.4 m -113.62 164.56 13.52 Favored 'General case' 0 N--CA 1.492 1.635 1 N-CA-C 99.391 -4.3 . . . . 0.0 99.391 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 92.9 p -120.4 -141.24 0.34 Allowed 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 103.265 -2.865 . . . . 0.0 103.265 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.437 ' C ' ' H ' ' A' ' 42' ' ' ARG . 26.6 ttt85 -130.76 74.03 1.57 Allowed 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 111.893 -2.412 . . . . 0.0 104.872 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.523 ' CG ' ' HD1' ' A' ' 25' ' ' HIS . 32.0 m-20 -80.69 40.17 0.51 Allowed 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.008 -1.077 . . . . 0.0 110.909 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.437 ' H ' ' C ' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -91.35 -69.71 0.72 Allowed 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 179.753 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -111.01 -56.5 2.36 Favored 'General case' 0 N--CA 1.504 2.26 0 CA-C-N 115.054 -0.975 . . . . 0.0 113.522 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.428 ' O ' ' O ' ' A' ' 45' ' ' PRO . 4.5 mmpt? -114.22 87.5 13.49 Favored Pre-proline 0 N--CA 1.507 2.412 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -179.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 44' ' ' LYS . 33.2 Cg_exo -42.81 -156.95 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 123.148 2.565 . . . . 0.0 114.94 168.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -106.66 145.32 32.11 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 113.519 -1.673 . . . . 0.0 111.76 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.49 116.29 14.03 Favored 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -132.92 172.63 12.35 Favored 'General case' 0 N--CA 1.512 2.63 0 C-N-CA 119.797 -0.761 . . . . 0.0 111.298 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.9 ttm -119.89 153.65 35.55 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.4 tp -90.93 125.27 35.72 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.822 -1.535 . . . . 0.0 110.491 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.18 -24.57 7.33 Favored Glycine 0 N--CA 1.501 2.983 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 54' ' ' GLU . 52.8 tttp -116.11 39.35 3.1 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' ' 52' ' ' LYS . 86.5 mt-30 1.49 61.77 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 125.794 1.934 . . . . 0.0 114.384 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 52' ' ' LYS . 43.7 tt0 -75.21 -23.38 57.61 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 113.715 -1.584 . . . . 0.0 107.406 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.5 m -113.15 -178.45 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 18.6 pt -90.26 167.04 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 C-N-CA 118.998 -1.081 . . . . 0.0 110.868 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.531 ' O ' ' N ' ' A' ' 59' ' ' TRP . 0.7 OUTLIER -45.69 -70.22 0.11 Allowed 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 114.311 -1.313 . . . . 0.0 111.138 -179.774 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -26.47 -36.66 0.01 OUTLIER Glycine 0 N--CA 1.496 2.654 0 O-C-N 125.175 1.547 . . . . 0.0 112.799 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.531 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.8 OUTLIER -83.59 -68.36 0.72 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.819 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.463 ' OE1' ' N ' ' A' ' 61' ' ' GLU . 10.1 tm-20 -33.73 -53.45 0.44 Allowed 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 113.934 -1.485 . . . . 0.0 110.721 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.503 ' OE2' ' NE2' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -73.71 -57.42 4.0 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 104.777 -2.305 . . . . 0.0 104.777 179.707 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -46.46 -78.57 0.08 OUTLIER Glycine 0 N--CA 1.485 1.963 0 C-N-CA 119.554 -1.307 . . . . 0.0 111.061 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 59' ' ' TRP . 32.3 t -39.63 -47.32 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 114.948 -0.626 . . . . 0.0 111.932 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.424 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -50.1 -51.27 44.32 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 123.265 1.507 . . . . 0.0 110.499 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.503 ' NE2' ' OE2' ' A' ' 61' ' ' GLU . 7.3 tt0 -65.94 2.98 0.9 Allowed 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 111.216 -2.72 . . . . 0.0 111.507 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.424 ' H ' ' C ' ' A' ' 64' ' ' ALA . 60.0 ttm -106.61 151.99 24.32 Favored 'General case' 0 N--CA 1.509 2.493 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 179.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 92.0 p -116.49 151.98 35.0 Favored 'General case' 0 N--CA 1.51 2.566 0 CA-C-O 122.69 1.233 . . . . 0.0 113.541 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 86.0 t -45.0 97.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 112.597 -2.092 . . . . 0.0 114.755 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.35 8.42 23.27 Favored Glycine 0 N--CA 1.5 2.937 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -105.4 145.31 30.97 Favored 'General case' 0 N--CA 1.506 2.361 0 CA-C-O 121.648 0.737 . . . . 0.0 111.566 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.9 ttt85 -126.17 141.45 51.93 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.261 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -149.54 177.52 9.66 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 113.007 -1.906 . . . . 0.0 115.507 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -127.03 105.14 8.39 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 103.07 -2.937 . . . . 0.0 103.07 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.1 mp -101.67 151.55 21.89 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 119.766 -0.774 . . . . 0.0 109.882 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 86.3 m -121.61 121.73 38.05 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 25.6 mt -111.41 139.92 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.429 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 66.8 p -113.87 154.35 45.92 Favored Pre-proline 0 N--CA 1.503 2.22 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.435 ' O ' ' O ' ' A' ' 81' ' ' ALA . 9.5 Cg_endo -37.55 -54.11 1.28 Allowed 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 121.784 1.656 . . . . 0.0 113.192 -174.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.52 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 0.9 OUTLIER -34.66 -35.87 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.445 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -104.53 -25.36 12.8 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 114.685 -1.143 . . . . 0.0 112.049 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 83' ' ' GLY . . . -105.1 164.9 11.46 Favored 'General case' 0 N--CA 1.505 2.315 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.119 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -11.43 71.4 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 126.515 2.384 . . . . 0.0 113.799 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 81' ' ' ALA . . . -82.95 53.66 4.89 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 119.26 -1.448 . . . . 0.0 111.487 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.488 ' CB ' ' O ' ' A' ' 83' ' ' GLY . . . 114.81 22.26 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 O-C-N 126.348 1.852 . . . . 0.0 109.531 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 48.2 m -128.26 46.59 2.56 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-O 121.096 0.474 . . . . 0.0 109.992 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -126.0 173.91 17.78 Favored Glycine 0 N--CA 1.5 2.947 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -125.93 150.3 68.63 Favored Pre-proline 0 N--CA 1.504 2.239 0 N-CA-C 103.469 -2.789 . . . . 0.0 103.469 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.526 ' O ' ' N ' ' A' ' 90' ' ' ILE . 36.6 Cg_endo -54.43 -77.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 120.978 1.119 . . . . 0.0 109.436 -177.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -21.25 -40.76 0.01 OUTLIER Glycine 0 N--CA 1.493 2.462 0 O-C-N 124.896 1.372 . . . . 0.0 114.973 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.526 ' N ' ' O ' ' A' ' 88' ' ' PRO . 6.1 mt -109.03 -65.27 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.321 0 CA-C-O 122.396 1.093 . . . . 0.0 111.44 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 35.5 mm -116.26 90.9 30.87 Favored Pre-proline 0 N--CA 1.505 2.311 0 CA-C-N 113.123 -1.853 . . . . 0.0 112.639 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -55.12 -179.29 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.17 1.913 . . . . 0.0 108.286 162.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -64.44 165.72 19.36 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 121.915 1.743 . . . . 0.0 112.881 -176.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 17.9 m80 9.33 76.0 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -115.93 156.71 25.71 Favored 'General case' 0 N--CA 1.505 2.298 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 68.9 m -91.1 139.49 30.7 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 31.5 mt -116.82 149.59 39.74 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.6 t -132.37 123.03 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -115.77 157.13 24.8 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 122.023 0.916 . . . . 0.0 110.166 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -127.72 90.82 3.17 Favored 'General case' 0 N--CA 1.493 1.689 1 N-CA-C 99.194 -4.372 . . . . 0.0 99.194 179.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.4 t -105.32 151.34 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.54 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -127.92 98.09 5.03 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 112.327 -2.215 . . . . 0.0 107.838 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 56.0 tp -69.87 119.44 14.1 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 11.4 mt -82.35 -55.97 4.18 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 113.902 -1.499 . . . . 0.0 110.639 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -173.95 -168.09 0.39 Allowed 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 114.71 -1.132 . . . . 0.0 111.065 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 25.7 mt -114.82 160.02 19.94 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 . . . . . 0 N--CA 1.504 2.251 0 CA-C-O 116.241 -1.838 . . . . 0.0 108.236 179.705 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.7 p -115.45 150.23 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -124.31 151.89 43.74 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.0 t -123.09 115.79 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -117.78 97.67 5.96 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.664 ' HG1' ' NE2' ' A' ' 70' ' ' GLN . 94.7 m -69.75 156.52 38.87 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.154 -1.018 . . . . 0.0 112.734 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.1 mt -121.38 -58.52 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.531 ' CB ' ' NH1' ' A' ' 71' ' ' ARG . 48.3 m -121.64 84.6 43.07 Favored Pre-proline 0 N--CA 1.501 2.086 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.877 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 8' ' ' SER . 6.8 Cg_exo -36.23 163.79 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.397 2.065 . . . . 0.0 113.264 178.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.2 -173.63 14.7 Favored Glycine 0 N--CA 1.499 2.885 0 N-CA-C 105.555 -3.018 . . . . 0.0 105.555 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.506 ' N ' ' OD1' ' A' ' 11' ' ' ASP . 13.0 p-10 -39.71 -59.87 1.08 Allowed 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.809 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.15 20.06 11.76 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 105.356 -3.098 . . . . 0.0 105.356 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 46.4 mtm180 -128.21 -38.5 1.78 Allowed 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 113.699 -1.251 . . . . 0.0 112.733 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.0 m -108.18 135.29 49.77 Favored 'General case' 0 N--CA 1.505 2.315 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.441 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 67.6 m-85 -130.94 177.16 2.37 Favored Pre-proline 0 N--CA 1.495 1.796 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -66.22 153.27 78.7 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 CA-C-N 119.408 0.824 . . . . 0.0 110.806 160.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -122.65 170.88 9.58 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 121.759 0.79 . . . . 0.0 109.361 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 42.4 mtp-105 -78.22 96.63 5.27 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.096 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.73 10.56 3.92 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -114.74 172.09 7.25 Favored 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 74.7 m -121.86 112.27 18.13 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.25 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 22.5 m -69.54 147.35 50.92 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.758 0.789 . . . . 0.0 109.518 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.1 t -123.09 112.31 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 101.592 -3.484 . . . . 0.0 101.592 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.0 m -122.44 151.62 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -120.38 99.21 6.44 Favored 'General case' 0 N--CA 1.508 2.463 0 CA-C-N 112.71 -2.041 . . . . 0.0 106.473 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.41 ' CD2' ' CD2' ' A' ' 99' ' ' PHE . 28.0 p90 -132.29 173.8 10.89 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.6 m -134.7 117.92 16.56 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 102.628 -3.101 . . . . 0.0 102.628 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 37' ' ' ASP . . . -104.57 120.8 6.73 Favored Glycine 0 N--CA 1.503 3.157 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.434 ' SD ' ' C ' ' A' ' 34' ' ' LYS . 37.4 tpp -141.05 151.0 43.69 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.488 ' C ' ' H ' ' A' ' 32' ' ' ASP . 3.2 mp -93.02 151.92 19.61 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -90.51 34.64 0.88 Allowed 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 33' ' ' GLY . 32.7 p30 -121.05 -26.58 5.11 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 113.463 -1.699 . . . . 0.0 111.106 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.538 ' N ' ' OD1' ' A' ' 32' ' ' ASP . . . 161.35 -43.66 0.4 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 120.55 2.98 . . . . 0.0 120.55 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.434 ' C ' ' SD ' ' A' ' 29' ' ' MET . 32.5 mmtp -129.34 176.87 7.6 Favored 'General case' 0 N--CA 1.523 3.198 0 CA-C-N 121.734 2.767 . . . . 0.0 113.025 -178.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 53.8 pttt -93.07 148.43 22.01 Favored 'General case' 0 N--CA 1.513 2.721 0 O-C-N 124.781 1.3 . . . . 0.0 111.717 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -136.21 -32.79 0.85 Allowed 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.25 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.463 ' O ' ' N ' ' A' ' 28' ' ' GLY . 7.5 t0 -137.75 121.47 17.46 Favored 'General case' 0 N--CA 1.526 3.336 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.5 m -130.68 162.45 29.4 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.479 ' O ' ' N ' ' A' ' 41' ' ' ASP . 88.4 p -100.73 46.21 0.95 Allowed 'General case' 0 N--CA 1.504 2.275 0 C-N-CA 121.061 -0.256 . . . . 0.0 111.45 179.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.519 ' C ' ' H ' ' A' ' 42' ' ' ARG . 10.1 tpp85 -29.85 -36.09 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 124.242 0.964 . . . . 0.0 112.949 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.479 ' N ' ' O ' ' A' ' 39' ' ' SER . 54.5 m-20 -54.98 15.43 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 116.652 2.093 . . . . 0.0 116.652 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.519 ' H ' ' C ' ' A' ' 40' ' ' ARG . 64.8 mtt85 -19.55 -58.12 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.552 ' N ' HD21 ' A' ' 43' ' ' ASN . 2.0 m120 -43.79 -64.44 0.66 Allowed 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.867 0.842 . . . . 0.0 110.838 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.454 ' O ' ' O ' ' A' ' 45' ' ' PRO . 46.1 pttt -122.61 73.25 42.24 Favored Pre-proline 0 N--CA 1.498 1.939 0 CA-C-N 113.996 -1.456 . . . . 0.0 110.168 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.454 ' O ' ' O ' ' A' ' 44' ' ' LYS . 21.6 Cg_exo -41.45 -154.3 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 125.099 3.866 . . . . 0.0 119.229 -163.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -91.35 135.61 33.7 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 112.468 -2.151 . . . . 0.0 107.882 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -133.05 143.9 49.67 Favored 'General case' 0 N--CA 1.514 2.753 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -149.07 174.64 12.1 Favored 'General case' 0 N--CA 1.504 2.242 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.156 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 41.6 ttm -118.04 142.74 47.06 Favored 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.3 tp -91.02 120.63 32.16 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.953 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.08 24.18 9.95 Favored Glycine 0 N--CA 1.5 2.903 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.48 ' O ' ' CB ' ' A' ' 53' ' ' GLN . 15.6 tppt? -125.29 -55.94 1.54 Allowed 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.48 ' CB ' ' O ' ' A' ' 52' ' ' LYS . 46.3 tt0 100.81 68.85 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 O-C-N 126.0 2.063 . . . . 0.0 108.29 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -109.12 -36.24 6.11 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 113.939 -1.482 . . . . 0.0 107.459 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.415 ' O ' ' O ' ' A' ' 56' ' ' ILE . 15.8 m -111.05 151.77 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.415 ' O ' ' O ' ' A' ' 55' ' ' VAL . 15.7 pt -48.48 174.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 C-N-CA 118.276 -1.37 . . . . 0.0 111.038 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.544 ' O ' ' N ' ' A' ' 59' ' ' TRP . 46.5 ttm180 -69.59 -63.28 1.1 Allowed 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -28.78 -34.73 0.01 OUTLIER Glycine 0 N--CA 1.499 2.837 0 O-C-N 124.472 1.107 . . . . 0.0 112.356 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.544 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.5 OUTLIER -81.42 -74.53 0.33 Allowed 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 113.177 -1.511 . . . . 0.0 107.553 179.877 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.518 ' OE1' ' N ' ' A' ' 61' ' ' GLU . 10.9 tm-20 -33.86 -51.37 0.4 Allowed 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.742 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.518 ' N ' ' OE1' ' A' ' 60' ' ' GLU . 17.7 tp10 -72.7 -55.48 6.73 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 112.544 -2.116 . . . . 0.0 108.095 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -55.29 -72.74 0.51 Allowed Glycine 0 N--CA 1.477 1.408 0 C-N-CA 119.246 -1.454 . . . . 0.0 110.17 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.498 ' N ' ' O ' ' A' ' 59' ' ' TRP . 40.6 t -39.56 -49.56 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 120.126 -0.629 . . . . 0.0 112.308 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.509 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -47.22 -62.09 1.58 Allowed 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 124.037 1.875 . . . . 0.0 110.139 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -48.43 -12.7 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 109.654 -3.43 . . . . 0.0 108.764 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.509 ' H ' ' C ' ' A' ' 64' ' ' ALA . 52.1 ttp -108.95 156.01 20.21 Favored 'General case' 0 N--CA 1.509 2.479 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.4 p -110.94 161.76 15.52 Favored 'General case' 0 N--CA 1.509 2.519 0 N-CA-C 116.338 1.977 . . . . 0.0 116.338 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 86.2 t -56.32 102.58 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-N 110.727 -2.942 . . . . 0.0 113.482 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.56 6.61 23.27 Favored Glycine 0 N--CA 1.499 2.867 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.664 ' NE2' ' HG1' ' A' ' 6' ' ' THR . 41.8 tt0 -107.12 148.86 28.29 Favored 'General case' 0 N--CA 1.504 2.27 0 CA-C-O 122.097 0.951 . . . . 0.0 110.29 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.531 ' NH1' ' CB ' ' A' ' 8' ' ' SER . 34.8 mtm-85 -122.35 128.35 50.89 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 113.577 -1.647 . . . . 0.0 107.977 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -134.91 172.02 13.58 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -124.57 103.17 8.0 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 102.766 -3.05 . . . . 0.0 102.766 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.8 mt -98.46 146.93 25.25 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.1 m -117.52 111.06 18.73 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 102.473 -3.158 . . . . 0.0 102.473 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 27.2 mt -109.41 137.79 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-O 121.462 0.649 . . . . 0.0 111.53 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.431 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 27.1 p -104.63 152.51 39.44 Favored Pre-proline 0 N--CA 1.504 2.27 0 CA-C-N 113.804 -1.543 . . . . 0.0 110.082 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -47.86 -38.83 31.2 Favored 'Trans proline' 0 N--CA 1.488 1.177 0 C-N-CA 122.574 2.183 . . . . 0.0 113.332 -173.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.521 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 7.0 p-10 -48.81 -40.44 29.22 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.101 -0.64 . . . . 0.0 110.943 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.7 m-30 -102.06 19.81 17.79 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.884 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -143.89 -96.79 0.11 Allowed 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.424 ' CD2' ' CG1' ' A' ' 91' ' ' ILE . 15.1 m-85 -120.08 99.29 6.52 Favored 'General case' 0 N--CA 1.504 2.238 0 CA-C-O 120.8 0.333 . . . . 0.0 110.331 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -108.68 34.84 5.32 Favored Glycine 0 N--CA 1.498 2.83 0 N-CA-C 107.61 -2.196 . . . . 0.0 107.61 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -132.79 -175.59 3.82 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 93.5 m -121.98 119.21 30.8 Favored 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -115.82 -81.73 0.94 Allowed Glycine 0 N--CA 1.503 3.125 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 -123.02 145.85 47.03 Favored Pre-proline 0 N--CA 1.508 2.435 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -84.55 117.7 2.09 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 C-N-CA 121.918 1.745 . . . . 0.0 109.937 176.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 119.63 -26.18 7.36 Favored Glycine 0 N--CA 1.5 2.926 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.0 mt -108.57 -59.34 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.487 ' O ' ' CG2' ' A' ' 91' ' ' ILE . 0.8 OUTLIER -124.18 85.55 54.92 Favored Pre-proline 0 N--CA 1.503 2.224 0 CA-C-N 112.465 -2.152 . . . . 0.0 110.204 179.983 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -69.4 162.34 42.28 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 N-CA-C 107.019 -1.954 . . . . 0.0 107.019 170.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 94' ' ' HIS . 73.5 Cg_endo -61.78 166.0 12.83 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.048 1.832 . . . . 0.0 109.373 176.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.406 ' C ' ' O ' ' A' ' 93' ' ' PRO . 20.3 m80 9.71 66.23 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.252 0 O-C-N 125.702 1.876 . . . . 0.0 114.576 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -111.52 158.4 19.22 Favored 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 122.423 1.106 . . . . 0.0 112.307 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 87.3 m -91.19 120.31 32.01 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 112.851 -1.977 . . . . 0.0 108.601 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 20.7 mt -97.75 147.19 24.63 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 103.893 -2.632 . . . . 0.0 103.893 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 56.5 t -132.71 124.11 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.432 ' CD2' ' NE1' ' A' ' 59' ' ' TRP . 2.0 m-85 -115.5 167.82 10.55 Favored 'General case' 0 N--CA 1.507 2.387 0 CA-C-O 123.264 1.507 . . . . 0.0 110.477 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -130.28 88.7 2.68 Favored 'General case' 0 N--CA 1.49 1.544 1 N-CA-C 98.222 -4.733 . . . . 0.0 98.222 179.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.5 t -100.95 151.46 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.442 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 -179.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 72.8 tt0 -127.27 97.36 4.88 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 112.377 -2.192 . . . . 0.0 106.806 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 43.8 tp -68.25 122.72 18.92 Favored 'General case' 0 N--CA 1.506 2.373 0 C-N-CA 115.591 -2.444 . . . . 0.0 104.936 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 11.4 mt -85.42 -62.29 1.56 Allowed 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.92 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.461 ' CG ' ' H ' ' A' ' 106' ' ' LEU . 34.1 ttpt -170.77 -175.24 1.76 Allowed 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 118.892 -1.123 . . . . 0.0 109.826 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.461 ' H ' ' CG ' ' A' ' 105' ' ' LYS . 24.2 mt -108.94 156.31 19.86 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 . . . . . 0 N--CA 1.504 2.271 0 CA-C-O 116.037 -1.935 . . . . 0.0 109.686 179.955 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.2 p -116.87 150.14 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -119.51 151.25 38.9 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 86.6 t -129.41 98.11 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.142 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -102.0 117.16 34.23 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 104.879 -2.267 . . . . 0.0 104.879 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 92.8 m -91.7 154.86 18.71 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 122.054 0.93 . . . . 0.0 111.729 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 62.5 mt -123.53 -51.11 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 9' ' ' PRO . 33.8 m -121.46 81.26 38.79 Favored Pre-proline 0 N--CA 1.509 2.516 0 C-N-CA 120.271 -0.572 . . . . 0.0 112.038 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 8' ' ' SER . 5.3 Cg_exo -37.33 164.75 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.373 2.049 . . . . 0.0 112.578 178.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.11 -171.97 14.37 Favored Glycine 0 N--CA 1.5 2.926 0 N-CA-C 107.048 -2.421 . . . . 0.0 107.048 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 12' ' ' GLY . 1.1 p30 -39.55 -52.29 2.18 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.707 -0.797 . . . . 0.0 112.689 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.476 ' N ' ' OD1' ' A' ' 11' ' ' ASP . . . 100.51 5.14 54.45 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 108.44 -1.864 . . . . 0.0 108.44 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 32.3 mtp85 -121.45 -35.76 3.2 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 42.4 m -107.7 138.43 43.94 Favored 'General case' 0 N--CA 1.509 2.488 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 35.0 m-85 -133.09 175.41 3.73 Favored Pre-proline 0 N--CA 1.498 1.952 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -66.27 145.63 78.58 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 CA-C-N 119.769 0.953 . . . . 0.0 109.967 165.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -118.96 169.89 9.5 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 122.373 1.083 . . . . 0.0 111.969 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 25.3 ttt85 -79.2 103.18 8.96 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 113.805 -1.543 . . . . 0.0 109.89 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.44 -10.09 6.49 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 108.353 -1.899 . . . . 0.0 108.353 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -114.93 176.1 5.2 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 89.2 m -112.62 163.2 14.81 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 2.2 m -114.27 143.26 45.14 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 104.613 -2.366 . . . . 0.0 104.613 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.8 t -117.72 102.5 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 103.397 -2.816 . . . . 0.0 103.397 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.8 m -122.46 152.0 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.363 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.525 ' NE2' ' O ' ' A' ' 40' ' ' ARG . 4.3 t-80 -129.63 128.12 41.98 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 102.721 -3.066 . . . . 0.0 102.721 178.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -139.77 176.23 8.91 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 115.335 1.605 . . . . 0.0 115.335 -179.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 91.7 m -132.87 121.55 23.08 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 103.246 -2.872 . . . . 0.0 103.246 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.84 123.15 7.55 Favored Glycine 0 N--CA 1.503 3.138 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 45.3 ttp -142.85 176.83 8.77 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.0 mt -115.78 170.2 8.64 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -27.56 -61.07 0.1 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 125.262 1.601 . . . . 0.0 114.061 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -160.48 43.81 0.19 Allowed 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 114.592 -1.186 . . . . 0.0 109.23 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -117.04 -78.4 0.67 Allowed Glycine 0 N--CA 1.502 3.051 0 C-N-CA 119.279 -1.439 . . . . 0.0 113.399 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.3 pttt -160.95 -177.13 5.91 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -90.99 135.54 33.67 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 114.055 -1.43 . . . . 0.0 110.39 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -118.65 -34.68 3.91 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -139.63 90.0 2.37 Favored 'General case' 0 N--CA 1.511 2.593 0 CA-C-O 120.866 0.365 . . . . 0.0 111.65 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 70.7 m -111.74 129.57 56.07 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 61.8 p -116.61 37.15 3.86 Favored 'General case' 0 N--CA 1.502 2.164 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.655 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.671 HH21 ' NH1' ' A' ' 42' ' ' ARG . 8.2 tpt180 -32.74 -63.97 0.2 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 124.029 0.831 . . . . 0.0 112.045 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.451 ' C ' ' H ' ' A' ' 43' ' ' ASN . 36.1 t70 -19.52 88.68 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 125.358 1.661 . . . . 0.0 114.165 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.671 ' NH1' HH21 ' A' ' 40' ' ' ARG . 26.4 mtm180 -82.58 38.03 0.54 Allowed 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 118.975 -1.09 . . . . 0.0 109.146 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.451 ' H ' ' C ' ' A' ' 41' ' ' ASP . 44.3 t30 -110.85 50.27 0.82 Allowed 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.442 ' O ' ' O ' ' A' ' 45' ' ' PRO . 55.2 mtmt 98.38 72.98 0.01 OUTLIER Pre-proline 0 N--CA 1.504 2.255 0 O-C-N 126.166 2.166 . . . . 0.0 108.889 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.442 ' O ' ' O ' ' A' ' 44' ' ' LYS . 33.3 Cg_exo -43.4 -160.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 124.248 3.299 . . . . 0.0 116.548 -178.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -85.01 142.3 29.7 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 113.596 -1.638 . . . . 0.0 109.5 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm -131.48 119.92 22.25 Favored 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -138.83 170.94 15.09 Favored 'General case' 0 N--CA 1.513 2.688 0 C-N-CA 119.306 -0.958 . . . . 0.0 112.402 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 43.1 ttm -115.75 154.6 29.29 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.1 tp -90.92 120.71 32.15 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.86 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.89 12.84 48.66 Favored Glycine 0 N--CA 1.499 2.84 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.303 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.427 ' O ' ' OE2' ' A' ' 54' ' ' GLU . 59.3 tttm -121.85 23.06 10.24 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 23.5 69.4 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 114.617 -1.174 . . . . 0.0 113.782 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.427 ' OE2' ' O ' ' A' ' 52' ' ' LYS . 66.6 mm-40 -106.28 -35.86 7.04 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 56' ' ' ILE . 18.6 m -116.59 152.56 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 CA-C-O 121.513 0.673 . . . . 0.0 110.543 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.425 ' O ' ' O ' ' A' ' 55' ' ' VAL . 4.8 pt -48.98 177.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.706 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.541 ' O ' ' N ' ' A' ' 59' ' ' TRP . 18.2 ttm180 -71.4 -61.01 1.93 Allowed 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -24.05 -39.16 0.01 OUTLIER Glycine 0 N--CA 1.495 2.622 0 O-C-N 124.929 1.393 . . . . 0.0 112.497 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.541 ' N ' ' O ' ' A' ' 57' ' ' ARG . 1.1 m95 -83.01 -70.01 0.59 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.412 ' O ' ' OE1' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -30.4 -59.82 0.19 Allowed 'General case' 0 N--CA 1.504 2.243 0 O-C-N 124.95 1.406 . . . . 0.0 110.05 -179.899 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -67.72 -52.66 35.03 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -49.77 -89.11 0.01 OUTLIER Glycine 0 N--CA 1.478 1.451 0 CA-C-N 114.363 -1.29 . . . . 0.0 111.282 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' A' ' 59' ' ' TRP . 40.0 t -31.76 -48.43 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.523 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -46.32 -59.79 2.72 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 124.169 1.937 . . . . 0.0 110.648 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -48.18 -11.77 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 109.305 -3.588 . . . . 0.0 109.276 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.523 ' H ' ' C ' ' A' ' 64' ' ' ALA . 85.2 mtp -97.53 156.12 16.65 Favored 'General case' 0 N--CA 1.513 2.691 0 C-N-CA 118.753 -1.179 . . . . 0.0 108.123 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 70' ' ' GLN . 73.1 p -120.11 147.66 44.58 Favored 'General case' 0 N--CA 1.51 2.544 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 59.1 t -36.8 96.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 CA-C-N 113.131 -1.849 . . . . 0.0 114.139 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.05 13.75 16.99 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 108.539 -1.824 . . . . 0.0 108.539 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 67' ' ' SER . 44.6 tt0 -109.68 138.17 46.43 Favored 'General case' 0 N--CA 1.503 2.225 0 CA-C-O 121.602 0.715 . . . . 0.0 109.795 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -126.83 138.99 53.42 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -144.43 178.01 8.24 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-N 112.006 -2.361 . . . . 0.0 114.6 -179.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.5 ttmp? -124.55 104.22 8.59 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 111.406 -2.634 . . . . 0.0 104.021 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.3 mp -100.42 146.0 27.54 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 119.676 -0.81 . . . . 0.0 108.878 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 90.2 m -121.72 104.47 9.62 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.4 HD13 ' H ' ' A' ' 76' ' ' ILE . 2.7 mp -95.41 141.71 14.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.206 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.3 p -112.97 153.59 45.2 Favored Pre-proline 0 N--CA 1.503 2.204 0 CA-C-N 114.631 -1.168 . . . . 0.0 108.011 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -40.25 -47.13 4.2 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.01 1.807 . . . . 0.0 112.964 -172.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.526 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 4.0 p-10 -43.88 -35.3 1.92 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -103.78 23.93 12.02 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -169.74 -88.87 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 117.36 2.356 . . . . 0.0 117.36 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 5.4 m-30 -108.0 104.41 13.86 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 113.769 -1.56 . . . . 0.0 110.665 -179.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -111.32 -64.84 0.51 Allowed Glycine 0 N--CA 1.501 3.009 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -125.43 46.31 2.4 Favored 'General case' 0 N--CA 1.503 2.215 0 CA-C-O 121.486 0.66 . . . . 0.0 110.821 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.445 ' O ' ' O ' ' A' ' 86' ' ' GLY . 97.5 m -127.54 -66.97 0.85 Allowed 'General case' 0 N--CA 1.501 2.119 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.566 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 85' ' ' THR . . . 35.98 176.98 0.01 OUTLIER Glycine 0 N--CA 1.498 2.819 0 N-CA-C 116.934 1.533 . . . . 0.0 116.934 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -129.42 157.85 75.05 Favored Pre-proline 0 N--CA 1.505 2.314 0 CA-C-N 114.529 -0.836 . . . . 0.0 109.786 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -82.43 66.66 8.15 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 C-N-CA 122.936 2.424 . . . . 0.0 116.571 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 121.41 27.97 1.71 Allowed Glycine 0 N--CA 1.509 3.55 0 C-N-CA 121.251 -0.499 . . . . 0.0 114.22 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 28.4 mt -139.63 -58.81 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 N-CA-C 103.853 -2.647 . . . . 0.0 103.853 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 14.6 mt -126.54 91.47 47.41 Favored Pre-proline 0 N--CA 1.492 1.643 0 CA-C-N 109.189 -3.641 . . . . 0.0 107.931 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -61.93 156.93 46.14 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.031 1.821 . . . . 0.0 107.769 167.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -53.5 175.43 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.602 2.201 . . . . 0.0 113.192 -175.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 9.58 64.22 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 116.301 1.963 . . . . 0.0 116.301 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -120.59 155.44 33.71 Favored 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 93.0 m -91.16 142.7 27.45 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 22.2 mt -113.35 157.91 21.25 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 53.4 t -135.28 98.39 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -93.36 155.42 17.4 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -122.66 89.99 3.21 Favored 'General case' 0 N--CA 1.491 1.606 1 N-CA-C 95.466 -5.753 . . . . 0.0 95.466 179.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 12.5 t -100.7 148.32 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 C-N-CA 118.817 -1.153 . . . . 0.0 113.793 -178.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -124.94 109.12 12.61 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 112.429 -2.169 . . . . 0.0 107.49 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 55.5 tp -79.68 116.73 20.04 Favored 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 102.396 -3.187 . . . . 0.0 102.396 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.479 ' O ' ' NZ ' ' A' ' 105' ' ' LYS . 15.4 mt -88.13 -54.57 4.15 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -178.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.479 ' NZ ' ' O ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -164.58 177.82 7.81 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.326 -179.722 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 28.6 mt -118.07 153.58 33.5 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 . . . . . 0 N--CA 1.503 2.206 0 CA-C-O 115.733 -2.08 . . . . 0.0 108.63 179.849 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 110.079 -1.209 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.466 ' C ' ' NE2' ' A' ' 3' ' ' GLN . 9.2 p -117.0 150.16 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.478 ' CD ' ' N ' ' A' ' 3' ' ' GLN . 16.0 mp0 -121.59 148.11 44.95 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 59.6 t -124.66 109.36 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.026 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -109.98 97.03 6.62 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 88.6 m -69.91 156.72 38.67 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 118.961 -1.095 . . . . 0.0 112.643 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -121.84 -54.77 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-N 113.569 -1.65 . . . . 0.0 107.213 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.422 ' O ' ' O ' ' A' ' 9' ' ' PRO . 37.0 t -124.1 82.66 56.46 Favored Pre-proline 0 N--CA 1.506 2.345 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.821 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 8' ' ' SER . 2.0 Cg_exo -35.84 161.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.336 2.024 . . . . 0.0 112.574 178.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.52 -171.25 14.74 Favored Glycine 0 N--CA 1.502 3.036 0 N-CA-C 107.426 -2.269 . . . . 0.0 107.426 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 68' ' ' VAL . 0.7 OUTLIER -39.92 -65.18 0.42 Allowed 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.589 0.709 . . . . 0.0 112.351 -179.969 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.95 16.16 16.14 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 105.809 -2.916 . . . . 0.0 105.809 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.0 mtp85 -125.47 -44.18 1.86 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 114.028 -1.086 . . . . 0.0 111.963 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.0 m -103.96 133.23 49.27 Favored 'General case' 0 N--CA 1.504 2.247 0 CA-C-O 121.522 0.677 . . . . 0.0 112.085 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.43 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 41.9 m-85 -130.97 175.21 3.86 Favored Pre-proline 0 N--CA 1.501 2.085 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -71.44 150.66 58.4 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 N-CA-C 109.485 -1.006 . . . . 0.0 109.485 164.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -120.24 172.39 7.82 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-O 121.929 0.871 . . . . 0.0 110.84 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 19.6 ttp180 -81.23 96.67 7.33 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.382 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.16 -1.24 5.77 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 108.597 -1.801 . . . . 0.0 108.597 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.5 ' O ' ' SD ' ' A' ' 49' ' ' MET . 82.0 mt-30 -114.63 172.56 6.95 Favored 'General case' 0 N--CA 1.503 2.209 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.2 m -108.67 153.08 23.93 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.3 m -111.27 141.5 44.72 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 104.972 -2.233 . . . . 0.0 104.972 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.6 t -118.8 109.16 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 100.689 -3.819 . . . . 0.0 100.689 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.4 m -124.36 155.46 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 125.751 1.907 . . . . 0.0 113.058 -179.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 -130.76 107.3 9.05 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 104.197 -2.52 . . . . 0.0 104.197 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.419 ' CD2' ' CD2' ' A' ' 99' ' ' PHE . 27.2 p90 -132.59 177.29 7.73 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 95.9 m -137.49 116.41 12.36 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 111.444 -2.616 . . . . 0.0 104.959 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -111.5 114.5 3.65 Favored Glycine 0 N--CA 1.501 2.992 0 N-CA-C 107.642 -2.183 . . . . 0.0 107.642 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 38.9 ttm -123.36 174.38 7.37 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 32.6 mt -120.51 172.7 7.65 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -33.12 -62.56 0.26 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 124.74 1.275 . . . . 0.0 113.12 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 55.8 p30 -160.57 44.79 0.2 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 114.462 -1.244 . . . . 0.0 108.7 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -114.55 -81.55 1.0 Allowed Glycine 0 N--CA 1.498 2.777 0 C-N-CA 118.987 -1.578 . . . . 0.0 112.193 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.01 -176.32 5.42 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -91.12 94.87 9.79 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 112.935 -1.939 . . . . 0.0 106.181 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.526 ' CE2' ' OD2' ' A' ' 37' ' ' ASP . 6.4 p90 -89.71 -41.04 12.14 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 112.422 -2.172 . . . . 0.0 109.072 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.526 ' OD2' ' CE2' ' A' ' 36' ' ' PHE . 24.3 m-20 -135.08 95.45 3.31 Favored 'General case' 0 N--CA 1.51 2.575 0 CA-C-O 121.419 0.628 . . . . 0.0 112.597 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 52.0 m -119.56 168.6 10.85 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.58 ' O ' ' N ' ' A' ' 41' ' ' ASP . 93.5 p -111.63 72.24 0.77 Allowed 'General case' 0 N--CA 1.505 2.299 0 CA-C-O 119.115 -0.469 . . . . 0.0 110.283 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 12.5 ptm85 -28.66 61.69 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.106 0 O-C-N 126.95 2.656 . . . . 0.0 116.899 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.58 ' N ' ' O ' ' A' ' 39' ' ' SER . 30.7 m-20 -19.58 -74.81 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 111.927 -2.397 . . . . 0.0 113.628 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.6 mtt180 -19.89 -47.41 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.039 0 O-C-N 125.331 1.645 . . . . 0.0 114.117 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.441 ' N ' ' O ' ' A' ' 41' ' ' ASP . 5.6 m120 -110.17 67.31 0.64 Allowed 'General case' 0 N--CA 1.501 2.124 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.767 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.42 ' O ' ' O ' ' A' ' 43' ' ' ASN . 13.0 mmmm 57.86 155.62 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.725 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.574 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -84.44 -158.45 0.09 OUTLIER 'Trans proline' 0 C--N 1.315 -1.193 0 C-N-CA 122.863 2.376 . . . . 0.0 112.54 175.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -96.61 145.81 25.4 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 114.43 -1.259 . . . . 0.0 112.774 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 31.9 mtmm -142.51 122.89 13.94 Favored 'General case' 0 N--CA 1.504 2.247 0 CA-C-O 118.782 -0.628 . . . . 0.0 110.667 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -133.17 167.07 21.02 Favored 'General case' 0 N--CA 1.513 2.678 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.5 ' SD ' ' O ' ' A' ' 20' ' ' GLN . 47.3 tpp -107.37 129.39 54.92 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 113.492 -1.685 . . . . 0.0 111.824 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.7 tp -90.66 146.39 24.07 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.157 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 129.51 -42.28 1.44 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 107.317 -2.313 . . . . 0.0 107.317 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 54' ' ' GLU . 6.2 tmtt? -120.39 43.57 2.69 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 3.63 58.65 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.094 0 O-C-N 125.64 1.838 . . . . 0.0 114.807 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.534 ' N ' ' O ' ' A' ' 52' ' ' LYS . 11.3 pt-20 -64.01 -6.29 6.01 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 118.759 -1.176 . . . . 0.0 110.738 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 56' ' ' ILE . 33.7 m -116.38 158.94 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.425 ' O ' ' O ' ' A' ' 55' ' ' VAL . 17.3 pt -49.31 174.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 C-N-CA 117.83 -1.548 . . . . 0.0 110.118 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.541 ' O ' ' N ' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -70.55 -60.53 2.21 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 57' ' ' ARG . . . -20.52 -44.17 0.01 OUTLIER Glycine 0 N--CA 1.502 3.046 0 O-C-N 125.407 1.692 . . . . 0.0 112.495 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.541 ' N ' ' O ' ' A' ' 57' ' ' ARG . 1.5 m95 -73.99 -75.78 0.15 Allowed 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 111.668 -2.266 . . . . 0.0 108.813 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 59' ' ' TRP . 4.1 tm-20 -22.54 -55.66 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 126.303 2.252 . . . . 0.0 110.898 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -78.72 -53.07 7.52 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 113.219 -1.81 . . . . 0.0 106.592 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -51.35 -73.24 0.4 Allowed Glycine 0 N--CA 1.482 1.709 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.526 ' N ' ' O ' ' A' ' 59' ' ' TRP . 24.9 t -44.14 -49.76 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 119.258 -0.977 . . . . 0.0 111.503 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.518 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -45.22 -61.88 1.48 Allowed 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 123.864 1.793 . . . . 0.0 111.181 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -46.63 -13.63 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 109.913 -3.312 . . . . 0.0 109.244 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.518 ' H ' ' C ' ' A' ' 64' ' ' ALA . 41.9 mtm -103.32 154.8 18.99 Favored 'General case' 0 N--CA 1.513 2.717 0 C-N-CA 118.847 -1.141 . . . . 0.0 109.098 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 82.7 p -116.41 153.59 31.79 Favored 'General case' 0 N--CA 1.505 2.286 0 CA-C-O 122.624 1.202 . . . . 0.0 113.428 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.417 ' O ' ' OD1' ' A' ' 11' ' ' ASP . 85.8 t -43.07 95.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 112.416 -2.175 . . . . 0.0 114.388 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.04 16.42 7.88 Favored Glycine 0 N--CA 1.497 2.759 0 N-CA-C 108.816 -1.714 . . . . 0.0 108.816 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -108.38 142.81 38.17 Favored 'General case' 0 N--CA 1.506 2.356 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.741 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 24.2 ttt85 -126.72 141.65 51.78 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -149.46 177.4 9.74 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 116.334 1.976 . . . . 0.0 116.334 -179.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -127.81 104.5 7.86 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 103.326 -2.842 . . . . 0.0 103.326 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.2 mp -101.8 146.65 27.5 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 119.606 -0.838 . . . . 0.0 109.194 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 73.2 m -117.05 104.0 10.81 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 102.309 -3.219 . . . . 0.0 102.309 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 21.4 mt -102.86 138.73 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.14 163.7 20.62 Favored Pre-proline 0 N--CA 1.503 2.219 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.865 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -37.74 -50.94 1.87 Allowed 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 122.561 2.174 . . . . 0.0 113.184 -175.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 80' ' ' TYR . 1.7 p30 -44.24 -42.72 6.76 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 120.191 -0.603 . . . . 0.0 111.608 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.476 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 6.8 m-85 -108.0 13.27 26.25 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.674 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.69 -111.48 0.23 Allowed 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -119.5 114.71 22.69 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 84' ' ' ALA . . . -90.55 -172.18 44.12 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 109.104 -1.599 . . . . 0.0 109.104 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.418 ' O ' ' O ' ' A' ' 83' ' ' GLY . . . 33.57 -156.21 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 74.7 m -101.59 56.53 0.83 Allowed 'General case' 0 N--CA 1.501 2.076 0 CA-C-O 120.926 0.393 . . . . 0.0 110.268 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -31.08 -86.27 0.01 OUTLIER Glycine 0 N--CA 1.494 2.533 0 CA-C-N 114.808 -1.087 . . . . 0.0 113.779 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 67.3 t60 -132.44 102.16 14.21 Favored Pre-proline 0 N--CA 1.504 2.26 0 CA-C-O 117.841 -1.076 . . . . 0.0 108.829 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -78.22 51.78 3.83 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 CA-C-N 120.778 1.314 . . . . 0.0 112.823 -173.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -128.91 -47.31 0.17 Allowed Glycine 0 N--CA 1.5 2.964 0 N-CA-C 109.036 -1.626 . . . . 0.0 109.036 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 20.7 mt -108.34 -46.03 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.6 mm -104.92 96.58 11.07 Favored Pre-proline 0 N--CA 1.499 2.006 0 CA-C-N 110.419 -3.082 . . . . 0.0 111.158 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -84.92 154.17 11.35 Favored 'Trans proline' 0 C--N 1.315 -1.209 0 C-N-CA 121.469 1.446 . . . . 0.0 108.614 176.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.401 ' O ' ' C ' ' A' ' 94' ' ' HIS . 26.7 Cg_endo -48.65 169.99 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.483 2.122 . . . . 0.0 112.182 -171.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.401 ' C ' ' O ' ' A' ' 93' ' ' PRO . 17.8 m80 9.56 61.97 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 O-C-N 125.787 1.929 . . . . 0.0 114.616 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -119.9 74.06 1.0 Allowed 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.388 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 99.9 m -29.46 131.46 0.07 Allowed 'General case' 0 N--CA 1.506 2.343 0 O-C-N 124.831 1.332 . . . . 0.0 110.544 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.8 mt -96.72 152.61 18.5 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.5 t -134.78 115.12 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.419 ' CD2' ' CD2' ' A' ' 26' ' ' TYR . 2.0 m-85 -108.15 163.09 13.46 Favored 'General case' 0 N--CA 1.504 2.232 0 CA-C-O 122.968 1.366 . . . . 0.0 109.477 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -128.78 90.03 2.98 Favored 'General case' 0 N--CA 1.492 1.664 1 N-CA-C 98.186 -4.746 . . . . 0.0 98.186 179.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.3 t -102.21 148.31 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.558 0 N-CA-C 116.89 2.181 . . . . 0.0 116.89 -178.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -129.72 99.7 5.23 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 112.922 -1.944 . . . . 0.0 108.626 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 50.4 tp -73.28 119.39 17.45 Favored 'General case' 0 N--CA 1.504 2.253 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.2 mt -85.66 -60.07 2.13 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.643 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.432 ' CG ' ' H ' ' A' ' 106' ' ' LEU . 60.4 tttm -168.72 -175.89 2.57 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.813 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.432 ' H ' ' CG ' ' A' ' 105' ' ' LYS . 20.9 mt -109.03 160.6 15.91 Favored 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 . . . . . 0 N--CA 1.503 2.216 0 CA-C-O 115.827 -2.035 . . . . 0.0 109.4 179.838 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.615 ' N ' ' CE1' ' A' ' 80' ' ' TYR . . . . . . . . 0 N--CA 1.486 2.031 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.5 p -114.96 147.81 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -121.87 154.53 36.96 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.6 t -126.98 114.12 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-N 112.929 -1.941 . . . . 0.0 109.3 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.528 ' OE2' ' NZ ' ' A' ' 73' ' ' LYS . 37.7 tt0 -118.06 101.52 8.31 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 42.0 m -70.04 150.73 46.32 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 118.938 -1.105 . . . . 0.0 113.623 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 77.2 mt -110.99 -55.35 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.9 t -129.65 90.78 42.57 Favored Pre-proline 0 N--CA 1.504 2.232 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.235 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -37.75 165.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 122.189 1.926 . . . . 0.0 112.54 174.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.6 -113.78 2.47 Favored Glycine 0 N--CA 1.5 2.938 0 N-CA-C 106.344 -2.702 . . . . 0.0 106.344 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.531 ' CG ' ' H ' ' A' ' 12' ' ' GLY . 9.8 p-10 -100.61 -62.5 1.23 Allowed 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.531 ' H ' ' CG ' ' A' ' 11' ' ' ASP . . . 104.88 28.05 5.76 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 42.4 mtp-105 -133.61 -39.0 0.9 Allowed 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.4 m -107.53 131.3 54.48 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.425 0.631 . . . . 0.0 112.279 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.461 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 23.1 m-85 -129.73 174.18 4.89 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -71.48 139.15 33.94 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 CA-C-N 119.857 0.985 . . . . 0.0 111.801 166.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -120.07 171.98 8.08 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 122.205 1.003 . . . . 0.0 111.271 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.9 ttt85 -71.28 104.31 3.1 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.189 -1.369 . . . . 0.0 111.588 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.33 8.84 5.77 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -121.97 174.15 7.08 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 57.5 m -119.44 114.56 22.5 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.544 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 58.5 m -69.26 153.28 43.9 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 24.6 t -128.06 102.46 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 103.677 -2.712 . . . . 0.0 103.677 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.9 m -122.48 149.66 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.465 0 N-CA-C 116.662 2.097 . . . . 0.0 116.662 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -128.35 112.19 14.17 Favored 'General case' 0 N--CA 1.51 2.528 0 N-CA-C 103.996 -2.594 . . . . 0.0 103.996 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' A' ' 26' ' ' TYR . 36.1 p90 -133.7 -175.07 3.7 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 90.8 m -140.17 123.25 16.72 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 102.06 -3.311 . . . . 0.0 102.06 179.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -114.41 125.09 6.68 Favored Glycine 0 N--CA 1.507 3.392 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.483 ' SD ' ' O ' ' A' ' 34' ' ' LYS . 1.8 tmm? -144.19 177.81 8.34 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.0 mt -117.11 170.51 8.6 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -26.66 -60.34 0.09 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 125.335 1.647 . . . . 0.0 114.139 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 54.8 p-10 -160.27 46.08 0.23 Allowed 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.035 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -114.68 -85.19 1.28 Allowed Glycine 0 N--CA 1.497 2.71 0 C-N-CA 119.022 -1.561 . . . . 0.0 112.474 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.483 ' O ' ' SD ' ' A' ' 29' ' ' MET . 0.0 OUTLIER -161.03 -175.01 4.66 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 112.697 -1.751 . . . . 0.0 114.252 -179.478 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.41 136.79 32.86 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 113.999 -1.455 . . . . 0.0 109.507 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -115.72 -37.37 3.95 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -139.19 109.61 6.55 Favored 'General case' 0 N--CA 1.505 2.313 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.194 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.2 m -121.2 167.58 12.53 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 26' ' ' TYR . 87.9 p -118.32 28.68 8.21 Favored 'General case' 0 N--CA 1.505 2.298 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.552 ' O ' ' N ' ' A' ' 42' ' ' ARG . 36.1 mtp85 -30.03 -62.88 0.14 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 124.603 1.189 . . . . 0.0 113.347 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -19.01 69.44 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.552 ' N ' ' O ' ' A' ' 40' ' ' ARG . 41.6 mtp180 -25.53 -74.4 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 124.592 1.183 . . . . 0.0 113.669 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -22.44 -73.18 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 113.213 -1.812 . . . . 0.0 115.515 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' A' ' 45' ' ' PRO . 2.1 tpmt? -125.5 114.81 25.28 Favored Pre-proline 0 N--CA 1.496 1.827 0 CA-C-N 114.541 -1.208 . . . . 0.0 112.089 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 44' ' ' LYS . 21.5 Cg_exo -42.12 -155.16 0.0 OUTLIER 'Trans proline' 0 N--CA 1.488 1.173 0 C-N-CA 122.355 2.037 . . . . 0.0 115.849 165.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -110.29 149.84 29.59 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 112.632 -2.076 . . . . 0.0 111.157 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 31.2 mttm -145.08 137.4 25.95 Favored 'General case' 0 N--CA 1.512 2.659 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -136.45 165.72 25.15 Favored 'General case' 0 N--CA 1.516 2.85 0 CA-C-N 119.972 1.26 . . . . 0.0 110.85 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 47.8 ttp -117.15 86.84 2.58 Favored 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 116.867 2.173 . . . . 0.0 116.867 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.4 tp -32.14 125.12 0.29 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 124.215 0.947 . . . . 0.0 112.867 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 129.48 -30.77 3.55 Favored Glycine 0 N--CA 1.499 2.84 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.48 ' O ' ' N ' ' A' ' 54' ' ' GLU . 80.1 tttt -121.03 43.76 2.7 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 52' ' ' LYS . 46.0 tt0 3.19 62.68 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.163 0 O-C-N 126.031 2.082 . . . . 0.0 113.306 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' A' ' 52' ' ' LYS . 43.8 tt0 -72.36 -24.77 61.32 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 113.541 -1.663 . . . . 0.0 106.686 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.4 m -113.8 156.5 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.818 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.7 pt -60.2 172.69 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 118.153 -1.419 . . . . 0.0 110.03 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.559 ' O ' ' N ' ' A' ' 59' ' ' TRP . 24.2 ttt85 -65.56 -59.99 3.39 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 118.214 -0.898 . . . . 0.0 112.624 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -28.13 -34.91 0.01 OUTLIER Glycine 0 N--CA 1.506 3.336 0 CA-C-O 122.916 1.287 . . . . 0.0 111.444 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.559 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.5 OUTLIER -83.01 -79.84 0.18 Allowed 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 112.24 -1.98 . . . . 0.0 107.746 179.829 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -28.48 -49.39 0.07 Allowed 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 113.347 -1.752 . . . . 0.0 110.692 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -77.33 -54.54 6.34 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -52.64 -74.95 0.25 Allowed Glycine 0 N--CA 1.482 1.752 0 N-CA-C 108.553 -1.819 . . . . 0.0 108.553 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.518 ' N ' ' O ' ' A' ' 59' ' ' TRP . 25.9 t -38.32 -45.47 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.612 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.8 -44.2 66.45 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 122.799 1.285 . . . . 0.0 109.445 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.443 ' N ' ' O ' ' A' ' 62' ' ' GLY . 6.7 tt0 -74.6 8.79 2.1 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 111.966 -2.379 . . . . 0.0 111.463 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 94.4 mtp -116.61 149.66 39.34 Favored 'General case' 0 N--CA 1.507 2.389 0 N-CA-C 104.664 -2.347 . . . . 0.0 104.664 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 80.3 p -116.52 153.87 31.4 Favored 'General case' 0 N--CA 1.51 2.571 0 CA-C-O 122.934 1.349 . . . . 0.0 113.899 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 63.0 t -43.03 100.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 112.04 -2.345 . . . . 0.0 116.15 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.26 4.52 28.97 Favored Glycine 0 N--CA 1.5 2.909 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.401 ' OE1' ' C ' ' A' ' 70' ' ' GLN . 0.8 OUTLIER -110.17 145.16 37.72 Favored 'General case' 0 N--CA 1.507 2.42 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.977 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -128.16 145.48 51.01 Favored 'General case' 0 N--CA 1.508 2.435 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.611 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -144.11 -177.72 5.59 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-N 112.776 -2.011 . . . . 0.0 115.538 -179.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.528 ' NZ ' ' OE2' ' A' ' 5' ' ' GLU . 6.6 ttpm? -125.49 106.79 10.04 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 101.767 -3.42 . . . . 0.0 101.767 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.1 mt -101.25 143.54 31.2 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 59.0 m -115.17 117.01 29.31 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 102.021 -3.326 . . . . 0.0 102.021 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 30.0 mt -110.82 142.4 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.422 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 32.7 p -114.31 158.32 40.09 Favored Pre-proline 0 N--CA 1.506 2.341 0 CA-C-N 114.427 -1.26 . . . . 0.0 108.141 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -35.0 -55.31 0.57 Allowed 'Trans proline' 0 C--N 1.315 -1.202 0 C-N-CA 121.871 1.714 . . . . 0.0 113.852 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.524 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 3.9 p-10 -42.15 -41.97 2.84 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.332 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.615 ' CE1' ' N ' ' A' ' 1' ' ' GLY . 7.5 m-85 -108.02 22.13 16.38 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -179.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -121.62 -103.49 0.4 Allowed 'General case' 0 N--CA 1.505 2.298 0 CA-C-N 118.683 0.674 . . . . 0.0 111.067 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.556 ' CE2' ' CD1' ' A' ' 91' ' ' ILE . 96.8 m-85 -118.66 -55.48 2.2 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.18 162.81 14.52 Favored Glycine 0 N--CA 1.505 3.281 0 C-N-CA 121.29 -0.481 . . . . 0.0 113.925 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -17.62 -53.34 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.049 0 O-C-N 125.639 1.435 . . . . 0.0 113.442 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 97.7 m -121.5 91.23 3.47 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -88.27 -102.05 0.94 Allowed Glycine 0 N--CA 1.492 2.414 0 C-N-CA 118.998 -1.573 . . . . 0.0 111.741 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -128.21 74.06 79.54 Favored Pre-proline 0 N--CA 1.503 2.185 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.177 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -30.2 100.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 123.347 2.698 . . . . 0.0 112.862 -178.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.44 -25.11 3.65 Favored Glycine 0 N--CA 1.498 2.809 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.9 mt -110.19 -66.04 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.556 ' CD1' ' CE2' ' A' ' 82' ' ' TYR . 2.4 mp -112.29 91.4 16.23 Favored Pre-proline 0 N--CA 1.502 2.159 0 CA-C-N 114.075 -1.421 . . . . 0.0 108.8 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_exo -39.39 153.62 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 122.635 2.224 . . . . 0.0 109.812 166.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -51.37 169.01 0.23 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.071 1.847 . . . . 0.0 113.447 -172.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 7.9 p80 9.4 65.12 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -118.29 149.76 40.6 Favored 'General case' 0 N--CA 1.505 2.32 0 CA-C-O 121.366 0.603 . . . . 0.0 110.901 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 29.5 m -91.28 144.57 25.46 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.2 mt -115.13 155.75 26.52 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 59.0 t -139.43 97.72 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -92.07 167.04 12.36 Favored 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 117.586 -1.646 . . . . 0.0 108.992 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -130.04 86.87 2.45 Favored 'General case' 0 N--CA 1.493 1.678 1 N-CA-C 97.387 -5.042 . . . . 0.0 97.387 178.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.7 t -100.8 149.82 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 -178.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -125.81 101.58 6.91 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 112.04 -2.345 . . . . 0.0 107.406 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 50.4 tp -74.83 113.8 12.53 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 103.35 -2.833 . . . . 0.0 103.35 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 9.3 mt -76.71 -55.19 5.72 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 113.315 -1.766 . . . . 0.0 111.479 -179.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -176.24 -168.18 0.25 Allowed 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 118.622 -1.231 . . . . 0.0 110.423 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.4 mt -115.21 150.25 36.42 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 . . . . . 0 N--CA 1.502 2.132 0 CA-C-O 115.79 -2.052 . . . . 0.0 109.24 179.892 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.1 p . . . . . 0 N--CA 1.503 2.19 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -124.07 154.96 39.18 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.4 t -124.86 112.76 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -114.31 90.97 3.47 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 97.9 m -69.78 154.84 41.43 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 119.008 -1.077 . . . . 0.0 112.425 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 58.9 mt -123.58 -52.01 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 CA-C-N 113.859 -1.519 . . . . 0.0 107.407 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 9' ' ' PRO . 38.9 t -122.03 80.66 42.99 Favored Pre-proline 0 N--CA 1.505 2.324 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.041 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 8' ' ' SER . 6.4 Cg_exo -36.96 166.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.812 2.341 . . . . 0.0 113.718 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -115.81 -172.68 16.99 Favored Glycine 0 N--CA 1.5 2.921 0 N-CA-C 105.75 -2.94 . . . . 0.0 105.75 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.462 ' CG ' ' H ' ' A' ' 12' ' ' GLY . 11.7 p-10 -44.73 -58.35 3.13 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 118.405 1.102 . . . . 0.0 111.173 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.462 ' H ' ' CG ' ' A' ' 11' ' ' ASP . . . 107.65 24.26 6.49 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 107.636 -2.186 . . . . 0.0 107.636 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 -128.83 -37.56 1.73 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 114.532 -0.834 . . . . 0.0 111.249 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.4 m -111.07 138.34 47.61 Favored 'General case' 0 N--CA 1.507 2.416 0 CA-C-O 121.833 0.825 . . . . 0.0 112.834 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.458 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 48.5 m-85 -133.07 173.78 5.48 Favored Pre-proline 0 N--CA 1.495 1.786 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -61.53 134.57 52.01 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 N-CA-C 110.09 -0.773 . . . . 0.0 110.09 164.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.412 ' NZ ' ' HB3' ' A' ' 17' ' ' LYS . 8.2 mtpm? -115.3 170.21 8.56 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.943 0.877 . . . . 0.0 110.484 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.9 mtm180 -73.64 97.01 2.56 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.198 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 122.84 18.98 3.1 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -115.82 170.1 8.72 Favored 'General case' 0 N--CA 1.504 2.245 0 CA-C-O 121.83 0.824 . . . . 0.0 110.116 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 95.4 m -125.1 110.33 14.01 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 114.481 -1.236 . . . . 0.0 107.915 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 27.5 m -69.76 149.29 48.13 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.16 -1.016 . . . . 0.0 110.074 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 93.3 t -125.17 97.8 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 101.14 -3.652 . . . . 0.0 101.14 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.413 HG21 ' CH2' ' A' ' 59' ' ' TRP . 2.8 m -121.13 151.26 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 48.3 t60 -130.24 116.55 18.54 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 104.675 -2.342 . . . . 0.0 104.675 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -134.01 179.33 6.31 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 123.044 1.402 . . . . 0.0 111.966 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.438 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 51.2 m -141.91 126.11 17.46 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 101.016 -3.698 . . . . 0.0 101.016 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -103.09 129.95 10.07 Favored Glycine 0 N--CA 1.5 2.93 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 39.5 ttm . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 179.954 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 66.4 t80 . . . . . 0 N--CA 1.495 1.819 0 N-CA-C 110.551 -0.166 . . . . 0.0 110.551 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -137.0 122.02 18.98 Favored 'General case' 0 N--CA 1.507 2.415 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.542 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -138.98 177.09 8.14 Favored 'General case' 0 N--CA 1.509 2.495 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.765 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 43.1 ttp -121.29 156.94 31.46 Favored 'General case' 0 N--CA 1.503 2.207 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.966 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.9 tp -90.95 120.32 31.86 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.15 12.71 30.8 Favored Glycine 0 N--CA 1.501 2.969 0 C-N-CA 121.059 -0.591 . . . . 0.0 114.04 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.475 ' O ' ' N ' ' A' ' 54' ' ' GLU . 59.3 tttp -128.24 45.81 2.7 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 118.349 1.074 . . . . 0.0 108.945 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' A' ' 52' ' ' LYS . 20.5 pt20 4.16 61.18 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 115.991 1.849 . . . . 0.0 115.991 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.475 ' N ' ' O ' ' A' ' 52' ' ' LYS . 6.8 mm-40 -102.98 -29.98 11.07 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 56' ' ' ILE . 13.0 m -114.87 155.76 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.426 ' O ' ' O ' ' A' ' 55' ' ' VAL . 17.0 pt -51.74 -179.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 C-N-CA 119.065 -1.054 . . . . 0.0 109.001 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.536 ' O ' ' N ' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -80.45 -58.59 3.05 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.44 ' H ' ' HB3' ' A' ' 80' ' ' TYR . . . -28.3 -35.93 0.01 OUTLIER Glycine 0 N--CA 1.501 3.025 0 O-C-N 124.531 1.145 . . . . 0.0 111.53 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.536 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.9 OUTLIER -78.78 -75.72 0.22 Allowed 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 113.236 -1.482 . . . . 0.0 107.237 179.822 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 59' ' ' TRP . 71.1 tt0 -25.87 -55.01 0.06 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 125.839 1.962 . . . . 0.0 110.828 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.405 ' N ' HH11 ' A' ' 57' ' ' ARG . 37.8 tt0 -75.27 -54.7 6.66 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -51.04 -75.09 0.23 Allowed Glycine 0 N--CA 1.482 1.753 0 C-N-CA 119.564 -1.303 . . . . 0.0 111.168 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' A' ' 59' ' ' TRP . 28.9 t -41.58 -49.91 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 119.594 -0.842 . . . . 0.0 112.292 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.467 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -45.9 -60.59 2.16 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 124.056 1.884 . . . . 0.0 111.157 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -48.68 -11.28 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 109.416 -3.538 . . . . 0.0 109.195 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.467 ' H ' ' C ' ' A' ' 64' ' ' ALA . 49.8 mtm -99.82 160.64 14.15 Favored 'General case' 0 N--CA 1.517 2.887 0 C-N-CA 118.518 -1.273 . . . . 0.0 108.823 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 96.7 p -115.32 150.63 35.97 Favored 'General case' 0 N--CA 1.51 2.539 0 CA-C-O 122.584 1.183 . . . . 0.0 113.919 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 63.8 t -49.21 99.63 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 112.641 -2.072 . . . . 0.0 113.681 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 113.95 9.27 16.38 Favored Glycine 0 N--CA 1.499 2.834 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -107.8 154.14 21.96 Favored 'General case' 0 N--CA 1.506 2.33 0 CA-C-O 122.428 1.109 . . . . 0.0 111.164 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.0 ttp180 -131.46 140.12 49.52 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 112.83 -1.986 . . . . 0.0 107.224 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -148.44 177.58 9.33 Favored 'General case' 0 N--CA 1.502 2.158 0 CA-C-N 112.947 -1.933 . . . . 0.0 115.496 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -126.47 105.28 8.65 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 111.295 -2.684 . . . . 0.0 103.936 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.4 mt -99.77 152.57 19.96 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 93.7 m -124.57 119.81 30.15 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 25.7 mt -112.13 140.28 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.1 p -111.13 155.53 42.44 Favored Pre-proline 0 N--CA 1.506 2.343 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.185 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -37.85 -51.59 1.84 Allowed 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 122.189 1.926 . . . . 0.0 114.695 -175.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 18.0 p-10 -39.28 -41.28 0.87 Allowed 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.44 ' HB3' ' H ' ' A' ' 58' ' ' GLY . 3.1 m-85 . . . . . 0 N--CA 1.493 1.694 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.312 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 62.3 m . . . . . 0 N--CA 1.5 2.067 0 CA-C-O 118.794 -0.622 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 24.2 mt -111.1 151.76 27.73 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.4 t -134.12 125.29 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -120.29 139.81 52.18 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.178 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 27' ' ' THR . 5.1 p-10 -117.57 98.84 6.6 Favored 'General case' 0 N--CA 1.501 2.076 1 N-CA-C 97.338 -5.06 . . . . 0.0 97.338 178.902 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.409 HG12 ' N ' ' A' ' 102' ' ' GLU . 16.5 t -108.51 153.62 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.355 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 -178.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.409 ' N ' HG12 ' A' ' 101' ' ' VAL . 41.3 tt0 -127.99 104.37 7.75 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 112.119 -2.309 . . . . 0.0 107.609 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 37.8 tp -75.49 121.45 22.37 Favored 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 102.556 -3.127 . . . . 0.0 102.556 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.3 mt -93.16 -57.86 2.49 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -157.96 173.81 16.2 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.605 0.717 . . . . 0.0 112.074 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 35.4 mt -117.59 143.19 46.36 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 . . . . . 0 N--CA 1.503 2.215 0 CA-C-O 116.286 -1.816 . . . . 0.0 110.007 179.885 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.9 p . . . . . 0 N--CA 1.502 2.153 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -122.92 156.39 34.77 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.4 t -125.44 114.84 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 108.039 -1.096 . . . . 0.0 108.039 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -115.22 90.02 3.24 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 90.5 m -69.83 155.67 40.2 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.048 -1.061 . . . . 0.0 112.488 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 59.0 mt -123.66 -51.59 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 CA-C-N 113.645 -1.616 . . . . 0.0 107.258 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.418 ' O ' ' O ' ' A' ' 9' ' ' PRO . 46.5 t -122.22 80.13 44.32 Favored Pre-proline 0 N--CA 1.506 2.328 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.283 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 8' ' ' SER . 6.4 Cg_exo -37.42 164.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.348 2.032 . . . . 0.0 112.808 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -123.51 -168.95 13.12 Favored Glycine 0 N--CA 1.498 2.826 0 N-CA-C 105.632 -2.987 . . . . 0.0 105.632 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 11' ' ' ASP . 12.3 p-10 -39.5 -62.93 0.62 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.747 -0.781 . . . . 0.0 112.575 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.58 15.25 21.44 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 105.838 -2.905 . . . . 0.0 105.838 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 30.4 mtm-85 -125.95 -39.4 2.11 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 113.307 -1.447 . . . . 0.0 112.774 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.1 m -108.2 137.14 46.68 Favored 'General case' 0 N--CA 1.507 2.395 0 CA-C-O 121.775 0.798 . . . . 0.0 112.763 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.445 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 57.0 m-85 -130.56 177.43 2.22 Favored Pre-proline 0 N--CA 1.496 1.859 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -69.57 146.77 62.37 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 N-CA-C 109.765 -0.898 . . . . 0.0 109.765 162.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -122.37 168.44 12.07 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 122.086 0.946 . . . . 0.0 110.248 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 19.1 ptt85 -72.61 126.58 30.22 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.648 -1.16 . . . . 0.0 108.677 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 111.38 -19.71 24.06 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.5 ' O ' ' SD ' ' A' ' 49' ' ' MET . 83.8 mt-30 -109.76 176.4 5.08 Favored 'General case' 0 N--CA 1.506 2.341 0 CA-C-O 121.766 0.793 . . . . 0.0 112.274 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 27.7 m -110.07 161.47 15.5 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 57.2 m -111.7 146.56 37.3 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 103.889 -2.634 . . . . 0.0 103.889 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 33.4 t -123.07 101.95 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 101.644 -3.465 . . . . 0.0 101.644 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 m -123.01 150.46 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 125.004 1.44 . . . . 0.0 114.324 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.403 ' ND1' ' C ' ' A' ' 25' ' ' HIS . 2.7 t-80 -130.61 113.77 14.62 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 103.598 -2.742 . . . . 0.0 103.598 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -131.21 176.63 8.11 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 123.184 1.468 . . . . 0.0 113.576 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 96.0 m -139.42 121.85 16.11 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 101.921 -3.363 . . . . 0.0 101.921 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -96.93 151.61 19.88 Favored Glycine 0 N--CA 1.498 2.824 0 C-N-CA 119.127 -1.511 . . . . 0.0 109.457 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 36.6 ttp . . . . . 0 N--CA 1.487 1.4 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 179.868 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 52.9 t80 . . . . . 0 N--CA 1.494 1.749 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.41 ' NZ ' ' CB ' ' A' ' 47' ' ' LYS . 9.1 mtmp? -143.08 125.29 15.45 Favored 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 118.745 -0.645 . . . . 0.0 111.695 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -137.53 171.94 13.71 Favored 'General case' 0 N--CA 1.515 2.795 0 CA-C-N 119.812 1.187 . . . . 0.0 114.158 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.5 ' SD ' ' O ' ' A' ' 20' ' ' GLN . 45.6 tpp -109.11 140.74 42.27 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 114.954 1.464 . . . . 0.0 114.954 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.8 tp -91.01 122.38 33.62 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 114.249 -1.341 . . . . 0.0 110.196 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.03 18.67 13.12 Favored Glycine 0 N--CA 1.5 2.9 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -122.57 -20.57 5.96 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-N 114.732 -0.734 . . . . 0.0 109.313 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.459 ' OE1' ' NH1' ' A' ' 57' ' ' ARG . 2.5 mm-40 54.48 67.84 0.95 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -109.76 -35.3 6.22 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.3 m -106.15 156.47 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.4 pt -50.98 174.96 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 118.368 -1.333 . . . . 0.0 110.548 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.531 ' O ' ' N ' ' A' ' 59' ' ' TRP . 4.2 tpp180 -68.71 -64.93 0.77 Allowed 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.061 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -28.95 -35.03 0.01 OUTLIER Glycine 0 N--CA 1.498 2.817 0 O-C-N 124.722 1.264 . . . . 0.0 112.308 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.531 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.5 OUTLIER -76.68 -70.57 0.45 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 179.858 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -33.49 -55.81 0.43 Allowed 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 113.723 -1.58 . . . . 0.0 109.992 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -70.16 -53.8 15.65 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 113.431 -1.713 . . . . 0.0 107.353 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -56.24 -75.81 0.23 Allowed Glycine 0 N--CA 1.48 1.574 0 C-N-CA 119.558 -1.306 . . . . 0.0 111.544 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 59' ' ' TRP . 41.2 t -38.37 -48.98 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 C-N-CA 120.332 -0.547 . . . . 0.0 112.243 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.467 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -46.86 -59.93 2.75 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 124.198 1.951 . . . . 0.0 110.584 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -51.27 -9.18 0.06 Allowed 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 109.37 -3.559 . . . . 0.0 109.719 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.467 ' H ' ' C ' ' A' ' 64' ' ' ALA . 90.3 mtp -98.23 154.94 17.43 Favored 'General case' 0 N--CA 1.512 2.646 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 84.8 p -116.39 151.13 36.59 Favored 'General case' 0 N--CA 1.507 2.424 0 CA-C-O 122.691 1.234 . . . . 0.0 113.75 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 95.5 t -44.93 98.14 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-N 112.499 -2.137 . . . . 0.0 114.385 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.02 11.9 15.23 Favored Glycine 0 N--CA 1.498 2.796 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -109.99 151.73 26.77 Favored 'General case' 0 N--CA 1.508 2.441 0 CA-C-O 122.215 1.007 . . . . 0.0 111.012 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -132.21 141.98 49.26 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 113.459 -1.7 . . . . 0.0 107.815 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -149.53 179.68 7.78 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 112.979 -1.918 . . . . 0.0 116.143 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -127.1 105.8 8.83 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 102.678 -3.082 . . . . 0.0 102.678 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.9 mt -101.66 153.86 19.39 Favored 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 121.315 0.579 . . . . 0.0 109.587 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 87.3 m -125.46 126.5 45.03 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 31.8 mt -115.64 141.4 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.5 p -110.31 152.32 43.17 Favored Pre-proline 0 N--CA 1.498 1.948 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -40.78 -54.9 2.21 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 121.738 1.625 . . . . 0.0 112.513 -172.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 18.8 p30 -37.35 -35.96 0.13 Allowed 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.39 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 . . . . . 0 N--CA 1.494 1.726 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.185 -179.692 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 27.2 m . . . . . 0 N--CA 1.498 1.964 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 34.2 mt -118.33 156.56 28.7 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 58.9 t -137.15 130.11 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -123.29 155.91 36.31 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 122.058 0.932 . . . . 0.0 111.208 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -126.81 90.0 3.09 Favored 'General case' 0 N--CA 1.493 1.704 1 N-CA-C 98.977 -4.453 . . . . 0.0 98.977 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 13.1 t -104.55 150.84 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.594 0 N-CA-C 116.73 2.122 . . . . 0.0 116.73 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -128.39 98.08 4.94 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 112.595 -2.093 . . . . 0.0 106.838 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 49.1 tp -73.01 117.2 14.45 Favored 'General case' 0 N--CA 1.503 2.192 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.5 mt -83.92 -57.55 3.15 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 114.296 -1.32 . . . . 0.0 113.784 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.438 ' HG2' ' H ' ' A' ' 106' ' ' LEU . 16.2 ttpp -168.91 -171.41 1.34 Allowed 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.271 -0.972 . . . . 0.0 108.733 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.438 ' H ' ' HG2' ' A' ' 105' ' ' LYS . 22.9 mt -116.6 157.5 25.22 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 . . . . . 0 N--CA 1.506 2.328 0 CA-C-O 116.176 -1.869 . . . . 0.0 110.172 179.912 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 N--CA 1.502 2.139 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -120.86 155.38 34.25 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 43.4 t -126.08 122.44 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.478 ' CD ' ' N ' ' A' ' 5' ' ' GLU . 8.9 mp0 -120.4 93.48 4.06 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 96.4 m -69.71 156.36 39.1 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 118.675 -1.21 . . . . 0.0 112.079 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 70.3 mt -121.95 -55.13 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-N 113.882 -1.508 . . . . 0.0 107.484 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.43 ' O ' ' O ' ' A' ' 9' ' ' PRO . 33.1 t -123.74 82.78 54.49 Favored Pre-proline 0 N--CA 1.506 2.329 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.382 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.43 ' O ' ' O ' ' A' ' 8' ' ' SER . 3.9 Cg_exo -35.84 164.39 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.689 2.26 . . . . 0.0 113.606 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -113.78 -176.43 19.22 Favored Glycine 0 N--CA 1.499 2.894 0 N-CA-C 105.797 -2.921 . . . . 0.0 105.797 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.475 ' CG ' ' H ' ' A' ' 12' ' ' GLY . 11.2 p-10 -43.85 -59.03 2.44 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 118.352 1.076 . . . . 0.0 111.586 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.475 ' H ' ' CG ' ' A' ' 11' ' ' ASP . . . 109.18 25.81 5.43 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 107.737 -2.145 . . . . 0.0 107.737 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.5 mmm180 -132.42 -36.68 1.1 Allowed 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 114.671 -0.764 . . . . 0.0 111.415 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 45.6 m -111.31 128.84 56.08 Favored 'General case' 0 N--CA 1.507 2.379 0 CA-C-O 121.584 0.707 . . . . 0.0 112.687 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.413 ' N ' ' CD1' ' A' ' 15' ' ' PHE . 37.6 m-85 -129.95 171.6 8.63 Favored Pre-proline 0 N--CA 1.497 1.92 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_exo -53.24 145.75 42.73 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 CA-C-N 119.588 0.888 . . . . 0.0 112.244 166.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -122.83 168.39 12.33 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 122.458 1.123 . . . . 0.0 111.175 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 42.9 mtp-105 -81.18 93.72 6.53 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 113.639 -1.619 . . . . 0.0 111.687 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.76 3.49 5.94 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 108.637 -1.785 . . . . 0.0 108.637 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -117.91 173.97 6.46 Favored 'General case' 0 N--CA 1.505 2.322 0 C-N-CA 120.254 -0.578 . . . . 0.0 109.567 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.7 m -110.0 164.8 12.27 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 31.6 m -117.22 128.38 55.04 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 33.3 t -108.5 111.48 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 101.106 -3.664 . . . . 0.0 101.106 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.402 HG21 ' CH2' ' A' ' 59' ' ' TRP . 5.1 m -125.88 155.06 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 125.007 1.442 . . . . 0.0 114.127 -179.037 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -129.87 107.88 9.72 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 104.512 -2.403 . . . . 0.0 104.512 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -130.48 175.29 9.1 Favored 'General case' 0 N--CA 1.503 2.2 0 CA-C-O 122.923 1.344 . . . . 0.0 114.458 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 93.7 m -138.17 121.8 17.42 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 102.292 -3.225 . . . . 0.0 102.292 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -111.2 138.1 14.74 Favored Glycine 0 N--CA 1.503 3.124 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 21.9 tpp . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 -179.871 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 68.8 t80 . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 120.713 0.292 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -130.36 117.81 20.31 Favored 'General case' 0 N--CA 1.509 2.499 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -136.23 170.77 15.48 Favored 'General case' 0 N--CA 1.51 2.54 0 C-N-CA 119.732 -0.787 . . . . 0.0 112.313 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 40.3 ttm -118.64 154.96 31.82 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.2 tp -91.03 120.88 32.37 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.889 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.42 34.21 5.38 Favored Glycine 0 N--CA 1.499 2.864 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.049 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.484 ' O ' ' CB ' ' A' ' 53' ' ' GLN . 23.0 ttmm -129.93 -51.01 1.13 Allowed 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.484 ' CB ' ' O ' ' A' ' 52' ' ' LYS . 37.3 tt0 100.9 67.74 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.161 0 O-C-N 125.837 1.961 . . . . 0.0 109.592 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -110.24 -35.94 5.95 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.1 m -116.73 159.06 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.854 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.409 ' H ' HG12 ' A' ' 56' ' ' ILE . 13.4 pt -56.51 179.97 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.527 ' O ' ' N ' ' A' ' 59' ' ' TRP . 34.8 ttt180 -74.48 -61.21 1.95 Allowed 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.92 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 57' ' ' ARG . . . -25.61 -39.32 0.01 OUTLIER Glycine 0 N--CA 1.501 2.988 0 O-C-N 124.986 1.428 . . . . 0.0 112.489 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.53 ' O ' ' N ' ' A' ' 63' ' ' VAL . 0.7 OUTLIER -73.26 -73.62 0.2 Allowed 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 179.721 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.484 ' OE1' ' N ' ' A' ' 61' ' ' GLU . 10.4 tm-20 -26.62 -55.7 0.08 Allowed 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 112.934 -1.939 . . . . 0.0 110.707 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.484 ' N ' ' OE1' ' A' ' 60' ' ' GLU . 50.3 tp10 -73.98 -54.96 6.76 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 112.927 -1.942 . . . . 0.0 106.23 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -52.16 -75.55 0.22 Allowed Glycine 0 N--CA 1.482 1.705 0 C-N-CA 119.617 -1.278 . . . . 0.0 110.961 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.53 ' N ' ' O ' ' A' ' 59' ' ' TRP . 30.8 t -40.92 -49.12 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 119.973 -0.691 . . . . 0.0 112.093 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.458 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -46.9 -59.01 3.37 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 124.012 1.863 . . . . 0.0 110.928 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -52.0 -8.04 0.06 Allowed 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 109.517 -3.492 . . . . 0.0 109.836 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.458 ' H ' ' C ' ' A' ' 64' ' ' ALA . 93.8 mtp -102.09 155.21 18.33 Favored 'General case' 0 N--CA 1.516 2.827 0 C-N-CA 119.036 -1.066 . . . . 0.0 108.242 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 90.4 p -114.94 150.11 36.24 Favored 'General case' 0 N--CA 1.511 2.582 0 CA-C-O 122.605 1.193 . . . . 0.0 113.211 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 87.2 t -43.84 96.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 112.594 -2.094 . . . . 0.0 113.246 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 113.06 11.89 13.12 Favored Glycine 0 N--CA 1.499 2.87 0 N-CA-C 108.735 -1.746 . . . . 0.0 108.735 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -103.66 143.93 32.12 Favored 'General case' 0 N--CA 1.503 2.209 0 C-N-CA 120.189 -0.605 . . . . 0.0 110.159 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 25.3 ttt85 -125.57 140.77 52.47 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -148.73 177.32 9.62 Favored 'General case' 0 N--CA 1.503 2.18 0 CA-C-N 113.046 -1.888 . . . . 0.0 116.048 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.45 ' CE ' ' OD1' ' A' ' 100' ' ' ASP . 4.6 tppp? -127.13 107.14 9.76 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 101.568 -3.493 . . . . 0.0 101.568 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.4 mt -103.58 152.85 21.25 Favored 'General case' 0 N--CA 1.503 2.207 0 C-N-CA 119.822 -0.751 . . . . 0.0 109.365 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 86.3 m -124.54 118.32 26.32 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 31.1 mt -111.76 141.92 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.425 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 41.7 p -107.78 156.68 37.64 Favored Pre-proline 0 N--CA 1.507 2.391 0 O-C-N 124.796 1.31 . . . . 0.0 109.373 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -36.18 -54.24 0.89 Allowed 'Trans proline' 0 C--N 1.316 -1.165 0 C-N-CA 121.986 1.791 . . . . 0.0 113.744 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 80' ' ' TYR . 1.7 p30 -45.36 -41.85 9.41 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.523 ' OH ' ' NH1' ' A' ' 57' ' ' ARG . 2.6 m-85 . . . . . 0 N--CA 1.493 1.695 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.304 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 58.0 m . . . . . 0 N--CA 1.503 2.198 0 CA-C-O 118.13 -0.938 . . . . 0.0 110.566 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 13.9 mt -107.36 157.05 18.26 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 120.514 1.506 . . . . 0.0 107.042 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.3 t -139.75 115.69 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -110.28 159.45 17.4 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 122.417 1.103 . . . . 0.0 110.241 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.45 ' OD1' ' CE ' ' A' ' 73' ' ' LYS . 54.9 m-20 -127.66 89.11 2.89 Favored 'General case' 0 N--CA 1.493 1.7 1 N-CA-C 98.575 -4.602 . . . . 0.0 98.575 179.314 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 12.2 t -103.1 148.83 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.699 0 N-CA-C 116.777 2.14 . . . . 0.0 116.777 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -127.92 96.75 4.58 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 112.701 -2.045 . . . . 0.0 107.419 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 51.6 tp -68.7 121.96 17.56 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.6 mt -89.39 -58.07 2.66 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.894 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.409 ' HG2' ' H ' ' A' ' 106' ' ' LEU . 21.3 ttmm -164.36 178.12 7.73 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.734 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.409 ' H ' ' HG2' ' A' ' 105' ' ' LYS . 17.1 mt -115.1 168.97 9.46 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 . . . . . 0 N--CA 1.514 2.757 0 CA-C-O 115.862 -2.018 . . . . 0.0 107.414 179.604 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.4 p . . . . . 0 N--CA 1.501 2.101 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.525 ' N ' ' OE1' ' A' ' 3' ' ' GLN . 3.3 mp0 -115.52 159.24 21.48 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.8 t -124.66 123.11 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.025 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.47 ' CD ' ' N ' ' A' ' 5' ' ' GLU . 9.3 mp0 -125.42 89.96 3.14 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 88.1 m -69.71 155.25 40.8 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.76 -1.176 . . . . 0.0 113.765 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 57.6 mt -122.45 -53.29 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-N 113.352 -1.749 . . . . 0.0 107.84 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.419 ' O ' ' O ' ' A' ' 9' ' ' PRO . 29.3 m -122.84 80.69 49.54 Favored Pre-proline 0 N--CA 1.506 2.366 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.759 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.419 ' O ' ' O ' ' A' ' 8' ' ' SER . 12.6 Cg_exo -38.2 164.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.37 2.047 . . . . 0.0 112.262 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -120.38 -178.76 16.23 Favored Glycine 0 N--CA 1.5 2.945 0 N-CA-C 105.322 -3.111 . . . . 0.0 105.322 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.431 ' CG ' ' H ' ' A' ' 12' ' ' GLY . 13.1 p-10 -45.76 -58.08 3.76 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 118.404 1.102 . . . . 0.0 111.075 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.431 ' H ' ' CG ' ' A' ' 11' ' ' ASP . . . 108.62 6.88 30.48 Favored Glycine 0 N--CA 1.498 2.814 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -110.81 -31.14 7.28 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 114.584 -0.808 . . . . 0.0 111.685 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 96.8 m -112.03 134.13 53.77 Favored 'General case' 0 N--CA 1.504 2.242 0 CA-C-N 118.876 0.762 . . . . 0.0 113.0 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.451 ' N ' ' CD1' ' A' ' 15' ' ' PHE . 57.3 m-85 -131.31 177.24 2.33 Favored Pre-proline 0 N--CA 1.5 2.029 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -72.09 145.29 44.13 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 C-N-CA 120.729 0.953 . . . . 0.0 110.391 161.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -121.58 168.63 11.53 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-O 121.786 0.803 . . . . 0.0 109.236 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.3 130.15 41.8 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.565 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 109.67 -22.69 23.58 Favored Glycine 0 N--CA 1.499 2.838 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.334 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -105.71 178.42 4.57 Favored 'General case' 0 N--CA 1.506 2.371 0 CA-C-O 121.981 0.896 . . . . 0.0 111.747 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.1 m -113.26 161.46 17.17 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 64.5 m -112.48 148.0 35.35 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.9 t -121.91 104.94 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 103.296 -2.853 . . . . 0.0 103.296 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 m -121.69 149.81 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.347 0 N-CA-C 116.217 1.932 . . . . 0.0 116.217 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -128.49 117.5 21.43 Favored 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 104.429 -2.434 . . . . 0.0 104.429 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -134.3 174.09 10.9 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 123.072 1.415 . . . . 0.0 114.801 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 81.3 m -138.92 122.04 16.85 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 102.335 -3.209 . . . . 0.0 102.335 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -112.57 140.45 16.27 Favored Glycine 0 N--CA 1.503 3.165 0 C-N-CA 120.174 -1.012 . . . . 0.0 112.337 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 57.2 mtm . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 179.973 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 71.4 t80 . . . . . 0 N--CA 1.489 1.481 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 72.0 mttt -142.45 133.95 26.53 Favored 'General case' 0 N--CA 1.515 2.801 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -144.46 173.4 11.83 Favored 'General case' 0 N--CA 1.515 2.777 0 CA-C-N 119.265 0.939 . . . . 0.0 112.766 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 44.5 ttm -116.47 148.97 40.25 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.3 tp -90.99 120.26 31.84 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 114.365 -1.288 . . . . 0.0 109.23 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.35 18.56 18.77 Favored Glycine 0 N--CA 1.499 2.875 0 N-CA-C 107.757 -2.137 . . . . 0.0 107.757 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -121.06 -19.98 6.98 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 114.383 -0.908 . . . . 0.0 109.387 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 55.9 69.02 0.78 Allowed 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.396 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -110.03 -35.86 6.02 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.431 ' O ' ' O ' ' A' ' 56' ' ' ILE . 4.2 m -113.99 152.69 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.176 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.431 ' O ' ' O ' ' A' ' 55' ' ' VAL . 13.3 pt -49.46 179.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.857 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.559 ' O ' ' N ' ' A' ' 59' ' ' TRP . 19.5 ttm180 -75.94 -58.96 2.97 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -34.12 -27.2 0.01 OUTLIER Glycine 0 N--CA 1.494 2.538 0 O-C-N 123.944 0.777 . . . . 0.0 111.925 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.559 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -91.33 -73.98 0.52 Allowed 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.874 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -36.98 -50.48 0.88 Allowed 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 114.333 -1.303 . . . . 0.0 110.228 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.417 ' OE1' ' O ' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -71.99 -57.7 4.07 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 104.818 -2.29 . . . . 0.0 104.818 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -50.95 -82.2 0.04 OUTLIER Glycine 0 N--CA 1.48 1.57 0 C-N-CA 119.011 -1.566 . . . . 0.0 109.7 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.533 ' N ' ' O ' ' A' ' 59' ' ' TRP . 62.1 t -29.95 -48.01 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.476 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -44.89 -60.2 2.17 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 124.349 2.023 . . . . 0.0 110.672 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -47.86 -12.06 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 109.027 -3.715 . . . . 0.0 109.548 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.476 ' H ' ' C ' ' A' ' 64' ' ' ALA . 33.4 mmt -89.92 158.51 17.38 Favored 'General case' 0 N--CA 1.508 2.433 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 86.1 p -122.19 136.12 54.86 Favored 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 121.64 0.733 . . . . 0.0 110.077 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.3 t -35.42 97.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-N 114.303 -1.317 . . . . 0.0 113.405 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.73 5.77 13.6 Favored Glycine 0 N--CA 1.5 2.906 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -107.02 149.23 27.78 Favored 'General case' 0 N--CA 1.508 2.457 0 CA-C-O 122.163 0.982 . . . . 0.0 110.291 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.0 ttp180 -133.61 143.4 48.61 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 113.621 -1.627 . . . . 0.0 107.365 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -153.22 179.22 8.93 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 113.312 -1.767 . . . . 0.0 115.066 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -124.75 104.01 8.41 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 103.364 -2.828 . . . . 0.0 103.364 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.2 mt -100.21 145.45 28.04 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.3 m -113.32 123.27 49.72 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 104.628 -2.36 . . . . 0.0 104.628 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 33.9 mt -112.6 131.13 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.491 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 61.6 p -104.71 154.31 38.62 Favored Pre-proline 0 N--CA 1.5 2.068 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -36.53 -54.08 0.99 Allowed 'Trans proline' 0 C--N 1.314 -1.261 0 C-N-CA 122.113 1.875 . . . . 0.0 113.663 -173.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 6.5 p-10 -42.2 -36.16 1.13 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 . . . . . 0 N--CA 1.5 2.065 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -179.66 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 84.5 m . . . . . 0 N--CA 1.5 2.026 0 CA-C-O 118.889 -0.577 . . . . 0.0 111.369 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 21.4 mt -107.57 144.61 34.34 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 49.9 t -132.39 119.65 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -111.85 163.87 13.71 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 122.513 1.149 . . . . 0.0 108.942 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -129.28 89.94 2.93 Favored 'General case' 0 C--N 1.301 -1.523 1 N-CA-C 97.383 -5.043 . . . . 0.0 97.383 179.221 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 12.3 t -103.89 151.17 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.447 0 N-CA-C 114.671 1.359 . . . . 0.0 114.671 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -125.82 103.05 7.59 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 112.007 -2.361 . . . . 0.0 108.122 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 43.6 tp -75.21 118.55 18.26 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 102.66 -3.089 . . . . 0.0 102.66 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.5 mt -85.35 -56.53 3.48 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 113.828 -1.533 . . . . 0.0 112.297 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.409 ' HB2' ' HZ1' ' A' ' 105' ' ' LYS . 0.1 OUTLIER -172.43 -168.34 0.52 Allowed 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.047 -1.061 . . . . 0.0 111.22 -179.865 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 22.2 mt -115.77 156.28 26.3 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 . . . . . 0 N--CA 1.505 2.277 0 CA-C-O 116.233 -1.842 . . . . 0.0 109.844 179.865 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 N--CA 1.503 2.216 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -123.47 153.57 40.31 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 97.0 t -129.51 102.15 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -99.73 161.32 13.69 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 102.854 -3.017 . . . . 0.0 102.854 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 72.8 m -121.31 156.38 32.68 Favored 'General case' 0 N--CA 1.504 2.253 0 CA-C-O 121.987 0.899 . . . . 0.0 112.301 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 74.8 mt -124.72 -54.17 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 9' ' ' PRO . 28.2 t -124.99 83.18 60.48 Favored Pre-proline 0 N--CA 1.508 2.459 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.052 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 8' ' ' SER . 13.5 Cg_exo -37.28 160.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.155 1.903 . . . . 0.0 111.612 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.25 -171.75 14.28 Favored Glycine 0 N--CA 1.503 3.142 0 N-CA-C 107.496 -2.241 . . . . 0.0 107.496 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 12' ' ' GLY . 1.3 p30 -39.61 -51.64 2.24 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.817 -0.753 . . . . 0.0 112.508 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.51 ' N ' ' OD1' ' A' ' 11' ' ' ASP . . . 97.43 2.88 58.77 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 108.126 -1.99 . . . . 0.0 108.126 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 34.6 mtm-85 -119.8 -36.02 3.39 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.8 m -106.99 134.3 50.34 Favored 'General case' 0 N--CA 1.506 2.345 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 33.0 m-85 -130.61 175.14 3.89 Favored Pre-proline 0 N--CA 1.495 1.816 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -66.43 155.13 71.55 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 CA-C-N 119.82 0.971 . . . . 0.0 110.006 165.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -121.7 172.83 7.85 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-O 121.893 0.854 . . . . 0.0 109.635 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.425 HH11 ' CB ' ' A' ' 18' ' ' ARG . 44.3 mtm105 -77.99 96.27 5.02 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.673 -1.148 . . . . 0.0 109.92 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.71 12.55 3.66 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.194 -1.563 . . . . 0.0 109.194 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.494 ' O ' ' SD ' ' A' ' 49' ' ' MET . 15.8 mm100 -113.85 167.88 10.26 Favored 'General case' 0 N--CA 1.504 2.245 0 CA-C-O 121.893 0.854 . . . . 0.0 109.236 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 97.1 m -118.6 114.32 22.6 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 114.226 -1.352 . . . . 0.0 107.551 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 56.9 m -74.67 146.15 42.58 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 118.871 -1.132 . . . . 0.0 108.606 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 94.7 t -117.69 99.67 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 101.311 -3.589 . . . . 0.0 101.311 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.8 m -121.21 148.26 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 N-CA-C 114.946 1.462 . . . . 0.0 114.946 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -122.24 143.73 49.41 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 102.948 -2.982 . . . . 0.0 102.948 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -157.97 175.53 13.72 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 118.895 -1.122 . . . . 0.0 112.931 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 93.7 m -135.12 126.36 28.19 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 101.375 -3.565 . . . . 0.0 101.375 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.86 127.79 8.74 Favored Glycine 0 N--CA 1.502 3.065 0 C-N-CA 120.04 -1.076 . . . . 0.0 111.963 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 68.5 mtp . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.915 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 44.0 t80 . . . . . 0 N--CA 1.495 1.818 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -143.06 122.88 13.42 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.487 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -135.4 171.55 14.28 Favored 'General case' 0 N--CA 1.512 2.627 0 CA-C-N 119.457 1.026 . . . . 0.0 112.466 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.494 ' SD ' ' O ' ' A' ' 20' ' ' GLN . 44.3 tpp -111.53 144.53 40.61 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 114.867 -1.06 . . . . 0.0 112.212 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.4 tp -90.8 121.43 32.66 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.601 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 117.27 -19.0 11.93 Favored Glycine 0 N--CA 1.501 2.967 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.888 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.429 ' O ' ' OE1' ' A' ' 54' ' ' GLU . 41.6 tptt -112.8 36.48 3.45 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.404 ' C ' ' O ' ' A' ' 52' ' ' LYS . 39.1 tt0 10.23 71.23 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 O-C-N 125.345 1.653 . . . . 0.0 113.664 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.429 ' OE1' ' O ' ' A' ' 52' ' ' LYS . 5.0 mm-40 -92.8 -24.06 18.65 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 113.408 -1.724 . . . . 0.0 106.828 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.1 m -115.92 -177.26 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 16.5 pt -90.27 169.94 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.193 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.549 ' O ' ' N ' ' A' ' 59' ' ' TRP . 19.4 ttm-85 -55.11 -63.18 1.24 Allowed 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.334 -0.947 . . . . 0.0 110.702 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -27.13 -35.31 0.01 OUTLIER Glycine 0 N--CA 1.496 2.694 0 O-C-N 124.933 1.396 . . . . 0.0 111.977 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.549 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.9 OUTLIER -86.76 -71.35 0.56 Allowed 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 114.058 -1.071 . . . . 0.0 108.646 179.856 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.422 ' OE1' ' O ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -28.53 -57.73 0.13 Allowed 'General case' 0 N--CA 1.504 2.255 0 O-C-N 125.066 1.478 . . . . 0.0 110.325 -179.867 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -73.25 -52.58 13.5 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -49.31 -79.9 0.07 OUTLIER Glycine 0 N--CA 1.477 1.375 0 C-N-CA 119.419 -1.372 . . . . 0.0 110.96 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.522 ' N ' ' O ' ' A' ' 59' ' ' TRP . 35.6 t -39.45 -47.71 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 120.226 -0.589 . . . . 0.0 112.358 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.476 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -45.3 -60.11 2.31 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 124.146 1.927 . . . . 0.0 111.094 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -48.51 -11.2 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 109.386 -3.552 . . . . 0.0 109.661 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.476 ' H ' ' C ' ' A' ' 64' ' ' ALA . 86.0 mtp -97.94 156.47 16.6 Favored 'General case' 0 N--CA 1.513 2.704 0 C-N-CA 118.854 -1.138 . . . . 0.0 108.606 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 79.8 p -118.64 149.13 41.91 Favored 'General case' 0 N--CA 1.508 2.443 0 CA-C-O 122.539 1.162 . . . . 0.0 112.8 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 99.5 t -43.52 97.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-N 112.801 -1.999 . . . . 0.0 114.716 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.36 12.92 16.14 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -108.03 145.05 34.51 Favored 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.106 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 25.7 ttt85 -123.79 135.1 53.59 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 105.464 -2.051 . . . . 0.0 105.464 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -136.82 172.61 12.75 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 112.026 -2.352 . . . . 0.0 116.142 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -129.58 103.77 7.06 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 111.069 -2.787 . . . . 0.0 103.917 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.421 ' N ' HD12 ' A' ' 74' ' ' LEU . 5.0 mp -100.69 149.47 23.75 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.889 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.6 m -121.09 104.51 9.83 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 21.3 mt -99.81 137.25 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.412 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 29.5 p -115.54 156.34 46.16 Favored Pre-proline 0 N--CA 1.501 2.123 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -35.97 -52.07 1.03 Allowed 'Trans proline' 0 C--N 1.314 -1.266 0 C-N-CA 121.937 1.758 . . . . 0.0 113.971 -175.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.412 ' OD1' ' OG ' ' A' ' 77' ' ' SER . 1.3 p30 -37.62 -38.64 0.28 Allowed 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 121.456 0.646 . . . . 0.0 112.301 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 . . . . . 0 N--CA 1.493 1.683 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.428 -179.812 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 91.2 m . . . . . 0 N--CA 1.5 2.066 0 CA-C-O 119.353 -0.355 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 18.4 mt -89.76 146.97 24.11 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 55.1 t -131.78 109.71 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -103.26 156.43 17.72 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 122.135 0.969 . . . . 0.0 109.211 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -127.07 93.68 3.82 Favored 'General case' 0 N--CA 1.493 1.679 1 N-CA-C 97.897 -4.853 . . . . 0.0 97.897 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.403 HG12 ' N ' ' A' ' 102' ' ' GLU . 11.4 t -108.38 154.89 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.434 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.403 ' N ' HG12 ' A' ' 101' ' ' VAL . 38.7 tt0 -128.74 102.36 6.53 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 111.612 -2.54 . . . . 0.0 107.741 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 37.0 tp -72.24 125.63 27.81 Favored 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 103.065 -2.939 . . . . 0.0 103.065 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 16.5 mt -96.25 -55.4 2.96 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.406 ' HG2' ' H ' ' A' ' 106' ' ' LEU . 56.0 tttp -166.09 177.3 7.07 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.071 -1.052 . . . . 0.0 111.474 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.406 ' H ' ' HG2' ' A' ' 105' ' ' LYS . 24.4 mt -114.55 150.94 34.18 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 . . . . . 0 N--CA 1.505 2.299 0 CA-C-O 116.17 -1.871 . . . . 0.0 109.996 179.731 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.8 p . . . . . 0 N--CA 1.504 2.229 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -121.26 157.77 29.57 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.5 t -122.65 115.42 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -117.11 94.69 4.67 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 69.0 m -69.92 155.88 39.91 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 114.806 1.409 . . . . 0.0 114.806 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 72.2 mt -122.57 -55.48 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 CA-C-N 113.031 -1.895 . . . . 0.0 107.387 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.423 ' O ' ' O ' ' A' ' 9' ' ' PRO . 34.7 t -121.99 81.96 43.27 Favored Pre-proline 0 N--CA 1.505 2.292 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.576 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 8' ' ' SER . 12.2 Cg_exo -38.4 164.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.165 1.91 . . . . 0.0 111.868 178.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.67 -172.39 15.02 Favored Glycine 0 N--CA 1.498 2.803 0 N-CA-C 104.916 -3.274 . . . . 0.0 104.916 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 11' ' ' ASP . 12.9 p-10 -39.72 -58.56 1.31 Allowed 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.434 -0.907 . . . . 0.0 112.8 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.32 23.27 9.11 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 105.081 -3.208 . . . . 0.0 105.081 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.02 -40.73 1.48 Allowed 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 113.757 -1.222 . . . . 0.0 111.545 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.4 m -108.62 136.46 48.19 Favored 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.454 ' N ' ' CD1' ' A' ' 15' ' ' PHE . 66.0 m-85 -131.65 176.75 2.65 Favored Pre-proline 0 N--CA 1.494 1.765 0 N-CA-C 105.195 -2.15 . . . . 0.0 105.195 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -70.7 149.18 60.5 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 CA-C-N 119.485 0.852 . . . . 0.0 111.194 164.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -121.78 173.38 7.51 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 122.289 1.043 . . . . 0.0 110.41 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.1 ttm180 -77.69 98.34 5.44 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 113.912 -1.494 . . . . 0.0 109.556 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.13 9.63 4.56 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -113.89 171.76 7.4 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 76.8 m -124.42 112.63 17.15 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.732 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.443 ' N ' ' O ' ' A' ' 48' ' ' PHE . 36.5 m -72.11 147.66 46.48 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.752 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.2 t -116.78 114.11 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 101.389 -3.56 . . . . 0.0 101.389 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.416 HG21 ' CZ3' ' A' ' 59' ' ' TRP . 1.0 OUTLIER -126.65 150.16 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.04 0 N-CA-C 119.404 3.112 . . . . 0.0 119.404 -178.798 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -133.48 142.85 48.46 Favored 'General case' 0 N--CA 1.506 2.33 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.468 ' CD1' ' N ' ' A' ' 26' ' ' TYR . 39.2 p90 -160.53 -179.38 7.6 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 118.474 -1.291 . . . . 0.0 113.53 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 91.5 m -140.73 122.84 15.67 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 101.657 -3.46 . . . . 0.0 101.657 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -102.26 147.69 17.34 Favored Glycine 0 N--CA 1.504 3.198 0 C-N-CA 119.999 -1.096 . . . . 0.0 110.377 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 13.4 tpp . . . . . 0 N--CA 1.496 1.832 0 C-N-CA 120.069 -0.652 . . . . 0.0 110.181 -179.84 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . 0.255 0.7 OUTLIER . . . . . 0 N--CA 1.495 1.786 0 CA-C-O 121.591 0.71 . . . . 0.0 109.954 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -134.98 123.96 24.13 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 113.5 -1.682 . . . . 0.0 107.259 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.443 ' O ' ' N ' ' A' ' 22' ' ' CYS . 22.1 p90 -135.41 -178.01 4.92 Favored 'General case' 0 N--CA 1.515 2.814 0 CA-C-N 120.579 1.536 . . . . 0.0 114.696 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 42.9 ttm -116.69 144.25 44.65 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-N 115.199 -0.909 . . . . 0.0 113.024 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.3 tp -90.89 120.98 32.35 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.626 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.82 -11.48 49.48 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.468 ' O ' ' N ' ' A' ' 54' ' ' GLU . 25.6 tptp -112.44 38.58 2.7 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.407 ' C ' ' O ' ' A' ' 52' ' ' LYS . 47.5 tt0 0.86 66.18 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 O-C-N 125.653 1.846 . . . . 0.0 112.958 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' A' ' 52' ' ' LYS . 39.2 tt0 -96.28 -26.08 15.54 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 112.731 -2.031 . . . . 0.0 107.199 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.437 ' O ' ' O ' ' A' ' 56' ' ' ILE . 4.9 m -124.32 152.54 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.465 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.174 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 55' ' ' VAL . 4.9 pt -45.89 177.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.408 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.54 ' O ' ' N ' ' A' ' 59' ' ' TRP . 30.5 ttp180 -79.25 -57.53 3.67 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-O 118.337 -0.84 . . . . 0.0 112.715 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -30.58 -32.73 0.01 OUTLIER Glycine 0 N--CA 1.503 3.11 0 CA-C-O 122.664 1.147 . . . . 0.0 111.427 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.54 ' N ' ' O ' ' A' ' 57' ' ' ARG . 2.4 m0 -90.06 -73.5 0.52 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 113.629 -1.286 . . . . 0.0 107.853 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -31.86 -54.61 0.28 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 124.792 1.308 . . . . 0.0 110.768 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -73.15 -51.64 17.12 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 113.977 -1.465 . . . . 0.0 107.614 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 65' ' ' GLN . . . -55.69 -82.44 0.05 OUTLIER Glycine 0 N--CA 1.479 1.54 0 N-CA-C 108.16 -1.976 . . . . 0.0 108.16 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' A' ' 59' ' ' TRP . 66.1 t -30.38 -45.1 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.414 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -51.11 -49.29 61.02 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 123.692 1.711 . . . . 0.0 109.569 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.481 ' N ' ' O ' ' A' ' 62' ' ' GLY . 42.6 tt0 -66.01 3.29 0.87 Allowed 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 110.202 -3.181 . . . . 0.0 110.892 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.414 ' H ' ' C ' ' A' ' 64' ' ' ALA . 48.4 ttm -109.51 156.19 20.42 Favored 'General case' 0 N--CA 1.51 2.531 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 99.7 p -115.32 151.41 34.64 Favored 'General case' 0 N--CA 1.509 2.502 0 CA-C-O 122.545 1.164 . . . . 0.0 112.694 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 95.5 t -46.34 99.51 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-N 112.804 -1.998 . . . . 0.0 114.581 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.66 3.69 28.59 Favored Glycine 0 N--CA 1.502 3.076 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -101.83 149.13 24.5 Favored 'General case' 0 N--CA 1.506 2.328 0 CA-C-O 121.988 0.899 . . . . 0.0 111.03 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.8 ttt85 -127.14 143.2 51.32 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 113.786 -1.552 . . . . 0.0 106.961 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -151.72 175.99 11.85 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 113.401 -1.727 . . . . 0.0 113.958 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.5 ttmp? -119.67 102.8 8.87 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 103.45 -2.796 . . . . 0.0 103.45 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.2 mt -96.26 149.69 21.39 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 97.1 m -119.47 116.53 26.3 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 104.486 -2.412 . . . . 0.0 104.486 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 53.5 mt -102.45 142.58 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.9 p -101.53 154.36 37.3 Favored Pre-proline 0 N--CA 1.501 2.083 0 O-C-N 124.985 1.428 . . . . 0.0 111.398 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -44.72 -41.89 14.8 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 C-N-CA 122.915 2.41 . . . . 0.0 117.695 -175.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -87.77 20.24 3.11 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 117.908 2.558 . . . . 0.0 117.908 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 . . . . . 0 N--CA 1.501 2.084 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.52 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 28.9 m . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 103.752 -2.684 . . . . 0.0 103.752 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 19.3 mt -106.48 150.19 26.33 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.1 t -132.14 104.32 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -96.89 166.97 11.37 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -127.5 85.92 2.42 Favored 'General case' 0 N--CA 1.491 1.598 1 N-CA-C 94.844 -5.984 . . . . 0.0 94.844 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.1 t -98.59 149.45 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.3 0 CA-C-O 122.759 1.266 . . . . 0.0 114.342 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -126.84 111.45 14.19 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 112.19 -2.277 . . . . 0.0 106.897 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 35.0 tp -79.49 113.72 17.86 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 101.125 -3.657 . . . . 0.0 101.125 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.3 mt -74.19 -57.78 3.73 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 118.684 -1.207 . . . . 0.0 111.49 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.401 ' HG2' ' H ' ' A' ' 106' ' ' LEU . 0.4 OUTLIER -175.32 -172.27 0.56 Allowed 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 118.32 -1.352 . . . . 0.0 109.619 -179.831 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.401 ' H ' ' HG2' ' A' ' 105' ' ' LYS . 16.1 mt -117.89 155.28 30.43 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 . . . . . 0 N--CA 1.512 2.645 0 CA-C-O 116.175 -1.869 . . . . 0.0 109.143 179.443 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.2 p . . . . . 0 N--CA 1.503 2.203 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -121.09 152.64 38.44 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 55.6 t -126.64 112.38 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.531 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.417 ' OE1' ' O ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -113.03 96.04 5.72 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 103.644 -2.725 . . . . 0.0 103.644 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.417 ' O ' ' OE1' ' A' ' 5' ' ' GLU . 87.1 m -69.87 156.58 38.86 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 118.56 -1.256 . . . . 0.0 112.494 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 71.7 mt -121.16 -55.09 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 CA-C-N 113.939 -1.482 . . . . 0.0 107.422 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.423 ' O ' ' O ' ' A' ' 9' ' ' PRO . 36.2 m -124.35 82.42 57.95 Favored Pre-proline 0 N--CA 1.507 2.407 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.742 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 8' ' ' SER . 3.4 Cg_exo -35.93 164.21 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.566 2.177 . . . . 0.0 113.434 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -114.84 -176.91 18.87 Favored Glycine 0 N--CA 1.501 3.023 0 N-CA-C 105.841 -2.903 . . . . 0.0 105.841 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.464 ' CG ' ' H ' ' A' ' 12' ' ' GLY . 11.6 p-10 -42.5 -58.48 2.24 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 118.174 0.987 . . . . 0.0 111.745 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.464 ' H ' ' CG ' ' A' ' 11' ' ' ASP . . . 109.33 24.63 5.85 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 107.738 -2.145 . . . . 0.0 107.738 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.3 mtm180 -133.53 -34.35 1.05 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 114.75 -0.725 . . . . 0.0 112.771 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.4 m -111.51 130.4 55.74 Favored 'General case' 0 N--CA 1.506 2.347 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 26.2 m-85 -130.31 173.35 5.9 Favored Pre-proline 0 N--CA 1.497 1.898 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -67.94 150.28 78.03 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 CA-C-N 119.997 1.035 . . . . 0.0 111.165 167.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -121.62 171.15 9.05 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-O 121.898 0.856 . . . . 0.0 110.911 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.2 ttt-85 -77.51 98.57 5.38 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.491 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.0 10.38 4.32 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -114.97 173.91 6.24 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.1 m -124.7 112.09 16.34 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 20.1 m -69.82 145.8 51.84 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.4 t -118.11 102.84 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 101.268 -3.605 . . . . 0.0 101.268 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.0 m -124.09 153.9 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.443 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -131.19 116.87 18.25 Favored 'General case' 0 N--CA 1.507 2.405 0 N-CA-C 104.991 -2.226 . . . . 0.0 104.991 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -132.16 177.38 7.61 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 122.997 1.379 . . . . 0.0 114.451 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 87.3 m -136.32 124.4 22.95 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 101.218 -3.623 . . . . 0.0 101.218 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -107.99 116.18 4.73 Favored Glycine 0 N--CA 1.501 3.022 0 C-N-CA 120.337 -0.935 . . . . 0.0 111.415 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 69.2 mtp . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 179.93 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 63.6 t80 . . . . . 0 N--CA 1.497 1.882 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.5 mtmp? -143.61 117.11 9.13 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.875 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -137.14 167.3 21.81 Favored 'General case' 0 N--CA 1.511 2.602 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.638 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.5 ' SD ' ' O ' ' A' ' 50' ' ' LEU . 7.8 tmm? -117.46 144.6 44.87 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.97 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.5 ' O ' ' SD ' ' A' ' 49' ' ' MET . 44.0 tp -90.81 134.52 34.38 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 114.516 -1.22 . . . . 0.0 111.443 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 132.97 -34.42 2.46 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 54' ' ' GLU . 80.3 tttt -122.62 44.39 2.65 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 4.42 58.73 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 126.015 2.072 . . . . 0.0 114.072 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 52' ' ' LYS . 50.4 mt-10 -63.74 -17.58 63.17 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 114.526 -1.215 . . . . 0.0 109.757 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 56' ' ' ILE . 21.1 m -117.6 159.79 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.32 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.425 ' O ' ' O ' ' A' ' 55' ' ' VAL . 16.2 pt -51.55 178.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 C-N-CA 118.64 -1.224 . . . . 0.0 108.534 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.532 ' O ' ' N ' ' A' ' 59' ' ' TRP . 17.6 ttm180 -75.18 -59.14 2.88 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.152 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -28.52 -34.98 0.01 OUTLIER Glycine 0 N--CA 1.497 2.738 0 O-C-N 124.614 1.196 . . . . 0.0 112.26 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.532 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.6 OUTLIER -81.39 -73.61 0.37 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 179.761 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 59' ' ' TRP . 32.4 tt0 -22.4 -57.24 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 O-C-N 125.914 2.009 . . . . 0.0 111.426 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -78.11 -52.21 9.09 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 113.075 -1.875 . . . . 0.0 106.491 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -49.65 -74.17 0.3 Allowed Glycine 0 N--CA 1.48 1.604 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.095 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.499 ' N ' ' O ' ' A' ' 59' ' ' TRP . 25.6 t -44.13 -50.59 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 C-N-CA 119.317 -0.953 . . . . 0.0 111.745 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.469 ' C ' ' N ' ' A' ' 66' ' ' MET . . . -44.19 -62.39 1.17 Allowed 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 123.989 1.852 . . . . 0.0 111.608 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -45.9 -13.98 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 109.429 -3.532 . . . . 0.0 109.3 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.469 ' N ' ' C ' ' A' ' 64' ' ' ALA . 20.2 mtm -98.36 158.23 15.71 Favored 'General case' 0 N--CA 1.514 2.733 0 C-N-CA 118.084 -1.446 . . . . 0.0 108.96 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 84.4 p -117.9 149.43 40.9 Favored 'General case' 0 N--CA 1.508 2.467 0 CA-C-O 122.558 1.17 . . . . 0.0 113.399 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 90.5 t -39.4 96.6 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 112.719 -2.037 . . . . 0.0 114.044 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.13 9.4 20.24 Favored Glycine 0 N--CA 1.5 2.919 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -103.0 141.6 35.52 Favored 'General case' 0 N--CA 1.502 2.168 0 CA-C-O 121.457 0.646 . . . . 0.0 110.355 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 24.7 ttt85 -125.34 141.13 52.25 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -149.65 176.13 10.93 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-N 113.064 -1.88 . . . . 0.0 115.853 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -127.61 105.01 8.19 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 103.851 -2.648 . . . . 0.0 103.851 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.429 ' N ' HD12 ' A' ' 74' ' ' LEU . 4.9 mp -102.47 152.27 21.33 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.591 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 92.0 m -123.73 117.18 24.37 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 22.8 mt -108.63 141.72 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 CA-C-O 121.099 0.476 . . . . 0.0 109.858 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.421 ' O ' ' OD1' ' A' ' 79' ' ' ASP . 33.4 p -114.65 155.34 46.24 Favored Pre-proline 0 N--CA 1.504 2.263 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.429 ' O ' ' N ' ' A' ' 80' ' ' TYR . 10.2 Cg_endo -37.68 -55.65 1.04 Allowed 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.683 1.588 . . . . 0.0 113.961 -175.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 14.7 p30 -34.04 -34.89 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.579 0.704 . . . . 0.0 112.567 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.429 ' N ' ' O ' ' A' ' 78' ' ' PRO . 6.9 m-85 . . . . . 0 N--CA 1.495 1.812 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.644 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 31.2 m . . . . . 0 N--CA 1.494 1.737 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 20.3 mt -110.19 153.33 24.91 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.7 t -138.11 123.59 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -118.86 155.03 31.95 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 122.119 0.961 . . . . 0.0 110.307 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -125.7 89.94 3.12 Favored 'General case' 0 N--CA 1.494 1.76 1 N-CA-C 97.424 -5.028 . . . . 0.0 97.424 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 9.9 t -102.93 151.29 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.483 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -128.59 100.9 5.93 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 111.832 -2.44 . . . . 0.0 108.284 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 45.9 tp -72.75 124.49 25.44 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 104.159 -2.534 . . . . 0.0 104.159 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.1 mt -91.56 -58.32 2.47 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 114.372 -1.285 . . . . 0.0 112.008 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.417 ' HG2' ' H ' ' A' ' 106' ' ' LEU . 29.3 tttm -168.93 -175.4 2.34 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.007 -1.077 . . . . 0.0 110.418 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.417 ' H ' ' HG2' ' A' ' 105' ' ' LYS . 17.9 mt -117.22 154.89 30.36 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 . . . . . 0 N--CA 1.505 2.313 0 CA-C-O 116.056 -1.926 . . . . 0.0 110.817 179.578 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.6 p . . . . . 0 N--CA 1.502 2.145 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -121.96 157.46 31.21 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.6 t -126.64 106.62 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -107.47 88.47 2.74 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 93.4 m -69.7 156.13 39.45 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.004 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.0 mt -122.76 -52.73 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-N 113.681 -1.599 . . . . 0.0 107.025 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.422 ' O ' ' O ' ' A' ' 9' ' ' PRO . 98.2 p -122.75 82.22 48.89 Favored Pre-proline 0 N--CA 1.505 2.302 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.462 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 8' ' ' SER . 7.8 Cg_exo -37.59 167.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.606 2.204 . . . . 0.0 113.234 178.083 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.16 -171.79 15.03 Favored Glycine 0 N--CA 1.503 3.132 0 N-CA-C 107.17 -2.372 . . . . 0.0 107.17 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 11' ' ' ASP . 13.9 p-10 -39.62 -61.09 0.86 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.576 -0.85 . . . . 0.0 112.897 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.17 17.88 12.08 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 106.126 -2.789 . . . . 0.0 106.126 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.9 mmt85 -127.41 -39.61 1.85 Allowed 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 114.006 -1.097 . . . . 0.0 111.925 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.1 m -108.29 133.7 52.15 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.435 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 32.8 m-85 -131.16 175.67 3.5 Favored Pre-proline 0 N--CA 1.496 1.855 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -72.58 140.81 33.46 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 CA-C-N 119.621 0.9 . . . . 0.0 109.988 163.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -121.23 174.08 6.92 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.714 0.769 . . . . 0.0 110.325 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 25.1 ttt85 -73.13 110.36 7.36 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.082 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.96 0.89 10.69 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -116.63 172.94 6.9 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 121.933 0.873 . . . . 0.0 110.628 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 97.0 m -125.25 117.67 24.32 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-N 113.975 -1.466 . . . . 0.0 108.234 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 55.8 m -69.58 150.55 46.96 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 77.0 t -122.71 101.48 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 102.945 -2.983 . . . . 0.0 102.945 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.3 m -121.64 149.19 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.498 0 N-CA-C 117.904 2.557 . . . . 0.0 117.904 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -124.68 111.92 16.16 Favored 'General case' 0 N--CA 1.507 2.378 0 N-CA-C 103.352 -2.833 . . . . 0.0 103.352 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.471 ' CD1' ' N ' ' A' ' 26' ' ' TYR . 19.8 p90 -129.89 168.32 16.81 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 123.485 1.612 . . . . 0.0 114.434 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 97.3 m -134.6 111.05 9.72 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 102.384 -3.191 . . . . 0.0 102.384 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.36 138.35 14.62 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.113 -1.518 . . . . 0.0 109.875 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 38.1 ttm . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 -179.834 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 61.9 t80 . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -135.43 125.45 25.93 Favored 'General case' 0 N--CA 1.507 2.386 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -136.62 175.35 9.69 Favored 'General case' 0 N--CA 1.508 2.472 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.903 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 41.9 ttm -113.97 149.92 34.58 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 59.3 tp -91.01 119.85 31.52 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 113.993 -1.458 . . . . 0.0 112.444 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.82 -1.41 61.4 Favored Glycine 0 N--CA 1.498 2.774 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.444 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.414 ' O ' ' C ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -118.56 41.29 3.02 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.747 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.414 ' C ' ' O ' ' A' ' 52' ' ' LYS . 85.2 mt-30 4.9 65.72 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 O-C-N 125.54 1.775 . . . . 0.0 113.944 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.44 ' OE1' ' O ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -93.58 -36.47 12.38 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 103.394 -2.817 . . . . 0.0 103.394 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.43 ' O ' ' O ' ' A' ' 56' ' ' ILE . 27.9 m -115.21 154.18 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.43 ' O ' ' O ' ' A' ' 55' ' ' VAL . 5.0 pt -48.29 175.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 118.971 -1.091 . . . . 0.0 110.353 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.555 ' NH1' ' CE2' ' A' ' 80' ' ' TYR . 23.5 ttt180 -72.78 -59.84 2.52 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 118.354 -0.832 . . . . 0.0 110.864 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -27.37 -37.19 0.01 OUTLIER Glycine 0 N--CA 1.502 3.048 0 O-C-N 124.539 1.15 . . . . 0.0 111.695 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.533 ' N ' ' O ' ' A' ' 57' ' ' ARG . 1.0 OUTLIER -79.61 -75.6 0.24 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 -29.1 -55.11 0.13 Allowed 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 112.983 -1.917 . . . . 0.0 110.788 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.525 ' OE1' ' NH1' ' A' ' 57' ' ' ARG . 37.7 tt0 -72.91 -50.27 24.64 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -58.37 -75.62 0.25 Allowed Glycine 0 N--CA 1.477 1.376 0 C-N-CA 119.512 -1.327 . . . . 0.0 111.028 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.525 ' N ' ' O ' ' A' ' 59' ' ' TRP . 35.9 t -39.76 -50.37 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 C-N-CA 119.901 -0.719 . . . . 0.0 112.868 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.469 ' C ' ' N ' ' A' ' 66' ' ' MET . . . -43.66 -62.17 1.18 Allowed 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 124.16 1.933 . . . . 0.0 111.642 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -44.92 -14.92 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 109.233 -3.622 . . . . 0.0 108.946 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.469 ' N ' ' C ' ' A' ' 64' ' ' ALA . 8.2 mtm -98.26 159.99 14.58 Favored 'General case' 0 N--CA 1.512 2.661 0 C-N-CA 118.467 -1.293 . . . . 0.0 107.895 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 77.7 p -117.63 150.43 39.04 Favored 'General case' 0 N--CA 1.507 2.415 0 CA-C-O 122.573 1.177 . . . . 0.0 112.937 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 96.2 t -44.03 103.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 112.711 -2.041 . . . . 0.0 114.471 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.64 8.16 21.23 Favored Glycine 0 N--CA 1.5 2.942 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -109.15 152.94 24.45 Favored 'General case' 0 N--CA 1.506 2.35 0 CA-C-O 122.311 1.053 . . . . 0.0 111.665 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 -131.26 140.61 49.85 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 113.17 -1.832 . . . . 0.0 107.367 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -146.7 178.58 8.2 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 112.527 -2.124 . . . . 0.0 115.879 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -126.91 104.99 8.32 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 102.866 -3.013 . . . . 0.0 102.866 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.8 mt -98.85 153.61 18.65 Favored 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 120.169 -0.612 . . . . 0.0 109.505 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 84.8 m -123.92 119.45 29.65 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 35.7 mt -111.53 141.08 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 69.3 p -109.09 150.69 41.31 Favored Pre-proline 0 N--CA 1.501 2.12 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -41.56 -54.6 2.67 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.627 1.552 . . . . 0.0 112.517 -171.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 10.9 p-10 -40.06 -27.21 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.555 ' CE2' ' NH1' ' A' ' 57' ' ' ARG . 4.5 m-85 . . . . . 0 N--CA 1.499 1.976 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 59.3 m . . . . . 0 N--CA 1.5 2.031 0 CA-C-O 119.274 -0.393 . . . . 0.0 111.447 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 15.1 mt -113.19 163.76 14.37 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 58.2 t -136.32 132.06 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -123.28 145.9 48.32 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -121.65 94.42 4.31 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 100.715 -3.809 . . . . 0.0 100.715 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 102' ' ' GLU . 19.9 t -109.09 152.86 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.45 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.464 ' N ' HG12 ' A' ' 101' ' ' VAL . 88.9 tt0 -126.02 98.16 5.39 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 112.169 -2.287 . . . . 0.0 106.827 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 47.9 tp -71.87 124.18 24.28 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 102.953 -2.98 . . . . 0.0 102.953 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.6 mt -92.93 -55.96 3.16 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.122 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -170.03 -168.28 0.73 Allowed 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.141 -1.024 . . . . 0.0 111.587 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 27.9 mt -115.82 156.17 26.55 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 . . . . . 0 N--CA 1.504 2.226 0 CA-C-O 116.195 -1.86 . . . . 0.0 109.564 179.882 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.6 p . . . . . 0 N--CA 1.501 2.112 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -122.43 158.12 30.42 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.5 t -124.48 113.14 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -112.96 90.28 3.3 Favored 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 91.3 m -69.78 156.28 39.26 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 114.312 -1.313 . . . . 0.0 113.437 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 56.4 mt -121.87 -51.19 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 CA-C-N 113.808 -1.542 . . . . 0.0 107.45 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.7 m -122.98 80.17 50.74 Favored Pre-proline 0 N--CA 1.506 2.369 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.272 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -40.05 160.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.715 2.277 . . . . 0.0 112.791 178.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -125.44 -175.27 14.16 Favored Glycine 0 N--CA 1.5 2.938 0 N-CA-C 106.631 -2.588 . . . . 0.0 106.631 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 12' ' ' GLY . 1.1 p30 -39.78 -52.84 2.3 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.599 -0.841 . . . . 0.0 112.906 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.468 ' N ' ' OD1' ' A' ' 11' ' ' ASP . . . 90.75 14.5 58.03 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 106.689 -2.564 . . . . 0.0 106.689 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 45.6 mtm-85 -124.68 -33.81 2.93 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 113.604 -1.298 . . . . 0.0 112.274 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.5 m -107.86 125.55 51.59 Favored 'General case' 0 N--CA 1.501 2.086 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.954 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.448 ' N ' ' CD1' ' A' ' 15' ' ' PHE . 36.9 m-85 -125.01 175.46 3.02 Favored Pre-proline 0 N--CA 1.501 2.097 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -66.68 154.8 73.18 Favored 'Trans proline' 0 C--N 1.315 -1.224 0 N-CA-C 109.474 -1.01 . . . . 0.0 109.474 164.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -119.23 169.04 10.31 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-O 121.967 0.889 . . . . 0.0 110.277 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 56.6 mtt-85 -77.18 107.5 9.61 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.343 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.19 -12.93 8.0 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 108.65 -1.78 . . . . 0.0 108.65 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -108.16 166.55 10.65 Favored 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 19.2 m -110.73 125.64 53.72 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.508 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 33.1 m -74.64 142.42 44.54 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 70.7 t -116.77 96.75 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 102.731 -3.063 . . . . 0.0 102.731 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.402 HG21 ' CH2' ' A' ' 59' ' ' TRP . 3.0 m -118.23 148.49 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 O-C-N 124.751 1.282 . . . . 0.0 113.915 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 49.9 t60 -128.76 117.93 21.94 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 103.472 -2.788 . . . . 0.0 103.472 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -134.88 176.06 9.0 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 122.951 1.357 . . . . 0.0 111.426 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 74.8 m -128.84 116.56 19.63 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 100.728 -3.804 . . . . 0.0 100.728 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -95.51 131.07 10.53 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 104.85 -3.3 . . . . 0.0 104.85 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 43.2 ttm . . . . . 0 C--N 1.302 -1.464 0 N-CA-C 104.732 -2.322 . . . . 0.0 104.732 -179.859 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 55.3 t80 . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 120.766 0.317 . . . . 0.0 111.367 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -133.17 121.95 23.3 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -137.82 172.48 12.89 Favored 'General case' 0 N--CA 1.508 2.474 0 C-N-CA 119.448 -0.901 . . . . 0.0 111.27 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.6 ttt -112.9 150.07 32.3 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.487 0.66 . . . . 0.0 112.73 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.4 tp -90.58 121.0 32.13 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.113 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.57 -3.7 39.71 Favored Glycine 0 N--CA 1.5 2.951 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.998 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' A' ' 54' ' ' GLU . 19.2 ttmm -115.84 42.46 2.32 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.411 ' C ' ' O ' ' A' ' 52' ' ' LYS . 72.8 mt-30 0.76 63.48 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.044 0 O-C-N 125.706 1.879 . . . . 0.0 113.655 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 52' ' ' LYS . 1.9 tm-20 -101.4 -23.9 14.28 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 113.796 -1.547 . . . . 0.0 106.864 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.2 m -112.7 158.73 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.577 0 C-N-CA 119.856 -0.738 . . . . 0.0 109.269 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.5 pt -59.1 173.95 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.484 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.549 ' O ' ' N ' ' A' ' 59' ' ' TRP . 3.6 tpp180 -66.99 -60.22 2.82 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 118.564 -0.731 . . . . 0.0 109.891 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -24.59 -38.9 0.01 OUTLIER Glycine 0 N--CA 1.499 2.889 0 O-C-N 125.1 1.5 . . . . 0.0 111.498 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.549 ' N ' ' O ' ' A' ' 57' ' ' ARG . 2.0 m95 -82.37 -74.88 0.33 Allowed 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 112.816 -1.692 . . . . 0.0 110.447 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 59' ' ' TRP . 29.9 tt0 -24.32 -54.6 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 125.97 2.044 . . . . 0.0 111.33 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -77.88 -54.18 6.62 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -50.36 -75.41 0.21 Allowed Glycine 0 N--CA 1.481 1.671 0 C-N-CA 119.729 -1.225 . . . . 0.0 110.544 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.53 ' N ' ' O ' ' A' ' 59' ' ' TRP . 25.1 t -43.53 -48.06 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 119.218 -0.993 . . . . 0.0 112.011 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.435 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -45.34 -58.75 3.09 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 123.783 1.754 . . . . 0.0 111.37 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -50.44 -9.02 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 109.873 -3.33 . . . . 0.0 110.617 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.435 ' H ' ' C ' ' A' ' 64' ' ' ALA . 40.8 mtm -103.97 151.05 23.66 Favored 'General case' 0 N--CA 1.519 2.989 0 C-N-CA 118.824 -1.15 . . . . 0.0 109.993 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 61.7 p -115.58 148.07 40.01 Favored 'General case' 0 N--CA 1.509 2.525 0 CA-C-O 122.756 1.265 . . . . 0.0 114.006 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 60.5 t -38.94 109.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-N 112.478 -2.146 . . . . 0.0 114.871 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.49 -2.51 36.9 Favored Glycine 0 N--CA 1.501 2.985 0 C-N-CA 119.58 -1.295 . . . . 0.0 111.296 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -99.97 153.61 19.05 Favored 'General case' 0 N--CA 1.506 2.338 0 CA-C-O 122.344 1.068 . . . . 0.0 111.87 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 31.1 ttp180 -131.7 143.82 50.54 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 113.137 -1.847 . . . . 0.0 107.209 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -151.98 176.78 11.14 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 116.574 2.064 . . . . 0.0 116.574 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -124.78 104.58 8.72 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 110.855 -2.884 . . . . 0.0 104.349 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.1 mt -96.83 150.06 21.15 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.7 m -121.1 103.39 8.98 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 37.5 mt -99.38 132.09 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.418 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 66.9 p -113.03 156.38 42.88 Favored Pre-proline 0 N--CA 1.501 2.094 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -34.32 -50.41 0.63 Allowed 'Trans proline' 0 C--N 1.314 -1.248 0 C-N-CA 122.231 1.954 . . . . 0.0 114.096 -176.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 80' ' ' TYR . 1.4 p30 -38.91 -41.12 0.72 Allowed 'General case' 0 N--CA 1.485 1.324 0 CA-C-O 121.837 0.827 . . . . 0.0 111.734 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.479 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 6.5 m-85 . . . . . 0 N--CA 1.494 1.749 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.838 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 97.5 m . . . . . 0 N--CA 1.497 1.875 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 20.6 mt -101.55 152.7 20.48 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.7 t -132.27 117.8 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.458 ' CE2' ' NE1' ' A' ' 59' ' ' TRP . 3.9 m-85 -109.32 160.06 16.47 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -128.61 88.27 2.71 Favored 'General case' 0 N--CA 1.497 1.892 1 N-CA-C 98.295 -4.705 . . . . 0.0 98.295 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.44 HG12 ' N ' ' A' ' 102' ' ' GLU . 14.7 t -101.98 152.5 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.64 0 N-CA-C 117.495 2.406 . . . . 0.0 117.495 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.44 ' N ' HG12 ' A' ' 101' ' ' VAL . 38.1 tt0 -129.25 104.88 7.78 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 112.3 -2.227 . . . . 0.0 106.755 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 36.8 tp -77.06 116.05 17.38 Favored 'General case' 0 N--CA 1.505 2.321 0 N-CA-C 101.888 -3.375 . . . . 0.0 101.888 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.7 mt -86.2 -61.99 1.62 Allowed 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 114.372 -1.285 . . . . 0.0 114.115 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 14.5 mmtt -157.16 -171.86 3.79 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.834 0.826 . . . . 0.0 111.351 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 21.4 mt -119.15 159.99 22.96 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 103.772 -2.677 . . . . 0.0 103.772 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 . . . . . 0 N--CA 1.508 2.445 0 CA-C-O 115.572 -2.156 . . . . 0.0 107.548 179.919 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.8 p . . . . . 0 N--CA 1.503 2.18 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -121.99 156.01 34.36 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.8 t -125.5 118.13 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -121.84 94.52 4.34 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 92.5 m -69.82 157.28 37.67 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 76.3 mt -121.98 -55.47 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 CA-C-N 113.656 -1.611 . . . . 0.0 107.132 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.423 ' O ' ' O ' ' A' ' 9' ' ' PRO . 36.6 m -120.94 84.44 38.84 Favored Pre-proline 0 N--CA 1.504 2.234 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.331 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 8' ' ' SER . 0.5 OUTLIER -34.71 159.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.3 2.0 . . . . 0.0 112.15 177.025 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -124.47 -164.75 12.01 Favored Glycine 0 N--CA 1.501 3.02 0 N-CA-C 107.992 -2.043 . . . . 0.0 107.992 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.466 ' CG ' ' H ' ' A' ' 12' ' ' GLY . 1.2 p-10 -39.55 -67.54 0.22 Allowed 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 121.816 0.817 . . . . 0.0 112.348 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.466 ' H ' ' CG ' ' A' ' 11' ' ' ASP . . . 104.33 12.61 28.61 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 105.3 -3.12 . . . . 0.0 105.3 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -124.38 -45.67 1.94 Allowed 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 113.797 -1.201 . . . . 0.0 112.188 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 38.6 m -103.12 129.2 49.91 Favored 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -128.97 173.04 6.11 Favored Pre-proline 0 N--CA 1.499 1.982 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -67.85 132.09 25.73 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 CA-C-N 119.707 0.931 . . . . 0.0 112.663 166.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -120.23 165.07 15.3 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.8 ptm85 -66.12 134.29 52.49 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.69 -25.71 11.63 Favored Glycine 0 N--CA 1.498 2.777 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -106.89 173.0 6.51 Favored 'General case' 0 N--CA 1.508 2.444 0 CA-C-O 121.715 0.769 . . . . 0.0 112.99 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.7 m -115.29 121.05 41.7 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.723 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 30.6 m -69.29 152.62 44.79 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.412 HG23 ' H ' ' A' ' 107' ' ' GLU . 97.6 t -130.11 102.78 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 101.763 -3.421 . . . . 0.0 101.763 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.7 m -120.72 152.66 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.374 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -129.13 113.82 15.56 Favored 'General case' 0 N--CA 1.506 2.349 0 N-CA-C 102.807 -3.035 . . . . 0.0 102.807 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.552 ' CD1' ' N ' ' A' ' 26' ' ' TYR . 33.0 p90 -132.25 175.91 8.85 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 122.974 1.369 . . . . 0.0 114.221 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.8 m -137.06 117.59 13.82 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 101.794 -3.41 . . . . 0.0 101.794 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -98.61 141.85 15.78 Favored Glycine 0 N--CA 1.501 3.003 0 C-N-CA 119.921 -1.133 . . . . 0.0 110.697 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 69.6 mmm . . . . . 0 C--N 1.303 -1.43 0 CA-C-N 113.387 -1.407 . . . . 0.0 107.613 -179.734 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 49.2 t80 . . . . . 0 N--CA 1.501 2.109 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -143.08 121.2 12.14 Favored 'General case' 0 N--CA 1.506 2.374 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -135.4 171.98 13.66 Favored 'General case' 0 N--CA 1.513 2.703 0 CA-C-N 118.988 0.813 . . . . 0.0 110.631 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 43.2 ttm -119.16 143.8 47.02 Favored 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.427 ' CD1' ' OE1' ' A' ' 60' ' ' GLU . 50.5 tp -91.17 134.88 34.18 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 113.986 -1.461 . . . . 0.0 110.646 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 126.73 -35.02 3.0 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 108.393 -1.883 . . . . 0.0 108.393 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 54' ' ' GLU . 80.0 tttt -123.76 43.14 3.05 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 114.585 -0.807 . . . . 0.0 109.176 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 12.53 49.27 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 125.602 1.814 . . . . 0.0 114.685 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 52' ' ' LYS . 96.1 mt-10 -49.2 -29.82 6.11 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.537 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.433 ' O ' ' O ' ' A' ' 56' ' ' ILE . 32.7 m -117.56 158.31 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.646 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 55' ' ' VAL . 23.9 pt -46.4 172.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 C-N-CA 118.753 -1.179 . . . . 0.0 111.323 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.546 ' O ' ' N ' ' A' ' 59' ' ' TRP . 20.7 ttm-85 -72.44 -61.06 1.93 Allowed 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 118.84 -0.6 . . . . 0.0 112.073 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -34.58 -28.22 0.01 OUTLIER Glycine 0 N--CA 1.499 2.835 0 CA-C-O 122.156 0.864 . . . . 0.0 111.761 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.546 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.6 OUTLIER -87.75 -74.76 0.44 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 179.804 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.427 ' OE1' ' CD1' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -32.86 -50.96 0.28 Allowed 'General case' 0 N--CA 1.501 2.077 0 CA-C-N 114.035 -1.439 . . . . 0.0 110.127 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -74.57 -54.36 7.64 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 113.743 -1.572 . . . . 0.0 107.042 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -53.71 -76.07 0.2 Allowed Glycine 0 N--CA 1.478 1.47 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' A' ' 59' ' ' TRP . 40.0 t -37.25 -45.41 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 CA-C-N 115.067 -0.566 . . . . 0.0 112.04 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.487 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -48.35 -56.07 9.08 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 123.78 1.752 . . . . 0.0 110.092 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -59.53 -0.51 0.17 Allowed 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 110.139 -3.21 . . . . 0.0 110.409 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.487 ' H ' ' C ' ' A' ' 64' ' ' ALA . 16.3 tpp -98.85 153.2 18.97 Favored 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 106.039 -1.838 . . . . 0.0 106.039 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 83.5 p -116.37 143.23 45.82 Favored 'General case' 0 N--CA 1.508 2.453 0 CA-C-O 122.289 1.042 . . . . 0.0 112.212 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.422 ' O ' ' OD1' ' A' ' 11' ' ' ASP . 96.7 t -41.9 98.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 113.315 -1.766 . . . . 0.0 114.622 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.71 7.1 22.52 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.443 ' OE1' ' SD ' ' A' ' 66' ' ' MET . 15.1 tt0 -105.13 149.09 26.17 Favored 'General case' 0 N--CA 1.51 2.545 0 C-N-CA 119.179 -1.008 . . . . 0.0 111.018 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 24.8 ttt85 -124.71 141.02 52.4 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 113.905 -1.498 . . . . 0.0 107.0 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -149.64 177.97 9.28 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 116.081 1.882 . . . . 0.0 116.081 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -127.09 104.83 8.19 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 102.457 -3.164 . . . . 0.0 102.457 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.6 mt -101.48 155.12 18.26 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 87.2 m -125.32 132.2 52.9 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 23.8 mt -118.99 138.85 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 CA-C-O 121.319 0.581 . . . . 0.0 110.651 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.44 ' HG ' ' CG ' ' A' ' 79' ' ' ASP . 76.9 p -111.11 151.45 43.07 Favored Pre-proline 0 N--CA 1.502 2.151 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.423 ' O ' ' N ' ' A' ' 80' ' ' TYR . 10.2 Cg_endo -39.41 -56.14 1.37 Allowed 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 121.859 1.706 . . . . 0.0 113.035 -172.061 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 3.9 p-10 -34.37 -34.34 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.442 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.423 ' N ' ' O ' ' A' ' 78' ' ' PRO . 4.8 m-85 . . . . . 0 N--CA 1.493 1.682 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.086 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 91.1 m . . . . . 0 N--CA 1.504 2.262 0 CA-C-O 119.157 -0.449 . . . . 0.0 110.85 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 29.0 mt -108.8 144.37 36.74 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 119.252 0.933 . . . . 0.0 108.718 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 43.7 t -128.73 127.2 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 N-CA-C 107.113 -1.439 . . . . 0.0 107.113 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -118.82 157.88 26.71 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 122.063 0.935 . . . . 0.0 111.958 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -127.07 94.16 3.94 Favored 'General case' 0 N--CA 1.494 1.762 1 N-CA-C 99.069 -4.419 . . . . 0.0 99.069 179.012 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.437 HG12 ' N ' ' A' ' 102' ' ' GLU . 16.4 t -107.36 152.94 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.524 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.437 ' N ' HG12 ' A' ' 101' ' ' VAL . 89.3 tt0 -127.36 100.65 6.13 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 111.877 -2.42 . . . . 0.0 106.357 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 40.9 tp -73.76 125.06 27.26 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 102.624 -3.102 . . . . 0.0 102.624 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.0 mt -94.0 -59.74 1.91 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.79 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 11.8 ptmm? -157.2 -178.58 7.46 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.0 mt -114.23 71.29 0.75 Allowed 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.412 ' H ' HG23 ' A' ' 23' ' ' VAL . 34.4 tt0 . . . . . 0 N--CA 1.502 2.159 0 CA-C-O 115.91 -1.995 . . . . 0.0 109.676 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 N--CA 1.503 2.18 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -121.99 154.01 37.78 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.2 t -126.51 114.03 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -114.83 109.53 18.3 Favored 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 96.2 m -83.75 153.71 23.99 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.744 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 56.0 mt -123.55 -50.58 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 CA-C-N 113.656 -1.611 . . . . 0.0 107.363 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.417 ' O ' ' O ' ' A' ' 9' ' ' PRO . 43.8 t -122.33 79.68 45.15 Favored Pre-proline 0 N--CA 1.507 2.406 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.634 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.417 ' O ' ' O ' ' A' ' 8' ' ' SER . 9.0 Cg_exo -37.56 166.27 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.863 2.375 . . . . 0.0 113.77 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.79 -167.42 12.92 Favored Glycine 0 N--CA 1.502 3.091 0 N-CA-C 105.304 -3.119 . . . . 0.0 105.304 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.485 ' CG ' ' H ' ' A' ' 12' ' ' GLY . 11.2 p-10 -46.97 -58.99 3.4 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 118.619 1.21 . . . . 0.0 110.798 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.485 ' H ' ' CG ' ' A' ' 11' ' ' ASP . . . 106.99 27.63 5.3 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 107.232 -2.347 . . . . 0.0 107.232 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 32.7 mtp85 -133.87 -35.0 0.98 Allowed 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 114.545 -0.828 . . . . 0.0 112.597 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.8 m -109.57 139.46 44.55 Favored 'General case' 0 N--CA 1.508 2.454 0 CA-C-O 121.807 0.813 . . . . 0.0 112.952 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.46 ' N ' ' CD1' ' A' ' 15' ' ' PHE . 50.5 m-85 -131.77 177.43 2.25 Favored Pre-proline 0 N--CA 1.499 1.988 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -67.13 138.74 48.33 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 121.145 1.23 . . . . 0.0 110.813 164.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -119.94 162.24 19.53 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 122.351 1.072 . . . . 0.0 109.232 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 29.8 mtm180 -71.07 126.68 30.23 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 114.189 -1.369 . . . . 0.0 108.146 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.51 -24.22 9.86 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -110.8 176.95 4.83 Favored 'General case' 0 N--CA 1.507 2.406 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.901 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 92.4 m -108.42 166.98 10.36 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.2 m -113.14 149.47 33.55 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 102.513 -3.143 . . . . 0.0 102.513 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 60.4 t -123.49 101.93 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 103.109 -2.923 . . . . 0.0 103.109 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.3 m -120.69 149.52 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.574 0 N-CA-C 116.516 2.043 . . . . 0.0 116.516 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -127.8 114.74 17.64 Favored 'General case' 0 N--CA 1.507 2.383 0 N-CA-C 103.67 -2.715 . . . . 0.0 103.67 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.499 ' N ' ' CD1' ' A' ' 26' ' ' TYR . 33.9 p90 -131.96 175.68 9.02 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 122.977 1.37 . . . . 0.0 113.702 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 84.8 m -134.65 116.89 15.47 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 101.308 -3.59 . . . . 0.0 101.308 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -102.55 128.7 9.63 Favored Glycine 0 N--CA 1.5 2.935 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 46.8 ttm . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 -179.83 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 49.7 t80 . . . . . 0 N--CA 1.499 2.013 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.95 130.88 21.65 Favored 'General case' 0 N--CA 1.508 2.45 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.41 ' C ' ' CD1' ' A' ' 48' ' ' PHE . 13.5 p90 -143.28 166.72 23.96 Favored 'General case' 0 N--CA 1.514 2.732 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.904 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.495 ' SD ' ' O ' ' A' ' 50' ' ' LEU . 2.7 tmm? -115.11 149.04 38.19 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 115.103 1.519 . . . . 0.0 115.103 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.495 ' O ' ' SD ' ' A' ' 49' ' ' MET . 52.3 tp -90.6 121.03 32.17 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 113.343 -1.753 . . . . 0.0 112.19 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.69 -24.71 7.09 Favored Glycine 0 N--CA 1.499 2.838 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 53' ' ' GLN . 2.3 tppp? -113.37 36.84 3.4 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.413 ' C ' ' O ' ' A' ' 52' ' ' LYS . 83.3 mt-30 7.8 63.56 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 125.281 1.613 . . . . 0.0 114.165 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -82.89 -30.23 28.7 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.419 ' O ' ' O ' ' A' ' 56' ' ' ILE . 32.6 m -118.78 151.13 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.419 ' O ' ' O ' ' A' ' 55' ' ' VAL . 1.6 pt -46.9 -176.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.542 ' O ' ' N ' ' A' ' 59' ' ' TRP . 8.8 tpt180 -81.16 -61.01 2.08 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.124 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -35.8 -26.86 0.01 OUTLIER Glycine 0 N--CA 1.497 2.703 0 CA-C-O 122.196 0.887 . . . . 0.0 110.919 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.542 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.8 OUTLIER -91.85 -76.07 0.46 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.776 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -33.94 -51.48 0.41 Allowed 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 113.752 -1.567 . . . . 0.0 110.031 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -73.06 -54.47 8.46 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 113.218 -1.81 . . . . 0.0 106.574 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -55.07 -80.55 0.07 OUTLIER Glycine 0 N--CA 1.476 1.335 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.533 ' N ' ' O ' ' A' ' 59' ' ' TRP . 53.1 t -32.3 -48.45 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 112.675 0.621 . . . . 0.0 112.675 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.475 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -46.37 -60.52 2.28 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 124.262 1.982 . . . . 0.0 110.905 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -48.01 -12.19 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 108.948 -3.751 . . . . 0.0 108.856 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.475 ' H ' ' C ' ' A' ' 64' ' ' ALA . 21.0 mtp -97.7 159.64 14.8 Favored 'General case' 0 N--CA 1.512 2.655 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 80.4 p -117.08 156.88 26.82 Favored 'General case' 0 N--CA 1.509 2.498 0 CA-C-O 122.804 1.288 . . . . 0.0 113.716 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 62.5 t -49.55 97.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 112.037 -2.347 . . . . 0.0 114.858 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.11 5.2 25.28 Favored Glycine 0 N--CA 1.499 2.841 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.488 ' OE1' ' N ' ' A' ' 71' ' ' ARG . 0.9 OUTLIER -106.73 148.61 28.22 Favored 'General case' 0 N--CA 1.505 2.325 0 CA-C-O 122.099 0.952 . . . . 0.0 111.399 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.488 ' N ' ' OE1' ' A' ' 70' ' ' GLN . 18.9 ttp180 -127.58 140.64 51.98 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 113.516 -1.674 . . . . 0.0 110.089 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -144.8 178.83 7.72 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 112.605 -2.089 . . . . 0.0 115.662 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -126.78 105.0 8.36 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 110.933 -2.849 . . . . 0.0 103.585 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.8 mt -96.73 149.7 21.53 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 86.5 m -124.59 112.72 17.14 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.5 mt -105.19 143.83 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 CA-C-O 121.448 0.642 . . . . 0.0 110.908 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 36.8 p -110.02 150.79 41.91 Favored Pre-proline 0 N--CA 1.496 1.869 0 N-CA-C 105.604 -1.998 . . . . 0.0 105.604 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.524 ' O ' ' N ' ' A' ' 80' ' ' TYR . 19.3 Cg_endo -44.33 -55.71 3.02 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 121.967 1.778 . . . . 0.0 113.614 -171.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 12.8 p-10 -38.82 -17.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.524 ' N ' ' O ' ' A' ' 78' ' ' PRO . 4.8 m-85 . . . . . 0 N--CA 1.5 2.043 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 94.8 m . . . . . 0 N--CA 1.502 2.16 0 CA-C-O 118.872 -0.585 . . . . 0.0 110.812 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 32.6 mt -108.21 153.07 23.72 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 50.4 t -133.31 121.15 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -114.26 151.33 33.03 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -122.73 94.07 4.16 Favored 'General case' 0 N--CA 1.496 1.839 1 N-CA-C 98.937 -4.468 . . . . 0.0 98.937 179.376 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.414 HG12 ' N ' ' A' ' 102' ' ' GLU . 17.2 t -107.78 150.53 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.425 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.414 ' N ' HG12 ' A' ' 101' ' ' VAL . 39.1 tt0 -126.67 102.48 7.09 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 112.39 -2.186 . . . . 0.0 106.843 179.476 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 43.6 tp -73.31 126.5 30.26 Favored 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 101.823 -3.399 . . . . 0.0 101.823 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.9 mt -93.51 -54.05 3.82 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.877 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.46 -172.13 0.88 Allowed 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 118.366 -1.334 . . . . 0.0 110.621 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 19.1 mt -118.24 152.97 34.7 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.426 ' OXT' ' OE1' ' A' ' 107' ' ' GLU . 9.7 tm-20 . . . . . 0 N--CA 1.501 2.095 0 CA-C-O 116.099 -1.905 . . . . 0.0 109.002 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.473 ' C ' ' NE2' ' A' ' 3' ' ' GLN . 11.8 p . . . . . 0 N--CA 1.502 2.143 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.483 ' CD ' ' N ' ' A' ' 3' ' ' GLN . 14.9 mp0 -121.57 156.05 33.71 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 42.2 t -126.5 106.55 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -108.38 87.45 2.5 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 98.9 m -69.66 157.82 36.53 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.017 -1.073 . . . . 0.0 111.674 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 64.1 mt -121.94 -53.93 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 CA-C-N 114.195 -1.366 . . . . 0.0 107.631 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.417 ' O ' ' O ' ' A' ' 9' ' ' PRO . 51.8 m -123.09 80.22 51.5 Favored Pre-proline 0 N--CA 1.507 2.378 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.49 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.417 ' O ' ' O ' ' A' ' 8' ' ' SER . 6.9 Cg_exo -36.95 166.66 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.866 2.377 . . . . 0.0 114.104 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.51 -176.7 17.99 Favored Glycine 0 N--CA 1.5 2.96 0 N-CA-C 105.063 -3.215 . . . . 0.0 105.063 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.489 ' CG ' ' H ' ' A' ' 12' ' ' GLY . 14.4 p-10 -43.04 -59.08 2.16 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 118.557 1.178 . . . . 0.0 111.735 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.489 ' H ' ' CG ' ' A' ' 11' ' ' ASP . . . 110.06 22.34 6.6 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 108.541 -1.824 . . . . 0.0 108.541 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 60.0 mtt-85 -133.67 -31.38 1.19 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 114.994 -0.603 . . . . 0.0 112.392 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.0 m -109.11 124.85 51.45 Favored 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.375 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.47 ' N ' ' CD1' ' A' ' 15' ' ' PHE . 23.1 m-85 -127.28 176.1 2.88 Favored Pre-proline 0 N--CA 1.501 2.101 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -73.8 139.33 27.51 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 CA-C-N 119.51 0.861 . . . . 0.0 110.177 163.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -120.63 167.07 12.82 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 121.765 0.793 . . . . 0.0 109.264 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 62.8 mtt180 -70.26 127.6 33.35 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.763 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.32 -25.61 9.14 Favored Glycine 0 N--CA 1.498 2.78 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.501 ' O ' ' SD ' ' A' ' 49' ' ' MET . 84.1 mt-30 -109.37 175.62 5.38 Favored 'General case' 0 N--CA 1.505 2.276 0 CA-C-O 121.713 0.768 . . . . 0.0 111.429 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.9 m -107.23 163.86 12.66 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 114.611 -1.177 . . . . 0.0 108.47 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 55.6 m -114.39 145.62 41.6 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 103.718 -2.697 . . . . 0.0 103.718 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 64.4 t -122.89 101.08 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 102.22 -3.252 . . . . 0.0 102.22 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.42 HG21 ' CH2' ' A' ' 59' ' ' TRP . 2.7 m -124.12 151.54 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -179.465 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -130.15 119.45 23.02 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 103.841 -2.651 . . . . 0.0 103.841 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 26' ' ' TYR . 35.4 p90 -135.22 172.55 12.84 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 123.072 1.415 . . . . 0.0 114.592 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 61.4 m -134.34 116.14 14.88 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 102.865 -3.013 . . . . 0.0 102.865 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.62 137.42 13.61 Favored Glycine 0 N--CA 1.5 2.92 0 C-N-CA 119.918 -1.134 . . . . 0.0 112.003 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 35.0 ttm . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 179.987 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 71.6 t80 . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -137.7 123.5 20.0 Favored 'General case' 0 N--CA 1.505 2.323 0 CA-C-O 118.863 -0.589 . . . . 0.0 110.952 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -136.8 168.04 20.3 Favored 'General case' 0 N--CA 1.513 2.696 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.501 ' SD ' ' O ' ' A' ' 20' ' ' GLN . 44.6 tpp -107.1 132.35 53.1 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 114.111 -1.404 . . . . 0.0 113.866 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.0 tp -90.88 122.42 33.56 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 114.483 -1.235 . . . . 0.0 110.707 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.73 18.48 10.72 Favored Glycine 0 N--CA 1.5 2.91 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.483 ' O ' ' CB ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -118.75 -53.12 2.31 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.483 ' CB ' ' O ' ' A' ' 52' ' ' LYS . 47.9 tt0 100.92 70.56 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.208 0 O-C-N 125.812 1.945 . . . . 0.0 108.049 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -109.39 -33.71 6.75 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 114.182 -1.372 . . . . 0.0 108.708 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.4 m -115.15 153.03 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.291 0 CA-C-O 121.287 0.565 . . . . 0.0 110.4 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.2 pt -51.08 177.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.094 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.544 ' O ' ' N ' ' A' ' 59' ' ' TRP . 8.7 tpt180 -70.52 -60.76 2.07 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 120.232 -0.587 . . . . 0.0 109.442 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -24.24 -38.88 0.01 OUTLIER Glycine 0 N--CA 1.501 2.98 0 O-C-N 125.122 1.514 . . . . 0.0 112.718 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.544 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.6 OUTLIER -82.66 -71.38 0.49 Allowed 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 179.828 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -28.77 -54.62 0.12 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 125.266 1.604 . . . . 0.0 110.939 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -76.67 -53.53 7.88 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -50.83 -75.54 0.21 Allowed Glycine 0 N--CA 1.478 1.465 0 C-N-CA 119.207 -1.473 . . . . 0.0 110.287 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 59' ' ' TRP . 35.2 t -42.03 -50.77 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 C-N-CA 119.471 -0.891 . . . . 0.0 112.42 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.471 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -45.0 -62.04 1.39 Allowed 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 123.893 1.806 . . . . 0.0 111.434 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -47.15 -12.91 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 109.606 -3.452 . . . . 0.0 109.176 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.471 ' H ' ' C ' ' A' ' 64' ' ' ALA . 6.6 mtm -99.63 157.27 16.58 Favored 'General case' 0 N--CA 1.512 2.657 0 C-N-CA 118.503 -1.279 . . . . 0.0 107.638 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 84.4 p -118.65 148.24 42.94 Favored 'General case' 0 N--CA 1.507 2.398 0 CA-C-O 122.458 1.123 . . . . 0.0 113.412 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 52.9 t -40.82 100.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-N 112.775 -2.011 . . . . 0.0 113.829 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.19 10.97 12.74 Favored Glycine 0 N--CA 1.5 2.963 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -107.2 146.45 31.38 Favored 'General case' 0 N--CA 1.505 2.297 0 CA-C-O 121.681 0.753 . . . . 0.0 111.05 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.1 mtp85 -126.26 139.56 53.22 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -149.42 177.07 10.03 Favored 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 116.58 2.067 . . . . 0.0 116.58 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -127.92 107.1 9.57 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 102.531 -3.137 . . . . 0.0 102.531 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.8 mt -104.47 153.31 21.28 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 90.3 m -124.01 124.96 43.7 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 104.613 -2.366 . . . . 0.0 104.613 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.1 mt -116.95 136.34 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.402 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 61.1 p -111.92 154.11 44.27 Favored Pre-proline 0 N--CA 1.505 2.292 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -34.36 -53.05 0.6 Allowed 'Trans proline' 0 C--N 1.315 -1.187 0 C-N-CA 122.1 1.867 . . . . 0.0 114.297 -174.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 80' ' ' TYR . 1.8 p30 -37.34 -39.65 0.3 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.503 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.452 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 5.0 m-85 . . . . . 0 N--CA 1.493 1.676 0 CA-C-N 114.965 -1.016 . . . . 0.0 112.022 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 88.1 m . . . . . 0 N--CA 1.5 2.033 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 27.8 mt -115.86 155.21 28.33 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.8 t -136.43 124.51 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -118.39 150.7 39.1 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 122.305 1.05 . . . . 0.0 111.057 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -124.09 93.59 3.97 Favored 'General case' 0 N--CA 1.493 1.706 1 N-CA-C 98.926 -4.472 . . . . 0.0 98.926 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.419 HG12 ' N ' ' A' ' 102' ' ' GLU . 12.7 t -108.09 155.57 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.513 0 N-CA-C 117.033 2.234 . . . . 0.0 117.033 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.419 ' N ' HG12 ' A' ' 101' ' ' VAL . 31.5 tt0 -129.2 103.33 6.89 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 111.574 -2.557 . . . . 0.0 108.143 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 39.5 tp -77.86 118.44 20.19 Favored 'General case' 0 N--CA 1.506 2.363 0 N-CA-C 102.722 -3.066 . . . . 0.0 102.722 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.1 mt -87.3 -55.63 3.72 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 113.845 -1.525 . . . . 0.0 112.518 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -171.69 -170.08 0.75 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.334 -0.946 . . . . 0.0 110.962 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 21.2 mt -117.65 156.28 28.45 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 . . . . . 0 N--CA 1.503 2.191 0 CA-C-O 116.822 -1.561 . . . . 0.0 108.974 179.83 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.9 p . . . . . 0 N--CA 1.501 2.117 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -123.68 154.88 38.77 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.7 t -125.14 118.99 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -120.21 96.86 5.33 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 92.1 m -69.83 156.12 39.52 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.031 -1.068 . . . . 0.0 113.077 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 74.0 mt -122.52 -55.55 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 CA-C-N 113.693 -1.594 . . . . 0.0 107.471 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.422 ' O ' ' O ' ' A' ' 9' ' ' PRO . 34.2 t -122.95 82.48 50.35 Favored Pre-proline 0 N--CA 1.506 2.344 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.515 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 8' ' ' SER . 5.2 Cg_exo -36.23 161.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.391 2.061 . . . . 0.0 112.731 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -118.32 -174.62 16.39 Favored Glycine 0 N--CA 1.5 2.904 0 N-CA-C 106.482 -2.647 . . . . 0.0 106.482 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 11' ' ' ASP . 13.0 p-10 -39.77 -60.39 1.0 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.492 -0.883 . . . . 0.0 112.916 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.06 18.74 12.91 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 105.599 -3.001 . . . . 0.0 105.599 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 54.8 mtt-85 -127.13 -40.32 1.85 Allowed 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 113.773 -1.213 . . . . 0.0 112.214 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.6 m -108.21 139.58 42.69 Favored 'General case' 0 N--CA 1.506 2.341 0 CA-C-O 121.968 0.89 . . . . 0.0 112.726 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 50.8 m-85 -131.79 177.46 2.23 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -62.19 155.09 58.55 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 N-CA-C 109.805 -0.883 . . . . 0.0 109.805 161.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -119.73 166.61 12.99 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.921 0.867 . . . . 0.0 108.923 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 59.2 mtt85 -81.18 95.07 6.8 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.559 -1.201 . . . . 0.0 109.178 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.07 3.7 4.8 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -113.61 173.02 6.62 Favored 'General case' 0 N--CA 1.506 2.35 0 C-N-CA 120.219 -0.593 . . . . 0.0 109.513 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 97.8 m -118.08 117.86 30.35 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.591 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 24.8 m -69.66 148.61 49.07 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 87.5 t -122.13 101.61 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 101.679 -3.452 . . . . 0.0 101.679 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.427 HG21 ' CH2' ' A' ' 59' ' ' TRP . 3.0 m -125.38 151.04 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -129.04 117.67 21.26 Favored 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.434 ' CD2' ' CD2' ' A' ' 99' ' ' PHE . 41.9 p90 -136.27 -179.13 5.49 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 96.2 m -137.02 118.73 15.02 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 105.006 -2.22 . . . . 0.0 105.006 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -102.91 124.85 8.29 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 120.905 -0.665 . . . . 0.0 112.057 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 48.9 mtm . . . . . 0 N--CA 1.499 1.991 0 CA-C-O 122.041 0.924 . . . . 0.0 110.524 179.944 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 47.9 t80 . . . . . 0 N--CA 1.494 1.762 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -137.79 122.71 18.94 Favored 'General case' 0 N--CA 1.506 2.369 0 CA-C-O 119.109 -0.472 . . . . 0.0 111.128 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -137.71 175.4 9.63 Favored 'General case' 0 N--CA 1.513 2.69 0 CA-C-N 119.412 1.006 . . . . 0.0 112.381 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 42.2 ttm -117.67 144.06 45.58 Favored 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.1 tp -91.09 124.25 35.18 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 114.295 -1.32 . . . . 0.0 111.812 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.18 -18.07 14.28 Favored Glycine 0 N--CA 1.501 3.026 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.874 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.41 ' O ' ' C ' ' A' ' 53' ' ' GLN . 53.9 tttm -118.98 39.32 3.57 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 120.949 -0.3 . . . . 0.0 110.372 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 52' ' ' LYS . 15.1 pt20 14.12 68.26 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 125.262 1.601 . . . . 0.0 114.587 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -91.39 -27.3 18.42 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 113.758 -1.564 . . . . 0.0 106.869 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.427 ' O ' ' O ' ' A' ' 56' ' ' ILE . 26.8 m -118.8 154.6 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.235 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.427 ' O ' ' O ' ' A' ' 55' ' ' VAL . 12.7 pt -49.43 175.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 C-N-CA 119.568 -0.853 . . . . 0.0 108.908 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.537 ' O ' ' N ' ' A' ' 59' ' ' TRP . 32.4 ttp180 -72.24 -56.31 5.74 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.199 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -25.35 -38.52 0.01 OUTLIER Glycine 0 N--CA 1.499 2.886 0 O-C-N 124.773 1.296 . . . . 0.0 112.188 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.537 ' N ' ' O ' ' A' ' 57' ' ' ARG . 1.4 m95 -82.02 -74.26 0.35 Allowed 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 112.919 -1.64 . . . . 0.0 108.386 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 59' ' ' TRP . 29.2 tt0 -24.18 -54.72 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 125.932 2.02 . . . . 0.0 111.174 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -77.85 -54.81 5.89 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -48.56 -75.97 0.17 Allowed Glycine 0 N--CA 1.482 1.702 0 C-N-CA 119.84 -1.172 . . . . 0.0 110.391 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.529 ' N ' ' O ' ' A' ' 59' ' ' TRP . 23.1 t -44.03 -48.7 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 119.298 -0.961 . . . . 0.0 111.837 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.471 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -46.36 -58.93 3.28 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 123.948 1.832 . . . . 0.0 111.341 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -51.05 -8.81 0.05 OUTLIER 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 109.68 -3.418 . . . . 0.0 109.887 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.471 ' H ' ' C ' ' A' ' 64' ' ' ALA . 93.4 mtp -102.73 158.62 16.12 Favored 'General case' 0 N--CA 1.513 2.723 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 88.3 p -118.51 153.83 33.53 Favored 'General case' 0 N--CA 1.509 2.525 0 CA-C-O 122.775 1.274 . . . . 0.0 113.677 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 86.7 t -49.18 97.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 112.608 -2.087 . . . . 0.0 113.568 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.19 12.95 12.73 Favored Glycine 0 N--CA 1.499 2.869 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -107.65 143.54 35.99 Favored 'General case' 0 N--CA 1.505 2.305 0 CA-C-O 121.368 0.604 . . . . 0.0 109.781 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 25.4 ttt85 -124.88 140.85 52.55 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -149.7 176.47 10.65 Favored 'General case' 0 N--CA 1.502 2.175 0 CA-C-N 113.316 -1.765 . . . . 0.0 115.452 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -125.75 103.8 8.01 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 104.117 -2.549 . . . . 0.0 104.117 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.1 mt -98.26 145.93 26.15 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 89.5 m -117.35 104.07 10.76 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 33.9 mt -102.3 134.27 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.972 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.4 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -112.99 157.39 40.81 Favored Pre-proline 0 N--CA 1.501 2.123 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -37.37 -53.22 1.38 Allowed 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 123.148 2.565 . . . . 0.0 114.881 -166.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.524 ' O ' ' NH2' ' A' ' 57' ' ' ARG . 13.1 p-10 -45.39 -36.63 4.4 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.491 ' CZ ' ' NE ' ' A' ' 57' ' ' ARG . 4.6 m-85 . . . . . 0 N--CA 1.498 1.931 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 93.3 m . . . . . 0 N--CA 1.496 1.839 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 23.8 mt -103.78 152.87 21.35 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 57.3 t -133.24 103.93 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.434 ' CD2' ' CD2' ' A' ' 26' ' ' TYR . 2.7 m-85 -96.85 158.64 15.33 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 118.163 -1.415 . . . . 0.0 108.437 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -123.57 88.03 2.85 Favored 'General case' 0 N--CA 1.491 1.607 1 N-CA-C 97.511 -4.996 . . . . 0.0 97.511 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.3 t -101.47 146.3 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.518 0 N-CA-C 116.626 2.084 . . . . 0.0 116.626 -178.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -123.54 104.57 9.13 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 112.541 -2.118 . . . . 0.0 106.076 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 35.8 tp -76.93 120.25 21.79 Favored 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 102.868 -3.012 . . . . 0.0 102.868 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.6 mt -87.16 -57.54 2.92 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 113.913 -1.494 . . . . 0.0 112.123 -179.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -170.27 -169.45 0.84 Allowed 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 119.502 -0.879 . . . . 0.0 111.455 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 22.0 mt -118.12 156.18 29.14 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 . . . . . 0 N--CA 1.504 2.266 0 CA-C-O 116.164 -1.874 . . . . 0.0 109.597 179.911 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.3 p . . . . . 0 N--CA 1.501 2.124 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -120.64 149.65 42.15 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.7 t -125.56 111.28 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -109.92 97.46 6.97 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 85.6 m -69.93 155.33 40.73 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 118.87 -1.132 . . . . 0.0 112.546 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 72.3 mt -123.31 -54.16 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 CA-C-N 113.493 -1.685 . . . . 0.0 107.123 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.431 ' O ' ' O ' ' A' ' 9' ' ' PRO . 43.2 m -123.66 83.16 53.91 Favored Pre-proline 0 N--CA 1.506 2.335 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.463 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 8' ' ' SER . 4.6 Cg_exo -35.92 163.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.51 2.14 . . . . 0.0 112.971 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.11 -172.08 15.15 Favored Glycine 0 N--CA 1.502 3.059 0 N-CA-C 107.872 -2.091 . . . . 0.0 107.872 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 12' ' ' GLY . 1.4 p30 -39.63 -51.69 2.25 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.867 -0.733 . . . . 0.0 112.701 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.526 ' N ' ' OD1' ' A' ' 11' ' ' ASP . . . 100.88 -1.13 55.21 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 62.9 mtt180 -118.3 -37.08 3.4 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.8 m -104.77 128.27 52.85 Favored 'General case' 0 N--CA 1.504 2.271 0 C-N-CA 119.828 -0.749 . . . . 0.0 111.757 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 27.4 m-85 -129.01 172.39 7.18 Favored Pre-proline 0 N--CA 1.502 2.145 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -63.41 128.88 23.64 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 CA-C-N 119.915 1.005 . . . . 0.0 110.504 167.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -118.0 167.58 11.32 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 122.279 1.038 . . . . 0.0 110.61 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.577 HH12 ' CD2' ' A' ' 50' ' ' LEU . 5.2 tpp180 -68.73 123.51 21.11 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.11 -1.405 . . . . 0.0 109.684 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.86 -19.39 18.49 Favored Glycine 0 N--CA 1.499 2.889 0 C-N-CA 120.336 -0.935 . . . . 0.0 110.845 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -112.17 178.13 4.41 Favored 'General case' 0 N--CA 1.507 2.414 0 CA-C-O 121.695 0.759 . . . . 0.0 112.57 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 42.1 m -111.07 166.96 10.63 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.3 m -118.48 147.25 43.82 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 67.9 t -122.96 100.55 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 101.71 -3.441 . . . . 0.0 101.71 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.2 m -120.47 145.86 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.325 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -121.49 141.59 50.88 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 102.517 -3.142 . . . . 0.0 102.517 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -160.39 176.97 11.06 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 118.487 -1.285 . . . . 0.0 112.263 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 97.4 m -136.97 121.89 18.85 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 101.368 -3.568 . . . . 0.0 101.368 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -110.41 113.24 3.48 Favored Glycine 0 N--CA 1.499 2.864 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 39.1 ttm . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 179.918 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 68.1 t80 . . . . . 0 N--CA 1.493 1.678 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -141.87 135.66 29.74 Favored 'General case' 0 N--CA 1.517 2.898 0 N-CA-C 114.822 1.415 . . . . 0.0 114.822 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -148.03 172.14 14.72 Favored 'General case' 0 N--CA 1.514 2.736 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 43.9 ttm -116.16 148.93 39.85 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.815 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.577 ' CD2' HH12 ' A' ' 18' ' ' ARG . 65.2 tp -90.77 119.37 30.94 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.966 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.19 35.22 4.55 Favored Glycine 0 N--CA 1.497 2.7 0 N-CA-C 108.591 -1.804 . . . . 0.0 108.591 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.488 ' O ' ' CB ' ' A' ' 53' ' ' GLN . 63.5 tttp -128.11 -54.16 1.29 Allowed 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.488 ' CB ' ' O ' ' A' ' 52' ' ' LYS . 63.7 tp60 100.56 66.21 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 O-C-N 125.757 1.91 . . . . 0.0 110.267 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -110.1 -36.64 5.79 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.422 ' O ' ' O ' ' A' ' 56' ' ' ILE . 11.5 m -118.73 152.43 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.737 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.422 ' O ' ' O ' ' A' ' 55' ' ' VAL . 3.8 pt -51.46 -174.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-N 114.176 -1.375 . . . . 0.0 110.043 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.539 ' O ' ' N ' ' A' ' 59' ' ' TRP . 45.2 ttm180 -84.58 -54.64 4.6 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 122.391 -0.193 . . . . 0.0 110.902 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -41.13 -20.57 0.04 OUTLIER Glycine 0 N--CA 1.492 2.422 0 C-N-CA 120.201 -1.0 . . . . 0.0 111.559 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.54 ' O ' ' N ' ' A' ' 63' ' ' VAL . 0.1 OUTLIER -92.25 -77.0 0.44 Allowed 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -35.76 -48.98 0.57 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.912 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -73.45 -54.63 7.82 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 105.739 -1.949 . . . . 0.0 105.739 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -53.68 -81.0 0.06 OUTLIER Glycine 0 N--CA 1.477 1.408 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.54 ' N ' ' O ' ' A' ' 59' ' ' TRP . 47.8 t -30.4 -46.83 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.458 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -46.02 -58.69 3.38 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 123.994 1.854 . . . . 0.0 110.177 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -50.12 -9.76 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 109.39 -3.55 . . . . 0.0 109.906 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.458 ' H ' ' C ' ' A' ' 64' ' ' ALA . 88.8 mtp -101.3 156.38 17.48 Favored 'General case' 0 N--CA 1.513 2.686 0 C-N-CA 119.102 -1.039 . . . . 0.0 108.528 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 83.0 p -115.97 148.93 39.57 Favored 'General case' 0 N--CA 1.506 2.335 0 CA-C-O 122.418 1.104 . . . . 0.0 113.003 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 90.6 t -41.57 94.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 112.846 -1.979 . . . . 0.0 113.962 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 113.28 16.92 7.98 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -108.17 144.08 36.09 Favored 'General case' 0 N--CA 1.507 2.379 0 C-N-CA 120.072 -0.651 . . . . 0.0 111.085 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 24.7 ttt85 -126.28 139.44 53.31 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -147.69 176.14 10.34 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-N 112.967 -1.924 . . . . 0.0 115.416 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -127.19 103.99 7.72 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 103.56 -2.756 . . . . 0.0 103.56 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.1 mp -97.78 146.03 25.8 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.161 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.3 m -119.34 107.15 13.03 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 104.505 -2.405 . . . . 0.0 104.505 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.4 mt -101.89 140.69 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.23 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.424 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 52.0 p -112.07 154.66 44.19 Favored Pre-proline 0 N--CA 1.504 2.229 0 CA-C-N 114.337 -1.302 . . . . 0.0 107.831 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -37.54 -54.77 1.15 Allowed 'Trans proline' 0 C--N 1.313 -1.316 0 C-N-CA 122.023 1.815 . . . . 0.0 113.836 -174.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 2.0 p-10 -34.12 -38.48 0.06 Allowed 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.895 -1.048 . . . . 0.0 113.095 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 . . . . . 0 N--CA 1.496 1.852 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.492 -179.584 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 66.3 m . . . . . 0 N--CA 1.498 1.946 0 CA-C-O 119.14 -0.457 . . . . 0.0 111.317 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 16.7 mt -101.54 143.3 31.71 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.8 t -131.6 112.65 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -106.25 163.3 12.92 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 122.519 1.152 . . . . 0.0 109.399 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -129.1 90.27 3.0 Favored 'General case' 0 N--CA 1.492 1.649 1 N-CA-C 98.222 -4.733 . . . . 0.0 98.222 179.211 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 16.1 t -105.68 151.43 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.51 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -127.13 103.35 7.39 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 111.806 -2.452 . . . . 0.0 107.979 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 42.4 tp -72.74 120.86 18.94 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 102.177 -3.268 . . . . 0.0 102.177 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 15.8 mt -90.22 -55.57 3.55 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -165.29 175.54 9.12 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.045 -1.062 . . . . 0.0 111.483 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.429 ' O ' ' OE1' ' A' ' 107' ' ' GLU . 18.2 mt -117.26 146.31 43.38 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.429 ' OE1' ' O ' ' A' ' 106' ' ' LEU . 5.7 mm-40 . . . . . 0 N--CA 1.505 2.32 0 CA-C-O 116.087 -1.911 . . . . 0.0 109.9 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.5 p . . . . . 0 N--CA 1.504 2.253 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.527 HE22 ' C ' ' A' ' 4' ' ' VAL . 4.7 tm0? -117.87 149.7 40.42 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.527 ' C ' HE22 ' A' ' 3' ' ' GLN . 40.5 t -123.51 101.73 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.524 ' OE2' ' NZ ' ' A' ' 73' ' ' LYS . 39.1 tt0 -103.24 107.88 18.87 Favored 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 93.9 m -83.65 154.14 23.86 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 122.229 1.014 . . . . 0.0 112.51 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 56.3 mt -124.15 -50.29 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 CA-C-N 113.313 -1.767 . . . . 0.0 107.282 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 9' ' ' PRO . 48.1 t -122.14 79.97 43.63 Favored Pre-proline 0 N--CA 1.507 2.384 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.498 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 8' ' ' SER . 5.8 Cg_exo -37.3 165.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.735 2.29 . . . . 0.0 113.528 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.43 -169.83 13.52 Favored Glycine 0 N--CA 1.5 2.914 0 N-CA-C 106.234 -2.746 . . . . 0.0 106.234 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.521 ' N ' ' OD1' ' A' ' 11' ' ' ASP . 13.0 p-10 -39.76 -60.68 0.95 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.518 -0.873 . . . . 0.0 112.678 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.22 14.32 18.85 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 106.844 -2.502 . . . . 0.0 106.844 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 45.6 mtm180 -128.9 -36.32 1.8 Allowed 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 114.468 -0.866 . . . . 0.0 113.324 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 36.6 m -107.65 138.36 44.01 Favored 'General case' 0 N--CA 1.508 2.468 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.457 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 61.7 m-85 -130.91 176.25 3.03 Favored Pre-proline 0 N--CA 1.497 1.916 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -69.84 133.61 25.85 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 CA-C-N 119.63 0.904 . . . . 0.0 111.149 164.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.0 mtmp? -119.48 162.32 19.07 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 122.313 1.054 . . . . 0.0 108.653 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 58.4 mtt-85 -61.86 144.28 55.12 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 114.39 -1.277 . . . . 0.0 107.714 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 107.17 -31.31 8.25 Favored Glycine 0 N--CA 1.498 2.781 0 C-N-CA 119.564 -1.303 . . . . 0.0 110.589 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -109.33 176.86 4.93 Favored 'General case' 0 N--CA 1.506 2.369 0 CA-C-O 121.781 0.801 . . . . 0.0 112.881 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 63.7 m -114.71 124.82 52.77 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 114.387 -1.279 . . . . 0.0 109.828 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 22.3 m -69.53 152.14 45.17 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.2 t -128.07 106.49 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 102.117 -3.29 . . . . 0.0 102.117 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.0 m -125.52 148.32 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.423 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -122.82 140.41 52.96 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 101.856 -3.387 . . . . 0.0 101.856 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -160.13 174.73 13.85 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 117.696 -1.602 . . . . 0.0 113.674 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.5 m -136.64 118.84 15.53 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 104.57 -2.382 . . . . 0.0 104.57 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.64 135.33 12.45 Favored Glycine 0 N--CA 1.503 3.112 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 63.9 mtp . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 122.102 0.953 . . . . 0.0 110.233 -179.821 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 72.2 t80 . . . . . 0 N--CA 1.5 2.036 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -140.9 133.22 28.25 Favored 'General case' 0 N--CA 1.514 2.731 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -139.04 174.92 10.01 Favored 'General case' 0 N--CA 1.515 2.779 0 CA-C-N 119.508 1.049 . . . . 0.0 111.771 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 44.6 ttm -115.24 134.66 54.94 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.3 tp -91.02 139.1 31.08 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 113.496 -1.684 . . . . 0.0 109.82 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 127.99 -36.26 2.55 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.284 -1.527 . . . . 0.0 109.284 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.411 ' O ' ' C ' ' A' ' 53' ' ' GLN . 19.7 tptp -130.38 42.67 3.23 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 119.147 -0.454 . . . . 0.0 112.087 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.411 ' C ' ' O ' ' A' ' 52' ' ' LYS . 65.7 tt0 23.98 77.32 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 124.578 1.173 . . . . 0.0 112.991 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.417 ' O ' ' OE1' ' A' ' 54' ' ' GLU . 8.1 tm-20 -84.3 -27.2 27.98 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.436 ' O ' ' O ' ' A' ' 56' ' ' ILE . 16.3 m -119.4 154.44 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.439 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.588 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.436 ' O ' ' O ' ' A' ' 55' ' ' VAL . 3.1 pt -45.8 174.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 C-N-CA 118.653 -1.219 . . . . 0.0 111.913 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.54 ' O ' ' N ' ' A' ' 59' ' ' TRP . 5.0 tpt180 -71.01 -58.96 3.06 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.883 -1.053 . . . . 0.0 113.171 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -32.52 -30.53 0.01 OUTLIER Glycine 0 N--CA 1.5 2.947 0 CA-C-O 122.825 1.236 . . . . 0.0 111.531 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.54 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.8 OUTLIER -92.2 -76.2 0.46 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 112.924 -1.638 . . . . 0.0 109.557 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.514 ' OE1' ' NH1' ' A' ' 57' ' ' ARG . 3.8 tm-20 -32.02 -50.3 0.21 Allowed 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.1 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -73.65 -56.39 5.06 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -51.35 -77.55 0.13 Allowed Glycine 0 N--CA 1.481 1.637 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.526 ' N ' ' O ' ' A' ' 59' ' ' TRP . 40.2 t -36.05 -45.87 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.435 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -50.09 -53.48 26.92 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 123.715 1.721 . . . . 0.0 109.618 179.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -61.97 0.29 0.41 Allowed 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 110.399 -3.091 . . . . 0.0 110.692 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.435 ' H ' ' C ' ' A' ' 64' ' ' ALA . 50.8 ttm -110.09 151.8 26.77 Favored 'General case' 0 N--CA 1.51 2.534 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 80.4 p -115.85 153.57 31.26 Favored 'General case' 0 N--CA 1.509 2.512 0 CA-C-O 122.832 1.301 . . . . 0.0 113.922 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 79.6 t -45.23 98.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-N 112.324 -2.216 . . . . 0.0 114.967 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.46 10.5 21.63 Favored Glycine 0 N--CA 1.498 2.795 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -108.58 152.13 25.18 Favored 'General case' 0 N--CA 1.509 2.517 0 CA-C-O 122.384 1.088 . . . . 0.0 111.249 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 -131.83 141.25 49.38 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 113.027 -1.897 . . . . 0.0 108.357 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -148.07 177.91 8.98 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 112.888 -1.96 . . . . 0.0 114.223 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.573 ' HB3' ' HZ3' ' A' ' 73' ' ' LYS . 6.3 ttpm? -122.8 103.55 8.71 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 102.986 -2.968 . . . . 0.0 102.986 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.7 mt -96.49 145.06 26.02 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 90.7 m -117.45 107.62 14.54 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 104.349 -2.463 . . . . 0.0 104.349 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 35.8 mt -101.55 140.05 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.665 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.454 ' HG ' ' CG ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -114.24 160.42 32.76 Favored Pre-proline 0 N--CA 1.497 1.887 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -45.09 -52.69 6.11 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.39 2.06 . . . . 0.0 112.736 -172.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.454 ' CG ' ' HG ' ' A' ' 77' ' ' SER . 24.5 p30 -39.66 -29.85 0.06 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 . . . . . 0 N--CA 1.501 2.106 0 N-CA-C 115.089 1.515 . . . . 0.0 115.089 -179.524 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 25.5 m . . . . . 0 N--CA 1.495 1.817 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 29.7 mt -109.17 151.65 26.19 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 104.929 -2.248 . . . . 0.0 104.929 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.4 t -134.81 102.7 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -96.49 163.38 13.07 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 117.83 -1.548 . . . . 0.0 107.812 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -125.41 87.7 2.74 Favored 'General case' 0 N--CA 1.492 1.633 1 N-CA-C 95.559 -5.719 . . . . 0.0 95.559 179.108 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 16.8 t -100.07 147.98 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.423 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -127.18 103.75 7.59 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 112.463 -2.153 . . . . 0.0 107.538 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 37.5 tp -74.39 114.37 12.68 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 102.866 -3.013 . . . . 0.0 102.866 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.1 mt -77.11 -53.97 7.11 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.187 -179.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 9.0 mtpt -174.5 -167.21 0.3 Allowed 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.64 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 22.5 mt -117.53 154.28 31.74 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 . . . . . 0 N--CA 1.501 2.123 0 CA-C-O 116.156 -1.878 . . . . 0.0 108.528 179.84 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.4 p . . . . . 0 N--CA 1.502 2.162 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -122.3 154.7 37.25 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 57.2 t -126.52 109.11 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 CA-C-N 115.197 -0.91 . . . . 0.0 108.567 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -109.9 96.0 5.96 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 89.7 m -69.89 156.33 39.24 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 118.813 -1.155 . . . . 0.0 113.106 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 69.1 mt -122.49 -54.72 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-N 113.361 -1.745 . . . . 0.0 107.356 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.416 ' O ' ' O ' ' A' ' 9' ' ' PRO . 48.6 m -123.85 82.43 55.26 Favored Pre-proline 0 N--CA 1.506 2.372 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.574 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.416 ' O ' ' O ' ' A' ' 8' ' ' SER . 5.3 Cg_exo -36.36 163.91 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.447 2.098 . . . . 0.0 113.176 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -118.02 -172.51 15.77 Favored Glycine 0 N--CA 1.5 2.961 0 N-CA-C 104.88 -3.288 . . . . 0.0 104.88 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.464 ' CG ' ' H ' ' A' ' 12' ' ' GLY . 10.6 p-10 -45.88 -58.46 3.51 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 118.635 1.218 . . . . 0.0 111.108 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.464 ' H ' ' CG ' ' A' ' 11' ' ' ASP . . . 106.5 27.02 5.68 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 107.246 -2.341 . . . . 0.0 107.246 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 57.7 mtt85 -132.39 -35.32 1.17 Allowed 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 114.457 -0.871 . . . . 0.0 111.871 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.8 m -111.28 136.8 49.86 Favored 'General case' 0 N--CA 1.506 2.326 0 CA-C-O 121.703 0.763 . . . . 0.0 112.848 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.448 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 59.0 m-85 -132.14 176.11 3.16 Favored Pre-proline 0 N--CA 1.496 1.851 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -70.91 140.24 37.92 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 CA-C-N 119.508 0.86 . . . . 0.0 111.484 163.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -122.74 169.95 10.55 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 121.716 0.77 . . . . 0.0 109.009 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.1 mtp-105 -70.23 126.34 29.37 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.078 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.42 -19.3 13.04 Favored Glycine 0 N--CA 1.498 2.775 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -108.56 174.12 6.02 Favored 'General case' 0 N--CA 1.504 2.225 0 CA-C-O 121.847 0.832 . . . . 0.0 111.391 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 42.5 m -118.82 129.93 55.49 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 114.039 -1.437 . . . . 0.0 107.753 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 59.3 m -78.75 149.45 32.69 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.5 t -121.85 101.6 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 103.12 -2.918 . . . . 0.0 103.12 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.0 m -121.59 150.69 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.49 0 N-CA-C 117.248 2.314 . . . . 0.0 117.248 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -123.31 107.04 11.22 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 179.346 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -127.59 170.15 12.95 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-O 123.237 1.494 . . . . 0.0 114.589 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 98.1 m -139.29 119.5 13.68 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 102.754 -3.054 . . . . 0.0 102.754 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.53 137.63 14.23 Favored Glycine 0 N--CA 1.501 3.001 0 C-N-CA 120.073 -1.06 . . . . 0.0 110.995 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 40.5 ttm . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 -179.964 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 67.2 t80 . . . . . 0 N--CA 1.5 2.041 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.49 116.29 14.03 Favored 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -132.92 172.63 12.35 Favored 'General case' 0 N--CA 1.512 2.63 0 C-N-CA 119.797 -0.761 . . . . 0.0 111.298 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.9 ttm -119.89 153.65 35.55 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.4 tp -90.93 125.27 35.72 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.822 -1.535 . . . . 0.0 110.491 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.18 -24.57 7.33 Favored Glycine 0 N--CA 1.501 2.983 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 54' ' ' GLU . 52.8 tttp -116.11 39.35 3.1 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' ' 52' ' ' LYS . 86.5 mt-30 1.49 61.77 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 125.794 1.934 . . . . 0.0 114.384 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 52' ' ' LYS . 43.7 tt0 -75.21 -23.38 57.61 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 113.715 -1.584 . . . . 0.0 107.406 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.5 m -113.15 -178.45 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 18.6 pt -90.26 167.04 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 C-N-CA 118.998 -1.081 . . . . 0.0 110.868 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.531 ' O ' ' N ' ' A' ' 59' ' ' TRP . 0.7 OUTLIER -45.69 -70.22 0.11 Allowed 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 114.311 -1.313 . . . . 0.0 111.138 -179.774 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -26.47 -36.66 0.01 OUTLIER Glycine 0 N--CA 1.496 2.654 0 O-C-N 125.175 1.547 . . . . 0.0 112.799 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.531 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.8 OUTLIER -83.59 -68.36 0.72 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.819 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.463 ' OE1' ' N ' ' A' ' 61' ' ' GLU . 10.1 tm-20 -33.73 -53.45 0.44 Allowed 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 113.934 -1.485 . . . . 0.0 110.721 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.463 ' N ' ' OE1' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -73.71 -57.42 4.0 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 104.777 -2.305 . . . . 0.0 104.777 179.707 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -46.46 -78.57 0.08 OUTLIER Glycine 0 N--CA 1.485 1.963 0 C-N-CA 119.554 -1.307 . . . . 0.0 111.061 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 59' ' ' TRP . 32.3 t -39.63 -47.32 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 114.948 -0.626 . . . . 0.0 111.932 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.404 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -50.1 -51.27 44.32 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 123.265 1.507 . . . . 0.0 110.499 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -65.94 2.98 0.9 Allowed 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 111.216 -2.72 . . . . 0.0 111.507 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.404 ' H ' ' C ' ' A' ' 64' ' ' ALA . 60.0 ttm -106.61 151.99 24.32 Favored 'General case' 0 N--CA 1.509 2.493 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 179.432 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 92.0 p -116.49 151.98 35.0 Favored 'General case' 0 N--CA 1.51 2.566 0 CA-C-O 122.69 1.233 . . . . 0.0 113.541 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 86.0 t -45.0 97.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 112.597 -2.092 . . . . 0.0 114.755 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.35 8.42 23.27 Favored Glycine 0 N--CA 1.5 2.937 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -105.4 145.31 30.97 Favored 'General case' 0 N--CA 1.506 2.361 0 CA-C-O 121.648 0.737 . . . . 0.0 111.566 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.9 ttt85 -126.17 141.45 51.93 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.261 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -149.54 177.52 9.66 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 113.007 -1.906 . . . . 0.0 115.507 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -127.03 105.14 8.39 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 103.07 -2.937 . . . . 0.0 103.07 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.41 ' N ' HD12 ' A' ' 74' ' ' LEU . 5.1 mp -101.67 151.55 21.89 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 119.766 -0.774 . . . . 0.0 109.882 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 86.3 m -121.61 121.73 38.05 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 25.6 mt -111.41 139.92 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.429 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 66.8 p -113.87 154.35 45.92 Favored Pre-proline 0 N--CA 1.503 2.22 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -37.55 -54.11 1.28 Allowed 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 121.784 1.656 . . . . 0.0 113.192 -174.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 0.9 OUTLIER -34.66 -35.87 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.445 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 . . . . . 0 N--CA 1.495 1.795 0 CA-C-N 114.685 -1.143 . . . . 0.0 112.049 -179.768 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 68.9 m . . . . . 0 N--CA 1.498 1.96 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 31.5 mt -116.82 149.59 39.74 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.6 t -132.37 123.03 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -115.77 157.13 24.8 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 122.023 0.916 . . . . 0.0 110.166 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -127.72 90.82 3.17 Favored 'General case' 0 N--CA 1.493 1.689 1 N-CA-C 99.194 -4.372 . . . . 0.0 99.194 179.294 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.4 t -105.32 151.34 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.54 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -127.92 98.09 5.03 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 112.327 -2.215 . . . . 0.0 107.838 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 56.0 tp -69.87 119.44 14.1 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 11.4 mt -82.35 -55.97 4.18 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 113.902 -1.499 . . . . 0.0 110.639 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -173.95 -168.09 0.39 Allowed 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 114.71 -1.132 . . . . 0.0 111.065 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 25.7 mt -114.82 160.02 19.94 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 . . . . . 0 N--CA 1.504 2.251 0 CA-C-O 116.241 -1.838 . . . . 0.0 108.236 179.705 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.503 2.217 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -124.31 151.89 43.74 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.0 t -123.09 115.79 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -117.78 97.67 5.96 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 94.7 m -69.75 156.52 38.87 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.154 -1.018 . . . . 0.0 112.734 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.1 mt -121.38 -58.52 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.531 ' CB ' ' NH1' ' A' ' 71' ' ' ARG . 48.3 m -121.64 84.6 43.07 Favored Pre-proline 0 N--CA 1.501 2.086 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.877 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 8' ' ' SER . 6.8 Cg_exo -36.23 163.79 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.397 2.065 . . . . 0.0 113.264 178.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.2 -173.63 14.7 Favored Glycine 0 N--CA 1.499 2.885 0 N-CA-C 105.555 -3.018 . . . . 0.0 105.555 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 11' ' ' ASP . 13.0 p-10 -39.71 -59.87 1.08 Allowed 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.809 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.15 20.06 11.76 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 105.356 -3.098 . . . . 0.0 105.356 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 46.4 mtm180 -128.21 -38.5 1.78 Allowed 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 113.699 -1.251 . . . . 0.0 112.733 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.0 m -108.18 135.29 49.77 Favored 'General case' 0 N--CA 1.505 2.315 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.441 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 67.6 m-85 -130.94 177.16 2.37 Favored Pre-proline 0 N--CA 1.495 1.796 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -66.22 153.27 78.7 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 CA-C-N 119.408 0.824 . . . . 0.0 110.806 160.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -122.65 170.88 9.58 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 121.759 0.79 . . . . 0.0 109.361 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 42.4 mtp-105 -78.22 96.63 5.27 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.096 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.73 10.56 3.92 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -114.74 172.09 7.25 Favored 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 74.7 m -121.86 112.27 18.13 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.25 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 22.5 m -69.54 147.35 50.92 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.758 0.789 . . . . 0.0 109.518 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.1 t -123.09 112.31 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 101.592 -3.484 . . . . 0.0 101.592 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.0 m -122.44 151.62 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -120.38 99.21 6.44 Favored 'General case' 0 N--CA 1.508 2.463 0 CA-C-N 112.71 -2.041 . . . . 0.0 106.473 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.41 ' CD2' ' CD2' ' A' ' 99' ' ' PHE . 28.0 p90 -132.29 173.8 10.89 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.6 m -134.7 117.92 16.56 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 102.628 -3.101 . . . . 0.0 102.628 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.57 120.8 6.73 Favored Glycine 0 N--CA 1.503 3.157 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 37.4 tpp . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -179.659 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 69.3 t80 . . . . . 0 N--CA 1.486 1.372 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -133.05 143.9 49.67 Favored 'General case' 0 N--CA 1.514 2.753 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -149.07 174.64 12.1 Favored 'General case' 0 N--CA 1.504 2.242 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.156 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 41.6 ttm -118.04 142.74 47.06 Favored 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.3 tp -91.02 120.63 32.16 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.953 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.08 24.18 9.95 Favored Glycine 0 N--CA 1.5 2.903 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.48 ' O ' ' CB ' ' A' ' 53' ' ' GLN . 15.6 tppt? -125.29 -55.94 1.54 Allowed 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.48 ' CB ' ' O ' ' A' ' 52' ' ' LYS . 46.3 tt0 100.81 68.85 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 O-C-N 126.0 2.063 . . . . 0.0 108.29 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -109.12 -36.24 6.11 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 113.939 -1.482 . . . . 0.0 107.459 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.415 ' O ' ' O ' ' A' ' 56' ' ' ILE . 15.8 m -111.05 151.77 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.415 ' O ' ' O ' ' A' ' 55' ' ' VAL . 15.7 pt -48.48 174.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 C-N-CA 118.276 -1.37 . . . . 0.0 111.038 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.544 ' O ' ' N ' ' A' ' 59' ' ' TRP . 46.5 ttm180 -69.59 -63.28 1.1 Allowed 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -28.78 -34.73 0.01 OUTLIER Glycine 0 N--CA 1.499 2.837 0 O-C-N 124.472 1.107 . . . . 0.0 112.356 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.544 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.5 OUTLIER -81.42 -74.53 0.33 Allowed 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 113.177 -1.511 . . . . 0.0 107.553 179.877 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.518 ' OE1' ' N ' ' A' ' 61' ' ' GLU . 10.9 tm-20 -33.86 -51.37 0.4 Allowed 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.742 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.518 ' N ' ' OE1' ' A' ' 60' ' ' GLU . 17.7 tp10 -72.7 -55.48 6.73 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 112.544 -2.116 . . . . 0.0 108.095 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -55.29 -72.74 0.51 Allowed Glycine 0 N--CA 1.477 1.408 0 C-N-CA 119.246 -1.454 . . . . 0.0 110.17 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.498 ' N ' ' O ' ' A' ' 59' ' ' TRP . 40.6 t -39.56 -49.56 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 120.126 -0.629 . . . . 0.0 112.308 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.477 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -47.22 -62.09 1.58 Allowed 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 124.037 1.875 . . . . 0.0 110.139 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -48.43 -12.7 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 109.654 -3.43 . . . . 0.0 108.764 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.477 ' H ' ' C ' ' A' ' 64' ' ' ALA . 52.1 ttp -108.95 156.01 20.21 Favored 'General case' 0 N--CA 1.509 2.479 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.4 p -110.94 161.76 15.52 Favored 'General case' 0 N--CA 1.509 2.519 0 N-CA-C 116.338 1.977 . . . . 0.0 116.338 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 86.2 t -56.32 102.58 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-N 110.727 -2.942 . . . . 0.0 113.482 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.56 6.61 23.27 Favored Glycine 0 N--CA 1.499 2.867 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -107.12 148.86 28.29 Favored 'General case' 0 N--CA 1.504 2.27 0 CA-C-O 122.097 0.951 . . . . 0.0 110.29 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.531 ' NH1' ' CB ' ' A' ' 8' ' ' SER . 34.8 mtm-85 -122.35 128.35 50.89 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 113.577 -1.647 . . . . 0.0 107.977 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -134.91 172.02 13.58 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -124.57 103.17 8.0 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 102.766 -3.05 . . . . 0.0 102.766 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.8 mt -98.46 146.93 25.25 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.1 m -117.52 111.06 18.73 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 102.473 -3.158 . . . . 0.0 102.473 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 27.2 mt -109.41 137.79 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-O 121.462 0.649 . . . . 0.0 111.53 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 27.1 p -104.63 152.51 39.44 Favored Pre-proline 0 N--CA 1.504 2.27 0 CA-C-N 113.804 -1.543 . . . . 0.0 110.082 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -47.86 -38.83 31.2 Favored 'Trans proline' 0 N--CA 1.488 1.177 0 C-N-CA 122.574 2.183 . . . . 0.0 113.332 -173.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 7.0 p-10 -48.81 -40.44 29.22 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.101 -0.64 . . . . 0.0 110.943 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.7 m-30 . . . . . 0 N--CA 1.49 1.527 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.884 -179.745 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 87.3 m . . . . . 0 N--CA 1.494 1.727 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 20.7 mt -97.75 147.19 24.63 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 103.893 -2.632 . . . . 0.0 103.893 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 56.5 t -132.71 124.11 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.41 ' CD2' ' CD2' ' A' ' 26' ' ' TYR . 2.0 m-85 -115.5 167.82 10.55 Favored 'General case' 0 N--CA 1.507 2.387 0 CA-C-O 123.264 1.507 . . . . 0.0 110.477 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -130.28 88.7 2.68 Favored 'General case' 0 N--CA 1.49 1.544 1 N-CA-C 98.222 -4.733 . . . . 0.0 98.222 179.102 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.5 t -100.95 151.46 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.442 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 -179.034 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 72.8 tt0 -127.27 97.36 4.88 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 112.377 -2.192 . . . . 0.0 106.806 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 43.8 tp -68.25 122.72 18.92 Favored 'General case' 0 N--CA 1.506 2.373 0 C-N-CA 115.591 -2.444 . . . . 0.0 104.936 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 11.4 mt -85.42 -62.29 1.56 Allowed 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.92 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.469 ' HG2' ' H ' ' A' ' 106' ' ' LEU . 34.1 ttpt -170.77 -175.24 1.76 Allowed 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 118.892 -1.123 . . . . 0.0 109.826 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.469 ' H ' ' HG2' ' A' ' 105' ' ' LYS . 24.2 mt -108.94 156.31 19.86 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 . . . . . 0 N--CA 1.504 2.271 0 CA-C-O 116.037 -1.935 . . . . 0.0 109.686 179.955 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.2 p . . . . . 0 N--CA 1.502 2.167 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -119.51 151.25 38.9 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 86.6 t -129.41 98.11 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.142 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -102.0 117.16 34.23 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 104.879 -2.267 . . . . 0.0 104.879 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 92.8 m -91.7 154.86 18.71 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 122.054 0.93 . . . . 0.0 111.729 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 62.5 mt -123.53 -51.11 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 9' ' ' PRO . 33.8 m -121.46 81.26 38.79 Favored Pre-proline 0 N--CA 1.509 2.516 0 C-N-CA 120.271 -0.572 . . . . 0.0 112.038 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 8' ' ' SER . 5.3 Cg_exo -37.33 164.75 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.373 2.049 . . . . 0.0 112.578 178.073 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.11 -171.97 14.37 Favored Glycine 0 N--CA 1.5 2.926 0 N-CA-C 107.048 -2.421 . . . . 0.0 107.048 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 12' ' ' GLY . 1.1 p30 -39.55 -52.29 2.18 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.707 -0.797 . . . . 0.0 112.689 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.476 ' N ' ' OD1' ' A' ' 11' ' ' ASP . . . 100.51 5.14 54.45 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 108.44 -1.864 . . . . 0.0 108.44 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 32.3 mtp85 -121.45 -35.76 3.2 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 42.4 m -107.7 138.43 43.94 Favored 'General case' 0 N--CA 1.509 2.488 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.452 ' N ' ' CD1' ' A' ' 15' ' ' PHE . 35.0 m-85 -133.09 175.41 3.73 Favored Pre-proline 0 N--CA 1.498 1.952 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -66.27 145.63 78.58 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 CA-C-N 119.769 0.953 . . . . 0.0 109.967 165.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -118.96 169.89 9.5 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 122.373 1.083 . . . . 0.0 111.969 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 25.3 ttt85 -79.2 103.18 8.96 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 113.805 -1.543 . . . . 0.0 109.89 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.44 -10.09 6.49 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 108.353 -1.899 . . . . 0.0 108.353 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -114.93 176.1 5.2 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 89.2 m -112.62 163.2 14.81 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 2.2 m -114.27 143.26 45.14 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 104.613 -2.366 . . . . 0.0 104.613 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.8 t -117.72 102.5 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 103.397 -2.816 . . . . 0.0 103.397 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.8 m -122.46 152.0 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.363 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 -129.63 128.12 41.98 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 102.721 -3.066 . . . . 0.0 102.721 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -139.77 176.23 8.91 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 115.335 1.605 . . . . 0.0 115.335 -179.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 91.7 m -132.87 121.55 23.08 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 103.246 -2.872 . . . . 0.0 103.246 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.84 123.15 7.55 Favored Glycine 0 N--CA 1.503 3.138 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 45.3 ttp . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.704 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 65.5 t80 . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm -131.48 119.92 22.25 Favored 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -138.83 170.94 15.09 Favored 'General case' 0 N--CA 1.513 2.688 0 C-N-CA 119.306 -0.958 . . . . 0.0 112.402 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 43.1 ttm -115.75 154.6 29.29 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.1 tp -90.92 120.71 32.15 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.86 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.89 12.84 48.66 Favored Glycine 0 N--CA 1.499 2.84 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.303 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.427 ' O ' ' OE2' ' A' ' 54' ' ' GLU . 59.3 tttm -121.85 23.06 10.24 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 23.5 69.4 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 114.617 -1.174 . . . . 0.0 113.782 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.427 ' OE2' ' O ' ' A' ' 52' ' ' LYS . 66.6 mm-40 -106.28 -35.86 7.04 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 56' ' ' ILE . 18.6 m -116.59 152.56 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 CA-C-O 121.513 0.673 . . . . 0.0 110.543 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.425 ' O ' ' O ' ' A' ' 55' ' ' VAL . 4.8 pt -48.98 177.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.706 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.541 ' O ' ' N ' ' A' ' 59' ' ' TRP . 18.2 ttm180 -71.4 -61.01 1.93 Allowed 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -24.05 -39.16 0.01 OUTLIER Glycine 0 N--CA 1.495 2.622 0 O-C-N 124.929 1.393 . . . . 0.0 112.497 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.541 ' N ' ' O ' ' A' ' 57' ' ' ARG . 1.1 m95 -83.01 -70.01 0.59 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.412 ' OE1' ' O ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -30.4 -59.82 0.19 Allowed 'General case' 0 N--CA 1.504 2.243 0 O-C-N 124.95 1.406 . . . . 0.0 110.05 -179.899 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -67.72 -52.66 35.03 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -49.77 -89.11 0.01 OUTLIER Glycine 0 N--CA 1.478 1.451 0 CA-C-N 114.363 -1.29 . . . . 0.0 111.282 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' A' ' 59' ' ' TRP . 40.0 t -31.76 -48.43 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.478 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -46.32 -59.79 2.72 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 124.169 1.937 . . . . 0.0 110.648 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -48.18 -11.77 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 109.305 -3.588 . . . . 0.0 109.276 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.478 ' H ' ' C ' ' A' ' 64' ' ' ALA . 85.2 mtp -97.53 156.12 16.65 Favored 'General case' 0 N--CA 1.513 2.691 0 C-N-CA 118.753 -1.179 . . . . 0.0 108.123 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 70' ' ' GLN . 73.1 p -120.11 147.66 44.58 Favored 'General case' 0 N--CA 1.51 2.544 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 59.1 t -36.8 96.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 CA-C-N 113.131 -1.849 . . . . 0.0 114.139 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.05 13.75 16.99 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 108.539 -1.824 . . . . 0.0 108.539 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 67' ' ' SER . 44.6 tt0 -109.68 138.17 46.43 Favored 'General case' 0 N--CA 1.503 2.225 0 CA-C-O 121.602 0.715 . . . . 0.0 109.795 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -126.83 138.99 53.42 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -144.43 178.01 8.24 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-N 112.006 -2.361 . . . . 0.0 114.6 -179.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.5 ttmp? -124.55 104.22 8.59 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 111.406 -2.634 . . . . 0.0 104.021 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.3 mp -100.42 146.0 27.54 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 119.676 -0.81 . . . . 0.0 108.878 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 90.2 m -121.72 104.47 9.62 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.512 HD12 ' H ' ' A' ' 76' ' ' ILE . 2.7 mp -95.41 141.71 14.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.206 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.3 p -112.97 153.59 45.2 Favored Pre-proline 0 N--CA 1.503 2.204 0 CA-C-N 114.631 -1.168 . . . . 0.0 108.011 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -40.25 -47.13 4.2 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.01 1.807 . . . . 0.0 112.964 -172.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 4.0 p-10 -43.88 -35.3 1.92 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 . . . . . 0 N--CA 1.498 1.937 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.644 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 93.0 m . . . . . 0 N--CA 1.497 1.907 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 22.2 mt -113.35 157.91 21.25 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 53.4 t -135.28 98.39 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -93.36 155.42 17.4 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -122.66 89.99 3.21 Favored 'General case' 0 N--CA 1.491 1.606 1 N-CA-C 95.466 -5.753 . . . . 0.0 95.466 179.232 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 12.5 t -100.7 148.32 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 C-N-CA 118.817 -1.153 . . . . 0.0 113.793 -178.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -124.94 109.12 12.61 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 112.429 -2.169 . . . . 0.0 107.49 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 55.5 tp -79.68 116.73 20.04 Favored 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 102.396 -3.187 . . . . 0.0 102.396 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.479 ' O ' ' NZ ' ' A' ' 105' ' ' LYS . 15.4 mt -88.13 -54.57 4.15 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -178.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.479 ' NZ ' ' O ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -164.58 177.82 7.81 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.326 -179.722 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 28.6 mt -118.07 153.58 33.5 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 . . . . . 0 N--CA 1.503 2.206 0 CA-C-O 115.733 -2.08 . . . . 0.0 108.63 179.849 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.466 ' C ' ' NE2' ' A' ' 3' ' ' GLN . 9.2 p . . . . . 0 N--CA 1.502 2.155 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.478 ' N ' ' CD ' ' A' ' 3' ' ' GLN . 16.0 mp0 -121.59 148.11 44.95 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 59.6 t -124.66 109.36 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.026 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -109.98 97.03 6.62 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 88.6 m -69.91 156.72 38.67 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 118.961 -1.095 . . . . 0.0 112.643 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -121.84 -54.77 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-N 113.569 -1.65 . . . . 0.0 107.213 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.422 ' O ' ' O ' ' A' ' 9' ' ' PRO . 37.0 t -124.1 82.66 56.46 Favored Pre-proline 0 N--CA 1.506 2.345 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.821 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 8' ' ' SER . 2.0 Cg_exo -35.84 161.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.336 2.024 . . . . 0.0 112.574 178.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.52 -171.25 14.74 Favored Glycine 0 N--CA 1.502 3.036 0 N-CA-C 107.426 -2.269 . . . . 0.0 107.426 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 68' ' ' VAL . 0.7 OUTLIER -39.92 -65.18 0.42 Allowed 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.589 0.709 . . . . 0.0 112.351 -179.969 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.95 16.16 16.14 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 105.809 -2.916 . . . . 0.0 105.809 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.0 mtp85 -125.47 -44.18 1.86 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 114.028 -1.086 . . . . 0.0 111.963 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.0 m -103.96 133.23 49.27 Favored 'General case' 0 N--CA 1.504 2.247 0 CA-C-O 121.522 0.677 . . . . 0.0 112.085 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.43 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 41.9 m-85 -130.97 175.21 3.86 Favored Pre-proline 0 N--CA 1.501 2.085 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -71.44 150.66 58.4 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 N-CA-C 109.485 -1.006 . . . . 0.0 109.485 164.323 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -120.24 172.39 7.82 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-O 121.929 0.871 . . . . 0.0 110.84 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 19.6 ttp180 -81.23 96.67 7.33 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.382 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.16 -1.24 5.77 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 108.597 -1.801 . . . . 0.0 108.597 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.5 ' O ' ' SD ' ' A' ' 49' ' ' MET . 82.0 mt-30 -114.63 172.56 6.95 Favored 'General case' 0 N--CA 1.503 2.209 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.2 m -108.67 153.08 23.93 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.3 m -111.27 141.5 44.72 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 104.972 -2.233 . . . . 0.0 104.972 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.6 t -118.8 109.16 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 100.689 -3.819 . . . . 0.0 100.689 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.444 HG21 ' CH2' ' A' ' 59' ' ' TRP . 5.4 m -124.36 155.46 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 125.751 1.907 . . . . 0.0 113.058 -179.151 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -130.76 107.3 9.05 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 104.197 -2.52 . . . . 0.0 104.197 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.419 ' CD2' ' CD2' ' A' ' 99' ' ' PHE . 27.2 p90 -132.59 177.29 7.73 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 95.9 m -137.49 116.41 12.36 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 111.444 -2.616 . . . . 0.0 104.959 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -111.5 114.5 3.65 Favored Glycine 0 N--CA 1.501 2.992 0 N-CA-C 107.642 -2.183 . . . . 0.0 107.642 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 38.9 ttm . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 -179.859 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 56.9 t80 . . . . . 0 N--CA 1.497 1.904 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 31.9 mtmm -142.51 122.89 13.94 Favored 'General case' 0 N--CA 1.504 2.247 0 CA-C-O 118.782 -0.628 . . . . 0.0 110.667 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -133.17 167.07 21.02 Favored 'General case' 0 N--CA 1.513 2.678 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.5 ' SD ' ' O ' ' A' ' 20' ' ' GLN . 47.3 tpp -107.37 129.39 54.92 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 113.492 -1.685 . . . . 0.0 111.824 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.7 tp -90.66 146.39 24.07 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.157 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 129.51 -42.28 1.44 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 107.317 -2.313 . . . . 0.0 107.317 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 54' ' ' GLU . 6.2 tmtt? -120.39 43.57 2.69 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 3.63 58.65 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.094 0 O-C-N 125.64 1.838 . . . . 0.0 114.807 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.534 ' N ' ' O ' ' A' ' 52' ' ' LYS . 11.3 pt-20 -64.01 -6.29 6.01 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 118.759 -1.176 . . . . 0.0 110.738 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 56' ' ' ILE . 33.7 m -116.38 158.94 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.425 ' O ' ' O ' ' A' ' 55' ' ' VAL . 17.3 pt -49.31 174.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 C-N-CA 117.83 -1.548 . . . . 0.0 110.118 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.541 ' O ' ' N ' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -70.55 -60.53 2.21 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 57' ' ' ARG . . . -20.52 -44.17 0.01 OUTLIER Glycine 0 N--CA 1.502 3.046 0 O-C-N 125.407 1.692 . . . . 0.0 112.495 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.541 ' N ' ' O ' ' A' ' 57' ' ' ARG . 1.5 m95 -73.99 -75.78 0.15 Allowed 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 111.668 -2.266 . . . . 0.0 108.813 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 59' ' ' TRP . 4.1 tm-20 -22.54 -55.66 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 126.303 2.252 . . . . 0.0 110.898 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -78.72 -53.07 7.52 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 113.219 -1.81 . . . . 0.0 106.592 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -51.35 -73.24 0.4 Allowed Glycine 0 N--CA 1.482 1.709 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.526 ' N ' ' O ' ' A' ' 59' ' ' TRP . 24.9 t -44.14 -49.76 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 119.258 -0.977 . . . . 0.0 111.503 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.471 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -45.22 -61.88 1.48 Allowed 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 123.864 1.793 . . . . 0.0 111.181 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -46.63 -13.63 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 109.913 -3.312 . . . . 0.0 109.244 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.471 ' H ' ' C ' ' A' ' 64' ' ' ALA . 41.9 mtm -103.32 154.8 18.99 Favored 'General case' 0 N--CA 1.513 2.717 0 C-N-CA 118.847 -1.141 . . . . 0.0 109.098 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 82.7 p -116.41 153.59 31.79 Favored 'General case' 0 N--CA 1.505 2.286 0 CA-C-O 122.624 1.202 . . . . 0.0 113.428 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.417 ' O ' ' OD1' ' A' ' 11' ' ' ASP . 85.8 t -43.07 95.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 112.416 -2.175 . . . . 0.0 114.388 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.04 16.42 7.88 Favored Glycine 0 N--CA 1.497 2.759 0 N-CA-C 108.816 -1.714 . . . . 0.0 108.816 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -108.38 142.81 38.17 Favored 'General case' 0 N--CA 1.506 2.356 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.741 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 24.2 ttt85 -126.72 141.65 51.78 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -149.46 177.4 9.74 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 116.334 1.976 . . . . 0.0 116.334 -179.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -127.81 104.5 7.86 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 103.326 -2.842 . . . . 0.0 103.326 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.407 ' N ' HD12 ' A' ' 74' ' ' LEU . 5.2 mp -101.8 146.65 27.5 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 119.606 -0.838 . . . . 0.0 109.194 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 73.2 m -117.05 104.0 10.81 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 102.309 -3.219 . . . . 0.0 102.309 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 21.4 mt -102.86 138.73 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.14 163.7 20.62 Favored Pre-proline 0 N--CA 1.503 2.219 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.865 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -37.74 -50.94 1.87 Allowed 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 122.561 2.174 . . . . 0.0 113.184 -175.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 80' ' ' TYR . 1.7 p30 -44.24 -42.72 6.76 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 120.191 -0.603 . . . . 0.0 111.608 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.476 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 6.8 m-85 . . . . . 0 N--CA 1.496 1.846 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.674 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 99.9 m . . . . . 0 N--CA 1.506 2.343 0 CA-C-O 118.324 -0.846 . . . . 0.0 110.544 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.8 mt -96.72 152.61 18.5 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.5 t -134.78 115.12 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.419 ' CD2' ' CD2' ' A' ' 26' ' ' TYR . 2.0 m-85 -108.15 163.09 13.46 Favored 'General case' 0 N--CA 1.504 2.232 0 CA-C-O 122.968 1.366 . . . . 0.0 109.477 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -128.78 90.03 2.98 Favored 'General case' 0 N--CA 1.492 1.664 1 N-CA-C 98.186 -4.746 . . . . 0.0 98.186 179.095 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.3 t -102.21 148.31 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.558 0 N-CA-C 116.89 2.181 . . . . 0.0 116.89 -178.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -129.72 99.7 5.23 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 112.922 -1.944 . . . . 0.0 108.626 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 50.4 tp -73.28 119.39 17.45 Favored 'General case' 0 N--CA 1.504 2.253 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.2 mt -85.66 -60.07 2.13 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.643 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.473 ' HG2' ' H ' ' A' ' 106' ' ' LEU . 60.4 tttm -168.72 -175.89 2.57 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.813 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.473 ' H ' ' HG2' ' A' ' 105' ' ' LYS . 20.9 mt -109.03 160.6 15.91 Favored 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 . . . . . 0 N--CA 1.503 2.216 0 CA-C-O 115.827 -2.035 . . . . 0.0 109.4 179.838 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.503 2.223 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -121.87 154.53 36.96 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.6 t -126.98 114.12 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-N 112.929 -1.941 . . . . 0.0 109.3 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.528 ' OE2' ' NZ ' ' A' ' 73' ' ' LYS . 37.7 tt0 -118.06 101.52 8.31 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 42.0 m -70.04 150.73 46.32 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 118.938 -1.105 . . . . 0.0 113.623 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 77.2 mt -110.99 -55.35 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.9 t -129.65 90.78 42.57 Favored Pre-proline 0 N--CA 1.504 2.232 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.235 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -37.75 165.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 122.189 1.926 . . . . 0.0 112.54 174.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.6 -113.78 2.47 Favored Glycine 0 N--CA 1.5 2.938 0 N-CA-C 106.344 -2.702 . . . . 0.0 106.344 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.507 ' CG ' ' H ' ' A' ' 12' ' ' GLY . 9.8 p-10 -100.61 -62.5 1.23 Allowed 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.507 ' H ' ' CG ' ' A' ' 11' ' ' ASP . . . 104.88 28.05 5.76 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 42.4 mtp-105 -133.61 -39.0 0.9 Allowed 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.4 m -107.53 131.3 54.48 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.425 0.631 . . . . 0.0 112.279 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.461 ' N ' ' CD1' ' A' ' 15' ' ' PHE . 23.1 m-85 -129.73 174.18 4.89 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -71.48 139.15 33.94 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 CA-C-N 119.857 0.985 . . . . 0.0 111.801 166.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -120.07 171.98 8.08 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 122.205 1.003 . . . . 0.0 111.271 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.9 ttt85 -71.28 104.31 3.1 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.189 -1.369 . . . . 0.0 111.588 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.33 8.84 5.77 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -121.97 174.15 7.08 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 57.5 m -119.44 114.56 22.5 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.544 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 58.5 m -69.26 153.28 43.9 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 24.6 t -128.06 102.46 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 103.677 -2.712 . . . . 0.0 103.677 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.9 m -122.48 149.66 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.465 0 N-CA-C 116.662 2.097 . . . . 0.0 116.662 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -128.35 112.19 14.17 Favored 'General case' 0 N--CA 1.51 2.528 0 N-CA-C 103.996 -2.594 . . . . 0.0 103.996 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' A' ' 26' ' ' TYR . 36.1 p90 -133.7 -175.07 3.7 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 90.8 m -140.17 123.25 16.72 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 102.06 -3.311 . . . . 0.0 102.06 179.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -114.41 125.09 6.68 Favored Glycine 0 N--CA 1.507 3.392 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.8 tmm? . . . . . 0 N--CA 1.493 1.692 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -179.874 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 59.0 t80 . . . . . 0 N--CA 1.497 1.89 0 CA-C-O 119.73 -0.176 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 31.2 mttm -145.08 137.4 25.95 Favored 'General case' 0 N--CA 1.512 2.659 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -136.45 165.72 25.15 Favored 'General case' 0 N--CA 1.516 2.85 0 CA-C-N 119.972 1.26 . . . . 0.0 110.85 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 47.8 ttp -117.15 86.84 2.58 Favored 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 116.867 2.173 . . . . 0.0 116.867 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.4 tp -32.14 125.12 0.29 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 124.215 0.947 . . . . 0.0 112.867 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 129.48 -30.77 3.55 Favored Glycine 0 N--CA 1.499 2.84 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.48 ' O ' ' N ' ' A' ' 54' ' ' GLU . 80.1 tttt -121.03 43.76 2.7 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 52' ' ' LYS . 46.0 tt0 3.19 62.68 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.163 0 O-C-N 126.031 2.082 . . . . 0.0 113.306 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' A' ' 52' ' ' LYS . 43.8 tt0 -72.36 -24.77 61.32 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 113.541 -1.663 . . . . 0.0 106.686 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.4 m -113.8 156.5 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.818 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.7 pt -60.2 172.69 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 118.153 -1.419 . . . . 0.0 110.03 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.559 ' O ' ' N ' ' A' ' 59' ' ' TRP . 24.2 ttt85 -65.56 -59.99 3.39 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 118.214 -0.898 . . . . 0.0 112.624 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -28.13 -34.91 0.01 OUTLIER Glycine 0 N--CA 1.506 3.336 0 CA-C-O 122.916 1.287 . . . . 0.0 111.444 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.559 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.5 OUTLIER -83.01 -79.84 0.18 Allowed 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 112.24 -1.98 . . . . 0.0 107.746 179.829 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -28.48 -49.39 0.07 Allowed 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 113.347 -1.752 . . . . 0.0 110.692 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -77.33 -54.54 6.34 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -52.64 -74.95 0.25 Allowed Glycine 0 N--CA 1.482 1.752 0 N-CA-C 108.553 -1.819 . . . . 0.0 108.553 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.518 ' N ' ' O ' ' A' ' 59' ' ' TRP . 25.9 t -38.32 -45.47 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.612 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.8 -44.2 66.45 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 122.799 1.285 . . . . 0.0 109.445 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.443 ' N ' ' O ' ' A' ' 62' ' ' GLY . 51.6 tt0 -74.6 8.79 2.1 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 111.966 -2.379 . . . . 0.0 111.463 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 94.4 mtp -116.61 149.66 39.34 Favored 'General case' 0 N--CA 1.507 2.389 0 N-CA-C 104.664 -2.347 . . . . 0.0 104.664 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 80.3 p -116.52 153.87 31.4 Favored 'General case' 0 N--CA 1.51 2.571 0 CA-C-O 122.934 1.349 . . . . 0.0 113.899 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 63.0 t -43.03 100.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 112.04 -2.345 . . . . 0.0 116.15 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.26 4.52 28.97 Favored Glycine 0 N--CA 1.5 2.909 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.401 ' OE1' ' C ' ' A' ' 70' ' ' GLN . 0.8 OUTLIER -110.17 145.16 37.72 Favored 'General case' 0 N--CA 1.507 2.42 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.977 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -128.16 145.48 51.01 Favored 'General case' 0 N--CA 1.508 2.435 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.611 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -144.11 -177.72 5.59 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-N 112.776 -2.011 . . . . 0.0 115.538 -179.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.55 ' HZ3' ' HB3' ' A' ' 73' ' ' LYS . 6.6 ttpm? -125.49 106.79 10.04 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 101.767 -3.42 . . . . 0.0 101.767 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.1 mt -101.25 143.54 31.2 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 59.0 m -115.17 117.01 29.31 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 102.021 -3.326 . . . . 0.0 102.021 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 30.0 mt -110.82 142.4 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.416 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 32.7 p -114.31 158.32 40.09 Favored Pre-proline 0 N--CA 1.506 2.341 0 CA-C-N 114.427 -1.26 . . . . 0.0 108.141 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -35.0 -55.31 0.57 Allowed 'Trans proline' 0 C--N 1.315 -1.202 0 C-N-CA 121.871 1.714 . . . . 0.0 113.852 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 3.9 p-10 -42.15 -41.97 2.84 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.332 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.486 ' CE2' ' NE ' ' A' ' 57' ' ' ARG . 7.5 m-85 . . . . . 0 N--CA 1.499 1.984 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 29.5 m . . . . . 0 N--CA 1.499 1.998 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.2 mt -115.13 155.75 26.52 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 59.0 t -139.43 97.72 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -92.07 167.04 12.36 Favored 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 117.586 -1.646 . . . . 0.0 108.992 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -130.04 86.87 2.45 Favored 'General case' 0 N--CA 1.493 1.678 1 N-CA-C 97.387 -5.042 . . . . 0.0 97.387 178.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.401 HG12 ' N ' ' A' ' 102' ' ' GLU . 14.7 t -100.8 149.82 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.401 ' N ' HG12 ' A' ' 101' ' ' VAL . 87.9 tt0 -125.81 101.58 6.91 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 112.04 -2.345 . . . . 0.0 107.406 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 50.4 tp -74.83 113.8 12.53 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 103.35 -2.833 . . . . 0.0 103.35 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 9.3 mt -76.71 -55.19 5.72 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 113.315 -1.766 . . . . 0.0 111.479 -179.244 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -176.24 -168.18 0.25 Allowed 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 118.622 -1.231 . . . . 0.0 110.423 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.4 mt -115.21 150.25 36.42 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 . . . . . 0 N--CA 1.502 2.132 0 CA-C-O 115.79 -2.052 . . . . 0.0 109.24 179.892 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.622 ' N ' ' CE1' ' A' ' 80' ' ' TYR . . . . . . . . 0 N--CA 1.487 2.06 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.1 p -116.82 150.17 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -124.07 154.96 39.18 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.4 t -124.86 112.76 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -114.31 90.97 3.47 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 97.9 m -69.78 154.84 41.43 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 119.008 -1.077 . . . . 0.0 112.425 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 58.9 mt -123.58 -52.01 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 CA-C-N 113.859 -1.519 . . . . 0.0 107.407 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 9' ' ' PRO . 38.9 t -122.03 80.66 42.99 Favored Pre-proline 0 N--CA 1.505 2.324 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.041 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 8' ' ' SER . 6.4 Cg_exo -36.96 166.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.812 2.341 . . . . 0.0 113.718 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -115.81 -172.68 16.99 Favored Glycine 0 N--CA 1.5 2.921 0 N-CA-C 105.75 -2.94 . . . . 0.0 105.75 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.462 ' CG ' ' H ' ' A' ' 12' ' ' GLY . 11.7 p-10 -44.73 -58.35 3.13 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 118.405 1.102 . . . . 0.0 111.173 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.462 ' H ' ' CG ' ' A' ' 11' ' ' ASP . . . 107.65 24.26 6.49 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 107.636 -2.186 . . . . 0.0 107.636 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 -128.83 -37.56 1.73 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 114.532 -0.834 . . . . 0.0 111.249 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.4 m -111.07 138.34 47.61 Favored 'General case' 0 N--CA 1.507 2.416 0 CA-C-O 121.833 0.825 . . . . 0.0 112.834 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.458 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 48.5 m-85 -133.07 173.78 5.48 Favored Pre-proline 0 N--CA 1.495 1.786 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -61.53 134.57 52.01 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 N-CA-C 110.09 -0.773 . . . . 0.0 110.09 164.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.412 ' HB3' ' NZ ' ' A' ' 17' ' ' LYS . 8.2 mtpm? -115.3 170.21 8.56 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.943 0.877 . . . . 0.0 110.484 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.9 mtm180 -73.64 97.01 2.56 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.198 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 122.84 18.98 3.1 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -115.82 170.1 8.72 Favored 'General case' 0 N--CA 1.504 2.245 0 CA-C-O 121.83 0.824 . . . . 0.0 110.116 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 95.4 m -125.1 110.33 14.01 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 114.481 -1.236 . . . . 0.0 107.915 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 27.5 m -69.76 149.29 48.13 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.16 -1.016 . . . . 0.0 110.074 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 93.3 t -125.17 97.8 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 101.14 -3.652 . . . . 0.0 101.14 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.413 HG21 ' CH2' ' A' ' 59' ' ' TRP . 2.8 m -121.13 151.26 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -130.24 116.55 18.54 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 104.675 -2.342 . . . . 0.0 104.675 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -134.01 179.33 6.31 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 123.044 1.402 . . . . 0.0 111.966 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.438 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 51.2 m -141.91 126.11 17.46 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 101.016 -3.698 . . . . 0.0 101.016 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -103.09 129.95 10.07 Favored Glycine 0 N--CA 1.5 2.93 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 39.5 ttm -129.59 170.54 13.63 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 30.4 mt -116.02 173.51 6.53 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -29.34 -61.76 0.13 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 125.053 1.47 . . . . 0.0 113.719 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -160.61 41.2 0.17 Allowed 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 114.628 -1.169 . . . . 0.0 109.641 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -119.36 -79.23 0.61 Allowed Glycine 0 N--CA 1.502 3.085 0 C-N-CA 119.274 -1.441 . . . . 0.0 113.763 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.47 -167.7 1.96 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -90.81 139.4 30.77 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.004 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.467 ' CD2' ' CG ' ' A' ' 37' ' ' ASP . 8.8 p90 -126.04 -38.13 2.2 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 112.968 -1.924 . . . . 0.0 107.303 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.467 ' CG ' ' CD2' ' A' ' 36' ' ' PHE . 43.5 m-20 -128.81 87.16 2.53 Favored 'General case' 0 N--CA 1.506 2.357 0 CA-C-N 115.086 -0.961 . . . . 0.0 113.511 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 51.7 m -107.08 163.46 12.97 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.579 ' O ' ' N ' ' A' ' 41' ' ' ASP . 96.0 p -123.2 51.62 1.44 Allowed 'General case' 0 N--CA 1.503 2.184 0 CA-C-O 118.885 -0.579 . . . . 0.0 110.281 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -28.64 73.68 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 126.472 2.358 . . . . 0.0 112.838 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.579 ' N ' ' O ' ' A' ' 39' ' ' SER . 7.5 t70 -18.98 -58.23 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.025 0 CA-C-N 110.505 -3.043 . . . . 0.0 113.046 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.406 ' C ' ' O ' ' A' ' 41' ' ' ASP . 41.0 ttt-85 -19.58 -45.33 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 O-C-N 125.414 1.696 . . . . 0.0 113.479 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.498 ' N ' ' O ' ' A' ' 41' ' ' ASP . 75.2 m-20 -108.67 58.06 0.61 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.21 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.563 ' HD2' ' HZ2' ' A' ' 47' ' ' LYS . 38.4 ttpt 56.33 127.08 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.495 0 CA-C-N 114.145 -1.389 . . . . 0.0 112.266 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' A' ' 44' ' ' LYS . 23.1 Cg_exo -42.48 -157.59 0.0 OUTLIER 'Trans proline' 0 N--CA 1.488 1.181 0 C-N-CA 122.489 2.126 . . . . 0.0 116.011 168.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -111.03 144.69 39.75 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 112.858 -1.974 . . . . 0.0 110.551 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.563 ' HZ2' ' HD2' ' A' ' 44' ' ' LYS . 34.4 mtmm -137.0 122.02 18.98 Favored 'General case' 0 N--CA 1.507 2.415 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.542 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -138.98 177.09 8.14 Favored 'General case' 0 N--CA 1.509 2.495 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.765 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 43.1 ttp -121.29 156.94 31.46 Favored 'General case' 0 N--CA 1.503 2.207 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.966 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.9 tp -90.95 120.32 31.86 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.15 12.71 30.8 Favored Glycine 0 N--CA 1.501 2.969 0 C-N-CA 121.059 -0.591 . . . . 0.0 114.04 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.475 ' O ' ' N ' ' A' ' 54' ' ' GLU . 59.3 tttp -128.24 45.81 2.7 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 118.349 1.074 . . . . 0.0 108.945 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' A' ' 52' ' ' LYS . 20.5 pt20 4.16 61.18 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 115.991 1.849 . . . . 0.0 115.991 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.475 ' N ' ' O ' ' A' ' 52' ' ' LYS . 6.8 mm-40 -102.98 -29.98 11.07 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 56' ' ' ILE . 13.0 m -114.87 155.76 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.426 ' O ' ' O ' ' A' ' 55' ' ' VAL . 17.0 pt -51.74 -179.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 C-N-CA 119.065 -1.054 . . . . 0.0 109.001 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.536 ' O ' ' N ' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -80.45 -58.59 3.05 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.44 ' H ' ' HB3' ' A' ' 80' ' ' TYR . . . -28.3 -35.93 0.01 OUTLIER Glycine 0 N--CA 1.501 3.025 0 O-C-N 124.531 1.145 . . . . 0.0 111.53 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.536 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.9 OUTLIER -78.78 -75.72 0.22 Allowed 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 113.236 -1.482 . . . . 0.0 107.237 179.822 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 59' ' ' TRP . 71.1 tt0 -25.87 -55.01 0.06 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 125.839 1.962 . . . . 0.0 110.828 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.405 ' N ' HH11 ' A' ' 57' ' ' ARG . 37.8 tt0 -75.27 -54.7 6.66 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -51.04 -75.09 0.23 Allowed Glycine 0 N--CA 1.482 1.753 0 C-N-CA 119.564 -1.303 . . . . 0.0 111.168 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' A' ' 59' ' ' TRP . 28.9 t -41.58 -49.91 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 119.594 -0.842 . . . . 0.0 112.292 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.467 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -45.9 -60.59 2.16 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 124.056 1.884 . . . . 0.0 111.157 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -48.68 -11.28 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 109.416 -3.538 . . . . 0.0 109.195 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.467 ' H ' ' C ' ' A' ' 64' ' ' ALA . 49.8 mtm -99.82 160.64 14.15 Favored 'General case' 0 N--CA 1.517 2.887 0 C-N-CA 118.518 -1.273 . . . . 0.0 108.823 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 96.7 p -115.32 150.63 35.97 Favored 'General case' 0 N--CA 1.51 2.539 0 CA-C-O 122.584 1.183 . . . . 0.0 113.919 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 63.8 t -49.21 99.63 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 112.641 -2.072 . . . . 0.0 113.681 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 113.95 9.27 16.38 Favored Glycine 0 N--CA 1.499 2.834 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -107.8 154.14 21.96 Favored 'General case' 0 N--CA 1.506 2.33 0 CA-C-O 122.428 1.109 . . . . 0.0 111.164 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.0 ttp180 -131.46 140.12 49.52 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 112.83 -1.986 . . . . 0.0 107.224 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -148.44 177.58 9.33 Favored 'General case' 0 N--CA 1.502 2.158 0 CA-C-N 112.947 -1.933 . . . . 0.0 115.496 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -126.47 105.28 8.65 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 111.295 -2.684 . . . . 0.0 103.936 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.4 mt -99.77 152.57 19.96 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 93.7 m -124.57 119.81 30.15 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 25.7 mt -112.13 140.28 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.417 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 35.1 p -111.13 155.53 42.44 Favored Pre-proline 0 N--CA 1.506 2.343 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.185 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -37.85 -51.59 1.84 Allowed 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 122.189 1.926 . . . . 0.0 114.695 -175.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 18.0 p-10 -39.28 -41.28 0.87 Allowed 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.622 ' CE1' ' N ' ' A' ' 1' ' ' GLY . 3.1 m-85 -100.79 -50.85 3.73 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.312 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -37.13 -91.9 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 114.827 1.418 . . . . 0.0 114.827 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -125.24 13.06 8.28 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.613 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 110.78 -104.71 1.8 Allowed Glycine 0 N--CA 1.502 3.098 0 N-CA-C 111.953 -0.459 . . . . 0.0 111.953 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -126.45 -52.23 1.49 Allowed 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 121.384 0.611 . . . . 0.0 109.931 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 97.5 m -113.06 158.5 20.25 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.897 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -130.34 -129.97 3.16 Favored Glycine 0 N--CA 1.5 2.955 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 91' ' ' ILE . 21.9 m80 -112.33 161.36 26.47 Favored Pre-proline 0 N--CA 1.502 2.173 0 CA-C-N 114.632 -0.784 . . . . 0.0 109.237 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -94.21 34.28 0.19 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.818 2.346 . . . . 0.0 108.602 164.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -130.89 -52.96 0.1 OUTLIER Glycine 0 N--CA 1.5 2.947 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.772 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.9 mt -116.8 -47.28 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.321 0 CA-C-O 121.937 0.875 . . . . 0.0 109.027 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.496 ' O ' ' N ' ' A' ' 87' ' ' HIS . 23.0 mm -114.17 77.02 3.77 Favored Pre-proline 0 N--CA 1.508 2.44 0 CA-C-N 113.94 -1.482 . . . . 0.0 113.316 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_exo -35.72 158.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.695 2.263 . . . . 0.0 110.468 162.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.407 ' O ' ' C ' ' A' ' 94' ' ' HIS . 57.5 Cg_endo -58.02 168.14 3.78 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 121.664 1.576 . . . . 0.0 110.051 177.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.407 ' C ' ' O ' ' A' ' 93' ' ' PRO . 90.5 m-70 9.64 60.02 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.237 0 O-C-N 125.572 1.795 . . . . 0.0 114.682 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -118.26 80.47 1.53 Allowed 'General case' 0 N--CA 1.5 2.068 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.22 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 62.3 m -29.36 145.09 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.067 0 O-C-N 124.886 1.366 . . . . 0.0 110.944 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 24.2 mt -111.1 151.76 27.73 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.4 t -134.12 125.29 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -120.29 139.81 52.18 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.178 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 27' ' ' THR . 5.1 p-10 -117.57 98.84 6.6 Favored 'General case' 0 N--CA 1.501 2.076 1 N-CA-C 97.338 -5.06 . . . . 0.0 97.338 178.902 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.409 HG12 ' N ' ' A' ' 102' ' ' GLU . 16.5 t -108.51 153.62 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.355 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 -178.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.409 ' N ' HG12 ' A' ' 101' ' ' VAL . 41.3 tt0 -127.99 104.37 7.75 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 112.119 -2.309 . . . . 0.0 107.609 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 37.8 tp -75.49 121.45 22.37 Favored 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 102.556 -3.127 . . . . 0.0 102.556 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.3 mt -93.16 -57.86 2.49 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -157.96 173.81 16.2 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.605 0.717 . . . . 0.0 112.074 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 35.4 mt -117.59 143.19 46.36 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 . . . . . 0 N--CA 1.503 2.215 0 CA-C-O 116.286 -1.816 . . . . 0.0 110.007 179.885 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.9 p -116.88 150.13 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -122.92 156.39 34.77 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.4 t -125.44 114.84 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 108.039 -1.096 . . . . 0.0 108.039 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -115.22 90.02 3.24 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 90.5 m -69.83 155.67 40.2 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.048 -1.061 . . . . 0.0 112.488 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 59.0 mt -123.66 -51.59 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 CA-C-N 113.645 -1.616 . . . . 0.0 107.258 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.418 ' O ' ' O ' ' A' ' 9' ' ' PRO . 46.5 t -122.22 80.13 44.32 Favored Pre-proline 0 N--CA 1.506 2.328 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.283 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 8' ' ' SER . 6.4 Cg_exo -37.42 164.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.348 2.032 . . . . 0.0 112.808 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -123.51 -168.95 13.12 Favored Glycine 0 N--CA 1.498 2.826 0 N-CA-C 105.632 -2.987 . . . . 0.0 105.632 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 11' ' ' ASP . 12.3 p-10 -39.5 -62.93 0.62 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.747 -0.781 . . . . 0.0 112.575 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.58 15.25 21.44 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 105.838 -2.905 . . . . 0.0 105.838 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 30.4 mtm-85 -125.95 -39.4 2.11 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 113.307 -1.447 . . . . 0.0 112.774 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.1 m -108.2 137.14 46.68 Favored 'General case' 0 N--CA 1.507 2.395 0 CA-C-O 121.775 0.798 . . . . 0.0 112.763 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.445 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 57.0 m-85 -130.56 177.43 2.22 Favored Pre-proline 0 N--CA 1.496 1.859 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -69.57 146.77 62.37 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 N-CA-C 109.765 -0.898 . . . . 0.0 109.765 162.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -122.37 168.44 12.07 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 122.086 0.946 . . . . 0.0 110.248 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 19.1 ptt85 -72.61 126.58 30.22 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.648 -1.16 . . . . 0.0 108.677 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 111.38 -19.71 24.06 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.5 ' O ' ' SD ' ' A' ' 49' ' ' MET . 83.8 mt-30 -109.76 176.4 5.08 Favored 'General case' 0 N--CA 1.506 2.341 0 CA-C-O 121.766 0.793 . . . . 0.0 112.274 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 27.7 m -110.07 161.47 15.5 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 57.2 m -111.7 146.56 37.3 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 103.889 -2.634 . . . . 0.0 103.889 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 33.4 t -123.07 101.95 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 101.644 -3.465 . . . . 0.0 101.644 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 m -123.01 150.46 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 125.004 1.44 . . . . 0.0 114.324 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.403 ' ND1' ' C ' ' A' ' 25' ' ' HIS . 2.7 t-80 -130.61 113.77 14.62 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 103.598 -2.742 . . . . 0.0 103.598 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -131.21 176.63 8.11 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 123.184 1.468 . . . . 0.0 113.576 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 96.0 m -139.42 121.85 16.11 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 101.921 -3.363 . . . . 0.0 101.921 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 37' ' ' ASP . . . -96.93 151.61 19.88 Favored Glycine 0 N--CA 1.498 2.824 0 C-N-CA 119.127 -1.511 . . . . 0.0 109.457 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 36.6 ttp -145.97 169.36 18.78 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 46.6 mt -118.79 174.66 6.15 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 105.534 -2.025 . . . . 0.0 105.534 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -29.09 -61.12 0.13 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 124.989 1.431 . . . . 0.0 113.447 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 32' ' ' ASP . 2.7 p30 -160.29 44.34 0.21 Allowed 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.041 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -115.9 -84.04 1.1 Allowed Glycine 0 N--CA 1.499 2.856 0 C-N-CA 119.044 -1.551 . . . . 0.0 113.802 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.92 -164.43 1.19 Allowed 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 112.503 -1.848 . . . . 0.0 113.11 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -90.41 140.43 29.72 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 122.512 1.148 . . . . 0.0 109.672 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -125.93 -35.78 2.44 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 112.888 -1.96 . . . . 0.0 107.475 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' A' ' 28' ' ' GLY . 33.6 t0 -127.07 104.59 8.07 Favored 'General case' 0 N--CA 1.513 2.693 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.038 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 52.6 m -119.77 175.28 5.95 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 104.459 -2.422 . . . . 0.0 104.459 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 76.7 p -107.54 56.73 0.63 Allowed 'General case' 0 N--CA 1.502 2.175 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.549 ' O ' ' N ' ' A' ' 42' ' ' ARG . 20.5 ttp85 -29.41 -67.95 0.08 Allowed 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 113.483 -1.689 . . . . 0.0 113.163 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -19.04 71.94 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 115.733 1.753 . . . . 0.0 115.733 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.549 ' N ' ' O ' ' A' ' 40' ' ' ARG . 12.8 mmt180 -32.04 -73.25 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 123.98 0.8 . . . . 0.0 112.87 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -20.95 -74.23 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 125.194 1.559 . . . . 0.0 114.131 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -134.25 141.24 38.57 Favored Pre-proline 0 N--CA 1.501 2.079 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -59.28 -159.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.218 0 C-N-CA 121.452 1.435 . . . . 0.0 113.387 -177.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -82.17 146.78 29.37 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 114.306 -1.316 . . . . 0.0 112.881 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.41 ' NZ ' ' CB ' ' A' ' 47' ' ' LYS . 9.1 mtmp? -143.08 125.29 15.45 Favored 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 118.745 -0.645 . . . . 0.0 111.695 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -137.53 171.94 13.71 Favored 'General case' 0 N--CA 1.515 2.795 0 CA-C-N 119.812 1.187 . . . . 0.0 114.158 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.5 ' SD ' ' O ' ' A' ' 20' ' ' GLN . 45.6 tpp -109.11 140.74 42.27 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 114.954 1.464 . . . . 0.0 114.954 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.8 tp -91.01 122.38 33.62 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 114.249 -1.341 . . . . 0.0 110.196 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.03 18.67 13.12 Favored Glycine 0 N--CA 1.5 2.9 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -122.57 -20.57 5.96 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-N 114.732 -0.734 . . . . 0.0 109.313 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.459 ' OE1' ' NH1' ' A' ' 57' ' ' ARG . 2.5 mm-40 54.48 67.84 0.95 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -109.76 -35.3 6.22 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.3 m -106.15 156.47 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.4 pt -50.98 174.96 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 118.368 -1.333 . . . . 0.0 110.548 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.531 ' O ' ' N ' ' A' ' 59' ' ' TRP . 4.2 tpp180 -68.71 -64.93 0.77 Allowed 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.061 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -28.95 -35.03 0.01 OUTLIER Glycine 0 N--CA 1.498 2.817 0 O-C-N 124.722 1.264 . . . . 0.0 112.308 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.531 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.5 OUTLIER -76.68 -70.57 0.45 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 179.858 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -33.49 -55.81 0.43 Allowed 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 113.723 -1.58 . . . . 0.0 109.992 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -70.16 -53.8 15.65 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 113.431 -1.713 . . . . 0.0 107.353 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -56.24 -75.81 0.23 Allowed Glycine 0 N--CA 1.48 1.574 0 C-N-CA 119.558 -1.306 . . . . 0.0 111.544 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 59' ' ' TRP . 41.2 t -38.37 -48.98 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 C-N-CA 120.332 -0.547 . . . . 0.0 112.243 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.467 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -46.86 -59.93 2.75 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 124.198 1.951 . . . . 0.0 110.584 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -51.27 -9.18 0.06 Allowed 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 109.37 -3.559 . . . . 0.0 109.719 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.467 ' H ' ' C ' ' A' ' 64' ' ' ALA . 90.3 mtp -98.23 154.94 17.43 Favored 'General case' 0 N--CA 1.512 2.646 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 84.8 p -116.39 151.13 36.59 Favored 'General case' 0 N--CA 1.507 2.424 0 CA-C-O 122.691 1.234 . . . . 0.0 113.75 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 95.5 t -44.93 98.14 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-N 112.499 -2.137 . . . . 0.0 114.385 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.02 11.9 15.23 Favored Glycine 0 N--CA 1.498 2.796 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -109.99 151.73 26.77 Favored 'General case' 0 N--CA 1.508 2.441 0 CA-C-O 122.215 1.007 . . . . 0.0 111.012 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -132.21 141.98 49.26 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 113.459 -1.7 . . . . 0.0 107.815 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -149.53 179.68 7.78 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 112.979 -1.918 . . . . 0.0 116.143 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -127.1 105.8 8.83 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 102.678 -3.082 . . . . 0.0 102.678 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.9 mt -101.66 153.86 19.39 Favored 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 121.315 0.579 . . . . 0.0 109.587 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 87.3 m -125.46 126.5 45.03 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 31.8 mt -115.64 141.4 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.421 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 35.5 p -110.31 152.32 43.17 Favored Pre-proline 0 N--CA 1.498 1.948 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.401 ' O ' ' N ' ' A' ' 81' ' ' ALA . 11.5 Cg_endo -40.78 -54.9 2.21 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 121.738 1.625 . . . . 0.0 112.513 -172.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 18.8 p30 -37.35 -35.96 0.13 Allowed 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.39 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -100.83 -16.78 17.16 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.185 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 83' ' ' GLY . . . -102.43 159.75 15.15 Favored 'General case' 0 N--CA 1.505 2.278 0 C-N-CA 119.688 -0.805 . . . . 0.0 108.965 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -1.37 62.37 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 125.93 2.019 . . . . 0.0 115.81 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 81' ' ' ALA . . . -5.05 -69.59 0.01 OUTLIER Glycine 0 N--CA 1.501 2.989 0 O-C-N 125.329 1.643 . . . . 0.0 115.653 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -122.34 -65.78 1.08 Allowed 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 97.5 m -121.7 137.25 54.83 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.61 -62.2 0.1 Allowed Glycine 0 N--CA 1.501 2.997 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -122.5 156.19 61.46 Favored Pre-proline 0 N--CA 1.505 2.289 0 CA-C-N 115.311 -0.444 . . . . 0.0 109.854 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -60.86 -69.9 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 122.023 1.815 . . . . 0.0 114.899 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -123.45 52.62 0.77 Allowed Glycine 0 N--CA 1.506 3.32 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.95 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.2 mt -130.58 -49.16 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 37.6 mm -113.47 90.08 16.65 Favored Pre-proline 0 N--CA 1.503 2.176 0 CA-C-N 111.783 -2.462 . . . . 0.0 111.772 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -52.23 158.97 4.63 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 N-CA-C 106.809 -2.035 . . . . 0.0 106.809 161.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -46.86 172.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 121.99 1.794 . . . . 0.0 113.068 -177.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 19.6 m80 9.55 75.58 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 116.528 2.047 . . . . 0.0 116.528 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -116.49 157.26 25.49 Favored 'General case' 0 N--CA 1.505 2.314 0 CA-C-O 121.112 0.482 . . . . 0.0 109.812 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 27.2 m -91.23 138.75 31.35 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 34.2 mt -118.33 156.56 28.7 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 58.9 t -137.15 130.11 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -123.29 155.91 36.31 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 122.058 0.932 . . . . 0.0 111.208 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -126.81 90.0 3.09 Favored 'General case' 0 N--CA 1.493 1.704 1 N-CA-C 98.977 -4.453 . . . . 0.0 98.977 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 13.1 t -104.55 150.84 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.594 0 N-CA-C 116.73 2.122 . . . . 0.0 116.73 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -128.39 98.08 4.94 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 112.595 -2.093 . . . . 0.0 106.838 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 49.1 tp -73.01 117.2 14.45 Favored 'General case' 0 N--CA 1.503 2.192 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.5 mt -83.92 -57.55 3.15 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 114.296 -1.32 . . . . 0.0 113.784 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.438 ' HG2' ' H ' ' A' ' 106' ' ' LEU . 16.2 ttpp -168.91 -171.41 1.34 Allowed 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.271 -0.972 . . . . 0.0 108.733 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.438 ' H ' ' HG2' ' A' ' 105' ' ' LYS . 22.9 mt -116.6 157.5 25.22 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 . . . . . 0 N--CA 1.506 2.328 0 CA-C-O 116.176 -1.869 . . . . 0.0 110.172 179.912 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 110.014 -1.235 . . . . 0.0 110.014 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.2 p -119.34 150.39 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -120.86 155.38 34.25 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 43.4 t -126.08 122.44 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.478 ' CD ' ' N ' ' A' ' 5' ' ' GLU . 8.9 mp0 -120.4 93.48 4.06 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 96.4 m -69.71 156.36 39.1 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 118.675 -1.21 . . . . 0.0 112.079 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 70.3 mt -121.95 -55.13 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-N 113.882 -1.508 . . . . 0.0 107.484 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.43 ' O ' ' O ' ' A' ' 9' ' ' PRO . 33.1 t -123.74 82.78 54.49 Favored Pre-proline 0 N--CA 1.506 2.329 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.382 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.43 ' O ' ' O ' ' A' ' 8' ' ' SER . 3.9 Cg_exo -35.84 164.39 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.689 2.26 . . . . 0.0 113.606 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -113.78 -176.43 19.22 Favored Glycine 0 N--CA 1.499 2.894 0 N-CA-C 105.797 -2.921 . . . . 0.0 105.797 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.475 ' CG ' ' H ' ' A' ' 12' ' ' GLY . 11.2 p-10 -43.85 -59.03 2.44 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 118.352 1.076 . . . . 0.0 111.586 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.475 ' H ' ' CG ' ' A' ' 11' ' ' ASP . . . 109.18 25.81 5.43 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 107.737 -2.145 . . . . 0.0 107.737 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.5 mmm180 -132.42 -36.68 1.1 Allowed 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 114.671 -0.764 . . . . 0.0 111.415 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 45.6 m -111.31 128.84 56.08 Favored 'General case' 0 N--CA 1.507 2.379 0 CA-C-O 121.584 0.707 . . . . 0.0 112.687 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.413 ' N ' ' CD1' ' A' ' 15' ' ' PHE . 37.6 m-85 -129.95 171.6 8.63 Favored Pre-proline 0 N--CA 1.497 1.92 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_exo -53.24 145.75 42.73 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 CA-C-N 119.588 0.888 . . . . 0.0 112.244 166.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -122.83 168.39 12.33 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 122.458 1.123 . . . . 0.0 111.175 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 42.9 mtp-105 -81.18 93.72 6.53 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 113.639 -1.619 . . . . 0.0 111.687 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.76 3.49 5.94 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 108.637 -1.785 . . . . 0.0 108.637 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -117.91 173.97 6.46 Favored 'General case' 0 N--CA 1.505 2.322 0 C-N-CA 120.254 -0.578 . . . . 0.0 109.567 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.7 m -110.0 164.8 12.27 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 31.6 m -117.22 128.38 55.04 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 33.3 t -108.5 111.48 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 101.106 -3.664 . . . . 0.0 101.106 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.402 HG21 ' CH2' ' A' ' 59' ' ' TRP . 5.1 m -125.88 155.06 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 125.007 1.442 . . . . 0.0 114.127 -179.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -129.87 107.88 9.72 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 104.512 -2.403 . . . . 0.0 104.512 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -130.48 175.29 9.1 Favored 'General case' 0 N--CA 1.503 2.2 0 CA-C-O 122.923 1.344 . . . . 0.0 114.458 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 93.7 m -138.17 121.8 17.42 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 102.292 -3.225 . . . . 0.0 102.292 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -111.2 138.1 14.74 Favored Glycine 0 N--CA 1.503 3.124 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.443 ' SD ' ' C ' ' A' ' 34' ' ' LYS . 21.9 tpp -140.68 -179.83 6.27 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.1 mt -120.02 161.77 20.38 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -24.62 -58.68 0.05 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 125.335 1.647 . . . . 0.0 113.852 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 3.0 p30 -160.17 42.17 0.19 Allowed 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.825 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -120.8 -80.27 0.59 Allowed Glycine 0 N--CA 1.5 2.946 0 C-N-CA 119.3 -1.429 . . . . 0.0 113.433 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.443 ' C ' ' SD ' ' A' ' 29' ' ' MET . 11.2 pttp -161.25 -166.49 1.56 Allowed 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.456 ' H ' ' CD ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -90.87 130.04 36.86 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 113.598 -1.637 . . . . 0.0 107.942 179.569 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.532 ' CD2' ' OD2' ' A' ' 37' ' ' ASP . 3.0 p90 -122.82 -35.75 2.99 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.011 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.532 ' OD2' ' CD2' ' A' ' 36' ' ' PHE . 45.6 m-20 -141.1 109.23 5.78 Favored 'General case' 0 N--CA 1.51 2.552 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 54.8 m -121.04 176.53 5.53 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 105.534 -2.025 . . . . 0.0 105.534 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.525 ' O ' ' N ' ' A' ' 41' ' ' ASP . 50.5 p -111.65 49.94 0.87 Allowed 'General case' 0 N--CA 1.505 2.307 0 CA-C-O 122.469 1.128 . . . . 0.0 108.484 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -29.48 -26.44 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 112.594 -2.094 . . . . 0.0 115.365 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 39' ' ' SER . 9.6 t70 -83.08 53.45 2.46 Favored 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 118.964 -1.094 . . . . 0.0 111.97 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -36.97 -34.76 0.08 Allowed 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.862 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.558 ' O ' ' ND2' ' A' ' 43' ' ' ASN . 0.5 OUTLIER -95.46 66.35 2.8 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.129 -179.785 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.483 ' CB ' ' O ' ' A' ' 43' ' ' ASN . 64.4 tttm 119.84 77.45 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.388 0 O-C-N 126.396 2.31 . . . . 0.0 106.43 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' A' ' 44' ' ' LYS . 34.5 Cg_exo -43.84 -156.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.231 0 C-N-CA 124.071 3.181 . . . . 0.0 116.038 178.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -94.69 138.11 32.95 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 113.21 -1.814 . . . . 0.0 110.903 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -130.36 117.81 20.31 Favored 'General case' 0 N--CA 1.509 2.499 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -136.23 170.77 15.48 Favored 'General case' 0 N--CA 1.51 2.54 0 C-N-CA 119.732 -0.787 . . . . 0.0 112.313 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 40.3 ttm -118.64 154.96 31.82 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.2 tp -91.03 120.88 32.37 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.889 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.42 34.21 5.38 Favored Glycine 0 N--CA 1.499 2.864 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.049 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.484 ' O ' ' CB ' ' A' ' 53' ' ' GLN . 23.0 ttmm -129.93 -51.01 1.13 Allowed 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.484 ' CB ' ' O ' ' A' ' 52' ' ' LYS . 37.3 tt0 100.9 67.74 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.161 0 O-C-N 125.837 1.961 . . . . 0.0 109.592 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -110.24 -35.94 5.95 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.1 m -116.73 159.06 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.854 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.409 ' H ' HG12 ' A' ' 56' ' ' ILE . 13.4 pt -56.51 179.97 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.527 ' O ' ' N ' ' A' ' 59' ' ' TRP . 34.8 ttt180 -74.48 -61.21 1.95 Allowed 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.92 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 57' ' ' ARG . . . -25.61 -39.32 0.01 OUTLIER Glycine 0 N--CA 1.501 2.988 0 O-C-N 124.986 1.428 . . . . 0.0 112.489 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.53 ' O ' ' N ' ' A' ' 63' ' ' VAL . 0.7 OUTLIER -73.26 -73.62 0.2 Allowed 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 179.721 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.484 ' OE1' ' N ' ' A' ' 61' ' ' GLU . 10.4 tm-20 -26.62 -55.7 0.08 Allowed 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 112.934 -1.939 . . . . 0.0 110.707 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.484 ' N ' ' OE1' ' A' ' 60' ' ' GLU . 50.3 tp10 -73.98 -54.96 6.76 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 112.927 -1.942 . . . . 0.0 106.23 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -52.16 -75.55 0.22 Allowed Glycine 0 N--CA 1.482 1.705 0 C-N-CA 119.617 -1.278 . . . . 0.0 110.961 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.53 ' N ' ' O ' ' A' ' 59' ' ' TRP . 30.8 t -40.92 -49.12 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 119.973 -0.691 . . . . 0.0 112.093 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.458 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -46.9 -59.01 3.37 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 124.012 1.863 . . . . 0.0 110.928 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -52.0 -8.04 0.06 Allowed 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 109.517 -3.492 . . . . 0.0 109.836 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.458 ' H ' ' C ' ' A' ' 64' ' ' ALA . 93.8 mtp -102.09 155.21 18.33 Favored 'General case' 0 N--CA 1.516 2.827 0 C-N-CA 119.036 -1.066 . . . . 0.0 108.242 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 90.4 p -114.94 150.11 36.24 Favored 'General case' 0 N--CA 1.511 2.582 0 CA-C-O 122.605 1.193 . . . . 0.0 113.211 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 87.2 t -43.84 96.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 112.594 -2.094 . . . . 0.0 113.246 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 113.06 11.89 13.12 Favored Glycine 0 N--CA 1.499 2.87 0 N-CA-C 108.735 -1.746 . . . . 0.0 108.735 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -103.66 143.93 32.12 Favored 'General case' 0 N--CA 1.503 2.209 0 C-N-CA 120.189 -0.605 . . . . 0.0 110.159 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 25.3 ttt85 -125.57 140.77 52.47 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -148.73 177.32 9.62 Favored 'General case' 0 N--CA 1.503 2.18 0 CA-C-N 113.046 -1.888 . . . . 0.0 116.048 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.45 ' CE ' ' OD1' ' A' ' 100' ' ' ASP . 4.6 tppp? -127.13 107.14 9.76 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 101.568 -3.493 . . . . 0.0 101.568 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.4 mt -103.58 152.85 21.25 Favored 'General case' 0 N--CA 1.503 2.207 0 C-N-CA 119.822 -0.751 . . . . 0.0 109.365 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 86.3 m -124.54 118.32 26.32 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 31.1 mt -111.76 141.92 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.425 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 41.7 p -107.78 156.68 37.64 Favored Pre-proline 0 N--CA 1.507 2.391 0 O-C-N 124.796 1.31 . . . . 0.0 109.373 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -36.18 -54.24 0.89 Allowed 'Trans proline' 0 C--N 1.316 -1.165 0 C-N-CA 121.986 1.791 . . . . 0.0 113.744 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 80' ' ' TYR . 1.7 p30 -45.36 -41.85 9.41 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.523 ' OH ' ' NH1' ' A' ' 57' ' ' ARG . 2.6 m-85 -102.1 17.71 22.6 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.304 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -122.85 -97.13 0.45 Allowed 'General case' 0 N--CA 1.508 2.447 0 CA-C-N 118.758 0.708 . . . . 0.0 111.783 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -121.41 -58.17 1.79 Allowed 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 120.848 0.356 . . . . 0.0 110.072 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 117.97 -152.13 17.69 Favored Glycine 0 N--CA 1.5 2.918 0 N-CA-C 108.028 -2.029 . . . . 0.0 108.028 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -107.5 28.99 7.59 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 89.9 m -130.0 57.53 1.69 Allowed 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -119.97 -166.62 13.3 Favored Glycine 0 N--CA 1.5 2.926 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.424 ' O ' ' O ' ' A' ' 91' ' ' ILE . 75.9 t60 -112.1 143.06 28.02 Favored Pre-proline 0 N--CA 1.502 2.164 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.68 150.63 45.39 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 N-CA-C 108.873 -1.241 . . . . 0.0 108.873 176.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 108.16 -47.13 1.08 Allowed Glycine 0 N--CA 1.5 2.901 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.9 mt -112.96 -56.6 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.424 ' O ' ' O ' ' A' ' 87' ' ' HIS . 20.4 mm -120.75 85.78 39.77 Favored Pre-proline 0 N--CA 1.508 2.459 0 CA-C-N 113.722 -1.581 . . . . 0.0 112.578 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -74.27 165.19 32.44 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.19 1.926 . . . . 0.0 107.326 170.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 94' ' ' HIS . 54.2 Cg_endo -55.85 172.59 0.52 Allowed 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.202 1.935 . . . . 0.0 110.81 178.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.4 ' C ' ' O ' ' A' ' 93' ' ' PRO . 90.9 m-70 9.52 61.32 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.23 0 O-C-N 125.619 1.824 . . . . 0.0 114.781 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -119.92 76.02 1.13 Allowed 'General case' 0 N--CA 1.501 2.116 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.49 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 58.0 m -29.42 142.4 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.198 0 O-C-N 124.761 1.288 . . . . 0.0 110.566 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 13.9 mt -107.36 157.05 18.26 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 120.514 1.506 . . . . 0.0 107.042 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.3 t -139.75 115.69 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -110.28 159.45 17.4 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 122.417 1.103 . . . . 0.0 110.241 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.45 ' OD1' ' CE ' ' A' ' 73' ' ' LYS . 54.9 m-20 -127.66 89.11 2.89 Favored 'General case' 0 N--CA 1.493 1.7 1 N-CA-C 98.575 -4.602 . . . . 0.0 98.575 179.314 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 12.2 t -103.1 148.83 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.699 0 N-CA-C 116.777 2.14 . . . . 0.0 116.777 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -127.92 96.75 4.58 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 112.701 -2.045 . . . . 0.0 107.419 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 51.6 tp -68.7 121.96 17.56 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.6 mt -89.39 -58.07 2.66 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.894 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.409 ' HG2' ' H ' ' A' ' 106' ' ' LEU . 21.3 ttmm -164.36 178.12 7.73 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.734 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.409 ' H ' ' HG2' ' A' ' 105' ' ' LYS . 17.1 mt -115.1 168.97 9.46 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 . . . . . 0 N--CA 1.514 2.757 0 CA-C-O 115.862 -2.018 . . . . 0.0 107.414 179.604 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.4 p -115.3 138.95 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.525 ' N ' ' OE1' ' A' ' 3' ' ' GLN . 3.3 mp0 -115.52 159.24 21.48 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.8 t -124.66 123.11 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.025 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.47 ' CD ' ' N ' ' A' ' 5' ' ' GLU . 9.3 mp0 -125.42 89.96 3.14 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 88.1 m -69.71 155.25 40.8 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.76 -1.176 . . . . 0.0 113.765 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 57.6 mt -122.45 -53.29 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-N 113.352 -1.749 . . . . 0.0 107.84 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.419 ' O ' ' O ' ' A' ' 9' ' ' PRO . 29.3 m -122.84 80.69 49.54 Favored Pre-proline 0 N--CA 1.506 2.366 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.759 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.419 ' O ' ' O ' ' A' ' 8' ' ' SER . 12.6 Cg_exo -38.2 164.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.37 2.047 . . . . 0.0 112.262 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -120.38 -178.76 16.23 Favored Glycine 0 N--CA 1.5 2.945 0 N-CA-C 105.322 -3.111 . . . . 0.0 105.322 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.431 ' CG ' ' H ' ' A' ' 12' ' ' GLY . 13.1 p-10 -45.76 -58.08 3.76 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 118.404 1.102 . . . . 0.0 111.075 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.431 ' H ' ' CG ' ' A' ' 11' ' ' ASP . . . 108.62 6.88 30.48 Favored Glycine 0 N--CA 1.498 2.814 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -110.81 -31.14 7.28 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 114.584 -0.808 . . . . 0.0 111.685 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 96.8 m -112.03 134.13 53.77 Favored 'General case' 0 N--CA 1.504 2.242 0 CA-C-N 118.876 0.762 . . . . 0.0 113.0 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.451 ' N ' ' CD1' ' A' ' 15' ' ' PHE . 57.3 m-85 -131.31 177.24 2.33 Favored Pre-proline 0 N--CA 1.5 2.029 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -72.09 145.29 44.13 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 C-N-CA 120.729 0.953 . . . . 0.0 110.391 161.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -121.58 168.63 11.53 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-O 121.786 0.803 . . . . 0.0 109.236 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.3 130.15 41.8 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.565 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 109.67 -22.69 23.58 Favored Glycine 0 N--CA 1.499 2.838 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.334 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -105.71 178.42 4.57 Favored 'General case' 0 N--CA 1.506 2.371 0 CA-C-O 121.981 0.896 . . . . 0.0 111.747 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.1 m -113.26 161.46 17.17 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 64.5 m -112.48 148.0 35.35 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.9 t -121.91 104.94 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 103.296 -2.853 . . . . 0.0 103.296 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 m -121.69 149.81 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.347 0 N-CA-C 116.217 1.932 . . . . 0.0 116.217 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -128.49 117.5 21.43 Favored 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 104.429 -2.434 . . . . 0.0 104.429 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -134.3 174.09 10.9 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 123.072 1.415 . . . . 0.0 114.801 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 81.3 m -138.92 122.04 16.85 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 102.335 -3.209 . . . . 0.0 102.335 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -112.57 140.45 16.27 Favored Glycine 0 N--CA 1.503 3.165 0 C-N-CA 120.174 -1.012 . . . . 0.0 112.337 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 57.2 mtm -137.85 175.37 9.65 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 29.0 mt -117.64 173.22 6.85 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -34.61 -62.9 0.33 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 124.564 1.165 . . . . 0.0 113.292 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -160.61 42.03 0.17 Allowed 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 114.508 -1.224 . . . . 0.0 109.25 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -117.82 -78.24 0.63 Allowed Glycine 0 N--CA 1.503 3.103 0 C-N-CA 119.283 -1.437 . . . . 0.0 113.721 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.53 -169.21 2.36 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -90.94 138.09 31.86 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 114.289 -1.323 . . . . 0.0 108.53 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.534 ' CD2' ' OD1' ' A' ' 37' ' ' ASP . 5.0 p90 -127.47 -39.7 1.84 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 113.192 -1.822 . . . . 0.0 106.152 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.534 ' OD1' ' CD2' ' A' ' 36' ' ' PHE . 1.0 OUTLIER -132.08 74.52 1.59 Allowed 'General case' 0 N--CA 1.507 2.403 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.3 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 68.8 m -110.64 113.33 25.85 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 56.7 p -108.8 51.41 0.74 Allowed 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -29.79 -46.66 0.06 Allowed 'General case' 0 N--CA 1.5 2.068 0 O-C-N 124.312 1.008 . . . . 0.0 112.782 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -19.12 86.3 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.3 mmm180 -77.9 -54.18 6.61 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -40.12 -64.26 0.52 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -122.66 79.84 48.07 Favored Pre-proline 0 N--CA 1.505 2.299 0 CA-C-N 115.051 -0.977 . . . . 0.0 112.112 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -55.29 -154.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 123.51 2.807 . . . . 0.0 115.102 -177.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -103.44 147.98 26.47 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 111.835 -2.438 . . . . 0.0 110.034 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 72.0 mttt -142.45 133.95 26.53 Favored 'General case' 0 N--CA 1.515 2.801 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -144.46 173.4 11.83 Favored 'General case' 0 N--CA 1.515 2.777 0 CA-C-N 119.265 0.939 . . . . 0.0 112.766 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 44.5 ttm -116.47 148.97 40.25 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.3 tp -90.99 120.26 31.84 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 114.365 -1.288 . . . . 0.0 109.23 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.35 18.56 18.77 Favored Glycine 0 N--CA 1.499 2.875 0 N-CA-C 107.757 -2.137 . . . . 0.0 107.757 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -121.06 -19.98 6.98 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 114.383 -0.908 . . . . 0.0 109.387 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 55.9 69.02 0.78 Allowed 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.396 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -110.03 -35.86 6.02 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.431 ' O ' ' O ' ' A' ' 56' ' ' ILE . 4.2 m -113.99 152.69 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.176 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.501 ' CG2' ' CE1' ' A' ' 82' ' ' TYR . 13.3 pt -49.46 179.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.857 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.559 ' O ' ' N ' ' A' ' 59' ' ' TRP . 19.5 ttm180 -75.94 -58.96 2.97 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -34.12 -27.2 0.01 OUTLIER Glycine 0 N--CA 1.494 2.538 0 O-C-N 123.944 0.777 . . . . 0.0 111.925 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.559 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -91.33 -73.98 0.52 Allowed 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.874 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -36.98 -50.48 0.88 Allowed 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 114.333 -1.303 . . . . 0.0 110.228 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.417 ' O ' ' OE1' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -71.99 -57.7 4.07 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 104.818 -2.29 . . . . 0.0 104.818 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -50.95 -82.2 0.04 OUTLIER Glycine 0 N--CA 1.48 1.57 0 C-N-CA 119.011 -1.566 . . . . 0.0 109.7 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.533 ' N ' ' O ' ' A' ' 59' ' ' TRP . 62.1 t -29.95 -48.01 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.476 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -44.89 -60.2 2.17 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 124.349 2.023 . . . . 0.0 110.672 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -47.86 -12.06 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 109.027 -3.715 . . . . 0.0 109.548 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.476 ' H ' ' C ' ' A' ' 64' ' ' ALA . 33.4 mmt -89.92 158.51 17.38 Favored 'General case' 0 N--CA 1.508 2.433 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 86.1 p -122.19 136.12 54.86 Favored 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 121.64 0.733 . . . . 0.0 110.077 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.3 t -35.42 97.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-N 114.303 -1.317 . . . . 0.0 113.405 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.73 5.77 13.6 Favored Glycine 0 N--CA 1.5 2.906 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -107.02 149.23 27.78 Favored 'General case' 0 N--CA 1.508 2.457 0 CA-C-O 122.163 0.982 . . . . 0.0 110.291 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.0 ttp180 -133.61 143.4 48.61 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 113.621 -1.627 . . . . 0.0 107.365 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -153.22 179.22 8.93 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 113.312 -1.767 . . . . 0.0 115.066 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -124.75 104.01 8.41 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 103.364 -2.828 . . . . 0.0 103.364 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.2 mt -100.21 145.45 28.04 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.3 m -113.32 123.27 49.72 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 104.628 -2.36 . . . . 0.0 104.628 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 33.9 mt -112.6 131.13 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.491 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.426 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 61.6 p -104.71 154.31 38.62 Favored Pre-proline 0 N--CA 1.5 2.068 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -36.53 -54.08 0.99 Allowed 'Trans proline' 0 C--N 1.314 -1.261 0 C-N-CA 122.113 1.875 . . . . 0.0 113.663 -173.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 6.5 p-10 -42.2 -36.16 1.13 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -106.85 23.2 14.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -130.67 -87.03 0.5 Allowed 'General case' 0 N--CA 1.506 2.34 0 CA-C-O 122.017 0.913 . . . . 0.0 112.415 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.501 ' CE1' ' CG2' ' A' ' 56' ' ' ILE . 43.6 m-85 -138.05 -45.91 0.52 Allowed 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.495 ' O ' ' CB ' ' A' ' 84' ' ' ALA . . . 1.54 128.9 0.0 OUTLIER Glycine 0 N--CA 1.496 2.687 0 CA-C-N 112.285 -2.234 . . . . 0.0 116.97 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.495 ' CB ' ' O ' ' A' ' 83' ' ' GLY . . . 120.59 -47.55 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 O-C-N 126.229 1.782 . . . . 0.0 110.468 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.445 ' O ' ' O ' ' A' ' 86' ' ' GLY . 87.5 m -117.96 -57.56 2.09 Favored 'General case' 0 N--CA 1.505 2.288 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 85' ' ' THR . . . 42.72 -176.47 0.01 OUTLIER Glycine 0 N--CA 1.493 2.488 0 CA-C-O 122.149 0.861 . . . . 0.0 113.251 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.492 ' N ' ' O ' ' A' ' 91' ' ' ILE . 18.4 m80 -115.38 153.48 47.56 Favored Pre-proline 0 N--CA 1.504 2.251 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -90.22 37.26 0.34 Allowed 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 122.072 1.848 . . . . 0.0 108.562 170.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -132.37 -50.66 0.09 OUTLIER Glycine 0 N--CA 1.499 2.862 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.57 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.3 mt -115.88 -50.92 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 CA-C-O 122.124 0.964 . . . . 0.0 109.779 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.492 ' O ' ' N ' ' A' ' 87' ' ' HIS . 23.0 mm -117.45 88.23 27.93 Favored Pre-proline 0 N--CA 1.51 2.555 0 CA-C-N 113.57 -1.65 . . . . 0.0 113.042 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -60.87 -175.44 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.016 1.811 . . . . 0.0 109.239 169.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -61.41 166.98 10.34 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.041 1.827 . . . . 0.0 110.593 178.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.445 ' CG ' ' O ' ' A' ' 94' ' ' HIS . 25.4 p-80 9.43 68.43 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.247 0 O-C-N 125.385 1.678 . . . . 0.0 115.097 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -116.27 74.36 0.9 Allowed 'General case' 0 N--CA 1.501 2.117 0 CA-C-O 120.747 0.308 . . . . 0.0 110.457 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 84.5 m -29.31 134.29 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.026 0 O-C-N 124.811 1.319 . . . . 0.0 111.369 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 21.4 mt -107.57 144.61 34.34 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 49.9 t -132.39 119.65 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -111.85 163.87 13.71 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 122.513 1.149 . . . . 0.0 108.942 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -129.28 89.94 2.93 Favored 'General case' 0 C--N 1.301 -1.523 1 N-CA-C 97.383 -5.043 . . . . 0.0 97.383 179.221 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 12.3 t -103.89 151.17 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.447 0 N-CA-C 114.671 1.359 . . . . 0.0 114.671 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -125.82 103.05 7.59 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 112.007 -2.361 . . . . 0.0 108.122 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 43.6 tp -75.21 118.55 18.26 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 102.66 -3.089 . . . . 0.0 102.66 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.5 mt -85.35 -56.53 3.48 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 113.828 -1.533 . . . . 0.0 112.297 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.409 ' HB2' ' HZ1' ' A' ' 105' ' ' LYS . 0.1 OUTLIER -172.43 -168.34 0.52 Allowed 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.047 -1.061 . . . . 0.0 111.22 -179.865 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 22.2 mt -115.77 156.28 26.3 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 . . . . . 0 N--CA 1.505 2.277 0 CA-C-O 116.233 -1.842 . . . . 0.0 109.844 179.865 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.8 p -114.04 147.65 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -123.47 153.57 40.31 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 97.0 t -129.51 102.15 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -99.73 161.32 13.69 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 102.854 -3.017 . . . . 0.0 102.854 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 72.8 m -121.31 156.38 32.68 Favored 'General case' 0 N--CA 1.504 2.253 0 CA-C-O 121.987 0.899 . . . . 0.0 112.301 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 74.8 mt -124.72 -54.17 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 9' ' ' PRO . 28.2 t -124.99 83.18 60.48 Favored Pre-proline 0 N--CA 1.508 2.459 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.052 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 8' ' ' SER . 13.5 Cg_exo -37.28 160.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.155 1.903 . . . . 0.0 111.612 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.25 -171.75 14.28 Favored Glycine 0 N--CA 1.503 3.142 0 N-CA-C 107.496 -2.241 . . . . 0.0 107.496 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 12' ' ' GLY . 1.3 p30 -39.61 -51.64 2.24 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.817 -0.753 . . . . 0.0 112.508 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.51 ' N ' ' OD1' ' A' ' 11' ' ' ASP . . . 97.43 2.88 58.77 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 108.126 -1.99 . . . . 0.0 108.126 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 34.6 mtm-85 -119.8 -36.02 3.39 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.8 m -106.99 134.3 50.34 Favored 'General case' 0 N--CA 1.506 2.345 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 33.0 m-85 -130.61 175.14 3.89 Favored Pre-proline 0 N--CA 1.495 1.816 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -66.43 155.13 71.55 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 CA-C-N 119.82 0.971 . . . . 0.0 110.006 165.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -121.7 172.83 7.85 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-O 121.893 0.854 . . . . 0.0 109.635 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.425 ' CB ' HH11 ' A' ' 18' ' ' ARG . 44.3 mtm105 -77.99 96.27 5.02 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.673 -1.148 . . . . 0.0 109.92 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.71 12.55 3.66 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.194 -1.563 . . . . 0.0 109.194 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.494 ' O ' ' SD ' ' A' ' 49' ' ' MET . 15.8 mm100 -113.85 167.88 10.26 Favored 'General case' 0 N--CA 1.504 2.245 0 CA-C-O 121.893 0.854 . . . . 0.0 109.236 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 97.1 m -118.6 114.32 22.6 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 114.226 -1.352 . . . . 0.0 107.551 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 56.9 m -74.67 146.15 42.58 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 118.871 -1.132 . . . . 0.0 108.606 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 94.7 t -117.69 99.67 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 101.311 -3.589 . . . . 0.0 101.311 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.8 m -121.21 148.26 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 N-CA-C 114.946 1.462 . . . . 0.0 114.946 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -122.24 143.73 49.41 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 102.948 -2.982 . . . . 0.0 102.948 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -157.97 175.53 13.72 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 118.895 -1.122 . . . . 0.0 112.931 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 93.7 m -135.12 126.36 28.19 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 101.375 -3.565 . . . . 0.0 101.375 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.86 127.79 8.74 Favored Glycine 0 N--CA 1.502 3.065 0 C-N-CA 120.04 -1.076 . . . . 0.0 111.963 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 68.5 mtp -128.77 176.93 7.43 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 30.8 mt -123.78 -169.21 1.91 Allowed 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.01 22.86 3.02 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.747 0.784 . . . . 0.0 109.889 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 33' ' ' GLY . 1.2 p30 -131.43 -48.64 0.98 Allowed 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.85 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.529 ' N ' ' OD1' ' A' ' 32' ' ' ASP . . . 118.42 33.56 1.2 Allowed Glycine 0 N--CA 1.501 3.032 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.122 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.402 ' O ' ' C ' ' A' ' 35' ' ' LYS . 55.9 mmtt -118.3 70.5 0.81 Allowed 'General case' 0 N--CA 1.504 2.238 0 CA-C-N 117.311 0.556 . . . . 0.0 110.506 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 34' ' ' LYS . 22.0 pttp -19.33 137.04 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.285 0 O-C-N 125.108 1.505 . . . . 0.0 114.065 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.532 ' CD2' ' OD1' ' A' ' 37' ' ' ASP . 2.3 p90 -130.49 -34.06 1.61 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 113.653 -1.612 . . . . 0.0 108.58 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.532 ' OD1' ' CD2' ' A' ' 36' ' ' PHE . 1.0 OUTLIER -134.7 89.29 2.52 Favored 'General case' 0 N--CA 1.511 2.619 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 51.1 m -113.69 135.14 54.25 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.6 p -127.16 57.04 1.49 Allowed 'General case' 0 N--CA 1.509 2.523 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 20.1 ttp85 -130.11 77.14 1.77 Allowed 'General case' 0 N--CA 1.502 2.157 0 CA-C-O 121.29 0.567 . . . . 0.0 111.165 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -90.59 -93.86 0.13 Allowed 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.61 -121.48 0.08 Allowed 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 36.9 m-20 -111.69 26.14 10.94 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-N 113.934 -1.485 . . . . 0.0 110.268 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.442 ' O ' ' O ' ' A' ' 45' ' ' PRO . 20.4 pttp -127.01 64.26 59.74 Favored Pre-proline 0 N--CA 1.503 2.222 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.442 ' O ' ' O ' ' A' ' 44' ' ' LYS . 20.0 Cg_endo -45.6 -158.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 121.96 1.773 . . . . 0.0 114.162 170.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -91.46 148.85 22.01 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 114.331 -1.304 . . . . 0.0 114.205 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -143.06 122.88 13.42 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.487 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -135.4 171.55 14.28 Favored 'General case' 0 N--CA 1.512 2.627 0 CA-C-N 119.457 1.026 . . . . 0.0 112.466 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.494 ' SD ' ' O ' ' A' ' 20' ' ' GLN . 44.3 tpp -111.53 144.53 40.61 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 114.867 -1.06 . . . . 0.0 112.212 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.4 tp -90.8 121.43 32.66 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.601 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 117.27 -19.0 11.93 Favored Glycine 0 N--CA 1.501 2.967 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.888 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.429 ' O ' ' OE1' ' A' ' 54' ' ' GLU . 41.6 tptt -112.8 36.48 3.45 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.404 ' C ' ' O ' ' A' ' 52' ' ' LYS . 39.1 tt0 10.23 71.23 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 O-C-N 125.345 1.653 . . . . 0.0 113.664 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.429 ' OE1' ' O ' ' A' ' 52' ' ' LYS . 5.0 mm-40 -92.8 -24.06 18.65 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 113.408 -1.724 . . . . 0.0 106.828 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.1 m -115.92 -177.26 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 16.5 pt -90.27 169.94 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.193 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.549 ' O ' ' N ' ' A' ' 59' ' ' TRP . 19.4 ttm-85 -55.11 -63.18 1.24 Allowed 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.334 -0.947 . . . . 0.0 110.702 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -27.13 -35.31 0.01 OUTLIER Glycine 0 N--CA 1.496 2.694 0 O-C-N 124.933 1.396 . . . . 0.0 111.977 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.549 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.9 OUTLIER -86.76 -71.35 0.56 Allowed 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 114.058 -1.071 . . . . 0.0 108.646 179.856 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.422 ' O ' ' OE1' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -28.53 -57.73 0.13 Allowed 'General case' 0 N--CA 1.504 2.255 0 O-C-N 125.066 1.478 . . . . 0.0 110.325 -179.867 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -73.25 -52.58 13.5 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -49.31 -79.9 0.07 OUTLIER Glycine 0 N--CA 1.477 1.375 0 C-N-CA 119.419 -1.372 . . . . 0.0 110.96 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.522 ' N ' ' O ' ' A' ' 59' ' ' TRP . 35.6 t -39.45 -47.71 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 120.226 -0.589 . . . . 0.0 112.358 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.476 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -45.3 -60.11 2.31 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 124.146 1.927 . . . . 0.0 111.094 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -48.51 -11.2 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 109.386 -3.552 . . . . 0.0 109.661 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.476 ' H ' ' C ' ' A' ' 64' ' ' ALA . 86.0 mtp -97.94 156.47 16.6 Favored 'General case' 0 N--CA 1.513 2.704 0 C-N-CA 118.854 -1.138 . . . . 0.0 108.606 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 79.8 p -118.64 149.13 41.91 Favored 'General case' 0 N--CA 1.508 2.443 0 CA-C-O 122.539 1.162 . . . . 0.0 112.8 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 99.5 t -43.52 97.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-N 112.801 -1.999 . . . . 0.0 114.716 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.36 12.92 16.14 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -108.03 145.05 34.51 Favored 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.106 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 25.7 ttt85 -123.79 135.1 53.59 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 105.464 -2.051 . . . . 0.0 105.464 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -136.82 172.61 12.75 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 112.026 -2.352 . . . . 0.0 116.142 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -129.58 103.77 7.06 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 111.069 -2.787 . . . . 0.0 103.917 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.421 ' N ' HD12 ' A' ' 74' ' ' LEU . 5.0 mp -100.69 149.47 23.75 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.889 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.6 m -121.09 104.51 9.83 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 21.3 mt -99.81 137.25 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.414 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 29.5 p -115.54 156.34 46.16 Favored Pre-proline 0 N--CA 1.501 2.123 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.413 ' O ' ' O ' ' A' ' 81' ' ' ALA . 7.6 Cg_endo -35.97 -52.07 1.03 Allowed 'Trans proline' 0 C--N 1.314 -1.266 0 C-N-CA 121.937 1.758 . . . . 0.0 113.971 -175.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.414 ' OD1' ' OG ' ' A' ' 77' ' ' SER . 1.3 p30 -37.62 -38.64 0.28 Allowed 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 121.456 0.646 . . . . 0.0 112.301 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -104.02 -27.98 11.8 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.428 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.492 ' O ' ' N ' ' A' ' 83' ' ' GLY . . . -97.37 165.47 12.0 Favored 'General case' 0 N--CA 1.506 2.337 0 C-N-CA 119.299 -0.96 . . . . 0.0 109.171 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -5.44 -57.87 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 126.618 2.449 . . . . 0.0 114.873 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 81' ' ' ALA . . . 124.44 163.13 11.61 Favored Glycine 0 N--CA 1.5 2.938 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.142 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -12.3 -85.85 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 116.169 1.914 . . . . 0.0 116.169 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 92.8 m -125.34 94.27 4.1 Favored 'General case' 0 N--CA 1.501 2.108 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.127 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -112.63 -54.25 0.47 Allowed Glycine 0 N--CA 1.501 3.008 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.216 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -122.94 62.92 19.62 Favored Pre-proline 0 N--CA 1.506 2.352 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -44.87 126.82 7.81 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 121.326 1.351 . . . . 0.0 109.916 172.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 118.25 -40.23 2.36 Favored Glycine 0 N--CA 1.501 3.026 0 N-CA-C 108.597 -1.801 . . . . 0.0 108.597 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.8 mt -108.93 -51.22 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 23.7 mm -118.32 85.28 24.91 Favored Pre-proline 0 N--CA 1.502 2.128 0 CA-C-N 112.105 -2.316 . . . . 0.0 110.54 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -60.68 164.35 13.75 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 N-CA-C 107.223 -1.876 . . . . 0.0 107.223 177.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.41 ' O ' ' C ' ' A' ' 94' ' ' HIS . 16.3 Cg_endo -44.57 167.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 121.43 1.42 . . . . 0.0 110.178 177.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.41 ' C ' ' O ' ' A' ' 93' ' ' PRO . 20.4 m80 9.67 63.71 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 O-C-N 125.714 1.884 . . . . 0.0 114.73 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -115.65 71.35 0.77 Allowed 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.091 0.472 . . . . 0.0 110.031 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 91.2 m -29.34 125.17 0.13 Allowed 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 113.99 -1.459 . . . . 0.0 110.905 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 18.4 mt -89.76 146.97 24.11 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 55.1 t -131.78 109.71 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -103.26 156.43 17.72 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 122.135 0.969 . . . . 0.0 109.211 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -127.07 93.68 3.82 Favored 'General case' 0 N--CA 1.493 1.679 1 N-CA-C 97.897 -4.853 . . . . 0.0 97.897 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.403 HG12 ' N ' ' A' ' 102' ' ' GLU . 11.4 t -108.38 154.89 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.434 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.403 ' N ' HG12 ' A' ' 101' ' ' VAL . 38.7 tt0 -128.74 102.36 6.53 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 111.612 -2.54 . . . . 0.0 107.741 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 37.0 tp -72.24 125.63 27.81 Favored 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 103.065 -2.939 . . . . 0.0 103.065 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 16.5 mt -96.25 -55.4 2.96 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.406 ' HG2' ' H ' ' A' ' 106' ' ' LEU . 56.0 tttp -166.09 177.3 7.07 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.071 -1.052 . . . . 0.0 111.474 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.406 ' H ' ' HG2' ' A' ' 105' ' ' LYS . 24.4 mt -114.55 150.94 34.18 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 . . . . . 0 N--CA 1.505 2.299 0 CA-C-O 116.17 -1.871 . . . . 0.0 109.996 179.731 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.231 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.8 p -110.22 143.84 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -121.26 157.77 29.57 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.5 t -122.65 115.42 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -117.11 94.69 4.67 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 69.0 m -69.92 155.88 39.91 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 114.806 1.409 . . . . 0.0 114.806 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 72.2 mt -122.57 -55.48 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 CA-C-N 113.031 -1.895 . . . . 0.0 107.387 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.423 ' O ' ' O ' ' A' ' 9' ' ' PRO . 34.7 t -121.99 81.96 43.27 Favored Pre-proline 0 N--CA 1.505 2.292 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.576 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 8' ' ' SER . 12.2 Cg_exo -38.4 164.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.165 1.91 . . . . 0.0 111.868 178.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.67 -172.39 15.02 Favored Glycine 0 N--CA 1.498 2.803 0 N-CA-C 104.916 -3.274 . . . . 0.0 104.916 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.524 ' N ' ' OD1' ' A' ' 11' ' ' ASP . 12.9 p-10 -39.72 -58.56 1.31 Allowed 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.434 -0.907 . . . . 0.0 112.8 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.32 23.27 9.11 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 105.081 -3.208 . . . . 0.0 105.081 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.02 -40.73 1.48 Allowed 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 113.757 -1.222 . . . . 0.0 111.545 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.4 m -108.62 136.46 48.19 Favored 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.454 ' N ' ' CD1' ' A' ' 15' ' ' PHE . 66.0 m-85 -131.65 176.75 2.65 Favored Pre-proline 0 N--CA 1.494 1.765 0 N-CA-C 105.195 -2.15 . . . . 0.0 105.195 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -70.7 149.18 60.5 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 CA-C-N 119.485 0.852 . . . . 0.0 111.194 164.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -121.78 173.38 7.51 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 122.289 1.043 . . . . 0.0 110.41 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.1 ttm180 -77.69 98.34 5.44 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 113.912 -1.494 . . . . 0.0 109.556 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.13 9.63 4.56 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -113.89 171.76 7.4 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 76.8 m -124.42 112.63 17.15 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.732 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.443 ' N ' ' O ' ' A' ' 48' ' ' PHE . 36.5 m -72.11 147.66 46.48 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.752 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.2 t -116.78 114.11 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 101.389 -3.56 . . . . 0.0 101.389 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.416 HG21 ' CZ3' ' A' ' 59' ' ' TRP . 1.0 OUTLIER -126.65 150.16 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.04 0 N-CA-C 119.404 3.112 . . . . 0.0 119.404 -178.798 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.411 ' CD2' ' OG ' ' A' ' 39' ' ' SER . 32.6 t-80 -133.48 142.85 48.46 Favored 'General case' 0 N--CA 1.506 2.33 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.515 ' CZ ' ' O ' ' A' ' 38' ' ' SER . 39.2 p90 -160.53 -179.38 7.6 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 118.474 -1.291 . . . . 0.0 113.53 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 91.5 m -140.73 122.84 15.67 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 101.657 -3.46 . . . . 0.0 101.657 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -102.26 147.69 17.34 Favored Glycine 0 N--CA 1.504 3.198 0 C-N-CA 119.999 -1.096 . . . . 0.0 110.377 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.435 ' SD ' ' C ' ' A' ' 34' ' ' LYS . 13.4 tpp -147.36 170.35 17.51 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 120.069 -0.652 . . . . 0.0 110.181 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.404 ' O ' ' C ' ' A' ' 31' ' ' GLU . 31.3 mt -115.04 149.2 37.84 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.527 ' N ' ' OE1' ' A' ' 31' ' ' GLU . 3.6 pm0 -20.64 -51.87 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -160.29 43.11 0.19 Allowed 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 118.732 -1.187 . . . . 0.0 110.408 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -121.44 -81.51 0.62 Allowed Glycine 0 N--CA 1.499 2.88 0 C-N-CA 119.439 -1.362 . . . . 0.0 112.859 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.435 ' C ' ' SD ' ' A' ' 29' ' ' MET . 0.0 OUTLIER -160.96 -163.71 1.08 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 113.972 -1.114 . . . . 0.0 113.516 -179.395 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -90.37 133.26 35.1 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.432 ' O ' ' OD1' ' A' ' 37' ' ' ASP . 55.6 p90 -108.21 -34.84 6.72 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 103.769 -2.678 . . . . 0.0 103.769 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 36' ' ' PHE . 0.7 OUTLIER -147.89 150.16 33.58 Favored 'General case' 0 N--CA 1.508 2.437 0 CA-C-O 122.132 0.967 . . . . 0.0 112.738 179.755 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.515 ' O ' ' CZ ' ' A' ' 26' ' ' TYR . 52.1 m -130.34 -159.83 0.99 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 41' ' ' ASP . 28.3 p -113.09 -82.94 0.6 Allowed 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 20.7 ttp85 -29.96 -37.47 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.127 0 CA-C-O 122.037 0.922 . . . . 0.0 112.301 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 39' ' ' SER . 64.1 t0 -18.78 -57.19 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 116.418 2.007 . . . . 0.0 116.418 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 62.7 mtt180 -90.86 -107.71 0.09 Allowed 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.457 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 44.2 m-20 -110.88 65.3 0.61 Allowed 'General case' 0 N--CA 1.506 2.341 0 N-CA-C 114.93 1.455 . . . . 0.0 114.93 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.457 ' CB ' ' O ' ' A' ' 43' ' ' ASN . 75.7 mmtt 94.45 172.13 0.03 OUTLIER Pre-proline 0 N--CA 1.508 2.448 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -58.27 -158.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.245 0 CA-C-N 120.588 1.246 . . . . 0.0 114.254 177.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . 0.255 0.7 OUTLIER -117.08 129.03 55.73 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 112.093 -2.321 . . . . 0.0 109.954 -179.502 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -134.98 123.96 24.13 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 113.5 -1.682 . . . . 0.0 107.259 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.443 ' O ' ' N ' ' A' ' 22' ' ' CYS . 22.1 p90 -135.41 -178.01 4.92 Favored 'General case' 0 N--CA 1.515 2.814 0 CA-C-N 120.579 1.536 . . . . 0.0 114.696 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 42.9 ttm -116.69 144.25 44.65 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-N 115.199 -0.909 . . . . 0.0 113.024 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.3 tp -90.89 120.98 32.35 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.626 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.82 -11.48 49.48 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.468 ' O ' ' N ' ' A' ' 54' ' ' GLU . 25.6 tptp -112.44 38.58 2.7 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.407 ' C ' ' O ' ' A' ' 52' ' ' LYS . 47.5 tt0 0.86 66.18 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 O-C-N 125.653 1.846 . . . . 0.0 112.958 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' A' ' 52' ' ' LYS . 39.2 tt0 -96.28 -26.08 15.54 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 112.731 -2.031 . . . . 0.0 107.199 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.437 ' O ' ' O ' ' A' ' 56' ' ' ILE . 4.9 m -124.32 152.54 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.465 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.174 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 55' ' ' VAL . 4.9 pt -45.89 177.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.408 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.54 ' O ' ' N ' ' A' ' 59' ' ' TRP . 30.5 ttp180 -79.25 -57.53 3.67 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-O 118.337 -0.84 . . . . 0.0 112.715 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -30.58 -32.73 0.01 OUTLIER Glycine 0 N--CA 1.503 3.11 0 CA-C-O 122.664 1.147 . . . . 0.0 111.427 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.54 ' N ' ' O ' ' A' ' 57' ' ' ARG . 2.4 m0 -90.06 -73.5 0.52 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 113.629 -1.286 . . . . 0.0 107.853 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -31.86 -54.61 0.28 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 124.792 1.308 . . . . 0.0 110.768 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -73.15 -51.64 17.12 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 113.977 -1.465 . . . . 0.0 107.614 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 65' ' ' GLN . . . -55.69 -82.44 0.05 OUTLIER Glycine 0 N--CA 1.479 1.54 0 N-CA-C 108.16 -1.976 . . . . 0.0 108.16 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' A' ' 59' ' ' TRP . 66.1 t -30.38 -45.1 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.414 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -51.11 -49.29 61.02 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 123.692 1.711 . . . . 0.0 109.569 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.481 ' N ' ' O ' ' A' ' 62' ' ' GLY . 42.6 tt0 -66.01 3.29 0.87 Allowed 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 110.202 -3.181 . . . . 0.0 110.892 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.414 ' H ' ' C ' ' A' ' 64' ' ' ALA . 48.4 ttm -109.51 156.19 20.42 Favored 'General case' 0 N--CA 1.51 2.531 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 99.7 p -115.32 151.41 34.64 Favored 'General case' 0 N--CA 1.509 2.502 0 CA-C-O 122.545 1.164 . . . . 0.0 112.694 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 95.5 t -46.34 99.51 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-N 112.804 -1.998 . . . . 0.0 114.581 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.66 3.69 28.59 Favored Glycine 0 N--CA 1.502 3.076 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -101.83 149.13 24.5 Favored 'General case' 0 N--CA 1.506 2.328 0 CA-C-O 121.988 0.899 . . . . 0.0 111.03 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.8 ttt85 -127.14 143.2 51.32 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 113.786 -1.552 . . . . 0.0 106.961 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -151.72 175.99 11.85 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 113.401 -1.727 . . . . 0.0 113.958 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.5 ttmp? -119.67 102.8 8.87 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 103.45 -2.796 . . . . 0.0 103.45 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.2 mt -96.26 149.69 21.39 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 97.1 m -119.47 116.53 26.3 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 104.486 -2.412 . . . . 0.0 104.486 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 53.5 mt -102.45 142.58 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.9 p -101.53 154.36 37.3 Favored Pre-proline 0 N--CA 1.501 2.083 0 O-C-N 124.985 1.428 . . . . 0.0 111.398 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -44.72 -41.89 14.8 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 C-N-CA 122.915 2.41 . . . . 0.0 117.695 -175.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -87.77 20.24 3.11 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 117.908 2.558 . . . . 0.0 117.908 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -113.79 -38.39 4.27 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -115.35 -73.47 0.65 Allowed 'General case' 0 N--CA 1.503 2.192 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.421 ' CD2' HD11 ' A' ' 97' ' ' LEU . 8.9 m-30 -106.6 -92.84 0.39 Allowed 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 114.154 -1.384 . . . . 0.0 107.564 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 94' ' ' HIS . . . 107.94 -87.65 0.5 Allowed Glycine 0 N--CA 1.502 3.074 0 N-CA-C 115.051 0.78 . . . . 0.0 115.051 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -124.73 -28.84 3.49 Favored 'General case' 0 N--CA 1.503 2.185 0 CA-C-O 120.943 0.402 . . . . 0.0 111.433 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 91.3 m -99.55 67.83 1.54 Allowed 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.563 0.697 . . . . 0.0 110.544 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -112.83 -164.57 16.29 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.411 ' H ' ' HB ' ' A' ' 91' ' ' ILE . 25.6 t-80 -115.6 82.71 10.32 Favored Pre-proline 0 N--CA 1.503 2.18 0 CA-C-O 118.865 -0.588 . . . . 0.0 111.416 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_exo -34.88 151.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 122.671 2.248 . . . . 0.0 111.433 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 107.38 -41.7 2.13 Favored Glycine 0 N--CA 1.5 2.959 0 N-CA-C 106.011 -2.836 . . . . 0.0 106.011 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.0 mm -119.53 -57.27 3.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 110.253 -2.974 . . . . 0.0 107.004 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.411 ' HB ' ' H ' ' A' ' 87' ' ' HIS . 34.5 mm -118.93 87.57 33.99 Favored Pre-proline 0 N--CA 1.506 2.348 0 CA-C-N 113.354 -1.748 . . . . 0.0 111.086 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -69.64 162.66 41.16 Favored 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 122.448 2.099 . . . . 0.0 108.316 171.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -48.65 177.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.15 1.9 . . . . 0.0 112.176 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.52 ' N ' ' O ' ' A' ' 83' ' ' GLY . 24.5 m80 9.7 65.95 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 116.242 1.942 . . . . 0.0 116.242 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -115.62 138.33 51.18 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 28.9 m -90.73 136.94 32.74 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 103.752 -2.684 . . . . 0.0 103.752 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.421 HD11 ' CD2' ' A' ' 82' ' ' TYR . 19.3 mt -106.48 150.19 26.33 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.1 t -132.14 104.32 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -96.89 166.97 11.37 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -127.5 85.92 2.42 Favored 'General case' 0 N--CA 1.491 1.598 1 N-CA-C 94.844 -5.984 . . . . 0.0 94.844 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.1 t -98.59 149.45 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.3 0 CA-C-O 122.759 1.266 . . . . 0.0 114.342 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -126.84 111.45 14.19 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 112.19 -2.277 . . . . 0.0 106.897 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 35.0 tp -79.49 113.72 17.86 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 101.125 -3.657 . . . . 0.0 101.125 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.3 mt -74.19 -57.78 3.73 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 118.684 -1.207 . . . . 0.0 111.49 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.401 ' HG2' ' H ' ' A' ' 106' ' ' LEU . 0.4 OUTLIER -175.32 -172.27 0.56 Allowed 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 118.32 -1.352 . . . . 0.0 109.619 -179.831 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.401 ' H ' ' HG2' ' A' ' 105' ' ' LYS . 16.1 mt -117.89 155.28 30.43 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 . . . . . 0 N--CA 1.512 2.645 0 CA-C-O 116.175 -1.869 . . . . 0.0 109.143 179.443 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.2 p -113.63 150.08 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -121.09 152.64 38.44 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 55.6 t -126.64 112.38 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.531 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.417 ' OE1' ' O ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -113.03 96.04 5.72 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 103.644 -2.725 . . . . 0.0 103.644 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.417 ' O ' ' OE1' ' A' ' 5' ' ' GLU . 87.1 m -69.87 156.58 38.86 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 118.56 -1.256 . . . . 0.0 112.494 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 71.7 mt -121.16 -55.09 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 CA-C-N 113.939 -1.482 . . . . 0.0 107.422 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.423 ' O ' ' O ' ' A' ' 9' ' ' PRO . 36.2 m -124.35 82.42 57.95 Favored Pre-proline 0 N--CA 1.507 2.407 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.742 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 8' ' ' SER . 3.4 Cg_exo -35.93 164.21 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.566 2.177 . . . . 0.0 113.434 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -114.84 -176.91 18.87 Favored Glycine 0 N--CA 1.501 3.023 0 N-CA-C 105.841 -2.903 . . . . 0.0 105.841 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.464 ' CG ' ' H ' ' A' ' 12' ' ' GLY . 11.6 p-10 -42.5 -58.48 2.24 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 118.174 0.987 . . . . 0.0 111.745 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.464 ' H ' ' CG ' ' A' ' 11' ' ' ASP . . . 109.33 24.63 5.85 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 107.738 -2.145 . . . . 0.0 107.738 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.3 mtm180 -133.53 -34.35 1.05 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 114.75 -0.725 . . . . 0.0 112.771 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.4 m -111.51 130.4 55.74 Favored 'General case' 0 N--CA 1.506 2.347 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 26.2 m-85 -130.31 173.35 5.9 Favored Pre-proline 0 N--CA 1.497 1.898 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -67.94 150.28 78.03 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 CA-C-N 119.997 1.035 . . . . 0.0 111.165 167.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -121.62 171.15 9.05 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-O 121.898 0.856 . . . . 0.0 110.911 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.2 ttt-85 -77.51 98.57 5.38 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.491 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.0 10.38 4.32 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -114.97 173.91 6.24 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.1 m -124.7 112.09 16.34 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 20.1 m -69.82 145.8 51.84 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.4 t -118.11 102.84 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 101.268 -3.605 . . . . 0.0 101.268 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.0 m -124.09 153.9 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.443 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 -131.19 116.87 18.25 Favored 'General case' 0 N--CA 1.507 2.405 0 N-CA-C 104.991 -2.226 . . . . 0.0 104.991 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -132.16 177.38 7.61 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 122.997 1.379 . . . . 0.0 114.451 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 87.3 m -136.32 124.4 22.95 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 101.218 -3.623 . . . . 0.0 101.218 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -107.99 116.18 4.73 Favored Glycine 0 N--CA 1.501 3.022 0 C-N-CA 120.337 -0.935 . . . . 0.0 111.415 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 69.2 mtp -125.13 178.62 5.45 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 34.3 mt -123.18 172.17 8.79 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -29.66 -61.13 0.15 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 124.919 1.387 . . . . 0.0 113.637 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -160.5 42.84 0.18 Allowed 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.051 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -118.83 -79.93 0.67 Allowed Glycine 0 N--CA 1.5 2.946 0 C-N-CA 119.374 -1.393 . . . . 0.0 113.885 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -161.1 -168.73 2.13 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -91.11 133.9 34.96 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 113.963 -1.471 . . . . 0.0 109.957 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.531 ' CD2' ' OD1' ' A' ' 37' ' ' ASP . 4.9 p90 -123.77 -36.54 2.73 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.531 ' OD1' ' CD2' ' A' ' 36' ' ' PHE . 1.0 OUTLIER -132.55 74.77 1.59 Allowed 'General case' 0 N--CA 1.509 2.497 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.673 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 69.0 m -105.75 121.51 44.18 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 63.9 p -113.22 65.16 0.64 Allowed 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.043 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -116.22 -72.08 0.71 Allowed 'General case' 0 N--CA 1.503 2.216 0 CA-C-O 120.838 0.352 . . . . 0.0 110.803 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -91.11 11.71 22.32 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -91.15 -96.83 0.12 Allowed 'General case' 0 N--CA 1.503 2.223 0 C-N-CA 119.995 -0.682 . . . . 0.0 112.384 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.415 ' O ' ' O ' ' A' ' 44' ' ' LYS . 4.4 m120 -110.77 62.43 0.61 Allowed 'General case' 0 N--CA 1.504 2.256 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.72 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.415 ' O ' ' O ' ' A' ' 43' ' ' ASN . 48.8 mttm 52.29 -178.02 0.02 OUTLIER Pre-proline 0 N--CA 1.499 2.003 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -60.39 -161.35 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.559 0 CA-C-N 119.875 0.991 . . . . 0.0 111.52 174.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -123.3 159.23 29.24 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 113.671 -1.604 . . . . 0.0 112.891 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.5 mtmp? -143.61 117.11 9.13 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.875 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -137.14 167.3 21.81 Favored 'General case' 0 N--CA 1.511 2.602 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.638 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.5 ' SD ' ' O ' ' A' ' 50' ' ' LEU . 7.8 tmm? -117.46 144.6 44.87 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.97 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.5 ' O ' ' SD ' ' A' ' 49' ' ' MET . 44.0 tp -90.81 134.52 34.38 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 114.516 -1.22 . . . . 0.0 111.443 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 132.97 -34.42 2.46 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 54' ' ' GLU . 80.3 tttt -122.62 44.39 2.65 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 4.42 58.73 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 126.015 2.072 . . . . 0.0 114.072 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 52' ' ' LYS . 50.4 mt-10 -63.74 -17.58 63.17 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 114.526 -1.215 . . . . 0.0 109.757 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 56' ' ' ILE . 21.1 m -117.6 159.79 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.32 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.425 ' O ' ' O ' ' A' ' 55' ' ' VAL . 16.2 pt -51.55 178.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 C-N-CA 118.64 -1.224 . . . . 0.0 108.534 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.532 ' O ' ' N ' ' A' ' 59' ' ' TRP . 17.6 ttm180 -75.18 -59.14 2.88 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.152 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -28.52 -34.98 0.01 OUTLIER Glycine 0 N--CA 1.497 2.738 0 O-C-N 124.614 1.196 . . . . 0.0 112.26 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.532 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.6 OUTLIER -81.39 -73.61 0.37 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 179.761 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 59' ' ' TRP . 32.4 tt0 -22.4 -57.24 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 O-C-N 125.914 2.009 . . . . 0.0 111.426 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -78.11 -52.21 9.09 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 113.075 -1.875 . . . . 0.0 106.491 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -49.65 -74.17 0.3 Allowed Glycine 0 N--CA 1.48 1.604 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.095 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.499 ' N ' ' O ' ' A' ' 59' ' ' TRP . 25.6 t -44.13 -50.59 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 C-N-CA 119.317 -0.953 . . . . 0.0 111.745 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.469 ' C ' ' N ' ' A' ' 66' ' ' MET . . . -44.19 -62.39 1.17 Allowed 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 123.989 1.852 . . . . 0.0 111.608 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -45.9 -13.98 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 109.429 -3.532 . . . . 0.0 109.3 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.469 ' N ' ' C ' ' A' ' 64' ' ' ALA . 20.2 mtm -98.36 158.23 15.71 Favored 'General case' 0 N--CA 1.514 2.733 0 C-N-CA 118.084 -1.446 . . . . 0.0 108.96 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 84.4 p -117.9 149.43 40.9 Favored 'General case' 0 N--CA 1.508 2.467 0 CA-C-O 122.558 1.17 . . . . 0.0 113.399 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 90.5 t -39.4 96.6 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 112.719 -2.037 . . . . 0.0 114.044 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.13 9.4 20.24 Favored Glycine 0 N--CA 1.5 2.919 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -103.0 141.6 35.52 Favored 'General case' 0 N--CA 1.502 2.168 0 CA-C-O 121.457 0.646 . . . . 0.0 110.355 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 24.7 ttt85 -125.34 141.13 52.25 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -149.65 176.13 10.93 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-N 113.064 -1.88 . . . . 0.0 115.853 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -127.61 105.01 8.19 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 103.851 -2.648 . . . . 0.0 103.851 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.429 ' N ' HD12 ' A' ' 74' ' ' LEU . 4.9 mp -102.47 152.27 21.33 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.591 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 92.0 m -123.73 117.18 24.37 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 22.8 mt -108.63 141.72 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 CA-C-O 121.099 0.476 . . . . 0.0 109.858 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.421 ' O ' ' OD1' ' A' ' 79' ' ' ASP . 33.4 p -114.65 155.34 46.24 Favored Pre-proline 0 N--CA 1.504 2.263 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.435 ' O ' ' N ' ' A' ' 81' ' ' ALA . 10.2 Cg_endo -37.68 -55.65 1.04 Allowed 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.683 1.588 . . . . 0.0 113.961 -175.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 14.7 p30 -34.04 -34.89 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.579 0.704 . . . . 0.0 112.567 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.429 ' N ' ' O ' ' A' ' 78' ' ' PRO . 6.9 m-85 -106.81 -20.29 13.38 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.644 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 78' ' ' PRO . . . -106.75 171.02 7.59 Favored 'General case' 0 N--CA 1.507 2.383 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.415 ' C ' ' O ' ' A' ' 81' ' ' ALA . 51.3 m-85 -7.99 -63.15 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.269 0 O-C-N 125.627 1.829 . . . . 0.0 114.704 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 115.15 -97.35 0.8 Allowed Glycine 0 N--CA 1.503 3.122 0 CA-C-N 115.776 -0.647 . . . . 0.0 113.901 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -127.71 -31.63 2.43 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 92.0 m -101.93 78.35 1.79 Allowed 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -111.01 -168.74 19.02 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 107.333 -2.307 . . . . 0.0 107.333 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.433 ' O ' ' O ' ' A' ' 91' ' ' ILE . 30.4 t-80 -111.86 135.84 21.2 Favored Pre-proline 0 N--CA 1.507 2.398 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -75.48 149.85 35.34 Favored 'Trans proline' 0 C--N 1.316 -1.18 0 C-N-CA 121.232 1.288 . . . . 0.0 109.666 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 107.04 -45.02 1.36 Allowed Glycine 0 N--CA 1.499 2.877 0 N-CA-C 108.257 -1.937 . . . . 0.0 108.257 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.4 mt -112.93 -53.78 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 87' ' ' HIS . 18.9 mm -118.99 86.02 30.5 Favored Pre-proline 0 N--CA 1.508 2.457 0 CA-C-N 113.689 -1.596 . . . . 0.0 111.908 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -65.0 161.51 36.56 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 N-CA-C 106.875 -2.01 . . . . 0.0 106.875 173.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -52.07 170.27 0.24 Allowed 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 121.918 1.745 . . . . 0.0 111.384 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 9.59 66.82 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 116.034 1.865 . . . . 0.0 116.034 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -116.85 152.7 33.91 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 31.2 m -91.02 143.26 26.89 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 20.3 mt -110.19 153.33 24.91 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.7 t -138.11 123.59 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -118.86 155.03 31.95 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 122.119 0.961 . . . . 0.0 110.307 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -125.7 89.94 3.12 Favored 'General case' 0 N--CA 1.494 1.76 1 N-CA-C 97.424 -5.028 . . . . 0.0 97.424 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 9.9 t -102.93 151.29 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.483 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -128.59 100.9 5.93 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 111.832 -2.44 . . . . 0.0 108.284 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 45.9 tp -72.75 124.49 25.44 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 104.159 -2.534 . . . . 0.0 104.159 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.1 mt -91.56 -58.32 2.47 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 114.372 -1.285 . . . . 0.0 112.008 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.417 ' HG2' ' H ' ' A' ' 106' ' ' LEU . 29.3 tttm -168.93 -175.4 2.34 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.007 -1.077 . . . . 0.0 110.418 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.417 ' H ' ' HG2' ' A' ' 105' ' ' LYS . 17.9 mt -117.22 154.89 30.36 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 . . . . . 0 N--CA 1.505 2.313 0 CA-C-O 116.056 -1.926 . . . . 0.0 110.817 179.578 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.6 p -117.58 150.26 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -121.96 157.46 31.21 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.6 t -126.64 106.62 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -107.47 88.47 2.74 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 93.4 m -69.7 156.13 39.45 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.004 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.0 mt -122.76 -52.73 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-N 113.681 -1.599 . . . . 0.0 107.025 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.422 ' O ' ' O ' ' A' ' 9' ' ' PRO . 98.2 p -122.75 82.22 48.89 Favored Pre-proline 0 N--CA 1.505 2.302 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.462 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 8' ' ' SER . 7.8 Cg_exo -37.59 167.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.606 2.204 . . . . 0.0 113.234 178.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.16 -171.79 15.03 Favored Glycine 0 N--CA 1.503 3.132 0 N-CA-C 107.17 -2.372 . . . . 0.0 107.17 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.521 ' N ' ' OD1' ' A' ' 11' ' ' ASP . 13.9 p-10 -39.62 -61.09 0.86 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.576 -0.85 . . . . 0.0 112.897 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.17 17.88 12.08 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 106.126 -2.789 . . . . 0.0 106.126 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.9 mmt85 -127.41 -39.61 1.85 Allowed 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 114.006 -1.097 . . . . 0.0 111.925 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.1 m -108.29 133.7 52.15 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.435 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 32.8 m-85 -131.16 175.67 3.5 Favored Pre-proline 0 N--CA 1.496 1.855 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -72.58 140.81 33.46 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 CA-C-N 119.621 0.9 . . . . 0.0 109.988 163.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -121.23 174.08 6.92 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.714 0.769 . . . . 0.0 110.325 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 25.1 ttt85 -73.13 110.36 7.36 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.082 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.96 0.89 10.69 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -116.63 172.94 6.9 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 121.933 0.873 . . . . 0.0 110.628 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 97.0 m -125.25 117.67 24.32 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-N 113.975 -1.466 . . . . 0.0 108.234 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 55.8 m -69.58 150.55 46.96 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 77.0 t -122.71 101.48 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 102.945 -2.983 . . . . 0.0 102.945 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.3 m -121.64 149.19 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.498 0 N-CA-C 117.904 2.557 . . . . 0.0 117.904 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -124.68 111.92 16.16 Favored 'General case' 0 N--CA 1.507 2.378 0 N-CA-C 103.352 -2.833 . . . . 0.0 103.352 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.471 ' N ' ' CD1' ' A' ' 26' ' ' TYR . 19.8 p90 -129.89 168.32 16.81 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 123.485 1.612 . . . . 0.0 114.434 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 97.3 m -134.6 111.05 9.72 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 102.384 -3.191 . . . . 0.0 102.384 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 37' ' ' ASP . . . -89.36 138.35 14.62 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.113 -1.518 . . . . 0.0 109.875 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 38.1 ttm -131.22 175.67 8.92 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 32.9 mt -116.61 -167.63 1.32 Allowed 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -89.18 24.61 2.1 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 33' ' ' GLY . 1.2 p30 -132.47 -48.24 0.9 Allowed 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.601 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.526 ' N ' ' OD1' ' A' ' 32' ' ' ASP . . . 120.92 31.53 1.19 Allowed Glycine 0 N--CA 1.501 3.032 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.621 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 35' ' ' LYS . 25.8 mmtp -118.93 81.55 1.72 Allowed 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 118.581 -0.723 . . . . 0.0 110.252 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.405 ' C ' ' O ' ' A' ' 34' ' ' LYS . 21.6 pttp -19.29 133.67 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.531 0 O-C-N 125.078 1.486 . . . . 0.0 113.211 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.527 ' CD2' ' OD1' ' A' ' 37' ' ' ASP . 0.6 OUTLIER -136.02 -31.07 0.93 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 113.906 -1.497 . . . . 0.0 110.195 -179.582 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.527 ' OD1' ' CD2' ' A' ' 36' ' ' PHE . 0.9 OUTLIER -132.08 92.83 3.17 Favored 'General case' 0 N--CA 1.516 2.853 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -179.737 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 52.6 m -108.66 173.57 6.26 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.574 ' O ' ' N ' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -116.13 78.21 1.17 Allowed 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.539 ' O ' ' N ' ' A' ' 42' ' ' ARG . 9.9 mmm180 -28.58 57.37 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.39 0 O-C-N 126.88 2.612 . . . . 0.0 117.687 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.574 ' N ' ' O ' ' A' ' 39' ' ' SER . 36.9 t70 -27.21 71.72 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 112.877 -1.965 . . . . 0.0 115.265 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.539 ' N ' ' O ' ' A' ' 40' ' ' ARG . 43.8 ttp180 -90.78 -63.16 1.31 Allowed 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.49 ' CG ' ' H ' ' A' ' 44' ' ' LYS . 11.8 p30 -110.4 -81.93 0.58 Allowed 'General case' 0 N--CA 1.5 2.034 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.478 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.49 ' H ' ' CG ' ' A' ' 43' ' ' ASN . 18.3 ptpt -125.94 152.41 72.8 Favored Pre-proline 0 N--CA 1.504 2.265 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 44' ' ' LYS . 20.1 Cg_endo -46.72 -160.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 123.102 2.534 . . . . 0.0 117.117 -175.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -94.6 143.91 26.03 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 113.592 -1.64 . . . . 0.0 110.077 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -135.43 125.45 25.93 Favored 'General case' 0 N--CA 1.507 2.386 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -136.62 175.35 9.69 Favored 'General case' 0 N--CA 1.508 2.472 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.903 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 41.9 ttm -113.97 149.92 34.58 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 59.3 tp -91.01 119.85 31.52 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 113.993 -1.458 . . . . 0.0 112.444 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.82 -1.41 61.4 Favored Glycine 0 N--CA 1.498 2.774 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.444 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.414 ' O ' ' C ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -118.56 41.29 3.02 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.747 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.414 ' C ' ' O ' ' A' ' 52' ' ' LYS . 85.2 mt-30 4.9 65.72 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 O-C-N 125.54 1.775 . . . . 0.0 113.944 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.44 ' O ' ' OE1' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -93.58 -36.47 12.38 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 103.394 -2.817 . . . . 0.0 103.394 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.43 ' O ' ' O ' ' A' ' 56' ' ' ILE . 27.9 m -115.21 154.18 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.43 ' O ' ' O ' ' A' ' 55' ' ' VAL . 5.0 pt -48.29 175.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 118.971 -1.091 . . . . 0.0 110.353 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.555 ' NH1' ' CE2' ' A' ' 80' ' ' TYR . 23.5 ttt180 -72.78 -59.84 2.52 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 118.354 -0.832 . . . . 0.0 110.864 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -27.37 -37.19 0.01 OUTLIER Glycine 0 N--CA 1.502 3.048 0 O-C-N 124.539 1.15 . . . . 0.0 111.695 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.533 ' N ' ' O ' ' A' ' 57' ' ' ARG . 1.0 OUTLIER -79.61 -75.6 0.24 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 -29.1 -55.11 0.13 Allowed 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 112.983 -1.917 . . . . 0.0 110.788 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.525 ' OE1' ' NH1' ' A' ' 57' ' ' ARG . 37.7 tt0 -72.91 -50.27 24.64 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -58.37 -75.62 0.25 Allowed Glycine 0 N--CA 1.477 1.376 0 C-N-CA 119.512 -1.327 . . . . 0.0 111.028 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.525 ' N ' ' O ' ' A' ' 59' ' ' TRP . 35.9 t -39.76 -50.37 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 C-N-CA 119.901 -0.719 . . . . 0.0 112.868 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.469 ' C ' ' N ' ' A' ' 66' ' ' MET . . . -43.66 -62.17 1.18 Allowed 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 124.16 1.933 . . . . 0.0 111.642 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -44.92 -14.92 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 109.233 -3.622 . . . . 0.0 108.946 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.469 ' N ' ' C ' ' A' ' 64' ' ' ALA . 8.2 mtm -98.26 159.99 14.58 Favored 'General case' 0 N--CA 1.512 2.661 0 C-N-CA 118.467 -1.293 . . . . 0.0 107.895 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 77.7 p -117.63 150.43 39.04 Favored 'General case' 0 N--CA 1.507 2.415 0 CA-C-O 122.573 1.177 . . . . 0.0 112.937 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 96.2 t -44.03 103.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 112.711 -2.041 . . . . 0.0 114.471 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.64 8.16 21.23 Favored Glycine 0 N--CA 1.5 2.942 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -109.15 152.94 24.45 Favored 'General case' 0 N--CA 1.506 2.35 0 CA-C-O 122.311 1.053 . . . . 0.0 111.665 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 -131.26 140.61 49.85 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 113.17 -1.832 . . . . 0.0 107.367 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -146.7 178.58 8.2 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 112.527 -2.124 . . . . 0.0 115.879 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -126.91 104.99 8.32 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 102.866 -3.013 . . . . 0.0 102.866 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.8 mt -98.85 153.61 18.65 Favored 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 120.169 -0.612 . . . . 0.0 109.505 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 84.8 m -123.92 119.45 29.65 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 35.7 mt -111.53 141.08 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 69.3 p -109.09 150.69 41.31 Favored Pre-proline 0 N--CA 1.501 2.12 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -41.56 -54.6 2.67 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.627 1.552 . . . . 0.0 112.517 -171.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 10.9 p-10 -40.06 -27.21 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.555 ' CE2' ' NH1' ' A' ' 57' ' ' ARG . 4.5 m-85 -103.54 24.87 10.42 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -171.03 -83.39 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 116.819 2.155 . . . . 0.0 116.819 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.401 ' O ' ' C ' ' A' ' 83' ' ' GLY . 6.4 m-30 -109.7 56.49 0.62 Allowed 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 113.72 -1.582 . . . . 0.0 110.939 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 82' ' ' TYR . . . -6.02 -114.55 0.0 OUTLIER Glycine 0 N--CA 1.503 3.113 0 O-C-N 125.505 1.753 . . . . 0.0 115.102 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -123.05 47.74 1.92 Allowed 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.432 ' O ' ' O ' ' A' ' 86' ' ' GLY . 94.2 m -124.03 -54.85 1.71 Allowed 'General case' 0 N--CA 1.5 2.059 0 CA-C-N 114.255 -1.339 . . . . 0.0 110.808 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 85' ' ' THR . . . 42.47 -171.21 0.01 OUTLIER Glycine 0 N--CA 1.493 2.459 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.716 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.448 ' N ' ' O ' ' A' ' 91' ' ' ILE . 22.1 m80 -116.22 159.62 38.95 Favored Pre-proline 0 N--CA 1.505 2.297 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -86.58 87.78 0.76 Allowed 'Trans proline' 0 C--N 1.314 -1.252 0 C-N-CA 122.808 2.339 . . . . 0.0 111.757 171.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 134.84 -32.1 2.64 Favored Glycine 0 N--CA 1.504 3.231 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.402 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.9 mt -105.7 -62.83 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.448 ' O ' ' N ' ' A' ' 87' ' ' HIS . 2.7 mp -121.97 87.11 46.89 Favored Pre-proline 0 N--CA 1.508 2.46 0 CA-C-N 114.592 -1.186 . . . . 0.0 109.766 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -54.16 -175.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.092 1.861 . . . . 0.0 108.989 167.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.24 168.16 5.16 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 121.951 1.767 . . . . 0.0 110.799 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 9.46 63.4 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.205 0 O-C-N 125.371 1.669 . . . . 0.0 115.235 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.404 ' O ' ' O ' ' A' ' 96' ' ' THR . . . -119.09 74.82 1.0 Allowed 'General case' 0 N--CA 1.503 2.209 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.159 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.404 ' O ' ' O ' ' A' ' 95' ' ' ALA . 59.3 m -29.51 148.72 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 114.447 -1.252 . . . . 0.0 111.447 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 15.1 mt -113.19 163.76 14.37 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 58.2 t -136.32 132.06 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -123.28 145.9 48.32 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -121.65 94.42 4.31 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 100.715 -3.809 . . . . 0.0 100.715 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 102' ' ' GLU . 19.9 t -109.09 152.86 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.45 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.464 ' N ' HG12 ' A' ' 101' ' ' VAL . 88.9 tt0 -126.02 98.16 5.39 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 112.169 -2.287 . . . . 0.0 106.827 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 47.9 tp -71.87 124.18 24.28 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 102.953 -2.98 . . . . 0.0 102.953 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.6 mt -92.93 -55.96 3.16 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.122 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -170.03 -168.28 0.73 Allowed 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.141 -1.024 . . . . 0.0 111.587 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 27.9 mt -115.82 156.17 26.55 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 . . . . . 0 N--CA 1.504 2.226 0 CA-C-O 116.195 -1.86 . . . . 0.0 109.564 179.882 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.6 p -105.88 147.62 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -122.43 158.12 30.42 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.5 t -124.48 113.14 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -112.96 90.28 3.3 Favored 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 91.3 m -69.78 156.28 39.26 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 114.312 -1.313 . . . . 0.0 113.437 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 56.4 mt -121.87 -51.19 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 CA-C-N 113.808 -1.542 . . . . 0.0 107.45 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.7 m -122.98 80.17 50.74 Favored Pre-proline 0 N--CA 1.506 2.369 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.272 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -40.05 160.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.715 2.277 . . . . 0.0 112.791 178.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -125.44 -175.27 14.16 Favored Glycine 0 N--CA 1.5 2.938 0 N-CA-C 106.631 -2.588 . . . . 0.0 106.631 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 12' ' ' GLY . 1.1 p30 -39.78 -52.84 2.3 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.599 -0.841 . . . . 0.0 112.906 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.468 ' N ' ' OD1' ' A' ' 11' ' ' ASP . . . 90.75 14.5 58.03 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 106.689 -2.564 . . . . 0.0 106.689 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 45.6 mtm-85 -124.68 -33.81 2.93 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 113.604 -1.298 . . . . 0.0 112.274 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.5 m -107.86 125.55 51.59 Favored 'General case' 0 N--CA 1.501 2.086 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.954 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.448 ' N ' ' CD1' ' A' ' 15' ' ' PHE . 36.9 m-85 -125.01 175.46 3.02 Favored Pre-proline 0 N--CA 1.501 2.097 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -66.68 154.8 73.18 Favored 'Trans proline' 0 C--N 1.315 -1.224 0 N-CA-C 109.474 -1.01 . . . . 0.0 109.474 164.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -119.23 169.04 10.31 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-O 121.967 0.889 . . . . 0.0 110.277 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 56.6 mtt-85 -77.18 107.5 9.61 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.343 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.19 -12.93 8.0 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 108.65 -1.78 . . . . 0.0 108.65 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -108.16 166.55 10.65 Favored 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 19.2 m -110.73 125.64 53.72 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.508 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 33.1 m -74.64 142.42 44.54 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 70.7 t -116.77 96.75 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 102.731 -3.063 . . . . 0.0 102.731 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.402 HG21 ' CH2' ' A' ' 59' ' ' TRP . 3.0 m -118.23 148.49 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 O-C-N 124.751 1.282 . . . . 0.0 113.915 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 49.9 t60 -128.76 117.93 21.94 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 103.472 -2.788 . . . . 0.0 103.472 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -134.88 176.06 9.0 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 122.951 1.357 . . . . 0.0 111.426 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 74.8 m -128.84 116.56 19.63 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 100.728 -3.804 . . . . 0.0 100.728 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -95.51 131.07 10.53 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 104.85 -3.3 . . . . 0.0 104.85 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 43.2 ttm -134.49 170.13 16.22 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 104.732 -2.322 . . . . 0.0 104.732 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.7 mt -111.76 -175.41 2.69 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 104.004 -2.591 . . . . 0.0 104.004 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -35.58 -62.67 0.39 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 124.26 0.975 . . . . 0.0 113.445 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 58.0 p-10 -161.15 44.01 0.17 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.383 -1.327 . . . . 0.0 109.28 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -117.68 -75.45 0.53 Allowed Glycine 0 N--CA 1.509 3.526 0 C-N-CA 119.164 -1.493 . . . . 0.0 115.608 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.09 -160.49 0.91 Allowed 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 119.421 -0.912 . . . . 0.0 112.977 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -89.99 142.96 27.2 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.524 ' CE2' ' OD2' ' A' ' 37' ' ' ASP . 1.9 p90 -135.36 -32.24 0.94 Allowed 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 112.818 -1.992 . . . . 0.0 108.076 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.524 ' OD2' ' CE2' ' A' ' 36' ' ' PHE . 9.6 m-20 -136.46 26.38 3.14 Favored 'General case' 0 N--CA 1.525 3.318 0 N-CA-C 117.806 2.521 . . . . 0.0 117.806 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 37' ' ' ASP . 48.7 m -43.32 168.22 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 114.86 -1.063 . . . . 0.0 110.285 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 90.7 p -105.18 48.89 0.82 Allowed 'General case' 0 N--CA 1.504 2.251 0 CA-C-O 120.9 0.381 . . . . 0.0 110.439 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -126.63 53.89 1.63 Allowed 'General case' 0 N--CA 1.505 2.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.366 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -90.53 -68.56 0.78 Allowed 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 119.666 -0.813 . . . . 0.0 113.05 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -91.27 -107.55 0.1 Allowed 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -110.42 -44.38 3.72 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 45' ' ' PRO . 6.4 mmmm -106.6 160.55 25.85 Favored Pre-proline 0 N--CA 1.507 2.422 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.26 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 44' ' ' LYS . 43.1 Cg_endo -52.9 -158.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.316 -1.156 0 C-N-CA 121.86 1.707 . . . . 0.0 111.446 175.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -94.81 135.46 36.28 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 114.228 -1.351 . . . . 0.0 111.367 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -133.17 121.95 23.3 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -137.82 172.48 12.89 Favored 'General case' 0 N--CA 1.508 2.474 0 C-N-CA 119.448 -0.901 . . . . 0.0 111.27 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.6 ttt -112.9 150.07 32.3 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.487 0.66 . . . . 0.0 112.73 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.4 tp -90.58 121.0 32.13 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.113 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.57 -3.7 39.71 Favored Glycine 0 N--CA 1.5 2.951 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.998 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' A' ' 54' ' ' GLU . 19.2 ttmm -115.84 42.46 2.32 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.411 ' C ' ' O ' ' A' ' 52' ' ' LYS . 72.8 mt-30 0.76 63.48 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.044 0 O-C-N 125.706 1.879 . . . . 0.0 113.655 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 52' ' ' LYS . 1.9 tm-20 -101.4 -23.9 14.28 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 113.796 -1.547 . . . . 0.0 106.864 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.2 m -112.7 158.73 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.577 0 C-N-CA 119.856 -0.738 . . . . 0.0 109.269 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.5 pt -59.1 173.95 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.484 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.549 ' O ' ' N ' ' A' ' 59' ' ' TRP . 3.6 tpp180 -66.99 -60.22 2.82 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 118.564 -0.731 . . . . 0.0 109.891 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -24.59 -38.9 0.01 OUTLIER Glycine 0 N--CA 1.499 2.889 0 O-C-N 125.1 1.5 . . . . 0.0 111.498 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.549 ' N ' ' O ' ' A' ' 57' ' ' ARG . 2.0 m95 -82.37 -74.88 0.33 Allowed 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 112.816 -1.692 . . . . 0.0 110.447 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 59' ' ' TRP . 29.9 tt0 -24.32 -54.6 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 125.97 2.044 . . . . 0.0 111.33 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -77.88 -54.18 6.62 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -50.36 -75.41 0.21 Allowed Glycine 0 N--CA 1.481 1.671 0 C-N-CA 119.729 -1.225 . . . . 0.0 110.544 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.53 ' N ' ' O ' ' A' ' 59' ' ' TRP . 25.1 t -43.53 -48.06 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 119.218 -0.993 . . . . 0.0 112.011 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.435 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -45.34 -58.75 3.09 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 123.783 1.754 . . . . 0.0 111.37 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -50.44 -9.02 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 109.873 -3.33 . . . . 0.0 110.617 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.435 ' H ' ' C ' ' A' ' 64' ' ' ALA . 40.8 mtm -103.97 151.05 23.66 Favored 'General case' 0 N--CA 1.519 2.989 0 C-N-CA 118.824 -1.15 . . . . 0.0 109.993 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 61.7 p -115.58 148.07 40.01 Favored 'General case' 0 N--CA 1.509 2.525 0 CA-C-O 122.756 1.265 . . . . 0.0 114.006 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 60.5 t -38.94 109.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-N 112.478 -2.146 . . . . 0.0 114.871 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.49 -2.51 36.9 Favored Glycine 0 N--CA 1.501 2.985 0 C-N-CA 119.58 -1.295 . . . . 0.0 111.296 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -99.97 153.61 19.05 Favored 'General case' 0 N--CA 1.506 2.338 0 CA-C-O 122.344 1.068 . . . . 0.0 111.87 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 31.1 ttp180 -131.7 143.82 50.54 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 113.137 -1.847 . . . . 0.0 107.209 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -151.98 176.78 11.14 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 116.574 2.064 . . . . 0.0 116.574 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -124.78 104.58 8.72 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 110.855 -2.884 . . . . 0.0 104.349 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.1 mt -96.83 150.06 21.15 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.7 m -121.1 103.39 8.98 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 37.5 mt -99.38 132.09 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.418 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 66.9 p -113.03 156.38 42.88 Favored Pre-proline 0 N--CA 1.501 2.094 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -34.32 -50.41 0.63 Allowed 'Trans proline' 0 C--N 1.314 -1.248 0 C-N-CA 122.231 1.954 . . . . 0.0 114.096 -176.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 80' ' ' TYR . 1.4 p30 -38.91 -41.12 0.72 Allowed 'General case' 0 N--CA 1.485 1.324 0 CA-C-O 121.837 0.827 . . . . 0.0 111.734 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.479 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 6.5 m-85 -105.78 -44.08 4.73 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.838 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.534 ' O ' ' N ' ' A' ' 83' ' ' GLY . . . -74.81 161.87 29.19 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.464 ' O ' ' N ' ' A' ' 84' ' ' ALA . 58.6 m-85 -0.56 62.49 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 126.709 2.505 . . . . 0.0 114.755 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 81' ' ' ALA . . . 13.9 -74.36 0.0 OUTLIER Glycine 0 N--CA 1.497 2.757 0 CA-C-N 113.711 -1.586 . . . . 0.0 115.635 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 82' ' ' TYR . . . -128.77 -62.97 0.99 Allowed 'General case' 0 N--CA 1.506 2.362 0 CA-C-N 117.429 0.615 . . . . 0.0 111.816 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 85.2 m -115.36 151.2 35.09 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -131.63 -103.7 0.94 Allowed Glycine 0 N--CA 1.5 2.959 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.534 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -127.64 78.8 74.43 Favored Pre-proline 0 N--CA 1.5 2.068 0 CA-C-N 114.738 -0.731 . . . . 0.0 110.377 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -30.46 112.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 123.139 2.559 . . . . 0.0 112.827 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 128.03 -31.3 3.71 Favored Glycine 0 N--CA 1.499 2.835 0 N-CA-C 108.517 -1.833 . . . . 0.0 108.517 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.4 mt -111.27 -49.89 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.288 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 23.9 mm -116.39 84.67 14.88 Favored Pre-proline 0 N--CA 1.508 2.429 0 CA-C-N 113.226 -1.806 . . . . 0.0 112.059 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -48.05 158.31 0.91 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.438 2.092 . . . . 0.0 109.449 174.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.524 ' O ' ' CG ' ' A' ' 94' ' ' HIS . 83.8 Cg_endo -62.09 82.25 0.1 OUTLIER 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 123.055 2.503 . . . . 0.0 113.573 178.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.524 ' CG ' ' O ' ' A' ' 93' ' ' PRO . 34.3 m80 107.13 71.99 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.343 0 O-C-N 125.685 1.865 . . . . 0.0 113.714 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -120.12 145.54 46.82 Favored 'General case' 0 N--CA 1.506 2.326 0 CA-C-O 121.652 0.739 . . . . 0.0 110.856 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 97.5 m -91.21 126.15 36.21 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 20.6 mt -101.55 152.7 20.48 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.7 t -132.27 117.8 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.458 ' CE2' ' NE1' ' A' ' 59' ' ' TRP . 3.9 m-85 -109.32 160.06 16.47 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -128.61 88.27 2.71 Favored 'General case' 0 N--CA 1.497 1.892 1 N-CA-C 98.295 -4.705 . . . . 0.0 98.295 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.44 HG12 ' N ' ' A' ' 102' ' ' GLU . 14.7 t -101.98 152.5 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.64 0 N-CA-C 117.495 2.406 . . . . 0.0 117.495 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.44 ' N ' HG12 ' A' ' 101' ' ' VAL . 38.1 tt0 -129.25 104.88 7.78 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 112.3 -2.227 . . . . 0.0 106.755 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 36.8 tp -77.06 116.05 17.38 Favored 'General case' 0 N--CA 1.505 2.321 0 N-CA-C 101.888 -3.375 . . . . 0.0 101.888 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.7 mt -86.2 -61.99 1.62 Allowed 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 114.372 -1.285 . . . . 0.0 114.115 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 14.5 mmtt -157.16 -171.86 3.79 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.834 0.826 . . . . 0.0 111.351 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 21.4 mt -119.15 159.99 22.96 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 103.772 -2.677 . . . . 0.0 103.772 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 . . . . . 0 N--CA 1.508 2.445 0 CA-C-O 115.572 -2.156 . . . . 0.0 107.548 179.919 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.994 -1.243 . . . . 0.0 109.994 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.8 p -112.02 150.17 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -121.99 156.01 34.36 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.8 t -125.5 118.13 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -121.84 94.52 4.34 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 92.5 m -69.82 157.28 37.67 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 76.3 mt -121.98 -55.47 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 CA-C-N 113.656 -1.611 . . . . 0.0 107.132 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.423 ' O ' ' O ' ' A' ' 9' ' ' PRO . 36.6 m -120.94 84.44 38.84 Favored Pre-proline 0 N--CA 1.504 2.234 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.331 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 8' ' ' SER . 0.5 OUTLIER -34.71 159.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.3 2.0 . . . . 0.0 112.15 177.025 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -124.47 -164.75 12.01 Favored Glycine 0 N--CA 1.501 3.02 0 N-CA-C 107.992 -2.043 . . . . 0.0 107.992 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.466 ' CG ' ' H ' ' A' ' 12' ' ' GLY . 1.2 p-10 -39.55 -67.54 0.22 Allowed 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 121.816 0.817 . . . . 0.0 112.348 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.466 ' H ' ' CG ' ' A' ' 11' ' ' ASP . . . 104.33 12.61 28.61 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 105.3 -3.12 . . . . 0.0 105.3 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -124.38 -45.67 1.94 Allowed 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 113.797 -1.201 . . . . 0.0 112.188 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 38.6 m -103.12 129.2 49.91 Favored 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -128.97 173.04 6.11 Favored Pre-proline 0 N--CA 1.499 1.982 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -67.85 132.09 25.73 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 CA-C-N 119.707 0.931 . . . . 0.0 112.663 166.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -120.23 165.07 15.3 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.8 ptm85 -66.12 134.29 52.49 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.69 -25.71 11.63 Favored Glycine 0 N--CA 1.498 2.777 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -106.89 173.0 6.51 Favored 'General case' 0 N--CA 1.508 2.444 0 CA-C-O 121.715 0.769 . . . . 0.0 112.99 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.7 m -115.29 121.05 41.7 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.723 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 30.6 m -69.29 152.62 44.79 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.412 HG23 ' H ' ' A' ' 107' ' ' GLU . 97.6 t -130.11 102.78 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 101.763 -3.421 . . . . 0.0 101.763 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.7 m -120.72 152.66 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.374 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -129.13 113.82 15.56 Favored 'General case' 0 N--CA 1.506 2.349 0 N-CA-C 102.807 -3.035 . . . . 0.0 102.807 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.552 ' N ' ' CD1' ' A' ' 26' ' ' TYR . 33.0 p90 -132.25 175.91 8.85 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 122.974 1.369 . . . . 0.0 114.221 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.8 m -137.06 117.59 13.82 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 101.794 -3.41 . . . . 0.0 101.794 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 37' ' ' ASP . . . -98.61 141.85 15.78 Favored Glycine 0 N--CA 1.501 3.003 0 C-N-CA 119.921 -1.133 . . . . 0.0 110.697 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.475 ' O ' ' O ' ' A' ' 30' ' ' LEU . 69.6 mmm -149.04 95.38 2.39 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 113.387 -1.407 . . . . 0.0 107.613 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.475 ' O ' ' O ' ' A' ' 29' ' ' MET . 23.6 mt -19.87 -113.78 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.307 0 O-C-N 125.487 1.742 . . . . 0.0 113.203 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -91.6 -69.55 0.73 Allowed 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 102.156 -3.276 . . . . 0.0 102.156 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 48.5 p-10 -162.16 33.42 0.12 Allowed 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 113.236 -1.802 . . . . 0.0 109.481 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -118.74 -68.75 0.33 Allowed Glycine 0 N--CA 1.51 3.605 0 N-CA-C 118.965 2.346 . . . . 0.0 118.965 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.91 172.44 8.19 Favored 'General case' 0 N--CA 1.509 2.517 0 CA-C-O 122.162 0.982 . . . . 0.0 113.566 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.2 mmtm -91.02 129.67 37.0 Favored 'General case' 0 N--CA 1.489 1.489 1 N-CA-C 99.68 -4.193 . . . . 0.0 99.68 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.534 ' CE2' ' OD2' ' A' ' 37' ' ' ASP . 1.2 p90 -125.19 -28.15 3.43 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.534 ' OD2' ' CE2' ' A' ' 36' ' ' PHE . 35.6 m-20 -139.43 85.61 2.06 Favored 'General case' 0 N--CA 1.506 2.373 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.3 m -112.31 160.56 17.55 Favored 'General case' 0 N--CA 1.505 2.282 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 26' ' ' TYR . 77.3 p -129.79 -52.95 1.15 Allowed 'General case' 0 N--CA 1.504 2.261 0 CA-C-O 121.617 0.722 . . . . 0.0 112.449 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 20.8 ttm-85 -28.88 -56.01 0.13 Allowed 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -19.28 -74.63 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 125.001 1.438 . . . . 0.0 114.792 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.578 ' O ' ' N ' ' A' ' 44' ' ' LYS . 1.3 mmp_? -91.31 60.52 4.2 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-O 118.688 -0.672 . . . . 0.0 109.67 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 47.9 p30 -8.75 58.91 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.353 0 N-CA-C 116.967 2.21 . . . . 0.0 116.967 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.578 ' N ' ' O ' ' A' ' 42' ' ' ARG . 47.1 mmtm -147.72 78.46 9.87 Favored Pre-proline 0 C--N 1.298 -1.647 0 CA-C-N 112.731 -2.031 . . . . 0.0 106.783 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.445 ' O ' ' O ' ' A' ' 44' ' ' LYS . 51.0 Cg_exo -43.76 -170.01 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 122.96 2.44 . . . . 0.0 116.88 -172.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -111.55 159.09 18.45 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 114.329 -1.305 . . . . 0.0 114.443 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -143.08 121.2 12.14 Favored 'General case' 0 N--CA 1.506 2.374 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -135.4 171.98 13.66 Favored 'General case' 0 N--CA 1.513 2.703 0 CA-C-N 118.988 0.813 . . . . 0.0 110.631 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 43.2 ttm -119.16 143.8 47.02 Favored 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.427 ' CD1' ' OE1' ' A' ' 60' ' ' GLU . 50.5 tp -91.17 134.88 34.18 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 113.986 -1.461 . . . . 0.0 110.646 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 126.73 -35.02 3.0 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 108.393 -1.883 . . . . 0.0 108.393 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 54' ' ' GLU . 80.0 tttt -123.76 43.14 3.05 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 114.585 -0.807 . . . . 0.0 109.176 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 12.53 49.27 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 125.602 1.814 . . . . 0.0 114.685 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 52' ' ' LYS . 96.1 mt-10 -49.2 -29.82 6.11 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.537 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.433 ' O ' ' O ' ' A' ' 56' ' ' ILE . 32.7 m -117.56 158.31 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.646 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 55' ' ' VAL . 23.9 pt -46.4 172.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 C-N-CA 118.753 -1.179 . . . . 0.0 111.323 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.546 ' O ' ' N ' ' A' ' 59' ' ' TRP . 20.7 ttm-85 -72.44 -61.06 1.93 Allowed 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 118.84 -0.6 . . . . 0.0 112.073 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -34.58 -28.22 0.01 OUTLIER Glycine 0 N--CA 1.499 2.835 0 CA-C-O 122.156 0.864 . . . . 0.0 111.761 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.546 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.6 OUTLIER -87.75 -74.76 0.44 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 179.804 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.427 ' OE1' ' CD1' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -32.86 -50.96 0.28 Allowed 'General case' 0 N--CA 1.501 2.077 0 CA-C-N 114.035 -1.439 . . . . 0.0 110.127 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -74.57 -54.36 7.64 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 113.743 -1.572 . . . . 0.0 107.042 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -53.71 -76.07 0.2 Allowed Glycine 0 N--CA 1.478 1.47 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' A' ' 59' ' ' TRP . 40.0 t -37.25 -45.41 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 CA-C-N 115.067 -0.566 . . . . 0.0 112.04 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.487 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -48.35 -56.07 9.08 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 123.78 1.752 . . . . 0.0 110.092 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -59.53 -0.51 0.17 Allowed 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 110.139 -3.21 . . . . 0.0 110.409 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.487 ' H ' ' C ' ' A' ' 64' ' ' ALA . 16.3 tpp -98.85 153.2 18.97 Favored 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 106.039 -1.838 . . . . 0.0 106.039 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 83.5 p -116.37 143.23 45.82 Favored 'General case' 0 N--CA 1.508 2.453 0 CA-C-O 122.289 1.042 . . . . 0.0 112.212 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.422 ' O ' ' OD1' ' A' ' 11' ' ' ASP . 96.7 t -41.9 98.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 113.315 -1.766 . . . . 0.0 114.622 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.71 7.1 22.52 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.443 ' OE1' ' SD ' ' A' ' 66' ' ' MET . 15.1 tt0 -105.13 149.09 26.17 Favored 'General case' 0 N--CA 1.51 2.545 0 C-N-CA 119.179 -1.008 . . . . 0.0 111.018 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 24.8 ttt85 -124.71 141.02 52.4 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 113.905 -1.498 . . . . 0.0 107.0 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -149.64 177.97 9.28 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 116.081 1.882 . . . . 0.0 116.081 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -127.09 104.83 8.19 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 102.457 -3.164 . . . . 0.0 102.457 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.6 mt -101.48 155.12 18.26 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 87.2 m -125.32 132.2 52.9 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 23.8 mt -118.99 138.85 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 CA-C-O 121.319 0.581 . . . . 0.0 110.651 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.426 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 76.9 p -111.11 151.45 43.07 Favored Pre-proline 0 N--CA 1.502 2.151 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.423 ' O ' ' N ' ' A' ' 80' ' ' TYR . 10.2 Cg_endo -39.41 -56.14 1.37 Allowed 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 121.859 1.706 . . . . 0.0 113.035 -172.061 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 3.9 p-10 -34.37 -34.34 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.442 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.423 ' N ' ' O ' ' A' ' 78' ' ' PRO . 4.8 m-85 -102.87 -50.29 3.57 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.086 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 83' ' ' GLY . . . -59.61 172.65 0.66 Allowed 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 117.437 -1.705 . . . . 0.0 108.912 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.401 ' C ' ' O ' ' A' ' 81' ' ' ALA . 67.6 m-85 -10.49 -52.07 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 125.994 2.059 . . . . 0.0 115.529 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 81' ' ' ALA . . . 123.99 -154.64 17.71 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 106.412 -2.675 . . . . 0.0 106.412 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -104.89 39.56 1.68 Allowed 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 87.1 m -128.31 58.65 1.53 Allowed 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 113.732 -1.576 . . . . 0.0 109.001 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -113.73 -175.98 19.16 Favored Glycine 0 N--CA 1.499 2.867 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -116.35 146.89 38.38 Favored Pre-proline 0 N--CA 1.503 2.219 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -74.22 46.56 1.39 Allowed 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 121.469 1.446 . . . . 0.0 110.806 174.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -129.21 -51.74 0.11 Allowed Glycine 0 N--CA 1.5 2.914 0 N-CA-C 110.026 -1.229 . . . . 0.0 110.026 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.6 mt -114.6 -54.33 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 23.0 mm -117.7 89.83 34.16 Favored Pre-proline 0 N--CA 1.504 2.246 0 CA-C-N 112.733 -2.03 . . . . 0.0 111.539 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.411 ' CB ' ' CD ' ' A' ' 93' ' ' PRO . 18.0 Cg_exo -71.68 -171.12 0.6 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.217 1.945 . . . . 0.0 107.572 168.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.411 ' CD ' ' CB ' ' A' ' 92' ' ' PRO . 49.9 Cg_exo -62.01 171.01 5.4 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.294 1.996 . . . . 0.0 110.049 175.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 16.0 m80 9.67 68.12 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 O-C-N 125.387 1.679 . . . . 0.0 115.045 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -116.88 74.2 0.9 Allowed 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.704 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 91.1 m -29.4 134.35 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.262 0 O-C-N 124.913 1.383 . . . . 0.0 110.85 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 29.0 mt -108.8 144.37 36.74 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 119.252 0.933 . . . . 0.0 108.718 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 43.7 t -128.73 127.2 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 N-CA-C 107.113 -1.439 . . . . 0.0 107.113 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -118.82 157.88 26.71 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 122.063 0.935 . . . . 0.0 111.958 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -127.07 94.16 3.94 Favored 'General case' 0 N--CA 1.494 1.762 1 N-CA-C 99.069 -4.419 . . . . 0.0 99.069 179.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.437 HG12 ' N ' ' A' ' 102' ' ' GLU . 16.4 t -107.36 152.94 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.524 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.437 ' N ' HG12 ' A' ' 101' ' ' VAL . 89.3 tt0 -127.36 100.65 6.13 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 111.877 -2.42 . . . . 0.0 106.357 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 40.9 tp -73.76 125.06 27.26 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 102.624 -3.102 . . . . 0.0 102.624 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.0 mt -94.0 -59.74 1.91 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.79 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 11.8 ptmm? -157.2 -178.58 7.46 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.0 mt -114.23 71.29 0.75 Allowed 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.412 ' H ' HG23 ' A' ' 23' ' ' VAL . 34.4 tt0 . . . . . 0 N--CA 1.502 2.159 0 CA-C-O 115.91 -1.995 . . . . 0.0 109.676 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.1 p -113.23 145.31 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -121.99 154.01 37.78 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.2 t -126.51 114.03 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -114.83 109.53 18.3 Favored 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 96.2 m -83.75 153.71 23.99 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.744 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 56.0 mt -123.55 -50.58 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 CA-C-N 113.656 -1.611 . . . . 0.0 107.363 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.417 ' O ' ' O ' ' A' ' 9' ' ' PRO . 43.8 t -122.33 79.68 45.15 Favored Pre-proline 0 N--CA 1.507 2.406 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.634 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.417 ' O ' ' O ' ' A' ' 8' ' ' SER . 9.0 Cg_exo -37.56 166.27 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.863 2.375 . . . . 0.0 113.77 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.79 -167.42 12.92 Favored Glycine 0 N--CA 1.502 3.091 0 N-CA-C 105.304 -3.119 . . . . 0.0 105.304 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.485 ' CG ' ' H ' ' A' ' 12' ' ' GLY . 11.2 p-10 -46.97 -58.99 3.4 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 118.619 1.21 . . . . 0.0 110.798 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.485 ' H ' ' CG ' ' A' ' 11' ' ' ASP . . . 106.99 27.63 5.3 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 107.232 -2.347 . . . . 0.0 107.232 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 32.7 mtp85 -133.87 -35.0 0.98 Allowed 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 114.545 -0.828 . . . . 0.0 112.597 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.8 m -109.57 139.46 44.55 Favored 'General case' 0 N--CA 1.508 2.454 0 CA-C-O 121.807 0.813 . . . . 0.0 112.952 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.46 ' N ' ' CD1' ' A' ' 15' ' ' PHE . 50.5 m-85 -131.77 177.43 2.25 Favored Pre-proline 0 N--CA 1.499 1.988 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -67.13 138.74 48.33 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 121.145 1.23 . . . . 0.0 110.813 164.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -119.94 162.24 19.53 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 122.351 1.072 . . . . 0.0 109.232 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 29.8 mtm180 -71.07 126.68 30.23 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 114.189 -1.369 . . . . 0.0 108.146 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.51 -24.22 9.86 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -110.8 176.95 4.83 Favored 'General case' 0 N--CA 1.507 2.406 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.901 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 92.4 m -108.42 166.98 10.36 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.2 m -113.14 149.47 33.55 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 102.513 -3.143 . . . . 0.0 102.513 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 60.4 t -123.49 101.93 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 103.109 -2.923 . . . . 0.0 103.109 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.3 m -120.69 149.52 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.574 0 N-CA-C 116.516 2.043 . . . . 0.0 116.516 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -127.8 114.74 17.64 Favored 'General case' 0 N--CA 1.507 2.383 0 N-CA-C 103.67 -2.715 . . . . 0.0 103.67 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.499 ' N ' ' CD1' ' A' ' 26' ' ' TYR . 33.9 p90 -131.96 175.68 9.02 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 122.977 1.37 . . . . 0.0 113.702 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 84.8 m -134.65 116.89 15.47 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 101.308 -3.59 . . . . 0.0 101.308 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 37' ' ' ASP . . . -102.55 128.7 9.63 Favored Glycine 0 N--CA 1.5 2.935 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 46.8 ttm -132.81 175.51 9.28 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 37.6 mt -115.84 170.36 8.53 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -33.77 -59.36 0.41 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 124.31 1.006 . . . . 0.0 112.706 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 57.6 p-10 -158.05 46.8 0.35 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.168 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -118.31 -79.21 0.65 Allowed Glycine 0 N--CA 1.501 2.99 0 C-N-CA 119.436 -1.364 . . . . 0.0 113.241 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -160.54 -163.01 1.02 Allowed 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 119.569 -0.852 . . . . 0.0 113.196 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -88.89 124.14 33.92 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 103.993 -2.595 . . . . 0.0 103.993 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.456 ' O ' ' CB ' ' A' ' 37' ' ' ASP . 0.9 OUTLIER -121.81 20.1 10.93 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.41 -179.547 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.456 ' CB ' ' O ' ' A' ' 36' ' ' PHE . 3.4 m-20 158.97 104.19 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.355 0 O-C-N 124.716 1.26 . . . . 0.0 111.917 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.2 m -118.5 169.41 9.8 Favored 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 98.5 p -114.91 45.86 1.52 Allowed 'General case' 0 N--CA 1.507 2.395 0 CA-C-N 116.209 -0.451 . . . . 0.0 112.071 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.3 tpt85 -126.26 65.02 1.23 Allowed 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -90.81 -88.75 0.17 Allowed 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.874 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.0 ttp180 -92.12 -108.5 0.1 Allowed 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.714 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.2 m-20 -111.09 -39.86 4.64 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -100.49 154.25 37.29 Favored Pre-proline 0 N--CA 1.51 2.548 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -75.14 -158.48 0.08 OUTLIER 'Trans proline' 0 N--CA 1.49 1.276 0 C-N-CA 123.066 2.511 . . . . 0.0 113.812 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -97.12 150.34 20.96 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 114.211 -1.359 . . . . 0.0 114.417 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.95 130.88 21.65 Favored 'General case' 0 N--CA 1.508 2.45 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.41 ' C ' ' CD1' ' A' ' 48' ' ' PHE . 13.5 p90 -143.28 166.72 23.96 Favored 'General case' 0 N--CA 1.514 2.732 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.904 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.495 ' SD ' ' O ' ' A' ' 50' ' ' LEU . 2.7 tmm? -115.11 149.04 38.19 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 115.103 1.519 . . . . 0.0 115.103 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.495 ' O ' ' SD ' ' A' ' 49' ' ' MET . 52.3 tp -90.6 121.03 32.17 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 113.343 -1.753 . . . . 0.0 112.19 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.69 -24.71 7.09 Favored Glycine 0 N--CA 1.499 2.838 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 53' ' ' GLN . 2.3 tppp? -113.37 36.84 3.4 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.413 ' C ' ' O ' ' A' ' 52' ' ' LYS . 83.3 mt-30 7.8 63.56 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 125.281 1.613 . . . . 0.0 114.165 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -82.89 -30.23 28.7 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.419 ' O ' ' O ' ' A' ' 56' ' ' ILE . 32.6 m -118.78 151.13 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.419 ' O ' ' O ' ' A' ' 55' ' ' VAL . 1.6 pt -46.9 -176.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.542 ' O ' ' N ' ' A' ' 59' ' ' TRP . 8.8 tpt180 -81.16 -61.01 2.08 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.124 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -35.8 -26.86 0.01 OUTLIER Glycine 0 N--CA 1.497 2.703 0 CA-C-O 122.196 0.887 . . . . 0.0 110.919 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.542 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.8 OUTLIER -91.85 -76.07 0.46 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.776 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -33.94 -51.48 0.41 Allowed 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 113.752 -1.567 . . . . 0.0 110.031 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -73.06 -54.47 8.46 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 113.218 -1.81 . . . . 0.0 106.574 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -55.07 -80.55 0.07 OUTLIER Glycine 0 N--CA 1.476 1.335 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.533 ' N ' ' O ' ' A' ' 59' ' ' TRP . 53.1 t -32.3 -48.45 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 112.675 0.621 . . . . 0.0 112.675 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.475 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -46.37 -60.52 2.28 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 124.262 1.982 . . . . 0.0 110.905 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -48.01 -12.19 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 108.948 -3.751 . . . . 0.0 108.856 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.475 ' H ' ' C ' ' A' ' 64' ' ' ALA . 21.0 mtp -97.7 159.64 14.8 Favored 'General case' 0 N--CA 1.512 2.655 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 80.4 p -117.08 156.88 26.82 Favored 'General case' 0 N--CA 1.509 2.498 0 CA-C-O 122.804 1.288 . . . . 0.0 113.716 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 62.5 t -49.55 97.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 112.037 -2.347 . . . . 0.0 114.858 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.11 5.2 25.28 Favored Glycine 0 N--CA 1.499 2.841 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.488 ' OE1' ' N ' ' A' ' 71' ' ' ARG . 0.9 OUTLIER -106.73 148.61 28.22 Favored 'General case' 0 N--CA 1.505 2.325 0 CA-C-O 122.099 0.952 . . . . 0.0 111.399 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.488 ' N ' ' OE1' ' A' ' 70' ' ' GLN . 18.9 ttp180 -127.58 140.64 51.98 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 113.516 -1.674 . . . . 0.0 110.089 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -144.8 178.83 7.72 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 112.605 -2.089 . . . . 0.0 115.662 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -126.78 105.0 8.36 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 110.933 -2.849 . . . . 0.0 103.585 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.8 mt -96.73 149.7 21.53 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 86.5 m -124.59 112.72 17.14 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.5 mt -105.19 143.83 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 CA-C-O 121.448 0.642 . . . . 0.0 110.908 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 36.8 p -110.02 150.79 41.91 Favored Pre-proline 0 N--CA 1.496 1.869 0 N-CA-C 105.604 -1.998 . . . . 0.0 105.604 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.524 ' O ' ' N ' ' A' ' 80' ' ' TYR . 19.3 Cg_endo -44.33 -55.71 3.02 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 121.967 1.778 . . . . 0.0 113.614 -171.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 12.8 p-10 -38.82 -17.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.524 ' N ' ' O ' ' A' ' 78' ' ' PRO . 4.8 m-85 -106.45 -31.87 8.36 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -111.05 -73.04 0.69 Allowed 'General case' 0 N--CA 1.506 2.373 0 N-CA-C 116.968 2.21 . . . . 0.0 116.968 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 13.0 m-30 -108.95 -85.97 0.52 Allowed 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 112.675 -2.057 . . . . 0.0 114.452 -179.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.71 68.67 1.33 Allowed Glycine 0 N--CA 1.495 2.616 0 N-CA-C 108.01 -2.036 . . . . 0.0 108.01 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 33.53 71.5 0.1 Allowed 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.683 0.754 . . . . 0.0 112.275 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 94.5 m -116.44 -44.88 2.84 Favored 'General case' 0 N--CA 1.503 2.22 0 CA-C-N 114.383 -1.28 . . . . 0.0 113.825 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -110.27 -54.95 0.54 Allowed Glycine 0 N--CA 1.508 3.44 0 C-N-CA 120.225 -0.988 . . . . 0.0 111.286 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.527 ' O ' ' ND1' ' A' ' 87' ' ' HIS . 33.4 p80 19.39 70.94 0.23 Allowed Pre-proline 0 N--CA 1.493 1.678 0 N-CA-C 117.685 2.476 . . . . 0.0 117.685 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -84.32 23.41 0.84 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 121.637 1.558 . . . . 0.0 108.273 164.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 87' ' ' HIS . . . 108.49 44.74 1.12 Allowed Glycine 0 N--CA 1.501 2.972 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.8 mt -136.52 -50.41 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.267 0 CA-C-O 122.625 1.202 . . . . 0.0 108.825 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 17.9 mm -112.73 59.64 0.61 Allowed Pre-proline 0 N--CA 1.5 2.047 0 CA-C-N 111.463 -2.608 . . . . 0.0 110.552 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -52.15 169.42 0.3 Allowed 'Trans proline' 0 C--N 1.311 -1.423 0 N-CA-C 107.938 -1.601 . . . . 0.0 107.938 -178.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -38.95 155.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 121.566 1.511 . . . . 0.0 111.808 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.434 ' CG ' ' O ' ' A' ' 94' ' ' HIS . 20.3 p-80 9.5 71.65 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.215 0 O-C-N 125.658 1.849 . . . . 0.0 114.713 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -114.52 75.46 0.93 Allowed 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 120.95 0.405 . . . . 0.0 110.511 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 94.8 m -29.24 139.2 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 CA-C-N 114.108 -1.405 . . . . 0.0 110.812 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 32.6 mt -108.21 153.07 23.72 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 50.4 t -133.31 121.15 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -114.26 151.33 33.03 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -122.73 94.07 4.16 Favored 'General case' 0 N--CA 1.496 1.839 1 N-CA-C 98.937 -4.468 . . . . 0.0 98.937 179.376 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.414 HG12 ' N ' ' A' ' 102' ' ' GLU . 17.2 t -107.78 150.53 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.425 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.414 ' N ' HG12 ' A' ' 101' ' ' VAL . 39.1 tt0 -126.67 102.48 7.09 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 112.39 -2.186 . . . . 0.0 106.843 179.476 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 43.6 tp -73.31 126.5 30.26 Favored 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 101.823 -3.399 . . . . 0.0 101.823 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.9 mt -93.51 -54.05 3.82 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.877 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.46 -172.13 0.88 Allowed 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 118.366 -1.334 . . . . 0.0 110.621 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 19.1 mt -118.24 152.97 34.7 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.426 ' OXT' ' OE1' ' A' ' 107' ' ' GLU . 9.7 tm-20 . . . . . 0 N--CA 1.501 2.095 0 CA-C-O 116.099 -1.905 . . . . 0.0 109.002 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.8 p -114.2 150.09 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.502 HE21 ' HB ' ' A' ' 75' ' ' THR . 4.1 mp0 -121.57 156.05 33.71 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 42.2 t -126.5 106.55 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -108.38 87.45 2.5 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 98.9 m -69.66 157.82 36.53 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.017 -1.073 . . . . 0.0 111.674 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 64.1 mt -121.94 -53.93 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 CA-C-N 114.195 -1.366 . . . . 0.0 107.631 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.417 ' O ' ' O ' ' A' ' 9' ' ' PRO . 51.8 m -123.09 80.22 51.5 Favored Pre-proline 0 N--CA 1.507 2.378 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.49 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.417 ' O ' ' O ' ' A' ' 8' ' ' SER . 6.9 Cg_exo -36.95 166.66 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.866 2.377 . . . . 0.0 114.104 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.51 -176.7 17.99 Favored Glycine 0 N--CA 1.5 2.96 0 N-CA-C 105.063 -3.215 . . . . 0.0 105.063 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.489 ' CG ' ' H ' ' A' ' 12' ' ' GLY . 14.4 p-10 -43.04 -59.08 2.16 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 118.557 1.178 . . . . 0.0 111.735 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.489 ' H ' ' CG ' ' A' ' 11' ' ' ASP . . . 110.06 22.34 6.6 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 108.541 -1.824 . . . . 0.0 108.541 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 60.0 mtt-85 -133.67 -31.38 1.19 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 114.994 -0.603 . . . . 0.0 112.392 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.0 m -109.11 124.85 51.45 Favored 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.375 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.47 ' N ' ' CD1' ' A' ' 15' ' ' PHE . 23.1 m-85 -127.28 176.1 2.88 Favored Pre-proline 0 N--CA 1.501 2.101 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -73.8 139.33 27.51 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 CA-C-N 119.51 0.861 . . . . 0.0 110.177 163.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -120.63 167.07 12.82 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 121.765 0.793 . . . . 0.0 109.264 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 62.8 mtt180 -70.26 127.6 33.35 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.763 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.32 -25.61 9.14 Favored Glycine 0 N--CA 1.498 2.78 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.501 ' O ' ' SD ' ' A' ' 49' ' ' MET . 84.1 mt-30 -109.37 175.62 5.38 Favored 'General case' 0 N--CA 1.505 2.276 0 CA-C-O 121.713 0.768 . . . . 0.0 111.429 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.9 m -107.23 163.86 12.66 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 114.611 -1.177 . . . . 0.0 108.47 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 55.6 m -114.39 145.62 41.6 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 103.718 -2.697 . . . . 0.0 103.718 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 64.4 t -122.89 101.08 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 102.22 -3.252 . . . . 0.0 102.22 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.42 HG21 ' CH2' ' A' ' 59' ' ' TRP . 2.7 m -124.12 151.54 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -179.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -130.15 119.45 23.02 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 103.841 -2.651 . . . . 0.0 103.841 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.438 ' N ' ' CD1' ' A' ' 26' ' ' TYR . 35.4 p90 -135.22 172.55 12.84 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 123.072 1.415 . . . . 0.0 114.592 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 61.4 m -134.34 116.14 14.88 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 102.865 -3.013 . . . . 0.0 102.865 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.62 137.42 13.61 Favored Glycine 0 N--CA 1.5 2.92 0 C-N-CA 119.918 -1.134 . . . . 0.0 112.003 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 35.0 ttm -134.16 175.33 9.58 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.3 mt -116.12 -173.33 2.34 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -90.16 21.38 3.78 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 121.569 0.7 . . . . 0.0 111.019 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.5 -44.81 1.82 Allowed 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 128.14 23.19 1.3 Allowed Glycine 0 N--CA 1.502 3.07 0 CA-C-O 118.501 -1.166 . . . . 0.0 115.52 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -118.7 152.81 35.43 Favored 'General case' 0 N--CA 1.502 2.174 0 CA-C-N 119.2 1.5 . . . . 0.0 107.488 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.474 ' H ' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -91.38 139.66 30.51 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 122.379 1.085 . . . . 0.0 109.442 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.424 ' CG ' ' N ' ' A' ' 37' ' ' ASP . 6.3 p90 -126.44 -38.76 2.08 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 113.434 -1.712 . . . . 0.0 106.83 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.424 ' N ' ' CG ' ' A' ' 36' ' ' PHE . 0.9 OUTLIER -141.25 94.45 2.7 Favored 'General case' 0 N--CA 1.508 2.467 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -179.772 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 52.7 m -114.92 167.38 10.84 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' A' ' 26' ' ' TYR . 76.8 p -120.76 53.52 1.12 Allowed 'General case' 0 N--CA 1.506 2.344 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.524 ' O ' ' N ' ' A' ' 42' ' ' ARG . 33.1 mtm-85 -118.04 -72.51 0.68 Allowed 'General case' 0 N--CA 1.504 2.236 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 41' ' ' ASP . 64.5 t0 -34.1 -30.85 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 122.719 1.247 . . . . 0.0 110.908 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 44' ' ' LYS . 17.9 ttm180 -90.63 71.74 6.79 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 112.467 -2.151 . . . . 0.0 106.474 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -9.24 -50.68 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 CA-C-N 112.754 -2.021 . . . . 0.0 115.33 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 42' ' ' ARG . 94.1 mttt -95.98 136.38 22.21 Favored Pre-proline 0 N--CA 1.5 2.039 0 N-CA-C 106.6 -1.629 . . . . 0.0 106.6 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.427 ' O ' ' O ' ' A' ' 44' ' ' LYS . 49.2 Cg_exo -44.16 -161.95 0.0 OUTLIER 'Trans proline' 0 C--N 1.316 -1.135 0 C-N-CA 121.774 1.649 . . . . 0.0 115.479 171.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -113.73 146.77 39.36 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 113.283 -1.781 . . . . 0.0 110.433 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -137.7 123.5 20.0 Favored 'General case' 0 N--CA 1.505 2.323 0 CA-C-O 118.863 -0.589 . . . . 0.0 110.952 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -136.8 168.04 20.3 Favored 'General case' 0 N--CA 1.513 2.696 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.501 ' SD ' ' O ' ' A' ' 20' ' ' GLN . 44.6 tpp -107.1 132.35 53.1 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 114.111 -1.404 . . . . 0.0 113.866 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.0 tp -90.88 122.42 33.56 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 114.483 -1.235 . . . . 0.0 110.707 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.73 18.48 10.72 Favored Glycine 0 N--CA 1.5 2.91 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.483 ' O ' ' CB ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -118.75 -53.12 2.31 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.483 ' CB ' ' O ' ' A' ' 52' ' ' LYS . 47.9 tt0 100.92 70.56 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.208 0 O-C-N 125.812 1.945 . . . . 0.0 108.049 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -109.39 -33.71 6.75 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 114.182 -1.372 . . . . 0.0 108.708 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.4 m -115.15 153.03 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.291 0 CA-C-O 121.287 0.565 . . . . 0.0 110.4 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.57 ' CG2' ' CE1' ' A' ' 82' ' ' TYR . 14.2 pt -51.08 177.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.094 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.544 ' O ' ' N ' ' A' ' 59' ' ' TRP . 8.7 tpt180 -70.52 -60.76 2.07 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 120.232 -0.587 . . . . 0.0 109.442 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -24.24 -38.88 0.01 OUTLIER Glycine 0 N--CA 1.501 2.98 0 O-C-N 125.122 1.514 . . . . 0.0 112.718 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.544 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.6 OUTLIER -82.66 -71.38 0.49 Allowed 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 179.828 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -28.77 -54.62 0.12 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 125.266 1.604 . . . . 0.0 110.939 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -76.67 -53.53 7.88 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -50.83 -75.54 0.21 Allowed Glycine 0 N--CA 1.478 1.465 0 C-N-CA 119.207 -1.473 . . . . 0.0 110.287 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 59' ' ' TRP . 35.2 t -42.03 -50.77 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 C-N-CA 119.471 -0.891 . . . . 0.0 112.42 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.471 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -45.0 -62.04 1.39 Allowed 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 123.893 1.806 . . . . 0.0 111.434 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -47.15 -12.91 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 109.606 -3.452 . . . . 0.0 109.176 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.471 ' H ' ' C ' ' A' ' 64' ' ' ALA . 6.6 mtm -99.63 157.27 16.58 Favored 'General case' 0 N--CA 1.512 2.657 0 C-N-CA 118.503 -1.279 . . . . 0.0 107.638 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 84.4 p -118.65 148.24 42.94 Favored 'General case' 0 N--CA 1.507 2.398 0 CA-C-O 122.458 1.123 . . . . 0.0 113.412 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 52.9 t -40.82 100.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-N 112.775 -2.011 . . . . 0.0 113.829 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.19 10.97 12.74 Favored Glycine 0 N--CA 1.5 2.963 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -107.2 146.45 31.38 Favored 'General case' 0 N--CA 1.505 2.297 0 CA-C-O 121.681 0.753 . . . . 0.0 111.05 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.1 mtp85 -126.26 139.56 53.22 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -149.42 177.07 10.03 Favored 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 116.58 2.067 . . . . 0.0 116.58 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -127.92 107.1 9.57 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 102.531 -3.137 . . . . 0.0 102.531 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.8 mt -104.47 153.31 21.28 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.502 ' HB ' HE21 ' A' ' 3' ' ' GLN . 90.3 m -124.01 124.96 43.7 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 104.613 -2.366 . . . . 0.0 104.613 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.1 mt -116.95 136.34 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.402 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 61.1 p -111.92 154.11 44.27 Favored Pre-proline 0 N--CA 1.505 2.292 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -34.36 -53.05 0.6 Allowed 'Trans proline' 0 C--N 1.315 -1.187 0 C-N-CA 122.1 1.867 . . . . 0.0 114.297 -174.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 80' ' ' TYR . 1.8 p30 -37.34 -39.65 0.3 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.503 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.452 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 5.0 m-85 -102.11 -39.69 7.16 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 114.965 -1.016 . . . . 0.0 112.022 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.58 -125.27 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 118.094 -1.442 . . . . 0.0 108.87 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.57 ' CE1' ' CG2' ' A' ' 56' ' ' ILE . 19.0 m-85 -116.63 85.95 2.41 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -106.55 42.54 1.89 Allowed Glycine 0 N--CA 1.502 3.055 0 C-N-CA 119.475 -1.345 . . . . 0.0 112.008 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -145.82 -82.56 0.14 Allowed 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 119.946 -0.702 . . . . 0.0 112.524 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 96.7 m -128.9 90.76 3.09 Favored 'General case' 0 N--CA 1.504 2.229 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.503 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -106.79 -143.42 11.21 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.534 ' N ' ' O ' ' A' ' 91' ' ' ILE . 22.3 m80 -104.25 149.13 36.97 Favored Pre-proline 0 N--CA 1.505 2.316 0 CA-C-O 119.47 -0.3 . . . . 0.0 110.565 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -90.5 34.96 0.32 Allowed 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 122.012 1.808 . . . . 0.0 109.29 172.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -134.68 -49.48 0.08 OUTLIER Glycine 0 N--CA 1.5 2.907 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.866 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.1 mt -114.44 -54.4 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.287 0 CA-C-O 122.45 1.119 . . . . 0.0 109.84 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.534 ' O ' ' N ' ' A' ' 87' ' ' HIS . 16.6 mm -110.72 85.2 4.68 Favored Pre-proline 0 N--CA 1.505 2.301 0 CA-C-N 112.95 -1.932 . . . . 0.0 112.092 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.427 ' O ' ' O ' ' A' ' 93' ' ' PRO . 20.3 Cg_endo -86.39 159.14 9.58 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 N-CA-C 107.626 -1.721 . . . . 0.0 107.626 171.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.427 ' O ' ' O ' ' A' ' 92' ' ' PRO . 15.0 Cg_endo -42.84 174.21 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.299 0 C-N-CA 122.654 2.236 . . . . 0.0 114.416 -175.152 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.401 ' C ' ' O ' ' A' ' 93' ' ' PRO . 2.0 m-70 9.87 61.61 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.403 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -124.15 78.63 1.66 Allowed 'General case' 0 N--CA 1.503 2.198 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.399 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 88.1 m -29.41 141.87 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 O-C-N 124.552 1.158 . . . . 0.0 112.119 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 27.8 mt -115.86 155.21 28.33 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.8 t -136.43 124.51 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -118.39 150.7 39.1 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 122.305 1.05 . . . . 0.0 111.057 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -124.09 93.59 3.97 Favored 'General case' 0 N--CA 1.493 1.706 1 N-CA-C 98.926 -4.472 . . . . 0.0 98.926 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.419 HG12 ' N ' ' A' ' 102' ' ' GLU . 12.7 t -108.09 155.57 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.513 0 N-CA-C 117.033 2.234 . . . . 0.0 117.033 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.419 ' N ' HG12 ' A' ' 101' ' ' VAL . 31.5 tt0 -129.2 103.33 6.89 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 111.574 -2.557 . . . . 0.0 108.143 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 39.5 tp -77.86 118.44 20.19 Favored 'General case' 0 N--CA 1.506 2.363 0 N-CA-C 102.722 -3.066 . . . . 0.0 102.722 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.1 mt -87.3 -55.63 3.72 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 113.845 -1.525 . . . . 0.0 112.518 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -171.69 -170.08 0.75 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.334 -0.946 . . . . 0.0 110.962 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 21.2 mt -117.65 156.28 28.45 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 . . . . . 0 N--CA 1.503 2.191 0 CA-C-O 116.822 -1.561 . . . . 0.0 108.974 179.83 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.9 p -116.12 150.26 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -123.68 154.88 38.77 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.7 t -125.14 118.99 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -120.21 96.86 5.33 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 92.1 m -69.83 156.12 39.52 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.031 -1.068 . . . . 0.0 113.077 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 74.0 mt -122.52 -55.55 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 CA-C-N 113.693 -1.594 . . . . 0.0 107.471 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.422 ' O ' ' O ' ' A' ' 9' ' ' PRO . 34.2 t -122.95 82.48 50.35 Favored Pre-proline 0 N--CA 1.506 2.344 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.515 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 8' ' ' SER . 5.2 Cg_exo -36.23 161.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.391 2.061 . . . . 0.0 112.731 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -118.32 -174.62 16.39 Favored Glycine 0 N--CA 1.5 2.904 0 N-CA-C 106.482 -2.647 . . . . 0.0 106.482 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.525 ' N ' ' OD1' ' A' ' 11' ' ' ASP . 13.0 p-10 -39.77 -60.39 1.0 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.492 -0.883 . . . . 0.0 112.916 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.06 18.74 12.91 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 105.599 -3.001 . . . . 0.0 105.599 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 54.8 mtt-85 -127.13 -40.32 1.85 Allowed 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 113.773 -1.213 . . . . 0.0 112.214 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.6 m -108.21 139.58 42.69 Favored 'General case' 0 N--CA 1.506 2.341 0 CA-C-O 121.968 0.89 . . . . 0.0 112.726 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 50.8 m-85 -131.79 177.46 2.23 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -62.19 155.09 58.55 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 N-CA-C 109.805 -0.883 . . . . 0.0 109.805 161.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -119.73 166.61 12.99 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.921 0.867 . . . . 0.0 108.923 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 59.2 mtt85 -81.18 95.07 6.8 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.559 -1.201 . . . . 0.0 109.178 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.07 3.7 4.8 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -113.61 173.02 6.62 Favored 'General case' 0 N--CA 1.506 2.35 0 C-N-CA 120.219 -0.593 . . . . 0.0 109.513 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 97.8 m -118.08 117.86 30.35 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.591 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 24.8 m -69.66 148.61 49.07 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 87.5 t -122.13 101.61 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 101.679 -3.452 . . . . 0.0 101.679 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.427 HG21 ' CH2' ' A' ' 59' ' ' TRP . 3.0 m -125.38 151.04 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -129.04 117.67 21.26 Favored 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.434 ' CD2' ' CD2' ' A' ' 99' ' ' PHE . 41.9 p90 -136.27 -179.13 5.49 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 96.2 m -137.02 118.73 15.02 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 105.006 -2.22 . . . . 0.0 105.006 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -102.91 124.85 8.29 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 120.905 -0.665 . . . . 0.0 112.057 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 48.9 mtm -134.28 -177.43 4.58 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 122.041 0.924 . . . . 0.0 110.524 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 12.2 mt -120.43 -173.26 2.54 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.357 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.612 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 9.5 pm0 -90.18 22.62 3.21 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.826 0.822 . . . . 0.0 109.332 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 33' ' ' GLY . 1.5 p30 -126.57 -46.01 1.61 Allowed 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 114.126 -1.397 . . . . 0.0 107.318 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.519 ' N ' ' OD1' ' A' ' 32' ' ' ASP . . . 124.79 29.88 1.01 Allowed Glycine 0 N--CA 1.503 3.117 0 N-CA-C 116.67 1.428 . . . . 0.0 116.67 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -117.5 144.37 45.13 Favored 'General case' 0 N--CA 1.506 2.328 0 CA-C-N 119.802 1.801 . . . . 0.0 107.953 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -91.06 135.44 33.75 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.417 ' O ' ' OD1' ' A' ' 37' ' ' ASP . 35.8 p90 -122.81 -36.43 2.89 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 36' ' ' PHE . 73.9 m-20 -139.86 125.33 19.11 Favored 'General case' 0 N--CA 1.517 2.917 0 CA-C-O 121.496 0.665 . . . . 0.0 111.763 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 52.4 m -130.56 162.49 29.16 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 82.3 p -104.22 35.98 2.52 Favored 'General case' 0 N--CA 1.505 2.323 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.016 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 18.1 ttp180 -130.14 56.62 1.74 Allowed 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -91.03 -69.61 0.72 Allowed 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 62.1 mtt85 -90.99 -102.33 0.1 Allowed 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -110.66 -53.14 2.72 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -110.37 153.78 43.27 Favored Pre-proline 0 N--CA 1.508 2.453 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.737 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -55.19 -158.62 0.01 OUTLIER 'Trans proline' 0 N--CA 1.488 1.186 0 C-N-CA 122.437 2.092 . . . . 0.0 114.349 -177.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -91.15 142.42 27.76 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 114.236 -1.347 . . . . 0.0 112.962 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -137.79 122.71 18.94 Favored 'General case' 0 N--CA 1.506 2.369 0 CA-C-O 119.109 -0.472 . . . . 0.0 111.128 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -137.71 175.4 9.63 Favored 'General case' 0 N--CA 1.513 2.69 0 CA-C-N 119.412 1.006 . . . . 0.0 112.381 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 42.2 ttm -117.67 144.06 45.58 Favored 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.1 tp -91.09 124.25 35.18 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 114.295 -1.32 . . . . 0.0 111.812 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.18 -18.07 14.28 Favored Glycine 0 N--CA 1.501 3.026 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.874 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.41 ' O ' ' C ' ' A' ' 53' ' ' GLN . 53.9 tttm -118.98 39.32 3.57 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 120.949 -0.3 . . . . 0.0 110.372 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 52' ' ' LYS . 15.1 pt20 14.12 68.26 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 125.262 1.601 . . . . 0.0 114.587 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -91.39 -27.3 18.42 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 113.758 -1.564 . . . . 0.0 106.869 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.427 ' O ' ' O ' ' A' ' 56' ' ' ILE . 26.8 m -118.8 154.6 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.235 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.427 ' O ' ' O ' ' A' ' 55' ' ' VAL . 12.7 pt -49.43 175.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 C-N-CA 119.568 -0.853 . . . . 0.0 108.908 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.537 ' O ' ' N ' ' A' ' 59' ' ' TRP . 32.4 ttp180 -72.24 -56.31 5.74 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.199 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -25.35 -38.52 0.01 OUTLIER Glycine 0 N--CA 1.499 2.886 0 O-C-N 124.773 1.296 . . . . 0.0 112.188 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.537 ' N ' ' O ' ' A' ' 57' ' ' ARG . 1.4 m95 -82.02 -74.26 0.35 Allowed 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 112.919 -1.64 . . . . 0.0 108.386 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 59' ' ' TRP . 29.2 tt0 -24.18 -54.72 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 125.932 2.02 . . . . 0.0 111.174 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -77.85 -54.81 5.89 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -48.56 -75.97 0.17 Allowed Glycine 0 N--CA 1.482 1.702 0 C-N-CA 119.84 -1.172 . . . . 0.0 110.391 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.529 ' N ' ' O ' ' A' ' 59' ' ' TRP . 23.1 t -44.03 -48.7 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 119.298 -0.961 . . . . 0.0 111.837 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.471 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -46.36 -58.93 3.28 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 123.948 1.832 . . . . 0.0 111.341 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -51.05 -8.81 0.05 OUTLIER 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 109.68 -3.418 . . . . 0.0 109.887 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.471 ' H ' ' C ' ' A' ' 64' ' ' ALA . 93.4 mtp -102.73 158.62 16.12 Favored 'General case' 0 N--CA 1.513 2.723 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 88.3 p -118.51 153.83 33.53 Favored 'General case' 0 N--CA 1.509 2.525 0 CA-C-O 122.775 1.274 . . . . 0.0 113.677 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 86.7 t -49.18 97.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 112.608 -2.087 . . . . 0.0 113.568 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.19 12.95 12.73 Favored Glycine 0 N--CA 1.499 2.869 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -107.65 143.54 35.99 Favored 'General case' 0 N--CA 1.505 2.305 0 CA-C-O 121.368 0.604 . . . . 0.0 109.781 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 25.4 ttt85 -124.88 140.85 52.55 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -149.7 176.47 10.65 Favored 'General case' 0 N--CA 1.502 2.175 0 CA-C-N 113.316 -1.765 . . . . 0.0 115.452 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -125.75 103.8 8.01 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 104.117 -2.549 . . . . 0.0 104.117 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.1 mt -98.26 145.93 26.15 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 89.5 m -117.35 104.07 10.76 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 33.9 mt -102.3 134.27 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.972 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.4 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -112.99 157.39 40.81 Favored Pre-proline 0 N--CA 1.501 2.123 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -37.37 -53.22 1.38 Allowed 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 123.148 2.565 . . . . 0.0 114.881 -166.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.524 ' O ' ' NH2' ' A' ' 57' ' ' ARG . 13.1 p-10 -45.39 -36.63 4.4 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.491 ' CZ ' ' NE ' ' A' ' 57' ' ' ARG . 4.6 m-85 -102.09 4.52 39.76 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.524 ' O ' ' CD1' ' A' ' 82' ' ' TYR . . . -124.67 -81.91 0.64 Allowed 'General case' 0 N--CA 1.507 2.394 0 CA-C-O 122.021 0.915 . . . . 0.0 110.613 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.524 ' CD1' ' O ' ' A' ' 81' ' ' ALA . 28.9 m-85 -141.96 111.69 6.69 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 113.924 -1.489 . . . . 0.0 111.069 -179.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 84' ' ' ALA . . . -88.38 179.03 46.31 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 105.164 -3.174 . . . . 0.0 105.164 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.499 ' N ' ' NE2' ' A' ' 94' ' ' HIS . . . 40.23 -162.41 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 CA-C-N 118.159 0.979 . . . . 0.0 111.026 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 92.3 m -108.88 145.35 35.48 Favored 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -130.07 -71.31 0.12 Allowed Glycine 0 N--CA 1.501 2.991 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.076 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.509 ' C ' ' H ' ' A' ' 89' ' ' GLY . 15.7 m80 -120.87 96.99 48.53 Favored Pre-proline 0 N--CA 1.505 2.281 0 CA-C-O 118.094 -0.955 . . . . 0.0 110.546 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -76.97 32.59 0.42 Allowed 'Trans proline' 0 C--N 1.315 -1.204 0 C-N-CA 121.115 1.21 . . . . 0.0 111.243 -172.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.509 ' H ' ' C ' ' A' ' 87' ' ' HIS . . . -128.36 -38.55 0.37 Allowed Glycine 0 N--CA 1.496 2.645 0 N-CA-C 108.144 -1.982 . . . . 0.0 108.144 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.7 mt -104.23 -54.91 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.463 HG12 ' CD2' ' A' ' 82' ' ' TYR . 1.5 mp -114.41 98.8 49.9 Favored Pre-proline 0 N--CA 1.503 2.203 0 CA-C-N 113.12 -1.855 . . . . 0.0 109.259 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -55.31 -179.36 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 122.05 1.833 . . . . 0.0 108.758 162.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -73.9 163.47 36.89 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 121.674 1.583 . . . . 0.0 111.43 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.499 ' NE2' ' N ' ' A' ' 84' ' ' ALA . 38.7 m170 9.31 70.32 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 115.677 1.732 . . . . 0.0 115.677 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -116.1 155.81 27.51 Favored 'General case' 0 N--CA 1.503 2.216 0 CA-C-O 121.68 0.752 . . . . 0.0 111.001 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 93.3 m -91.25 131.22 36.91 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 114.416 -1.265 . . . . 0.0 108.467 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 23.8 mt -103.78 152.87 21.35 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 57.3 t -133.24 103.93 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.434 ' CD2' ' CD2' ' A' ' 26' ' ' TYR . 2.7 m-85 -96.85 158.64 15.33 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 118.163 -1.415 . . . . 0.0 108.437 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -123.57 88.03 2.85 Favored 'General case' 0 N--CA 1.491 1.607 1 N-CA-C 97.511 -4.996 . . . . 0.0 97.511 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.3 t -101.47 146.3 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.518 0 N-CA-C 116.626 2.084 . . . . 0.0 116.626 -178.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -123.54 104.57 9.13 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 112.541 -2.118 . . . . 0.0 106.076 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 35.8 tp -76.93 120.25 21.79 Favored 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 102.868 -3.012 . . . . 0.0 102.868 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.6 mt -87.16 -57.54 2.92 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 113.913 -1.494 . . . . 0.0 112.123 -179.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -170.27 -169.45 0.84 Allowed 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 119.502 -0.879 . . . . 0.0 111.455 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 22.0 mt -118.12 156.18 29.14 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 . . . . . 0 N--CA 1.504 2.266 0 CA-C-O 116.164 -1.874 . . . . 0.0 109.597 179.911 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.404 ' N ' ' OD2' ' A' ' 79' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.3 p -114.44 150.06 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -120.64 149.65 42.15 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.7 t -125.56 111.28 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -109.92 97.46 6.97 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 85.6 m -69.93 155.33 40.73 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 118.87 -1.132 . . . . 0.0 112.546 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 72.3 mt -123.31 -54.16 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 CA-C-N 113.493 -1.685 . . . . 0.0 107.123 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.431 ' O ' ' O ' ' A' ' 9' ' ' PRO . 43.2 m -123.66 83.16 53.91 Favored Pre-proline 0 N--CA 1.506 2.335 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.463 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 8' ' ' SER . 4.6 Cg_exo -35.92 163.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.51 2.14 . . . . 0.0 112.971 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.11 -172.08 15.15 Favored Glycine 0 N--CA 1.502 3.059 0 N-CA-C 107.872 -2.091 . . . . 0.0 107.872 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 12' ' ' GLY . 1.4 p30 -39.63 -51.69 2.25 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.867 -0.733 . . . . 0.0 112.701 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.526 ' N ' ' OD1' ' A' ' 11' ' ' ASP . . . 100.88 -1.13 55.21 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 62.9 mtt180 -118.3 -37.08 3.4 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.8 m -104.77 128.27 52.85 Favored 'General case' 0 N--CA 1.504 2.271 0 C-N-CA 119.828 -0.749 . . . . 0.0 111.757 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 27.4 m-85 -129.01 172.39 7.18 Favored Pre-proline 0 N--CA 1.502 2.145 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -63.41 128.88 23.64 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 CA-C-N 119.915 1.005 . . . . 0.0 110.504 167.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -118.0 167.58 11.32 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 122.279 1.038 . . . . 0.0 110.61 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.577 HH12 ' CD2' ' A' ' 50' ' ' LEU . 5.2 tpp180 -68.73 123.51 21.11 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.11 -1.405 . . . . 0.0 109.684 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.86 -19.39 18.49 Favored Glycine 0 N--CA 1.499 2.889 0 C-N-CA 120.336 -0.935 . . . . 0.0 110.845 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -112.17 178.13 4.41 Favored 'General case' 0 N--CA 1.507 2.414 0 CA-C-O 121.695 0.759 . . . . 0.0 112.57 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 42.1 m -111.07 166.96 10.63 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.3 m -118.48 147.25 43.82 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 67.9 t -122.96 100.55 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 101.71 -3.441 . . . . 0.0 101.71 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.2 m -120.47 145.86 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.325 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.525 ' CE1' ' OD2' ' A' ' 41' ' ' ASP . 1.6 t60 -121.49 141.59 50.88 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 102.517 -3.142 . . . . 0.0 102.517 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -160.39 176.97 11.06 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 118.487 -1.285 . . . . 0.0 112.263 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 97.4 m -136.97 121.89 18.85 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 101.368 -3.568 . . . . 0.0 101.368 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -110.41 113.24 3.48 Favored Glycine 0 N--CA 1.499 2.864 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 39.1 ttm -122.56 173.97 7.36 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 21.1 mt -119.03 -174.81 2.78 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -90.19 26.54 1.87 Allowed 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 122.219 1.009 . . . . 0.0 108.606 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 33' ' ' GLY . 1.4 p30 -130.67 -50.09 1.06 Allowed 'General case' 0 N--CA 1.502 2.132 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.649 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.521 ' N ' ' OD1' ' A' ' 32' ' ' ASP . . . 119.36 24.5 2.91 Favored Glycine 0 N--CA 1.505 3.25 0 N-CA-C 114.618 0.607 . . . . 0.0 114.618 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.407 ' O ' ' C ' ' A' ' 35' ' ' LYS . 2.1 mptp? -113.73 67.96 0.68 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 117.944 0.872 . . . . 0.0 111.646 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 34' ' ' LYS . 60.2 pttt -19.64 135.0 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.369 0 O-C-N 125.157 1.536 . . . . 0.0 113.452 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.528 ' CD2' ' OD2' ' A' ' 37' ' ' ASP . 2.5 p90 -131.8 -33.82 1.36 Allowed 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 113.675 -1.602 . . . . 0.0 108.577 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.528 ' OD2' ' CD2' ' A' ' 36' ' ' PHE . 62.1 m-20 -137.27 86.99 2.24 Favored 'General case' 0 N--CA 1.515 2.779 0 N-CA-C 118.587 2.81 . . . . 0.0 118.587 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.8 m -112.46 173.07 6.55 Favored 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 100.53 -3.878 . . . . 0.0 100.53 179.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 88.5 p -117.18 -133.31 0.33 Allowed 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 121.476 1.944 . . . . 0.0 109.719 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.426 ' O ' ' O ' ' A' ' 44' ' ' LYS . 26.0 ttt85 -131.18 78.08 1.81 Allowed 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 112.84 -1.982 . . . . 0.0 110.547 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.525 ' OD2' ' CE1' ' A' ' 25' ' ' HIS . 10.1 t70 -88.09 34.14 0.73 Allowed 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 118.003 -1.479 . . . . 0.0 108.486 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.4 ttm-85 -91.56 -60.91 1.76 Allowed 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.001 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -110.41 -66.12 1.1 Allowed 'General case' 0 N--CA 1.501 2.094 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.527 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' A' ' 40' ' ' ARG . 98.8 mttt -120.9 153.65 57.35 Favored Pre-proline 0 N--CA 1.507 2.417 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -87.84 -157.8 0.07 OUTLIER 'Trans proline' 0 C--N 1.314 -1.255 0 C-N-CA 123.284 2.656 . . . . 0.0 110.655 178.326 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -96.36 149.24 21.92 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 114.055 -1.429 . . . . 0.0 109.928 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -141.87 135.66 29.74 Favored 'General case' 0 N--CA 1.517 2.898 0 N-CA-C 114.822 1.415 . . . . 0.0 114.822 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -148.03 172.14 14.72 Favored 'General case' 0 N--CA 1.514 2.736 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 43.9 ttm -116.16 148.93 39.85 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.815 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.577 ' CD2' HH12 ' A' ' 18' ' ' ARG . 65.2 tp -90.77 119.37 30.94 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.966 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.19 35.22 4.55 Favored Glycine 0 N--CA 1.497 2.7 0 N-CA-C 108.591 -1.804 . . . . 0.0 108.591 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.488 ' O ' ' CB ' ' A' ' 53' ' ' GLN . 63.5 tttp -128.11 -54.16 1.29 Allowed 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.488 ' CB ' ' O ' ' A' ' 52' ' ' LYS . 63.7 tp60 100.56 66.21 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 O-C-N 125.757 1.91 . . . . 0.0 110.267 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -110.1 -36.64 5.79 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.422 ' O ' ' O ' ' A' ' 56' ' ' ILE . 11.5 m -118.73 152.43 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.737 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.422 ' O ' ' O ' ' A' ' 55' ' ' VAL . 3.8 pt -51.46 -174.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-N 114.176 -1.375 . . . . 0.0 110.043 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.539 ' O ' ' N ' ' A' ' 59' ' ' TRP . 45.2 ttm180 -84.58 -54.64 4.6 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 122.391 -0.193 . . . . 0.0 110.902 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -41.13 -20.57 0.04 OUTLIER Glycine 0 N--CA 1.492 2.422 0 C-N-CA 120.201 -1.0 . . . . 0.0 111.559 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.54 ' O ' ' N ' ' A' ' 63' ' ' VAL . 0.1 OUTLIER -92.25 -77.0 0.44 Allowed 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -35.76 -48.98 0.57 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.912 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -73.45 -54.63 7.82 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 105.739 -1.949 . . . . 0.0 105.739 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -53.68 -81.0 0.06 OUTLIER Glycine 0 N--CA 1.477 1.408 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.54 ' N ' ' O ' ' A' ' 59' ' ' TRP . 47.8 t -30.4 -46.83 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.458 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -46.02 -58.69 3.38 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 123.994 1.854 . . . . 0.0 110.177 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -50.12 -9.76 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 109.39 -3.55 . . . . 0.0 109.906 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.458 ' H ' ' C ' ' A' ' 64' ' ' ALA . 88.8 mtp -101.3 156.38 17.48 Favored 'General case' 0 N--CA 1.513 2.686 0 C-N-CA 119.102 -1.039 . . . . 0.0 108.528 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 83.0 p -115.97 148.93 39.57 Favored 'General case' 0 N--CA 1.506 2.335 0 CA-C-O 122.418 1.104 . . . . 0.0 113.003 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 90.6 t -41.57 94.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 112.846 -1.979 . . . . 0.0 113.962 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 113.28 16.92 7.98 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -108.17 144.08 36.09 Favored 'General case' 0 N--CA 1.507 2.379 0 C-N-CA 120.072 -0.651 . . . . 0.0 111.085 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 24.7 ttt85 -126.28 139.44 53.31 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -147.69 176.14 10.34 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-N 112.967 -1.924 . . . . 0.0 115.416 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -127.19 103.99 7.72 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 103.56 -2.756 . . . . 0.0 103.56 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.1 mp -97.78 146.03 25.8 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.161 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.3 m -119.34 107.15 13.03 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 104.505 -2.405 . . . . 0.0 104.505 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.4 mt -101.89 140.69 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.23 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.424 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 52.0 p -112.07 154.66 44.19 Favored Pre-proline 0 N--CA 1.504 2.229 0 CA-C-N 114.337 -1.302 . . . . 0.0 107.831 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -37.54 -54.77 1.15 Allowed 'Trans proline' 0 C--N 1.313 -1.316 0 C-N-CA 122.023 1.815 . . . . 0.0 113.836 -174.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 2.0 p-10 -34.12 -38.48 0.06 Allowed 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.895 -1.048 . . . . 0.0 113.095 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -104.55 -51.21 3.13 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.492 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -41.02 -92.01 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -121.18 -15.37 8.19 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 114.869 -1.059 . . . . 0.0 109.633 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 125.48 -172.09 17.43 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 107.843 -2.103 . . . . 0.0 107.843 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -107.46 25.26 11.67 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.435 ' O ' ' O ' ' A' ' 86' ' ' GLY . 63.8 m -129.59 43.86 3.06 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 85' ' ' THR . . . -42.99 174.06 0.01 OUTLIER Glycine 0 N--CA 1.49 2.289 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.697 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.525 ' N ' ' O ' ' A' ' 91' ' ' ILE . 73.2 t60 -115.33 145.3 34.0 Favored Pre-proline 0 N--CA 1.5 2.046 0 N-CA-C 104.592 -2.373 . . . . 0.0 104.592 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -72.41 149.32 50.21 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 N-CA-C 108.228 -1.489 . . . . 0.0 108.228 174.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 114.1 -54.73 0.55 Allowed Glycine 0 N--CA 1.5 2.966 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.8 mt -117.02 -62.14 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.392 0 CA-C-O 122.221 1.01 . . . . 0.0 109.38 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.525 ' O ' ' N ' ' A' ' 87' ' ' HIS . 32.4 mm -118.36 86.45 27.83 Favored Pre-proline 0 N--CA 1.506 2.358 0 CA-C-N 113.071 -1.877 . . . . 0.0 112.63 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -65.47 -175.61 0.45 Allowed 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 121.845 1.696 . . . . 0.0 108.037 172.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.407 ' O ' ' C ' ' A' ' 94' ' ' HIS . 89.2 Cg_exo -54.25 170.22 0.56 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.8 1.667 . . . . 0.0 110.015 174.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.412 ' O ' ' CG ' ' A' ' 94' ' ' HIS . 1.1 t60 9.55 66.98 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.208 0 O-C-N 125.448 1.718 . . . . 0.0 115.097 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -119.35 65.23 0.79 Allowed 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 66.3 m -29.06 134.57 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 125.216 1.572 . . . . 0.0 111.317 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 16.7 mt -101.54 143.3 31.71 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.8 t -131.6 112.65 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -106.25 163.3 12.92 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 122.519 1.152 . . . . 0.0 109.399 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -129.1 90.27 3.0 Favored 'General case' 0 N--CA 1.492 1.649 1 N-CA-C 98.222 -4.733 . . . . 0.0 98.222 179.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 16.1 t -105.68 151.43 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.51 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -127.13 103.35 7.39 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 111.806 -2.452 . . . . 0.0 107.979 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 42.4 tp -72.74 120.86 18.94 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 102.177 -3.268 . . . . 0.0 102.177 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 15.8 mt -90.22 -55.57 3.55 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -165.29 175.54 9.12 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.045 -1.062 . . . . 0.0 111.483 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.429 ' O ' ' OE1' ' A' ' 107' ' ' GLU . 18.2 mt -117.26 146.31 43.38 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.429 ' OE1' ' O ' ' A' ' 106' ' ' LEU . 5.7 mm-40 . . . . . 0 N--CA 1.505 2.32 0 CA-C-O 116.087 -1.911 . . . . 0.0 109.9 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.628 ' N ' ' CE1' ' A' ' 80' ' ' TYR . . . . . . . . 0 N--CA 1.485 1.951 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.5 p -109.18 140.59 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.253 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.527 HE22 ' C ' ' A' ' 4' ' ' VAL . 4.7 tm0? -117.87 149.7 40.42 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.527 ' C ' HE22 ' A' ' 3' ' ' GLN . 40.5 t -123.51 101.73 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.524 ' OE2' ' NZ ' ' A' ' 73' ' ' LYS . 39.1 tt0 -103.24 107.88 18.87 Favored 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 93.9 m -83.65 154.14 23.86 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 122.229 1.014 . . . . 0.0 112.51 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 56.3 mt -124.15 -50.29 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 CA-C-N 113.313 -1.767 . . . . 0.0 107.282 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 9' ' ' PRO . 48.1 t -122.14 79.97 43.63 Favored Pre-proline 0 N--CA 1.507 2.384 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.498 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 8' ' ' SER . 5.8 Cg_exo -37.3 165.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.735 2.29 . . . . 0.0 113.528 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.43 -169.83 13.52 Favored Glycine 0 N--CA 1.5 2.914 0 N-CA-C 106.234 -2.746 . . . . 0.0 106.234 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.521 ' N ' ' OD1' ' A' ' 11' ' ' ASP . 13.0 p-10 -39.76 -60.68 0.95 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.518 -0.873 . . . . 0.0 112.678 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.22 14.32 18.85 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 106.844 -2.502 . . . . 0.0 106.844 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 45.6 mtm180 -128.9 -36.32 1.8 Allowed 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 114.468 -0.866 . . . . 0.0 113.324 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 36.6 m -107.65 138.36 44.01 Favored 'General case' 0 N--CA 1.508 2.468 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.457 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 61.7 m-85 -130.91 176.25 3.03 Favored Pre-proline 0 N--CA 1.497 1.916 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -69.84 133.61 25.85 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 CA-C-N 119.63 0.904 . . . . 0.0 111.149 164.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.0 mtmp? -119.48 162.32 19.07 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 122.313 1.054 . . . . 0.0 108.653 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 58.4 mtt-85 -61.86 144.28 55.12 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 114.39 -1.277 . . . . 0.0 107.714 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 107.17 -31.31 8.25 Favored Glycine 0 N--CA 1.498 2.781 0 C-N-CA 119.564 -1.303 . . . . 0.0 110.589 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -109.33 176.86 4.93 Favored 'General case' 0 N--CA 1.506 2.369 0 CA-C-O 121.781 0.801 . . . . 0.0 112.881 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 63.7 m -114.71 124.82 52.77 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 114.387 -1.279 . . . . 0.0 109.828 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 22.3 m -69.53 152.14 45.17 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.2 t -128.07 106.49 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 102.117 -3.29 . . . . 0.0 102.117 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.0 m -125.52 148.32 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.423 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -122.82 140.41 52.96 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 101.856 -3.387 . . . . 0.0 101.856 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -160.13 174.73 13.85 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 117.696 -1.602 . . . . 0.0 113.674 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.5 m -136.64 118.84 15.53 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 104.57 -2.382 . . . . 0.0 104.57 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.64 135.33 12.45 Favored Glycine 0 N--CA 1.503 3.112 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 63.9 mtp -140.28 178.75 7.07 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 122.102 0.953 . . . . 0.0 110.233 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 24.6 mt -116.08 175.77 5.4 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -33.78 -63.5 0.26 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 124.934 1.396 . . . . 0.0 113.179 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -160.93 38.4 0.15 Allowed 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 114.369 -1.287 . . . . 0.0 109.447 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -119.25 -82.47 0.78 Allowed Glycine 0 N--CA 1.499 2.881 0 C-N-CA 118.684 -1.722 . . . . 0.0 114.896 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.24 174.1 10.91 Favored 'General case' 0 N--CA 1.505 2.292 0 N-CA-C 116.536 2.05 . . . . 0.0 116.536 -179.288 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -91.72 137.06 32.67 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 112.109 -2.314 . . . . 0.0 105.191 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -118.84 -33.97 4.07 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -141.76 107.6 5.14 Favored 'General case' 0 N--CA 1.511 2.607 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.7 m -120.39 168.08 11.67 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 68.3 p -118.32 63.18 0.76 Allowed 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 19.0 ttm180 -116.41 -70.46 0.79 Allowed 'General case' 0 N--CA 1.504 2.257 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.172 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -19.71 -61.03 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.387 0 O-C-N 125.18 1.55 . . . . 0.0 113.163 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.48 ' HA ' ' HE ' ' A' ' 42' ' ' ARG . 1.4 mmp_? -91.02 71.66 6.39 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 103.45 -2.796 . . . . 0.0 103.45 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.4 ' C ' ' O ' ' A' ' 42' ' ' ARG . 5.1 m120 -8.47 -57.13 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.13 0 O-C-N 126.239 2.212 . . . . 0.0 114.248 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.466 ' N ' ' O ' ' A' ' 42' ' ' ARG . 4.5 mptp? -52.08 158.71 1.69 Allowed Pre-proline 0 N--CA 1.495 1.781 0 C-N-CA 119.073 -1.051 . . . . 0.0 108.341 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.22 -162.02 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 121.663 1.575 . . . . 0.0 110.717 171.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -114.37 152.66 31.13 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-N 114.73 -1.123 . . . . 0.0 112.843 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -140.9 133.22 28.25 Favored 'General case' 0 N--CA 1.514 2.731 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -139.04 174.92 10.01 Favored 'General case' 0 N--CA 1.515 2.779 0 CA-C-N 119.508 1.049 . . . . 0.0 111.771 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 44.6 ttm -115.24 134.66 54.94 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.3 tp -91.02 139.1 31.08 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 113.496 -1.684 . . . . 0.0 109.82 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 127.99 -36.26 2.55 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.284 -1.527 . . . . 0.0 109.284 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.411 ' O ' ' C ' ' A' ' 53' ' ' GLN . 19.7 tptp -130.38 42.67 3.23 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 119.147 -0.454 . . . . 0.0 112.087 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.411 ' C ' ' O ' ' A' ' 52' ' ' LYS . 65.7 tt0 23.98 77.32 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 124.578 1.173 . . . . 0.0 112.991 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.417 ' O ' ' OE1' ' A' ' 54' ' ' GLU . 8.1 tm-20 -84.3 -27.2 27.98 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.436 ' O ' ' O ' ' A' ' 56' ' ' ILE . 16.3 m -119.4 154.44 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.439 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.588 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.436 ' O ' ' O ' ' A' ' 55' ' ' VAL . 3.1 pt -45.8 174.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 C-N-CA 118.653 -1.219 . . . . 0.0 111.913 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.54 ' O ' ' N ' ' A' ' 59' ' ' TRP . 5.0 tpt180 -71.01 -58.96 3.06 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.883 -1.053 . . . . 0.0 113.171 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -32.52 -30.53 0.01 OUTLIER Glycine 0 N--CA 1.5 2.947 0 CA-C-O 122.825 1.236 . . . . 0.0 111.531 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.54 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.8 OUTLIER -92.2 -76.2 0.46 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 112.924 -1.638 . . . . 0.0 109.557 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.514 ' OE1' ' NH1' ' A' ' 57' ' ' ARG . 3.8 tm-20 -32.02 -50.3 0.21 Allowed 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.1 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -73.65 -56.39 5.06 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -51.35 -77.55 0.13 Allowed Glycine 0 N--CA 1.481 1.637 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.526 ' N ' ' O ' ' A' ' 59' ' ' TRP . 40.2 t -36.05 -45.87 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.435 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -50.09 -53.48 26.92 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 123.715 1.721 . . . . 0.0 109.618 179.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -61.97 0.29 0.41 Allowed 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 110.399 -3.091 . . . . 0.0 110.692 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.435 ' H ' ' C ' ' A' ' 64' ' ' ALA . 50.8 ttm -110.09 151.8 26.77 Favored 'General case' 0 N--CA 1.51 2.534 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 80.4 p -115.85 153.57 31.26 Favored 'General case' 0 N--CA 1.509 2.512 0 CA-C-O 122.832 1.301 . . . . 0.0 113.922 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 79.6 t -45.23 98.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-N 112.324 -2.216 . . . . 0.0 114.967 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.46 10.5 21.63 Favored Glycine 0 N--CA 1.498 2.795 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -108.58 152.13 25.18 Favored 'General case' 0 N--CA 1.509 2.517 0 CA-C-O 122.384 1.088 . . . . 0.0 111.249 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 -131.83 141.25 49.38 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 113.027 -1.897 . . . . 0.0 108.357 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -148.07 177.91 8.98 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 112.888 -1.96 . . . . 0.0 114.223 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.573 ' HB3' ' HZ3' ' A' ' 73' ' ' LYS . 6.3 ttpm? -122.8 103.55 8.71 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 102.986 -2.968 . . . . 0.0 102.986 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.7 mt -96.49 145.06 26.02 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 90.7 m -117.45 107.62 14.54 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 104.349 -2.463 . . . . 0.0 104.349 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 35.8 mt -101.55 140.05 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.665 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.454 ' HG ' ' CG ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -114.24 160.42 32.76 Favored Pre-proline 0 N--CA 1.497 1.887 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -45.09 -52.69 6.11 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.39 2.06 . . . . 0.0 112.736 -172.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.454 ' CG ' ' HG ' ' A' ' 77' ' ' SER . 24.5 p30 -39.66 -29.85 0.06 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.628 ' CE1' ' N ' ' A' ' 1' ' ' GLY . 6.0 m-85 -105.52 18.67 21.85 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 115.089 1.515 . . . . 0.0 115.089 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -166.1 -84.09 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.412 ' CD2' HD11 ' A' ' 97' ' ' LEU . 7.9 m-30 -107.76 60.07 0.62 Allowed 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 114.419 -1.264 . . . . 0.0 111.355 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -8.9 -90.04 0.01 OUTLIER Glycine 0 N--CA 1.499 2.844 0 N-CA-C 116.697 1.439 . . . . 0.0 116.697 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -130.88 -55.95 1.05 Allowed 'General case' 0 N--CA 1.505 2.299 0 O-C-N 122.045 -0.679 . . . . 0.0 112.612 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 97.6 m -112.73 97.24 6.43 Favored 'General case' 0 N--CA 1.502 2.142 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.913 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -109.25 -83.01 1.43 Allowed Glycine 0 N--CA 1.501 2.988 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 29.1 t60 -144.19 75.62 15.35 Favored Pre-proline 0 N--CA 1.506 2.34 0 CA-C-N 118.033 0.916 . . . . 0.0 111.411 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -37.84 140.5 0.28 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.22 1.947 . . . . 0.0 110.796 177.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 113.92 -42.62 1.89 Allowed Glycine 0 N--CA 1.501 3.029 0 N-CA-C 107.491 -2.244 . . . . 0.0 107.491 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.6 mt -108.08 -52.84 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 37.6 mm -117.88 85.62 23.23 Favored Pre-proline 0 N--CA 1.502 2.151 0 CA-C-N 112.193 -2.276 . . . . 0.0 110.27 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -45.36 154.78 0.47 Allowed 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 122.234 1.956 . . . . 0.0 108.378 167.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -49.19 160.8 0.73 Allowed 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 121.657 1.571 . . . . 0.0 112.498 -174.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 8.9 p80 9.42 70.78 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 116.868 2.173 . . . . 0.0 116.868 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -111.96 154.67 24.92 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 25.5 m -91.12 140.42 29.83 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.412 HD11 ' CD2' ' A' ' 82' ' ' TYR . 29.7 mt -109.17 151.65 26.19 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 104.929 -2.248 . . . . 0.0 104.929 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.4 t -134.81 102.7 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -96.49 163.38 13.07 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 117.83 -1.548 . . . . 0.0 107.812 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -125.41 87.7 2.74 Favored 'General case' 0 N--CA 1.492 1.633 1 N-CA-C 95.559 -5.719 . . . . 0.0 95.559 179.108 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 16.8 t -100.07 147.98 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.423 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -127.18 103.75 7.59 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 112.463 -2.153 . . . . 0.0 107.538 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 37.5 tp -74.39 114.37 12.68 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 102.866 -3.013 . . . . 0.0 102.866 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.1 mt -77.11 -53.97 7.11 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.187 -179.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 9.0 mtpt -174.5 -167.21 0.3 Allowed 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.64 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 22.5 mt -117.53 154.28 31.74 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 . . . . . 0 N--CA 1.501 2.123 0 CA-C-O 116.156 -1.878 . . . . 0.0 108.528 179.84 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.353 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.4 p -110.88 150.26 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -122.3 154.7 37.25 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 57.2 t -126.52 109.11 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 CA-C-N 115.197 -0.91 . . . . 0.0 108.567 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -109.9 96.0 5.96 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 89.7 m -69.89 156.33 39.24 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 118.813 -1.155 . . . . 0.0 113.106 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 69.1 mt -122.49 -54.72 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-N 113.361 -1.745 . . . . 0.0 107.356 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.416 ' O ' ' O ' ' A' ' 9' ' ' PRO . 48.6 m -123.85 82.43 55.26 Favored Pre-proline 0 N--CA 1.506 2.372 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.574 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.416 ' O ' ' O ' ' A' ' 8' ' ' SER . 5.3 Cg_exo -36.36 163.91 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.447 2.098 . . . . 0.0 113.176 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -118.02 -172.51 15.77 Favored Glycine 0 N--CA 1.5 2.961 0 N-CA-C 104.88 -3.288 . . . . 0.0 104.88 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.464 ' CG ' ' H ' ' A' ' 12' ' ' GLY . 10.6 p-10 -45.88 -58.46 3.51 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 118.635 1.218 . . . . 0.0 111.108 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.464 ' H ' ' CG ' ' A' ' 11' ' ' ASP . . . 106.5 27.02 5.68 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 107.246 -2.341 . . . . 0.0 107.246 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 57.7 mtt85 -132.39 -35.32 1.17 Allowed 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 114.457 -0.871 . . . . 0.0 111.871 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.8 m -111.28 136.8 49.86 Favored 'General case' 0 N--CA 1.506 2.326 0 CA-C-O 121.703 0.763 . . . . 0.0 112.848 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.448 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 59.0 m-85 -132.14 176.11 3.16 Favored Pre-proline 0 N--CA 1.496 1.851 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -70.91 140.24 37.92 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 CA-C-N 119.508 0.86 . . . . 0.0 111.484 163.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -122.74 169.95 10.55 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 121.716 0.77 . . . . 0.0 109.009 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.1 mtp-105 -70.23 126.34 29.37 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.078 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.42 -19.3 13.04 Favored Glycine 0 N--CA 1.498 2.775 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -108.56 174.12 6.02 Favored 'General case' 0 N--CA 1.504 2.225 0 CA-C-O 121.847 0.832 . . . . 0.0 111.391 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 42.5 m -118.82 129.93 55.49 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 114.039 -1.437 . . . . 0.0 107.753 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 59.3 m -78.75 149.45 32.69 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.5 t -121.85 101.6 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 103.12 -2.918 . . . . 0.0 103.12 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.0 m -121.59 150.69 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.49 0 N-CA-C 117.248 2.314 . . . . 0.0 117.248 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.483 ' ND1' ' CG ' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -123.31 107.04 11.22 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 179.346 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -127.59 170.15 12.95 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-O 123.237 1.494 . . . . 0.0 114.589 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 98.1 m -139.29 119.5 13.68 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 102.754 -3.054 . . . . 0.0 102.754 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.53 137.63 14.23 Favored Glycine 0 N--CA 1.501 3.001 0 C-N-CA 120.073 -1.06 . . . . 0.0 110.995 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 40.5 ttm -136.05 168.54 19.18 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.1 mt -112.59 173.45 6.37 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 107.994 -1.114 . . . . 0.0 107.994 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.434 ' OE1' ' O ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -32.66 -63.33 0.21 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 124.792 1.308 . . . . 0.0 111.943 179.857 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.425 ' OD1' ' OE2' ' A' ' 31' ' ' GLU . 12.3 p-10 -160.29 42.69 0.19 Allowed 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.303 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -118.49 -80.22 0.7 Allowed Glycine 0 N--CA 1.5 2.938 0 C-N-CA 119.222 -1.466 . . . . 0.0 112.979 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.9 pttp -161.11 -168.01 1.94 Allowed 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.402 ' HG2' ' H ' ' A' ' 35' ' ' LYS . 60.8 pttt -90.7 137.7 32.15 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.528 ' CE2' ' OD2' ' A' ' 37' ' ' ASP . 6.5 p90 -127.87 -38.31 1.86 Allowed 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 113.098 -1.865 . . . . 0.0 107.111 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.528 ' OD2' ' CE2' ' A' ' 36' ' ' PHE . 29.6 m-20 -129.88 80.78 1.98 Allowed 'General case' 0 N--CA 1.508 2.444 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 56.4 m -113.62 164.56 13.52 Favored 'General case' 0 N--CA 1.492 1.635 1 N-CA-C 99.391 -4.3 . . . . 0.0 99.391 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 92.9 p -120.4 -141.24 0.34 Allowed 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 103.265 -2.865 . . . . 0.0 103.265 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 26.6 ttt85 -130.76 74.03 1.57 Allowed 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 111.893 -2.412 . . . . 0.0 104.872 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.483 ' CG ' ' ND1' ' A' ' 25' ' ' HIS . 32.0 m-20 -80.69 40.17 0.51 Allowed 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.008 -1.077 . . . . 0.0 110.909 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.35 -69.71 0.72 Allowed 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -111.01 -56.5 2.36 Favored 'General case' 0 N--CA 1.504 2.26 0 CA-C-N 115.054 -0.975 . . . . 0.0 113.522 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.428 ' O ' ' O ' ' A' ' 45' ' ' PRO . 4.5 mmpt? -114.22 87.5 13.49 Favored Pre-proline 0 N--CA 1.507 2.412 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -179.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 44' ' ' LYS . 33.2 Cg_exo -42.81 -156.95 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 123.148 2.565 . . . . 0.0 114.94 168.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -106.66 145.32 32.11 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 113.519 -1.673 . . . . 0.0 111.76 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.49 116.29 14.03 Favored 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -132.92 172.63 12.35 Favored 'General case' 0 N--CA 1.512 2.63 0 C-N-CA 119.797 -0.761 . . . . 0.0 111.298 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.9 ttm -119.89 153.65 35.55 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.4 tp -90.93 125.27 35.72 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.822 -1.535 . . . . 0.0 110.491 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.18 -24.57 7.33 Favored Glycine 0 N--CA 1.501 2.983 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 54' ' ' GLU . 52.8 tttp -116.11 39.35 3.1 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' ' 52' ' ' LYS . 86.5 mt-30 1.49 61.77 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 125.794 1.934 . . . . 0.0 114.384 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 52' ' ' LYS . 43.7 tt0 -75.21 -23.38 57.61 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 113.715 -1.584 . . . . 0.0 107.406 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.5 m -113.15 -178.45 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 18.6 pt -90.26 167.04 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 C-N-CA 118.998 -1.081 . . . . 0.0 110.868 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.531 ' O ' ' N ' ' A' ' 59' ' ' TRP . 0.7 OUTLIER -45.69 -70.22 0.11 Allowed 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 114.311 -1.313 . . . . 0.0 111.138 -179.774 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -26.47 -36.66 0.01 OUTLIER Glycine 0 N--CA 1.496 2.654 0 O-C-N 125.175 1.547 . . . . 0.0 112.799 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.531 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.8 OUTLIER -83.59 -68.36 0.72 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.819 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.463 ' OE1' ' N ' ' A' ' 61' ' ' GLU . 10.1 tm-20 -33.73 -53.45 0.44 Allowed 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 113.934 -1.485 . . . . 0.0 110.721 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.463 ' N ' ' OE1' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -73.71 -57.42 4.0 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 104.777 -2.305 . . . . 0.0 104.777 179.707 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -46.46 -78.57 0.08 OUTLIER Glycine 0 N--CA 1.485 1.963 0 C-N-CA 119.554 -1.307 . . . . 0.0 111.061 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 59' ' ' TRP . 32.3 t -39.63 -47.32 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 114.948 -0.626 . . . . 0.0 111.932 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.404 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -50.1 -51.27 44.32 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 123.265 1.507 . . . . 0.0 110.499 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -65.94 2.98 0.9 Allowed 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 111.216 -2.72 . . . . 0.0 111.507 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.404 ' H ' ' C ' ' A' ' 64' ' ' ALA . 60.0 ttm -106.61 151.99 24.32 Favored 'General case' 0 N--CA 1.509 2.493 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 179.432 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 92.0 p -116.49 151.98 35.0 Favored 'General case' 0 N--CA 1.51 2.566 0 CA-C-O 122.69 1.233 . . . . 0.0 113.541 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 86.0 t -45.0 97.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 112.597 -2.092 . . . . 0.0 114.755 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.35 8.42 23.27 Favored Glycine 0 N--CA 1.5 2.937 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -105.4 145.31 30.97 Favored 'General case' 0 N--CA 1.506 2.361 0 CA-C-O 121.648 0.737 . . . . 0.0 111.566 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.9 ttt85 -126.17 141.45 51.93 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.261 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -149.54 177.52 9.66 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 113.007 -1.906 . . . . 0.0 115.507 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -127.03 105.14 8.39 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 103.07 -2.937 . . . . 0.0 103.07 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.41 ' N ' HD12 ' A' ' 74' ' ' LEU . 5.1 mp -101.67 151.55 21.89 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 119.766 -0.774 . . . . 0.0 109.882 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 86.3 m -121.61 121.73 38.05 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 25.6 mt -111.41 139.92 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.429 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 66.8 p -113.87 154.35 45.92 Favored Pre-proline 0 N--CA 1.503 2.22 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.435 ' O ' ' O ' ' A' ' 81' ' ' ALA . 9.5 Cg_endo -37.55 -54.11 1.28 Allowed 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 121.784 1.656 . . . . 0.0 113.192 -174.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 0.9 OUTLIER -34.66 -35.87 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.445 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -104.53 -25.36 12.8 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 114.685 -1.143 . . . . 0.0 112.049 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 83' ' ' GLY . . . -105.1 164.9 11.46 Favored 'General case' 0 N--CA 1.505 2.315 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.119 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -11.43 71.4 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 126.515 2.384 . . . . 0.0 113.799 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 81' ' ' ALA . . . -82.95 53.66 4.89 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 119.26 -1.448 . . . . 0.0 111.487 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.488 ' CB ' ' O ' ' A' ' 83' ' ' GLY . . . 114.81 22.26 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 O-C-N 126.348 1.852 . . . . 0.0 109.531 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 48.2 m -128.26 46.59 2.56 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-O 121.096 0.474 . . . . 0.0 109.992 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -126.0 173.91 17.78 Favored Glycine 0 N--CA 1.5 2.947 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -125.93 150.3 68.63 Favored Pre-proline 0 N--CA 1.504 2.239 0 N-CA-C 103.469 -2.789 . . . . 0.0 103.469 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.526 ' O ' ' N ' ' A' ' 90' ' ' ILE . 36.6 Cg_endo -54.43 -77.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 120.978 1.119 . . . . 0.0 109.436 -177.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -21.25 -40.76 0.01 OUTLIER Glycine 0 N--CA 1.493 2.462 0 O-C-N 124.896 1.372 . . . . 0.0 114.973 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.526 ' N ' ' O ' ' A' ' 88' ' ' PRO . 6.1 mt -109.03 -65.27 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.321 0 CA-C-O 122.396 1.093 . . . . 0.0 111.44 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 35.5 mm -116.26 90.9 30.87 Favored Pre-proline 0 N--CA 1.505 2.311 0 CA-C-N 113.123 -1.853 . . . . 0.0 112.639 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -55.12 -179.29 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.17 1.913 . . . . 0.0 108.286 162.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -64.44 165.72 19.36 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 121.915 1.743 . . . . 0.0 112.881 -176.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 17.9 m80 9.33 76.0 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -115.93 156.71 25.71 Favored 'General case' 0 N--CA 1.505 2.298 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 68.9 m -91.1 139.49 30.7 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 31.5 mt -116.82 149.59 39.74 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.6 t -132.37 123.03 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -115.77 157.13 24.8 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 122.023 0.916 . . . . 0.0 110.166 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -127.72 90.82 3.17 Favored 'General case' 0 N--CA 1.493 1.689 1 N-CA-C 99.194 -4.372 . . . . 0.0 99.194 179.294 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.4 t -105.32 151.34 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.54 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -127.92 98.09 5.03 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 112.327 -2.215 . . . . 0.0 107.838 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 56.0 tp -69.87 119.44 14.1 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 11.4 mt -82.35 -55.97 4.18 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 113.902 -1.499 . . . . 0.0 110.639 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -173.95 -168.09 0.39 Allowed 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 114.71 -1.132 . . . . 0.0 111.065 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 25.7 mt -114.82 160.02 19.94 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 . . . . . 0 N--CA 1.504 2.251 0 CA-C-O 116.241 -1.838 . . . . 0.0 108.236 179.705 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.7 p -115.45 150.23 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -124.31 151.89 43.74 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.0 t -123.09 115.79 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -117.78 97.67 5.96 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 94.7 m -69.75 156.52 38.87 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.154 -1.018 . . . . 0.0 112.734 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.1 mt -121.38 -58.52 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.531 ' CB ' ' NH1' ' A' ' 71' ' ' ARG . 48.3 m -121.64 84.6 43.07 Favored Pre-proline 0 N--CA 1.501 2.086 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.877 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 8' ' ' SER . 6.8 Cg_exo -36.23 163.79 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.397 2.065 . . . . 0.0 113.264 178.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.2 -173.63 14.7 Favored Glycine 0 N--CA 1.499 2.885 0 N-CA-C 105.555 -3.018 . . . . 0.0 105.555 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.506 ' N ' ' OD1' ' A' ' 11' ' ' ASP . 13.0 p-10 -39.71 -59.87 1.08 Allowed 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.809 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.15 20.06 11.76 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 105.356 -3.098 . . . . 0.0 105.356 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 46.4 mtm180 -128.21 -38.5 1.78 Allowed 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 113.699 -1.251 . . . . 0.0 112.733 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.0 m -108.18 135.29 49.77 Favored 'General case' 0 N--CA 1.505 2.315 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.441 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 67.6 m-85 -130.94 177.16 2.37 Favored Pre-proline 0 N--CA 1.495 1.796 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -66.22 153.27 78.7 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 CA-C-N 119.408 0.824 . . . . 0.0 110.806 160.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -122.65 170.88 9.58 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 121.759 0.79 . . . . 0.0 109.361 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 42.4 mtp-105 -78.22 96.63 5.27 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.096 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.73 10.56 3.92 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -114.74 172.09 7.25 Favored 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 74.7 m -121.86 112.27 18.13 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.25 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 22.5 m -69.54 147.35 50.92 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.758 0.789 . . . . 0.0 109.518 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.1 t -123.09 112.31 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 101.592 -3.484 . . . . 0.0 101.592 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.0 m -122.44 151.62 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -120.38 99.21 6.44 Favored 'General case' 0 N--CA 1.508 2.463 0 CA-C-N 112.71 -2.041 . . . . 0.0 106.473 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.41 ' CD2' ' CD2' ' A' ' 99' ' ' PHE . 28.0 p90 -132.29 173.8 10.89 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.6 m -134.7 117.92 16.56 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 102.628 -3.101 . . . . 0.0 102.628 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 37' ' ' ASP . . . -104.57 120.8 6.73 Favored Glycine 0 N--CA 1.503 3.157 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.434 ' SD ' ' C ' ' A' ' 34' ' ' LYS . 37.4 tpp -141.05 151.0 43.69 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.52 ' H ' HD12 ' A' ' 30' ' ' LEU . 3.2 mp -93.02 151.92 19.61 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -90.51 34.64 0.88 Allowed 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 33' ' ' GLY . 32.7 p30 -121.05 -26.58 5.11 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 113.463 -1.699 . . . . 0.0 111.106 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.538 ' N ' ' OD1' ' A' ' 32' ' ' ASP . . . 161.35 -43.66 0.4 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 120.55 2.98 . . . . 0.0 120.55 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.486 ' O ' HD12 ' A' ' 30' ' ' LEU . 32.5 mmtp -129.34 176.87 7.6 Favored 'General case' 0 N--CA 1.523 3.198 0 CA-C-N 121.734 2.767 . . . . 0.0 113.025 -178.399 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.418 ' H ' ' HG2' ' A' ' 35' ' ' LYS . 53.8 pttt -93.07 148.43 22.01 Favored 'General case' 0 N--CA 1.513 2.721 0 O-C-N 124.781 1.3 . . . . 0.0 111.717 179.283 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -136.21 -32.79 0.85 Allowed 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.25 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.463 ' O ' ' N ' ' A' ' 28' ' ' GLY . 7.5 t0 -137.75 121.47 17.46 Favored 'General case' 0 N--CA 1.526 3.336 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.5 m -130.68 162.45 29.4 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.479 ' O ' ' N ' ' A' ' 41' ' ' ASP . 88.4 p -100.73 46.21 0.95 Allowed 'General case' 0 N--CA 1.504 2.275 0 C-N-CA 121.061 -0.256 . . . . 0.0 111.45 179.584 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.486 ' C ' ' H ' ' A' ' 42' ' ' ARG . 10.1 tpp85 -29.85 -36.09 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 124.242 0.964 . . . . 0.0 112.949 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.479 ' N ' ' O ' ' A' ' 39' ' ' SER . 54.5 m-20 -54.98 15.43 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 116.652 2.093 . . . . 0.0 116.652 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.486 ' H ' ' C ' ' A' ' 40' ' ' ARG . 64.8 mtt85 -19.55 -58.12 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -43.79 -64.44 0.66 Allowed 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.867 0.842 . . . . 0.0 110.838 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.454 ' O ' ' O ' ' A' ' 45' ' ' PRO . 46.1 pttt -122.61 73.25 42.24 Favored Pre-proline 0 N--CA 1.498 1.939 0 CA-C-N 113.996 -1.456 . . . . 0.0 110.168 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.454 ' O ' ' O ' ' A' ' 44' ' ' LYS . 21.6 Cg_exo -41.45 -154.3 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 125.099 3.866 . . . . 0.0 119.229 -163.256 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -91.35 135.61 33.7 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 112.468 -2.151 . . . . 0.0 107.882 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -133.05 143.9 49.67 Favored 'General case' 0 N--CA 1.514 2.753 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -149.07 174.64 12.1 Favored 'General case' 0 N--CA 1.504 2.242 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.156 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 41.6 ttm -118.04 142.74 47.06 Favored 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.3 tp -91.02 120.63 32.16 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.953 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.08 24.18 9.95 Favored Glycine 0 N--CA 1.5 2.903 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.48 ' O ' ' CB ' ' A' ' 53' ' ' GLN . 15.6 tppt? -125.29 -55.94 1.54 Allowed 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.48 ' CB ' ' O ' ' A' ' 52' ' ' LYS . 46.3 tt0 100.81 68.85 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 O-C-N 126.0 2.063 . . . . 0.0 108.29 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -109.12 -36.24 6.11 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 113.939 -1.482 . . . . 0.0 107.459 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.415 ' O ' ' O ' ' A' ' 56' ' ' ILE . 15.8 m -111.05 151.77 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.415 ' O ' ' O ' ' A' ' 55' ' ' VAL . 15.7 pt -48.48 174.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 C-N-CA 118.276 -1.37 . . . . 0.0 111.038 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.544 ' O ' ' N ' ' A' ' 59' ' ' TRP . 46.5 ttm180 -69.59 -63.28 1.1 Allowed 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -28.78 -34.73 0.01 OUTLIER Glycine 0 N--CA 1.499 2.837 0 O-C-N 124.472 1.107 . . . . 0.0 112.356 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.544 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.5 OUTLIER -81.42 -74.53 0.33 Allowed 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 113.177 -1.511 . . . . 0.0 107.553 179.877 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.518 ' OE1' ' N ' ' A' ' 61' ' ' GLU . 10.9 tm-20 -33.86 -51.37 0.4 Allowed 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.742 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.518 ' N ' ' OE1' ' A' ' 60' ' ' GLU . 17.7 tp10 -72.7 -55.48 6.73 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 112.544 -2.116 . . . . 0.0 108.095 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -55.29 -72.74 0.51 Allowed Glycine 0 N--CA 1.477 1.408 0 C-N-CA 119.246 -1.454 . . . . 0.0 110.17 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.498 ' N ' ' O ' ' A' ' 59' ' ' TRP . 40.6 t -39.56 -49.56 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 120.126 -0.629 . . . . 0.0 112.308 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.477 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -47.22 -62.09 1.58 Allowed 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 124.037 1.875 . . . . 0.0 110.139 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -48.43 -12.7 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 109.654 -3.43 . . . . 0.0 108.764 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.477 ' H ' ' C ' ' A' ' 64' ' ' ALA . 52.1 ttp -108.95 156.01 20.21 Favored 'General case' 0 N--CA 1.509 2.479 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.4 p -110.94 161.76 15.52 Favored 'General case' 0 N--CA 1.509 2.519 0 N-CA-C 116.338 1.977 . . . . 0.0 116.338 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 86.2 t -56.32 102.58 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-N 110.727 -2.942 . . . . 0.0 113.482 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.56 6.61 23.27 Favored Glycine 0 N--CA 1.499 2.867 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -107.12 148.86 28.29 Favored 'General case' 0 N--CA 1.504 2.27 0 CA-C-O 122.097 0.951 . . . . 0.0 110.29 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.531 ' NH1' ' CB ' ' A' ' 8' ' ' SER . 34.8 mtm-85 -122.35 128.35 50.89 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 113.577 -1.647 . . . . 0.0 107.977 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -134.91 172.02 13.58 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -124.57 103.17 8.0 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 102.766 -3.05 . . . . 0.0 102.766 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.8 mt -98.46 146.93 25.25 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.1 m -117.52 111.06 18.73 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 102.473 -3.158 . . . . 0.0 102.473 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 27.2 mt -109.41 137.79 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-O 121.462 0.649 . . . . 0.0 111.53 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 27.1 p -104.63 152.51 39.44 Favored Pre-proline 0 N--CA 1.504 2.27 0 CA-C-N 113.804 -1.543 . . . . 0.0 110.082 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -47.86 -38.83 31.2 Favored 'Trans proline' 0 N--CA 1.488 1.177 0 C-N-CA 122.574 2.183 . . . . 0.0 113.332 -173.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 7.0 p-10 -48.81 -40.44 29.22 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.101 -0.64 . . . . 0.0 110.943 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.7 m-30 -102.06 19.81 17.79 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.884 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -143.89 -96.79 0.11 Allowed 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.424 ' CD2' ' CG1' ' A' ' 91' ' ' ILE . 15.1 m-85 -120.08 99.29 6.52 Favored 'General case' 0 N--CA 1.504 2.238 0 CA-C-O 120.8 0.333 . . . . 0.0 110.331 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -108.68 34.84 5.32 Favored Glycine 0 N--CA 1.498 2.83 0 N-CA-C 107.61 -2.196 . . . . 0.0 107.61 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -132.79 -175.59 3.82 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 93.5 m -121.98 119.21 30.8 Favored 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.423 ' H ' HG22 ' A' ' 91' ' ' ILE . . . -115.82 -81.73 0.94 Allowed Glycine 0 N--CA 1.503 3.125 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 -123.02 145.85 47.03 Favored Pre-proline 0 N--CA 1.508 2.435 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -84.55 117.7 2.09 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 C-N-CA 121.918 1.745 . . . . 0.0 109.937 176.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 119.63 -26.18 7.36 Favored Glycine 0 N--CA 1.5 2.926 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.0 mt -108.57 -59.34 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.487 ' O ' ' CG2' ' A' ' 91' ' ' ILE . 0.8 OUTLIER -124.18 85.55 54.92 Favored Pre-proline 0 N--CA 1.503 2.224 0 CA-C-N 112.465 -2.152 . . . . 0.0 110.204 179.983 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -69.4 162.34 42.28 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 N-CA-C 107.019 -1.954 . . . . 0.0 107.019 170.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 94' ' ' HIS . 73.5 Cg_endo -61.78 166.0 12.83 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.048 1.832 . . . . 0.0 109.373 176.448 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.406 ' C ' ' O ' ' A' ' 93' ' ' PRO . 20.3 m80 9.71 66.23 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.252 0 O-C-N 125.702 1.876 . . . . 0.0 114.576 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -111.52 158.4 19.22 Favored 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 122.423 1.106 . . . . 0.0 112.307 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 87.3 m -91.19 120.31 32.01 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 112.851 -1.977 . . . . 0.0 108.601 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 20.7 mt -97.75 147.19 24.63 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 103.893 -2.632 . . . . 0.0 103.893 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 56.5 t -132.71 124.11 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.41 ' CD2' ' CD2' ' A' ' 26' ' ' TYR . 2.0 m-85 -115.5 167.82 10.55 Favored 'General case' 0 N--CA 1.507 2.387 0 CA-C-O 123.264 1.507 . . . . 0.0 110.477 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -130.28 88.7 2.68 Favored 'General case' 0 N--CA 1.49 1.544 1 N-CA-C 98.222 -4.733 . . . . 0.0 98.222 179.102 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.5 t -100.95 151.46 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.442 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 -179.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 72.8 tt0 -127.27 97.36 4.88 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 112.377 -2.192 . . . . 0.0 106.806 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 43.8 tp -68.25 122.72 18.92 Favored 'General case' 0 N--CA 1.506 2.373 0 C-N-CA 115.591 -2.444 . . . . 0.0 104.936 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 11.4 mt -85.42 -62.29 1.56 Allowed 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.92 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.469 ' HG2' ' H ' ' A' ' 106' ' ' LEU . 34.1 ttpt -170.77 -175.24 1.76 Allowed 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 118.892 -1.123 . . . . 0.0 109.826 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.469 ' H ' ' HG2' ' A' ' 105' ' ' LYS . 24.2 mt -108.94 156.31 19.86 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 . . . . . 0 N--CA 1.504 2.271 0 CA-C-O 116.037 -1.935 . . . . 0.0 109.686 179.955 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.2 p -116.87 150.14 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -119.51 151.25 38.9 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 86.6 t -129.41 98.11 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.142 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -102.0 117.16 34.23 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 104.879 -2.267 . . . . 0.0 104.879 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 92.8 m -91.7 154.86 18.71 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 122.054 0.93 . . . . 0.0 111.729 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 62.5 mt -123.53 -51.11 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 9' ' ' PRO . 33.8 m -121.46 81.26 38.79 Favored Pre-proline 0 N--CA 1.509 2.516 0 C-N-CA 120.271 -0.572 . . . . 0.0 112.038 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 8' ' ' SER . 5.3 Cg_exo -37.33 164.75 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.373 2.049 . . . . 0.0 112.578 178.073 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.11 -171.97 14.37 Favored Glycine 0 N--CA 1.5 2.926 0 N-CA-C 107.048 -2.421 . . . . 0.0 107.048 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 12' ' ' GLY . 1.1 p30 -39.55 -52.29 2.18 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.707 -0.797 . . . . 0.0 112.689 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.476 ' N ' ' OD1' ' A' ' 11' ' ' ASP . . . 100.51 5.14 54.45 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 108.44 -1.864 . . . . 0.0 108.44 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 32.3 mtp85 -121.45 -35.76 3.2 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 42.4 m -107.7 138.43 43.94 Favored 'General case' 0 N--CA 1.509 2.488 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.452 ' N ' ' CD1' ' A' ' 15' ' ' PHE . 35.0 m-85 -133.09 175.41 3.73 Favored Pre-proline 0 N--CA 1.498 1.952 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -66.27 145.63 78.58 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 CA-C-N 119.769 0.953 . . . . 0.0 109.967 165.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -118.96 169.89 9.5 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 122.373 1.083 . . . . 0.0 111.969 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 25.3 ttt85 -79.2 103.18 8.96 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 113.805 -1.543 . . . . 0.0 109.89 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.44 -10.09 6.49 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 108.353 -1.899 . . . . 0.0 108.353 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -114.93 176.1 5.2 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 89.2 m -112.62 163.2 14.81 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 2.2 m -114.27 143.26 45.14 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 104.613 -2.366 . . . . 0.0 104.613 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.8 t -117.72 102.5 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 103.397 -2.816 . . . . 0.0 103.397 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.8 m -122.46 152.0 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.363 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.525 ' NE2' ' O ' ' A' ' 40' ' ' ARG . 4.3 t-80 -129.63 128.12 41.98 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 102.721 -3.066 . . . . 0.0 102.721 178.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -139.77 176.23 8.91 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 115.335 1.605 . . . . 0.0 115.335 -179.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 91.7 m -132.87 121.55 23.08 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 103.246 -2.872 . . . . 0.0 103.246 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.84 123.15 7.55 Favored Glycine 0 N--CA 1.503 3.138 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 45.3 ttp -142.85 176.83 8.77 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.0 mt -115.78 170.2 8.64 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -27.56 -61.07 0.1 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 125.262 1.601 . . . . 0.0 114.061 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -160.48 43.81 0.19 Allowed 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 114.592 -1.186 . . . . 0.0 109.23 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -117.04 -78.4 0.67 Allowed Glycine 0 N--CA 1.502 3.051 0 C-N-CA 119.279 -1.439 . . . . 0.0 113.399 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.3 pttt -160.95 -177.13 5.91 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -90.99 135.54 33.67 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 114.055 -1.43 . . . . 0.0 110.39 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -118.65 -34.68 3.91 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -139.63 90.0 2.37 Favored 'General case' 0 N--CA 1.511 2.593 0 CA-C-O 120.866 0.365 . . . . 0.0 111.65 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 70.7 m -111.74 129.57 56.07 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 61.8 p -116.61 37.15 3.86 Favored 'General case' 0 N--CA 1.502 2.164 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.655 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.683 HH21 ' NH1' ' A' ' 42' ' ' ARG . 8.2 tpt180 -32.74 -63.97 0.2 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 124.029 0.831 . . . . 0.0 112.045 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.426 ' C ' ' H ' ' A' ' 43' ' ' ASN . 36.1 t70 -19.52 88.68 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 125.358 1.661 . . . . 0.0 114.165 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.683 ' NH1' HH21 ' A' ' 40' ' ' ARG . 26.4 mtm180 -82.58 38.03 0.54 Allowed 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 118.975 -1.09 . . . . 0.0 109.146 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.426 ' H ' ' C ' ' A' ' 41' ' ' ASP . 44.3 t30 -110.85 50.27 0.82 Allowed 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.442 ' O ' ' O ' ' A' ' 45' ' ' PRO . 55.2 mtmt 98.38 72.98 0.01 OUTLIER Pre-proline 0 N--CA 1.504 2.255 0 O-C-N 126.166 2.166 . . . . 0.0 108.889 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.442 ' O ' ' O ' ' A' ' 44' ' ' LYS . 33.3 Cg_exo -43.4 -160.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 124.248 3.299 . . . . 0.0 116.548 -178.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -85.01 142.3 29.7 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 113.596 -1.638 . . . . 0.0 109.5 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm -131.48 119.92 22.25 Favored 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -138.83 170.94 15.09 Favored 'General case' 0 N--CA 1.513 2.688 0 C-N-CA 119.306 -0.958 . . . . 0.0 112.402 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 43.1 ttm -115.75 154.6 29.29 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.1 tp -90.92 120.71 32.15 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.86 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.89 12.84 48.66 Favored Glycine 0 N--CA 1.499 2.84 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.303 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.427 ' O ' ' OE2' ' A' ' 54' ' ' GLU . 59.3 tttm -121.85 23.06 10.24 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 23.5 69.4 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 114.617 -1.174 . . . . 0.0 113.782 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.427 ' OE2' ' O ' ' A' ' 52' ' ' LYS . 66.6 mm-40 -106.28 -35.86 7.04 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 56' ' ' ILE . 18.6 m -116.59 152.56 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 CA-C-O 121.513 0.673 . . . . 0.0 110.543 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.425 ' O ' ' O ' ' A' ' 55' ' ' VAL . 4.8 pt -48.98 177.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.706 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.541 ' O ' ' N ' ' A' ' 59' ' ' TRP . 18.2 ttm180 -71.4 -61.01 1.93 Allowed 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -24.05 -39.16 0.01 OUTLIER Glycine 0 N--CA 1.495 2.622 0 O-C-N 124.929 1.393 . . . . 0.0 112.497 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.541 ' N ' ' O ' ' A' ' 57' ' ' ARG . 1.1 m95 -83.01 -70.01 0.59 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.412 ' O ' ' OE1' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -30.4 -59.82 0.19 Allowed 'General case' 0 N--CA 1.504 2.243 0 O-C-N 124.95 1.406 . . . . 0.0 110.05 -179.899 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -67.72 -52.66 35.03 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -49.77 -89.11 0.01 OUTLIER Glycine 0 N--CA 1.478 1.451 0 CA-C-N 114.363 -1.29 . . . . 0.0 111.282 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' A' ' 59' ' ' TRP . 40.0 t -31.76 -48.43 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.478 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -46.32 -59.79 2.72 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 124.169 1.937 . . . . 0.0 110.648 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -48.18 -11.77 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 109.305 -3.588 . . . . 0.0 109.276 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.478 ' H ' ' C ' ' A' ' 64' ' ' ALA . 85.2 mtp -97.53 156.12 16.65 Favored 'General case' 0 N--CA 1.513 2.691 0 C-N-CA 118.753 -1.179 . . . . 0.0 108.123 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 70' ' ' GLN . 73.1 p -120.11 147.66 44.58 Favored 'General case' 0 N--CA 1.51 2.544 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 59.1 t -36.8 96.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 CA-C-N 113.131 -1.849 . . . . 0.0 114.139 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.05 13.75 16.99 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 108.539 -1.824 . . . . 0.0 108.539 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 67' ' ' SER . 44.6 tt0 -109.68 138.17 46.43 Favored 'General case' 0 N--CA 1.503 2.225 0 CA-C-O 121.602 0.715 . . . . 0.0 109.795 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -126.83 138.99 53.42 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -144.43 178.01 8.24 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-N 112.006 -2.361 . . . . 0.0 114.6 -179.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.5 ttmp? -124.55 104.22 8.59 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 111.406 -2.634 . . . . 0.0 104.021 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.3 mp -100.42 146.0 27.54 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 119.676 -0.81 . . . . 0.0 108.878 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 90.2 m -121.72 104.47 9.62 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.512 ' H ' HD12 ' A' ' 76' ' ' ILE . 2.7 mp -95.41 141.71 14.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.206 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.3 p -112.97 153.59 45.2 Favored Pre-proline 0 N--CA 1.503 2.204 0 CA-C-N 114.631 -1.168 . . . . 0.0 108.011 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -40.25 -47.13 4.2 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.01 1.807 . . . . 0.0 112.964 -172.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 4.0 p-10 -43.88 -35.3 1.92 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -103.78 23.93 12.02 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -169.74 -88.87 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 117.36 2.356 . . . . 0.0 117.36 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.495 ' CE2' HD11 ' A' ' 97' ' ' LEU . 5.4 m-30 -108.0 104.41 13.86 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 113.769 -1.56 . . . . 0.0 110.665 -179.075 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -111.32 -64.84 0.51 Allowed Glycine 0 N--CA 1.501 3.009 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -125.43 46.31 2.4 Favored 'General case' 0 N--CA 1.503 2.215 0 CA-C-O 121.486 0.66 . . . . 0.0 110.821 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.445 ' O ' ' O ' ' A' ' 86' ' ' GLY . 97.5 m -127.54 -66.97 0.85 Allowed 'General case' 0 N--CA 1.501 2.119 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.566 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 85' ' ' THR . . . 35.98 176.98 0.01 OUTLIER Glycine 0 N--CA 1.498 2.819 0 N-CA-C 116.934 1.533 . . . . 0.0 116.934 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -129.42 157.85 75.05 Favored Pre-proline 0 N--CA 1.505 2.314 0 CA-C-N 114.529 -0.836 . . . . 0.0 109.786 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -82.43 66.66 8.15 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 C-N-CA 122.936 2.424 . . . . 0.0 116.571 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 121.41 27.97 1.71 Allowed Glycine 0 N--CA 1.509 3.55 0 C-N-CA 121.251 -0.499 . . . . 0.0 114.22 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 28.4 mt -139.63 -58.81 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 N-CA-C 103.853 -2.647 . . . . 0.0 103.853 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.482 HD13 ' CE2' ' A' ' 82' ' ' TYR . 14.6 mt -126.54 91.47 47.41 Favored Pre-proline 0 N--CA 1.492 1.643 0 CA-C-N 109.189 -3.641 . . . . 0.0 107.931 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -61.93 156.93 46.14 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.031 1.821 . . . . 0.0 107.769 167.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -53.5 175.43 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.602 2.201 . . . . 0.0 113.192 -175.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 40.6 m80 9.58 64.22 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 116.301 1.963 . . . . 0.0 116.301 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -120.59 155.44 33.71 Favored 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 93.0 m -91.16 142.7 27.45 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.495 HD11 ' CE2' ' A' ' 82' ' ' TYR . 22.2 mt -113.35 157.91 21.25 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 53.4 t -135.28 98.39 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -93.36 155.42 17.4 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -122.66 89.99 3.21 Favored 'General case' 0 N--CA 1.491 1.606 1 N-CA-C 95.466 -5.753 . . . . 0.0 95.466 179.232 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 12.5 t -100.7 148.32 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 C-N-CA 118.817 -1.153 . . . . 0.0 113.793 -178.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -124.94 109.12 12.61 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 112.429 -2.169 . . . . 0.0 107.49 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 55.5 tp -79.68 116.73 20.04 Favored 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 102.396 -3.187 . . . . 0.0 102.396 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.479 ' O ' ' NZ ' ' A' ' 105' ' ' LYS . 15.4 mt -88.13 -54.57 4.15 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -178.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.479 ' NZ ' ' O ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -164.58 177.82 7.81 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.326 -179.722 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 28.6 mt -118.07 153.58 33.5 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 . . . . . 0 N--CA 1.503 2.206 0 CA-C-O 115.733 -2.08 . . . . 0.0 108.63 179.849 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 110.079 -1.209 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.2 p -117.0 150.16 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.478 ' N ' ' CD ' ' A' ' 3' ' ' GLN . 4.3 mp0 -121.59 148.11 44.95 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 59.6 t -124.66 109.36 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.026 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -109.98 97.03 6.62 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 88.6 m -69.91 156.72 38.67 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 118.961 -1.095 . . . . 0.0 112.643 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -121.84 -54.77 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-N 113.569 -1.65 . . . . 0.0 107.213 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.422 ' O ' ' O ' ' A' ' 9' ' ' PRO . 37.0 t -124.1 82.66 56.46 Favored Pre-proline 0 N--CA 1.506 2.345 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.821 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 8' ' ' SER . 2.0 Cg_exo -35.84 161.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.336 2.024 . . . . 0.0 112.574 178.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.52 -171.25 14.74 Favored Glycine 0 N--CA 1.502 3.036 0 N-CA-C 107.426 -2.269 . . . . 0.0 107.426 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 68' ' ' VAL . 0.7 OUTLIER -39.92 -65.18 0.42 Allowed 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.589 0.709 . . . . 0.0 112.351 -179.969 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.95 16.16 16.14 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 105.809 -2.916 . . . . 0.0 105.809 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.0 mtp85 -125.47 -44.18 1.86 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 114.028 -1.086 . . . . 0.0 111.963 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.0 m -103.96 133.23 49.27 Favored 'General case' 0 N--CA 1.504 2.247 0 CA-C-O 121.522 0.677 . . . . 0.0 112.085 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.43 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 41.9 m-85 -130.97 175.21 3.86 Favored Pre-proline 0 N--CA 1.501 2.085 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -71.44 150.66 58.4 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 N-CA-C 109.485 -1.006 . . . . 0.0 109.485 164.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -120.24 172.39 7.82 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-O 121.929 0.871 . . . . 0.0 110.84 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 19.6 ttp180 -81.23 96.67 7.33 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.382 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.16 -1.24 5.77 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 108.597 -1.801 . . . . 0.0 108.597 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.5 ' O ' ' SD ' ' A' ' 49' ' ' MET . 82.0 mt-30 -114.63 172.56 6.95 Favored 'General case' 0 N--CA 1.503 2.209 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.2 m -108.67 153.08 23.93 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.3 m -111.27 141.5 44.72 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 104.972 -2.233 . . . . 0.0 104.972 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.6 t -118.8 109.16 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 100.689 -3.819 . . . . 0.0 100.689 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.444 HG21 ' CH2' ' A' ' 59' ' ' TRP . 5.4 m -124.36 155.46 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 125.751 1.907 . . . . 0.0 113.058 -179.151 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 -130.76 107.3 9.05 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 104.197 -2.52 . . . . 0.0 104.197 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.419 ' CD2' ' CD2' ' A' ' 99' ' ' PHE . 27.2 p90 -132.59 177.29 7.73 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 95.9 m -137.49 116.41 12.36 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 111.444 -2.616 . . . . 0.0 104.959 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -111.5 114.5 3.65 Favored Glycine 0 N--CA 1.501 2.992 0 N-CA-C 107.642 -2.183 . . . . 0.0 107.642 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 38.9 ttm -123.36 174.38 7.37 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 32.6 mt -120.51 172.7 7.65 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -33.12 -62.56 0.26 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 124.74 1.275 . . . . 0.0 113.12 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 55.8 p30 -160.57 44.79 0.2 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 114.462 -1.244 . . . . 0.0 108.7 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -114.55 -81.55 1.0 Allowed Glycine 0 N--CA 1.498 2.777 0 C-N-CA 118.987 -1.578 . . . . 0.0 112.193 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.01 -176.32 5.42 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -91.12 94.87 9.79 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 112.935 -1.939 . . . . 0.0 106.181 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.526 ' CE2' ' OD2' ' A' ' 37' ' ' ASP . 6.4 p90 -89.71 -41.04 12.14 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 112.422 -2.172 . . . . 0.0 109.072 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.526 ' OD2' ' CE2' ' A' ' 36' ' ' PHE . 24.3 m-20 -135.08 95.45 3.31 Favored 'General case' 0 N--CA 1.51 2.575 0 CA-C-O 121.419 0.628 . . . . 0.0 112.597 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 52.0 m -119.56 168.6 10.85 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.58 ' O ' ' N ' ' A' ' 41' ' ' ASP . 93.5 p -111.63 72.24 0.77 Allowed 'General case' 0 N--CA 1.505 2.299 0 CA-C-O 119.115 -0.469 . . . . 0.0 110.283 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 12.5 ptm85 -28.66 61.69 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.106 0 O-C-N 126.95 2.656 . . . . 0.0 116.899 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.58 ' N ' ' O ' ' A' ' 39' ' ' SER . 30.7 m-20 -19.58 -74.81 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 111.927 -2.397 . . . . 0.0 113.628 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.6 mtt180 -19.89 -47.41 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.039 0 O-C-N 125.331 1.645 . . . . 0.0 114.117 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.441 ' N ' ' O ' ' A' ' 41' ' ' ASP . 5.6 m120 -110.17 67.31 0.64 Allowed 'General case' 0 N--CA 1.501 2.124 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.767 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.42 ' O ' ' O ' ' A' ' 43' ' ' ASN . 13.0 mmmm 57.86 155.62 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.725 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.574 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -84.44 -158.45 0.09 OUTLIER 'Trans proline' 0 C--N 1.315 -1.193 0 C-N-CA 122.863 2.376 . . . . 0.0 112.54 175.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -96.61 145.81 25.4 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 114.43 -1.259 . . . . 0.0 112.774 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 31.9 mtmm -142.51 122.89 13.94 Favored 'General case' 0 N--CA 1.504 2.247 0 CA-C-O 118.782 -0.628 . . . . 0.0 110.667 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -133.17 167.07 21.02 Favored 'General case' 0 N--CA 1.513 2.678 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.5 ' SD ' ' O ' ' A' ' 20' ' ' GLN . 47.3 tpp -107.37 129.39 54.92 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 113.492 -1.685 . . . . 0.0 111.824 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.7 tp -90.66 146.39 24.07 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.157 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 129.51 -42.28 1.44 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 107.317 -2.313 . . . . 0.0 107.317 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 54' ' ' GLU . 6.2 tmtt? -120.39 43.57 2.69 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 3.63 58.65 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.094 0 O-C-N 125.64 1.838 . . . . 0.0 114.807 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.534 ' N ' ' O ' ' A' ' 52' ' ' LYS . 11.3 pt-20 -64.01 -6.29 6.01 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 118.759 -1.176 . . . . 0.0 110.738 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 56' ' ' ILE . 33.7 m -116.38 158.94 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.425 ' O ' ' O ' ' A' ' 55' ' ' VAL . 17.3 pt -49.31 174.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 C-N-CA 117.83 -1.548 . . . . 0.0 110.118 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.541 ' O ' ' N ' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -70.55 -60.53 2.21 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 57' ' ' ARG . . . -20.52 -44.17 0.01 OUTLIER Glycine 0 N--CA 1.502 3.046 0 O-C-N 125.407 1.692 . . . . 0.0 112.495 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.541 ' N ' ' O ' ' A' ' 57' ' ' ARG . 1.5 m95 -73.99 -75.78 0.15 Allowed 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 111.668 -2.266 . . . . 0.0 108.813 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 59' ' ' TRP . 4.1 tm-20 -22.54 -55.66 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 126.303 2.252 . . . . 0.0 110.898 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -78.72 -53.07 7.52 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 113.219 -1.81 . . . . 0.0 106.592 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -51.35 -73.24 0.4 Allowed Glycine 0 N--CA 1.482 1.709 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.526 ' N ' ' O ' ' A' ' 59' ' ' TRP . 24.9 t -44.14 -49.76 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 119.258 -0.977 . . . . 0.0 111.503 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.471 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -45.22 -61.88 1.48 Allowed 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 123.864 1.793 . . . . 0.0 111.181 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -46.63 -13.63 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 109.913 -3.312 . . . . 0.0 109.244 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.471 ' H ' ' C ' ' A' ' 64' ' ' ALA . 41.9 mtm -103.32 154.8 18.99 Favored 'General case' 0 N--CA 1.513 2.717 0 C-N-CA 118.847 -1.141 . . . . 0.0 109.098 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 82.7 p -116.41 153.59 31.79 Favored 'General case' 0 N--CA 1.505 2.286 0 CA-C-O 122.624 1.202 . . . . 0.0 113.428 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.417 ' O ' ' OD1' ' A' ' 11' ' ' ASP . 85.8 t -43.07 95.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 112.416 -2.175 . . . . 0.0 114.388 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.04 16.42 7.88 Favored Glycine 0 N--CA 1.497 2.759 0 N-CA-C 108.816 -1.714 . . . . 0.0 108.816 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -108.38 142.81 38.17 Favored 'General case' 0 N--CA 1.506 2.356 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.741 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 24.2 ttt85 -126.72 141.65 51.78 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -149.46 177.4 9.74 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 116.334 1.976 . . . . 0.0 116.334 -179.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -127.81 104.5 7.86 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 103.326 -2.842 . . . . 0.0 103.326 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.407 ' N ' HD12 ' A' ' 74' ' ' LEU . 5.2 mp -101.8 146.65 27.5 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 119.606 -0.838 . . . . 0.0 109.194 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 73.2 m -117.05 104.0 10.81 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 102.309 -3.219 . . . . 0.0 102.309 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 21.4 mt -102.86 138.73 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.14 163.7 20.62 Favored Pre-proline 0 N--CA 1.503 2.219 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.865 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -37.74 -50.94 1.87 Allowed 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 122.561 2.174 . . . . 0.0 113.184 -175.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 80' ' ' TYR . 1.7 p30 -44.24 -42.72 6.76 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 120.191 -0.603 . . . . 0.0 111.608 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.476 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 6.8 m-85 -108.0 13.27 26.25 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.674 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.69 -111.48 0.23 Allowed 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -119.5 114.71 22.69 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 84' ' ' ALA . . . -90.55 -172.18 44.12 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 109.104 -1.599 . . . . 0.0 109.104 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.418 ' O ' ' O ' ' A' ' 83' ' ' GLY . . . 33.57 -156.21 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 74.7 m -101.59 56.53 0.83 Allowed 'General case' 0 N--CA 1.501 2.076 0 CA-C-O 120.926 0.393 . . . . 0.0 110.268 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -31.08 -86.27 0.01 OUTLIER Glycine 0 N--CA 1.494 2.533 0 CA-C-N 114.808 -1.087 . . . . 0.0 113.779 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 67.3 t60 -132.44 102.16 14.21 Favored Pre-proline 0 N--CA 1.504 2.26 0 CA-C-O 117.841 -1.076 . . . . 0.0 108.829 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -78.22 51.78 3.83 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 CA-C-N 120.778 1.314 . . . . 0.0 112.823 -173.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -128.91 -47.31 0.17 Allowed Glycine 0 N--CA 1.5 2.964 0 N-CA-C 109.036 -1.626 . . . . 0.0 109.036 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 20.7 mt -108.34 -46.03 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.6 mm -104.92 96.58 11.07 Favored Pre-proline 0 N--CA 1.499 2.006 0 CA-C-N 110.419 -3.082 . . . . 0.0 111.158 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -84.92 154.17 11.35 Favored 'Trans proline' 0 C--N 1.315 -1.209 0 C-N-CA 121.469 1.446 . . . . 0.0 108.614 176.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.401 ' O ' ' C ' ' A' ' 94' ' ' HIS . 26.7 Cg_endo -48.65 169.99 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.483 2.122 . . . . 0.0 112.182 -171.437 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.401 ' C ' ' O ' ' A' ' 93' ' ' PRO . 17.8 m80 9.56 61.97 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 O-C-N 125.787 1.929 . . . . 0.0 114.616 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -119.9 74.06 1.0 Allowed 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.388 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 99.9 m -29.46 131.46 0.07 Allowed 'General case' 0 N--CA 1.506 2.343 0 O-C-N 124.831 1.332 . . . . 0.0 110.544 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.8 mt -96.72 152.61 18.5 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.5 t -134.78 115.12 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.419 ' CD2' ' CD2' ' A' ' 26' ' ' TYR . 2.0 m-85 -108.15 163.09 13.46 Favored 'General case' 0 N--CA 1.504 2.232 0 CA-C-O 122.968 1.366 . . . . 0.0 109.477 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -128.78 90.03 2.98 Favored 'General case' 0 N--CA 1.492 1.664 1 N-CA-C 98.186 -4.746 . . . . 0.0 98.186 179.095 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.3 t -102.21 148.31 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.558 0 N-CA-C 116.89 2.181 . . . . 0.0 116.89 -178.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -129.72 99.7 5.23 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 112.922 -1.944 . . . . 0.0 108.626 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 50.4 tp -73.28 119.39 17.45 Favored 'General case' 0 N--CA 1.504 2.253 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.2 mt -85.66 -60.07 2.13 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.643 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.473 ' HG2' ' H ' ' A' ' 106' ' ' LEU . 60.4 tttm -168.72 -175.89 2.57 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.813 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.473 ' H ' ' HG2' ' A' ' 105' ' ' LYS . 20.9 mt -109.03 160.6 15.91 Favored 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 . . . . . 0 N--CA 1.503 2.216 0 CA-C-O 115.827 -2.035 . . . . 0.0 109.4 179.838 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.615 ' N ' ' CE1' ' A' ' 80' ' ' TYR . . . . . . . . 0 N--CA 1.486 2.031 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.5 p -114.96 147.81 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -121.87 154.53 36.96 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.6 t -126.98 114.12 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-N 112.929 -1.941 . . . . 0.0 109.3 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.528 ' OE2' ' NZ ' ' A' ' 73' ' ' LYS . 37.7 tt0 -118.06 101.52 8.31 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 42.0 m -70.04 150.73 46.32 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 118.938 -1.105 . . . . 0.0 113.623 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 77.2 mt -110.99 -55.35 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.9 t -129.65 90.78 42.57 Favored Pre-proline 0 N--CA 1.504 2.232 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.235 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -37.75 165.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 122.189 1.926 . . . . 0.0 112.54 174.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.6 -113.78 2.47 Favored Glycine 0 N--CA 1.5 2.938 0 N-CA-C 106.344 -2.702 . . . . 0.0 106.344 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.507 ' CG ' ' H ' ' A' ' 12' ' ' GLY . 9.8 p-10 -100.61 -62.5 1.23 Allowed 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.507 ' H ' ' CG ' ' A' ' 11' ' ' ASP . . . 104.88 28.05 5.76 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 42.4 mtp-105 -133.61 -39.0 0.9 Allowed 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.4 m -107.53 131.3 54.48 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.425 0.631 . . . . 0.0 112.279 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.461 ' N ' ' CD1' ' A' ' 15' ' ' PHE . 23.1 m-85 -129.73 174.18 4.89 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -71.48 139.15 33.94 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 CA-C-N 119.857 0.985 . . . . 0.0 111.801 166.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -120.07 171.98 8.08 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 122.205 1.003 . . . . 0.0 111.271 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.9 ttt85 -71.28 104.31 3.1 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.189 -1.369 . . . . 0.0 111.588 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.33 8.84 5.77 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -121.97 174.15 7.08 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 57.5 m -119.44 114.56 22.5 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.544 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 58.5 m -69.26 153.28 43.9 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.537 HG13 ' HZ2' ' A' ' 47' ' ' LYS . 24.6 t -128.06 102.46 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 103.677 -2.712 . . . . 0.0 103.677 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.9 m -122.48 149.66 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.465 0 N-CA-C 116.662 2.097 . . . . 0.0 116.662 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -128.35 112.19 14.17 Favored 'General case' 0 N--CA 1.51 2.528 0 N-CA-C 103.996 -2.594 . . . . 0.0 103.996 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.436 ' N ' ' CD1' ' A' ' 26' ' ' TYR . 36.1 p90 -133.7 -175.07 3.7 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 90.8 m -140.17 123.25 16.72 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 102.06 -3.311 . . . . 0.0 102.06 179.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -114.41 125.09 6.68 Favored Glycine 0 N--CA 1.507 3.392 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.483 ' SD ' ' O ' ' A' ' 34' ' ' LYS . 1.8 tmm? -144.19 177.81 8.34 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.0 mt -117.11 170.51 8.6 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -26.66 -60.34 0.09 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 125.335 1.647 . . . . 0.0 114.139 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 54.8 p-10 -160.27 46.08 0.23 Allowed 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.035 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -114.68 -85.19 1.28 Allowed Glycine 0 N--CA 1.497 2.71 0 C-N-CA 119.022 -1.561 . . . . 0.0 112.474 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.483 ' O ' ' SD ' ' A' ' 29' ' ' MET . 0.0 OUTLIER -161.03 -175.01 4.66 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 112.697 -1.751 . . . . 0.0 114.252 -179.478 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.458 ' HD3' ' H ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -91.41 136.79 32.86 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 113.999 -1.455 . . . . 0.0 109.507 179.663 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -115.72 -37.37 3.95 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -139.19 109.61 6.55 Favored 'General case' 0 N--CA 1.505 2.313 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.194 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.2 m -121.2 167.58 12.53 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 87.9 p -118.32 28.68 8.21 Favored 'General case' 0 N--CA 1.505 2.298 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.552 ' O ' ' N ' ' A' ' 42' ' ' ARG . 36.1 mtp85 -30.03 -62.88 0.14 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 124.603 1.189 . . . . 0.0 113.347 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -19.01 69.44 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.552 ' N ' ' O ' ' A' ' 40' ' ' ARG . 41.6 mtp180 -25.53 -74.4 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 124.592 1.183 . . . . 0.0 113.669 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -22.44 -73.18 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 113.213 -1.812 . . . . 0.0 115.515 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' A' ' 45' ' ' PRO . 2.1 tpmt? -125.5 114.81 25.28 Favored Pre-proline 0 N--CA 1.496 1.827 0 CA-C-N 114.541 -1.208 . . . . 0.0 112.089 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 44' ' ' LYS . 21.5 Cg_exo -42.12 -155.16 0.0 OUTLIER 'Trans proline' 0 N--CA 1.488 1.173 0 C-N-CA 122.355 2.037 . . . . 0.0 115.849 165.388 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -110.29 149.84 29.59 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 112.632 -2.076 . . . . 0.0 111.157 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.537 ' HZ2' HG13 ' A' ' 23' ' ' VAL . 31.2 mttm -145.08 137.4 25.95 Favored 'General case' 0 N--CA 1.512 2.659 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -136.45 165.72 25.15 Favored 'General case' 0 N--CA 1.516 2.85 0 CA-C-N 119.972 1.26 . . . . 0.0 110.85 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 47.8 ttp -117.15 86.84 2.58 Favored 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 116.867 2.173 . . . . 0.0 116.867 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.4 tp -32.14 125.12 0.29 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 124.215 0.947 . . . . 0.0 112.867 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 129.48 -30.77 3.55 Favored Glycine 0 N--CA 1.499 2.84 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.48 ' O ' ' N ' ' A' ' 54' ' ' GLU . 80.1 tttt -121.03 43.76 2.7 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 52' ' ' LYS . 46.0 tt0 3.19 62.68 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.163 0 O-C-N 126.031 2.082 . . . . 0.0 113.306 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' A' ' 52' ' ' LYS . 43.8 tt0 -72.36 -24.77 61.32 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 113.541 -1.663 . . . . 0.0 106.686 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.4 m -113.8 156.5 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.818 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.7 pt -60.2 172.69 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 118.153 -1.419 . . . . 0.0 110.03 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.559 ' O ' ' N ' ' A' ' 59' ' ' TRP . 24.2 ttt85 -65.56 -59.99 3.39 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 118.214 -0.898 . . . . 0.0 112.624 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -28.13 -34.91 0.01 OUTLIER Glycine 0 N--CA 1.506 3.336 0 CA-C-O 122.916 1.287 . . . . 0.0 111.444 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.559 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.5 OUTLIER -83.01 -79.84 0.18 Allowed 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 112.24 -1.98 . . . . 0.0 107.746 179.829 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -28.48 -49.39 0.07 Allowed 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 113.347 -1.752 . . . . 0.0 110.692 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -77.33 -54.54 6.34 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -52.64 -74.95 0.25 Allowed Glycine 0 N--CA 1.482 1.752 0 N-CA-C 108.553 -1.819 . . . . 0.0 108.553 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.518 ' N ' ' O ' ' A' ' 59' ' ' TRP . 25.9 t -38.32 -45.47 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.612 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.8 -44.2 66.45 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 122.799 1.285 . . . . 0.0 109.445 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.443 ' N ' ' O ' ' A' ' 62' ' ' GLY . 51.6 tt0 -74.6 8.79 2.1 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 111.966 -2.379 . . . . 0.0 111.463 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 94.4 mtp -116.61 149.66 39.34 Favored 'General case' 0 N--CA 1.507 2.389 0 N-CA-C 104.664 -2.347 . . . . 0.0 104.664 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 80.3 p -116.52 153.87 31.4 Favored 'General case' 0 N--CA 1.51 2.571 0 CA-C-O 122.934 1.349 . . . . 0.0 113.899 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 63.0 t -43.03 100.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 112.04 -2.345 . . . . 0.0 116.15 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.26 4.52 28.97 Favored Glycine 0 N--CA 1.5 2.909 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.401 ' OE1' ' C ' ' A' ' 70' ' ' GLN . 0.8 OUTLIER -110.17 145.16 37.72 Favored 'General case' 0 N--CA 1.507 2.42 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.977 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -128.16 145.48 51.01 Favored 'General case' 0 N--CA 1.508 2.435 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.611 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -144.11 -177.72 5.59 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-N 112.776 -2.011 . . . . 0.0 115.538 -179.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.55 ' HB3' ' HZ3' ' A' ' 73' ' ' LYS . 6.6 ttpm? -125.49 106.79 10.04 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 101.767 -3.42 . . . . 0.0 101.767 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.1 mt -101.25 143.54 31.2 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 59.0 m -115.17 117.01 29.31 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 102.021 -3.326 . . . . 0.0 102.021 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 30.0 mt -110.82 142.4 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.422 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 32.7 p -114.31 158.32 40.09 Favored Pre-proline 0 N--CA 1.506 2.341 0 CA-C-N 114.427 -1.26 . . . . 0.0 108.141 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -35.0 -55.31 0.57 Allowed 'Trans proline' 0 C--N 1.315 -1.202 0 C-N-CA 121.871 1.714 . . . . 0.0 113.852 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 3.9 p-10 -42.15 -41.97 2.84 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.332 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.615 ' CE1' ' N ' ' A' ' 1' ' ' GLY . 7.5 m-85 -108.02 22.13 16.38 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -179.587 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -121.62 -103.49 0.4 Allowed 'General case' 0 N--CA 1.505 2.298 0 CA-C-N 118.683 0.674 . . . . 0.0 111.067 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.556 ' CE2' ' CD1' ' A' ' 91' ' ' ILE . 96.8 m-85 -118.66 -55.48 2.2 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.18 162.81 14.52 Favored Glycine 0 N--CA 1.505 3.281 0 C-N-CA 121.29 -0.481 . . . . 0.0 113.925 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -17.62 -53.34 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.049 0 O-C-N 125.639 1.435 . . . . 0.0 113.442 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 97.7 m -121.5 91.23 3.47 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -88.27 -102.05 0.94 Allowed Glycine 0 N--CA 1.492 2.414 0 C-N-CA 118.998 -1.573 . . . . 0.0 111.741 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -128.21 74.06 79.54 Favored Pre-proline 0 N--CA 1.503 2.185 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.177 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -30.2 100.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 123.347 2.698 . . . . 0.0 112.862 -178.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.44 -25.11 3.65 Favored Glycine 0 N--CA 1.498 2.809 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.9 mt -110.19 -66.04 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.556 ' CD1' ' CE2' ' A' ' 82' ' ' TYR . 2.4 mp -112.29 91.4 16.23 Favored Pre-proline 0 N--CA 1.502 2.159 0 CA-C-N 114.075 -1.421 . . . . 0.0 108.8 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_exo -39.39 153.62 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 122.635 2.224 . . . . 0.0 109.812 166.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -51.37 169.01 0.23 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.071 1.847 . . . . 0.0 113.447 -172.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 7.9 p80 9.4 65.12 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -118.29 149.76 40.6 Favored 'General case' 0 N--CA 1.505 2.32 0 CA-C-O 121.366 0.603 . . . . 0.0 110.901 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 29.5 m -91.28 144.57 25.46 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.2 mt -115.13 155.75 26.52 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 59.0 t -139.43 97.72 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -92.07 167.04 12.36 Favored 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 117.586 -1.646 . . . . 0.0 108.992 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -130.04 86.87 2.45 Favored 'General case' 0 N--CA 1.493 1.678 1 N-CA-C 97.387 -5.042 . . . . 0.0 97.387 178.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.401 HG12 ' N ' ' A' ' 102' ' ' GLU . 14.7 t -100.8 149.82 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.401 ' N ' HG12 ' A' ' 101' ' ' VAL . 87.9 tt0 -125.81 101.58 6.91 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 112.04 -2.345 . . . . 0.0 107.406 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 50.4 tp -74.83 113.8 12.53 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 103.35 -2.833 . . . . 0.0 103.35 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 9.3 mt -76.71 -55.19 5.72 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 113.315 -1.766 . . . . 0.0 111.479 -179.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -176.24 -168.18 0.25 Allowed 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 118.622 -1.231 . . . . 0.0 110.423 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.4 mt -115.21 150.25 36.42 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 . . . . . 0 N--CA 1.502 2.132 0 CA-C-O 115.79 -2.052 . . . . 0.0 109.24 179.892 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.1 p . . . . . 0 N--CA 1.503 2.19 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -124.07 154.96 39.18 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.4 t -124.86 112.76 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -114.31 90.97 3.47 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 97.9 m -69.78 154.84 41.43 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 119.008 -1.077 . . . . 0.0 112.425 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 58.9 mt -123.58 -52.01 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 CA-C-N 113.859 -1.519 . . . . 0.0 107.407 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 9' ' ' PRO . 38.9 t -122.03 80.66 42.99 Favored Pre-proline 0 N--CA 1.505 2.324 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.041 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 8' ' ' SER . 6.4 Cg_exo -36.96 166.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.812 2.341 . . . . 0.0 113.718 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -115.81 -172.68 16.99 Favored Glycine 0 N--CA 1.5 2.921 0 N-CA-C 105.75 -2.94 . . . . 0.0 105.75 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.462 ' CG ' ' H ' ' A' ' 12' ' ' GLY . 11.7 p-10 -44.73 -58.35 3.13 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 118.405 1.102 . . . . 0.0 111.173 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.462 ' H ' ' CG ' ' A' ' 11' ' ' ASP . . . 107.65 24.26 6.49 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 107.636 -2.186 . . . . 0.0 107.636 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 -128.83 -37.56 1.73 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 114.532 -0.834 . . . . 0.0 111.249 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.4 m -111.07 138.34 47.61 Favored 'General case' 0 N--CA 1.507 2.416 0 CA-C-O 121.833 0.825 . . . . 0.0 112.834 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.458 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 48.5 m-85 -133.07 173.78 5.48 Favored Pre-proline 0 N--CA 1.495 1.786 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -61.53 134.57 52.01 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 N-CA-C 110.09 -0.773 . . . . 0.0 110.09 164.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.412 ' NZ ' ' HB3' ' A' ' 17' ' ' LYS . 8.2 mtpm? -115.3 170.21 8.56 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.943 0.877 . . . . 0.0 110.484 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.9 mtm180 -73.64 97.01 2.56 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.198 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 122.84 18.98 3.1 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -115.82 170.1 8.72 Favored 'General case' 0 N--CA 1.504 2.245 0 CA-C-O 121.83 0.824 . . . . 0.0 110.116 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 95.4 m -125.1 110.33 14.01 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 114.481 -1.236 . . . . 0.0 107.915 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 27.5 m -69.76 149.29 48.13 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.16 -1.016 . . . . 0.0 110.074 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 93.3 t -125.17 97.8 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 101.14 -3.652 . . . . 0.0 101.14 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.413 HG21 ' CH2' ' A' ' 59' ' ' TRP . 2.8 m -121.13 151.26 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 48.3 t60 -130.24 116.55 18.54 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 104.675 -2.342 . . . . 0.0 104.675 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -134.01 179.33 6.31 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 123.044 1.402 . . . . 0.0 111.966 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.438 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 51.2 m -141.91 126.11 17.46 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 101.016 -3.698 . . . . 0.0 101.016 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -103.09 129.95 10.07 Favored Glycine 0 N--CA 1.5 2.93 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 39.5 ttm . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 179.954 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 66.4 t80 . . . . . 0 N--CA 1.495 1.819 0 N-CA-C 110.551 -0.166 . . . . 0.0 110.551 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -137.0 122.02 18.98 Favored 'General case' 0 N--CA 1.507 2.415 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.542 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -138.98 177.09 8.14 Favored 'General case' 0 N--CA 1.509 2.495 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.765 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 43.1 ttp -121.29 156.94 31.46 Favored 'General case' 0 N--CA 1.503 2.207 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.966 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.9 tp -90.95 120.32 31.86 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.15 12.71 30.8 Favored Glycine 0 N--CA 1.501 2.969 0 C-N-CA 121.059 -0.591 . . . . 0.0 114.04 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.475 ' O ' ' N ' ' A' ' 54' ' ' GLU . 59.3 tttp -128.24 45.81 2.7 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 118.349 1.074 . . . . 0.0 108.945 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' A' ' 52' ' ' LYS . 20.5 pt20 4.16 61.18 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 115.991 1.849 . . . . 0.0 115.991 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.475 ' N ' ' O ' ' A' ' 52' ' ' LYS . 6.8 mm-40 -102.98 -29.98 11.07 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 56' ' ' ILE . 13.0 m -114.87 155.76 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.426 ' O ' ' O ' ' A' ' 55' ' ' VAL . 17.0 pt -51.74 -179.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 C-N-CA 119.065 -1.054 . . . . 0.0 109.001 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.536 ' O ' ' N ' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -80.45 -58.59 3.05 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.44 ' H ' ' HB3' ' A' ' 80' ' ' TYR . . . -28.3 -35.93 0.01 OUTLIER Glycine 0 N--CA 1.501 3.025 0 O-C-N 124.531 1.145 . . . . 0.0 111.53 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.536 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.9 OUTLIER -78.78 -75.72 0.22 Allowed 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 113.236 -1.482 . . . . 0.0 107.237 179.822 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 59' ' ' TRP . 71.1 tt0 -25.87 -55.01 0.06 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 125.839 1.962 . . . . 0.0 110.828 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.405 ' N ' HH11 ' A' ' 57' ' ' ARG . 37.8 tt0 -75.27 -54.7 6.66 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -51.04 -75.09 0.23 Allowed Glycine 0 N--CA 1.482 1.753 0 C-N-CA 119.564 -1.303 . . . . 0.0 111.168 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' A' ' 59' ' ' TRP . 28.9 t -41.58 -49.91 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 119.594 -0.842 . . . . 0.0 112.292 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.467 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -45.9 -60.59 2.16 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 124.056 1.884 . . . . 0.0 111.157 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -48.68 -11.28 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 109.416 -3.538 . . . . 0.0 109.195 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.467 ' H ' ' C ' ' A' ' 64' ' ' ALA . 49.8 mtm -99.82 160.64 14.15 Favored 'General case' 0 N--CA 1.517 2.887 0 C-N-CA 118.518 -1.273 . . . . 0.0 108.823 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 96.7 p -115.32 150.63 35.97 Favored 'General case' 0 N--CA 1.51 2.539 0 CA-C-O 122.584 1.183 . . . . 0.0 113.919 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 63.8 t -49.21 99.63 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 112.641 -2.072 . . . . 0.0 113.681 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 113.95 9.27 16.38 Favored Glycine 0 N--CA 1.499 2.834 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -107.8 154.14 21.96 Favored 'General case' 0 N--CA 1.506 2.33 0 CA-C-O 122.428 1.109 . . . . 0.0 111.164 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.0 ttp180 -131.46 140.12 49.52 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 112.83 -1.986 . . . . 0.0 107.224 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -148.44 177.58 9.33 Favored 'General case' 0 N--CA 1.502 2.158 0 CA-C-N 112.947 -1.933 . . . . 0.0 115.496 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -126.47 105.28 8.65 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 111.295 -2.684 . . . . 0.0 103.936 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.4 mt -99.77 152.57 19.96 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 93.7 m -124.57 119.81 30.15 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 25.7 mt -112.13 140.28 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.1 p -111.13 155.53 42.44 Favored Pre-proline 0 N--CA 1.506 2.343 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.185 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -37.85 -51.59 1.84 Allowed 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 122.189 1.926 . . . . 0.0 114.695 -175.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 18.0 p-10 -39.28 -41.28 0.87 Allowed 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.44 ' HB3' ' H ' ' A' ' 58' ' ' GLY . 3.1 m-85 . . . . . 0 N--CA 1.493 1.694 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.312 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 62.3 m . . . . . 0 N--CA 1.5 2.067 0 CA-C-O 118.794 -0.622 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 24.2 mt -111.1 151.76 27.73 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.4 t -134.12 125.29 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -120.29 139.81 52.18 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.178 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 27' ' ' THR . 5.1 p-10 -117.57 98.84 6.6 Favored 'General case' 0 N--CA 1.501 2.076 1 N-CA-C 97.338 -5.06 . . . . 0.0 97.338 178.902 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.409 HG12 ' N ' ' A' ' 102' ' ' GLU . 16.5 t -108.51 153.62 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.355 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 -178.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.409 ' N ' HG12 ' A' ' 101' ' ' VAL . 41.3 tt0 -127.99 104.37 7.75 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 112.119 -2.309 . . . . 0.0 107.609 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 37.8 tp -75.49 121.45 22.37 Favored 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 102.556 -3.127 . . . . 0.0 102.556 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.3 mt -93.16 -57.86 2.49 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -157.96 173.81 16.2 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.605 0.717 . . . . 0.0 112.074 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 35.4 mt -117.59 143.19 46.36 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 . . . . . 0 N--CA 1.503 2.215 0 CA-C-O 116.286 -1.816 . . . . 0.0 110.007 179.885 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.9 p . . . . . 0 N--CA 1.502 2.153 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -122.92 156.39 34.77 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.4 t -125.44 114.84 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 108.039 -1.096 . . . . 0.0 108.039 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -115.22 90.02 3.24 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 90.5 m -69.83 155.67 40.2 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.048 -1.061 . . . . 0.0 112.488 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 59.0 mt -123.66 -51.59 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 CA-C-N 113.645 -1.616 . . . . 0.0 107.258 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.418 ' O ' ' O ' ' A' ' 9' ' ' PRO . 46.5 t -122.22 80.13 44.32 Favored Pre-proline 0 N--CA 1.506 2.328 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.283 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 8' ' ' SER . 6.4 Cg_exo -37.42 164.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.348 2.032 . . . . 0.0 112.808 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -123.51 -168.95 13.12 Favored Glycine 0 N--CA 1.498 2.826 0 N-CA-C 105.632 -2.987 . . . . 0.0 105.632 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 11' ' ' ASP . 12.3 p-10 -39.5 -62.93 0.62 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.747 -0.781 . . . . 0.0 112.575 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.58 15.25 21.44 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 105.838 -2.905 . . . . 0.0 105.838 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 30.4 mtm-85 -125.95 -39.4 2.11 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 113.307 -1.447 . . . . 0.0 112.774 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.1 m -108.2 137.14 46.68 Favored 'General case' 0 N--CA 1.507 2.395 0 CA-C-O 121.775 0.798 . . . . 0.0 112.763 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.445 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 57.0 m-85 -130.56 177.43 2.22 Favored Pre-proline 0 N--CA 1.496 1.859 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -69.57 146.77 62.37 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 N-CA-C 109.765 -0.898 . . . . 0.0 109.765 162.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -122.37 168.44 12.07 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 122.086 0.946 . . . . 0.0 110.248 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 19.1 ptt85 -72.61 126.58 30.22 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.648 -1.16 . . . . 0.0 108.677 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 111.38 -19.71 24.06 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.5 ' O ' ' SD ' ' A' ' 49' ' ' MET . 25.7 mt-30 -109.76 176.4 5.08 Favored 'General case' 0 N--CA 1.506 2.341 0 CA-C-O 121.766 0.793 . . . . 0.0 112.274 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 27.7 m -110.07 161.47 15.5 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 57.2 m -111.7 146.56 37.3 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 103.889 -2.634 . . . . 0.0 103.889 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 33.4 t -123.07 101.95 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 101.644 -3.465 . . . . 0.0 101.644 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 m -123.01 150.46 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 125.004 1.44 . . . . 0.0 114.324 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.403 ' ND1' ' C ' ' A' ' 25' ' ' HIS . 2.7 t-80 -130.61 113.77 14.62 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 103.598 -2.742 . . . . 0.0 103.598 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -131.21 176.63 8.11 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 123.184 1.468 . . . . 0.0 113.576 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 96.0 m -139.42 121.85 16.11 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 101.921 -3.363 . . . . 0.0 101.921 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -96.93 151.61 19.88 Favored Glycine 0 N--CA 1.498 2.824 0 C-N-CA 119.127 -1.511 . . . . 0.0 109.457 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 36.6 ttp . . . . . 0 N--CA 1.487 1.4 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 179.868 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 52.9 t80 . . . . . 0 N--CA 1.494 1.749 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.41 ' NZ ' ' CB ' ' A' ' 47' ' ' LYS . 9.1 mtmp? -143.08 125.29 15.45 Favored 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 118.745 -0.645 . . . . 0.0 111.695 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -137.53 171.94 13.71 Favored 'General case' 0 N--CA 1.515 2.795 0 CA-C-N 119.812 1.187 . . . . 0.0 114.158 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.5 ' SD ' ' O ' ' A' ' 20' ' ' GLN . 45.6 tpp -109.11 140.74 42.27 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 114.954 1.464 . . . . 0.0 114.954 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.8 tp -91.01 122.38 33.62 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 114.249 -1.341 . . . . 0.0 110.196 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.03 18.67 13.12 Favored Glycine 0 N--CA 1.5 2.9 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -122.57 -20.57 5.96 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-N 114.732 -0.734 . . . . 0.0 109.313 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.669 HE22 ' NH1' ' A' ' 57' ' ' ARG . 9.6 mm100 54.48 67.84 0.95 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -109.76 -35.3 6.22 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.3 m -106.15 156.47 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.4 pt -50.98 174.96 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 118.368 -1.333 . . . . 0.0 110.548 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.669 ' NH1' HE22 ' A' ' 53' ' ' GLN . 4.2 tpp180 -68.71 -64.93 0.77 Allowed 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.061 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -28.95 -35.03 0.01 OUTLIER Glycine 0 N--CA 1.498 2.817 0 O-C-N 124.722 1.264 . . . . 0.0 112.308 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.531 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.5 OUTLIER -76.68 -70.57 0.45 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 179.858 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -33.49 -55.81 0.43 Allowed 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 113.723 -1.58 . . . . 0.0 109.992 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -70.16 -53.8 15.65 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 113.431 -1.713 . . . . 0.0 107.353 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -56.24 -75.81 0.23 Allowed Glycine 0 N--CA 1.48 1.574 0 C-N-CA 119.558 -1.306 . . . . 0.0 111.544 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 59' ' ' TRP . 41.2 t -38.37 -48.98 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 C-N-CA 120.332 -0.547 . . . . 0.0 112.243 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.467 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -46.86 -59.93 2.75 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 124.198 1.951 . . . . 0.0 110.584 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -51.27 -9.18 0.06 Allowed 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 109.37 -3.559 . . . . 0.0 109.719 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.467 ' H ' ' C ' ' A' ' 64' ' ' ALA . 90.3 mtp -98.23 154.94 17.43 Favored 'General case' 0 N--CA 1.512 2.646 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 84.8 p -116.39 151.13 36.59 Favored 'General case' 0 N--CA 1.507 2.424 0 CA-C-O 122.691 1.234 . . . . 0.0 113.75 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 95.5 t -44.93 98.14 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-N 112.499 -2.137 . . . . 0.0 114.385 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.02 11.9 15.23 Favored Glycine 0 N--CA 1.498 2.796 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -109.99 151.73 26.77 Favored 'General case' 0 N--CA 1.508 2.441 0 CA-C-O 122.215 1.007 . . . . 0.0 111.012 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -132.21 141.98 49.26 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 113.459 -1.7 . . . . 0.0 107.815 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -149.53 179.68 7.78 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 112.979 -1.918 . . . . 0.0 116.143 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -127.1 105.8 8.83 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 102.678 -3.082 . . . . 0.0 102.678 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.9 mt -101.66 153.86 19.39 Favored 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 121.315 0.579 . . . . 0.0 109.587 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 87.3 m -125.46 126.5 45.03 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 31.8 mt -115.64 141.4 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.5 p -110.31 152.32 43.17 Favored Pre-proline 0 N--CA 1.498 1.948 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -40.78 -54.9 2.21 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 121.738 1.625 . . . . 0.0 112.513 -172.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 18.8 p30 -37.35 -35.96 0.13 Allowed 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.39 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 . . . . . 0 N--CA 1.494 1.726 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.185 -179.692 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 27.2 m . . . . . 0 N--CA 1.498 1.964 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 34.2 mt -118.33 156.56 28.7 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 58.9 t -137.15 130.11 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -123.29 155.91 36.31 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 122.058 0.932 . . . . 0.0 111.208 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -126.81 90.0 3.09 Favored 'General case' 0 N--CA 1.493 1.704 1 N-CA-C 98.977 -4.453 . . . . 0.0 98.977 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 13.1 t -104.55 150.84 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.594 0 N-CA-C 116.73 2.122 . . . . 0.0 116.73 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -128.39 98.08 4.94 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 112.595 -2.093 . . . . 0.0 106.838 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 49.1 tp -73.01 117.2 14.45 Favored 'General case' 0 N--CA 1.503 2.192 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.5 mt -83.92 -57.55 3.15 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 114.296 -1.32 . . . . 0.0 113.784 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.438 ' HG2' ' H ' ' A' ' 106' ' ' LEU . 16.2 ttpp -168.91 -171.41 1.34 Allowed 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.271 -0.972 . . . . 0.0 108.733 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.438 ' H ' ' HG2' ' A' ' 105' ' ' LYS . 22.9 mt -116.6 157.5 25.22 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 . . . . . 0 N--CA 1.506 2.328 0 CA-C-O 116.176 -1.869 . . . . 0.0 110.172 179.912 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 N--CA 1.502 2.139 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -120.86 155.38 34.25 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 43.4 t -126.08 122.44 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.478 ' N ' ' CD ' ' A' ' 5' ' ' GLU . 8.9 mp0 -120.4 93.48 4.06 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 96.4 m -69.71 156.36 39.1 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 118.675 -1.21 . . . . 0.0 112.079 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 70.3 mt -121.95 -55.13 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-N 113.882 -1.508 . . . . 0.0 107.484 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.43 ' O ' ' O ' ' A' ' 9' ' ' PRO . 33.1 t -123.74 82.78 54.49 Favored Pre-proline 0 N--CA 1.506 2.329 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.382 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.43 ' O ' ' O ' ' A' ' 8' ' ' SER . 3.9 Cg_exo -35.84 164.39 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.689 2.26 . . . . 0.0 113.606 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -113.78 -176.43 19.22 Favored Glycine 0 N--CA 1.499 2.894 0 N-CA-C 105.797 -2.921 . . . . 0.0 105.797 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.475 ' CG ' ' H ' ' A' ' 12' ' ' GLY . 11.2 p-10 -43.85 -59.03 2.44 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 118.352 1.076 . . . . 0.0 111.586 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.475 ' H ' ' CG ' ' A' ' 11' ' ' ASP . . . 109.18 25.81 5.43 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 107.737 -2.145 . . . . 0.0 107.737 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.5 mmm180 -132.42 -36.68 1.1 Allowed 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 114.671 -0.764 . . . . 0.0 111.415 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 45.6 m -111.31 128.84 56.08 Favored 'General case' 0 N--CA 1.507 2.379 0 CA-C-O 121.584 0.707 . . . . 0.0 112.687 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.413 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 37.6 m-85 -129.95 171.6 8.63 Favored Pre-proline 0 N--CA 1.497 1.92 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_exo -53.24 145.75 42.73 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 CA-C-N 119.588 0.888 . . . . 0.0 112.244 166.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -122.83 168.39 12.33 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 122.458 1.123 . . . . 0.0 111.175 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 42.9 mtp-105 -81.18 93.72 6.53 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 113.639 -1.619 . . . . 0.0 111.687 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.76 3.49 5.94 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 108.637 -1.785 . . . . 0.0 108.637 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -117.91 173.97 6.46 Favored 'General case' 0 N--CA 1.505 2.322 0 C-N-CA 120.254 -0.578 . . . . 0.0 109.567 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.7 m -110.0 164.8 12.27 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 31.6 m -117.22 128.38 55.04 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 33.3 t -108.5 111.48 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 101.106 -3.664 . . . . 0.0 101.106 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.402 HG21 ' CH2' ' A' ' 59' ' ' TRP . 5.1 m -125.88 155.06 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 125.007 1.442 . . . . 0.0 114.127 -179.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -129.87 107.88 9.72 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 104.512 -2.403 . . . . 0.0 104.512 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -130.48 175.29 9.1 Favored 'General case' 0 N--CA 1.503 2.2 0 CA-C-O 122.923 1.344 . . . . 0.0 114.458 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 93.7 m -138.17 121.8 17.42 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 102.292 -3.225 . . . . 0.0 102.292 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -111.2 138.1 14.74 Favored Glycine 0 N--CA 1.503 3.124 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 21.9 tpp . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 -179.871 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 68.8 t80 . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 120.713 0.292 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -130.36 117.81 20.31 Favored 'General case' 0 N--CA 1.509 2.499 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -136.23 170.77 15.48 Favored 'General case' 0 N--CA 1.51 2.54 0 C-N-CA 119.732 -0.787 . . . . 0.0 112.313 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 40.3 ttm -118.64 154.96 31.82 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.2 tp -91.03 120.88 32.37 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.889 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.42 34.21 5.38 Favored Glycine 0 N--CA 1.499 2.864 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.049 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.484 ' O ' ' CB ' ' A' ' 53' ' ' GLN . 23.0 ttmm -129.93 -51.01 1.13 Allowed 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.484 ' CB ' ' O ' ' A' ' 52' ' ' LYS . 37.3 tt0 100.9 67.74 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.161 0 O-C-N 125.837 1.961 . . . . 0.0 109.592 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -110.24 -35.94 5.95 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.1 m -116.73 159.06 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.854 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.409 ' H ' HG12 ' A' ' 56' ' ' ILE . 13.4 pt -56.51 179.97 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.527 ' O ' ' N ' ' A' ' 59' ' ' TRP . 34.8 ttt180 -74.48 -61.21 1.95 Allowed 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.92 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 57' ' ' ARG . . . -25.61 -39.32 0.01 OUTLIER Glycine 0 N--CA 1.501 2.988 0 O-C-N 124.986 1.428 . . . . 0.0 112.489 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.53 ' O ' ' N ' ' A' ' 63' ' ' VAL . 0.7 OUTLIER -73.26 -73.62 0.2 Allowed 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 179.721 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.484 ' OE1' ' N ' ' A' ' 61' ' ' GLU . 10.4 tm-20 -26.62 -55.7 0.08 Allowed 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 112.934 -1.939 . . . . 0.0 110.707 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.484 ' N ' ' OE1' ' A' ' 60' ' ' GLU . 50.3 tp10 -73.98 -54.96 6.76 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 112.927 -1.942 . . . . 0.0 106.23 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -52.16 -75.55 0.22 Allowed Glycine 0 N--CA 1.482 1.705 0 C-N-CA 119.617 -1.278 . . . . 0.0 110.961 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.53 ' N ' ' O ' ' A' ' 59' ' ' TRP . 30.8 t -40.92 -49.12 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 119.973 -0.691 . . . . 0.0 112.093 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.458 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -46.9 -59.01 3.37 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 124.012 1.863 . . . . 0.0 110.928 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -52.0 -8.04 0.06 Allowed 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 109.517 -3.492 . . . . 0.0 109.836 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.458 ' H ' ' C ' ' A' ' 64' ' ' ALA . 93.8 mtp -102.09 155.21 18.33 Favored 'General case' 0 N--CA 1.516 2.827 0 C-N-CA 119.036 -1.066 . . . . 0.0 108.242 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 90.4 p -114.94 150.11 36.24 Favored 'General case' 0 N--CA 1.511 2.582 0 CA-C-O 122.605 1.193 . . . . 0.0 113.211 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 87.2 t -43.84 96.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 112.594 -2.094 . . . . 0.0 113.246 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 113.06 11.89 13.12 Favored Glycine 0 N--CA 1.499 2.87 0 N-CA-C 108.735 -1.746 . . . . 0.0 108.735 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -103.66 143.93 32.12 Favored 'General case' 0 N--CA 1.503 2.209 0 C-N-CA 120.189 -0.605 . . . . 0.0 110.159 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 25.3 ttt85 -125.57 140.77 52.47 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -148.73 177.32 9.62 Favored 'General case' 0 N--CA 1.503 2.18 0 CA-C-N 113.046 -1.888 . . . . 0.0 116.048 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.45 ' CE ' ' OD1' ' A' ' 100' ' ' ASP . 4.6 tppp? -127.13 107.14 9.76 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 101.568 -3.493 . . . . 0.0 101.568 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.4 mt -103.58 152.85 21.25 Favored 'General case' 0 N--CA 1.503 2.207 0 C-N-CA 119.822 -0.751 . . . . 0.0 109.365 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 86.3 m -124.54 118.32 26.32 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 31.1 mt -111.76 141.92 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.425 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 41.7 p -107.78 156.68 37.64 Favored Pre-proline 0 N--CA 1.507 2.391 0 O-C-N 124.796 1.31 . . . . 0.0 109.373 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -36.18 -54.24 0.89 Allowed 'Trans proline' 0 C--N 1.316 -1.165 0 C-N-CA 121.986 1.791 . . . . 0.0 113.744 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 80' ' ' TYR . 1.7 p30 -45.36 -41.85 9.41 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.523 ' OH ' ' NH1' ' A' ' 57' ' ' ARG . 2.6 m-85 . . . . . 0 N--CA 1.493 1.695 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.304 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 58.0 m . . . . . 0 N--CA 1.503 2.198 0 CA-C-O 118.13 -0.938 . . . . 0.0 110.566 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 13.9 mt -107.36 157.05 18.26 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 120.514 1.506 . . . . 0.0 107.042 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.3 t -139.75 115.69 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -110.28 159.45 17.4 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 122.417 1.103 . . . . 0.0 110.241 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.45 ' OD1' ' CE ' ' A' ' 73' ' ' LYS . 54.9 m-20 -127.66 89.11 2.89 Favored 'General case' 0 N--CA 1.493 1.7 1 N-CA-C 98.575 -4.602 . . . . 0.0 98.575 179.314 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 12.2 t -103.1 148.83 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.699 0 N-CA-C 116.777 2.14 . . . . 0.0 116.777 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -127.92 96.75 4.58 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 112.701 -2.045 . . . . 0.0 107.419 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 51.6 tp -68.7 121.96 17.56 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.6 mt -89.39 -58.07 2.66 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.894 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.409 ' HG2' ' H ' ' A' ' 106' ' ' LEU . 21.3 ttmm -164.36 178.12 7.73 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.734 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.409 ' H ' ' HG2' ' A' ' 105' ' ' LYS . 17.1 mt -115.1 168.97 9.46 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 . . . . . 0 N--CA 1.514 2.757 0 CA-C-O 115.862 -2.018 . . . . 0.0 107.414 179.604 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.4 p . . . . . 0 N--CA 1.501 2.101 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.525 ' N ' ' OE1' ' A' ' 3' ' ' GLN . 3.3 mp0 -115.52 159.24 21.48 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.8 t -124.66 123.11 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.025 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.47 ' CD ' ' N ' ' A' ' 5' ' ' GLU . 9.3 mp0 -125.42 89.96 3.14 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 88.1 m -69.71 155.25 40.8 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.76 -1.176 . . . . 0.0 113.765 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 57.6 mt -122.45 -53.29 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-N 113.352 -1.749 . . . . 0.0 107.84 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.419 ' O ' ' O ' ' A' ' 9' ' ' PRO . 29.3 m -122.84 80.69 49.54 Favored Pre-proline 0 N--CA 1.506 2.366 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.759 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.419 ' O ' ' O ' ' A' ' 8' ' ' SER . 12.6 Cg_exo -38.2 164.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.37 2.047 . . . . 0.0 112.262 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -120.38 -178.76 16.23 Favored Glycine 0 N--CA 1.5 2.945 0 N-CA-C 105.322 -3.111 . . . . 0.0 105.322 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.431 ' CG ' ' H ' ' A' ' 12' ' ' GLY . 13.1 p-10 -45.76 -58.08 3.76 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 118.404 1.102 . . . . 0.0 111.075 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.431 ' H ' ' CG ' ' A' ' 11' ' ' ASP . . . 108.62 6.88 30.48 Favored Glycine 0 N--CA 1.498 2.814 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -110.81 -31.14 7.28 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 114.584 -0.808 . . . . 0.0 111.685 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 96.8 m -112.03 134.13 53.77 Favored 'General case' 0 N--CA 1.504 2.242 0 CA-C-N 118.876 0.762 . . . . 0.0 113.0 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.451 ' N ' ' CD1' ' A' ' 15' ' ' PHE . 57.3 m-85 -131.31 177.24 2.33 Favored Pre-proline 0 N--CA 1.5 2.029 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -72.09 145.29 44.13 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 C-N-CA 120.729 0.953 . . . . 0.0 110.391 161.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -121.58 168.63 11.53 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-O 121.786 0.803 . . . . 0.0 109.236 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.3 130.15 41.8 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.565 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 109.67 -22.69 23.58 Favored Glycine 0 N--CA 1.499 2.838 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.334 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -105.71 178.42 4.57 Favored 'General case' 0 N--CA 1.506 2.371 0 CA-C-O 121.981 0.896 . . . . 0.0 111.747 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.1 m -113.26 161.46 17.17 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 64.5 m -112.48 148.0 35.35 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.9 t -121.91 104.94 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 103.296 -2.853 . . . . 0.0 103.296 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 m -121.69 149.81 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.347 0 N-CA-C 116.217 1.932 . . . . 0.0 116.217 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -128.49 117.5 21.43 Favored 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 104.429 -2.434 . . . . 0.0 104.429 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -134.3 174.09 10.9 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 123.072 1.415 . . . . 0.0 114.801 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 81.3 m -138.92 122.04 16.85 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 102.335 -3.209 . . . . 0.0 102.335 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -112.57 140.45 16.27 Favored Glycine 0 N--CA 1.503 3.165 0 C-N-CA 120.174 -1.012 . . . . 0.0 112.337 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 57.2 mtm . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 179.973 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 71.4 t80 . . . . . 0 N--CA 1.489 1.481 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 72.0 mttt -142.45 133.95 26.53 Favored 'General case' 0 N--CA 1.515 2.801 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -144.46 173.4 11.83 Favored 'General case' 0 N--CA 1.515 2.777 0 CA-C-N 119.265 0.939 . . . . 0.0 112.766 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 44.5 ttm -116.47 148.97 40.25 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.3 tp -90.99 120.26 31.84 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 114.365 -1.288 . . . . 0.0 109.23 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.35 18.56 18.77 Favored Glycine 0 N--CA 1.499 2.875 0 N-CA-C 107.757 -2.137 . . . . 0.0 107.757 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -121.06 -19.98 6.98 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 114.383 -0.908 . . . . 0.0 109.387 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 55.9 69.02 0.78 Allowed 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.396 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -110.03 -35.86 6.02 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.431 ' O ' ' O ' ' A' ' 56' ' ' ILE . 4.2 m -113.99 152.69 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.176 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.431 ' O ' ' O ' ' A' ' 55' ' ' VAL . 13.3 pt -49.46 179.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.857 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.559 ' O ' ' N ' ' A' ' 59' ' ' TRP . 19.5 ttm180 -75.94 -58.96 2.97 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -34.12 -27.2 0.01 OUTLIER Glycine 0 N--CA 1.494 2.538 0 O-C-N 123.944 0.777 . . . . 0.0 111.925 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.559 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -91.33 -73.98 0.52 Allowed 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.874 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -36.98 -50.48 0.88 Allowed 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 114.333 -1.303 . . . . 0.0 110.228 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.417 ' OE1' ' O ' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -71.99 -57.7 4.07 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 104.818 -2.29 . . . . 0.0 104.818 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -50.95 -82.2 0.04 OUTLIER Glycine 0 N--CA 1.48 1.57 0 C-N-CA 119.011 -1.566 . . . . 0.0 109.7 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.533 ' N ' ' O ' ' A' ' 59' ' ' TRP . 62.1 t -29.95 -48.01 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.476 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -44.89 -60.2 2.17 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 124.349 2.023 . . . . 0.0 110.672 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -47.86 -12.06 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 109.027 -3.715 . . . . 0.0 109.548 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.476 ' H ' ' C ' ' A' ' 64' ' ' ALA . 33.4 mmt -89.92 158.51 17.38 Favored 'General case' 0 N--CA 1.508 2.433 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 86.1 p -122.19 136.12 54.86 Favored 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 121.64 0.733 . . . . 0.0 110.077 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.3 t -35.42 97.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-N 114.303 -1.317 . . . . 0.0 113.405 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.73 5.77 13.6 Favored Glycine 0 N--CA 1.5 2.906 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -107.02 149.23 27.78 Favored 'General case' 0 N--CA 1.508 2.457 0 CA-C-O 122.163 0.982 . . . . 0.0 110.291 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.0 ttp180 -133.61 143.4 48.61 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 113.621 -1.627 . . . . 0.0 107.365 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -153.22 179.22 8.93 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 113.312 -1.767 . . . . 0.0 115.066 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -124.75 104.01 8.41 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 103.364 -2.828 . . . . 0.0 103.364 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.2 mt -100.21 145.45 28.04 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.3 m -113.32 123.27 49.72 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 104.628 -2.36 . . . . 0.0 104.628 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 33.9 mt -112.6 131.13 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.491 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 61.6 p -104.71 154.31 38.62 Favored Pre-proline 0 N--CA 1.5 2.068 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -36.53 -54.08 0.99 Allowed 'Trans proline' 0 C--N 1.314 -1.261 0 C-N-CA 122.113 1.875 . . . . 0.0 113.663 -173.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.527 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 6.5 p-10 -42.2 -36.16 1.13 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 . . . . . 0 N--CA 1.5 2.065 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -179.66 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 84.5 m . . . . . 0 N--CA 1.5 2.026 0 CA-C-O 118.889 -0.577 . . . . 0.0 111.369 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 21.4 mt -107.57 144.61 34.34 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 49.9 t -132.39 119.65 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -111.85 163.87 13.71 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 122.513 1.149 . . . . 0.0 108.942 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -129.28 89.94 2.93 Favored 'General case' 0 C--N 1.301 -1.523 1 N-CA-C 97.383 -5.043 . . . . 0.0 97.383 179.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 12.3 t -103.89 151.17 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.447 0 N-CA-C 114.671 1.359 . . . . 0.0 114.671 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -125.82 103.05 7.59 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 112.007 -2.361 . . . . 0.0 108.122 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 43.6 tp -75.21 118.55 18.26 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 102.66 -3.089 . . . . 0.0 102.66 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.5 mt -85.35 -56.53 3.48 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 113.828 -1.533 . . . . 0.0 112.297 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.409 ' HB2' ' HZ1' ' A' ' 105' ' ' LYS . 0.1 OUTLIER -172.43 -168.34 0.52 Allowed 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.047 -1.061 . . . . 0.0 111.22 -179.865 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 22.2 mt -115.77 156.28 26.3 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 . . . . . 0 N--CA 1.505 2.277 0 CA-C-O 116.233 -1.842 . . . . 0.0 109.844 179.865 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 N--CA 1.503 2.216 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -123.47 153.57 40.31 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 97.0 t -129.51 102.15 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -99.73 161.32 13.69 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 102.854 -3.017 . . . . 0.0 102.854 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 72.8 m -121.31 156.38 32.68 Favored 'General case' 0 N--CA 1.504 2.253 0 CA-C-O 121.987 0.899 . . . . 0.0 112.301 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 74.8 mt -124.72 -54.17 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 9' ' ' PRO . 28.2 t -124.99 83.18 60.48 Favored Pre-proline 0 N--CA 1.508 2.459 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.052 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 8' ' ' SER . 13.5 Cg_exo -37.28 160.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.155 1.903 . . . . 0.0 111.612 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.25 -171.75 14.28 Favored Glycine 0 N--CA 1.503 3.142 0 N-CA-C 107.496 -2.241 . . . . 0.0 107.496 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 12' ' ' GLY . 1.3 p30 -39.61 -51.64 2.24 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.817 -0.753 . . . . 0.0 112.508 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.51 ' N ' ' OD1' ' A' ' 11' ' ' ASP . . . 97.43 2.88 58.77 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 108.126 -1.99 . . . . 0.0 108.126 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 34.6 mtm-85 -119.8 -36.02 3.39 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.8 m -106.99 134.3 50.34 Favored 'General case' 0 N--CA 1.506 2.345 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 33.0 m-85 -130.61 175.14 3.89 Favored Pre-proline 0 N--CA 1.495 1.816 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -66.43 155.13 71.55 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 CA-C-N 119.82 0.971 . . . . 0.0 110.006 165.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -121.7 172.83 7.85 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-O 121.893 0.854 . . . . 0.0 109.635 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.425 HH11 ' CB ' ' A' ' 18' ' ' ARG . 44.3 mtm105 -77.99 96.27 5.02 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.673 -1.148 . . . . 0.0 109.92 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.71 12.55 3.66 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.194 -1.563 . . . . 0.0 109.194 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.494 ' O ' ' SD ' ' A' ' 49' ' ' MET . 15.8 mm100 -113.85 167.88 10.26 Favored 'General case' 0 N--CA 1.504 2.245 0 CA-C-O 121.893 0.854 . . . . 0.0 109.236 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 97.1 m -118.6 114.32 22.6 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 114.226 -1.352 . . . . 0.0 107.551 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 56.9 m -74.67 146.15 42.58 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 118.871 -1.132 . . . . 0.0 108.606 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 94.7 t -117.69 99.67 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 101.311 -3.589 . . . . 0.0 101.311 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.8 m -121.21 148.26 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 N-CA-C 114.946 1.462 . . . . 0.0 114.946 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -122.24 143.73 49.41 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 102.948 -2.982 . . . . 0.0 102.948 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -157.97 175.53 13.72 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 118.895 -1.122 . . . . 0.0 112.931 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 93.7 m -135.12 126.36 28.19 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 101.375 -3.565 . . . . 0.0 101.375 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.86 127.79 8.74 Favored Glycine 0 N--CA 1.502 3.065 0 C-N-CA 120.04 -1.076 . . . . 0.0 111.963 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 68.5 mtp . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.915 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 44.0 t80 . . . . . 0 N--CA 1.495 1.818 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -143.06 122.88 13.42 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.487 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -135.4 171.55 14.28 Favored 'General case' 0 N--CA 1.512 2.627 0 CA-C-N 119.457 1.026 . . . . 0.0 112.466 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.494 ' SD ' ' O ' ' A' ' 20' ' ' GLN . 44.3 tpp -111.53 144.53 40.61 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 114.867 -1.06 . . . . 0.0 112.212 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.4 tp -90.8 121.43 32.66 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.601 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 117.27 -19.0 11.93 Favored Glycine 0 N--CA 1.501 2.967 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.888 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.429 ' O ' ' OE1' ' A' ' 54' ' ' GLU . 41.6 tptt -112.8 36.48 3.45 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.404 ' C ' ' O ' ' A' ' 52' ' ' LYS . 39.1 tt0 10.23 71.23 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 O-C-N 125.345 1.653 . . . . 0.0 113.664 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.429 ' OE1' ' O ' ' A' ' 52' ' ' LYS . 5.0 mm-40 -92.8 -24.06 18.65 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 113.408 -1.724 . . . . 0.0 106.828 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.1 m -115.92 -177.26 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 16.5 pt -90.27 169.94 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.193 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.549 ' O ' ' N ' ' A' ' 59' ' ' TRP . 19.4 ttm-85 -55.11 -63.18 1.24 Allowed 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.334 -0.947 . . . . 0.0 110.702 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -27.13 -35.31 0.01 OUTLIER Glycine 0 N--CA 1.496 2.694 0 O-C-N 124.933 1.396 . . . . 0.0 111.977 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.549 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.9 OUTLIER -86.76 -71.35 0.56 Allowed 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 114.058 -1.071 . . . . 0.0 108.646 179.856 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.422 ' OE1' ' O ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -28.53 -57.73 0.13 Allowed 'General case' 0 N--CA 1.504 2.255 0 O-C-N 125.066 1.478 . . . . 0.0 110.325 -179.867 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -73.25 -52.58 13.5 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -49.31 -79.9 0.07 OUTLIER Glycine 0 N--CA 1.477 1.375 0 C-N-CA 119.419 -1.372 . . . . 0.0 110.96 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.522 ' N ' ' O ' ' A' ' 59' ' ' TRP . 35.6 t -39.45 -47.71 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 120.226 -0.589 . . . . 0.0 112.358 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.476 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -45.3 -60.11 2.31 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 124.146 1.927 . . . . 0.0 111.094 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -48.51 -11.2 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 109.386 -3.552 . . . . 0.0 109.661 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.476 ' H ' ' C ' ' A' ' 64' ' ' ALA . 86.0 mtp -97.94 156.47 16.6 Favored 'General case' 0 N--CA 1.513 2.704 0 C-N-CA 118.854 -1.138 . . . . 0.0 108.606 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 79.8 p -118.64 149.13 41.91 Favored 'General case' 0 N--CA 1.508 2.443 0 CA-C-O 122.539 1.162 . . . . 0.0 112.8 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 99.5 t -43.52 97.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-N 112.801 -1.999 . . . . 0.0 114.716 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.36 12.92 16.14 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -108.03 145.05 34.51 Favored 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.106 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 25.7 ttt85 -123.79 135.1 53.59 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 105.464 -2.051 . . . . 0.0 105.464 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -136.82 172.61 12.75 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 112.026 -2.352 . . . . 0.0 116.142 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -129.58 103.77 7.06 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 111.069 -2.787 . . . . 0.0 103.917 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.421 HD12 ' N ' ' A' ' 74' ' ' LEU . 5.0 mp -100.69 149.47 23.75 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.889 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.6 m -121.09 104.51 9.83 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 21.3 mt -99.81 137.25 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.412 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 29.5 p -115.54 156.34 46.16 Favored Pre-proline 0 N--CA 1.501 2.123 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -35.97 -52.07 1.03 Allowed 'Trans proline' 0 C--N 1.314 -1.266 0 C-N-CA 121.937 1.758 . . . . 0.0 113.971 -175.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.412 ' OD1' ' OG ' ' A' ' 77' ' ' SER . 1.3 p30 -37.62 -38.64 0.28 Allowed 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 121.456 0.646 . . . . 0.0 112.301 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 . . . . . 0 N--CA 1.493 1.683 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.428 -179.812 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 91.2 m . . . . . 0 N--CA 1.5 2.066 0 CA-C-O 119.353 -0.355 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 18.4 mt -89.76 146.97 24.11 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 55.1 t -131.78 109.71 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -103.26 156.43 17.72 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 122.135 0.969 . . . . 0.0 109.211 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -127.07 93.68 3.82 Favored 'General case' 0 N--CA 1.493 1.679 1 N-CA-C 97.897 -4.853 . . . . 0.0 97.897 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.403 HG12 ' N ' ' A' ' 102' ' ' GLU . 11.4 t -108.38 154.89 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.434 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.403 ' N ' HG12 ' A' ' 101' ' ' VAL . 38.7 tt0 -128.74 102.36 6.53 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 111.612 -2.54 . . . . 0.0 107.741 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 37.0 tp -72.24 125.63 27.81 Favored 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 103.065 -2.939 . . . . 0.0 103.065 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 16.5 mt -96.25 -55.4 2.96 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.406 ' HG2' ' H ' ' A' ' 106' ' ' LEU . 56.0 tttp -166.09 177.3 7.07 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.071 -1.052 . . . . 0.0 111.474 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.406 ' H ' ' HG2' ' A' ' 105' ' ' LYS . 24.4 mt -114.55 150.94 34.18 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 . . . . . 0 N--CA 1.505 2.299 0 CA-C-O 116.17 -1.871 . . . . 0.0 109.996 179.731 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.8 p . . . . . 0 N--CA 1.504 2.229 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.504 HE21 ' CG ' ' A' ' 5' ' ' GLU . 41.2 tt0 -121.26 157.77 29.57 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.5 t -122.65 115.42 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.504 ' CG ' HE21 ' A' ' 3' ' ' GLN . 94.4 mt-10 -117.11 94.69 4.67 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 69.0 m -69.92 155.88 39.91 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 114.806 1.409 . . . . 0.0 114.806 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 72.2 mt -122.57 -55.48 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 CA-C-N 113.031 -1.895 . . . . 0.0 107.387 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.423 ' O ' ' O ' ' A' ' 9' ' ' PRO . 34.7 t -121.99 81.96 43.27 Favored Pre-proline 0 N--CA 1.505 2.292 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.576 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 8' ' ' SER . 12.2 Cg_exo -38.4 164.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.165 1.91 . . . . 0.0 111.868 178.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.67 -172.39 15.02 Favored Glycine 0 N--CA 1.498 2.803 0 N-CA-C 104.916 -3.274 . . . . 0.0 104.916 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 11' ' ' ASP . 12.9 p-10 -39.72 -58.56 1.31 Allowed 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.434 -0.907 . . . . 0.0 112.8 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.32 23.27 9.11 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 105.081 -3.208 . . . . 0.0 105.081 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.02 -40.73 1.48 Allowed 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 113.757 -1.222 . . . . 0.0 111.545 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.4 m -108.62 136.46 48.19 Favored 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.454 ' N ' ' CD1' ' A' ' 15' ' ' PHE . 66.0 m-85 -131.65 176.75 2.65 Favored Pre-proline 0 N--CA 1.494 1.765 0 N-CA-C 105.195 -2.15 . . . . 0.0 105.195 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -70.7 149.18 60.5 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 CA-C-N 119.485 0.852 . . . . 0.0 111.194 164.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -121.78 173.38 7.51 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 122.289 1.043 . . . . 0.0 110.41 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.1 ttm180 -77.69 98.34 5.44 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 113.912 -1.494 . . . . 0.0 109.556 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.13 9.63 4.56 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -113.89 171.76 7.4 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 76.8 m -124.42 112.63 17.15 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.732 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.443 ' N ' ' O ' ' A' ' 48' ' ' PHE . 36.5 m -72.11 147.66 46.48 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.752 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.2 t -116.78 114.11 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 101.389 -3.56 . . . . 0.0 101.389 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.416 HG21 ' CZ3' ' A' ' 59' ' ' TRP . 1.0 OUTLIER -126.65 150.16 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.04 0 N-CA-C 119.404 3.112 . . . . 0.0 119.404 -178.798 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -133.48 142.85 48.46 Favored 'General case' 0 N--CA 1.506 2.33 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.468 ' CD1' ' N ' ' A' ' 26' ' ' TYR . 39.2 p90 -160.53 -179.38 7.6 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 118.474 -1.291 . . . . 0.0 113.53 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 91.5 m -140.73 122.84 15.67 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 101.657 -3.46 . . . . 0.0 101.657 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -102.26 147.69 17.34 Favored Glycine 0 N--CA 1.504 3.198 0 C-N-CA 119.999 -1.096 . . . . 0.0 110.377 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 13.4 tpp . . . . . 0 N--CA 1.496 1.832 0 C-N-CA 120.069 -0.652 . . . . 0.0 110.181 -179.84 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . 0.255 0.7 OUTLIER . . . . . 0 N--CA 1.495 1.786 0 CA-C-O 121.591 0.71 . . . . 0.0 109.954 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -134.98 123.96 24.13 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 113.5 -1.682 . . . . 0.0 107.259 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.443 ' O ' ' N ' ' A' ' 22' ' ' CYS . 22.1 p90 -135.41 -178.01 4.92 Favored 'General case' 0 N--CA 1.515 2.814 0 CA-C-N 120.579 1.536 . . . . 0.0 114.696 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 42.9 ttm -116.69 144.25 44.65 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-N 115.199 -0.909 . . . . 0.0 113.024 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.3 tp -90.89 120.98 32.35 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.626 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.82 -11.48 49.48 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.468 ' O ' ' N ' ' A' ' 54' ' ' GLU . 25.6 tptp -112.44 38.58 2.7 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.407 ' C ' ' O ' ' A' ' 52' ' ' LYS . 47.5 tt0 0.86 66.18 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 O-C-N 125.653 1.846 . . . . 0.0 112.958 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' A' ' 52' ' ' LYS . 39.2 tt0 -96.28 -26.08 15.54 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 112.731 -2.031 . . . . 0.0 107.199 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.437 ' O ' ' O ' ' A' ' 56' ' ' ILE . 4.9 m -124.32 152.54 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.465 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.174 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 55' ' ' VAL . 4.9 pt -45.89 177.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.408 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.54 ' O ' ' N ' ' A' ' 59' ' ' TRP . 30.5 ttp180 -79.25 -57.53 3.67 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-O 118.337 -0.84 . . . . 0.0 112.715 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -30.58 -32.73 0.01 OUTLIER Glycine 0 N--CA 1.503 3.11 0 CA-C-O 122.664 1.147 . . . . 0.0 111.427 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.54 ' N ' ' O ' ' A' ' 57' ' ' ARG . 2.4 m0 -90.06 -73.5 0.52 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 113.629 -1.286 . . . . 0.0 107.853 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -31.86 -54.61 0.28 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 124.792 1.308 . . . . 0.0 110.768 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -73.15 -51.64 17.12 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 113.977 -1.465 . . . . 0.0 107.614 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 65' ' ' GLN . . . -55.69 -82.44 0.05 OUTLIER Glycine 0 N--CA 1.479 1.54 0 N-CA-C 108.16 -1.976 . . . . 0.0 108.16 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' A' ' 59' ' ' TRP . 66.1 t -30.38 -45.1 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.414 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -51.11 -49.29 61.02 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 123.692 1.711 . . . . 0.0 109.569 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.481 ' N ' ' O ' ' A' ' 62' ' ' GLY . 6.0 tt0 -66.01 3.29 0.87 Allowed 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 110.202 -3.181 . . . . 0.0 110.892 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.414 ' H ' ' C ' ' A' ' 64' ' ' ALA . 48.4 ttm -109.51 156.19 20.42 Favored 'General case' 0 N--CA 1.51 2.531 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 99.7 p -115.32 151.41 34.64 Favored 'General case' 0 N--CA 1.509 2.502 0 CA-C-O 122.545 1.164 . . . . 0.0 112.694 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 95.5 t -46.34 99.51 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-N 112.804 -1.998 . . . . 0.0 114.581 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.66 3.69 28.59 Favored Glycine 0 N--CA 1.502 3.076 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -101.83 149.13 24.5 Favored 'General case' 0 N--CA 1.506 2.328 0 CA-C-O 121.988 0.899 . . . . 0.0 111.03 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.8 ttt85 -127.14 143.2 51.32 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 113.786 -1.552 . . . . 0.0 106.961 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -151.72 175.99 11.85 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 113.401 -1.727 . . . . 0.0 113.958 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.5 ttmp? -119.67 102.8 8.87 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 103.45 -2.796 . . . . 0.0 103.45 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.2 mt -96.26 149.69 21.39 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 97.1 m -119.47 116.53 26.3 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 104.486 -2.412 . . . . 0.0 104.486 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 53.5 mt -102.45 142.58 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.9 p -101.53 154.36 37.3 Favored Pre-proline 0 N--CA 1.501 2.083 0 O-C-N 124.985 1.428 . . . . 0.0 111.398 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -44.72 -41.89 14.8 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 C-N-CA 122.915 2.41 . . . . 0.0 117.695 -175.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -87.77 20.24 3.11 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 117.908 2.558 . . . . 0.0 117.908 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 . . . . . 0 N--CA 1.501 2.084 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.52 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 28.9 m . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 103.752 -2.684 . . . . 0.0 103.752 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 19.3 mt -106.48 150.19 26.33 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.1 t -132.14 104.32 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -96.89 166.97 11.37 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -127.5 85.92 2.42 Favored 'General case' 0 N--CA 1.491 1.598 1 N-CA-C 94.844 -5.984 . . . . 0.0 94.844 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.1 t -98.59 149.45 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.3 0 CA-C-O 122.759 1.266 . . . . 0.0 114.342 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -126.84 111.45 14.19 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 112.19 -2.277 . . . . 0.0 106.897 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 35.0 tp -79.49 113.72 17.86 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 101.125 -3.657 . . . . 0.0 101.125 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.3 mt -74.19 -57.78 3.73 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 118.684 -1.207 . . . . 0.0 111.49 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.401 ' HG2' ' H ' ' A' ' 106' ' ' LEU . 0.4 OUTLIER -175.32 -172.27 0.56 Allowed 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 118.32 -1.352 . . . . 0.0 109.619 -179.831 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.401 ' H ' ' HG2' ' A' ' 105' ' ' LYS . 16.1 mt -117.89 155.28 30.43 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 . . . . . 0 N--CA 1.512 2.645 0 CA-C-O 116.175 -1.869 . . . . 0.0 109.143 179.443 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.2 p . . . . . 0 N--CA 1.503 2.203 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -121.09 152.64 38.44 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 55.6 t -126.64 112.38 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.531 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.417 ' OE1' ' O ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -113.03 96.04 5.72 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 103.644 -2.725 . . . . 0.0 103.644 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.417 ' O ' ' OE1' ' A' ' 5' ' ' GLU . 87.1 m -69.87 156.58 38.86 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 118.56 -1.256 . . . . 0.0 112.494 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 71.7 mt -121.16 -55.09 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 CA-C-N 113.939 -1.482 . . . . 0.0 107.422 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.423 ' O ' ' O ' ' A' ' 9' ' ' PRO . 36.2 m -124.35 82.42 57.95 Favored Pre-proline 0 N--CA 1.507 2.407 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.742 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 8' ' ' SER . 3.4 Cg_exo -35.93 164.21 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.566 2.177 . . . . 0.0 113.434 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -114.84 -176.91 18.87 Favored Glycine 0 N--CA 1.501 3.023 0 N-CA-C 105.841 -2.903 . . . . 0.0 105.841 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.464 ' CG ' ' H ' ' A' ' 12' ' ' GLY . 11.6 p-10 -42.5 -58.48 2.24 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 118.174 0.987 . . . . 0.0 111.745 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.464 ' H ' ' CG ' ' A' ' 11' ' ' ASP . . . 109.33 24.63 5.85 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 107.738 -2.145 . . . . 0.0 107.738 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.3 mtm180 -133.53 -34.35 1.05 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 114.75 -0.725 . . . . 0.0 112.771 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.4 m -111.51 130.4 55.74 Favored 'General case' 0 N--CA 1.506 2.347 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 26.2 m-85 -130.31 173.35 5.9 Favored Pre-proline 0 N--CA 1.497 1.898 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -67.94 150.28 78.03 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 CA-C-N 119.997 1.035 . . . . 0.0 111.165 167.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -121.62 171.15 9.05 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-O 121.898 0.856 . . . . 0.0 110.911 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.2 ttt-85 -77.51 98.57 5.38 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.491 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.0 10.38 4.32 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -114.97 173.91 6.24 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.1 m -124.7 112.09 16.34 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 20.1 m -69.82 145.8 51.84 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.4 t -118.11 102.84 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 101.268 -3.605 . . . . 0.0 101.268 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.0 m -124.09 153.9 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.443 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 -131.19 116.87 18.25 Favored 'General case' 0 N--CA 1.507 2.405 0 N-CA-C 104.991 -2.226 . . . . 0.0 104.991 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -132.16 177.38 7.61 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 122.997 1.379 . . . . 0.0 114.451 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 87.3 m -136.32 124.4 22.95 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 101.218 -3.623 . . . . 0.0 101.218 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -107.99 116.18 4.73 Favored Glycine 0 N--CA 1.501 3.022 0 C-N-CA 120.337 -0.935 . . . . 0.0 111.415 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 69.2 mtp . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 179.93 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 63.6 t80 . . . . . 0 N--CA 1.497 1.882 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.5 mtmp? -143.61 117.11 9.13 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.875 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -137.14 167.3 21.81 Favored 'General case' 0 N--CA 1.511 2.602 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.638 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.5 ' SD ' ' O ' ' A' ' 50' ' ' LEU . 7.8 tmm? -117.46 144.6 44.87 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.97 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.5 ' O ' ' SD ' ' A' ' 49' ' ' MET . 44.0 tp -90.81 134.52 34.38 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 114.516 -1.22 . . . . 0.0 111.443 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 132.97 -34.42 2.46 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 54' ' ' GLU . 80.3 tttt -122.62 44.39 2.65 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 4.42 58.73 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 126.015 2.072 . . . . 0.0 114.072 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 52' ' ' LYS . 50.4 mt-10 -63.74 -17.58 63.17 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 114.526 -1.215 . . . . 0.0 109.757 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 56' ' ' ILE . 21.1 m -117.6 159.79 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.32 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.425 ' O ' ' O ' ' A' ' 55' ' ' VAL . 16.2 pt -51.55 178.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 C-N-CA 118.64 -1.224 . . . . 0.0 108.534 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.532 ' O ' ' N ' ' A' ' 59' ' ' TRP . 17.6 ttm180 -75.18 -59.14 2.88 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.152 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -28.52 -34.98 0.01 OUTLIER Glycine 0 N--CA 1.497 2.738 0 O-C-N 124.614 1.196 . . . . 0.0 112.26 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.532 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.6 OUTLIER -81.39 -73.61 0.37 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 179.761 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 59' ' ' TRP . 32.4 tt0 -22.4 -57.24 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 O-C-N 125.914 2.009 . . . . 0.0 111.426 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -78.11 -52.21 9.09 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 113.075 -1.875 . . . . 0.0 106.491 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -49.65 -74.17 0.3 Allowed Glycine 0 N--CA 1.48 1.604 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.095 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.499 ' N ' ' O ' ' A' ' 59' ' ' TRP . 25.6 t -44.13 -50.59 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 C-N-CA 119.317 -0.953 . . . . 0.0 111.745 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.469 ' C ' ' N ' ' A' ' 66' ' ' MET . . . -44.19 -62.39 1.17 Allowed 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 123.989 1.852 . . . . 0.0 111.608 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -45.9 -13.98 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 109.429 -3.532 . . . . 0.0 109.3 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.469 ' N ' ' C ' ' A' ' 64' ' ' ALA . 20.2 mtm -98.36 158.23 15.71 Favored 'General case' 0 N--CA 1.514 2.733 0 C-N-CA 118.084 -1.446 . . . . 0.0 108.96 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 84.4 p -117.9 149.43 40.9 Favored 'General case' 0 N--CA 1.508 2.467 0 CA-C-O 122.558 1.17 . . . . 0.0 113.399 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 90.5 t -39.4 96.6 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 112.719 -2.037 . . . . 0.0 114.044 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.13 9.4 20.24 Favored Glycine 0 N--CA 1.5 2.919 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -103.0 141.6 35.52 Favored 'General case' 0 N--CA 1.502 2.168 0 CA-C-O 121.457 0.646 . . . . 0.0 110.355 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 24.7 ttt85 -125.34 141.13 52.25 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -149.65 176.13 10.93 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-N 113.064 -1.88 . . . . 0.0 115.853 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -127.61 105.01 8.19 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 103.851 -2.648 . . . . 0.0 103.851 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.429 HD12 ' N ' ' A' ' 74' ' ' LEU . 4.9 mp -102.47 152.27 21.33 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.591 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 92.0 m -123.73 117.18 24.37 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 22.8 mt -108.63 141.72 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 CA-C-O 121.099 0.476 . . . . 0.0 109.858 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.421 ' O ' ' OD1' ' A' ' 79' ' ' ASP . 33.4 p -114.65 155.34 46.24 Favored Pre-proline 0 N--CA 1.504 2.263 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.429 ' O ' ' N ' ' A' ' 80' ' ' TYR . 10.2 Cg_endo -37.68 -55.65 1.04 Allowed 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.683 1.588 . . . . 0.0 113.961 -175.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 14.7 p30 -34.04 -34.89 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.579 0.704 . . . . 0.0 112.567 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.429 ' N ' ' O ' ' A' ' 78' ' ' PRO . 6.9 m-85 . . . . . 0 N--CA 1.495 1.812 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.644 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 31.2 m . . . . . 0 N--CA 1.494 1.737 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 20.3 mt -110.19 153.33 24.91 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.7 t -138.11 123.59 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -118.86 155.03 31.95 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 122.119 0.961 . . . . 0.0 110.307 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -125.7 89.94 3.12 Favored 'General case' 0 N--CA 1.494 1.76 1 N-CA-C 97.424 -5.028 . . . . 0.0 97.424 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 9.9 t -102.93 151.29 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.483 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -128.59 100.9 5.93 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 111.832 -2.44 . . . . 0.0 108.284 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 45.9 tp -72.75 124.49 25.44 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 104.159 -2.534 . . . . 0.0 104.159 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.1 mt -91.56 -58.32 2.47 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 114.372 -1.285 . . . . 0.0 112.008 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.417 ' HG2' ' H ' ' A' ' 106' ' ' LEU . 29.3 tttm -168.93 -175.4 2.34 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.007 -1.077 . . . . 0.0 110.418 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.417 ' H ' ' HG2' ' A' ' 105' ' ' LYS . 17.9 mt -117.22 154.89 30.36 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 . . . . . 0 N--CA 1.505 2.313 0 CA-C-O 116.056 -1.926 . . . . 0.0 110.817 179.578 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.6 p . . . . . 0 N--CA 1.502 2.145 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -121.96 157.46 31.21 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.6 t -126.64 106.62 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -107.47 88.47 2.74 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 93.4 m -69.7 156.13 39.45 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.004 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.0 mt -122.76 -52.73 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-N 113.681 -1.599 . . . . 0.0 107.025 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.422 ' O ' ' O ' ' A' ' 9' ' ' PRO . 98.2 p -122.75 82.22 48.89 Favored Pre-proline 0 N--CA 1.505 2.302 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.462 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 8' ' ' SER . 7.8 Cg_exo -37.59 167.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.606 2.204 . . . . 0.0 113.234 178.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.16 -171.79 15.03 Favored Glycine 0 N--CA 1.503 3.132 0 N-CA-C 107.17 -2.372 . . . . 0.0 107.17 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 11' ' ' ASP . 13.9 p-10 -39.62 -61.09 0.86 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.576 -0.85 . . . . 0.0 112.897 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.17 17.88 12.08 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 106.126 -2.789 . . . . 0.0 106.126 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.9 mmt85 -127.41 -39.61 1.85 Allowed 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 114.006 -1.097 . . . . 0.0 111.925 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.1 m -108.29 133.7 52.15 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.435 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 32.8 m-85 -131.16 175.67 3.5 Favored Pre-proline 0 N--CA 1.496 1.855 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -72.58 140.81 33.46 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 CA-C-N 119.621 0.9 . . . . 0.0 109.988 163.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -121.23 174.08 6.92 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.714 0.769 . . . . 0.0 110.325 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 25.1 ttt85 -73.13 110.36 7.36 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.082 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.96 0.89 10.69 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -116.63 172.94 6.9 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 121.933 0.873 . . . . 0.0 110.628 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 97.0 m -125.25 117.67 24.32 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-N 113.975 -1.466 . . . . 0.0 108.234 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 55.8 m -69.58 150.55 46.96 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 77.0 t -122.71 101.48 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 102.945 -2.983 . . . . 0.0 102.945 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.3 m -121.64 149.19 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.498 0 N-CA-C 117.904 2.557 . . . . 0.0 117.904 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -124.68 111.92 16.16 Favored 'General case' 0 N--CA 1.507 2.378 0 N-CA-C 103.352 -2.833 . . . . 0.0 103.352 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.471 ' CD1' ' N ' ' A' ' 26' ' ' TYR . 19.8 p90 -129.89 168.32 16.81 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 123.485 1.612 . . . . 0.0 114.434 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 97.3 m -134.6 111.05 9.72 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 102.384 -3.191 . . . . 0.0 102.384 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.36 138.35 14.62 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.113 -1.518 . . . . 0.0 109.875 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 38.1 ttm . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 -179.834 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 61.9 t80 . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -135.43 125.45 25.93 Favored 'General case' 0 N--CA 1.507 2.386 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -136.62 175.35 9.69 Favored 'General case' 0 N--CA 1.508 2.472 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.903 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 41.9 ttm -113.97 149.92 34.58 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 59.3 tp -91.01 119.85 31.52 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 113.993 -1.458 . . . . 0.0 112.444 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.82 -1.41 61.4 Favored Glycine 0 N--CA 1.498 2.774 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.444 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.414 ' O ' ' C ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -118.56 41.29 3.02 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.747 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.414 ' C ' ' O ' ' A' ' 52' ' ' LYS . 85.2 mt-30 4.9 65.72 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 O-C-N 125.54 1.775 . . . . 0.0 113.944 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.44 ' OE1' ' O ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -93.58 -36.47 12.38 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 103.394 -2.817 . . . . 0.0 103.394 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.43 ' O ' ' O ' ' A' ' 56' ' ' ILE . 27.9 m -115.21 154.18 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.43 ' O ' ' O ' ' A' ' 55' ' ' VAL . 5.0 pt -48.29 175.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 118.971 -1.091 . . . . 0.0 110.353 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.555 ' NH1' ' CE2' ' A' ' 80' ' ' TYR . 23.5 ttt180 -72.78 -59.84 2.52 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 118.354 -0.832 . . . . 0.0 110.864 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -27.37 -37.19 0.01 OUTLIER Glycine 0 N--CA 1.502 3.048 0 O-C-N 124.539 1.15 . . . . 0.0 111.695 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.533 ' N ' ' O ' ' A' ' 57' ' ' ARG . 1.0 OUTLIER -79.61 -75.6 0.24 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 -29.1 -55.11 0.13 Allowed 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 112.983 -1.917 . . . . 0.0 110.788 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.525 ' OE1' ' NH1' ' A' ' 57' ' ' ARG . 37.7 tt0 -72.91 -50.27 24.64 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -58.37 -75.62 0.25 Allowed Glycine 0 N--CA 1.477 1.376 0 C-N-CA 119.512 -1.327 . . . . 0.0 111.028 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.525 ' N ' ' O ' ' A' ' 59' ' ' TRP . 35.9 t -39.76 -50.37 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 C-N-CA 119.901 -0.719 . . . . 0.0 112.868 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.469 ' C ' ' N ' ' A' ' 66' ' ' MET . . . -43.66 -62.17 1.18 Allowed 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 124.16 1.933 . . . . 0.0 111.642 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -44.92 -14.92 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 109.233 -3.622 . . . . 0.0 108.946 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.469 ' N ' ' C ' ' A' ' 64' ' ' ALA . 8.2 mtm -98.26 159.99 14.58 Favored 'General case' 0 N--CA 1.512 2.661 0 C-N-CA 118.467 -1.293 . . . . 0.0 107.895 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 77.7 p -117.63 150.43 39.04 Favored 'General case' 0 N--CA 1.507 2.415 0 CA-C-O 122.573 1.177 . . . . 0.0 112.937 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 96.2 t -44.03 103.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 112.711 -2.041 . . . . 0.0 114.471 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.64 8.16 21.23 Favored Glycine 0 N--CA 1.5 2.942 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -109.15 152.94 24.45 Favored 'General case' 0 N--CA 1.506 2.35 0 CA-C-O 122.311 1.053 . . . . 0.0 111.665 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 -131.26 140.61 49.85 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 113.17 -1.832 . . . . 0.0 107.367 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -146.7 178.58 8.2 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 112.527 -2.124 . . . . 0.0 115.879 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -126.91 104.99 8.32 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 102.866 -3.013 . . . . 0.0 102.866 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.8 mt -98.85 153.61 18.65 Favored 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 120.169 -0.612 . . . . 0.0 109.505 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 84.8 m -123.92 119.45 29.65 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 35.7 mt -111.53 141.08 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 69.3 p -109.09 150.69 41.31 Favored Pre-proline 0 N--CA 1.501 2.12 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -41.56 -54.6 2.67 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.627 1.552 . . . . 0.0 112.517 -171.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.511 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 10.9 p-10 -40.06 -27.21 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.555 ' CE2' ' NH1' ' A' ' 57' ' ' ARG . 4.5 m-85 . . . . . 0 N--CA 1.499 1.976 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 59.3 m . . . . . 0 N--CA 1.5 2.031 0 CA-C-O 119.274 -0.393 . . . . 0.0 111.447 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 15.1 mt -113.19 163.76 14.37 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 58.2 t -136.32 132.06 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -123.28 145.9 48.32 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -121.65 94.42 4.31 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 100.715 -3.809 . . . . 0.0 100.715 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 102' ' ' GLU . 19.9 t -109.09 152.86 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.45 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.464 ' N ' HG12 ' A' ' 101' ' ' VAL . 88.9 tt0 -126.02 98.16 5.39 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 112.169 -2.287 . . . . 0.0 106.827 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 47.9 tp -71.87 124.18 24.28 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 102.953 -2.98 . . . . 0.0 102.953 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.6 mt -92.93 -55.96 3.16 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.122 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -170.03 -168.28 0.73 Allowed 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.141 -1.024 . . . . 0.0 111.587 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 27.9 mt -115.82 156.17 26.55 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 . . . . . 0 N--CA 1.504 2.226 0 CA-C-O 116.195 -1.86 . . . . 0.0 109.564 179.882 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.6 p . . . . . 0 N--CA 1.501 2.112 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.445 HE21 ' CG ' ' A' ' 5' ' ' GLU . 39.8 tt0 -122.43 158.12 30.42 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.5 t -124.48 113.14 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.445 ' CG ' HE21 ' A' ' 3' ' ' GLN . 50.5 mt-10 -112.96 90.28 3.3 Favored 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 91.3 m -69.78 156.28 39.26 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 114.312 -1.313 . . . . 0.0 113.437 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 56.4 mt -121.87 -51.19 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 CA-C-N 113.808 -1.542 . . . . 0.0 107.45 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.7 m -122.98 80.17 50.74 Favored Pre-proline 0 N--CA 1.506 2.369 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.272 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -40.05 160.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.715 2.277 . . . . 0.0 112.791 178.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -125.44 -175.27 14.16 Favored Glycine 0 N--CA 1.5 2.938 0 N-CA-C 106.631 -2.588 . . . . 0.0 106.631 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 12' ' ' GLY . 1.1 p30 -39.78 -52.84 2.3 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.599 -0.841 . . . . 0.0 112.906 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.468 ' N ' ' OD1' ' A' ' 11' ' ' ASP . . . 90.75 14.5 58.03 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 106.689 -2.564 . . . . 0.0 106.689 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 45.6 mtm-85 -124.68 -33.81 2.93 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 113.604 -1.298 . . . . 0.0 112.274 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.5 m -107.86 125.55 51.59 Favored 'General case' 0 N--CA 1.501 2.086 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.954 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.448 ' N ' ' CD1' ' A' ' 15' ' ' PHE . 36.9 m-85 -125.01 175.46 3.02 Favored Pre-proline 0 N--CA 1.501 2.097 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -66.68 154.8 73.18 Favored 'Trans proline' 0 C--N 1.315 -1.224 0 N-CA-C 109.474 -1.01 . . . . 0.0 109.474 164.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -119.23 169.04 10.31 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-O 121.967 0.889 . . . . 0.0 110.277 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 56.6 mtt-85 -77.18 107.5 9.61 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.343 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.19 -12.93 8.0 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 108.65 -1.78 . . . . 0.0 108.65 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -108.16 166.55 10.65 Favored 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 19.2 m -110.73 125.64 53.72 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.508 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 33.1 m -74.64 142.42 44.54 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 70.7 t -116.77 96.75 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 102.731 -3.063 . . . . 0.0 102.731 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.402 HG21 ' CH2' ' A' ' 59' ' ' TRP . 3.0 m -118.23 148.49 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 O-C-N 124.751 1.282 . . . . 0.0 113.915 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 49.9 t60 -128.76 117.93 21.94 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 103.472 -2.788 . . . . 0.0 103.472 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -134.88 176.06 9.0 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 122.951 1.357 . . . . 0.0 111.426 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 74.8 m -128.84 116.56 19.63 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 100.728 -3.804 . . . . 0.0 100.728 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -95.51 131.07 10.53 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 104.85 -3.3 . . . . 0.0 104.85 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 43.2 ttm . . . . . 0 C--N 1.302 -1.464 0 N-CA-C 104.732 -2.322 . . . . 0.0 104.732 -179.859 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 55.3 t80 . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 120.766 0.317 . . . . 0.0 111.367 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -133.17 121.95 23.3 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -137.82 172.48 12.89 Favored 'General case' 0 N--CA 1.508 2.474 0 C-N-CA 119.448 -0.901 . . . . 0.0 111.27 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.6 ttt -112.9 150.07 32.3 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.487 0.66 . . . . 0.0 112.73 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.4 tp -90.58 121.0 32.13 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.113 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.57 -3.7 39.71 Favored Glycine 0 N--CA 1.5 2.951 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.998 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' A' ' 54' ' ' GLU . 19.2 ttmm -115.84 42.46 2.32 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.411 ' C ' ' O ' ' A' ' 52' ' ' LYS . 72.8 mt-30 0.76 63.48 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.044 0 O-C-N 125.706 1.879 . . . . 0.0 113.655 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 52' ' ' LYS . 1.9 tm-20 -101.4 -23.9 14.28 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 113.796 -1.547 . . . . 0.0 106.864 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.2 m -112.7 158.73 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.577 0 C-N-CA 119.856 -0.738 . . . . 0.0 109.269 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.5 pt -59.1 173.95 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.484 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.549 ' O ' ' N ' ' A' ' 59' ' ' TRP . 3.6 tpp180 -66.99 -60.22 2.82 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 118.564 -0.731 . . . . 0.0 109.891 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -24.59 -38.9 0.01 OUTLIER Glycine 0 N--CA 1.499 2.889 0 O-C-N 125.1 1.5 . . . . 0.0 111.498 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.549 ' N ' ' O ' ' A' ' 57' ' ' ARG . 2.0 m95 -82.37 -74.88 0.33 Allowed 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 112.816 -1.692 . . . . 0.0 110.447 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 59' ' ' TRP . 29.9 tt0 -24.32 -54.6 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 125.97 2.044 . . . . 0.0 111.33 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -77.88 -54.18 6.62 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -50.36 -75.41 0.21 Allowed Glycine 0 N--CA 1.481 1.671 0 C-N-CA 119.729 -1.225 . . . . 0.0 110.544 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.53 ' N ' ' O ' ' A' ' 59' ' ' TRP . 25.1 t -43.53 -48.06 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 119.218 -0.993 . . . . 0.0 112.011 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.435 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -45.34 -58.75 3.09 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 123.783 1.754 . . . . 0.0 111.37 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -50.44 -9.02 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 109.873 -3.33 . . . . 0.0 110.617 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.435 ' H ' ' C ' ' A' ' 64' ' ' ALA . 40.8 mtm -103.97 151.05 23.66 Favored 'General case' 0 N--CA 1.519 2.989 0 C-N-CA 118.824 -1.15 . . . . 0.0 109.993 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 61.7 p -115.58 148.07 40.01 Favored 'General case' 0 N--CA 1.509 2.525 0 CA-C-O 122.756 1.265 . . . . 0.0 114.006 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 60.5 t -38.94 109.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-N 112.478 -2.146 . . . . 0.0 114.871 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.49 -2.51 36.9 Favored Glycine 0 N--CA 1.501 2.985 0 C-N-CA 119.58 -1.295 . . . . 0.0 111.296 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -99.97 153.61 19.05 Favored 'General case' 0 N--CA 1.506 2.338 0 CA-C-O 122.344 1.068 . . . . 0.0 111.87 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 31.1 ttp180 -131.7 143.82 50.54 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 113.137 -1.847 . . . . 0.0 107.209 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -151.98 176.78 11.14 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 116.574 2.064 . . . . 0.0 116.574 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -124.78 104.58 8.72 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 110.855 -2.884 . . . . 0.0 104.349 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.1 mt -96.83 150.06 21.15 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.7 m -121.1 103.39 8.98 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 37.5 mt -99.38 132.09 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.418 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 66.9 p -113.03 156.38 42.88 Favored Pre-proline 0 N--CA 1.501 2.094 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -34.32 -50.41 0.63 Allowed 'Trans proline' 0 C--N 1.314 -1.248 0 C-N-CA 122.231 1.954 . . . . 0.0 114.096 -176.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 80' ' ' TYR . 1.4 p30 -38.91 -41.12 0.72 Allowed 'General case' 0 N--CA 1.485 1.324 0 CA-C-O 121.837 0.827 . . . . 0.0 111.734 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.479 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 6.5 m-85 . . . . . 0 N--CA 1.494 1.749 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.838 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 97.5 m . . . . . 0 N--CA 1.497 1.875 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 20.6 mt -101.55 152.7 20.48 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.7 t -132.27 117.8 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.458 ' CE2' ' NE1' ' A' ' 59' ' ' TRP . 3.9 m-85 -109.32 160.06 16.47 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -128.61 88.27 2.71 Favored 'General case' 0 N--CA 1.497 1.892 1 N-CA-C 98.295 -4.705 . . . . 0.0 98.295 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.44 HG12 ' N ' ' A' ' 102' ' ' GLU . 14.7 t -101.98 152.5 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.64 0 N-CA-C 117.495 2.406 . . . . 0.0 117.495 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.44 ' N ' HG12 ' A' ' 101' ' ' VAL . 38.1 tt0 -129.25 104.88 7.78 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 112.3 -2.227 . . . . 0.0 106.755 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 36.8 tp -77.06 116.05 17.38 Favored 'General case' 0 N--CA 1.505 2.321 0 N-CA-C 101.888 -3.375 . . . . 0.0 101.888 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.7 mt -86.2 -61.99 1.62 Allowed 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 114.372 -1.285 . . . . 0.0 114.115 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 14.5 mmtt -157.16 -171.86 3.79 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.834 0.826 . . . . 0.0 111.351 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 21.4 mt -119.15 159.99 22.96 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 103.772 -2.677 . . . . 0.0 103.772 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 . . . . . 0 N--CA 1.508 2.445 0 CA-C-O 115.572 -2.156 . . . . 0.0 107.548 179.919 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.8 p . . . . . 0 N--CA 1.503 2.18 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.577 HE21 ' CG ' ' A' ' 5' ' ' GLU . 40.6 tt0 -121.99 156.01 34.36 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.8 t -125.5 118.13 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.577 ' CG ' HE21 ' A' ' 3' ' ' GLN . 6.1 mm-40 -121.84 94.52 4.34 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 92.5 m -69.82 157.28 37.67 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 76.3 mt -121.98 -55.47 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 CA-C-N 113.656 -1.611 . . . . 0.0 107.132 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.423 ' O ' ' O ' ' A' ' 9' ' ' PRO . 36.6 m -120.94 84.44 38.84 Favored Pre-proline 0 N--CA 1.504 2.234 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.331 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 8' ' ' SER . 0.5 OUTLIER -34.71 159.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.3 2.0 . . . . 0.0 112.15 177.025 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -124.47 -164.75 12.01 Favored Glycine 0 N--CA 1.501 3.02 0 N-CA-C 107.992 -2.043 . . . . 0.0 107.992 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.466 ' CG ' ' H ' ' A' ' 12' ' ' GLY . 1.2 p-10 -39.55 -67.54 0.22 Allowed 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 121.816 0.817 . . . . 0.0 112.348 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.466 ' H ' ' CG ' ' A' ' 11' ' ' ASP . . . 104.33 12.61 28.61 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 105.3 -3.12 . . . . 0.0 105.3 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -124.38 -45.67 1.94 Allowed 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 113.797 -1.201 . . . . 0.0 112.188 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 38.6 m -103.12 129.2 49.91 Favored 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -128.97 173.04 6.11 Favored Pre-proline 0 N--CA 1.499 1.982 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -67.85 132.09 25.73 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 CA-C-N 119.707 0.931 . . . . 0.0 112.663 166.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -120.23 165.07 15.3 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.8 ptm85 -66.12 134.29 52.49 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.69 -25.71 11.63 Favored Glycine 0 N--CA 1.498 2.777 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -106.89 173.0 6.51 Favored 'General case' 0 N--CA 1.508 2.444 0 CA-C-O 121.715 0.769 . . . . 0.0 112.99 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.7 m -115.29 121.05 41.7 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.723 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 30.6 m -69.29 152.62 44.79 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.412 HG23 ' H ' ' A' ' 107' ' ' GLU . 97.6 t -130.11 102.78 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 101.763 -3.421 . . . . 0.0 101.763 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.7 m -120.72 152.66 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.374 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -129.13 113.82 15.56 Favored 'General case' 0 N--CA 1.506 2.349 0 N-CA-C 102.807 -3.035 . . . . 0.0 102.807 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.552 ' CD1' ' N ' ' A' ' 26' ' ' TYR . 33.0 p90 -132.25 175.91 8.85 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 122.974 1.369 . . . . 0.0 114.221 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.8 m -137.06 117.59 13.82 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 101.794 -3.41 . . . . 0.0 101.794 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -98.61 141.85 15.78 Favored Glycine 0 N--CA 1.501 3.003 0 C-N-CA 119.921 -1.133 . . . . 0.0 110.697 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 69.6 mmm . . . . . 0 C--N 1.303 -1.43 0 CA-C-N 113.387 -1.407 . . . . 0.0 107.613 -179.734 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 49.2 t80 . . . . . 0 N--CA 1.501 2.109 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -143.08 121.2 12.14 Favored 'General case' 0 N--CA 1.506 2.374 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -135.4 171.98 13.66 Favored 'General case' 0 N--CA 1.513 2.703 0 CA-C-N 118.988 0.813 . . . . 0.0 110.631 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 43.2 ttm -119.16 143.8 47.02 Favored 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.427 ' CD1' ' OE1' ' A' ' 60' ' ' GLU . 50.5 tp -91.17 134.88 34.18 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 113.986 -1.461 . . . . 0.0 110.646 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 126.73 -35.02 3.0 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 108.393 -1.883 . . . . 0.0 108.393 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 54' ' ' GLU . 80.0 tttt -123.76 43.14 3.05 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 114.585 -0.807 . . . . 0.0 109.176 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 12.53 49.27 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 125.602 1.814 . . . . 0.0 114.685 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 52' ' ' LYS . 96.1 mt-10 -49.2 -29.82 6.11 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.537 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.433 ' O ' ' O ' ' A' ' 56' ' ' ILE . 32.7 m -117.56 158.31 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.646 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 55' ' ' VAL . 23.9 pt -46.4 172.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 C-N-CA 118.753 -1.179 . . . . 0.0 111.323 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.546 ' O ' ' N ' ' A' ' 59' ' ' TRP . 20.7 ttm-85 -72.44 -61.06 1.93 Allowed 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 118.84 -0.6 . . . . 0.0 112.073 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -34.58 -28.22 0.01 OUTLIER Glycine 0 N--CA 1.499 2.835 0 CA-C-O 122.156 0.864 . . . . 0.0 111.761 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.546 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.6 OUTLIER -87.75 -74.76 0.44 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 179.804 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.427 ' OE1' ' CD1' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -32.86 -50.96 0.28 Allowed 'General case' 0 N--CA 1.501 2.077 0 CA-C-N 114.035 -1.439 . . . . 0.0 110.127 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -74.57 -54.36 7.64 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 113.743 -1.572 . . . . 0.0 107.042 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -53.71 -76.07 0.2 Allowed Glycine 0 N--CA 1.478 1.47 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' A' ' 59' ' ' TRP . 40.0 t -37.25 -45.41 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 CA-C-N 115.067 -0.566 . . . . 0.0 112.04 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.487 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -48.35 -56.07 9.08 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 123.78 1.752 . . . . 0.0 110.092 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -59.53 -0.51 0.17 Allowed 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 110.139 -3.21 . . . . 0.0 110.409 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.593 ' SD ' ' NE2' ' A' ' 70' ' ' GLN . 16.3 tpp -98.85 153.2 18.97 Favored 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 106.039 -1.838 . . . . 0.0 106.039 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 83.5 p -116.37 143.23 45.82 Favored 'General case' 0 N--CA 1.508 2.453 0 CA-C-O 122.289 1.042 . . . . 0.0 112.212 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.422 ' O ' ' OD1' ' A' ' 11' ' ' ASP . 96.7 t -41.9 98.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 113.315 -1.766 . . . . 0.0 114.622 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.71 7.1 22.52 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.593 ' NE2' ' SD ' ' A' ' 66' ' ' MET . 44.3 tt0 -105.13 149.09 26.17 Favored 'General case' 0 N--CA 1.51 2.545 0 C-N-CA 119.179 -1.008 . . . . 0.0 111.018 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 24.8 ttt85 -124.71 141.02 52.4 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 113.905 -1.498 . . . . 0.0 107.0 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -149.64 177.97 9.28 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 116.081 1.882 . . . . 0.0 116.081 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -127.09 104.83 8.19 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 102.457 -3.164 . . . . 0.0 102.457 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.6 mt -101.48 155.12 18.26 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 87.2 m -125.32 132.2 52.9 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 23.8 mt -118.99 138.85 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 CA-C-O 121.319 0.581 . . . . 0.0 110.651 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.44 ' HG ' ' CG ' ' A' ' 79' ' ' ASP . 76.9 p -111.11 151.45 43.07 Favored Pre-proline 0 N--CA 1.502 2.151 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.423 ' O ' ' N ' ' A' ' 80' ' ' TYR . 10.2 Cg_endo -39.41 -56.14 1.37 Allowed 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 121.859 1.706 . . . . 0.0 113.035 -172.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.531 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 3.9 p-10 -34.37 -34.34 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.442 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.423 ' N ' ' O ' ' A' ' 78' ' ' PRO . 4.8 m-85 . . . . . 0 N--CA 1.493 1.682 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.086 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 91.1 m . . . . . 0 N--CA 1.504 2.262 0 CA-C-O 119.157 -0.449 . . . . 0.0 110.85 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 29.0 mt -108.8 144.37 36.74 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 119.252 0.933 . . . . 0.0 108.718 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 43.7 t -128.73 127.2 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 N-CA-C 107.113 -1.439 . . . . 0.0 107.113 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -118.82 157.88 26.71 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 122.063 0.935 . . . . 0.0 111.958 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -127.07 94.16 3.94 Favored 'General case' 0 N--CA 1.494 1.762 1 N-CA-C 99.069 -4.419 . . . . 0.0 99.069 179.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.437 HG12 ' N ' ' A' ' 102' ' ' GLU . 16.4 t -107.36 152.94 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.524 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.437 ' N ' HG12 ' A' ' 101' ' ' VAL . 89.3 tt0 -127.36 100.65 6.13 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 111.877 -2.42 . . . . 0.0 106.357 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 40.9 tp -73.76 125.06 27.26 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 102.624 -3.102 . . . . 0.0 102.624 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.0 mt -94.0 -59.74 1.91 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.79 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 11.8 ptmm? -157.2 -178.58 7.46 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.0 mt -114.23 71.29 0.75 Allowed 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.412 ' H ' HG23 ' A' ' 23' ' ' VAL . 34.4 tt0 . . . . . 0 N--CA 1.502 2.159 0 CA-C-O 115.91 -1.995 . . . . 0.0 109.676 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 N--CA 1.503 2.18 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -121.99 154.01 37.78 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.2 t -126.51 114.03 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -114.83 109.53 18.3 Favored 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 96.2 m -83.75 153.71 23.99 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.744 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 56.0 mt -123.55 -50.58 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 CA-C-N 113.656 -1.611 . . . . 0.0 107.363 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.417 ' O ' ' O ' ' A' ' 9' ' ' PRO . 43.8 t -122.33 79.68 45.15 Favored Pre-proline 0 N--CA 1.507 2.406 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.634 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.417 ' O ' ' O ' ' A' ' 8' ' ' SER . 9.0 Cg_exo -37.56 166.27 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.863 2.375 . . . . 0.0 113.77 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.79 -167.42 12.92 Favored Glycine 0 N--CA 1.502 3.091 0 N-CA-C 105.304 -3.119 . . . . 0.0 105.304 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.485 ' CG ' ' H ' ' A' ' 12' ' ' GLY . 11.2 p-10 -46.97 -58.99 3.4 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 118.619 1.21 . . . . 0.0 110.798 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.485 ' H ' ' CG ' ' A' ' 11' ' ' ASP . . . 106.99 27.63 5.3 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 107.232 -2.347 . . . . 0.0 107.232 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 32.7 mtp85 -133.87 -35.0 0.98 Allowed 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 114.545 -0.828 . . . . 0.0 112.597 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.8 m -109.57 139.46 44.55 Favored 'General case' 0 N--CA 1.508 2.454 0 CA-C-O 121.807 0.813 . . . . 0.0 112.952 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 50.5 m-85 -131.77 177.43 2.25 Favored Pre-proline 0 N--CA 1.499 1.988 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -67.13 138.74 48.33 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 121.145 1.23 . . . . 0.0 110.813 164.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -119.94 162.24 19.53 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 122.351 1.072 . . . . 0.0 109.232 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 29.8 mtm180 -71.07 126.68 30.23 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 114.189 -1.369 . . . . 0.0 108.146 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.51 -24.22 9.86 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -110.8 176.95 4.83 Favored 'General case' 0 N--CA 1.507 2.406 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.901 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 92.4 m -108.42 166.98 10.36 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.2 m -113.14 149.47 33.55 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 102.513 -3.143 . . . . 0.0 102.513 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 60.4 t -123.49 101.93 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 103.109 -2.923 . . . . 0.0 103.109 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.3 m -120.69 149.52 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.574 0 N-CA-C 116.516 2.043 . . . . 0.0 116.516 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -127.8 114.74 17.64 Favored 'General case' 0 N--CA 1.507 2.383 0 N-CA-C 103.67 -2.715 . . . . 0.0 103.67 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.499 ' CD1' ' N ' ' A' ' 26' ' ' TYR . 33.9 p90 -131.96 175.68 9.02 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 122.977 1.37 . . . . 0.0 113.702 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 84.8 m -134.65 116.89 15.47 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 101.308 -3.59 . . . . 0.0 101.308 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -102.55 128.7 9.63 Favored Glycine 0 N--CA 1.5 2.935 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 46.8 ttm . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 -179.83 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 49.7 t80 . . . . . 0 N--CA 1.499 2.013 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.95 130.88 21.65 Favored 'General case' 0 N--CA 1.508 2.45 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.41 ' CD1' ' C ' ' A' ' 48' ' ' PHE . 13.5 p90 -143.28 166.72 23.96 Favored 'General case' 0 N--CA 1.514 2.732 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.904 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.495 ' SD ' ' O ' ' A' ' 50' ' ' LEU . 2.7 tmm? -115.11 149.04 38.19 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 115.103 1.519 . . . . 0.0 115.103 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.495 ' O ' ' SD ' ' A' ' 49' ' ' MET . 52.3 tp -90.6 121.03 32.17 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 113.343 -1.753 . . . . 0.0 112.19 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.69 -24.71 7.09 Favored Glycine 0 N--CA 1.499 2.838 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 53' ' ' GLN . 2.3 tppp? -113.37 36.84 3.4 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.413 ' C ' ' O ' ' A' ' 52' ' ' LYS . 83.3 mt-30 7.8 63.56 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 125.281 1.613 . . . . 0.0 114.165 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -82.89 -30.23 28.7 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.419 ' O ' ' O ' ' A' ' 56' ' ' ILE . 32.6 m -118.78 151.13 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.419 ' O ' ' O ' ' A' ' 55' ' ' VAL . 1.6 pt -46.9 -176.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.542 ' O ' ' N ' ' A' ' 59' ' ' TRP . 8.8 tpt180 -81.16 -61.01 2.08 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.124 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -35.8 -26.86 0.01 OUTLIER Glycine 0 N--CA 1.497 2.703 0 CA-C-O 122.196 0.887 . . . . 0.0 110.919 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.542 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.8 OUTLIER -91.85 -76.07 0.46 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.776 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -33.94 -51.48 0.41 Allowed 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 113.752 -1.567 . . . . 0.0 110.031 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -73.06 -54.47 8.46 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 113.218 -1.81 . . . . 0.0 106.574 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -55.07 -80.55 0.07 OUTLIER Glycine 0 N--CA 1.476 1.335 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.533 ' N ' ' O ' ' A' ' 59' ' ' TRP . 53.1 t -32.3 -48.45 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 112.675 0.621 . . . . 0.0 112.675 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.475 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -46.37 -60.52 2.28 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 124.262 1.982 . . . . 0.0 110.905 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -48.01 -12.19 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 108.948 -3.751 . . . . 0.0 108.856 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.475 ' H ' ' C ' ' A' ' 64' ' ' ALA . 21.0 mtp -97.7 159.64 14.8 Favored 'General case' 0 N--CA 1.512 2.655 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 80.4 p -117.08 156.88 26.82 Favored 'General case' 0 N--CA 1.509 2.498 0 CA-C-O 122.804 1.288 . . . . 0.0 113.716 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 62.5 t -49.55 97.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 112.037 -2.347 . . . . 0.0 114.858 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.11 5.2 25.28 Favored Glycine 0 N--CA 1.499 2.841 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.488 ' OE1' ' N ' ' A' ' 71' ' ' ARG . 0.9 OUTLIER -106.73 148.61 28.22 Favored 'General case' 0 N--CA 1.505 2.325 0 CA-C-O 122.099 0.952 . . . . 0.0 111.399 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.488 ' N ' ' OE1' ' A' ' 70' ' ' GLN . 18.9 ttp180 -127.58 140.64 51.98 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 113.516 -1.674 . . . . 0.0 110.089 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -144.8 178.83 7.72 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 112.605 -2.089 . . . . 0.0 115.662 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -126.78 105.0 8.36 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 110.933 -2.849 . . . . 0.0 103.585 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.8 mt -96.73 149.7 21.53 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 86.5 m -124.59 112.72 17.14 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.5 mt -105.19 143.83 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 CA-C-O 121.448 0.642 . . . . 0.0 110.908 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 36.8 p -110.02 150.79 41.91 Favored Pre-proline 0 N--CA 1.496 1.869 0 N-CA-C 105.604 -1.998 . . . . 0.0 105.604 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.524 ' O ' ' N ' ' A' ' 80' ' ' TYR . 19.3 Cg_endo -44.33 -55.71 3.02 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 121.967 1.778 . . . . 0.0 113.614 -171.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 12.8 p-10 -38.82 -17.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.524 ' N ' ' O ' ' A' ' 78' ' ' PRO . 4.8 m-85 . . . . . 0 N--CA 1.5 2.043 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 94.8 m . . . . . 0 N--CA 1.502 2.16 0 CA-C-O 118.872 -0.585 . . . . 0.0 110.812 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 32.6 mt -108.21 153.07 23.72 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 50.4 t -133.31 121.15 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -114.26 151.33 33.03 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -122.73 94.07 4.16 Favored 'General case' 0 N--CA 1.496 1.839 1 N-CA-C 98.937 -4.468 . . . . 0.0 98.937 179.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.414 HG12 ' N ' ' A' ' 102' ' ' GLU . 17.2 t -107.78 150.53 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.425 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.414 ' N ' HG12 ' A' ' 101' ' ' VAL . 39.1 tt0 -126.67 102.48 7.09 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 112.39 -2.186 . . . . 0.0 106.843 179.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 43.6 tp -73.31 126.5 30.26 Favored 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 101.823 -3.399 . . . . 0.0 101.823 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.9 mt -93.51 -54.05 3.82 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.877 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.46 -172.13 0.88 Allowed 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 118.366 -1.334 . . . . 0.0 110.621 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 19.1 mt -118.24 152.97 34.7 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.426 ' OE1' ' OXT' ' A' ' 107' ' ' GLU . 9.7 tm-20 . . . . . 0 N--CA 1.501 2.095 0 CA-C-O 116.099 -1.905 . . . . 0.0 109.002 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.473 ' C ' ' NE2' ' A' ' 3' ' ' GLN . 11.8 p . . . . . 0 N--CA 1.502 2.143 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.483 ' N ' ' CD ' ' A' ' 3' ' ' GLN . 14.9 mp0 -121.57 156.05 33.71 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 42.2 t -126.5 106.55 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -108.38 87.45 2.5 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 98.9 m -69.66 157.82 36.53 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.017 -1.073 . . . . 0.0 111.674 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 64.1 mt -121.94 -53.93 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 CA-C-N 114.195 -1.366 . . . . 0.0 107.631 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.417 ' O ' ' O ' ' A' ' 9' ' ' PRO . 51.8 m -123.09 80.22 51.5 Favored Pre-proline 0 N--CA 1.507 2.378 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.49 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.417 ' O ' ' O ' ' A' ' 8' ' ' SER . 6.9 Cg_exo -36.95 166.66 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.866 2.377 . . . . 0.0 114.104 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.51 -176.7 17.99 Favored Glycine 0 N--CA 1.5 2.96 0 N-CA-C 105.063 -3.215 . . . . 0.0 105.063 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.489 ' CG ' ' H ' ' A' ' 12' ' ' GLY . 14.4 p-10 -43.04 -59.08 2.16 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 118.557 1.178 . . . . 0.0 111.735 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.489 ' H ' ' CG ' ' A' ' 11' ' ' ASP . . . 110.06 22.34 6.6 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 108.541 -1.824 . . . . 0.0 108.541 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 60.0 mtt-85 -133.67 -31.38 1.19 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 114.994 -0.603 . . . . 0.0 112.392 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.0 m -109.11 124.85 51.45 Favored 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.375 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.47 ' N ' ' CD1' ' A' ' 15' ' ' PHE . 23.1 m-85 -127.28 176.1 2.88 Favored Pre-proline 0 N--CA 1.501 2.101 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -73.8 139.33 27.51 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 CA-C-N 119.51 0.861 . . . . 0.0 110.177 163.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -120.63 167.07 12.82 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 121.765 0.793 . . . . 0.0 109.264 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 62.8 mtt180 -70.26 127.6 33.35 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.763 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.32 -25.61 9.14 Favored Glycine 0 N--CA 1.498 2.78 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.501 ' O ' ' SD ' ' A' ' 49' ' ' MET . 25.8 mt-30 -109.37 175.62 5.38 Favored 'General case' 0 N--CA 1.505 2.276 0 CA-C-O 121.713 0.768 . . . . 0.0 111.429 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.9 m -107.23 163.86 12.66 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 114.611 -1.177 . . . . 0.0 108.47 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 55.6 m -114.39 145.62 41.6 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 103.718 -2.697 . . . . 0.0 103.718 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 64.4 t -122.89 101.08 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 102.22 -3.252 . . . . 0.0 102.22 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.42 HG21 ' CH2' ' A' ' 59' ' ' TRP . 2.7 m -124.12 151.54 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -179.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -130.15 119.45 23.02 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 103.841 -2.651 . . . . 0.0 103.841 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 26' ' ' TYR . 35.4 p90 -135.22 172.55 12.84 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 123.072 1.415 . . . . 0.0 114.592 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 61.4 m -134.34 116.14 14.88 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 102.865 -3.013 . . . . 0.0 102.865 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.62 137.42 13.61 Favored Glycine 0 N--CA 1.5 2.92 0 C-N-CA 119.918 -1.134 . . . . 0.0 112.003 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 35.0 ttm . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 179.987 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 71.6 t80 . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -137.7 123.5 20.0 Favored 'General case' 0 N--CA 1.505 2.323 0 CA-C-O 118.863 -0.589 . . . . 0.0 110.952 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -136.8 168.04 20.3 Favored 'General case' 0 N--CA 1.513 2.696 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.501 ' SD ' ' O ' ' A' ' 20' ' ' GLN . 44.6 tpp -107.1 132.35 53.1 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 114.111 -1.404 . . . . 0.0 113.866 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.0 tp -90.88 122.42 33.56 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 114.483 -1.235 . . . . 0.0 110.707 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.73 18.48 10.72 Favored Glycine 0 N--CA 1.5 2.91 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.483 ' O ' ' CB ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -118.75 -53.12 2.31 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.483 ' CB ' ' O ' ' A' ' 52' ' ' LYS . 47.9 tt0 100.92 70.56 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.208 0 O-C-N 125.812 1.945 . . . . 0.0 108.049 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -109.39 -33.71 6.75 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 114.182 -1.372 . . . . 0.0 108.708 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.4 m -115.15 153.03 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.291 0 CA-C-O 121.287 0.565 . . . . 0.0 110.4 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.2 pt -51.08 177.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.094 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.544 ' O ' ' N ' ' A' ' 59' ' ' TRP . 8.7 tpt180 -70.52 -60.76 2.07 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 120.232 -0.587 . . . . 0.0 109.442 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -24.24 -38.88 0.01 OUTLIER Glycine 0 N--CA 1.501 2.98 0 O-C-N 125.122 1.514 . . . . 0.0 112.718 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.544 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.6 OUTLIER -82.66 -71.38 0.49 Allowed 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 179.828 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -28.77 -54.62 0.12 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 125.266 1.604 . . . . 0.0 110.939 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -76.67 -53.53 7.88 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -50.83 -75.54 0.21 Allowed Glycine 0 N--CA 1.478 1.465 0 C-N-CA 119.207 -1.473 . . . . 0.0 110.287 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 59' ' ' TRP . 35.2 t -42.03 -50.77 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 C-N-CA 119.471 -0.891 . . . . 0.0 112.42 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.471 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -45.0 -62.04 1.39 Allowed 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 123.893 1.806 . . . . 0.0 111.434 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -47.15 -12.91 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 109.606 -3.452 . . . . 0.0 109.176 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.471 ' H ' ' C ' ' A' ' 64' ' ' ALA . 6.6 mtm -99.63 157.27 16.58 Favored 'General case' 0 N--CA 1.512 2.657 0 C-N-CA 118.503 -1.279 . . . . 0.0 107.638 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 84.4 p -118.65 148.24 42.94 Favored 'General case' 0 N--CA 1.507 2.398 0 CA-C-O 122.458 1.123 . . . . 0.0 113.412 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 52.9 t -40.82 100.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-N 112.775 -2.011 . . . . 0.0 113.829 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.19 10.97 12.74 Favored Glycine 0 N--CA 1.5 2.963 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -107.2 146.45 31.38 Favored 'General case' 0 N--CA 1.505 2.297 0 CA-C-O 121.681 0.753 . . . . 0.0 111.05 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.1 mtp85 -126.26 139.56 53.22 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -149.42 177.07 10.03 Favored 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 116.58 2.067 . . . . 0.0 116.58 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -127.92 107.1 9.57 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 102.531 -3.137 . . . . 0.0 102.531 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.8 mt -104.47 153.31 21.28 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 90.3 m -124.01 124.96 43.7 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 104.613 -2.366 . . . . 0.0 104.613 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.1 mt -116.95 136.34 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.402 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 61.1 p -111.92 154.11 44.27 Favored Pre-proline 0 N--CA 1.505 2.292 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -34.36 -53.05 0.6 Allowed 'Trans proline' 0 C--N 1.315 -1.187 0 C-N-CA 122.1 1.867 . . . . 0.0 114.297 -174.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 80' ' ' TYR . 1.8 p30 -37.34 -39.65 0.3 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.503 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.452 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 5.0 m-85 . . . . . 0 N--CA 1.493 1.676 0 CA-C-N 114.965 -1.016 . . . . 0.0 112.022 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 88.1 m . . . . . 0 N--CA 1.5 2.033 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 27.8 mt -115.86 155.21 28.33 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.8 t -136.43 124.51 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -118.39 150.7 39.1 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 122.305 1.05 . . . . 0.0 111.057 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -124.09 93.59 3.97 Favored 'General case' 0 N--CA 1.493 1.706 1 N-CA-C 98.926 -4.472 . . . . 0.0 98.926 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.419 HG12 ' N ' ' A' ' 102' ' ' GLU . 12.7 t -108.09 155.57 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.513 0 N-CA-C 117.033 2.234 . . . . 0.0 117.033 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.419 ' N ' HG12 ' A' ' 101' ' ' VAL . 31.5 tt0 -129.2 103.33 6.89 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 111.574 -2.557 . . . . 0.0 108.143 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 39.5 tp -77.86 118.44 20.19 Favored 'General case' 0 N--CA 1.506 2.363 0 N-CA-C 102.722 -3.066 . . . . 0.0 102.722 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.1 mt -87.3 -55.63 3.72 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 113.845 -1.525 . . . . 0.0 112.518 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -171.69 -170.08 0.75 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.334 -0.946 . . . . 0.0 110.962 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 21.2 mt -117.65 156.28 28.45 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 . . . . . 0 N--CA 1.503 2.191 0 CA-C-O 116.822 -1.561 . . . . 0.0 108.974 179.83 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.9 p . . . . . 0 N--CA 1.501 2.117 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -123.68 154.88 38.77 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.7 t -125.14 118.99 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -120.21 96.86 5.33 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 92.1 m -69.83 156.12 39.52 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.031 -1.068 . . . . 0.0 113.077 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 74.0 mt -122.52 -55.55 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 CA-C-N 113.693 -1.594 . . . . 0.0 107.471 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.422 ' O ' ' O ' ' A' ' 9' ' ' PRO . 34.2 t -122.95 82.48 50.35 Favored Pre-proline 0 N--CA 1.506 2.344 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.515 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 8' ' ' SER . 5.2 Cg_exo -36.23 161.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.391 2.061 . . . . 0.0 112.731 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -118.32 -174.62 16.39 Favored Glycine 0 N--CA 1.5 2.904 0 N-CA-C 106.482 -2.647 . . . . 0.0 106.482 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 11' ' ' ASP . 13.0 p-10 -39.77 -60.39 1.0 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.492 -0.883 . . . . 0.0 112.916 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.06 18.74 12.91 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 105.599 -3.001 . . . . 0.0 105.599 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 54.8 mtt-85 -127.13 -40.32 1.85 Allowed 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 113.773 -1.213 . . . . 0.0 112.214 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.6 m -108.21 139.58 42.69 Favored 'General case' 0 N--CA 1.506 2.341 0 CA-C-O 121.968 0.89 . . . . 0.0 112.726 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 50.8 m-85 -131.79 177.46 2.23 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -62.19 155.09 58.55 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 N-CA-C 109.805 -0.883 . . . . 0.0 109.805 161.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -119.73 166.61 12.99 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.921 0.867 . . . . 0.0 108.923 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 59.2 mtt85 -81.18 95.07 6.8 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.559 -1.201 . . . . 0.0 109.178 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.07 3.7 4.8 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -113.61 173.02 6.62 Favored 'General case' 0 N--CA 1.506 2.35 0 C-N-CA 120.219 -0.593 . . . . 0.0 109.513 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 97.8 m -118.08 117.86 30.35 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.591 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 24.8 m -69.66 148.61 49.07 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 87.5 t -122.13 101.61 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 101.679 -3.452 . . . . 0.0 101.679 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.427 HG21 ' CH2' ' A' ' 59' ' ' TRP . 3.0 m -125.38 151.04 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -129.04 117.67 21.26 Favored 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.434 ' CD2' ' CD2' ' A' ' 99' ' ' PHE . 41.9 p90 -136.27 -179.13 5.49 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 96.2 m -137.02 118.73 15.02 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 105.006 -2.22 . . . . 0.0 105.006 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -102.91 124.85 8.29 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 120.905 -0.665 . . . . 0.0 112.057 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 48.9 mtm . . . . . 0 N--CA 1.499 1.991 0 CA-C-O 122.041 0.924 . . . . 0.0 110.524 179.944 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 47.9 t80 . . . . . 0 N--CA 1.494 1.762 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -137.79 122.71 18.94 Favored 'General case' 0 N--CA 1.506 2.369 0 CA-C-O 119.109 -0.472 . . . . 0.0 111.128 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -137.71 175.4 9.63 Favored 'General case' 0 N--CA 1.513 2.69 0 CA-C-N 119.412 1.006 . . . . 0.0 112.381 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 42.2 ttm -117.67 144.06 45.58 Favored 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.1 tp -91.09 124.25 35.18 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 114.295 -1.32 . . . . 0.0 111.812 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.18 -18.07 14.28 Favored Glycine 0 N--CA 1.501 3.026 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.874 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.41 ' O ' ' C ' ' A' ' 53' ' ' GLN . 53.9 tttm -118.98 39.32 3.57 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 120.949 -0.3 . . . . 0.0 110.372 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 52' ' ' LYS . 15.1 pt20 14.12 68.26 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 125.262 1.601 . . . . 0.0 114.587 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -91.39 -27.3 18.42 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 113.758 -1.564 . . . . 0.0 106.869 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.427 ' O ' ' O ' ' A' ' 56' ' ' ILE . 26.8 m -118.8 154.6 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.235 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.427 ' O ' ' O ' ' A' ' 55' ' ' VAL . 12.7 pt -49.43 175.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 C-N-CA 119.568 -0.853 . . . . 0.0 108.908 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.537 ' O ' ' N ' ' A' ' 59' ' ' TRP . 32.4 ttp180 -72.24 -56.31 5.74 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.199 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -25.35 -38.52 0.01 OUTLIER Glycine 0 N--CA 1.499 2.886 0 O-C-N 124.773 1.296 . . . . 0.0 112.188 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.537 ' N ' ' O ' ' A' ' 57' ' ' ARG . 1.4 m95 -82.02 -74.26 0.35 Allowed 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 112.919 -1.64 . . . . 0.0 108.386 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 59' ' ' TRP . 29.2 tt0 -24.18 -54.72 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 125.932 2.02 . . . . 0.0 111.174 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -77.85 -54.81 5.89 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -48.56 -75.97 0.17 Allowed Glycine 0 N--CA 1.482 1.702 0 C-N-CA 119.84 -1.172 . . . . 0.0 110.391 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.529 ' N ' ' O ' ' A' ' 59' ' ' TRP . 23.1 t -44.03 -48.7 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 119.298 -0.961 . . . . 0.0 111.837 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.471 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -46.36 -58.93 3.28 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 123.948 1.832 . . . . 0.0 111.341 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -51.05 -8.81 0.05 OUTLIER 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 109.68 -3.418 . . . . 0.0 109.887 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.471 ' H ' ' C ' ' A' ' 64' ' ' ALA . 93.4 mtp -102.73 158.62 16.12 Favored 'General case' 0 N--CA 1.513 2.723 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 88.3 p -118.51 153.83 33.53 Favored 'General case' 0 N--CA 1.509 2.525 0 CA-C-O 122.775 1.274 . . . . 0.0 113.677 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 86.7 t -49.18 97.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 112.608 -2.087 . . . . 0.0 113.568 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.19 12.95 12.73 Favored Glycine 0 N--CA 1.499 2.869 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -107.65 143.54 35.99 Favored 'General case' 0 N--CA 1.505 2.305 0 CA-C-O 121.368 0.604 . . . . 0.0 109.781 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 25.4 ttt85 -124.88 140.85 52.55 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -149.7 176.47 10.65 Favored 'General case' 0 N--CA 1.502 2.175 0 CA-C-N 113.316 -1.765 . . . . 0.0 115.452 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -125.75 103.8 8.01 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 104.117 -2.549 . . . . 0.0 104.117 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.1 mt -98.26 145.93 26.15 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 89.5 m -117.35 104.07 10.76 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 33.9 mt -102.3 134.27 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.972 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.4 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -112.99 157.39 40.81 Favored Pre-proline 0 N--CA 1.501 2.123 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -37.37 -53.22 1.38 Allowed 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 123.148 2.565 . . . . 0.0 114.881 -166.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.524 ' O ' ' NH2' ' A' ' 57' ' ' ARG . 13.1 p-10 -45.39 -36.63 4.4 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.491 ' CZ ' ' NE ' ' A' ' 57' ' ' ARG . 4.6 m-85 . . . . . 0 N--CA 1.498 1.931 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 93.3 m . . . . . 0 N--CA 1.496 1.839 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 23.8 mt -103.78 152.87 21.35 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 57.3 t -133.24 103.93 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.434 ' CD2' ' CD2' ' A' ' 26' ' ' TYR . 2.7 m-85 -96.85 158.64 15.33 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 118.163 -1.415 . . . . 0.0 108.437 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -123.57 88.03 2.85 Favored 'General case' 0 N--CA 1.491 1.607 1 N-CA-C 97.511 -4.996 . . . . 0.0 97.511 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.3 t -101.47 146.3 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.518 0 N-CA-C 116.626 2.084 . . . . 0.0 116.626 -178.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -123.54 104.57 9.13 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 112.541 -2.118 . . . . 0.0 106.076 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 35.8 tp -76.93 120.25 21.79 Favored 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 102.868 -3.012 . . . . 0.0 102.868 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.6 mt -87.16 -57.54 2.92 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 113.913 -1.494 . . . . 0.0 112.123 -179.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -170.27 -169.45 0.84 Allowed 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 119.502 -0.879 . . . . 0.0 111.455 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 22.0 mt -118.12 156.18 29.14 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 . . . . . 0 N--CA 1.504 2.266 0 CA-C-O 116.164 -1.874 . . . . 0.0 109.597 179.911 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.3 p . . . . . 0 N--CA 1.501 2.124 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -120.64 149.65 42.15 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.7 t -125.56 111.28 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -109.92 97.46 6.97 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 85.6 m -69.93 155.33 40.73 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 118.87 -1.132 . . . . 0.0 112.546 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 72.3 mt -123.31 -54.16 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 CA-C-N 113.493 -1.685 . . . . 0.0 107.123 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.431 ' O ' ' O ' ' A' ' 9' ' ' PRO . 43.2 m -123.66 83.16 53.91 Favored Pre-proline 0 N--CA 1.506 2.335 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.463 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 8' ' ' SER . 4.6 Cg_exo -35.92 163.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.51 2.14 . . . . 0.0 112.971 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.11 -172.08 15.15 Favored Glycine 0 N--CA 1.502 3.059 0 N-CA-C 107.872 -2.091 . . . . 0.0 107.872 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 12' ' ' GLY . 1.4 p30 -39.63 -51.69 2.25 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.867 -0.733 . . . . 0.0 112.701 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.526 ' N ' ' OD1' ' A' ' 11' ' ' ASP . . . 100.88 -1.13 55.21 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 62.9 mtt180 -118.3 -37.08 3.4 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.8 m -104.77 128.27 52.85 Favored 'General case' 0 N--CA 1.504 2.271 0 C-N-CA 119.828 -0.749 . . . . 0.0 111.757 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 27.4 m-85 -129.01 172.39 7.18 Favored Pre-proline 0 N--CA 1.502 2.145 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -63.41 128.88 23.64 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 CA-C-N 119.915 1.005 . . . . 0.0 110.504 167.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -118.0 167.58 11.32 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 122.279 1.038 . . . . 0.0 110.61 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.577 HH12 ' CD2' ' A' ' 50' ' ' LEU . 5.2 tpp180 -68.73 123.51 21.11 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.11 -1.405 . . . . 0.0 109.684 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.86 -19.39 18.49 Favored Glycine 0 N--CA 1.499 2.889 0 C-N-CA 120.336 -0.935 . . . . 0.0 110.845 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -112.17 178.13 4.41 Favored 'General case' 0 N--CA 1.507 2.414 0 CA-C-O 121.695 0.759 . . . . 0.0 112.57 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 42.1 m -111.07 166.96 10.63 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.3 m -118.48 147.25 43.82 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 67.9 t -122.96 100.55 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 101.71 -3.441 . . . . 0.0 101.71 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.2 m -120.47 145.86 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.325 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -121.49 141.59 50.88 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 102.517 -3.142 . . . . 0.0 102.517 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -160.39 176.97 11.06 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 118.487 -1.285 . . . . 0.0 112.263 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 97.4 m -136.97 121.89 18.85 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 101.368 -3.568 . . . . 0.0 101.368 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -110.41 113.24 3.48 Favored Glycine 0 N--CA 1.499 2.864 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 39.1 ttm . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 179.918 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 68.1 t80 . . . . . 0 N--CA 1.493 1.678 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -141.87 135.66 29.74 Favored 'General case' 0 N--CA 1.517 2.898 0 N-CA-C 114.822 1.415 . . . . 0.0 114.822 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -148.03 172.14 14.72 Favored 'General case' 0 N--CA 1.514 2.736 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 43.9 ttm -116.16 148.93 39.85 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.815 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.577 ' CD2' HH12 ' A' ' 18' ' ' ARG . 65.2 tp -90.77 119.37 30.94 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.966 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.19 35.22 4.55 Favored Glycine 0 N--CA 1.497 2.7 0 N-CA-C 108.591 -1.804 . . . . 0.0 108.591 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.488 ' O ' ' CB ' ' A' ' 53' ' ' GLN . 63.5 tttp -128.11 -54.16 1.29 Allowed 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.488 ' CB ' ' O ' ' A' ' 52' ' ' LYS . 63.7 tp60 100.56 66.21 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 O-C-N 125.757 1.91 . . . . 0.0 110.267 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -110.1 -36.64 5.79 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.422 ' O ' ' O ' ' A' ' 56' ' ' ILE . 11.5 m -118.73 152.43 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.737 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.422 ' O ' ' O ' ' A' ' 55' ' ' VAL . 3.8 pt -51.46 -174.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-N 114.176 -1.375 . . . . 0.0 110.043 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.539 ' O ' ' N ' ' A' ' 59' ' ' TRP . 45.2 ttm180 -84.58 -54.64 4.6 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 122.391 -0.193 . . . . 0.0 110.902 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -41.13 -20.57 0.04 OUTLIER Glycine 0 N--CA 1.492 2.422 0 C-N-CA 120.201 -1.0 . . . . 0.0 111.559 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.54 ' O ' ' N ' ' A' ' 63' ' ' VAL . 0.1 OUTLIER -92.25 -77.0 0.44 Allowed 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -35.76 -48.98 0.57 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.912 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -73.45 -54.63 7.82 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 105.739 -1.949 . . . . 0.0 105.739 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -53.68 -81.0 0.06 OUTLIER Glycine 0 N--CA 1.477 1.408 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.54 ' N ' ' O ' ' A' ' 59' ' ' TRP . 47.8 t -30.4 -46.83 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.458 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -46.02 -58.69 3.38 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 123.994 1.854 . . . . 0.0 110.177 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -50.12 -9.76 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 109.39 -3.55 . . . . 0.0 109.906 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.458 ' H ' ' C ' ' A' ' 64' ' ' ALA . 88.8 mtp -101.3 156.38 17.48 Favored 'General case' 0 N--CA 1.513 2.686 0 C-N-CA 119.102 -1.039 . . . . 0.0 108.528 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 83.0 p -115.97 148.93 39.57 Favored 'General case' 0 N--CA 1.506 2.335 0 CA-C-O 122.418 1.104 . . . . 0.0 113.003 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 90.6 t -41.57 94.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 112.846 -1.979 . . . . 0.0 113.962 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 113.28 16.92 7.98 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -108.17 144.08 36.09 Favored 'General case' 0 N--CA 1.507 2.379 0 C-N-CA 120.072 -0.651 . . . . 0.0 111.085 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 24.7 ttt85 -126.28 139.44 53.31 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -147.69 176.14 10.34 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-N 112.967 -1.924 . . . . 0.0 115.416 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -127.19 103.99 7.72 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 103.56 -2.756 . . . . 0.0 103.56 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.1 mp -97.78 146.03 25.8 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.161 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.3 m -119.34 107.15 13.03 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 104.505 -2.405 . . . . 0.0 104.505 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.4 mt -101.89 140.69 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.23 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.424 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 52.0 p -112.07 154.66 44.19 Favored Pre-proline 0 N--CA 1.504 2.229 0 CA-C-N 114.337 -1.302 . . . . 0.0 107.831 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -37.54 -54.77 1.15 Allowed 'Trans proline' 0 C--N 1.313 -1.316 0 C-N-CA 122.023 1.815 . . . . 0.0 113.836 -174.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.528 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 2.0 p-10 -34.12 -38.48 0.06 Allowed 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.895 -1.048 . . . . 0.0 113.095 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 . . . . . 0 N--CA 1.496 1.852 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.492 -179.584 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 66.3 m . . . . . 0 N--CA 1.498 1.946 0 CA-C-O 119.14 -0.457 . . . . 0.0 111.317 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 16.7 mt -101.54 143.3 31.71 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.8 t -131.6 112.65 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -106.25 163.3 12.92 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 122.519 1.152 . . . . 0.0 109.399 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -129.1 90.27 3.0 Favored 'General case' 0 N--CA 1.492 1.649 1 N-CA-C 98.222 -4.733 . . . . 0.0 98.222 179.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 16.1 t -105.68 151.43 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.51 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -127.13 103.35 7.39 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 111.806 -2.452 . . . . 0.0 107.979 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 42.4 tp -72.74 120.86 18.94 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 102.177 -3.268 . . . . 0.0 102.177 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 15.8 mt -90.22 -55.57 3.55 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -165.29 175.54 9.12 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.045 -1.062 . . . . 0.0 111.483 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.429 ' O ' ' OE1' ' A' ' 107' ' ' GLU . 18.2 mt -117.26 146.31 43.38 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.429 ' OE1' ' O ' ' A' ' 106' ' ' LEU . 5.7 mm-40 . . . . . 0 N--CA 1.505 2.32 0 CA-C-O 116.087 -1.911 . . . . 0.0 109.9 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.5 p . . . . . 0 N--CA 1.504 2.253 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.527 HE22 ' C ' ' A' ' 4' ' ' VAL . 4.7 tm0? -117.87 149.7 40.42 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.527 ' C ' HE22 ' A' ' 3' ' ' GLN . 40.5 t -123.51 101.73 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.524 ' OE2' ' NZ ' ' A' ' 73' ' ' LYS . 39.1 tt0 -103.24 107.88 18.87 Favored 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 93.9 m -83.65 154.14 23.86 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 122.229 1.014 . . . . 0.0 112.51 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 56.3 mt -124.15 -50.29 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 CA-C-N 113.313 -1.767 . . . . 0.0 107.282 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 9' ' ' PRO . 48.1 t -122.14 79.97 43.63 Favored Pre-proline 0 N--CA 1.507 2.384 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.498 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 8' ' ' SER . 5.8 Cg_exo -37.3 165.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.735 2.29 . . . . 0.0 113.528 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.43 -169.83 13.52 Favored Glycine 0 N--CA 1.5 2.914 0 N-CA-C 106.234 -2.746 . . . . 0.0 106.234 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.521 ' N ' ' OD1' ' A' ' 11' ' ' ASP . 13.0 p-10 -39.76 -60.68 0.95 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.518 -0.873 . . . . 0.0 112.678 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.22 14.32 18.85 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 106.844 -2.502 . . . . 0.0 106.844 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 45.6 mtm180 -128.9 -36.32 1.8 Allowed 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 114.468 -0.866 . . . . 0.0 113.324 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 36.6 m -107.65 138.36 44.01 Favored 'General case' 0 N--CA 1.508 2.468 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.457 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 61.7 m-85 -130.91 176.25 3.03 Favored Pre-proline 0 N--CA 1.497 1.916 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -69.84 133.61 25.85 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 CA-C-N 119.63 0.904 . . . . 0.0 111.149 164.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.0 mtmp? -119.48 162.32 19.07 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 122.313 1.054 . . . . 0.0 108.653 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 58.4 mtt-85 -61.86 144.28 55.12 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 114.39 -1.277 . . . . 0.0 107.714 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 107.17 -31.31 8.25 Favored Glycine 0 N--CA 1.498 2.781 0 C-N-CA 119.564 -1.303 . . . . 0.0 110.589 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.413 HE21 ' HB3' ' A' ' 106' ' ' LEU . 26.4 mt-30 -109.33 176.86 4.93 Favored 'General case' 0 N--CA 1.506 2.369 0 CA-C-O 121.781 0.801 . . . . 0.0 112.881 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 63.7 m -114.71 124.82 52.77 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 114.387 -1.279 . . . . 0.0 109.828 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 22.3 m -69.53 152.14 45.17 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.2 t -128.07 106.49 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 102.117 -3.29 . . . . 0.0 102.117 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.0 m -125.52 148.32 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.423 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -122.82 140.41 52.96 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 101.856 -3.387 . . . . 0.0 101.856 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -160.13 174.73 13.85 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 117.696 -1.602 . . . . 0.0 113.674 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.5 m -136.64 118.84 15.53 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 104.57 -2.382 . . . . 0.0 104.57 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.64 135.33 12.45 Favored Glycine 0 N--CA 1.503 3.112 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 63.9 mtp . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 122.102 0.953 . . . . 0.0 110.233 -179.821 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 72.2 t80 . . . . . 0 N--CA 1.5 2.036 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -140.9 133.22 28.25 Favored 'General case' 0 N--CA 1.514 2.731 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -139.04 174.92 10.01 Favored 'General case' 0 N--CA 1.515 2.779 0 CA-C-N 119.508 1.049 . . . . 0.0 111.771 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 44.6 ttm -115.24 134.66 54.94 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.3 tp -91.02 139.1 31.08 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 113.496 -1.684 . . . . 0.0 109.82 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 127.99 -36.26 2.55 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.284 -1.527 . . . . 0.0 109.284 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.411 ' O ' ' C ' ' A' ' 53' ' ' GLN . 19.7 tptp -130.38 42.67 3.23 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 119.147 -0.454 . . . . 0.0 112.087 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.411 ' C ' ' O ' ' A' ' 52' ' ' LYS . 8.4 tt0 23.98 77.32 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 124.578 1.173 . . . . 0.0 112.991 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.417 ' O ' ' OE1' ' A' ' 54' ' ' GLU . 8.1 tm-20 -84.3 -27.2 27.98 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.436 ' O ' ' O ' ' A' ' 56' ' ' ILE . 16.3 m -119.4 154.44 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.439 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.588 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.436 ' O ' ' O ' ' A' ' 55' ' ' VAL . 3.1 pt -45.8 174.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 C-N-CA 118.653 -1.219 . . . . 0.0 111.913 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.54 ' O ' ' N ' ' A' ' 59' ' ' TRP . 5.0 tpt180 -71.01 -58.96 3.06 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.883 -1.053 . . . . 0.0 113.171 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -32.52 -30.53 0.01 OUTLIER Glycine 0 N--CA 1.5 2.947 0 CA-C-O 122.825 1.236 . . . . 0.0 111.531 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.54 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.8 OUTLIER -92.2 -76.2 0.46 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 112.924 -1.638 . . . . 0.0 109.557 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.514 ' OE1' ' NH1' ' A' ' 57' ' ' ARG . 3.8 tm-20 -32.02 -50.3 0.21 Allowed 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.1 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -73.65 -56.39 5.06 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -51.35 -77.55 0.13 Allowed Glycine 0 N--CA 1.481 1.637 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.526 ' N ' ' O ' ' A' ' 59' ' ' TRP . 40.2 t -36.05 -45.87 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.435 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -50.09 -53.48 26.92 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 123.715 1.721 . . . . 0.0 109.618 179.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -61.97 0.29 0.41 Allowed 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 110.399 -3.091 . . . . 0.0 110.692 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.435 ' H ' ' C ' ' A' ' 64' ' ' ALA . 50.8 ttm -110.09 151.8 26.77 Favored 'General case' 0 N--CA 1.51 2.534 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 80.4 p -115.85 153.57 31.26 Favored 'General case' 0 N--CA 1.509 2.512 0 CA-C-O 122.832 1.301 . . . . 0.0 113.922 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 79.6 t -45.23 98.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-N 112.324 -2.216 . . . . 0.0 114.967 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.46 10.5 21.63 Favored Glycine 0 N--CA 1.498 2.795 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -108.58 152.13 25.18 Favored 'General case' 0 N--CA 1.509 2.517 0 CA-C-O 122.384 1.088 . . . . 0.0 111.249 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 -131.83 141.25 49.38 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 113.027 -1.897 . . . . 0.0 108.357 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -148.07 177.91 8.98 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 112.888 -1.96 . . . . 0.0 114.223 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.573 ' HZ3' ' HB3' ' A' ' 73' ' ' LYS . 6.3 ttpm? -122.8 103.55 8.71 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 102.986 -2.968 . . . . 0.0 102.986 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.7 mt -96.49 145.06 26.02 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 90.7 m -117.45 107.62 14.54 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 104.349 -2.463 . . . . 0.0 104.349 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 35.8 mt -101.55 140.05 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.665 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.454 ' HG ' ' CG ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -114.24 160.42 32.76 Favored Pre-proline 0 N--CA 1.497 1.887 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -45.09 -52.69 6.11 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.39 2.06 . . . . 0.0 112.736 -172.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.454 ' CG ' ' HG ' ' A' ' 77' ' ' SER . 24.5 p30 -39.66 -29.85 0.06 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 . . . . . 0 N--CA 1.501 2.106 0 N-CA-C 115.089 1.515 . . . . 0.0 115.089 -179.524 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 25.5 m . . . . . 0 N--CA 1.495 1.817 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 29.7 mt -109.17 151.65 26.19 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 104.929 -2.248 . . . . 0.0 104.929 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.4 t -134.81 102.7 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -96.49 163.38 13.07 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 117.83 -1.548 . . . . 0.0 107.812 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -125.41 87.7 2.74 Favored 'General case' 0 N--CA 1.492 1.633 1 N-CA-C 95.559 -5.719 . . . . 0.0 95.559 179.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 16.8 t -100.07 147.98 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.423 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -127.18 103.75 7.59 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 112.463 -2.153 . . . . 0.0 107.538 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 37.5 tp -74.39 114.37 12.68 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 102.866 -3.013 . . . . 0.0 102.866 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.1 mt -77.11 -53.97 7.11 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.187 -179.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 9.0 mtpt -174.5 -167.21 0.3 Allowed 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.64 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.413 ' HB3' HE21 ' A' ' 20' ' ' GLN . 22.5 mt -117.53 154.28 31.74 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 . . . . . 0 N--CA 1.501 2.123 0 CA-C-O 116.156 -1.878 . . . . 0.0 108.528 179.84 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.4 p . . . . . 0 N--CA 1.502 2.162 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -122.3 154.7 37.25 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 57.2 t -126.52 109.11 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 CA-C-N 115.197 -0.91 . . . . 0.0 108.567 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -109.9 96.0 5.96 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 89.7 m -69.89 156.33 39.24 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 118.813 -1.155 . . . . 0.0 113.106 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 69.1 mt -122.49 -54.72 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-N 113.361 -1.745 . . . . 0.0 107.356 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.416 ' O ' ' O ' ' A' ' 9' ' ' PRO . 48.6 m -123.85 82.43 55.26 Favored Pre-proline 0 N--CA 1.506 2.372 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.574 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.416 ' O ' ' O ' ' A' ' 8' ' ' SER . 5.3 Cg_exo -36.36 163.91 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.447 2.098 . . . . 0.0 113.176 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -118.02 -172.51 15.77 Favored Glycine 0 N--CA 1.5 2.961 0 N-CA-C 104.88 -3.288 . . . . 0.0 104.88 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.464 ' CG ' ' H ' ' A' ' 12' ' ' GLY . 10.6 p-10 -45.88 -58.46 3.51 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 118.635 1.218 . . . . 0.0 111.108 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.464 ' H ' ' CG ' ' A' ' 11' ' ' ASP . . . 106.5 27.02 5.68 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 107.246 -2.341 . . . . 0.0 107.246 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 57.7 mtt85 -132.39 -35.32 1.17 Allowed 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 114.457 -0.871 . . . . 0.0 111.871 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.8 m -111.28 136.8 49.86 Favored 'General case' 0 N--CA 1.506 2.326 0 CA-C-O 121.703 0.763 . . . . 0.0 112.848 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.448 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 59.0 m-85 -132.14 176.11 3.16 Favored Pre-proline 0 N--CA 1.496 1.851 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -70.91 140.24 37.92 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 CA-C-N 119.508 0.86 . . . . 0.0 111.484 163.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -122.74 169.95 10.55 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 121.716 0.77 . . . . 0.0 109.009 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.1 mtp-105 -70.23 126.34 29.37 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.078 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.42 -19.3 13.04 Favored Glycine 0 N--CA 1.498 2.775 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -108.56 174.12 6.02 Favored 'General case' 0 N--CA 1.504 2.225 0 CA-C-O 121.847 0.832 . . . . 0.0 111.391 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 42.5 m -118.82 129.93 55.49 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 114.039 -1.437 . . . . 0.0 107.753 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 59.3 m -78.75 149.45 32.69 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.5 t -121.85 101.6 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 103.12 -2.918 . . . . 0.0 103.12 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.0 m -121.59 150.69 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.49 0 N-CA-C 117.248 2.314 . . . . 0.0 117.248 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -123.31 107.04 11.22 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 179.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -127.59 170.15 12.95 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-O 123.237 1.494 . . . . 0.0 114.589 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 98.1 m -139.29 119.5 13.68 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 102.754 -3.054 . . . . 0.0 102.754 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.53 137.63 14.23 Favored Glycine 0 N--CA 1.501 3.001 0 C-N-CA 120.073 -1.06 . . . . 0.0 110.995 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 40.5 ttm . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 -179.964 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 67.2 t80 . . . . . 0 N--CA 1.5 2.041 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.49 116.29 14.03 Favored 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -132.92 172.63 12.35 Favored 'General case' 0 N--CA 1.512 2.63 0 C-N-CA 119.797 -0.761 . . . . 0.0 111.298 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.9 ttm -119.89 153.65 35.55 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.4 tp -90.93 125.27 35.72 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.822 -1.535 . . . . 0.0 110.491 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.18 -24.57 7.33 Favored Glycine 0 N--CA 1.501 2.983 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 54' ' ' GLU . 52.8 tttp -116.11 39.35 3.1 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' ' 52' ' ' LYS . 86.5 mt-30 1.49 61.77 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 125.794 1.934 . . . . 0.0 114.384 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 52' ' ' LYS . 43.7 tt0 -75.21 -23.38 57.61 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 113.715 -1.584 . . . . 0.0 107.406 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.5 m -113.15 -178.45 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 18.6 pt -90.26 167.04 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 C-N-CA 118.998 -1.081 . . . . 0.0 110.868 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.531 ' O ' ' N ' ' A' ' 59' ' ' TRP . 0.7 OUTLIER -45.69 -70.22 0.11 Allowed 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 114.311 -1.313 . . . . 0.0 111.138 -179.774 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -26.47 -36.66 0.01 OUTLIER Glycine 0 N--CA 1.496 2.654 0 O-C-N 125.175 1.547 . . . . 0.0 112.799 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.531 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.8 OUTLIER -83.59 -68.36 0.72 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.819 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.463 ' OE1' ' N ' ' A' ' 61' ' ' GLU . 10.1 tm-20 -33.73 -53.45 0.44 Allowed 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 113.934 -1.485 . . . . 0.0 110.721 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.503 ' OE2' ' NE2' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -73.71 -57.42 4.0 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 104.777 -2.305 . . . . 0.0 104.777 179.707 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -46.46 -78.57 0.08 OUTLIER Glycine 0 N--CA 1.485 1.963 0 C-N-CA 119.554 -1.307 . . . . 0.0 111.061 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 59' ' ' TRP . 32.3 t -39.63 -47.32 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 114.948 -0.626 . . . . 0.0 111.932 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.404 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -50.1 -51.27 44.32 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 123.265 1.507 . . . . 0.0 110.499 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.503 ' NE2' ' OE2' ' A' ' 61' ' ' GLU . 7.3 tt0 -65.94 2.98 0.9 Allowed 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 111.216 -2.72 . . . . 0.0 111.507 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.404 ' H ' ' C ' ' A' ' 64' ' ' ALA . 60.0 ttm -106.61 151.99 24.32 Favored 'General case' 0 N--CA 1.509 2.493 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 179.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 92.0 p -116.49 151.98 35.0 Favored 'General case' 0 N--CA 1.51 2.566 0 CA-C-O 122.69 1.233 . . . . 0.0 113.541 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 86.0 t -45.0 97.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 112.597 -2.092 . . . . 0.0 114.755 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.35 8.42 23.27 Favored Glycine 0 N--CA 1.5 2.937 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -105.4 145.31 30.97 Favored 'General case' 0 N--CA 1.506 2.361 0 CA-C-O 121.648 0.737 . . . . 0.0 111.566 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.9 ttt85 -126.17 141.45 51.93 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.261 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -149.54 177.52 9.66 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 113.007 -1.906 . . . . 0.0 115.507 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -127.03 105.14 8.39 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 103.07 -2.937 . . . . 0.0 103.07 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.41 HD12 ' N ' ' A' ' 74' ' ' LEU . 5.1 mp -101.67 151.55 21.89 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 119.766 -0.774 . . . . 0.0 109.882 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 86.3 m -121.61 121.73 38.05 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 25.6 mt -111.41 139.92 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.429 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 66.8 p -113.87 154.35 45.92 Favored Pre-proline 0 N--CA 1.503 2.22 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -37.55 -54.11 1.28 Allowed 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 121.784 1.656 . . . . 0.0 113.192 -174.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.52 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 0.9 OUTLIER -34.66 -35.87 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.445 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 . . . . . 0 N--CA 1.495 1.795 0 CA-C-N 114.685 -1.143 . . . . 0.0 112.049 -179.768 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 68.9 m . . . . . 0 N--CA 1.498 1.96 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 31.5 mt -116.82 149.59 39.74 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.6 t -132.37 123.03 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -115.77 157.13 24.8 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 122.023 0.916 . . . . 0.0 110.166 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -127.72 90.82 3.17 Favored 'General case' 0 N--CA 1.493 1.689 1 N-CA-C 99.194 -4.372 . . . . 0.0 99.194 179.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.4 t -105.32 151.34 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.54 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -127.92 98.09 5.03 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 112.327 -2.215 . . . . 0.0 107.838 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 56.0 tp -69.87 119.44 14.1 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 11.4 mt -82.35 -55.97 4.18 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 113.902 -1.499 . . . . 0.0 110.639 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -173.95 -168.09 0.39 Allowed 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 114.71 -1.132 . . . . 0.0 111.065 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 25.7 mt -114.82 160.02 19.94 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 . . . . . 0 N--CA 1.504 2.251 0 CA-C-O 116.241 -1.838 . . . . 0.0 108.236 179.705 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.503 2.217 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -124.31 151.89 43.74 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.0 t -123.09 115.79 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -117.78 97.67 5.96 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 94.7 m -69.75 156.52 38.87 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.154 -1.018 . . . . 0.0 112.734 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.1 mt -121.38 -58.52 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.531 ' CB ' ' NH1' ' A' ' 71' ' ' ARG . 48.3 m -121.64 84.6 43.07 Favored Pre-proline 0 N--CA 1.501 2.086 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.877 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 8' ' ' SER . 6.8 Cg_exo -36.23 163.79 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.397 2.065 . . . . 0.0 113.264 178.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.2 -173.63 14.7 Favored Glycine 0 N--CA 1.499 2.885 0 N-CA-C 105.555 -3.018 . . . . 0.0 105.555 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 11' ' ' ASP . 13.0 p-10 -39.71 -59.87 1.08 Allowed 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.809 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.15 20.06 11.76 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 105.356 -3.098 . . . . 0.0 105.356 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 46.4 mtm180 -128.21 -38.5 1.78 Allowed 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 113.699 -1.251 . . . . 0.0 112.733 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.0 m -108.18 135.29 49.77 Favored 'General case' 0 N--CA 1.505 2.315 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.441 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 67.6 m-85 -130.94 177.16 2.37 Favored Pre-proline 0 N--CA 1.495 1.796 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -66.22 153.27 78.7 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 CA-C-N 119.408 0.824 . . . . 0.0 110.806 160.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -122.65 170.88 9.58 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 121.759 0.79 . . . . 0.0 109.361 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 42.4 mtp-105 -78.22 96.63 5.27 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.096 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.73 10.56 3.92 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -114.74 172.09 7.25 Favored 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 74.7 m -121.86 112.27 18.13 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.25 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 22.5 m -69.54 147.35 50.92 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.758 0.789 . . . . 0.0 109.518 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.1 t -123.09 112.31 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 101.592 -3.484 . . . . 0.0 101.592 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.0 m -122.44 151.62 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -120.38 99.21 6.44 Favored 'General case' 0 N--CA 1.508 2.463 0 CA-C-N 112.71 -2.041 . . . . 0.0 106.473 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.41 ' CD2' ' CD2' ' A' ' 99' ' ' PHE . 28.0 p90 -132.29 173.8 10.89 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.6 m -134.7 117.92 16.56 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 102.628 -3.101 . . . . 0.0 102.628 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.57 120.8 6.73 Favored Glycine 0 N--CA 1.503 3.157 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 37.4 tpp . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -179.659 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 69.3 t80 . . . . . 0 N--CA 1.486 1.372 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -133.05 143.9 49.67 Favored 'General case' 0 N--CA 1.514 2.753 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -149.07 174.64 12.1 Favored 'General case' 0 N--CA 1.504 2.242 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.156 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 41.6 ttm -118.04 142.74 47.06 Favored 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.3 tp -91.02 120.63 32.16 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.953 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.08 24.18 9.95 Favored Glycine 0 N--CA 1.5 2.903 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.48 ' O ' ' CB ' ' A' ' 53' ' ' GLN . 15.6 tppt? -125.29 -55.94 1.54 Allowed 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.48 ' CB ' ' O ' ' A' ' 52' ' ' LYS . 46.3 tt0 100.81 68.85 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 O-C-N 126.0 2.063 . . . . 0.0 108.29 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -109.12 -36.24 6.11 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 113.939 -1.482 . . . . 0.0 107.459 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.415 ' O ' ' O ' ' A' ' 56' ' ' ILE . 15.8 m -111.05 151.77 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.415 ' O ' ' O ' ' A' ' 55' ' ' VAL . 15.7 pt -48.48 174.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 C-N-CA 118.276 -1.37 . . . . 0.0 111.038 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.544 ' O ' ' N ' ' A' ' 59' ' ' TRP . 46.5 ttm180 -69.59 -63.28 1.1 Allowed 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -28.78 -34.73 0.01 OUTLIER Glycine 0 N--CA 1.499 2.837 0 O-C-N 124.472 1.107 . . . . 0.0 112.356 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.544 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.5 OUTLIER -81.42 -74.53 0.33 Allowed 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 113.177 -1.511 . . . . 0.0 107.553 179.877 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.518 ' OE1' ' N ' ' A' ' 61' ' ' GLU . 10.9 tm-20 -33.86 -51.37 0.4 Allowed 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.742 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.518 ' N ' ' OE1' ' A' ' 60' ' ' GLU . 17.7 tp10 -72.7 -55.48 6.73 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 112.544 -2.116 . . . . 0.0 108.095 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -55.29 -72.74 0.51 Allowed Glycine 0 N--CA 1.477 1.408 0 C-N-CA 119.246 -1.454 . . . . 0.0 110.17 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.498 ' N ' ' O ' ' A' ' 59' ' ' TRP . 40.6 t -39.56 -49.56 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 120.126 -0.629 . . . . 0.0 112.308 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.477 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -47.22 -62.09 1.58 Allowed 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 124.037 1.875 . . . . 0.0 110.139 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -48.43 -12.7 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 109.654 -3.43 . . . . 0.0 108.764 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.477 ' H ' ' C ' ' A' ' 64' ' ' ALA . 52.1 ttp -108.95 156.01 20.21 Favored 'General case' 0 N--CA 1.509 2.479 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.4 p -110.94 161.76 15.52 Favored 'General case' 0 N--CA 1.509 2.519 0 N-CA-C 116.338 1.977 . . . . 0.0 116.338 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 86.2 t -56.32 102.58 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-N 110.727 -2.942 . . . . 0.0 113.482 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.56 6.61 23.27 Favored Glycine 0 N--CA 1.499 2.867 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -107.12 148.86 28.29 Favored 'General case' 0 N--CA 1.504 2.27 0 CA-C-O 122.097 0.951 . . . . 0.0 110.29 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.531 ' NH1' ' CB ' ' A' ' 8' ' ' SER . 34.8 mtm-85 -122.35 128.35 50.89 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 113.577 -1.647 . . . . 0.0 107.977 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -134.91 172.02 13.58 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -124.57 103.17 8.0 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 102.766 -3.05 . . . . 0.0 102.766 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.8 mt -98.46 146.93 25.25 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.1 m -117.52 111.06 18.73 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 102.473 -3.158 . . . . 0.0 102.473 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 27.2 mt -109.41 137.79 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-O 121.462 0.649 . . . . 0.0 111.53 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 27.1 p -104.63 152.51 39.44 Favored Pre-proline 0 N--CA 1.504 2.27 0 CA-C-N 113.804 -1.543 . . . . 0.0 110.082 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -47.86 -38.83 31.2 Favored 'Trans proline' 0 N--CA 1.488 1.177 0 C-N-CA 122.574 2.183 . . . . 0.0 113.332 -173.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.521 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 7.0 p-10 -48.81 -40.44 29.22 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.101 -0.64 . . . . 0.0 110.943 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.7 m-30 . . . . . 0 N--CA 1.49 1.527 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.884 -179.745 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 87.3 m . . . . . 0 N--CA 1.494 1.727 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 20.7 mt -97.75 147.19 24.63 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 103.893 -2.632 . . . . 0.0 103.893 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 56.5 t -132.71 124.11 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.41 ' CD2' ' CD2' ' A' ' 26' ' ' TYR . 2.0 m-85 -115.5 167.82 10.55 Favored 'General case' 0 N--CA 1.507 2.387 0 CA-C-O 123.264 1.507 . . . . 0.0 110.477 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -130.28 88.7 2.68 Favored 'General case' 0 N--CA 1.49 1.544 1 N-CA-C 98.222 -4.733 . . . . 0.0 98.222 179.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.5 t -100.95 151.46 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.442 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 -179.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 72.8 tt0 -127.27 97.36 4.88 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 112.377 -2.192 . . . . 0.0 106.806 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 43.8 tp -68.25 122.72 18.92 Favored 'General case' 0 N--CA 1.506 2.373 0 C-N-CA 115.591 -2.444 . . . . 0.0 104.936 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 11.4 mt -85.42 -62.29 1.56 Allowed 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.92 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.469 ' HG2' ' H ' ' A' ' 106' ' ' LEU . 34.1 ttpt -170.77 -175.24 1.76 Allowed 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 118.892 -1.123 . . . . 0.0 109.826 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.469 ' H ' ' HG2' ' A' ' 105' ' ' LYS . 24.2 mt -108.94 156.31 19.86 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 . . . . . 0 N--CA 1.504 2.271 0 CA-C-O 116.037 -1.935 . . . . 0.0 109.686 179.955 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.2 p . . . . . 0 N--CA 1.502 2.167 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -119.51 151.25 38.9 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 86.6 t -129.41 98.11 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.142 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -102.0 117.16 34.23 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 104.879 -2.267 . . . . 0.0 104.879 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 92.8 m -91.7 154.86 18.71 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 122.054 0.93 . . . . 0.0 111.729 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 62.5 mt -123.53 -51.11 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 9' ' ' PRO . 33.8 m -121.46 81.26 38.79 Favored Pre-proline 0 N--CA 1.509 2.516 0 C-N-CA 120.271 -0.572 . . . . 0.0 112.038 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 8' ' ' SER . 5.3 Cg_exo -37.33 164.75 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.373 2.049 . . . . 0.0 112.578 178.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.11 -171.97 14.37 Favored Glycine 0 N--CA 1.5 2.926 0 N-CA-C 107.048 -2.421 . . . . 0.0 107.048 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 12' ' ' GLY . 1.1 p30 -39.55 -52.29 2.18 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.707 -0.797 . . . . 0.0 112.689 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.476 ' N ' ' OD1' ' A' ' 11' ' ' ASP . . . 100.51 5.14 54.45 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 108.44 -1.864 . . . . 0.0 108.44 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 32.3 mtp85 -121.45 -35.76 3.2 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 42.4 m -107.7 138.43 43.94 Favored 'General case' 0 N--CA 1.509 2.488 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.452 ' N ' ' CD1' ' A' ' 15' ' ' PHE . 35.0 m-85 -133.09 175.41 3.73 Favored Pre-proline 0 N--CA 1.498 1.952 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -66.27 145.63 78.58 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 CA-C-N 119.769 0.953 . . . . 0.0 109.967 165.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -118.96 169.89 9.5 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 122.373 1.083 . . . . 0.0 111.969 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 25.3 ttt85 -79.2 103.18 8.96 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 113.805 -1.543 . . . . 0.0 109.89 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.44 -10.09 6.49 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 108.353 -1.899 . . . . 0.0 108.353 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -114.93 176.1 5.2 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 89.2 m -112.62 163.2 14.81 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 2.2 m -114.27 143.26 45.14 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 104.613 -2.366 . . . . 0.0 104.613 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.8 t -117.72 102.5 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 103.397 -2.816 . . . . 0.0 103.397 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.8 m -122.46 152.0 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.363 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 -129.63 128.12 41.98 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 102.721 -3.066 . . . . 0.0 102.721 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -139.77 176.23 8.91 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 115.335 1.605 . . . . 0.0 115.335 -179.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 91.7 m -132.87 121.55 23.08 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 103.246 -2.872 . . . . 0.0 103.246 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.84 123.15 7.55 Favored Glycine 0 N--CA 1.503 3.138 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 45.3 ttp . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.704 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 65.5 t80 . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm -131.48 119.92 22.25 Favored 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -138.83 170.94 15.09 Favored 'General case' 0 N--CA 1.513 2.688 0 C-N-CA 119.306 -0.958 . . . . 0.0 112.402 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 43.1 ttm -115.75 154.6 29.29 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.1 tp -90.92 120.71 32.15 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.86 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.89 12.84 48.66 Favored Glycine 0 N--CA 1.499 2.84 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.303 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.427 ' O ' ' OE2' ' A' ' 54' ' ' GLU . 59.3 tttm -121.85 23.06 10.24 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 23.5 69.4 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 114.617 -1.174 . . . . 0.0 113.782 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.427 ' OE2' ' O ' ' A' ' 52' ' ' LYS . 66.6 mm-40 -106.28 -35.86 7.04 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 56' ' ' ILE . 18.6 m -116.59 152.56 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 CA-C-O 121.513 0.673 . . . . 0.0 110.543 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.425 ' O ' ' O ' ' A' ' 55' ' ' VAL . 4.8 pt -48.98 177.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.706 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.541 ' O ' ' N ' ' A' ' 59' ' ' TRP . 18.2 ttm180 -71.4 -61.01 1.93 Allowed 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -24.05 -39.16 0.01 OUTLIER Glycine 0 N--CA 1.495 2.622 0 O-C-N 124.929 1.393 . . . . 0.0 112.497 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.541 ' N ' ' O ' ' A' ' 57' ' ' ARG . 1.1 m95 -83.01 -70.01 0.59 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.412 ' OE1' ' O ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -30.4 -59.82 0.19 Allowed 'General case' 0 N--CA 1.504 2.243 0 O-C-N 124.95 1.406 . . . . 0.0 110.05 -179.899 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -67.72 -52.66 35.03 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -49.77 -89.11 0.01 OUTLIER Glycine 0 N--CA 1.478 1.451 0 CA-C-N 114.363 -1.29 . . . . 0.0 111.282 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' A' ' 59' ' ' TRP . 40.0 t -31.76 -48.43 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.478 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -46.32 -59.79 2.72 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 124.169 1.937 . . . . 0.0 110.648 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -48.18 -11.77 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 109.305 -3.588 . . . . 0.0 109.276 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.478 ' H ' ' C ' ' A' ' 64' ' ' ALA . 85.2 mtp -97.53 156.12 16.65 Favored 'General case' 0 N--CA 1.513 2.691 0 C-N-CA 118.753 -1.179 . . . . 0.0 108.123 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 70' ' ' GLN . 73.1 p -120.11 147.66 44.58 Favored 'General case' 0 N--CA 1.51 2.544 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 59.1 t -36.8 96.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 CA-C-N 113.131 -1.849 . . . . 0.0 114.139 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.05 13.75 16.99 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 108.539 -1.824 . . . . 0.0 108.539 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 67' ' ' SER . 44.6 tt0 -109.68 138.17 46.43 Favored 'General case' 0 N--CA 1.503 2.225 0 CA-C-O 121.602 0.715 . . . . 0.0 109.795 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -126.83 138.99 53.42 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -144.43 178.01 8.24 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-N 112.006 -2.361 . . . . 0.0 114.6 -179.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.5 ttmp? -124.55 104.22 8.59 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 111.406 -2.634 . . . . 0.0 104.021 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.3 mp -100.42 146.0 27.54 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 119.676 -0.81 . . . . 0.0 108.878 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 90.2 m -121.72 104.47 9.62 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.512 ' H ' HD12 ' A' ' 76' ' ' ILE . 2.7 mp -95.41 141.71 14.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.206 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.3 p -112.97 153.59 45.2 Favored Pre-proline 0 N--CA 1.503 2.204 0 CA-C-N 114.631 -1.168 . . . . 0.0 108.011 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -40.25 -47.13 4.2 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.01 1.807 . . . . 0.0 112.964 -172.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.526 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 4.0 p-10 -43.88 -35.3 1.92 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 . . . . . 0 N--CA 1.498 1.937 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.644 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 93.0 m . . . . . 0 N--CA 1.497 1.907 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 22.2 mt -113.35 157.91 21.25 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 53.4 t -135.28 98.39 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -93.36 155.42 17.4 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -122.66 89.99 3.21 Favored 'General case' 0 N--CA 1.491 1.606 1 N-CA-C 95.466 -5.753 . . . . 0.0 95.466 179.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 12.5 t -100.7 148.32 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 C-N-CA 118.817 -1.153 . . . . 0.0 113.793 -178.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -124.94 109.12 12.61 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 112.429 -2.169 . . . . 0.0 107.49 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 55.5 tp -79.68 116.73 20.04 Favored 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 102.396 -3.187 . . . . 0.0 102.396 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.479 ' O ' ' NZ ' ' A' ' 105' ' ' LYS . 15.4 mt -88.13 -54.57 4.15 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -178.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.479 ' NZ ' ' O ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -164.58 177.82 7.81 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.326 -179.722 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 28.6 mt -118.07 153.58 33.5 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 . . . . . 0 N--CA 1.503 2.206 0 CA-C-O 115.733 -2.08 . . . . 0.0 108.63 179.849 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.466 ' C ' ' NE2' ' A' ' 3' ' ' GLN . 9.2 p . . . . . 0 N--CA 1.502 2.155 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.478 ' CD ' ' N ' ' A' ' 3' ' ' GLN . 16.0 mp0 -121.59 148.11 44.95 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 59.6 t -124.66 109.36 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.026 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -109.98 97.03 6.62 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 88.6 m -69.91 156.72 38.67 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 118.961 -1.095 . . . . 0.0 112.643 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -121.84 -54.77 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-N 113.569 -1.65 . . . . 0.0 107.213 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.422 ' O ' ' O ' ' A' ' 9' ' ' PRO . 37.0 t -124.1 82.66 56.46 Favored Pre-proline 0 N--CA 1.506 2.345 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.821 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 8' ' ' SER . 2.0 Cg_exo -35.84 161.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.336 2.024 . . . . 0.0 112.574 178.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.52 -171.25 14.74 Favored Glycine 0 N--CA 1.502 3.036 0 N-CA-C 107.426 -2.269 . . . . 0.0 107.426 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 68' ' ' VAL . 0.7 OUTLIER -39.92 -65.18 0.42 Allowed 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.589 0.709 . . . . 0.0 112.351 -179.969 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.95 16.16 16.14 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 105.809 -2.916 . . . . 0.0 105.809 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.0 mtp85 -125.47 -44.18 1.86 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 114.028 -1.086 . . . . 0.0 111.963 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.0 m -103.96 133.23 49.27 Favored 'General case' 0 N--CA 1.504 2.247 0 CA-C-O 121.522 0.677 . . . . 0.0 112.085 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.43 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 41.9 m-85 -130.97 175.21 3.86 Favored Pre-proline 0 N--CA 1.501 2.085 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -71.44 150.66 58.4 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 N-CA-C 109.485 -1.006 . . . . 0.0 109.485 164.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -120.24 172.39 7.82 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-O 121.929 0.871 . . . . 0.0 110.84 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 19.6 ttp180 -81.23 96.67 7.33 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.382 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.16 -1.24 5.77 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 108.597 -1.801 . . . . 0.0 108.597 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.5 ' O ' ' SD ' ' A' ' 49' ' ' MET . 82.0 mt-30 -114.63 172.56 6.95 Favored 'General case' 0 N--CA 1.503 2.209 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.2 m -108.67 153.08 23.93 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.3 m -111.27 141.5 44.72 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 104.972 -2.233 . . . . 0.0 104.972 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.6 t -118.8 109.16 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 100.689 -3.819 . . . . 0.0 100.689 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.444 HG21 ' CH2' ' A' ' 59' ' ' TRP . 5.4 m -124.36 155.46 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 125.751 1.907 . . . . 0.0 113.058 -179.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 -130.76 107.3 9.05 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 104.197 -2.52 . . . . 0.0 104.197 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.419 ' CD2' ' CD2' ' A' ' 99' ' ' PHE . 27.2 p90 -132.59 177.29 7.73 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 95.9 m -137.49 116.41 12.36 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 111.444 -2.616 . . . . 0.0 104.959 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -111.5 114.5 3.65 Favored Glycine 0 N--CA 1.501 2.992 0 N-CA-C 107.642 -2.183 . . . . 0.0 107.642 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 38.9 ttm . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 -179.859 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 56.9 t80 . . . . . 0 N--CA 1.497 1.904 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 31.9 mtmm -142.51 122.89 13.94 Favored 'General case' 0 N--CA 1.504 2.247 0 CA-C-O 118.782 -0.628 . . . . 0.0 110.667 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -133.17 167.07 21.02 Favored 'General case' 0 N--CA 1.513 2.678 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.5 ' SD ' ' O ' ' A' ' 20' ' ' GLN . 47.3 tpp -107.37 129.39 54.92 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 113.492 -1.685 . . . . 0.0 111.824 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.7 tp -90.66 146.39 24.07 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.157 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 129.51 -42.28 1.44 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 107.317 -2.313 . . . . 0.0 107.317 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 54' ' ' GLU . 6.2 tmtt? -120.39 43.57 2.69 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 3.63 58.65 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.094 0 O-C-N 125.64 1.838 . . . . 0.0 114.807 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.534 ' N ' ' O ' ' A' ' 52' ' ' LYS . 11.3 pt-20 -64.01 -6.29 6.01 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 118.759 -1.176 . . . . 0.0 110.738 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 56' ' ' ILE . 33.7 m -116.38 158.94 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.425 ' O ' ' O ' ' A' ' 55' ' ' VAL . 17.3 pt -49.31 174.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 C-N-CA 117.83 -1.548 . . . . 0.0 110.118 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.541 ' O ' ' N ' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -70.55 -60.53 2.21 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 57' ' ' ARG . . . -20.52 -44.17 0.01 OUTLIER Glycine 0 N--CA 1.502 3.046 0 O-C-N 125.407 1.692 . . . . 0.0 112.495 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.541 ' N ' ' O ' ' A' ' 57' ' ' ARG . 1.5 m95 -73.99 -75.78 0.15 Allowed 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 111.668 -2.266 . . . . 0.0 108.813 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 59' ' ' TRP . 4.1 tm-20 -22.54 -55.66 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 126.303 2.252 . . . . 0.0 110.898 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -78.72 -53.07 7.52 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 113.219 -1.81 . . . . 0.0 106.592 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -51.35 -73.24 0.4 Allowed Glycine 0 N--CA 1.482 1.709 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.526 ' N ' ' O ' ' A' ' 59' ' ' TRP . 24.9 t -44.14 -49.76 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 119.258 -0.977 . . . . 0.0 111.503 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.471 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -45.22 -61.88 1.48 Allowed 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 123.864 1.793 . . . . 0.0 111.181 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -46.63 -13.63 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 109.913 -3.312 . . . . 0.0 109.244 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.471 ' H ' ' C ' ' A' ' 64' ' ' ALA . 41.9 mtm -103.32 154.8 18.99 Favored 'General case' 0 N--CA 1.513 2.717 0 C-N-CA 118.847 -1.141 . . . . 0.0 109.098 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 82.7 p -116.41 153.59 31.79 Favored 'General case' 0 N--CA 1.505 2.286 0 CA-C-O 122.624 1.202 . . . . 0.0 113.428 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.417 ' O ' ' OD1' ' A' ' 11' ' ' ASP . 85.8 t -43.07 95.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 112.416 -2.175 . . . . 0.0 114.388 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.04 16.42 7.88 Favored Glycine 0 N--CA 1.497 2.759 0 N-CA-C 108.816 -1.714 . . . . 0.0 108.816 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -108.38 142.81 38.17 Favored 'General case' 0 N--CA 1.506 2.356 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.741 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 24.2 ttt85 -126.72 141.65 51.78 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -149.46 177.4 9.74 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 116.334 1.976 . . . . 0.0 116.334 -179.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -127.81 104.5 7.86 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 103.326 -2.842 . . . . 0.0 103.326 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.407 HD12 ' N ' ' A' ' 74' ' ' LEU . 5.2 mp -101.8 146.65 27.5 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 119.606 -0.838 . . . . 0.0 109.194 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 73.2 m -117.05 104.0 10.81 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 102.309 -3.219 . . . . 0.0 102.309 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 21.4 mt -102.86 138.73 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.14 163.7 20.62 Favored Pre-proline 0 N--CA 1.503 2.219 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.865 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -37.74 -50.94 1.87 Allowed 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 122.561 2.174 . . . . 0.0 113.184 -175.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 80' ' ' TYR . 1.7 p30 -44.24 -42.72 6.76 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 120.191 -0.603 . . . . 0.0 111.608 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.476 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 6.8 m-85 . . . . . 0 N--CA 1.496 1.846 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.674 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 99.9 m . . . . . 0 N--CA 1.506 2.343 0 CA-C-O 118.324 -0.846 . . . . 0.0 110.544 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.8 mt -96.72 152.61 18.5 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.5 t -134.78 115.12 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.419 ' CD2' ' CD2' ' A' ' 26' ' ' TYR . 2.0 m-85 -108.15 163.09 13.46 Favored 'General case' 0 N--CA 1.504 2.232 0 CA-C-O 122.968 1.366 . . . . 0.0 109.477 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -128.78 90.03 2.98 Favored 'General case' 0 N--CA 1.492 1.664 1 N-CA-C 98.186 -4.746 . . . . 0.0 98.186 179.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.3 t -102.21 148.31 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.558 0 N-CA-C 116.89 2.181 . . . . 0.0 116.89 -178.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -129.72 99.7 5.23 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 112.922 -1.944 . . . . 0.0 108.626 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 50.4 tp -73.28 119.39 17.45 Favored 'General case' 0 N--CA 1.504 2.253 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.2 mt -85.66 -60.07 2.13 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.643 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.473 ' HG2' ' H ' ' A' ' 106' ' ' LEU . 60.4 tttm -168.72 -175.89 2.57 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.813 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.473 ' H ' ' HG2' ' A' ' 105' ' ' LYS . 20.9 mt -109.03 160.6 15.91 Favored 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 . . . . . 0 N--CA 1.503 2.216 0 CA-C-O 115.827 -2.035 . . . . 0.0 109.4 179.838 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.503 2.223 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -121.87 154.53 36.96 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.6 t -126.98 114.12 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-N 112.929 -1.941 . . . . 0.0 109.3 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.528 ' OE2' ' NZ ' ' A' ' 73' ' ' LYS . 37.7 tt0 -118.06 101.52 8.31 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 42.0 m -70.04 150.73 46.32 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 118.938 -1.105 . . . . 0.0 113.623 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 77.2 mt -110.99 -55.35 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.9 t -129.65 90.78 42.57 Favored Pre-proline 0 N--CA 1.504 2.232 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.235 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -37.75 165.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 122.189 1.926 . . . . 0.0 112.54 174.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.6 -113.78 2.47 Favored Glycine 0 N--CA 1.5 2.938 0 N-CA-C 106.344 -2.702 . . . . 0.0 106.344 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.507 ' CG ' ' H ' ' A' ' 12' ' ' GLY . 9.8 p-10 -100.61 -62.5 1.23 Allowed 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.507 ' H ' ' CG ' ' A' ' 11' ' ' ASP . . . 104.88 28.05 5.76 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 42.4 mtp-105 -133.61 -39.0 0.9 Allowed 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.4 m -107.53 131.3 54.48 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.425 0.631 . . . . 0.0 112.279 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.461 ' N ' ' CD1' ' A' ' 15' ' ' PHE . 23.1 m-85 -129.73 174.18 4.89 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -71.48 139.15 33.94 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 CA-C-N 119.857 0.985 . . . . 0.0 111.801 166.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -120.07 171.98 8.08 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 122.205 1.003 . . . . 0.0 111.271 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.9 ttt85 -71.28 104.31 3.1 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.189 -1.369 . . . . 0.0 111.588 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.33 8.84 5.77 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -121.97 174.15 7.08 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 57.5 m -119.44 114.56 22.5 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.544 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 58.5 m -69.26 153.28 43.9 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 24.6 t -128.06 102.46 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 103.677 -2.712 . . . . 0.0 103.677 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.9 m -122.48 149.66 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.465 0 N-CA-C 116.662 2.097 . . . . 0.0 116.662 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -128.35 112.19 14.17 Favored 'General case' 0 N--CA 1.51 2.528 0 N-CA-C 103.996 -2.594 . . . . 0.0 103.996 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' A' ' 26' ' ' TYR . 36.1 p90 -133.7 -175.07 3.7 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 90.8 m -140.17 123.25 16.72 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 102.06 -3.311 . . . . 0.0 102.06 179.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -114.41 125.09 6.68 Favored Glycine 0 N--CA 1.507 3.392 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.8 tmm? . . . . . 0 N--CA 1.493 1.692 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -179.874 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 59.0 t80 . . . . . 0 N--CA 1.497 1.89 0 CA-C-O 119.73 -0.176 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 31.2 mttm -145.08 137.4 25.95 Favored 'General case' 0 N--CA 1.512 2.659 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -136.45 165.72 25.15 Favored 'General case' 0 N--CA 1.516 2.85 0 CA-C-N 119.972 1.26 . . . . 0.0 110.85 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 47.8 ttp -117.15 86.84 2.58 Favored 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 116.867 2.173 . . . . 0.0 116.867 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.4 tp -32.14 125.12 0.29 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 124.215 0.947 . . . . 0.0 112.867 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 129.48 -30.77 3.55 Favored Glycine 0 N--CA 1.499 2.84 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.48 ' O ' ' N ' ' A' ' 54' ' ' GLU . 80.1 tttt -121.03 43.76 2.7 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 52' ' ' LYS . 46.0 tt0 3.19 62.68 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.163 0 O-C-N 126.031 2.082 . . . . 0.0 113.306 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' A' ' 52' ' ' LYS . 43.8 tt0 -72.36 -24.77 61.32 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 113.541 -1.663 . . . . 0.0 106.686 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.4 m -113.8 156.5 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.818 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.7 pt -60.2 172.69 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 118.153 -1.419 . . . . 0.0 110.03 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.559 ' O ' ' N ' ' A' ' 59' ' ' TRP . 24.2 ttt85 -65.56 -59.99 3.39 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 118.214 -0.898 . . . . 0.0 112.624 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -28.13 -34.91 0.01 OUTLIER Glycine 0 N--CA 1.506 3.336 0 CA-C-O 122.916 1.287 . . . . 0.0 111.444 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.559 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.5 OUTLIER -83.01 -79.84 0.18 Allowed 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 112.24 -1.98 . . . . 0.0 107.746 179.829 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -28.48 -49.39 0.07 Allowed 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 113.347 -1.752 . . . . 0.0 110.692 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -77.33 -54.54 6.34 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -52.64 -74.95 0.25 Allowed Glycine 0 N--CA 1.482 1.752 0 N-CA-C 108.553 -1.819 . . . . 0.0 108.553 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.518 ' N ' ' O ' ' A' ' 59' ' ' TRP . 25.9 t -38.32 -45.47 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.612 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.8 -44.2 66.45 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 122.799 1.285 . . . . 0.0 109.445 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.443 ' N ' ' O ' ' A' ' 62' ' ' GLY . 6.7 tt0 -74.6 8.79 2.1 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 111.966 -2.379 . . . . 0.0 111.463 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 94.4 mtp -116.61 149.66 39.34 Favored 'General case' 0 N--CA 1.507 2.389 0 N-CA-C 104.664 -2.347 . . . . 0.0 104.664 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 80.3 p -116.52 153.87 31.4 Favored 'General case' 0 N--CA 1.51 2.571 0 CA-C-O 122.934 1.349 . . . . 0.0 113.899 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 63.0 t -43.03 100.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 112.04 -2.345 . . . . 0.0 116.15 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.26 4.52 28.97 Favored Glycine 0 N--CA 1.5 2.909 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.401 ' OE1' ' C ' ' A' ' 70' ' ' GLN . 0.8 OUTLIER -110.17 145.16 37.72 Favored 'General case' 0 N--CA 1.507 2.42 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.977 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -128.16 145.48 51.01 Favored 'General case' 0 N--CA 1.508 2.435 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.611 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -144.11 -177.72 5.59 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-N 112.776 -2.011 . . . . 0.0 115.538 -179.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.55 ' HB3' ' HZ3' ' A' ' 73' ' ' LYS . 6.6 ttpm? -125.49 106.79 10.04 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 101.767 -3.42 . . . . 0.0 101.767 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.1 mt -101.25 143.54 31.2 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 59.0 m -115.17 117.01 29.31 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 102.021 -3.326 . . . . 0.0 102.021 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 30.0 mt -110.82 142.4 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.416 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 32.7 p -114.31 158.32 40.09 Favored Pre-proline 0 N--CA 1.506 2.341 0 CA-C-N 114.427 -1.26 . . . . 0.0 108.141 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -35.0 -55.31 0.57 Allowed 'Trans proline' 0 C--N 1.315 -1.202 0 C-N-CA 121.871 1.714 . . . . 0.0 113.852 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.524 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 3.9 p-10 -42.15 -41.97 2.84 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.332 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.486 ' CE2' ' NE ' ' A' ' 57' ' ' ARG . 7.5 m-85 . . . . . 0 N--CA 1.499 1.984 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 29.5 m . . . . . 0 N--CA 1.499 1.998 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.2 mt -115.13 155.75 26.52 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 59.0 t -139.43 97.72 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -92.07 167.04 12.36 Favored 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 117.586 -1.646 . . . . 0.0 108.992 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -130.04 86.87 2.45 Favored 'General case' 0 N--CA 1.493 1.678 1 N-CA-C 97.387 -5.042 . . . . 0.0 97.387 178.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.401 HG12 ' N ' ' A' ' 102' ' ' GLU . 14.7 t -100.8 149.82 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.401 ' N ' HG12 ' A' ' 101' ' ' VAL . 87.9 tt0 -125.81 101.58 6.91 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 112.04 -2.345 . . . . 0.0 107.406 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 50.4 tp -74.83 113.8 12.53 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 103.35 -2.833 . . . . 0.0 103.35 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 9.3 mt -76.71 -55.19 5.72 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 113.315 -1.766 . . . . 0.0 111.479 -179.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -176.24 -168.18 0.25 Allowed 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 118.622 -1.231 . . . . 0.0 110.423 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.4 mt -115.21 150.25 36.42 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 . . . . . 0 N--CA 1.502 2.132 0 CA-C-O 115.79 -2.052 . . . . 0.0 109.24 179.892 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.622 ' N ' ' CE1' ' A' ' 80' ' ' TYR . . . . . . . . 0 N--CA 1.487 2.06 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.1 p -116.82 150.17 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -124.07 154.96 39.18 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.4 t -124.86 112.76 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -114.31 90.97 3.47 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 97.9 m -69.78 154.84 41.43 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 119.008 -1.077 . . . . 0.0 112.425 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 58.9 mt -123.58 -52.01 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 CA-C-N 113.859 -1.519 . . . . 0.0 107.407 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 9' ' ' PRO . 38.9 t -122.03 80.66 42.99 Favored Pre-proline 0 N--CA 1.505 2.324 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.041 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 8' ' ' SER . 6.4 Cg_exo -36.96 166.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.812 2.341 . . . . 0.0 113.718 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -115.81 -172.68 16.99 Favored Glycine 0 N--CA 1.5 2.921 0 N-CA-C 105.75 -2.94 . . . . 0.0 105.75 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.462 ' CG ' ' H ' ' A' ' 12' ' ' GLY . 11.7 p-10 -44.73 -58.35 3.13 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 118.405 1.102 . . . . 0.0 111.173 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.462 ' H ' ' CG ' ' A' ' 11' ' ' ASP . . . 107.65 24.26 6.49 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 107.636 -2.186 . . . . 0.0 107.636 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 -128.83 -37.56 1.73 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 114.532 -0.834 . . . . 0.0 111.249 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.4 m -111.07 138.34 47.61 Favored 'General case' 0 N--CA 1.507 2.416 0 CA-C-O 121.833 0.825 . . . . 0.0 112.834 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.458 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 48.5 m-85 -133.07 173.78 5.48 Favored Pre-proline 0 N--CA 1.495 1.786 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -61.53 134.57 52.01 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 N-CA-C 110.09 -0.773 . . . . 0.0 110.09 164.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.412 ' NZ ' ' HB3' ' A' ' 17' ' ' LYS . 8.2 mtpm? -115.3 170.21 8.56 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.943 0.877 . . . . 0.0 110.484 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.9 mtm180 -73.64 97.01 2.56 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.198 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 122.84 18.98 3.1 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -115.82 170.1 8.72 Favored 'General case' 0 N--CA 1.504 2.245 0 CA-C-O 121.83 0.824 . . . . 0.0 110.116 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 95.4 m -125.1 110.33 14.01 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 114.481 -1.236 . . . . 0.0 107.915 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 27.5 m -69.76 149.29 48.13 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.16 -1.016 . . . . 0.0 110.074 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 93.3 t -125.17 97.8 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 101.14 -3.652 . . . . 0.0 101.14 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.413 HG21 ' CH2' ' A' ' 59' ' ' TRP . 2.8 m -121.13 151.26 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 48.3 t60 -130.24 116.55 18.54 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 104.675 -2.342 . . . . 0.0 104.675 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -134.01 179.33 6.31 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 123.044 1.402 . . . . 0.0 111.966 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.438 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 51.2 m -141.91 126.11 17.46 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 101.016 -3.698 . . . . 0.0 101.016 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -103.09 129.95 10.07 Favored Glycine 0 N--CA 1.5 2.93 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 39.5 ttm -129.59 170.54 13.63 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 30.4 mt -116.02 173.51 6.53 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -29.34 -61.76 0.13 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 125.053 1.47 . . . . 0.0 113.719 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -160.61 41.2 0.17 Allowed 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 114.628 -1.169 . . . . 0.0 109.641 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -119.36 -79.23 0.61 Allowed Glycine 0 N--CA 1.502 3.085 0 C-N-CA 119.274 -1.441 . . . . 0.0 113.763 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.47 -167.7 1.96 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -90.81 139.4 30.77 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.004 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.467 ' CD2' ' CG ' ' A' ' 37' ' ' ASP . 8.8 p90 -126.04 -38.13 2.2 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 112.968 -1.924 . . . . 0.0 107.303 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.467 ' CG ' ' CD2' ' A' ' 36' ' ' PHE . 43.5 m-20 -128.81 87.16 2.53 Favored 'General case' 0 N--CA 1.506 2.357 0 CA-C-N 115.086 -0.961 . . . . 0.0 113.511 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 51.7 m -107.08 163.46 12.97 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.579 ' O ' ' N ' ' A' ' 41' ' ' ASP . 96.0 p -123.2 51.62 1.44 Allowed 'General case' 0 N--CA 1.503 2.184 0 CA-C-O 118.885 -0.579 . . . . 0.0 110.281 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -28.64 73.68 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 126.472 2.358 . . . . 0.0 112.838 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.579 ' N ' ' O ' ' A' ' 39' ' ' SER . 7.5 t70 -18.98 -58.23 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.025 0 CA-C-N 110.505 -3.043 . . . . 0.0 113.046 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.406 ' C ' ' O ' ' A' ' 41' ' ' ASP . 41.0 ttt-85 -19.58 -45.33 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 O-C-N 125.414 1.696 . . . . 0.0 113.479 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.498 ' N ' ' O ' ' A' ' 41' ' ' ASP . 75.2 m-20 -108.67 58.06 0.61 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.21 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.563 ' HD2' ' HZ2' ' A' ' 47' ' ' LYS . 38.4 ttpt 56.33 127.08 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.495 0 CA-C-N 114.145 -1.389 . . . . 0.0 112.266 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' A' ' 44' ' ' LYS . 23.1 Cg_exo -42.48 -157.59 0.0 OUTLIER 'Trans proline' 0 N--CA 1.488 1.181 0 C-N-CA 122.489 2.126 . . . . 0.0 116.011 168.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -111.03 144.69 39.75 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 112.858 -1.974 . . . . 0.0 110.551 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.563 ' HZ2' ' HD2' ' A' ' 44' ' ' LYS . 34.4 mtmm -137.0 122.02 18.98 Favored 'General case' 0 N--CA 1.507 2.415 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.542 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -138.98 177.09 8.14 Favored 'General case' 0 N--CA 1.509 2.495 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.765 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 43.1 ttp -121.29 156.94 31.46 Favored 'General case' 0 N--CA 1.503 2.207 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.966 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.9 tp -90.95 120.32 31.86 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.15 12.71 30.8 Favored Glycine 0 N--CA 1.501 2.969 0 C-N-CA 121.059 -0.591 . . . . 0.0 114.04 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.475 ' O ' ' N ' ' A' ' 54' ' ' GLU . 59.3 tttp -128.24 45.81 2.7 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 118.349 1.074 . . . . 0.0 108.945 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' A' ' 52' ' ' LYS . 20.5 pt20 4.16 61.18 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 115.991 1.849 . . . . 0.0 115.991 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.475 ' N ' ' O ' ' A' ' 52' ' ' LYS . 6.8 mm-40 -102.98 -29.98 11.07 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 56' ' ' ILE . 13.0 m -114.87 155.76 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.426 ' O ' ' O ' ' A' ' 55' ' ' VAL . 17.0 pt -51.74 -179.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 C-N-CA 119.065 -1.054 . . . . 0.0 109.001 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.536 ' O ' ' N ' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -80.45 -58.59 3.05 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.44 ' H ' ' HB3' ' A' ' 80' ' ' TYR . . . -28.3 -35.93 0.01 OUTLIER Glycine 0 N--CA 1.501 3.025 0 O-C-N 124.531 1.145 . . . . 0.0 111.53 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.536 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.9 OUTLIER -78.78 -75.72 0.22 Allowed 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 113.236 -1.482 . . . . 0.0 107.237 179.822 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 59' ' ' TRP . 71.1 tt0 -25.87 -55.01 0.06 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 125.839 1.962 . . . . 0.0 110.828 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.405 ' N ' HH11 ' A' ' 57' ' ' ARG . 37.8 tt0 -75.27 -54.7 6.66 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -51.04 -75.09 0.23 Allowed Glycine 0 N--CA 1.482 1.753 0 C-N-CA 119.564 -1.303 . . . . 0.0 111.168 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' A' ' 59' ' ' TRP . 28.9 t -41.58 -49.91 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 119.594 -0.842 . . . . 0.0 112.292 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.467 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -45.9 -60.59 2.16 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 124.056 1.884 . . . . 0.0 111.157 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -48.68 -11.28 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 109.416 -3.538 . . . . 0.0 109.195 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.467 ' H ' ' C ' ' A' ' 64' ' ' ALA . 49.8 mtm -99.82 160.64 14.15 Favored 'General case' 0 N--CA 1.517 2.887 0 C-N-CA 118.518 -1.273 . . . . 0.0 108.823 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 96.7 p -115.32 150.63 35.97 Favored 'General case' 0 N--CA 1.51 2.539 0 CA-C-O 122.584 1.183 . . . . 0.0 113.919 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 63.8 t -49.21 99.63 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 112.641 -2.072 . . . . 0.0 113.681 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 113.95 9.27 16.38 Favored Glycine 0 N--CA 1.499 2.834 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -107.8 154.14 21.96 Favored 'General case' 0 N--CA 1.506 2.33 0 CA-C-O 122.428 1.109 . . . . 0.0 111.164 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.0 ttp180 -131.46 140.12 49.52 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 112.83 -1.986 . . . . 0.0 107.224 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -148.44 177.58 9.33 Favored 'General case' 0 N--CA 1.502 2.158 0 CA-C-N 112.947 -1.933 . . . . 0.0 115.496 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -126.47 105.28 8.65 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 111.295 -2.684 . . . . 0.0 103.936 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.4 mt -99.77 152.57 19.96 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 93.7 m -124.57 119.81 30.15 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 25.7 mt -112.13 140.28 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.417 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 35.1 p -111.13 155.53 42.44 Favored Pre-proline 0 N--CA 1.506 2.343 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.185 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -37.85 -51.59 1.84 Allowed 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 122.189 1.926 . . . . 0.0 114.695 -175.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 18.0 p-10 -39.28 -41.28 0.87 Allowed 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.622 ' CE1' ' N ' ' A' ' 1' ' ' GLY . 3.1 m-85 -100.79 -50.85 3.73 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.312 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -37.13 -91.9 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 114.827 1.418 . . . . 0.0 114.827 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -125.24 13.06 8.28 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.613 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 110.78 -104.71 1.8 Allowed Glycine 0 N--CA 1.502 3.098 0 N-CA-C 111.953 -0.459 . . . . 0.0 111.953 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -126.45 -52.23 1.49 Allowed 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 121.384 0.611 . . . . 0.0 109.931 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 97.5 m -113.06 158.5 20.25 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.897 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -130.34 -129.97 3.16 Favored Glycine 0 N--CA 1.5 2.955 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 91' ' ' ILE . 21.9 m80 -112.33 161.36 26.47 Favored Pre-proline 0 N--CA 1.502 2.173 0 CA-C-N 114.632 -0.784 . . . . 0.0 109.237 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -94.21 34.28 0.19 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.818 2.346 . . . . 0.0 108.602 164.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -130.89 -52.96 0.1 OUTLIER Glycine 0 N--CA 1.5 2.947 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.772 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.9 mt -116.8 -47.28 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.321 0 CA-C-O 121.937 0.875 . . . . 0.0 109.027 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.496 ' O ' ' N ' ' A' ' 87' ' ' HIS . 23.0 mm -114.17 77.02 3.77 Favored Pre-proline 0 N--CA 1.508 2.44 0 CA-C-N 113.94 -1.482 . . . . 0.0 113.316 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_exo -35.72 158.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.695 2.263 . . . . 0.0 110.468 162.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.407 ' O ' ' C ' ' A' ' 94' ' ' HIS . 57.5 Cg_endo -58.02 168.14 3.78 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 121.664 1.576 . . . . 0.0 110.051 177.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.407 ' C ' ' O ' ' A' ' 93' ' ' PRO . 90.5 m-70 9.64 60.02 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.237 0 O-C-N 125.572 1.795 . . . . 0.0 114.682 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -118.26 80.47 1.53 Allowed 'General case' 0 N--CA 1.5 2.068 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.22 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 62.3 m -29.36 145.09 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.067 0 O-C-N 124.886 1.366 . . . . 0.0 110.944 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 24.2 mt -111.1 151.76 27.73 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.4 t -134.12 125.29 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -120.29 139.81 52.18 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.178 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 27' ' ' THR . 5.1 p-10 -117.57 98.84 6.6 Favored 'General case' 0 N--CA 1.501 2.076 1 N-CA-C 97.338 -5.06 . . . . 0.0 97.338 178.902 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.409 HG12 ' N ' ' A' ' 102' ' ' GLU . 16.5 t -108.51 153.62 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.355 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 -178.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.409 ' N ' HG12 ' A' ' 101' ' ' VAL . 41.3 tt0 -127.99 104.37 7.75 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 112.119 -2.309 . . . . 0.0 107.609 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 37.8 tp -75.49 121.45 22.37 Favored 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 102.556 -3.127 . . . . 0.0 102.556 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.3 mt -93.16 -57.86 2.49 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -157.96 173.81 16.2 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.605 0.717 . . . . 0.0 112.074 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 35.4 mt -117.59 143.19 46.36 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 . . . . . 0 N--CA 1.503 2.215 0 CA-C-O 116.286 -1.816 . . . . 0.0 110.007 179.885 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.9 p -116.88 150.13 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -122.92 156.39 34.77 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.4 t -125.44 114.84 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 108.039 -1.096 . . . . 0.0 108.039 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -115.22 90.02 3.24 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 90.5 m -69.83 155.67 40.2 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.048 -1.061 . . . . 0.0 112.488 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 59.0 mt -123.66 -51.59 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 CA-C-N 113.645 -1.616 . . . . 0.0 107.258 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.418 ' O ' ' O ' ' A' ' 9' ' ' PRO . 46.5 t -122.22 80.13 44.32 Favored Pre-proline 0 N--CA 1.506 2.328 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.283 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 8' ' ' SER . 6.4 Cg_exo -37.42 164.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.348 2.032 . . . . 0.0 112.808 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -123.51 -168.95 13.12 Favored Glycine 0 N--CA 1.498 2.826 0 N-CA-C 105.632 -2.987 . . . . 0.0 105.632 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 11' ' ' ASP . 12.3 p-10 -39.5 -62.93 0.62 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.747 -0.781 . . . . 0.0 112.575 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.58 15.25 21.44 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 105.838 -2.905 . . . . 0.0 105.838 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 30.4 mtm-85 -125.95 -39.4 2.11 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 113.307 -1.447 . . . . 0.0 112.774 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.1 m -108.2 137.14 46.68 Favored 'General case' 0 N--CA 1.507 2.395 0 CA-C-O 121.775 0.798 . . . . 0.0 112.763 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.445 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 57.0 m-85 -130.56 177.43 2.22 Favored Pre-proline 0 N--CA 1.496 1.859 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -69.57 146.77 62.37 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 N-CA-C 109.765 -0.898 . . . . 0.0 109.765 162.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -122.37 168.44 12.07 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 122.086 0.946 . . . . 0.0 110.248 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 19.1 ptt85 -72.61 126.58 30.22 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.648 -1.16 . . . . 0.0 108.677 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 111.38 -19.71 24.06 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.5 ' O ' ' SD ' ' A' ' 49' ' ' MET . 25.7 mt-30 -109.76 176.4 5.08 Favored 'General case' 0 N--CA 1.506 2.341 0 CA-C-O 121.766 0.793 . . . . 0.0 112.274 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 27.7 m -110.07 161.47 15.5 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 57.2 m -111.7 146.56 37.3 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 103.889 -2.634 . . . . 0.0 103.889 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 33.4 t -123.07 101.95 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 101.644 -3.465 . . . . 0.0 101.644 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 m -123.01 150.46 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 125.004 1.44 . . . . 0.0 114.324 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.403 ' ND1' ' C ' ' A' ' 25' ' ' HIS . 2.7 t-80 -130.61 113.77 14.62 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 103.598 -2.742 . . . . 0.0 103.598 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -131.21 176.63 8.11 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 123.184 1.468 . . . . 0.0 113.576 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 96.0 m -139.42 121.85 16.11 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 101.921 -3.363 . . . . 0.0 101.921 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 37' ' ' ASP . . . -96.93 151.61 19.88 Favored Glycine 0 N--CA 1.498 2.824 0 C-N-CA 119.127 -1.511 . . . . 0.0 109.457 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 36.6 ttp -145.97 169.36 18.78 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 46.6 mt -118.79 174.66 6.15 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 105.534 -2.025 . . . . 0.0 105.534 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -29.09 -61.12 0.13 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 124.989 1.431 . . . . 0.0 113.447 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 32' ' ' ASP . 2.7 p30 -160.29 44.34 0.21 Allowed 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.041 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -115.9 -84.04 1.1 Allowed Glycine 0 N--CA 1.499 2.856 0 C-N-CA 119.044 -1.551 . . . . 0.0 113.802 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.92 -164.43 1.19 Allowed 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 112.503 -1.848 . . . . 0.0 113.11 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -90.41 140.43 29.72 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 122.512 1.148 . . . . 0.0 109.672 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -125.93 -35.78 2.44 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 112.888 -1.96 . . . . 0.0 107.475 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' A' ' 28' ' ' GLY . 33.6 t0 -127.07 104.59 8.07 Favored 'General case' 0 N--CA 1.513 2.693 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.038 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 52.6 m -119.77 175.28 5.95 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 104.459 -2.422 . . . . 0.0 104.459 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 76.7 p -107.54 56.73 0.63 Allowed 'General case' 0 N--CA 1.502 2.175 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.549 ' O ' ' N ' ' A' ' 42' ' ' ARG . 20.5 ttp85 -29.41 -67.95 0.08 Allowed 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 113.483 -1.689 . . . . 0.0 113.163 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -19.04 71.94 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 115.733 1.753 . . . . 0.0 115.733 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.549 ' N ' ' O ' ' A' ' 40' ' ' ARG . 12.8 mmt180 -32.04 -73.25 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 123.98 0.8 . . . . 0.0 112.87 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -20.95 -74.23 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 125.194 1.559 . . . . 0.0 114.131 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -134.25 141.24 38.57 Favored Pre-proline 0 N--CA 1.501 2.079 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -59.28 -159.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.218 0 C-N-CA 121.452 1.435 . . . . 0.0 113.387 -177.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -82.17 146.78 29.37 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 114.306 -1.316 . . . . 0.0 112.881 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.41 ' NZ ' ' CB ' ' A' ' 47' ' ' LYS . 9.1 mtmp? -143.08 125.29 15.45 Favored 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 118.745 -0.645 . . . . 0.0 111.695 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -137.53 171.94 13.71 Favored 'General case' 0 N--CA 1.515 2.795 0 CA-C-N 119.812 1.187 . . . . 0.0 114.158 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.5 ' SD ' ' O ' ' A' ' 20' ' ' GLN . 45.6 tpp -109.11 140.74 42.27 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 114.954 1.464 . . . . 0.0 114.954 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.8 tp -91.01 122.38 33.62 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 114.249 -1.341 . . . . 0.0 110.196 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.03 18.67 13.12 Favored Glycine 0 N--CA 1.5 2.9 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -122.57 -20.57 5.96 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-N 114.732 -0.734 . . . . 0.0 109.313 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.669 HE22 ' NH1' ' A' ' 57' ' ' ARG . 9.6 mm100 54.48 67.84 0.95 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -109.76 -35.3 6.22 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.3 m -106.15 156.47 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.4 pt -50.98 174.96 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 118.368 -1.333 . . . . 0.0 110.548 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.669 ' NH1' HE22 ' A' ' 53' ' ' GLN . 4.2 tpp180 -68.71 -64.93 0.77 Allowed 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.061 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -28.95 -35.03 0.01 OUTLIER Glycine 0 N--CA 1.498 2.817 0 O-C-N 124.722 1.264 . . . . 0.0 112.308 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.531 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.5 OUTLIER -76.68 -70.57 0.45 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 179.858 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -33.49 -55.81 0.43 Allowed 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 113.723 -1.58 . . . . 0.0 109.992 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -70.16 -53.8 15.65 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 113.431 -1.713 . . . . 0.0 107.353 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -56.24 -75.81 0.23 Allowed Glycine 0 N--CA 1.48 1.574 0 C-N-CA 119.558 -1.306 . . . . 0.0 111.544 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 59' ' ' TRP . 41.2 t -38.37 -48.98 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 C-N-CA 120.332 -0.547 . . . . 0.0 112.243 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.467 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -46.86 -59.93 2.75 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 124.198 1.951 . . . . 0.0 110.584 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -51.27 -9.18 0.06 Allowed 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 109.37 -3.559 . . . . 0.0 109.719 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.467 ' H ' ' C ' ' A' ' 64' ' ' ALA . 90.3 mtp -98.23 154.94 17.43 Favored 'General case' 0 N--CA 1.512 2.646 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 84.8 p -116.39 151.13 36.59 Favored 'General case' 0 N--CA 1.507 2.424 0 CA-C-O 122.691 1.234 . . . . 0.0 113.75 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 95.5 t -44.93 98.14 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-N 112.499 -2.137 . . . . 0.0 114.385 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.02 11.9 15.23 Favored Glycine 0 N--CA 1.498 2.796 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -109.99 151.73 26.77 Favored 'General case' 0 N--CA 1.508 2.441 0 CA-C-O 122.215 1.007 . . . . 0.0 111.012 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -132.21 141.98 49.26 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 113.459 -1.7 . . . . 0.0 107.815 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -149.53 179.68 7.78 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 112.979 -1.918 . . . . 0.0 116.143 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -127.1 105.8 8.83 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 102.678 -3.082 . . . . 0.0 102.678 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.9 mt -101.66 153.86 19.39 Favored 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 121.315 0.579 . . . . 0.0 109.587 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 87.3 m -125.46 126.5 45.03 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 31.8 mt -115.64 141.4 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.421 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 35.5 p -110.31 152.32 43.17 Favored Pre-proline 0 N--CA 1.498 1.948 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.401 ' O ' ' N ' ' A' ' 81' ' ' ALA . 11.5 Cg_endo -40.78 -54.9 2.21 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 121.738 1.625 . . . . 0.0 112.513 -172.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 18.8 p30 -37.35 -35.96 0.13 Allowed 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.39 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -100.83 -16.78 17.16 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.185 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 83' ' ' GLY . . . -102.43 159.75 15.15 Favored 'General case' 0 N--CA 1.505 2.278 0 C-N-CA 119.688 -0.805 . . . . 0.0 108.965 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -1.37 62.37 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 125.93 2.019 . . . . 0.0 115.81 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 81' ' ' ALA . . . -5.05 -69.59 0.01 OUTLIER Glycine 0 N--CA 1.501 2.989 0 O-C-N 125.329 1.643 . . . . 0.0 115.653 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -122.34 -65.78 1.08 Allowed 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 97.5 m -121.7 137.25 54.83 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.61 -62.2 0.1 Allowed Glycine 0 N--CA 1.501 2.997 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -122.5 156.19 61.46 Favored Pre-proline 0 N--CA 1.505 2.289 0 CA-C-N 115.311 -0.444 . . . . 0.0 109.854 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -60.86 -69.9 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 122.023 1.815 . . . . 0.0 114.899 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -123.45 52.62 0.77 Allowed Glycine 0 N--CA 1.506 3.32 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.95 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.2 mt -130.58 -49.16 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 37.6 mm -113.47 90.08 16.65 Favored Pre-proline 0 N--CA 1.503 2.176 0 CA-C-N 111.783 -2.462 . . . . 0.0 111.772 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -52.23 158.97 4.63 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 N-CA-C 106.809 -2.035 . . . . 0.0 106.809 161.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -46.86 172.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 121.99 1.794 . . . . 0.0 113.068 -177.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 19.6 m80 9.55 75.58 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 116.528 2.047 . . . . 0.0 116.528 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -116.49 157.26 25.49 Favored 'General case' 0 N--CA 1.505 2.314 0 CA-C-O 121.112 0.482 . . . . 0.0 109.812 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 27.2 m -91.23 138.75 31.35 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 34.2 mt -118.33 156.56 28.7 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 58.9 t -137.15 130.11 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -123.29 155.91 36.31 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 122.058 0.932 . . . . 0.0 111.208 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -126.81 90.0 3.09 Favored 'General case' 0 N--CA 1.493 1.704 1 N-CA-C 98.977 -4.453 . . . . 0.0 98.977 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 13.1 t -104.55 150.84 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.594 0 N-CA-C 116.73 2.122 . . . . 0.0 116.73 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -128.39 98.08 4.94 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 112.595 -2.093 . . . . 0.0 106.838 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 49.1 tp -73.01 117.2 14.45 Favored 'General case' 0 N--CA 1.503 2.192 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.5 mt -83.92 -57.55 3.15 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 114.296 -1.32 . . . . 0.0 113.784 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.438 ' HG2' ' H ' ' A' ' 106' ' ' LEU . 16.2 ttpp -168.91 -171.41 1.34 Allowed 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.271 -0.972 . . . . 0.0 108.733 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.438 ' H ' ' HG2' ' A' ' 105' ' ' LYS . 22.9 mt -116.6 157.5 25.22 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 . . . . . 0 N--CA 1.506 2.328 0 CA-C-O 116.176 -1.869 . . . . 0.0 110.172 179.912 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 110.014 -1.235 . . . . 0.0 110.014 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.2 p -119.34 150.39 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -120.86 155.38 34.25 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 43.4 t -126.08 122.44 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.478 ' N ' ' CD ' ' A' ' 5' ' ' GLU . 8.9 mp0 -120.4 93.48 4.06 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 96.4 m -69.71 156.36 39.1 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 118.675 -1.21 . . . . 0.0 112.079 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 70.3 mt -121.95 -55.13 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-N 113.882 -1.508 . . . . 0.0 107.484 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.43 ' O ' ' O ' ' A' ' 9' ' ' PRO . 33.1 t -123.74 82.78 54.49 Favored Pre-proline 0 N--CA 1.506 2.329 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.382 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.43 ' O ' ' O ' ' A' ' 8' ' ' SER . 3.9 Cg_exo -35.84 164.39 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.689 2.26 . . . . 0.0 113.606 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -113.78 -176.43 19.22 Favored Glycine 0 N--CA 1.499 2.894 0 N-CA-C 105.797 -2.921 . . . . 0.0 105.797 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.475 ' CG ' ' H ' ' A' ' 12' ' ' GLY . 11.2 p-10 -43.85 -59.03 2.44 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 118.352 1.076 . . . . 0.0 111.586 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.475 ' H ' ' CG ' ' A' ' 11' ' ' ASP . . . 109.18 25.81 5.43 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 107.737 -2.145 . . . . 0.0 107.737 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.5 mmm180 -132.42 -36.68 1.1 Allowed 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 114.671 -0.764 . . . . 0.0 111.415 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 45.6 m -111.31 128.84 56.08 Favored 'General case' 0 N--CA 1.507 2.379 0 CA-C-O 121.584 0.707 . . . . 0.0 112.687 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.413 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 37.6 m-85 -129.95 171.6 8.63 Favored Pre-proline 0 N--CA 1.497 1.92 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_exo -53.24 145.75 42.73 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 CA-C-N 119.588 0.888 . . . . 0.0 112.244 166.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -122.83 168.39 12.33 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 122.458 1.123 . . . . 0.0 111.175 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 42.9 mtp-105 -81.18 93.72 6.53 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 113.639 -1.619 . . . . 0.0 111.687 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.76 3.49 5.94 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 108.637 -1.785 . . . . 0.0 108.637 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -117.91 173.97 6.46 Favored 'General case' 0 N--CA 1.505 2.322 0 C-N-CA 120.254 -0.578 . . . . 0.0 109.567 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.7 m -110.0 164.8 12.27 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 31.6 m -117.22 128.38 55.04 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 33.3 t -108.5 111.48 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 101.106 -3.664 . . . . 0.0 101.106 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.402 HG21 ' CH2' ' A' ' 59' ' ' TRP . 5.1 m -125.88 155.06 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 125.007 1.442 . . . . 0.0 114.127 -179.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -129.87 107.88 9.72 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 104.512 -2.403 . . . . 0.0 104.512 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -130.48 175.29 9.1 Favored 'General case' 0 N--CA 1.503 2.2 0 CA-C-O 122.923 1.344 . . . . 0.0 114.458 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 93.7 m -138.17 121.8 17.42 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 102.292 -3.225 . . . . 0.0 102.292 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -111.2 138.1 14.74 Favored Glycine 0 N--CA 1.503 3.124 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.443 ' SD ' ' C ' ' A' ' 34' ' ' LYS . 21.9 tpp -140.68 -179.83 6.27 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.1 mt -120.02 161.77 20.38 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -24.62 -58.68 0.05 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 125.335 1.647 . . . . 0.0 113.852 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 32' ' ' ASP . 3.0 p30 -160.17 42.17 0.19 Allowed 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.825 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -120.8 -80.27 0.59 Allowed Glycine 0 N--CA 1.5 2.946 0 C-N-CA 119.3 -1.429 . . . . 0.0 113.433 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.443 ' C ' ' SD ' ' A' ' 29' ' ' MET . 11.2 pttp -161.25 -166.49 1.56 Allowed 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.456 ' CD ' ' H ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -90.87 130.04 36.86 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 113.598 -1.637 . . . . 0.0 107.942 179.569 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.532 ' CD2' ' OD2' ' A' ' 37' ' ' ASP . 3.0 p90 -122.82 -35.75 2.99 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.011 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.532 ' OD2' ' CD2' ' A' ' 36' ' ' PHE . 45.6 m-20 -141.1 109.23 5.78 Favored 'General case' 0 N--CA 1.51 2.552 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 54.8 m -121.04 176.53 5.53 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 105.534 -2.025 . . . . 0.0 105.534 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.525 ' O ' ' N ' ' A' ' 41' ' ' ASP . 50.5 p -111.65 49.94 0.87 Allowed 'General case' 0 N--CA 1.505 2.307 0 CA-C-O 122.469 1.128 . . . . 0.0 108.484 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -29.48 -26.44 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 112.594 -2.094 . . . . 0.0 115.365 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 39' ' ' SER . 9.6 t70 -83.08 53.45 2.46 Favored 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 118.964 -1.094 . . . . 0.0 111.97 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -36.97 -34.76 0.08 Allowed 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.862 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.483 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 18.4 p30 -95.46 66.35 2.8 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.129 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.483 ' CB ' ' O ' ' A' ' 43' ' ' ASN . 64.4 tttm 119.84 77.45 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.388 0 O-C-N 126.396 2.31 . . . . 0.0 106.43 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' A' ' 44' ' ' LYS . 34.5 Cg_exo -43.84 -156.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.231 0 C-N-CA 124.071 3.181 . . . . 0.0 116.038 178.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -94.69 138.11 32.95 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 113.21 -1.814 . . . . 0.0 110.903 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -130.36 117.81 20.31 Favored 'General case' 0 N--CA 1.509 2.499 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -136.23 170.77 15.48 Favored 'General case' 0 N--CA 1.51 2.54 0 C-N-CA 119.732 -0.787 . . . . 0.0 112.313 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 40.3 ttm -118.64 154.96 31.82 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.2 tp -91.03 120.88 32.37 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.889 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.42 34.21 5.38 Favored Glycine 0 N--CA 1.499 2.864 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.049 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.484 ' O ' ' CB ' ' A' ' 53' ' ' GLN . 23.0 ttmm -129.93 -51.01 1.13 Allowed 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.484 ' CB ' ' O ' ' A' ' 52' ' ' LYS . 37.3 tt0 100.9 67.74 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.161 0 O-C-N 125.837 1.961 . . . . 0.0 109.592 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -110.24 -35.94 5.95 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.1 m -116.73 159.06 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.854 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.409 ' H ' HG12 ' A' ' 56' ' ' ILE . 13.4 pt -56.51 179.97 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.527 ' O ' ' N ' ' A' ' 59' ' ' TRP . 34.8 ttt180 -74.48 -61.21 1.95 Allowed 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.92 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 57' ' ' ARG . . . -25.61 -39.32 0.01 OUTLIER Glycine 0 N--CA 1.501 2.988 0 O-C-N 124.986 1.428 . . . . 0.0 112.489 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.53 ' O ' ' N ' ' A' ' 63' ' ' VAL . 0.7 OUTLIER -73.26 -73.62 0.2 Allowed 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 179.721 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.484 ' OE1' ' N ' ' A' ' 61' ' ' GLU . 10.4 tm-20 -26.62 -55.7 0.08 Allowed 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 112.934 -1.939 . . . . 0.0 110.707 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.484 ' N ' ' OE1' ' A' ' 60' ' ' GLU . 50.3 tp10 -73.98 -54.96 6.76 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 112.927 -1.942 . . . . 0.0 106.23 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -52.16 -75.55 0.22 Allowed Glycine 0 N--CA 1.482 1.705 0 C-N-CA 119.617 -1.278 . . . . 0.0 110.961 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.53 ' N ' ' O ' ' A' ' 59' ' ' TRP . 30.8 t -40.92 -49.12 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 119.973 -0.691 . . . . 0.0 112.093 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.458 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -46.9 -59.01 3.37 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 124.012 1.863 . . . . 0.0 110.928 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -52.0 -8.04 0.06 Allowed 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 109.517 -3.492 . . . . 0.0 109.836 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.458 ' H ' ' C ' ' A' ' 64' ' ' ALA . 93.8 mtp -102.09 155.21 18.33 Favored 'General case' 0 N--CA 1.516 2.827 0 C-N-CA 119.036 -1.066 . . . . 0.0 108.242 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 90.4 p -114.94 150.11 36.24 Favored 'General case' 0 N--CA 1.511 2.582 0 CA-C-O 122.605 1.193 . . . . 0.0 113.211 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 87.2 t -43.84 96.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 112.594 -2.094 . . . . 0.0 113.246 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 113.06 11.89 13.12 Favored Glycine 0 N--CA 1.499 2.87 0 N-CA-C 108.735 -1.746 . . . . 0.0 108.735 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -103.66 143.93 32.12 Favored 'General case' 0 N--CA 1.503 2.209 0 C-N-CA 120.189 -0.605 . . . . 0.0 110.159 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 25.3 ttt85 -125.57 140.77 52.47 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -148.73 177.32 9.62 Favored 'General case' 0 N--CA 1.503 2.18 0 CA-C-N 113.046 -1.888 . . . . 0.0 116.048 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.45 ' CE ' ' OD1' ' A' ' 100' ' ' ASP . 4.6 tppp? -127.13 107.14 9.76 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 101.568 -3.493 . . . . 0.0 101.568 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.4 mt -103.58 152.85 21.25 Favored 'General case' 0 N--CA 1.503 2.207 0 C-N-CA 119.822 -0.751 . . . . 0.0 109.365 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 86.3 m -124.54 118.32 26.32 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 31.1 mt -111.76 141.92 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.425 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 41.7 p -107.78 156.68 37.64 Favored Pre-proline 0 N--CA 1.507 2.391 0 O-C-N 124.796 1.31 . . . . 0.0 109.373 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -36.18 -54.24 0.89 Allowed 'Trans proline' 0 C--N 1.316 -1.165 0 C-N-CA 121.986 1.791 . . . . 0.0 113.744 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 80' ' ' TYR . 1.7 p30 -45.36 -41.85 9.41 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.523 ' OH ' ' NH1' ' A' ' 57' ' ' ARG . 2.6 m-85 -102.1 17.71 22.6 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.304 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -122.85 -97.13 0.45 Allowed 'General case' 0 N--CA 1.508 2.447 0 CA-C-N 118.758 0.708 . . . . 0.0 111.783 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -121.41 -58.17 1.79 Allowed 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 120.848 0.356 . . . . 0.0 110.072 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 117.97 -152.13 17.69 Favored Glycine 0 N--CA 1.5 2.918 0 N-CA-C 108.028 -2.029 . . . . 0.0 108.028 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -107.5 28.99 7.59 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 89.9 m -130.0 57.53 1.69 Allowed 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -119.97 -166.62 13.3 Favored Glycine 0 N--CA 1.5 2.926 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.424 ' O ' ' O ' ' A' ' 91' ' ' ILE . 75.9 t60 -112.1 143.06 28.02 Favored Pre-proline 0 N--CA 1.502 2.164 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.68 150.63 45.39 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 N-CA-C 108.873 -1.241 . . . . 0.0 108.873 176.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 108.16 -47.13 1.08 Allowed Glycine 0 N--CA 1.5 2.901 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.9 mt -112.96 -56.6 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.424 ' O ' ' O ' ' A' ' 87' ' ' HIS . 20.4 mm -120.75 85.78 39.77 Favored Pre-proline 0 N--CA 1.508 2.459 0 CA-C-N 113.722 -1.581 . . . . 0.0 112.578 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -74.27 165.19 32.44 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.19 1.926 . . . . 0.0 107.326 170.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 94' ' ' HIS . 54.2 Cg_endo -55.85 172.59 0.52 Allowed 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.202 1.935 . . . . 0.0 110.81 178.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.4 ' C ' ' O ' ' A' ' 93' ' ' PRO . 90.9 m-70 9.52 61.32 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.23 0 O-C-N 125.619 1.824 . . . . 0.0 114.781 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -119.92 76.02 1.13 Allowed 'General case' 0 N--CA 1.501 2.116 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.49 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 58.0 m -29.42 142.4 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.198 0 O-C-N 124.761 1.288 . . . . 0.0 110.566 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 13.9 mt -107.36 157.05 18.26 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 120.514 1.506 . . . . 0.0 107.042 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.3 t -139.75 115.69 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -110.28 159.45 17.4 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 122.417 1.103 . . . . 0.0 110.241 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.45 ' OD1' ' CE ' ' A' ' 73' ' ' LYS . 54.9 m-20 -127.66 89.11 2.89 Favored 'General case' 0 N--CA 1.493 1.7 1 N-CA-C 98.575 -4.602 . . . . 0.0 98.575 179.314 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 12.2 t -103.1 148.83 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.699 0 N-CA-C 116.777 2.14 . . . . 0.0 116.777 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -127.92 96.75 4.58 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 112.701 -2.045 . . . . 0.0 107.419 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 51.6 tp -68.7 121.96 17.56 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.6 mt -89.39 -58.07 2.66 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.894 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.409 ' HG2' ' H ' ' A' ' 106' ' ' LEU . 21.3 ttmm -164.36 178.12 7.73 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.734 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.409 ' H ' ' HG2' ' A' ' 105' ' ' LYS . 17.1 mt -115.1 168.97 9.46 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 . . . . . 0 N--CA 1.514 2.757 0 CA-C-O 115.862 -2.018 . . . . 0.0 107.414 179.604 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.4 p -115.3 138.95 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 3' ' ' GLN . 3.3 mp0 -115.52 159.24 21.48 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.8 t -124.66 123.11 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.025 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.47 ' N ' ' CD ' ' A' ' 5' ' ' GLU . 9.3 mp0 -125.42 89.96 3.14 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 88.1 m -69.71 155.25 40.8 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.76 -1.176 . . . . 0.0 113.765 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 57.6 mt -122.45 -53.29 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-N 113.352 -1.749 . . . . 0.0 107.84 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.419 ' O ' ' O ' ' A' ' 9' ' ' PRO . 29.3 m -122.84 80.69 49.54 Favored Pre-proline 0 N--CA 1.506 2.366 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.759 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.419 ' O ' ' O ' ' A' ' 8' ' ' SER . 12.6 Cg_exo -38.2 164.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.37 2.047 . . . . 0.0 112.262 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -120.38 -178.76 16.23 Favored Glycine 0 N--CA 1.5 2.945 0 N-CA-C 105.322 -3.111 . . . . 0.0 105.322 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.431 ' CG ' ' H ' ' A' ' 12' ' ' GLY . 13.1 p-10 -45.76 -58.08 3.76 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 118.404 1.102 . . . . 0.0 111.075 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.431 ' H ' ' CG ' ' A' ' 11' ' ' ASP . . . 108.62 6.88 30.48 Favored Glycine 0 N--CA 1.498 2.814 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -110.81 -31.14 7.28 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 114.584 -0.808 . . . . 0.0 111.685 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 96.8 m -112.03 134.13 53.77 Favored 'General case' 0 N--CA 1.504 2.242 0 CA-C-N 118.876 0.762 . . . . 0.0 113.0 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 57.3 m-85 -131.31 177.24 2.33 Favored Pre-proline 0 N--CA 1.5 2.029 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -72.09 145.29 44.13 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 C-N-CA 120.729 0.953 . . . . 0.0 110.391 161.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -121.58 168.63 11.53 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-O 121.786 0.803 . . . . 0.0 109.236 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.3 130.15 41.8 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.565 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 109.67 -22.69 23.58 Favored Glycine 0 N--CA 1.499 2.838 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.334 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -105.71 178.42 4.57 Favored 'General case' 0 N--CA 1.506 2.371 0 CA-C-O 121.981 0.896 . . . . 0.0 111.747 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.1 m -113.26 161.46 17.17 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 64.5 m -112.48 148.0 35.35 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.9 t -121.91 104.94 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 103.296 -2.853 . . . . 0.0 103.296 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 m -121.69 149.81 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.347 0 N-CA-C 116.217 1.932 . . . . 0.0 116.217 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -128.49 117.5 21.43 Favored 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 104.429 -2.434 . . . . 0.0 104.429 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -134.3 174.09 10.9 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 123.072 1.415 . . . . 0.0 114.801 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 81.3 m -138.92 122.04 16.85 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 102.335 -3.209 . . . . 0.0 102.335 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -112.57 140.45 16.27 Favored Glycine 0 N--CA 1.503 3.165 0 C-N-CA 120.174 -1.012 . . . . 0.0 112.337 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 57.2 mtm -137.85 175.37 9.65 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 29.0 mt -117.64 173.22 6.85 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -34.61 -62.9 0.33 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 124.564 1.165 . . . . 0.0 113.292 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -160.61 42.03 0.17 Allowed 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 114.508 -1.224 . . . . 0.0 109.25 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -117.82 -78.24 0.63 Allowed Glycine 0 N--CA 1.503 3.103 0 C-N-CA 119.283 -1.437 . . . . 0.0 113.721 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.53 -169.21 2.36 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -90.94 138.09 31.86 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 114.289 -1.323 . . . . 0.0 108.53 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.534 ' CD2' ' OD1' ' A' ' 37' ' ' ASP . 5.0 p90 -127.47 -39.7 1.84 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 113.192 -1.822 . . . . 0.0 106.152 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.534 ' OD1' ' CD2' ' A' ' 36' ' ' PHE . 1.0 OUTLIER -132.08 74.52 1.59 Allowed 'General case' 0 N--CA 1.507 2.403 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.3 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 68.8 m -110.64 113.33 25.85 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 56.7 p -108.8 51.41 0.74 Allowed 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -29.79 -46.66 0.06 Allowed 'General case' 0 N--CA 1.5 2.068 0 O-C-N 124.312 1.008 . . . . 0.0 112.782 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -19.12 86.3 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.3 mmm180 -77.9 -54.18 6.61 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.541 HD22 ' C ' ' A' ' 43' ' ' ASN . 0.6 OUTLIER -40.12 -64.26 0.52 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 179.778 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -122.66 79.84 48.07 Favored Pre-proline 0 N--CA 1.505 2.299 0 CA-C-N 115.051 -0.977 . . . . 0.0 112.112 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -55.29 -154.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 123.51 2.807 . . . . 0.0 115.102 -177.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -103.44 147.98 26.47 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 111.835 -2.438 . . . . 0.0 110.034 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 72.0 mttt -142.45 133.95 26.53 Favored 'General case' 0 N--CA 1.515 2.801 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -144.46 173.4 11.83 Favored 'General case' 0 N--CA 1.515 2.777 0 CA-C-N 119.265 0.939 . . . . 0.0 112.766 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 44.5 ttm -116.47 148.97 40.25 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.3 tp -90.99 120.26 31.84 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 114.365 -1.288 . . . . 0.0 109.23 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.35 18.56 18.77 Favored Glycine 0 N--CA 1.499 2.875 0 N-CA-C 107.757 -2.137 . . . . 0.0 107.757 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -121.06 -19.98 6.98 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 114.383 -0.908 . . . . 0.0 109.387 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 55.9 69.02 0.78 Allowed 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.396 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -110.03 -35.86 6.02 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.431 ' O ' ' O ' ' A' ' 56' ' ' ILE . 4.2 m -113.99 152.69 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.176 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.501 ' CG2' ' CE1' ' A' ' 82' ' ' TYR . 13.3 pt -49.46 179.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.857 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.559 ' O ' ' N ' ' A' ' 59' ' ' TRP . 19.5 ttm180 -75.94 -58.96 2.97 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -34.12 -27.2 0.01 OUTLIER Glycine 0 N--CA 1.494 2.538 0 O-C-N 123.944 0.777 . . . . 0.0 111.925 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.559 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -91.33 -73.98 0.52 Allowed 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.874 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -36.98 -50.48 0.88 Allowed 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 114.333 -1.303 . . . . 0.0 110.228 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.417 ' O ' ' OE1' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -71.99 -57.7 4.07 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 104.818 -2.29 . . . . 0.0 104.818 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -50.95 -82.2 0.04 OUTLIER Glycine 0 N--CA 1.48 1.57 0 C-N-CA 119.011 -1.566 . . . . 0.0 109.7 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.533 ' N ' ' O ' ' A' ' 59' ' ' TRP . 62.1 t -29.95 -48.01 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.476 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -44.89 -60.2 2.17 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 124.349 2.023 . . . . 0.0 110.672 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -47.86 -12.06 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 109.027 -3.715 . . . . 0.0 109.548 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.476 ' H ' ' C ' ' A' ' 64' ' ' ALA . 33.4 mmt -89.92 158.51 17.38 Favored 'General case' 0 N--CA 1.508 2.433 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 86.1 p -122.19 136.12 54.86 Favored 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 121.64 0.733 . . . . 0.0 110.077 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.3 t -35.42 97.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-N 114.303 -1.317 . . . . 0.0 113.405 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.73 5.77 13.6 Favored Glycine 0 N--CA 1.5 2.906 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -107.02 149.23 27.78 Favored 'General case' 0 N--CA 1.508 2.457 0 CA-C-O 122.163 0.982 . . . . 0.0 110.291 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.0 ttp180 -133.61 143.4 48.61 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 113.621 -1.627 . . . . 0.0 107.365 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -153.22 179.22 8.93 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 113.312 -1.767 . . . . 0.0 115.066 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -124.75 104.01 8.41 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 103.364 -2.828 . . . . 0.0 103.364 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.2 mt -100.21 145.45 28.04 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.3 m -113.32 123.27 49.72 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 104.628 -2.36 . . . . 0.0 104.628 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 33.9 mt -112.6 131.13 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.491 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.426 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 61.6 p -104.71 154.31 38.62 Favored Pre-proline 0 N--CA 1.5 2.068 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -36.53 -54.08 0.99 Allowed 'Trans proline' 0 C--N 1.314 -1.261 0 C-N-CA 122.113 1.875 . . . . 0.0 113.663 -173.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.527 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 6.5 p-10 -42.2 -36.16 1.13 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -106.85 23.2 14.73 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -130.67 -87.03 0.5 Allowed 'General case' 0 N--CA 1.506 2.34 0 CA-C-O 122.017 0.913 . . . . 0.0 112.415 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.501 ' CE1' ' CG2' ' A' ' 56' ' ' ILE . 43.6 m-85 -138.05 -45.91 0.52 Allowed 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.495 ' O ' ' CB ' ' A' ' 84' ' ' ALA . . . 1.54 128.9 0.0 OUTLIER Glycine 0 N--CA 1.496 2.687 0 CA-C-N 112.285 -2.234 . . . . 0.0 116.97 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.495 ' CB ' ' O ' ' A' ' 83' ' ' GLY . . . 120.59 -47.55 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 O-C-N 126.229 1.782 . . . . 0.0 110.468 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.445 ' O ' ' O ' ' A' ' 86' ' ' GLY . 87.5 m -117.96 -57.56 2.09 Favored 'General case' 0 N--CA 1.505 2.288 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 85' ' ' THR . . . 42.72 -176.47 0.01 OUTLIER Glycine 0 N--CA 1.493 2.488 0 CA-C-O 122.149 0.861 . . . . 0.0 113.251 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.492 ' N ' ' O ' ' A' ' 91' ' ' ILE . 18.4 m80 -115.38 153.48 47.56 Favored Pre-proline 0 N--CA 1.504 2.251 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -90.22 37.26 0.34 Allowed 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 122.072 1.848 . . . . 0.0 108.562 170.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -132.37 -50.66 0.09 OUTLIER Glycine 0 N--CA 1.499 2.862 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.57 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.3 mt -115.88 -50.92 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 CA-C-O 122.124 0.964 . . . . 0.0 109.779 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.492 ' O ' ' N ' ' A' ' 87' ' ' HIS . 23.0 mm -117.45 88.23 27.93 Favored Pre-proline 0 N--CA 1.51 2.555 0 CA-C-N 113.57 -1.65 . . . . 0.0 113.042 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -60.87 -175.44 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.016 1.811 . . . . 0.0 109.239 169.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -61.41 166.98 10.34 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.041 1.827 . . . . 0.0 110.593 178.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.445 ' CG ' ' O ' ' A' ' 94' ' ' HIS . 25.4 p-80 9.43 68.43 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.247 0 O-C-N 125.385 1.678 . . . . 0.0 115.097 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -116.27 74.36 0.9 Allowed 'General case' 0 N--CA 1.501 2.117 0 CA-C-O 120.747 0.308 . . . . 0.0 110.457 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 84.5 m -29.31 134.29 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.026 0 O-C-N 124.811 1.319 . . . . 0.0 111.369 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 21.4 mt -107.57 144.61 34.34 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 49.9 t -132.39 119.65 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -111.85 163.87 13.71 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 122.513 1.149 . . . . 0.0 108.942 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -129.28 89.94 2.93 Favored 'General case' 0 C--N 1.301 -1.523 1 N-CA-C 97.383 -5.043 . . . . 0.0 97.383 179.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 12.3 t -103.89 151.17 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.447 0 N-CA-C 114.671 1.359 . . . . 0.0 114.671 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -125.82 103.05 7.59 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 112.007 -2.361 . . . . 0.0 108.122 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 43.6 tp -75.21 118.55 18.26 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 102.66 -3.089 . . . . 0.0 102.66 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.5 mt -85.35 -56.53 3.48 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 113.828 -1.533 . . . . 0.0 112.297 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.409 ' HB2' ' HZ1' ' A' ' 105' ' ' LYS . 0.1 OUTLIER -172.43 -168.34 0.52 Allowed 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.047 -1.061 . . . . 0.0 111.22 -179.865 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 22.2 mt -115.77 156.28 26.3 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 . . . . . 0 N--CA 1.505 2.277 0 CA-C-O 116.233 -1.842 . . . . 0.0 109.844 179.865 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.8 p -114.04 147.65 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -123.47 153.57 40.31 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 97.0 t -129.51 102.15 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -99.73 161.32 13.69 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 102.854 -3.017 . . . . 0.0 102.854 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 72.8 m -121.31 156.38 32.68 Favored 'General case' 0 N--CA 1.504 2.253 0 CA-C-O 121.987 0.899 . . . . 0.0 112.301 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 74.8 mt -124.72 -54.17 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 9' ' ' PRO . 28.2 t -124.99 83.18 60.48 Favored Pre-proline 0 N--CA 1.508 2.459 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.052 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 8' ' ' SER . 13.5 Cg_exo -37.28 160.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.155 1.903 . . . . 0.0 111.612 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.25 -171.75 14.28 Favored Glycine 0 N--CA 1.503 3.142 0 N-CA-C 107.496 -2.241 . . . . 0.0 107.496 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 12' ' ' GLY . 1.3 p30 -39.61 -51.64 2.24 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.817 -0.753 . . . . 0.0 112.508 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.51 ' N ' ' OD1' ' A' ' 11' ' ' ASP . . . 97.43 2.88 58.77 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 108.126 -1.99 . . . . 0.0 108.126 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 34.6 mtm-85 -119.8 -36.02 3.39 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.8 m -106.99 134.3 50.34 Favored 'General case' 0 N--CA 1.506 2.345 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 33.0 m-85 -130.61 175.14 3.89 Favored Pre-proline 0 N--CA 1.495 1.816 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -66.43 155.13 71.55 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 CA-C-N 119.82 0.971 . . . . 0.0 110.006 165.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -121.7 172.83 7.85 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-O 121.893 0.854 . . . . 0.0 109.635 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.425 ' CB ' HH11 ' A' ' 18' ' ' ARG . 44.3 mtm105 -77.99 96.27 5.02 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.673 -1.148 . . . . 0.0 109.92 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.71 12.55 3.66 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.194 -1.563 . . . . 0.0 109.194 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.494 ' O ' ' SD ' ' A' ' 49' ' ' MET . 15.8 mm100 -113.85 167.88 10.26 Favored 'General case' 0 N--CA 1.504 2.245 0 CA-C-O 121.893 0.854 . . . . 0.0 109.236 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 97.1 m -118.6 114.32 22.6 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 114.226 -1.352 . . . . 0.0 107.551 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 56.9 m -74.67 146.15 42.58 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 118.871 -1.132 . . . . 0.0 108.606 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 94.7 t -117.69 99.67 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 101.311 -3.589 . . . . 0.0 101.311 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.8 m -121.21 148.26 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 N-CA-C 114.946 1.462 . . . . 0.0 114.946 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -122.24 143.73 49.41 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 102.948 -2.982 . . . . 0.0 102.948 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -157.97 175.53 13.72 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 118.895 -1.122 . . . . 0.0 112.931 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 93.7 m -135.12 126.36 28.19 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 101.375 -3.565 . . . . 0.0 101.375 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.86 127.79 8.74 Favored Glycine 0 N--CA 1.502 3.065 0 C-N-CA 120.04 -1.076 . . . . 0.0 111.963 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 68.5 mtp -128.77 176.93 7.43 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 30.8 mt -123.78 -169.21 1.91 Allowed 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.01 22.86 3.02 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.747 0.784 . . . . 0.0 109.889 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 33' ' ' GLY . 1.2 p30 -131.43 -48.64 0.98 Allowed 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.85 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.529 ' N ' ' OD1' ' A' ' 32' ' ' ASP . . . 118.42 33.56 1.2 Allowed Glycine 0 N--CA 1.501 3.032 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.122 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.402 ' O ' ' C ' ' A' ' 35' ' ' LYS . 55.9 mmtt -118.3 70.5 0.81 Allowed 'General case' 0 N--CA 1.504 2.238 0 CA-C-N 117.311 0.556 . . . . 0.0 110.506 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 34' ' ' LYS . 22.0 pttp -19.33 137.04 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.285 0 O-C-N 125.108 1.505 . . . . 0.0 114.065 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.532 ' CD2' ' OD1' ' A' ' 37' ' ' ASP . 2.3 p90 -130.49 -34.06 1.61 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 113.653 -1.612 . . . . 0.0 108.58 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.532 ' OD1' ' CD2' ' A' ' 36' ' ' PHE . 1.0 OUTLIER -134.7 89.29 2.52 Favored 'General case' 0 N--CA 1.511 2.619 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 51.1 m -113.69 135.14 54.25 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.6 p -127.16 57.04 1.49 Allowed 'General case' 0 N--CA 1.509 2.523 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 20.1 ttp85 -130.11 77.14 1.77 Allowed 'General case' 0 N--CA 1.502 2.157 0 CA-C-O 121.29 0.567 . . . . 0.0 111.165 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -90.59 -93.86 0.13 Allowed 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.546 ' C ' HD22 ' A' ' 43' ' ' ASN . 0.0 OUTLIER -92.61 -121.48 0.08 Allowed 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.546 HD22 ' C ' ' A' ' 42' ' ' ARG . 3.0 m120 -111.69 26.14 10.94 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-N 113.934 -1.485 . . . . 0.0 110.268 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.442 ' O ' ' O ' ' A' ' 45' ' ' PRO . 20.4 pttp -127.01 64.26 59.74 Favored Pre-proline 0 N--CA 1.503 2.222 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.442 ' O ' ' O ' ' A' ' 44' ' ' LYS . 20.0 Cg_endo -45.6 -158.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 121.96 1.773 . . . . 0.0 114.162 170.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -91.46 148.85 22.01 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 114.331 -1.304 . . . . 0.0 114.205 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -143.06 122.88 13.42 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.487 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -135.4 171.55 14.28 Favored 'General case' 0 N--CA 1.512 2.627 0 CA-C-N 119.457 1.026 . . . . 0.0 112.466 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.494 ' SD ' ' O ' ' A' ' 20' ' ' GLN . 44.3 tpp -111.53 144.53 40.61 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 114.867 -1.06 . . . . 0.0 112.212 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.4 tp -90.8 121.43 32.66 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.601 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 117.27 -19.0 11.93 Favored Glycine 0 N--CA 1.501 2.967 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.888 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.429 ' O ' ' OE1' ' A' ' 54' ' ' GLU . 41.6 tptt -112.8 36.48 3.45 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.404 ' C ' ' O ' ' A' ' 52' ' ' LYS . 39.1 tt0 10.23 71.23 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 O-C-N 125.345 1.653 . . . . 0.0 113.664 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.429 ' OE1' ' O ' ' A' ' 52' ' ' LYS . 5.0 mm-40 -92.8 -24.06 18.65 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 113.408 -1.724 . . . . 0.0 106.828 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.1 m -115.92 -177.26 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 16.5 pt -90.27 169.94 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.193 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.549 ' O ' ' N ' ' A' ' 59' ' ' TRP . 19.4 ttm-85 -55.11 -63.18 1.24 Allowed 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.334 -0.947 . . . . 0.0 110.702 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -27.13 -35.31 0.01 OUTLIER Glycine 0 N--CA 1.496 2.694 0 O-C-N 124.933 1.396 . . . . 0.0 111.977 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.549 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.9 OUTLIER -86.76 -71.35 0.56 Allowed 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 114.058 -1.071 . . . . 0.0 108.646 179.856 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.422 ' O ' ' OE1' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -28.53 -57.73 0.13 Allowed 'General case' 0 N--CA 1.504 2.255 0 O-C-N 125.066 1.478 . . . . 0.0 110.325 -179.867 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -73.25 -52.58 13.5 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -49.31 -79.9 0.07 OUTLIER Glycine 0 N--CA 1.477 1.375 0 C-N-CA 119.419 -1.372 . . . . 0.0 110.96 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.522 ' N ' ' O ' ' A' ' 59' ' ' TRP . 35.6 t -39.45 -47.71 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 120.226 -0.589 . . . . 0.0 112.358 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.476 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -45.3 -60.11 2.31 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 124.146 1.927 . . . . 0.0 111.094 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -48.51 -11.2 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 109.386 -3.552 . . . . 0.0 109.661 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.476 ' H ' ' C ' ' A' ' 64' ' ' ALA . 86.0 mtp -97.94 156.47 16.6 Favored 'General case' 0 N--CA 1.513 2.704 0 C-N-CA 118.854 -1.138 . . . . 0.0 108.606 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 79.8 p -118.64 149.13 41.91 Favored 'General case' 0 N--CA 1.508 2.443 0 CA-C-O 122.539 1.162 . . . . 0.0 112.8 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 99.5 t -43.52 97.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-N 112.801 -1.999 . . . . 0.0 114.716 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.36 12.92 16.14 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -108.03 145.05 34.51 Favored 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.106 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 25.7 ttt85 -123.79 135.1 53.59 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 105.464 -2.051 . . . . 0.0 105.464 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -136.82 172.61 12.75 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 112.026 -2.352 . . . . 0.0 116.142 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -129.58 103.77 7.06 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 111.069 -2.787 . . . . 0.0 103.917 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.421 HD12 ' N ' ' A' ' 74' ' ' LEU . 5.0 mp -100.69 149.47 23.75 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.889 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.6 m -121.09 104.51 9.83 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 21.3 mt -99.81 137.25 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.414 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 29.5 p -115.54 156.34 46.16 Favored Pre-proline 0 N--CA 1.501 2.123 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.413 ' O ' ' O ' ' A' ' 81' ' ' ALA . 7.6 Cg_endo -35.97 -52.07 1.03 Allowed 'Trans proline' 0 C--N 1.314 -1.266 0 C-N-CA 121.937 1.758 . . . . 0.0 113.971 -175.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.414 ' OD1' ' OG ' ' A' ' 77' ' ' SER . 1.3 p30 -37.62 -38.64 0.28 Allowed 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 121.456 0.646 . . . . 0.0 112.301 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -104.02 -27.98 11.8 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.428 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.492 ' O ' ' N ' ' A' ' 83' ' ' GLY . . . -97.37 165.47 12.0 Favored 'General case' 0 N--CA 1.506 2.337 0 C-N-CA 119.299 -0.96 . . . . 0.0 109.171 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -5.44 -57.87 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 126.618 2.449 . . . . 0.0 114.873 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 81' ' ' ALA . . . 124.44 163.13 11.61 Favored Glycine 0 N--CA 1.5 2.938 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.142 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -12.3 -85.85 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 116.169 1.914 . . . . 0.0 116.169 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 92.8 m -125.34 94.27 4.1 Favored 'General case' 0 N--CA 1.501 2.108 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.127 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -112.63 -54.25 0.47 Allowed Glycine 0 N--CA 1.501 3.008 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.216 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -122.94 62.92 19.62 Favored Pre-proline 0 N--CA 1.506 2.352 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -44.87 126.82 7.81 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 121.326 1.351 . . . . 0.0 109.916 172.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 118.25 -40.23 2.36 Favored Glycine 0 N--CA 1.501 3.026 0 N-CA-C 108.597 -1.801 . . . . 0.0 108.597 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.8 mt -108.93 -51.22 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 23.7 mm -118.32 85.28 24.91 Favored Pre-proline 0 N--CA 1.502 2.128 0 CA-C-N 112.105 -2.316 . . . . 0.0 110.54 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -60.68 164.35 13.75 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 N-CA-C 107.223 -1.876 . . . . 0.0 107.223 177.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.41 ' O ' ' C ' ' A' ' 94' ' ' HIS . 16.3 Cg_endo -44.57 167.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 121.43 1.42 . . . . 0.0 110.178 177.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.41 ' C ' ' O ' ' A' ' 93' ' ' PRO . 20.4 m80 9.67 63.71 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 O-C-N 125.714 1.884 . . . . 0.0 114.73 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -115.65 71.35 0.77 Allowed 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.091 0.472 . . . . 0.0 110.031 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 91.2 m -29.34 125.17 0.13 Allowed 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 113.99 -1.459 . . . . 0.0 110.905 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 18.4 mt -89.76 146.97 24.11 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 55.1 t -131.78 109.71 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -103.26 156.43 17.72 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 122.135 0.969 . . . . 0.0 109.211 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -127.07 93.68 3.82 Favored 'General case' 0 N--CA 1.493 1.679 1 N-CA-C 97.897 -4.853 . . . . 0.0 97.897 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.403 HG12 ' N ' ' A' ' 102' ' ' GLU . 11.4 t -108.38 154.89 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.434 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.403 ' N ' HG12 ' A' ' 101' ' ' VAL . 38.7 tt0 -128.74 102.36 6.53 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 111.612 -2.54 . . . . 0.0 107.741 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 37.0 tp -72.24 125.63 27.81 Favored 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 103.065 -2.939 . . . . 0.0 103.065 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 16.5 mt -96.25 -55.4 2.96 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.406 ' HG2' ' H ' ' A' ' 106' ' ' LEU . 56.0 tttp -166.09 177.3 7.07 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.071 -1.052 . . . . 0.0 111.474 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.406 ' H ' ' HG2' ' A' ' 105' ' ' LYS . 24.4 mt -114.55 150.94 34.18 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 . . . . . 0 N--CA 1.505 2.299 0 CA-C-O 116.17 -1.871 . . . . 0.0 109.996 179.731 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.231 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.8 p -110.22 143.84 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.504 HE21 ' CG ' ' A' ' 5' ' ' GLU . 41.2 tt0 -121.26 157.77 29.57 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.5 t -122.65 115.42 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.504 ' CG ' HE21 ' A' ' 3' ' ' GLN . 94.4 mt-10 -117.11 94.69 4.67 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 69.0 m -69.92 155.88 39.91 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 114.806 1.409 . . . . 0.0 114.806 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 72.2 mt -122.57 -55.48 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 CA-C-N 113.031 -1.895 . . . . 0.0 107.387 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.423 ' O ' ' O ' ' A' ' 9' ' ' PRO . 34.7 t -121.99 81.96 43.27 Favored Pre-proline 0 N--CA 1.505 2.292 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.576 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 8' ' ' SER . 12.2 Cg_exo -38.4 164.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.165 1.91 . . . . 0.0 111.868 178.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.67 -172.39 15.02 Favored Glycine 0 N--CA 1.498 2.803 0 N-CA-C 104.916 -3.274 . . . . 0.0 104.916 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.524 ' N ' ' OD1' ' A' ' 11' ' ' ASP . 12.9 p-10 -39.72 -58.56 1.31 Allowed 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.434 -0.907 . . . . 0.0 112.8 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.32 23.27 9.11 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 105.081 -3.208 . . . . 0.0 105.081 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.02 -40.73 1.48 Allowed 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 113.757 -1.222 . . . . 0.0 111.545 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.4 m -108.62 136.46 48.19 Favored 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.454 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 66.0 m-85 -131.65 176.75 2.65 Favored Pre-proline 0 N--CA 1.494 1.765 0 N-CA-C 105.195 -2.15 . . . . 0.0 105.195 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -70.7 149.18 60.5 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 CA-C-N 119.485 0.852 . . . . 0.0 111.194 164.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -121.78 173.38 7.51 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 122.289 1.043 . . . . 0.0 110.41 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.1 ttm180 -77.69 98.34 5.44 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 113.912 -1.494 . . . . 0.0 109.556 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.13 9.63 4.56 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -113.89 171.76 7.4 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 76.8 m -124.42 112.63 17.15 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.732 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.443 ' N ' ' O ' ' A' ' 48' ' ' PHE . 36.5 m -72.11 147.66 46.48 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.752 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.2 t -116.78 114.11 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 101.389 -3.56 . . . . 0.0 101.389 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.416 HG21 ' CZ3' ' A' ' 59' ' ' TRP . 1.0 OUTLIER -126.65 150.16 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.04 0 N-CA-C 119.404 3.112 . . . . 0.0 119.404 -178.798 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.528 ' CE1' ' OG ' ' A' ' 39' ' ' SER . 84.1 t60 -133.48 142.85 48.46 Favored 'General case' 0 N--CA 1.506 2.33 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.515 ' CZ ' ' O ' ' A' ' 38' ' ' SER . 39.2 p90 -160.53 -179.38 7.6 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 118.474 -1.291 . . . . 0.0 113.53 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 91.5 m -140.73 122.84 15.67 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 101.657 -3.46 . . . . 0.0 101.657 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -102.26 147.69 17.34 Favored Glycine 0 N--CA 1.504 3.198 0 C-N-CA 119.999 -1.096 . . . . 0.0 110.377 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.435 ' SD ' ' C ' ' A' ' 34' ' ' LYS . 13.4 tpp -147.36 170.35 17.51 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 120.069 -0.652 . . . . 0.0 110.181 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.404 ' O ' ' C ' ' A' ' 31' ' ' GLU . 31.3 mt -115.04 149.2 37.84 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' A' ' 31' ' ' GLU . 3.6 pm0 -20.64 -51.87 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -160.29 43.11 0.19 Allowed 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 118.732 -1.187 . . . . 0.0 110.408 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -121.44 -81.51 0.62 Allowed Glycine 0 N--CA 1.499 2.88 0 C-N-CA 119.439 -1.362 . . . . 0.0 112.859 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.435 ' C ' ' SD ' ' A' ' 29' ' ' MET . 0.0 OUTLIER -160.96 -163.71 1.08 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 113.972 -1.114 . . . . 0.0 113.516 -179.395 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -90.37 133.26 35.1 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.432 ' O ' ' OD1' ' A' ' 37' ' ' ASP . 55.6 p90 -108.21 -34.84 6.72 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 103.769 -2.678 . . . . 0.0 103.769 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 36' ' ' PHE . 0.7 OUTLIER -147.89 150.16 33.58 Favored 'General case' 0 N--CA 1.508 2.437 0 CA-C-O 122.132 0.967 . . . . 0.0 112.738 179.755 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.515 ' O ' ' CZ ' ' A' ' 26' ' ' TYR . 52.1 m -130.34 -159.83 0.99 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.528 ' OG ' ' CE1' ' A' ' 25' ' ' HIS . 28.3 p -113.09 -82.94 0.6 Allowed 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 20.7 ttp85 -29.96 -37.47 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.127 0 CA-C-O 122.037 0.922 . . . . 0.0 112.301 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 39' ' ' SER . 64.1 t0 -18.78 -57.19 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 116.418 2.007 . . . . 0.0 116.418 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.541 ' C ' HD22 ' A' ' 43' ' ' ASN . 62.7 mtt180 -90.86 -107.71 0.09 Allowed 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.541 HD22 ' C ' ' A' ' 42' ' ' ARG . 3.4 m120 -110.88 65.3 0.61 Allowed 'General case' 0 N--CA 1.506 2.341 0 N-CA-C 114.93 1.455 . . . . 0.0 114.93 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.457 ' CB ' ' O ' ' A' ' 43' ' ' ASN . 75.7 mmtt 94.45 172.13 0.03 OUTLIER Pre-proline 0 N--CA 1.508 2.448 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -58.27 -158.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.245 0 CA-C-N 120.588 1.246 . . . . 0.0 114.254 177.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . 0.255 0.7 OUTLIER -117.08 129.03 55.73 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 112.093 -2.321 . . . . 0.0 109.954 -179.502 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -134.98 123.96 24.13 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 113.5 -1.682 . . . . 0.0 107.259 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.443 ' O ' ' N ' ' A' ' 22' ' ' CYS . 22.1 p90 -135.41 -178.01 4.92 Favored 'General case' 0 N--CA 1.515 2.814 0 CA-C-N 120.579 1.536 . . . . 0.0 114.696 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 42.9 ttm -116.69 144.25 44.65 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-N 115.199 -0.909 . . . . 0.0 113.024 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.3 tp -90.89 120.98 32.35 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.626 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.82 -11.48 49.48 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.468 ' O ' ' N ' ' A' ' 54' ' ' GLU . 25.6 tptp -112.44 38.58 2.7 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.407 ' C ' ' O ' ' A' ' 52' ' ' LYS . 47.5 tt0 0.86 66.18 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 O-C-N 125.653 1.846 . . . . 0.0 112.958 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' A' ' 52' ' ' LYS . 39.2 tt0 -96.28 -26.08 15.54 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 112.731 -2.031 . . . . 0.0 107.199 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.437 ' O ' ' O ' ' A' ' 56' ' ' ILE . 4.9 m -124.32 152.54 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.465 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.174 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 55' ' ' VAL . 4.9 pt -45.89 177.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.408 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.54 ' O ' ' N ' ' A' ' 59' ' ' TRP . 30.5 ttp180 -79.25 -57.53 3.67 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-O 118.337 -0.84 . . . . 0.0 112.715 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -30.58 -32.73 0.01 OUTLIER Glycine 0 N--CA 1.503 3.11 0 CA-C-O 122.664 1.147 . . . . 0.0 111.427 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.54 ' N ' ' O ' ' A' ' 57' ' ' ARG . 2.4 m0 -90.06 -73.5 0.52 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 113.629 -1.286 . . . . 0.0 107.853 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -31.86 -54.61 0.28 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 124.792 1.308 . . . . 0.0 110.768 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -73.15 -51.64 17.12 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 113.977 -1.465 . . . . 0.0 107.614 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 65' ' ' GLN . . . -55.69 -82.44 0.05 OUTLIER Glycine 0 N--CA 1.479 1.54 0 N-CA-C 108.16 -1.976 . . . . 0.0 108.16 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' A' ' 59' ' ' TRP . 66.1 t -30.38 -45.1 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.414 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -51.11 -49.29 61.02 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 123.692 1.711 . . . . 0.0 109.569 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.481 ' N ' ' O ' ' A' ' 62' ' ' GLY . 6.0 tt0 -66.01 3.29 0.87 Allowed 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 110.202 -3.181 . . . . 0.0 110.892 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.414 ' H ' ' C ' ' A' ' 64' ' ' ALA . 48.4 ttm -109.51 156.19 20.42 Favored 'General case' 0 N--CA 1.51 2.531 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 99.7 p -115.32 151.41 34.64 Favored 'General case' 0 N--CA 1.509 2.502 0 CA-C-O 122.545 1.164 . . . . 0.0 112.694 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 95.5 t -46.34 99.51 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-N 112.804 -1.998 . . . . 0.0 114.581 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.66 3.69 28.59 Favored Glycine 0 N--CA 1.502 3.076 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -101.83 149.13 24.5 Favored 'General case' 0 N--CA 1.506 2.328 0 CA-C-O 121.988 0.899 . . . . 0.0 111.03 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.8 ttt85 -127.14 143.2 51.32 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 113.786 -1.552 . . . . 0.0 106.961 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -151.72 175.99 11.85 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 113.401 -1.727 . . . . 0.0 113.958 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.5 ttmp? -119.67 102.8 8.87 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 103.45 -2.796 . . . . 0.0 103.45 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.2 mt -96.26 149.69 21.39 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 97.1 m -119.47 116.53 26.3 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 104.486 -2.412 . . . . 0.0 104.486 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 53.5 mt -102.45 142.58 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.9 p -101.53 154.36 37.3 Favored Pre-proline 0 N--CA 1.501 2.083 0 O-C-N 124.985 1.428 . . . . 0.0 111.398 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -44.72 -41.89 14.8 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 C-N-CA 122.915 2.41 . . . . 0.0 117.695 -175.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -87.77 20.24 3.11 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 117.908 2.558 . . . . 0.0 117.908 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -113.79 -38.39 4.27 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -115.35 -73.47 0.65 Allowed 'General case' 0 N--CA 1.503 2.192 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.421 ' CD2' HD11 ' A' ' 97' ' ' LEU . 8.9 m-30 -106.6 -92.84 0.39 Allowed 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 114.154 -1.384 . . . . 0.0 107.564 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 94' ' ' HIS . . . 107.94 -87.65 0.5 Allowed Glycine 0 N--CA 1.502 3.074 0 N-CA-C 115.051 0.78 . . . . 0.0 115.051 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -124.73 -28.84 3.49 Favored 'General case' 0 N--CA 1.503 2.185 0 CA-C-O 120.943 0.402 . . . . 0.0 111.433 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 91.3 m -99.55 67.83 1.54 Allowed 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.563 0.697 . . . . 0.0 110.544 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -112.83 -164.57 16.29 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.411 ' H ' ' HB ' ' A' ' 91' ' ' ILE . 25.6 t-80 -115.6 82.71 10.32 Favored Pre-proline 0 N--CA 1.503 2.18 0 CA-C-O 118.865 -0.588 . . . . 0.0 111.416 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_exo -34.88 151.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 122.671 2.248 . . . . 0.0 111.433 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 107.38 -41.7 2.13 Favored Glycine 0 N--CA 1.5 2.959 0 N-CA-C 106.011 -2.836 . . . . 0.0 106.011 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.0 mm -119.53 -57.27 3.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 110.253 -2.974 . . . . 0.0 107.004 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.411 ' HB ' ' H ' ' A' ' 87' ' ' HIS . 34.5 mm -118.93 87.57 33.99 Favored Pre-proline 0 N--CA 1.506 2.348 0 CA-C-N 113.354 -1.748 . . . . 0.0 111.086 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -69.64 162.66 41.16 Favored 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 122.448 2.099 . . . . 0.0 108.316 171.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -48.65 177.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.15 1.9 . . . . 0.0 112.176 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.52 ' N ' ' O ' ' A' ' 83' ' ' GLY . 24.5 m80 9.7 65.95 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 116.242 1.942 . . . . 0.0 116.242 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -115.62 138.33 51.18 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 28.9 m -90.73 136.94 32.74 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 103.752 -2.684 . . . . 0.0 103.752 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.421 HD11 ' CD2' ' A' ' 82' ' ' TYR . 19.3 mt -106.48 150.19 26.33 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.1 t -132.14 104.32 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -96.89 166.97 11.37 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -127.5 85.92 2.42 Favored 'General case' 0 N--CA 1.491 1.598 1 N-CA-C 94.844 -5.984 . . . . 0.0 94.844 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.1 t -98.59 149.45 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.3 0 CA-C-O 122.759 1.266 . . . . 0.0 114.342 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -126.84 111.45 14.19 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 112.19 -2.277 . . . . 0.0 106.897 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 35.0 tp -79.49 113.72 17.86 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 101.125 -3.657 . . . . 0.0 101.125 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.3 mt -74.19 -57.78 3.73 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 118.684 -1.207 . . . . 0.0 111.49 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.401 ' HG2' ' H ' ' A' ' 106' ' ' LEU . 0.4 OUTLIER -175.32 -172.27 0.56 Allowed 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 118.32 -1.352 . . . . 0.0 109.619 -179.831 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.401 ' H ' ' HG2' ' A' ' 105' ' ' LYS . 16.1 mt -117.89 155.28 30.43 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 . . . . . 0 N--CA 1.512 2.645 0 CA-C-O 116.175 -1.869 . . . . 0.0 109.143 179.443 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.2 p -113.63 150.08 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -121.09 152.64 38.44 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 55.6 t -126.64 112.38 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.531 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.417 ' OE1' ' O ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -113.03 96.04 5.72 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 103.644 -2.725 . . . . 0.0 103.644 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.417 ' O ' ' OE1' ' A' ' 5' ' ' GLU . 87.1 m -69.87 156.58 38.86 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 118.56 -1.256 . . . . 0.0 112.494 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 71.7 mt -121.16 -55.09 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 CA-C-N 113.939 -1.482 . . . . 0.0 107.422 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.423 ' O ' ' O ' ' A' ' 9' ' ' PRO . 36.2 m -124.35 82.42 57.95 Favored Pre-proline 0 N--CA 1.507 2.407 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.742 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 8' ' ' SER . 3.4 Cg_exo -35.93 164.21 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.566 2.177 . . . . 0.0 113.434 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -114.84 -176.91 18.87 Favored Glycine 0 N--CA 1.501 3.023 0 N-CA-C 105.841 -2.903 . . . . 0.0 105.841 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.464 ' CG ' ' H ' ' A' ' 12' ' ' GLY . 11.6 p-10 -42.5 -58.48 2.24 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 118.174 0.987 . . . . 0.0 111.745 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.464 ' H ' ' CG ' ' A' ' 11' ' ' ASP . . . 109.33 24.63 5.85 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 107.738 -2.145 . . . . 0.0 107.738 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.3 mtm180 -133.53 -34.35 1.05 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 114.75 -0.725 . . . . 0.0 112.771 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.4 m -111.51 130.4 55.74 Favored 'General case' 0 N--CA 1.506 2.347 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 26.2 m-85 -130.31 173.35 5.9 Favored Pre-proline 0 N--CA 1.497 1.898 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -67.94 150.28 78.03 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 CA-C-N 119.997 1.035 . . . . 0.0 111.165 167.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -121.62 171.15 9.05 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-O 121.898 0.856 . . . . 0.0 110.911 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.2 ttt-85 -77.51 98.57 5.38 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.491 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.0 10.38 4.32 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -114.97 173.91 6.24 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.1 m -124.7 112.09 16.34 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 20.1 m -69.82 145.8 51.84 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.4 t -118.11 102.84 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 101.268 -3.605 . . . . 0.0 101.268 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.0 m -124.09 153.9 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.443 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 -131.19 116.87 18.25 Favored 'General case' 0 N--CA 1.507 2.405 0 N-CA-C 104.991 -2.226 . . . . 0.0 104.991 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -132.16 177.38 7.61 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 122.997 1.379 . . . . 0.0 114.451 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 87.3 m -136.32 124.4 22.95 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 101.218 -3.623 . . . . 0.0 101.218 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -107.99 116.18 4.73 Favored Glycine 0 N--CA 1.501 3.022 0 C-N-CA 120.337 -0.935 . . . . 0.0 111.415 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 69.2 mtp -125.13 178.62 5.45 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 34.3 mt -123.18 172.17 8.79 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -29.66 -61.13 0.15 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 124.919 1.387 . . . . 0.0 113.637 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -160.5 42.84 0.18 Allowed 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.051 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -118.83 -79.93 0.67 Allowed Glycine 0 N--CA 1.5 2.946 0 C-N-CA 119.374 -1.393 . . . . 0.0 113.885 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -161.1 -168.73 2.13 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -91.11 133.9 34.96 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 113.963 -1.471 . . . . 0.0 109.957 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.531 ' CD2' ' OD1' ' A' ' 37' ' ' ASP . 4.9 p90 -123.77 -36.54 2.73 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.531 ' OD1' ' CD2' ' A' ' 36' ' ' PHE . 1.0 OUTLIER -132.55 74.77 1.59 Allowed 'General case' 0 N--CA 1.509 2.497 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.673 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 69.0 m -105.75 121.51 44.18 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 63.9 p -113.22 65.16 0.64 Allowed 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.043 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -116.22 -72.08 0.71 Allowed 'General case' 0 N--CA 1.503 2.216 0 CA-C-O 120.838 0.352 . . . . 0.0 110.803 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -91.11 11.71 22.32 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -91.15 -96.83 0.12 Allowed 'General case' 0 N--CA 1.503 2.223 0 C-N-CA 119.995 -0.682 . . . . 0.0 112.384 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.415 ' O ' ' O ' ' A' ' 44' ' ' LYS . 4.4 m120 -110.77 62.43 0.61 Allowed 'General case' 0 N--CA 1.504 2.256 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.72 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.415 ' O ' ' O ' ' A' ' 43' ' ' ASN . 48.8 mttm 52.29 -178.02 0.02 OUTLIER Pre-proline 0 N--CA 1.499 2.003 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -60.39 -161.35 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.559 0 CA-C-N 119.875 0.991 . . . . 0.0 111.52 174.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -123.3 159.23 29.24 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 113.671 -1.604 . . . . 0.0 112.891 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.5 mtmp? -143.61 117.11 9.13 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.875 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -137.14 167.3 21.81 Favored 'General case' 0 N--CA 1.511 2.602 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.638 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.5 ' SD ' ' O ' ' A' ' 50' ' ' LEU . 7.8 tmm? -117.46 144.6 44.87 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.97 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.5 ' O ' ' SD ' ' A' ' 49' ' ' MET . 44.0 tp -90.81 134.52 34.38 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 114.516 -1.22 . . . . 0.0 111.443 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 132.97 -34.42 2.46 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 54' ' ' GLU . 80.3 tttt -122.62 44.39 2.65 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 4.42 58.73 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 126.015 2.072 . . . . 0.0 114.072 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 52' ' ' LYS . 50.4 mt-10 -63.74 -17.58 63.17 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 114.526 -1.215 . . . . 0.0 109.757 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 56' ' ' ILE . 21.1 m -117.6 159.79 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.32 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.425 ' O ' ' O ' ' A' ' 55' ' ' VAL . 16.2 pt -51.55 178.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 C-N-CA 118.64 -1.224 . . . . 0.0 108.534 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.532 ' O ' ' N ' ' A' ' 59' ' ' TRP . 17.6 ttm180 -75.18 -59.14 2.88 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.152 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -28.52 -34.98 0.01 OUTLIER Glycine 0 N--CA 1.497 2.738 0 O-C-N 124.614 1.196 . . . . 0.0 112.26 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.532 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.6 OUTLIER -81.39 -73.61 0.37 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 179.761 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 59' ' ' TRP . 32.4 tt0 -22.4 -57.24 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 O-C-N 125.914 2.009 . . . . 0.0 111.426 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -78.11 -52.21 9.09 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 113.075 -1.875 . . . . 0.0 106.491 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -49.65 -74.17 0.3 Allowed Glycine 0 N--CA 1.48 1.604 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.095 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.499 ' N ' ' O ' ' A' ' 59' ' ' TRP . 25.6 t -44.13 -50.59 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 C-N-CA 119.317 -0.953 . . . . 0.0 111.745 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.469 ' C ' ' N ' ' A' ' 66' ' ' MET . . . -44.19 -62.39 1.17 Allowed 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 123.989 1.852 . . . . 0.0 111.608 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -45.9 -13.98 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 109.429 -3.532 . . . . 0.0 109.3 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.469 ' N ' ' C ' ' A' ' 64' ' ' ALA . 20.2 mtm -98.36 158.23 15.71 Favored 'General case' 0 N--CA 1.514 2.733 0 C-N-CA 118.084 -1.446 . . . . 0.0 108.96 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 84.4 p -117.9 149.43 40.9 Favored 'General case' 0 N--CA 1.508 2.467 0 CA-C-O 122.558 1.17 . . . . 0.0 113.399 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 90.5 t -39.4 96.6 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 112.719 -2.037 . . . . 0.0 114.044 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.13 9.4 20.24 Favored Glycine 0 N--CA 1.5 2.919 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -103.0 141.6 35.52 Favored 'General case' 0 N--CA 1.502 2.168 0 CA-C-O 121.457 0.646 . . . . 0.0 110.355 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 24.7 ttt85 -125.34 141.13 52.25 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -149.65 176.13 10.93 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-N 113.064 -1.88 . . . . 0.0 115.853 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -127.61 105.01 8.19 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 103.851 -2.648 . . . . 0.0 103.851 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.429 HD12 ' N ' ' A' ' 74' ' ' LEU . 4.9 mp -102.47 152.27 21.33 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.591 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 92.0 m -123.73 117.18 24.37 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 22.8 mt -108.63 141.72 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 CA-C-O 121.099 0.476 . . . . 0.0 109.858 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.421 ' O ' ' OD1' ' A' ' 79' ' ' ASP . 33.4 p -114.65 155.34 46.24 Favored Pre-proline 0 N--CA 1.504 2.263 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.435 ' O ' ' N ' ' A' ' 81' ' ' ALA . 10.2 Cg_endo -37.68 -55.65 1.04 Allowed 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.683 1.588 . . . . 0.0 113.961 -175.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 14.7 p30 -34.04 -34.89 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.579 0.704 . . . . 0.0 112.567 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.429 ' N ' ' O ' ' A' ' 78' ' ' PRO . 6.9 m-85 -106.81 -20.29 13.38 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.644 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 78' ' ' PRO . . . -106.75 171.02 7.59 Favored 'General case' 0 N--CA 1.507 2.383 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.415 ' C ' ' O ' ' A' ' 81' ' ' ALA . 51.3 m-85 -7.99 -63.15 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.269 0 O-C-N 125.627 1.829 . . . . 0.0 114.704 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 115.15 -97.35 0.8 Allowed Glycine 0 N--CA 1.503 3.122 0 CA-C-N 115.776 -0.647 . . . . 0.0 113.901 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -127.71 -31.63 2.43 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 92.0 m -101.93 78.35 1.79 Allowed 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -111.01 -168.74 19.02 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 107.333 -2.307 . . . . 0.0 107.333 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.433 ' O ' ' O ' ' A' ' 91' ' ' ILE . 30.4 t-80 -111.86 135.84 21.2 Favored Pre-proline 0 N--CA 1.507 2.398 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -75.48 149.85 35.34 Favored 'Trans proline' 0 C--N 1.316 -1.18 0 C-N-CA 121.232 1.288 . . . . 0.0 109.666 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 107.04 -45.02 1.36 Allowed Glycine 0 N--CA 1.499 2.877 0 N-CA-C 108.257 -1.937 . . . . 0.0 108.257 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.4 mt -112.93 -53.78 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 87' ' ' HIS . 18.9 mm -118.99 86.02 30.5 Favored Pre-proline 0 N--CA 1.508 2.457 0 CA-C-N 113.689 -1.596 . . . . 0.0 111.908 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -65.0 161.51 36.56 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 N-CA-C 106.875 -2.01 . . . . 0.0 106.875 173.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -52.07 170.27 0.24 Allowed 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 121.918 1.745 . . . . 0.0 111.384 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 9.59 66.82 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 116.034 1.865 . . . . 0.0 116.034 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -116.85 152.7 33.91 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 31.2 m -91.02 143.26 26.89 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 20.3 mt -110.19 153.33 24.91 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.7 t -138.11 123.59 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -118.86 155.03 31.95 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 122.119 0.961 . . . . 0.0 110.307 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -125.7 89.94 3.12 Favored 'General case' 0 N--CA 1.494 1.76 1 N-CA-C 97.424 -5.028 . . . . 0.0 97.424 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 9.9 t -102.93 151.29 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.483 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -128.59 100.9 5.93 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 111.832 -2.44 . . . . 0.0 108.284 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 45.9 tp -72.75 124.49 25.44 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 104.159 -2.534 . . . . 0.0 104.159 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.1 mt -91.56 -58.32 2.47 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 114.372 -1.285 . . . . 0.0 112.008 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.417 ' HG2' ' H ' ' A' ' 106' ' ' LEU . 29.3 tttm -168.93 -175.4 2.34 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.007 -1.077 . . . . 0.0 110.418 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.417 ' H ' ' HG2' ' A' ' 105' ' ' LYS . 17.9 mt -117.22 154.89 30.36 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 . . . . . 0 N--CA 1.505 2.313 0 CA-C-O 116.056 -1.926 . . . . 0.0 110.817 179.578 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.6 p -117.58 150.26 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -121.96 157.46 31.21 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.6 t -126.64 106.62 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -107.47 88.47 2.74 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 93.4 m -69.7 156.13 39.45 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.004 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.0 mt -122.76 -52.73 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-N 113.681 -1.599 . . . . 0.0 107.025 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.422 ' O ' ' O ' ' A' ' 9' ' ' PRO . 98.2 p -122.75 82.22 48.89 Favored Pre-proline 0 N--CA 1.505 2.302 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.462 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 8' ' ' SER . 7.8 Cg_exo -37.59 167.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.606 2.204 . . . . 0.0 113.234 178.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.16 -171.79 15.03 Favored Glycine 0 N--CA 1.503 3.132 0 N-CA-C 107.17 -2.372 . . . . 0.0 107.17 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.521 ' N ' ' OD1' ' A' ' 11' ' ' ASP . 13.9 p-10 -39.62 -61.09 0.86 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.576 -0.85 . . . . 0.0 112.897 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.17 17.88 12.08 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 106.126 -2.789 . . . . 0.0 106.126 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.9 mmt85 -127.41 -39.61 1.85 Allowed 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 114.006 -1.097 . . . . 0.0 111.925 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.1 m -108.29 133.7 52.15 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.435 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 32.8 m-85 -131.16 175.67 3.5 Favored Pre-proline 0 N--CA 1.496 1.855 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -72.58 140.81 33.46 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 CA-C-N 119.621 0.9 . . . . 0.0 109.988 163.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -121.23 174.08 6.92 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.714 0.769 . . . . 0.0 110.325 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 25.1 ttt85 -73.13 110.36 7.36 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.082 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.96 0.89 10.69 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -116.63 172.94 6.9 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 121.933 0.873 . . . . 0.0 110.628 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 97.0 m -125.25 117.67 24.32 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-N 113.975 -1.466 . . . . 0.0 108.234 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 55.8 m -69.58 150.55 46.96 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 77.0 t -122.71 101.48 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 102.945 -2.983 . . . . 0.0 102.945 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.3 m -121.64 149.19 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.498 0 N-CA-C 117.904 2.557 . . . . 0.0 117.904 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -124.68 111.92 16.16 Favored 'General case' 0 N--CA 1.507 2.378 0 N-CA-C 103.352 -2.833 . . . . 0.0 103.352 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.471 ' CD1' ' N ' ' A' ' 26' ' ' TYR . 19.8 p90 -129.89 168.32 16.81 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 123.485 1.612 . . . . 0.0 114.434 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 97.3 m -134.6 111.05 9.72 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 102.384 -3.191 . . . . 0.0 102.384 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 37' ' ' ASP . . . -89.36 138.35 14.62 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.113 -1.518 . . . . 0.0 109.875 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 38.1 ttm -131.22 175.67 8.92 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 32.9 mt -116.61 -167.63 1.32 Allowed 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -89.18 24.61 2.1 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 33' ' ' GLY . 1.2 p30 -132.47 -48.24 0.9 Allowed 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.601 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.526 ' N ' ' OD1' ' A' ' 32' ' ' ASP . . . 120.92 31.53 1.19 Allowed Glycine 0 N--CA 1.501 3.032 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.621 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 35' ' ' LYS . 25.8 mmtp -118.93 81.55 1.72 Allowed 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 118.581 -0.723 . . . . 0.0 110.252 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.405 ' C ' ' O ' ' A' ' 34' ' ' LYS . 21.6 pttp -19.29 133.67 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.531 0 O-C-N 125.078 1.486 . . . . 0.0 113.211 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.527 ' CD2' ' OD1' ' A' ' 37' ' ' ASP . 0.6 OUTLIER -136.02 -31.07 0.93 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 113.906 -1.497 . . . . 0.0 110.195 -179.582 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.527 ' OD1' ' CD2' ' A' ' 36' ' ' PHE . 0.9 OUTLIER -132.08 92.83 3.17 Favored 'General case' 0 N--CA 1.516 2.853 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -179.737 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 52.6 m -108.66 173.57 6.26 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.574 ' O ' ' N ' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -116.13 78.21 1.17 Allowed 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.539 ' O ' ' N ' ' A' ' 42' ' ' ARG . 9.9 mmm180 -28.58 57.37 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.39 0 O-C-N 126.88 2.612 . . . . 0.0 117.687 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.574 ' N ' ' O ' ' A' ' 39' ' ' SER . 36.9 t70 -27.21 71.72 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 112.877 -1.965 . . . . 0.0 115.265 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.539 ' N ' ' O ' ' A' ' 40' ' ' ARG . 43.8 ttp180 -90.78 -63.16 1.31 Allowed 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.843 ' H ' HD22 ' A' ' 43' ' ' ASN . 0.0 OUTLIER -110.4 -81.93 0.58 Allowed 'General case' 0 N--CA 1.5 2.034 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.478 179.899 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.688 ' H ' ' ND2' ' A' ' 43' ' ' ASN . 18.3 ptpt -125.94 152.41 72.8 Favored Pre-proline 0 N--CA 1.504 2.265 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 44' ' ' LYS . 20.1 Cg_endo -46.72 -160.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 123.102 2.534 . . . . 0.0 117.117 -175.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -94.6 143.91 26.03 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 113.592 -1.64 . . . . 0.0 110.077 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -135.43 125.45 25.93 Favored 'General case' 0 N--CA 1.507 2.386 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -136.62 175.35 9.69 Favored 'General case' 0 N--CA 1.508 2.472 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.903 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 41.9 ttm -113.97 149.92 34.58 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 59.3 tp -91.01 119.85 31.52 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 113.993 -1.458 . . . . 0.0 112.444 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.82 -1.41 61.4 Favored Glycine 0 N--CA 1.498 2.774 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.444 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.414 ' O ' ' C ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -118.56 41.29 3.02 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.747 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.414 ' C ' ' O ' ' A' ' 52' ' ' LYS . 85.2 mt-30 4.9 65.72 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 O-C-N 125.54 1.775 . . . . 0.0 113.944 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.44 ' O ' ' OE1' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -93.58 -36.47 12.38 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 103.394 -2.817 . . . . 0.0 103.394 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.43 ' O ' ' O ' ' A' ' 56' ' ' ILE . 27.9 m -115.21 154.18 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.43 ' O ' ' O ' ' A' ' 55' ' ' VAL . 5.0 pt -48.29 175.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 118.971 -1.091 . . . . 0.0 110.353 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.555 ' NH1' ' CE2' ' A' ' 80' ' ' TYR . 23.5 ttt180 -72.78 -59.84 2.52 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 118.354 -0.832 . . . . 0.0 110.864 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -27.37 -37.19 0.01 OUTLIER Glycine 0 N--CA 1.502 3.048 0 O-C-N 124.539 1.15 . . . . 0.0 111.695 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.533 ' N ' ' O ' ' A' ' 57' ' ' ARG . 1.0 OUTLIER -79.61 -75.6 0.24 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 -29.1 -55.11 0.13 Allowed 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 112.983 -1.917 . . . . 0.0 110.788 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.525 ' OE1' ' NH1' ' A' ' 57' ' ' ARG . 37.7 tt0 -72.91 -50.27 24.64 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -58.37 -75.62 0.25 Allowed Glycine 0 N--CA 1.477 1.376 0 C-N-CA 119.512 -1.327 . . . . 0.0 111.028 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.525 ' N ' ' O ' ' A' ' 59' ' ' TRP . 35.9 t -39.76 -50.37 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 C-N-CA 119.901 -0.719 . . . . 0.0 112.868 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.469 ' C ' ' N ' ' A' ' 66' ' ' MET . . . -43.66 -62.17 1.18 Allowed 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 124.16 1.933 . . . . 0.0 111.642 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -44.92 -14.92 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 109.233 -3.622 . . . . 0.0 108.946 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.469 ' N ' ' C ' ' A' ' 64' ' ' ALA . 8.2 mtm -98.26 159.99 14.58 Favored 'General case' 0 N--CA 1.512 2.661 0 C-N-CA 118.467 -1.293 . . . . 0.0 107.895 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 77.7 p -117.63 150.43 39.04 Favored 'General case' 0 N--CA 1.507 2.415 0 CA-C-O 122.573 1.177 . . . . 0.0 112.937 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 96.2 t -44.03 103.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 112.711 -2.041 . . . . 0.0 114.471 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.64 8.16 21.23 Favored Glycine 0 N--CA 1.5 2.942 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -109.15 152.94 24.45 Favored 'General case' 0 N--CA 1.506 2.35 0 CA-C-O 122.311 1.053 . . . . 0.0 111.665 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 -131.26 140.61 49.85 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 113.17 -1.832 . . . . 0.0 107.367 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -146.7 178.58 8.2 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 112.527 -2.124 . . . . 0.0 115.879 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -126.91 104.99 8.32 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 102.866 -3.013 . . . . 0.0 102.866 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.8 mt -98.85 153.61 18.65 Favored 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 120.169 -0.612 . . . . 0.0 109.505 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 84.8 m -123.92 119.45 29.65 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 35.7 mt -111.53 141.08 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 69.3 p -109.09 150.69 41.31 Favored Pre-proline 0 N--CA 1.501 2.12 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -41.56 -54.6 2.67 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.627 1.552 . . . . 0.0 112.517 -171.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.511 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 10.9 p-10 -40.06 -27.21 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.555 ' CE2' ' NH1' ' A' ' 57' ' ' ARG . 4.5 m-85 -103.54 24.87 10.42 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -171.03 -83.39 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 116.819 2.155 . . . . 0.0 116.819 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.401 ' O ' ' C ' ' A' ' 83' ' ' GLY . 6.4 m-30 -109.7 56.49 0.62 Allowed 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 113.72 -1.582 . . . . 0.0 110.939 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 82' ' ' TYR . . . -6.02 -114.55 0.0 OUTLIER Glycine 0 N--CA 1.503 3.113 0 O-C-N 125.505 1.753 . . . . 0.0 115.102 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -123.05 47.74 1.92 Allowed 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.432 ' O ' ' O ' ' A' ' 86' ' ' GLY . 94.2 m -124.03 -54.85 1.71 Allowed 'General case' 0 N--CA 1.5 2.059 0 CA-C-N 114.255 -1.339 . . . . 0.0 110.808 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 85' ' ' THR . . . 42.47 -171.21 0.01 OUTLIER Glycine 0 N--CA 1.493 2.459 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.716 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.448 ' N ' ' O ' ' A' ' 91' ' ' ILE . 22.1 m80 -116.22 159.62 38.95 Favored Pre-proline 0 N--CA 1.505 2.297 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -86.58 87.78 0.76 Allowed 'Trans proline' 0 C--N 1.314 -1.252 0 C-N-CA 122.808 2.339 . . . . 0.0 111.757 171.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 134.84 -32.1 2.64 Favored Glycine 0 N--CA 1.504 3.231 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.402 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.9 mt -105.7 -62.83 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.448 ' O ' ' N ' ' A' ' 87' ' ' HIS . 2.7 mp -121.97 87.11 46.89 Favored Pre-proline 0 N--CA 1.508 2.46 0 CA-C-N 114.592 -1.186 . . . . 0.0 109.766 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -54.16 -175.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.092 1.861 . . . . 0.0 108.989 167.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.24 168.16 5.16 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 121.951 1.767 . . . . 0.0 110.799 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.476 ' H ' ' CD2' ' A' ' 94' ' ' HIS . 41.1 m170 9.46 63.4 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.205 0 O-C-N 125.371 1.669 . . . . 0.0 115.235 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.404 ' O ' ' O ' ' A' ' 96' ' ' THR . . . -119.09 74.82 1.0 Allowed 'General case' 0 N--CA 1.503 2.209 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.159 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.404 ' O ' ' O ' ' A' ' 95' ' ' ALA . 59.3 m -29.51 148.72 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 114.447 -1.252 . . . . 0.0 111.447 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 15.1 mt -113.19 163.76 14.37 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 58.2 t -136.32 132.06 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -123.28 145.9 48.32 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -121.65 94.42 4.31 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 100.715 -3.809 . . . . 0.0 100.715 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 102' ' ' GLU . 19.9 t -109.09 152.86 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.45 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.464 ' N ' HG12 ' A' ' 101' ' ' VAL . 88.9 tt0 -126.02 98.16 5.39 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 112.169 -2.287 . . . . 0.0 106.827 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 47.9 tp -71.87 124.18 24.28 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 102.953 -2.98 . . . . 0.0 102.953 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.6 mt -92.93 -55.96 3.16 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.122 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -170.03 -168.28 0.73 Allowed 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.141 -1.024 . . . . 0.0 111.587 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 27.9 mt -115.82 156.17 26.55 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 . . . . . 0 N--CA 1.504 2.226 0 CA-C-O 116.195 -1.86 . . . . 0.0 109.564 179.882 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.6 p -105.88 147.62 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.445 HE21 ' CG ' ' A' ' 5' ' ' GLU . 39.8 tt0 -122.43 158.12 30.42 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.5 t -124.48 113.14 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.445 ' CG ' HE21 ' A' ' 3' ' ' GLN . 50.5 mt-10 -112.96 90.28 3.3 Favored 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 91.3 m -69.78 156.28 39.26 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 114.312 -1.313 . . . . 0.0 113.437 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 56.4 mt -121.87 -51.19 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 CA-C-N 113.808 -1.542 . . . . 0.0 107.45 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.7 m -122.98 80.17 50.74 Favored Pre-proline 0 N--CA 1.506 2.369 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.272 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -40.05 160.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.715 2.277 . . . . 0.0 112.791 178.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -125.44 -175.27 14.16 Favored Glycine 0 N--CA 1.5 2.938 0 N-CA-C 106.631 -2.588 . . . . 0.0 106.631 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 12' ' ' GLY . 1.1 p30 -39.78 -52.84 2.3 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.599 -0.841 . . . . 0.0 112.906 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.468 ' N ' ' OD1' ' A' ' 11' ' ' ASP . . . 90.75 14.5 58.03 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 106.689 -2.564 . . . . 0.0 106.689 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 45.6 mtm-85 -124.68 -33.81 2.93 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 113.604 -1.298 . . . . 0.0 112.274 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.5 m -107.86 125.55 51.59 Favored 'General case' 0 N--CA 1.501 2.086 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.954 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.448 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 36.9 m-85 -125.01 175.46 3.02 Favored Pre-proline 0 N--CA 1.501 2.097 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -66.68 154.8 73.18 Favored 'Trans proline' 0 C--N 1.315 -1.224 0 N-CA-C 109.474 -1.01 . . . . 0.0 109.474 164.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -119.23 169.04 10.31 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-O 121.967 0.889 . . . . 0.0 110.277 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 56.6 mtt-85 -77.18 107.5 9.61 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.343 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.19 -12.93 8.0 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 108.65 -1.78 . . . . 0.0 108.65 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -108.16 166.55 10.65 Favored 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 19.2 m -110.73 125.64 53.72 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.508 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 33.1 m -74.64 142.42 44.54 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 70.7 t -116.77 96.75 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 102.731 -3.063 . . . . 0.0 102.731 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.402 HG21 ' CH2' ' A' ' 59' ' ' TRP . 3.0 m -118.23 148.49 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 O-C-N 124.751 1.282 . . . . 0.0 113.915 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 49.9 t60 -128.76 117.93 21.94 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 103.472 -2.788 . . . . 0.0 103.472 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -134.88 176.06 9.0 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 122.951 1.357 . . . . 0.0 111.426 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 74.8 m -128.84 116.56 19.63 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 100.728 -3.804 . . . . 0.0 100.728 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -95.51 131.07 10.53 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 104.85 -3.3 . . . . 0.0 104.85 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 43.2 ttm -134.49 170.13 16.22 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 104.732 -2.322 . . . . 0.0 104.732 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.7 mt -111.76 -175.41 2.69 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 104.004 -2.591 . . . . 0.0 104.004 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -35.58 -62.67 0.39 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 124.26 0.975 . . . . 0.0 113.445 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 58.0 p-10 -161.15 44.01 0.17 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.383 -1.327 . . . . 0.0 109.28 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -117.68 -75.45 0.53 Allowed Glycine 0 N--CA 1.509 3.526 0 C-N-CA 119.164 -1.493 . . . . 0.0 115.608 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.09 -160.49 0.91 Allowed 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 119.421 -0.912 . . . . 0.0 112.977 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -89.99 142.96 27.2 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.524 ' CE2' ' OD2' ' A' ' 37' ' ' ASP . 1.9 p90 -135.36 -32.24 0.94 Allowed 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 112.818 -1.992 . . . . 0.0 108.076 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.524 ' OD2' ' CE2' ' A' ' 36' ' ' PHE . 9.6 m-20 -136.46 26.38 3.14 Favored 'General case' 0 N--CA 1.525 3.318 0 N-CA-C 117.806 2.521 . . . . 0.0 117.806 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 37' ' ' ASP . 48.7 m -43.32 168.22 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 114.86 -1.063 . . . . 0.0 110.285 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 90.7 p -105.18 48.89 0.82 Allowed 'General case' 0 N--CA 1.504 2.251 0 CA-C-O 120.9 0.381 . . . . 0.0 110.439 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -126.63 53.89 1.63 Allowed 'General case' 0 N--CA 1.505 2.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.366 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -90.53 -68.56 0.78 Allowed 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 119.666 -0.813 . . . . 0.0 113.05 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -91.27 -107.55 0.1 Allowed 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -110.42 -44.38 3.72 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 45' ' ' PRO . 6.4 mmmm -106.6 160.55 25.85 Favored Pre-proline 0 N--CA 1.507 2.422 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.26 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 44' ' ' LYS . 43.1 Cg_endo -52.9 -158.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.316 -1.156 0 C-N-CA 121.86 1.707 . . . . 0.0 111.446 175.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -94.81 135.46 36.28 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 114.228 -1.351 . . . . 0.0 111.367 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -133.17 121.95 23.3 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -137.82 172.48 12.89 Favored 'General case' 0 N--CA 1.508 2.474 0 C-N-CA 119.448 -0.901 . . . . 0.0 111.27 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.6 ttt -112.9 150.07 32.3 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.487 0.66 . . . . 0.0 112.73 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.4 tp -90.58 121.0 32.13 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.113 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.57 -3.7 39.71 Favored Glycine 0 N--CA 1.5 2.951 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.998 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' A' ' 54' ' ' GLU . 19.2 ttmm -115.84 42.46 2.32 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.411 ' C ' ' O ' ' A' ' 52' ' ' LYS . 72.8 mt-30 0.76 63.48 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.044 0 O-C-N 125.706 1.879 . . . . 0.0 113.655 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 52' ' ' LYS . 1.9 tm-20 -101.4 -23.9 14.28 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 113.796 -1.547 . . . . 0.0 106.864 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.2 m -112.7 158.73 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.577 0 C-N-CA 119.856 -0.738 . . . . 0.0 109.269 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.5 pt -59.1 173.95 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.484 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.549 ' O ' ' N ' ' A' ' 59' ' ' TRP . 3.6 tpp180 -66.99 -60.22 2.82 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 118.564 -0.731 . . . . 0.0 109.891 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -24.59 -38.9 0.01 OUTLIER Glycine 0 N--CA 1.499 2.889 0 O-C-N 125.1 1.5 . . . . 0.0 111.498 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.549 ' N ' ' O ' ' A' ' 57' ' ' ARG . 2.0 m95 -82.37 -74.88 0.33 Allowed 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 112.816 -1.692 . . . . 0.0 110.447 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 59' ' ' TRP . 29.9 tt0 -24.32 -54.6 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 125.97 2.044 . . . . 0.0 111.33 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -77.88 -54.18 6.62 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -50.36 -75.41 0.21 Allowed Glycine 0 N--CA 1.481 1.671 0 C-N-CA 119.729 -1.225 . . . . 0.0 110.544 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.53 ' N ' ' O ' ' A' ' 59' ' ' TRP . 25.1 t -43.53 -48.06 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 119.218 -0.993 . . . . 0.0 112.011 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.435 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -45.34 -58.75 3.09 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 123.783 1.754 . . . . 0.0 111.37 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -50.44 -9.02 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 109.873 -3.33 . . . . 0.0 110.617 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.435 ' H ' ' C ' ' A' ' 64' ' ' ALA . 40.8 mtm -103.97 151.05 23.66 Favored 'General case' 0 N--CA 1.519 2.989 0 C-N-CA 118.824 -1.15 . . . . 0.0 109.993 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 61.7 p -115.58 148.07 40.01 Favored 'General case' 0 N--CA 1.509 2.525 0 CA-C-O 122.756 1.265 . . . . 0.0 114.006 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 60.5 t -38.94 109.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-N 112.478 -2.146 . . . . 0.0 114.871 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.49 -2.51 36.9 Favored Glycine 0 N--CA 1.501 2.985 0 C-N-CA 119.58 -1.295 . . . . 0.0 111.296 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -99.97 153.61 19.05 Favored 'General case' 0 N--CA 1.506 2.338 0 CA-C-O 122.344 1.068 . . . . 0.0 111.87 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 31.1 ttp180 -131.7 143.82 50.54 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 113.137 -1.847 . . . . 0.0 107.209 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -151.98 176.78 11.14 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 116.574 2.064 . . . . 0.0 116.574 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -124.78 104.58 8.72 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 110.855 -2.884 . . . . 0.0 104.349 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.1 mt -96.83 150.06 21.15 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.7 m -121.1 103.39 8.98 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 37.5 mt -99.38 132.09 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.418 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 66.9 p -113.03 156.38 42.88 Favored Pre-proline 0 N--CA 1.501 2.094 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -34.32 -50.41 0.63 Allowed 'Trans proline' 0 C--N 1.314 -1.248 0 C-N-CA 122.231 1.954 . . . . 0.0 114.096 -176.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 80' ' ' TYR . 1.4 p30 -38.91 -41.12 0.72 Allowed 'General case' 0 N--CA 1.485 1.324 0 CA-C-O 121.837 0.827 . . . . 0.0 111.734 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.479 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 6.5 m-85 -105.78 -44.08 4.73 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.838 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.534 ' O ' ' N ' ' A' ' 83' ' ' GLY . . . -74.81 161.87 29.19 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.464 ' O ' ' N ' ' A' ' 84' ' ' ALA . 58.6 m-85 -0.56 62.49 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 126.709 2.505 . . . . 0.0 114.755 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 81' ' ' ALA . . . 13.9 -74.36 0.0 OUTLIER Glycine 0 N--CA 1.497 2.757 0 CA-C-N 113.711 -1.586 . . . . 0.0 115.635 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 82' ' ' TYR . . . -128.77 -62.97 0.99 Allowed 'General case' 0 N--CA 1.506 2.362 0 CA-C-N 117.429 0.615 . . . . 0.0 111.816 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 85.2 m -115.36 151.2 35.09 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -131.63 -103.7 0.94 Allowed Glycine 0 N--CA 1.5 2.959 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.534 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -127.64 78.8 74.43 Favored Pre-proline 0 N--CA 1.5 2.068 0 CA-C-N 114.738 -0.731 . . . . 0.0 110.377 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -30.46 112.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 123.139 2.559 . . . . 0.0 112.827 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 128.03 -31.3 3.71 Favored Glycine 0 N--CA 1.499 2.835 0 N-CA-C 108.517 -1.833 . . . . 0.0 108.517 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.4 mt -111.27 -49.89 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.288 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 23.9 mm -116.39 84.67 14.88 Favored Pre-proline 0 N--CA 1.508 2.429 0 CA-C-N 113.226 -1.806 . . . . 0.0 112.059 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -48.05 158.31 0.91 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.438 2.092 . . . . 0.0 109.449 174.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.526 ' O ' ' CD2' ' A' ' 94' ' ' HIS . 83.8 Cg_endo -62.09 82.25 0.1 OUTLIER 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 123.055 2.503 . . . . 0.0 113.573 178.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.526 ' CD2' ' O ' ' A' ' 93' ' ' PRO . 74.3 m-70 107.13 71.99 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.343 0 O-C-N 125.685 1.865 . . . . 0.0 113.714 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -120.12 145.54 46.82 Favored 'General case' 0 N--CA 1.506 2.326 0 CA-C-O 121.652 0.739 . . . . 0.0 110.856 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 97.5 m -91.21 126.15 36.21 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 20.6 mt -101.55 152.7 20.48 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.7 t -132.27 117.8 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.458 ' CE2' ' NE1' ' A' ' 59' ' ' TRP . 3.9 m-85 -109.32 160.06 16.47 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -128.61 88.27 2.71 Favored 'General case' 0 N--CA 1.497 1.892 1 N-CA-C 98.295 -4.705 . . . . 0.0 98.295 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.44 HG12 ' N ' ' A' ' 102' ' ' GLU . 14.7 t -101.98 152.5 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.64 0 N-CA-C 117.495 2.406 . . . . 0.0 117.495 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.44 ' N ' HG12 ' A' ' 101' ' ' VAL . 38.1 tt0 -129.25 104.88 7.78 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 112.3 -2.227 . . . . 0.0 106.755 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 36.8 tp -77.06 116.05 17.38 Favored 'General case' 0 N--CA 1.505 2.321 0 N-CA-C 101.888 -3.375 . . . . 0.0 101.888 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.7 mt -86.2 -61.99 1.62 Allowed 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 114.372 -1.285 . . . . 0.0 114.115 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 14.5 mmtt -157.16 -171.86 3.79 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.834 0.826 . . . . 0.0 111.351 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 21.4 mt -119.15 159.99 22.96 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 103.772 -2.677 . . . . 0.0 103.772 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 . . . . . 0 N--CA 1.508 2.445 0 CA-C-O 115.572 -2.156 . . . . 0.0 107.548 179.919 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.994 -1.243 . . . . 0.0 109.994 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.8 p -112.02 150.17 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.577 HE21 ' CG ' ' A' ' 5' ' ' GLU . 40.6 tt0 -121.99 156.01 34.36 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.8 t -125.5 118.13 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.577 ' CG ' HE21 ' A' ' 3' ' ' GLN . 6.1 mm-40 -121.84 94.52 4.34 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 92.5 m -69.82 157.28 37.67 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 76.3 mt -121.98 -55.47 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 CA-C-N 113.656 -1.611 . . . . 0.0 107.132 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.423 ' O ' ' O ' ' A' ' 9' ' ' PRO . 36.6 m -120.94 84.44 38.84 Favored Pre-proline 0 N--CA 1.504 2.234 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.331 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 8' ' ' SER . 0.5 OUTLIER -34.71 159.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.3 2.0 . . . . 0.0 112.15 177.025 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -124.47 -164.75 12.01 Favored Glycine 0 N--CA 1.501 3.02 0 N-CA-C 107.992 -2.043 . . . . 0.0 107.992 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.466 ' CG ' ' H ' ' A' ' 12' ' ' GLY . 1.2 p-10 -39.55 -67.54 0.22 Allowed 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 121.816 0.817 . . . . 0.0 112.348 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.466 ' H ' ' CG ' ' A' ' 11' ' ' ASP . . . 104.33 12.61 28.61 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 105.3 -3.12 . . . . 0.0 105.3 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -124.38 -45.67 1.94 Allowed 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 113.797 -1.201 . . . . 0.0 112.188 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 38.6 m -103.12 129.2 49.91 Favored 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -128.97 173.04 6.11 Favored Pre-proline 0 N--CA 1.499 1.982 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -67.85 132.09 25.73 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 CA-C-N 119.707 0.931 . . . . 0.0 112.663 166.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -120.23 165.07 15.3 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.8 ptm85 -66.12 134.29 52.49 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.69 -25.71 11.63 Favored Glycine 0 N--CA 1.498 2.777 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -106.89 173.0 6.51 Favored 'General case' 0 N--CA 1.508 2.444 0 CA-C-O 121.715 0.769 . . . . 0.0 112.99 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.7 m -115.29 121.05 41.7 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.723 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 30.6 m -69.29 152.62 44.79 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.412 HG23 ' H ' ' A' ' 107' ' ' GLU . 97.6 t -130.11 102.78 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 101.763 -3.421 . . . . 0.0 101.763 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.7 m -120.72 152.66 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.374 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -129.13 113.82 15.56 Favored 'General case' 0 N--CA 1.506 2.349 0 N-CA-C 102.807 -3.035 . . . . 0.0 102.807 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.552 ' CD1' ' N ' ' A' ' 26' ' ' TYR . 33.0 p90 -132.25 175.91 8.85 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 122.974 1.369 . . . . 0.0 114.221 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.8 m -137.06 117.59 13.82 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 101.794 -3.41 . . . . 0.0 101.794 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 37' ' ' ASP . . . -98.61 141.85 15.78 Favored Glycine 0 N--CA 1.501 3.003 0 C-N-CA 119.921 -1.133 . . . . 0.0 110.697 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.475 ' O ' ' O ' ' A' ' 30' ' ' LEU . 69.6 mmm -149.04 95.38 2.39 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 113.387 -1.407 . . . . 0.0 107.613 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.475 ' O ' ' O ' ' A' ' 29' ' ' MET . 23.6 mt -19.87 -113.78 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.307 0 O-C-N 125.487 1.742 . . . . 0.0 113.203 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -91.6 -69.55 0.73 Allowed 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 102.156 -3.276 . . . . 0.0 102.156 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 48.5 p-10 -162.16 33.42 0.12 Allowed 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 113.236 -1.802 . . . . 0.0 109.481 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -118.74 -68.75 0.33 Allowed Glycine 0 N--CA 1.51 3.605 0 N-CA-C 118.965 2.346 . . . . 0.0 118.965 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.91 172.44 8.19 Favored 'General case' 0 N--CA 1.509 2.517 0 CA-C-O 122.162 0.982 . . . . 0.0 113.566 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.2 mmtm -91.02 129.67 37.0 Favored 'General case' 0 N--CA 1.489 1.489 1 N-CA-C 99.68 -4.193 . . . . 0.0 99.68 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.534 ' CE2' ' OD2' ' A' ' 37' ' ' ASP . 1.2 p90 -125.19 -28.15 3.43 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.534 ' OD2' ' CE2' ' A' ' 36' ' ' PHE . 35.6 m-20 -139.43 85.61 2.06 Favored 'General case' 0 N--CA 1.506 2.373 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.3 m -112.31 160.56 17.55 Favored 'General case' 0 N--CA 1.505 2.282 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 26' ' ' TYR . 77.3 p -129.79 -52.95 1.15 Allowed 'General case' 0 N--CA 1.504 2.261 0 CA-C-O 121.617 0.722 . . . . 0.0 112.449 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 20.8 ttm-85 -28.88 -56.01 0.13 Allowed 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -19.28 -74.63 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 125.001 1.438 . . . . 0.0 114.792 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.578 ' O ' ' N ' ' A' ' 44' ' ' LYS . 1.3 mmp_? -91.31 60.52 4.2 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-O 118.688 -0.672 . . . . 0.0 109.67 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.517 HD22 ' C ' ' A' ' 42' ' ' ARG . 0.1 OUTLIER -8.75 58.91 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.353 0 N-CA-C 116.967 2.21 . . . . 0.0 116.967 -179.733 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.578 ' N ' ' O ' ' A' ' 42' ' ' ARG . 47.1 mmtm -147.72 78.46 9.87 Favored Pre-proline 0 C--N 1.298 -1.647 0 CA-C-N 112.731 -2.031 . . . . 0.0 106.783 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.445 ' O ' ' O ' ' A' ' 44' ' ' LYS . 51.0 Cg_exo -43.76 -170.01 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 122.96 2.44 . . . . 0.0 116.88 -172.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -111.55 159.09 18.45 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 114.329 -1.305 . . . . 0.0 114.443 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -143.08 121.2 12.14 Favored 'General case' 0 N--CA 1.506 2.374 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -135.4 171.98 13.66 Favored 'General case' 0 N--CA 1.513 2.703 0 CA-C-N 118.988 0.813 . . . . 0.0 110.631 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 43.2 ttm -119.16 143.8 47.02 Favored 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.427 ' CD1' ' OE1' ' A' ' 60' ' ' GLU . 50.5 tp -91.17 134.88 34.18 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 113.986 -1.461 . . . . 0.0 110.646 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 126.73 -35.02 3.0 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 108.393 -1.883 . . . . 0.0 108.393 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 54' ' ' GLU . 80.0 tttt -123.76 43.14 3.05 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 114.585 -0.807 . . . . 0.0 109.176 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 12.53 49.27 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 125.602 1.814 . . . . 0.0 114.685 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 52' ' ' LYS . 96.1 mt-10 -49.2 -29.82 6.11 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.537 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.433 ' O ' ' O ' ' A' ' 56' ' ' ILE . 32.7 m -117.56 158.31 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.646 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 55' ' ' VAL . 23.9 pt -46.4 172.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 C-N-CA 118.753 -1.179 . . . . 0.0 111.323 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.546 ' O ' ' N ' ' A' ' 59' ' ' TRP . 20.7 ttm-85 -72.44 -61.06 1.93 Allowed 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 118.84 -0.6 . . . . 0.0 112.073 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -34.58 -28.22 0.01 OUTLIER Glycine 0 N--CA 1.499 2.835 0 CA-C-O 122.156 0.864 . . . . 0.0 111.761 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.546 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.6 OUTLIER -87.75 -74.76 0.44 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 179.804 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.427 ' OE1' ' CD1' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -32.86 -50.96 0.28 Allowed 'General case' 0 N--CA 1.501 2.077 0 CA-C-N 114.035 -1.439 . . . . 0.0 110.127 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -74.57 -54.36 7.64 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 113.743 -1.572 . . . . 0.0 107.042 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -53.71 -76.07 0.2 Allowed Glycine 0 N--CA 1.478 1.47 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' A' ' 59' ' ' TRP . 40.0 t -37.25 -45.41 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 CA-C-N 115.067 -0.566 . . . . 0.0 112.04 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.487 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -48.35 -56.07 9.08 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 123.78 1.752 . . . . 0.0 110.092 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -59.53 -0.51 0.17 Allowed 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 110.139 -3.21 . . . . 0.0 110.409 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.593 ' SD ' ' NE2' ' A' ' 70' ' ' GLN . 16.3 tpp -98.85 153.2 18.97 Favored 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 106.039 -1.838 . . . . 0.0 106.039 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 83.5 p -116.37 143.23 45.82 Favored 'General case' 0 N--CA 1.508 2.453 0 CA-C-O 122.289 1.042 . . . . 0.0 112.212 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.422 ' O ' ' OD1' ' A' ' 11' ' ' ASP . 96.7 t -41.9 98.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 113.315 -1.766 . . . . 0.0 114.622 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.71 7.1 22.52 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.593 ' NE2' ' SD ' ' A' ' 66' ' ' MET . 44.3 tt0 -105.13 149.09 26.17 Favored 'General case' 0 N--CA 1.51 2.545 0 C-N-CA 119.179 -1.008 . . . . 0.0 111.018 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 24.8 ttt85 -124.71 141.02 52.4 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 113.905 -1.498 . . . . 0.0 107.0 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -149.64 177.97 9.28 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 116.081 1.882 . . . . 0.0 116.081 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -127.09 104.83 8.19 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 102.457 -3.164 . . . . 0.0 102.457 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.6 mt -101.48 155.12 18.26 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 87.2 m -125.32 132.2 52.9 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 23.8 mt -118.99 138.85 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 CA-C-O 121.319 0.581 . . . . 0.0 110.651 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.426 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 76.9 p -111.11 151.45 43.07 Favored Pre-proline 0 N--CA 1.502 2.151 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.423 ' O ' ' N ' ' A' ' 80' ' ' TYR . 10.2 Cg_endo -39.41 -56.14 1.37 Allowed 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 121.859 1.706 . . . . 0.0 113.035 -172.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.531 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 3.9 p-10 -34.37 -34.34 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.442 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.423 ' N ' ' O ' ' A' ' 78' ' ' PRO . 4.8 m-85 -102.87 -50.29 3.57 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.086 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 83' ' ' GLY . . . -59.61 172.65 0.66 Allowed 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 117.437 -1.705 . . . . 0.0 108.912 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.401 ' C ' ' O ' ' A' ' 81' ' ' ALA . 67.6 m-85 -10.49 -52.07 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 125.994 2.059 . . . . 0.0 115.529 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 81' ' ' ALA . . . 123.99 -154.64 17.71 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 106.412 -2.675 . . . . 0.0 106.412 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -104.89 39.56 1.68 Allowed 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 87.1 m -128.31 58.65 1.53 Allowed 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 113.732 -1.576 . . . . 0.0 109.001 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -113.73 -175.98 19.16 Favored Glycine 0 N--CA 1.499 2.867 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -116.35 146.89 38.38 Favored Pre-proline 0 N--CA 1.503 2.219 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -74.22 46.56 1.39 Allowed 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 121.469 1.446 . . . . 0.0 110.806 174.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -129.21 -51.74 0.11 Allowed Glycine 0 N--CA 1.5 2.914 0 N-CA-C 110.026 -1.229 . . . . 0.0 110.026 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.6 mt -114.6 -54.33 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 23.0 mm -117.7 89.83 34.16 Favored Pre-proline 0 N--CA 1.504 2.246 0 CA-C-N 112.733 -2.03 . . . . 0.0 111.539 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.411 ' CB ' ' CD ' ' A' ' 93' ' ' PRO . 18.0 Cg_exo -71.68 -171.12 0.6 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.217 1.945 . . . . 0.0 107.572 168.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.411 ' CD ' ' CB ' ' A' ' 92' ' ' PRO . 49.9 Cg_exo -62.01 171.01 5.4 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.294 1.996 . . . . 0.0 110.049 175.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 16.0 m80 9.67 68.12 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 O-C-N 125.387 1.679 . . . . 0.0 115.045 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -116.88 74.2 0.9 Allowed 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.704 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 91.1 m -29.4 134.35 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.262 0 O-C-N 124.913 1.383 . . . . 0.0 110.85 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 29.0 mt -108.8 144.37 36.74 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 119.252 0.933 . . . . 0.0 108.718 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 43.7 t -128.73 127.2 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 N-CA-C 107.113 -1.439 . . . . 0.0 107.113 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -118.82 157.88 26.71 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 122.063 0.935 . . . . 0.0 111.958 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -127.07 94.16 3.94 Favored 'General case' 0 N--CA 1.494 1.762 1 N-CA-C 99.069 -4.419 . . . . 0.0 99.069 179.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.437 HG12 ' N ' ' A' ' 102' ' ' GLU . 16.4 t -107.36 152.94 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.524 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.437 ' N ' HG12 ' A' ' 101' ' ' VAL . 89.3 tt0 -127.36 100.65 6.13 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 111.877 -2.42 . . . . 0.0 106.357 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 40.9 tp -73.76 125.06 27.26 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 102.624 -3.102 . . . . 0.0 102.624 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.0 mt -94.0 -59.74 1.91 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.79 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 11.8 ptmm? -157.2 -178.58 7.46 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.0 mt -114.23 71.29 0.75 Allowed 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.412 ' H ' HG23 ' A' ' 23' ' ' VAL . 34.4 tt0 . . . . . 0 N--CA 1.502 2.159 0 CA-C-O 115.91 -1.995 . . . . 0.0 109.676 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.1 p -113.23 145.31 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -121.99 154.01 37.78 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.2 t -126.51 114.03 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -114.83 109.53 18.3 Favored 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 96.2 m -83.75 153.71 23.99 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.744 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 56.0 mt -123.55 -50.58 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 CA-C-N 113.656 -1.611 . . . . 0.0 107.363 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.417 ' O ' ' O ' ' A' ' 9' ' ' PRO . 43.8 t -122.33 79.68 45.15 Favored Pre-proline 0 N--CA 1.507 2.406 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.634 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.417 ' O ' ' O ' ' A' ' 8' ' ' SER . 9.0 Cg_exo -37.56 166.27 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.863 2.375 . . . . 0.0 113.77 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.79 -167.42 12.92 Favored Glycine 0 N--CA 1.502 3.091 0 N-CA-C 105.304 -3.119 . . . . 0.0 105.304 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.485 ' CG ' ' H ' ' A' ' 12' ' ' GLY . 11.2 p-10 -46.97 -58.99 3.4 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 118.619 1.21 . . . . 0.0 110.798 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.485 ' H ' ' CG ' ' A' ' 11' ' ' ASP . . . 106.99 27.63 5.3 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 107.232 -2.347 . . . . 0.0 107.232 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 32.7 mtp85 -133.87 -35.0 0.98 Allowed 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 114.545 -0.828 . . . . 0.0 112.597 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.8 m -109.57 139.46 44.55 Favored 'General case' 0 N--CA 1.508 2.454 0 CA-C-O 121.807 0.813 . . . . 0.0 112.952 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 50.5 m-85 -131.77 177.43 2.25 Favored Pre-proline 0 N--CA 1.499 1.988 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -67.13 138.74 48.33 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 121.145 1.23 . . . . 0.0 110.813 164.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -119.94 162.24 19.53 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 122.351 1.072 . . . . 0.0 109.232 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 29.8 mtm180 -71.07 126.68 30.23 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 114.189 -1.369 . . . . 0.0 108.146 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.51 -24.22 9.86 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -110.8 176.95 4.83 Favored 'General case' 0 N--CA 1.507 2.406 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.901 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 92.4 m -108.42 166.98 10.36 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.2 m -113.14 149.47 33.55 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 102.513 -3.143 . . . . 0.0 102.513 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 60.4 t -123.49 101.93 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 103.109 -2.923 . . . . 0.0 103.109 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.3 m -120.69 149.52 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.574 0 N-CA-C 116.516 2.043 . . . . 0.0 116.516 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -127.8 114.74 17.64 Favored 'General case' 0 N--CA 1.507 2.383 0 N-CA-C 103.67 -2.715 . . . . 0.0 103.67 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.499 ' CD1' ' N ' ' A' ' 26' ' ' TYR . 33.9 p90 -131.96 175.68 9.02 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 122.977 1.37 . . . . 0.0 113.702 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 84.8 m -134.65 116.89 15.47 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 101.308 -3.59 . . . . 0.0 101.308 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 37' ' ' ASP . . . -102.55 128.7 9.63 Favored Glycine 0 N--CA 1.5 2.935 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 46.8 ttm -132.81 175.51 9.28 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 37.6 mt -115.84 170.36 8.53 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -33.77 -59.36 0.41 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 124.31 1.006 . . . . 0.0 112.706 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 57.6 p-10 -158.05 46.8 0.35 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.168 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -118.31 -79.21 0.65 Allowed Glycine 0 N--CA 1.501 2.99 0 C-N-CA 119.436 -1.364 . . . . 0.0 113.241 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -160.54 -163.01 1.02 Allowed 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 119.569 -0.852 . . . . 0.0 113.196 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -88.89 124.14 33.92 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 103.993 -2.595 . . . . 0.0 103.993 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.456 ' O ' ' CB ' ' A' ' 37' ' ' ASP . 0.9 OUTLIER -121.81 20.1 10.93 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.41 -179.547 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.456 ' CB ' ' O ' ' A' ' 36' ' ' PHE . 3.4 m-20 158.97 104.19 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.355 0 O-C-N 124.716 1.26 . . . . 0.0 111.917 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.2 m -118.5 169.41 9.8 Favored 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 98.5 p -114.91 45.86 1.52 Allowed 'General case' 0 N--CA 1.507 2.395 0 CA-C-N 116.209 -0.451 . . . . 0.0 112.071 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.3 tpt85 -126.26 65.02 1.23 Allowed 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -90.81 -88.75 0.17 Allowed 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.874 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.533 ' C ' HD22 ' A' ' 43' ' ' ASN . 18.0 ttp180 -92.12 -108.5 0.1 Allowed 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.714 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.533 HD22 ' C ' ' A' ' 42' ' ' ARG . 3.3 m120 -111.09 -39.86 4.64 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -100.49 154.25 37.29 Favored Pre-proline 0 N--CA 1.51 2.548 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -75.14 -158.48 0.08 OUTLIER 'Trans proline' 0 N--CA 1.49 1.276 0 C-N-CA 123.066 2.511 . . . . 0.0 113.812 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -97.12 150.34 20.96 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 114.211 -1.359 . . . . 0.0 114.417 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.95 130.88 21.65 Favored 'General case' 0 N--CA 1.508 2.45 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.41 ' CD1' ' C ' ' A' ' 48' ' ' PHE . 13.5 p90 -143.28 166.72 23.96 Favored 'General case' 0 N--CA 1.514 2.732 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.904 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.495 ' SD ' ' O ' ' A' ' 50' ' ' LEU . 2.7 tmm? -115.11 149.04 38.19 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 115.103 1.519 . . . . 0.0 115.103 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.495 ' O ' ' SD ' ' A' ' 49' ' ' MET . 52.3 tp -90.6 121.03 32.17 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 113.343 -1.753 . . . . 0.0 112.19 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.69 -24.71 7.09 Favored Glycine 0 N--CA 1.499 2.838 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 53' ' ' GLN . 2.3 tppp? -113.37 36.84 3.4 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.413 ' C ' ' O ' ' A' ' 52' ' ' LYS . 83.3 mt-30 7.8 63.56 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 125.281 1.613 . . . . 0.0 114.165 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -82.89 -30.23 28.7 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.419 ' O ' ' O ' ' A' ' 56' ' ' ILE . 32.6 m -118.78 151.13 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.419 ' O ' ' O ' ' A' ' 55' ' ' VAL . 1.6 pt -46.9 -176.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.542 ' O ' ' N ' ' A' ' 59' ' ' TRP . 8.8 tpt180 -81.16 -61.01 2.08 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.124 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -35.8 -26.86 0.01 OUTLIER Glycine 0 N--CA 1.497 2.703 0 CA-C-O 122.196 0.887 . . . . 0.0 110.919 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.542 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.8 OUTLIER -91.85 -76.07 0.46 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.776 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -33.94 -51.48 0.41 Allowed 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 113.752 -1.567 . . . . 0.0 110.031 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -73.06 -54.47 8.46 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 113.218 -1.81 . . . . 0.0 106.574 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -55.07 -80.55 0.07 OUTLIER Glycine 0 N--CA 1.476 1.335 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.533 ' N ' ' O ' ' A' ' 59' ' ' TRP . 53.1 t -32.3 -48.45 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 112.675 0.621 . . . . 0.0 112.675 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.475 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -46.37 -60.52 2.28 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 124.262 1.982 . . . . 0.0 110.905 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -48.01 -12.19 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 108.948 -3.751 . . . . 0.0 108.856 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.475 ' H ' ' C ' ' A' ' 64' ' ' ALA . 21.0 mtp -97.7 159.64 14.8 Favored 'General case' 0 N--CA 1.512 2.655 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 80.4 p -117.08 156.88 26.82 Favored 'General case' 0 N--CA 1.509 2.498 0 CA-C-O 122.804 1.288 . . . . 0.0 113.716 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 62.5 t -49.55 97.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 112.037 -2.347 . . . . 0.0 114.858 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.11 5.2 25.28 Favored Glycine 0 N--CA 1.499 2.841 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.488 ' OE1' ' N ' ' A' ' 71' ' ' ARG . 0.9 OUTLIER -106.73 148.61 28.22 Favored 'General case' 0 N--CA 1.505 2.325 0 CA-C-O 122.099 0.952 . . . . 0.0 111.399 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.488 ' N ' ' OE1' ' A' ' 70' ' ' GLN . 18.9 ttp180 -127.58 140.64 51.98 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 113.516 -1.674 . . . . 0.0 110.089 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -144.8 178.83 7.72 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 112.605 -2.089 . . . . 0.0 115.662 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -126.78 105.0 8.36 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 110.933 -2.849 . . . . 0.0 103.585 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.8 mt -96.73 149.7 21.53 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 86.5 m -124.59 112.72 17.14 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.5 mt -105.19 143.83 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 CA-C-O 121.448 0.642 . . . . 0.0 110.908 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 36.8 p -110.02 150.79 41.91 Favored Pre-proline 0 N--CA 1.496 1.869 0 N-CA-C 105.604 -1.998 . . . . 0.0 105.604 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.524 ' O ' ' N ' ' A' ' 80' ' ' TYR . 19.3 Cg_endo -44.33 -55.71 3.02 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 121.967 1.778 . . . . 0.0 113.614 -171.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 12.8 p-10 -38.82 -17.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.524 ' N ' ' O ' ' A' ' 78' ' ' PRO . 4.8 m-85 -106.45 -31.87 8.36 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -111.05 -73.04 0.69 Allowed 'General case' 0 N--CA 1.506 2.373 0 N-CA-C 116.968 2.21 . . . . 0.0 116.968 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 13.0 m-30 -108.95 -85.97 0.52 Allowed 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 112.675 -2.057 . . . . 0.0 114.452 -179.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.71 68.67 1.33 Allowed Glycine 0 N--CA 1.495 2.616 0 N-CA-C 108.01 -2.036 . . . . 0.0 108.01 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 33.53 71.5 0.1 Allowed 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.683 0.754 . . . . 0.0 112.275 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 94.5 m -116.44 -44.88 2.84 Favored 'General case' 0 N--CA 1.503 2.22 0 CA-C-N 114.383 -1.28 . . . . 0.0 113.825 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -110.27 -54.95 0.54 Allowed Glycine 0 N--CA 1.508 3.44 0 C-N-CA 120.225 -0.988 . . . . 0.0 111.286 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.527 ' O ' ' ND1' ' A' ' 87' ' ' HIS . 33.4 p80 19.39 70.94 0.23 Allowed Pre-proline 0 N--CA 1.493 1.678 0 N-CA-C 117.685 2.476 . . . . 0.0 117.685 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -84.32 23.41 0.84 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 121.637 1.558 . . . . 0.0 108.273 164.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 87' ' ' HIS . . . 108.49 44.74 1.12 Allowed Glycine 0 N--CA 1.501 2.972 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.8 mt -136.52 -50.41 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.267 0 CA-C-O 122.625 1.202 . . . . 0.0 108.825 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 17.9 mm -112.73 59.64 0.61 Allowed Pre-proline 0 N--CA 1.5 2.047 0 CA-C-N 111.463 -2.608 . . . . 0.0 110.552 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -52.15 169.42 0.3 Allowed 'Trans proline' 0 C--N 1.311 -1.423 0 N-CA-C 107.938 -1.601 . . . . 0.0 107.938 -178.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -38.95 155.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 121.566 1.511 . . . . 0.0 111.808 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.434 ' CG ' ' O ' ' A' ' 94' ' ' HIS . 20.3 p-80 9.5 71.65 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.215 0 O-C-N 125.658 1.849 . . . . 0.0 114.713 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -114.52 75.46 0.93 Allowed 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 120.95 0.405 . . . . 0.0 110.511 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 94.8 m -29.24 139.2 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 CA-C-N 114.108 -1.405 . . . . 0.0 110.812 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 32.6 mt -108.21 153.07 23.72 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 50.4 t -133.31 121.15 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -114.26 151.33 33.03 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -122.73 94.07 4.16 Favored 'General case' 0 N--CA 1.496 1.839 1 N-CA-C 98.937 -4.468 . . . . 0.0 98.937 179.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.414 HG12 ' N ' ' A' ' 102' ' ' GLU . 17.2 t -107.78 150.53 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.425 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.414 ' N ' HG12 ' A' ' 101' ' ' VAL . 39.1 tt0 -126.67 102.48 7.09 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 112.39 -2.186 . . . . 0.0 106.843 179.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 43.6 tp -73.31 126.5 30.26 Favored 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 101.823 -3.399 . . . . 0.0 101.823 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.9 mt -93.51 -54.05 3.82 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.877 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.46 -172.13 0.88 Allowed 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 118.366 -1.334 . . . . 0.0 110.621 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 19.1 mt -118.24 152.97 34.7 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.426 ' OE1' ' OXT' ' A' ' 107' ' ' GLU . 9.7 tm-20 . . . . . 0 N--CA 1.501 2.095 0 CA-C-O 116.099 -1.905 . . . . 0.0 109.002 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.473 ' C ' ' NE2' ' A' ' 3' ' ' GLN . 11.8 p -114.2 150.09 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.483 ' CD ' ' N ' ' A' ' 3' ' ' GLN . 14.9 mp0 -121.57 156.05 33.71 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 42.2 t -126.5 106.55 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -108.38 87.45 2.5 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 98.9 m -69.66 157.82 36.53 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.017 -1.073 . . . . 0.0 111.674 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 64.1 mt -121.94 -53.93 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 CA-C-N 114.195 -1.366 . . . . 0.0 107.631 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.417 ' O ' ' O ' ' A' ' 9' ' ' PRO . 51.8 m -123.09 80.22 51.5 Favored Pre-proline 0 N--CA 1.507 2.378 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.49 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.417 ' O ' ' O ' ' A' ' 8' ' ' SER . 6.9 Cg_exo -36.95 166.66 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.866 2.377 . . . . 0.0 114.104 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.51 -176.7 17.99 Favored Glycine 0 N--CA 1.5 2.96 0 N-CA-C 105.063 -3.215 . . . . 0.0 105.063 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.489 ' CG ' ' H ' ' A' ' 12' ' ' GLY . 14.4 p-10 -43.04 -59.08 2.16 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 118.557 1.178 . . . . 0.0 111.735 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.489 ' H ' ' CG ' ' A' ' 11' ' ' ASP . . . 110.06 22.34 6.6 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 108.541 -1.824 . . . . 0.0 108.541 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 60.0 mtt-85 -133.67 -31.38 1.19 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 114.994 -0.603 . . . . 0.0 112.392 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.0 m -109.11 124.85 51.45 Favored 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.375 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 23.1 m-85 -127.28 176.1 2.88 Favored Pre-proline 0 N--CA 1.501 2.101 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -73.8 139.33 27.51 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 CA-C-N 119.51 0.861 . . . . 0.0 110.177 163.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -120.63 167.07 12.82 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 121.765 0.793 . . . . 0.0 109.264 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 62.8 mtt180 -70.26 127.6 33.35 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.763 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.32 -25.61 9.14 Favored Glycine 0 N--CA 1.498 2.78 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.501 ' O ' ' SD ' ' A' ' 49' ' ' MET . 25.8 mt-30 -109.37 175.62 5.38 Favored 'General case' 0 N--CA 1.505 2.276 0 CA-C-O 121.713 0.768 . . . . 0.0 111.429 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.9 m -107.23 163.86 12.66 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 114.611 -1.177 . . . . 0.0 108.47 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 55.6 m -114.39 145.62 41.6 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 103.718 -2.697 . . . . 0.0 103.718 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 64.4 t -122.89 101.08 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 102.22 -3.252 . . . . 0.0 102.22 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.42 HG21 ' CH2' ' A' ' 59' ' ' TRP . 2.7 m -124.12 151.54 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -179.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -130.15 119.45 23.02 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 103.841 -2.651 . . . . 0.0 103.841 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 26' ' ' TYR . 35.4 p90 -135.22 172.55 12.84 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 123.072 1.415 . . . . 0.0 114.592 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 61.4 m -134.34 116.14 14.88 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 102.865 -3.013 . . . . 0.0 102.865 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.62 137.42 13.61 Favored Glycine 0 N--CA 1.5 2.92 0 C-N-CA 119.918 -1.134 . . . . 0.0 112.003 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 35.0 ttm -134.16 175.33 9.58 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.3 mt -116.12 -173.33 2.34 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -90.16 21.38 3.78 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 121.569 0.7 . . . . 0.0 111.019 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.5 -44.81 1.82 Allowed 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 128.14 23.19 1.3 Allowed Glycine 0 N--CA 1.502 3.07 0 CA-C-O 118.501 -1.166 . . . . 0.0 115.52 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -118.7 152.81 35.43 Favored 'General case' 0 N--CA 1.502 2.174 0 CA-C-N 119.2 1.5 . . . . 0.0 107.488 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.474 ' HD2' ' H ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -91.38 139.66 30.51 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 122.379 1.085 . . . . 0.0 109.442 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.424 ' CG ' ' N ' ' A' ' 37' ' ' ASP . 6.3 p90 -126.44 -38.76 2.08 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 113.434 -1.712 . . . . 0.0 106.83 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.424 ' N ' ' CG ' ' A' ' 36' ' ' PHE . 0.9 OUTLIER -141.25 94.45 2.7 Favored 'General case' 0 N--CA 1.508 2.467 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -179.772 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 52.7 m -114.92 167.38 10.84 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' A' ' 26' ' ' TYR . 76.8 p -120.76 53.52 1.12 Allowed 'General case' 0 N--CA 1.506 2.344 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.524 ' O ' ' N ' ' A' ' 42' ' ' ARG . 33.1 mtm-85 -118.04 -72.51 0.68 Allowed 'General case' 0 N--CA 1.504 2.236 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 41' ' ' ASP . 64.5 t0 -34.1 -30.85 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 122.719 1.247 . . . . 0.0 110.908 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 44' ' ' LYS . 17.9 ttm180 -90.63 71.74 6.79 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 112.467 -2.151 . . . . 0.0 106.474 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -9.24 -50.68 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 CA-C-N 112.754 -2.021 . . . . 0.0 115.33 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 42' ' ' ARG . 94.1 mttt -95.98 136.38 22.21 Favored Pre-proline 0 N--CA 1.5 2.039 0 N-CA-C 106.6 -1.629 . . . . 0.0 106.6 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.427 ' O ' ' O ' ' A' ' 44' ' ' LYS . 49.2 Cg_exo -44.16 -161.95 0.0 OUTLIER 'Trans proline' 0 C--N 1.316 -1.135 0 C-N-CA 121.774 1.649 . . . . 0.0 115.479 171.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -113.73 146.77 39.36 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 113.283 -1.781 . . . . 0.0 110.433 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -137.7 123.5 20.0 Favored 'General case' 0 N--CA 1.505 2.323 0 CA-C-O 118.863 -0.589 . . . . 0.0 110.952 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -136.8 168.04 20.3 Favored 'General case' 0 N--CA 1.513 2.696 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.501 ' SD ' ' O ' ' A' ' 20' ' ' GLN . 44.6 tpp -107.1 132.35 53.1 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 114.111 -1.404 . . . . 0.0 113.866 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.0 tp -90.88 122.42 33.56 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 114.483 -1.235 . . . . 0.0 110.707 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.73 18.48 10.72 Favored Glycine 0 N--CA 1.5 2.91 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.483 ' O ' ' CB ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -118.75 -53.12 2.31 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.483 ' CB ' ' O ' ' A' ' 52' ' ' LYS . 47.9 tt0 100.92 70.56 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.208 0 O-C-N 125.812 1.945 . . . . 0.0 108.049 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -109.39 -33.71 6.75 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 114.182 -1.372 . . . . 0.0 108.708 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.4 m -115.15 153.03 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.291 0 CA-C-O 121.287 0.565 . . . . 0.0 110.4 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.57 ' CG2' ' CE1' ' A' ' 82' ' ' TYR . 14.2 pt -51.08 177.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.094 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.544 ' O ' ' N ' ' A' ' 59' ' ' TRP . 8.7 tpt180 -70.52 -60.76 2.07 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 120.232 -0.587 . . . . 0.0 109.442 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -24.24 -38.88 0.01 OUTLIER Glycine 0 N--CA 1.501 2.98 0 O-C-N 125.122 1.514 . . . . 0.0 112.718 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.544 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.6 OUTLIER -82.66 -71.38 0.49 Allowed 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 179.828 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -28.77 -54.62 0.12 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 125.266 1.604 . . . . 0.0 110.939 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -76.67 -53.53 7.88 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -50.83 -75.54 0.21 Allowed Glycine 0 N--CA 1.478 1.465 0 C-N-CA 119.207 -1.473 . . . . 0.0 110.287 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 59' ' ' TRP . 35.2 t -42.03 -50.77 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 C-N-CA 119.471 -0.891 . . . . 0.0 112.42 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.471 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -45.0 -62.04 1.39 Allowed 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 123.893 1.806 . . . . 0.0 111.434 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -47.15 -12.91 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 109.606 -3.452 . . . . 0.0 109.176 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.471 ' H ' ' C ' ' A' ' 64' ' ' ALA . 6.6 mtm -99.63 157.27 16.58 Favored 'General case' 0 N--CA 1.512 2.657 0 C-N-CA 118.503 -1.279 . . . . 0.0 107.638 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 84.4 p -118.65 148.24 42.94 Favored 'General case' 0 N--CA 1.507 2.398 0 CA-C-O 122.458 1.123 . . . . 0.0 113.412 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 52.9 t -40.82 100.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-N 112.775 -2.011 . . . . 0.0 113.829 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.19 10.97 12.74 Favored Glycine 0 N--CA 1.5 2.963 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -107.2 146.45 31.38 Favored 'General case' 0 N--CA 1.505 2.297 0 CA-C-O 121.681 0.753 . . . . 0.0 111.05 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.1 mtp85 -126.26 139.56 53.22 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -149.42 177.07 10.03 Favored 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 116.58 2.067 . . . . 0.0 116.58 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -127.92 107.1 9.57 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 102.531 -3.137 . . . . 0.0 102.531 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.8 mt -104.47 153.31 21.28 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 90.3 m -124.01 124.96 43.7 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 104.613 -2.366 . . . . 0.0 104.613 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.1 mt -116.95 136.34 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.402 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 61.1 p -111.92 154.11 44.27 Favored Pre-proline 0 N--CA 1.505 2.292 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -34.36 -53.05 0.6 Allowed 'Trans proline' 0 C--N 1.315 -1.187 0 C-N-CA 122.1 1.867 . . . . 0.0 114.297 -174.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 80' ' ' TYR . 1.8 p30 -37.34 -39.65 0.3 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.503 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.452 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 5.0 m-85 -102.11 -39.69 7.16 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 114.965 -1.016 . . . . 0.0 112.022 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.58 -125.27 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 118.094 -1.442 . . . . 0.0 108.87 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.57 ' CE1' ' CG2' ' A' ' 56' ' ' ILE . 19.0 m-85 -116.63 85.95 2.41 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -106.55 42.54 1.89 Allowed Glycine 0 N--CA 1.502 3.055 0 C-N-CA 119.475 -1.345 . . . . 0.0 112.008 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -145.82 -82.56 0.14 Allowed 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 119.946 -0.702 . . . . 0.0 112.524 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 96.7 m -128.9 90.76 3.09 Favored 'General case' 0 N--CA 1.504 2.229 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.503 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -106.79 -143.42 11.21 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.534 ' N ' ' O ' ' A' ' 91' ' ' ILE . 22.3 m80 -104.25 149.13 36.97 Favored Pre-proline 0 N--CA 1.505 2.316 0 CA-C-O 119.47 -0.3 . . . . 0.0 110.565 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -90.5 34.96 0.32 Allowed 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 122.012 1.808 . . . . 0.0 109.29 172.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -134.68 -49.48 0.08 OUTLIER Glycine 0 N--CA 1.5 2.907 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.866 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.1 mt -114.44 -54.4 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.287 0 CA-C-O 122.45 1.119 . . . . 0.0 109.84 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.534 ' O ' ' N ' ' A' ' 87' ' ' HIS . 16.6 mm -110.72 85.2 4.68 Favored Pre-proline 0 N--CA 1.505 2.301 0 CA-C-N 112.95 -1.932 . . . . 0.0 112.092 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.427 ' O ' ' O ' ' A' ' 93' ' ' PRO . 20.3 Cg_endo -86.39 159.14 9.58 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 N-CA-C 107.626 -1.721 . . . . 0.0 107.626 171.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.427 ' O ' ' O ' ' A' ' 92' ' ' PRO . 15.0 Cg_endo -42.84 174.21 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.299 0 C-N-CA 122.654 2.236 . . . . 0.0 114.416 -175.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.452 ' H ' ' CD2' ' A' ' 94' ' ' HIS . 35.9 m170 9.87 61.61 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.403 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -124.15 78.63 1.66 Allowed 'General case' 0 N--CA 1.503 2.198 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.399 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 88.1 m -29.41 141.87 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 O-C-N 124.552 1.158 . . . . 0.0 112.119 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 27.8 mt -115.86 155.21 28.33 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.8 t -136.43 124.51 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -118.39 150.7 39.1 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 122.305 1.05 . . . . 0.0 111.057 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -124.09 93.59 3.97 Favored 'General case' 0 N--CA 1.493 1.706 1 N-CA-C 98.926 -4.472 . . . . 0.0 98.926 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.419 HG12 ' N ' ' A' ' 102' ' ' GLU . 12.7 t -108.09 155.57 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.513 0 N-CA-C 117.033 2.234 . . . . 0.0 117.033 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.419 ' N ' HG12 ' A' ' 101' ' ' VAL . 31.5 tt0 -129.2 103.33 6.89 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 111.574 -2.557 . . . . 0.0 108.143 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 39.5 tp -77.86 118.44 20.19 Favored 'General case' 0 N--CA 1.506 2.363 0 N-CA-C 102.722 -3.066 . . . . 0.0 102.722 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.1 mt -87.3 -55.63 3.72 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 113.845 -1.525 . . . . 0.0 112.518 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -171.69 -170.08 0.75 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.334 -0.946 . . . . 0.0 110.962 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 21.2 mt -117.65 156.28 28.45 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 . . . . . 0 N--CA 1.503 2.191 0 CA-C-O 116.822 -1.561 . . . . 0.0 108.974 179.83 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.9 p -116.12 150.26 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -123.68 154.88 38.77 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.7 t -125.14 118.99 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -120.21 96.86 5.33 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 92.1 m -69.83 156.12 39.52 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.031 -1.068 . . . . 0.0 113.077 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 74.0 mt -122.52 -55.55 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 CA-C-N 113.693 -1.594 . . . . 0.0 107.471 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.422 ' O ' ' O ' ' A' ' 9' ' ' PRO . 34.2 t -122.95 82.48 50.35 Favored Pre-proline 0 N--CA 1.506 2.344 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.515 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 8' ' ' SER . 5.2 Cg_exo -36.23 161.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.391 2.061 . . . . 0.0 112.731 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -118.32 -174.62 16.39 Favored Glycine 0 N--CA 1.5 2.904 0 N-CA-C 106.482 -2.647 . . . . 0.0 106.482 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.525 ' N ' ' OD1' ' A' ' 11' ' ' ASP . 13.0 p-10 -39.77 -60.39 1.0 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.492 -0.883 . . . . 0.0 112.916 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.06 18.74 12.91 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 105.599 -3.001 . . . . 0.0 105.599 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 54.8 mtt-85 -127.13 -40.32 1.85 Allowed 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 113.773 -1.213 . . . . 0.0 112.214 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.6 m -108.21 139.58 42.69 Favored 'General case' 0 N--CA 1.506 2.341 0 CA-C-O 121.968 0.89 . . . . 0.0 112.726 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 50.8 m-85 -131.79 177.46 2.23 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -62.19 155.09 58.55 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 N-CA-C 109.805 -0.883 . . . . 0.0 109.805 161.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -119.73 166.61 12.99 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.921 0.867 . . . . 0.0 108.923 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 59.2 mtt85 -81.18 95.07 6.8 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.559 -1.201 . . . . 0.0 109.178 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.07 3.7 4.8 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -113.61 173.02 6.62 Favored 'General case' 0 N--CA 1.506 2.35 0 C-N-CA 120.219 -0.593 . . . . 0.0 109.513 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 97.8 m -118.08 117.86 30.35 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.591 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 24.8 m -69.66 148.61 49.07 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 87.5 t -122.13 101.61 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 101.679 -3.452 . . . . 0.0 101.679 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.427 HG21 ' CH2' ' A' ' 59' ' ' TRP . 3.0 m -125.38 151.04 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -129.04 117.67 21.26 Favored 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.434 ' CD2' ' CD2' ' A' ' 99' ' ' PHE . 41.9 p90 -136.27 -179.13 5.49 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 96.2 m -137.02 118.73 15.02 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 105.006 -2.22 . . . . 0.0 105.006 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -102.91 124.85 8.29 Favored Glycine 0 N--CA 1.504 3.229 0 C-N-CA 120.905 -0.665 . . . . 0.0 112.057 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 48.9 mtm -134.28 -177.43 4.58 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 122.041 0.924 . . . . 0.0 110.524 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 12.2 mt -120.43 -173.26 2.54 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.357 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.612 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 9.5 pm0 -90.18 22.62 3.21 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.826 0.822 . . . . 0.0 109.332 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 33' ' ' GLY . 1.5 p30 -126.57 -46.01 1.61 Allowed 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 114.126 -1.397 . . . . 0.0 107.318 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.519 ' N ' ' OD1' ' A' ' 32' ' ' ASP . . . 124.79 29.88 1.01 Allowed Glycine 0 N--CA 1.503 3.117 0 N-CA-C 116.67 1.428 . . . . 0.0 116.67 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -117.5 144.37 45.13 Favored 'General case' 0 N--CA 1.506 2.328 0 CA-C-N 119.802 1.801 . . . . 0.0 107.953 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -91.06 135.44 33.75 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.417 ' O ' ' OD1' ' A' ' 37' ' ' ASP . 35.8 p90 -122.81 -36.43 2.89 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 36' ' ' PHE . 73.9 m-20 -139.86 125.33 19.11 Favored 'General case' 0 N--CA 1.517 2.917 0 CA-C-O 121.496 0.665 . . . . 0.0 111.763 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 52.4 m -130.56 162.49 29.16 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 82.3 p -104.22 35.98 2.52 Favored 'General case' 0 N--CA 1.505 2.323 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.016 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 18.1 ttp180 -130.14 56.62 1.74 Allowed 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -91.03 -69.61 0.72 Allowed 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 62.1 mtt85 -90.99 -102.33 0.1 Allowed 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -110.66 -53.14 2.72 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -110.37 153.78 43.27 Favored Pre-proline 0 N--CA 1.508 2.453 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.737 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -55.19 -158.62 0.01 OUTLIER 'Trans proline' 0 N--CA 1.488 1.186 0 C-N-CA 122.437 2.092 . . . . 0.0 114.349 -177.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -91.15 142.42 27.76 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 114.236 -1.347 . . . . 0.0 112.962 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -137.79 122.71 18.94 Favored 'General case' 0 N--CA 1.506 2.369 0 CA-C-O 119.109 -0.472 . . . . 0.0 111.128 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -137.71 175.4 9.63 Favored 'General case' 0 N--CA 1.513 2.69 0 CA-C-N 119.412 1.006 . . . . 0.0 112.381 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 42.2 ttm -117.67 144.06 45.58 Favored 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.1 tp -91.09 124.25 35.18 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 114.295 -1.32 . . . . 0.0 111.812 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.18 -18.07 14.28 Favored Glycine 0 N--CA 1.501 3.026 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.874 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.41 ' O ' ' C ' ' A' ' 53' ' ' GLN . 53.9 tttm -118.98 39.32 3.57 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 120.949 -0.3 . . . . 0.0 110.372 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 52' ' ' LYS . 15.1 pt20 14.12 68.26 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 125.262 1.601 . . . . 0.0 114.587 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -91.39 -27.3 18.42 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 113.758 -1.564 . . . . 0.0 106.869 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.427 ' O ' ' O ' ' A' ' 56' ' ' ILE . 26.8 m -118.8 154.6 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.235 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.427 ' O ' ' O ' ' A' ' 55' ' ' VAL . 12.7 pt -49.43 175.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 C-N-CA 119.568 -0.853 . . . . 0.0 108.908 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.537 ' O ' ' N ' ' A' ' 59' ' ' TRP . 32.4 ttp180 -72.24 -56.31 5.74 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.199 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -25.35 -38.52 0.01 OUTLIER Glycine 0 N--CA 1.499 2.886 0 O-C-N 124.773 1.296 . . . . 0.0 112.188 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.537 ' N ' ' O ' ' A' ' 57' ' ' ARG . 1.4 m95 -82.02 -74.26 0.35 Allowed 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 112.919 -1.64 . . . . 0.0 108.386 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 59' ' ' TRP . 29.2 tt0 -24.18 -54.72 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 125.932 2.02 . . . . 0.0 111.174 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -77.85 -54.81 5.89 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -48.56 -75.97 0.17 Allowed Glycine 0 N--CA 1.482 1.702 0 C-N-CA 119.84 -1.172 . . . . 0.0 110.391 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.529 ' N ' ' O ' ' A' ' 59' ' ' TRP . 23.1 t -44.03 -48.7 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 119.298 -0.961 . . . . 0.0 111.837 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.471 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -46.36 -58.93 3.28 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 123.948 1.832 . . . . 0.0 111.341 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -51.05 -8.81 0.05 OUTLIER 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 109.68 -3.418 . . . . 0.0 109.887 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.471 ' H ' ' C ' ' A' ' 64' ' ' ALA . 93.4 mtp -102.73 158.62 16.12 Favored 'General case' 0 N--CA 1.513 2.723 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 88.3 p -118.51 153.83 33.53 Favored 'General case' 0 N--CA 1.509 2.525 0 CA-C-O 122.775 1.274 . . . . 0.0 113.677 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 86.7 t -49.18 97.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 112.608 -2.087 . . . . 0.0 113.568 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.19 12.95 12.73 Favored Glycine 0 N--CA 1.499 2.869 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -107.65 143.54 35.99 Favored 'General case' 0 N--CA 1.505 2.305 0 CA-C-O 121.368 0.604 . . . . 0.0 109.781 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 25.4 ttt85 -124.88 140.85 52.55 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -149.7 176.47 10.65 Favored 'General case' 0 N--CA 1.502 2.175 0 CA-C-N 113.316 -1.765 . . . . 0.0 115.452 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -125.75 103.8 8.01 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 104.117 -2.549 . . . . 0.0 104.117 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.1 mt -98.26 145.93 26.15 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 89.5 m -117.35 104.07 10.76 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 33.9 mt -102.3 134.27 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.972 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.4 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -112.99 157.39 40.81 Favored Pre-proline 0 N--CA 1.501 2.123 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -37.37 -53.22 1.38 Allowed 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 123.148 2.565 . . . . 0.0 114.881 -166.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.524 ' O ' ' NH2' ' A' ' 57' ' ' ARG . 13.1 p-10 -45.39 -36.63 4.4 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.491 ' CZ ' ' NE ' ' A' ' 57' ' ' ARG . 4.6 m-85 -102.09 4.52 39.76 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.524 ' O ' ' CD1' ' A' ' 82' ' ' TYR . . . -124.67 -81.91 0.64 Allowed 'General case' 0 N--CA 1.507 2.394 0 CA-C-O 122.021 0.915 . . . . 0.0 110.613 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.524 ' CD1' ' O ' ' A' ' 81' ' ' ALA . 28.9 m-85 -141.96 111.69 6.69 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 113.924 -1.489 . . . . 0.0 111.069 -179.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 84' ' ' ALA . . . -88.38 179.03 46.31 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 105.164 -3.174 . . . . 0.0 105.164 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.499 ' N ' ' NE2' ' A' ' 94' ' ' HIS . . . 40.23 -162.41 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 CA-C-N 118.159 0.979 . . . . 0.0 111.026 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 92.3 m -108.88 145.35 35.48 Favored 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -130.07 -71.31 0.12 Allowed Glycine 0 N--CA 1.501 2.991 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.076 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.509 ' C ' ' H ' ' A' ' 89' ' ' GLY . 15.7 m80 -120.87 96.99 48.53 Favored Pre-proline 0 N--CA 1.505 2.281 0 CA-C-O 118.094 -0.955 . . . . 0.0 110.546 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -76.97 32.59 0.42 Allowed 'Trans proline' 0 C--N 1.315 -1.204 0 C-N-CA 121.115 1.21 . . . . 0.0 111.243 -172.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.509 ' H ' ' C ' ' A' ' 87' ' ' HIS . . . -128.36 -38.55 0.37 Allowed Glycine 0 N--CA 1.496 2.645 0 N-CA-C 108.144 -1.982 . . . . 0.0 108.144 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.7 mt -104.23 -54.91 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.463 HG12 ' CD2' ' A' ' 82' ' ' TYR . 1.5 mp -114.41 98.8 49.9 Favored Pre-proline 0 N--CA 1.503 2.203 0 CA-C-N 113.12 -1.855 . . . . 0.0 109.259 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -55.31 -179.36 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 122.05 1.833 . . . . 0.0 108.758 162.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -73.9 163.47 36.89 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 121.674 1.583 . . . . 0.0 111.43 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.499 ' NE2' ' N ' ' A' ' 84' ' ' ALA . 38.7 m170 9.31 70.32 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 115.677 1.732 . . . . 0.0 115.677 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -116.1 155.81 27.51 Favored 'General case' 0 N--CA 1.503 2.216 0 CA-C-O 121.68 0.752 . . . . 0.0 111.001 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 93.3 m -91.25 131.22 36.91 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 114.416 -1.265 . . . . 0.0 108.467 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 23.8 mt -103.78 152.87 21.35 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 57.3 t -133.24 103.93 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.434 ' CD2' ' CD2' ' A' ' 26' ' ' TYR . 2.7 m-85 -96.85 158.64 15.33 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 118.163 -1.415 . . . . 0.0 108.437 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -123.57 88.03 2.85 Favored 'General case' 0 N--CA 1.491 1.607 1 N-CA-C 97.511 -4.996 . . . . 0.0 97.511 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.3 t -101.47 146.3 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.518 0 N-CA-C 116.626 2.084 . . . . 0.0 116.626 -178.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -123.54 104.57 9.13 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 112.541 -2.118 . . . . 0.0 106.076 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 35.8 tp -76.93 120.25 21.79 Favored 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 102.868 -3.012 . . . . 0.0 102.868 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.6 mt -87.16 -57.54 2.92 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 113.913 -1.494 . . . . 0.0 112.123 -179.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -170.27 -169.45 0.84 Allowed 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 119.502 -0.879 . . . . 0.0 111.455 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 22.0 mt -118.12 156.18 29.14 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 . . . . . 0 N--CA 1.504 2.266 0 CA-C-O 116.164 -1.874 . . . . 0.0 109.597 179.911 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.404 ' N ' ' OD2' ' A' ' 79' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.3 p -114.44 150.06 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -120.64 149.65 42.15 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.7 t -125.56 111.28 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -109.92 97.46 6.97 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 85.6 m -69.93 155.33 40.73 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 118.87 -1.132 . . . . 0.0 112.546 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 72.3 mt -123.31 -54.16 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 CA-C-N 113.493 -1.685 . . . . 0.0 107.123 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.431 ' O ' ' O ' ' A' ' 9' ' ' PRO . 43.2 m -123.66 83.16 53.91 Favored Pre-proline 0 N--CA 1.506 2.335 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.463 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 8' ' ' SER . 4.6 Cg_exo -35.92 163.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.51 2.14 . . . . 0.0 112.971 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.11 -172.08 15.15 Favored Glycine 0 N--CA 1.502 3.059 0 N-CA-C 107.872 -2.091 . . . . 0.0 107.872 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 12' ' ' GLY . 1.4 p30 -39.63 -51.69 2.25 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.867 -0.733 . . . . 0.0 112.701 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.526 ' N ' ' OD1' ' A' ' 11' ' ' ASP . . . 100.88 -1.13 55.21 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 62.9 mtt180 -118.3 -37.08 3.4 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.8 m -104.77 128.27 52.85 Favored 'General case' 0 N--CA 1.504 2.271 0 C-N-CA 119.828 -0.749 . . . . 0.0 111.757 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 27.4 m-85 -129.01 172.39 7.18 Favored Pre-proline 0 N--CA 1.502 2.145 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -63.41 128.88 23.64 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 CA-C-N 119.915 1.005 . . . . 0.0 110.504 167.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -118.0 167.58 11.32 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 122.279 1.038 . . . . 0.0 110.61 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.577 HH12 ' CD2' ' A' ' 50' ' ' LEU . 5.2 tpp180 -68.73 123.51 21.11 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.11 -1.405 . . . . 0.0 109.684 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.86 -19.39 18.49 Favored Glycine 0 N--CA 1.499 2.889 0 C-N-CA 120.336 -0.935 . . . . 0.0 110.845 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -112.17 178.13 4.41 Favored 'General case' 0 N--CA 1.507 2.414 0 CA-C-O 121.695 0.759 . . . . 0.0 112.57 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 42.1 m -111.07 166.96 10.63 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.3 m -118.48 147.25 43.82 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 67.9 t -122.96 100.55 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 101.71 -3.441 . . . . 0.0 101.71 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.2 m -120.47 145.86 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.325 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.525 ' CE1' ' OD2' ' A' ' 41' ' ' ASP . 1.6 t60 -121.49 141.59 50.88 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 102.517 -3.142 . . . . 0.0 102.517 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -160.39 176.97 11.06 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 118.487 -1.285 . . . . 0.0 112.263 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 97.4 m -136.97 121.89 18.85 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 101.368 -3.568 . . . . 0.0 101.368 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -110.41 113.24 3.48 Favored Glycine 0 N--CA 1.499 2.864 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 39.1 ttm -122.56 173.97 7.36 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 21.1 mt -119.03 -174.81 2.78 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -90.19 26.54 1.87 Allowed 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 122.219 1.009 . . . . 0.0 108.606 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 33' ' ' GLY . 1.4 p30 -130.67 -50.09 1.06 Allowed 'General case' 0 N--CA 1.502 2.132 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.649 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.521 ' N ' ' OD1' ' A' ' 32' ' ' ASP . . . 119.36 24.5 2.91 Favored Glycine 0 N--CA 1.505 3.25 0 N-CA-C 114.618 0.607 . . . . 0.0 114.618 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.407 ' O ' ' C ' ' A' ' 35' ' ' LYS . 2.1 mptp? -113.73 67.96 0.68 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 117.944 0.872 . . . . 0.0 111.646 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 34' ' ' LYS . 60.2 pttt -19.64 135.0 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.369 0 O-C-N 125.157 1.536 . . . . 0.0 113.452 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.528 ' CD2' ' OD2' ' A' ' 37' ' ' ASP . 2.5 p90 -131.8 -33.82 1.36 Allowed 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 113.675 -1.602 . . . . 0.0 108.577 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.528 ' OD2' ' CD2' ' A' ' 36' ' ' PHE . 62.1 m-20 -137.27 86.99 2.24 Favored 'General case' 0 N--CA 1.515 2.779 0 N-CA-C 118.587 2.81 . . . . 0.0 118.587 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.8 m -112.46 173.07 6.55 Favored 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 100.53 -3.878 . . . . 0.0 100.53 179.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 88.5 p -117.18 -133.31 0.33 Allowed 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 121.476 1.944 . . . . 0.0 109.719 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.426 ' O ' ' O ' ' A' ' 44' ' ' LYS . 26.0 ttt85 -131.18 78.08 1.81 Allowed 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 112.84 -1.982 . . . . 0.0 110.547 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.525 ' OD2' ' CE1' ' A' ' 25' ' ' HIS . 10.1 t70 -88.09 34.14 0.73 Allowed 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 118.003 -1.479 . . . . 0.0 108.486 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.4 ttm-85 -91.56 -60.91 1.76 Allowed 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.001 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.519 HD22 ' C ' ' A' ' 43' ' ' ASN . 0.5 OUTLIER -110.41 -66.12 1.1 Allowed 'General case' 0 N--CA 1.501 2.094 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.527 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' A' ' 40' ' ' ARG . 98.8 mttt -120.9 153.65 57.35 Favored Pre-proline 0 N--CA 1.507 2.417 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -87.84 -157.8 0.07 OUTLIER 'Trans proline' 0 C--N 1.314 -1.255 0 C-N-CA 123.284 2.656 . . . . 0.0 110.655 178.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -96.36 149.24 21.92 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 114.055 -1.429 . . . . 0.0 109.928 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -141.87 135.66 29.74 Favored 'General case' 0 N--CA 1.517 2.898 0 N-CA-C 114.822 1.415 . . . . 0.0 114.822 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -148.03 172.14 14.72 Favored 'General case' 0 N--CA 1.514 2.736 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 43.9 ttm -116.16 148.93 39.85 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.815 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.577 ' CD2' HH12 ' A' ' 18' ' ' ARG . 65.2 tp -90.77 119.37 30.94 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.966 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.19 35.22 4.55 Favored Glycine 0 N--CA 1.497 2.7 0 N-CA-C 108.591 -1.804 . . . . 0.0 108.591 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.488 ' O ' ' CB ' ' A' ' 53' ' ' GLN . 63.5 tttp -128.11 -54.16 1.29 Allowed 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.488 ' CB ' ' O ' ' A' ' 52' ' ' LYS . 63.7 tp60 100.56 66.21 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 O-C-N 125.757 1.91 . . . . 0.0 110.267 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -110.1 -36.64 5.79 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.422 ' O ' ' O ' ' A' ' 56' ' ' ILE . 11.5 m -118.73 152.43 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.737 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.422 ' O ' ' O ' ' A' ' 55' ' ' VAL . 3.8 pt -51.46 -174.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-N 114.176 -1.375 . . . . 0.0 110.043 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.539 ' O ' ' N ' ' A' ' 59' ' ' TRP . 45.2 ttm180 -84.58 -54.64 4.6 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 122.391 -0.193 . . . . 0.0 110.902 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -41.13 -20.57 0.04 OUTLIER Glycine 0 N--CA 1.492 2.422 0 C-N-CA 120.201 -1.0 . . . . 0.0 111.559 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.54 ' O ' ' N ' ' A' ' 63' ' ' VAL . 0.1 OUTLIER -92.25 -77.0 0.44 Allowed 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -35.76 -48.98 0.57 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.912 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -73.45 -54.63 7.82 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 105.739 -1.949 . . . . 0.0 105.739 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -53.68 -81.0 0.06 OUTLIER Glycine 0 N--CA 1.477 1.408 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.54 ' N ' ' O ' ' A' ' 59' ' ' TRP . 47.8 t -30.4 -46.83 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.458 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -46.02 -58.69 3.38 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 123.994 1.854 . . . . 0.0 110.177 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -50.12 -9.76 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 109.39 -3.55 . . . . 0.0 109.906 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.458 ' H ' ' C ' ' A' ' 64' ' ' ALA . 88.8 mtp -101.3 156.38 17.48 Favored 'General case' 0 N--CA 1.513 2.686 0 C-N-CA 119.102 -1.039 . . . . 0.0 108.528 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 83.0 p -115.97 148.93 39.57 Favored 'General case' 0 N--CA 1.506 2.335 0 CA-C-O 122.418 1.104 . . . . 0.0 113.003 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 90.6 t -41.57 94.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 112.846 -1.979 . . . . 0.0 113.962 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 113.28 16.92 7.98 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -108.17 144.08 36.09 Favored 'General case' 0 N--CA 1.507 2.379 0 C-N-CA 120.072 -0.651 . . . . 0.0 111.085 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 24.7 ttt85 -126.28 139.44 53.31 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -147.69 176.14 10.34 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-N 112.967 -1.924 . . . . 0.0 115.416 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -127.19 103.99 7.72 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 103.56 -2.756 . . . . 0.0 103.56 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.1 mp -97.78 146.03 25.8 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.161 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.3 m -119.34 107.15 13.03 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 104.505 -2.405 . . . . 0.0 104.505 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.4 mt -101.89 140.69 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.23 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.424 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 52.0 p -112.07 154.66 44.19 Favored Pre-proline 0 N--CA 1.504 2.229 0 CA-C-N 114.337 -1.302 . . . . 0.0 107.831 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -37.54 -54.77 1.15 Allowed 'Trans proline' 0 C--N 1.313 -1.316 0 C-N-CA 122.023 1.815 . . . . 0.0 113.836 -174.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.528 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 2.0 p-10 -34.12 -38.48 0.06 Allowed 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.895 -1.048 . . . . 0.0 113.095 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -104.55 -51.21 3.13 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.492 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -41.02 -92.01 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -121.18 -15.37 8.19 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 114.869 -1.059 . . . . 0.0 109.633 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 125.48 -172.09 17.43 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 107.843 -2.103 . . . . 0.0 107.843 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -107.46 25.26 11.67 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.435 ' O ' ' O ' ' A' ' 86' ' ' GLY . 63.8 m -129.59 43.86 3.06 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 85' ' ' THR . . . -42.99 174.06 0.01 OUTLIER Glycine 0 N--CA 1.49 2.289 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.697 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.525 ' N ' ' O ' ' A' ' 91' ' ' ILE . 73.2 t60 -115.33 145.3 34.0 Favored Pre-proline 0 N--CA 1.5 2.046 0 N-CA-C 104.592 -2.373 . . . . 0.0 104.592 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -72.41 149.32 50.21 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 N-CA-C 108.228 -1.489 . . . . 0.0 108.228 174.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 114.1 -54.73 0.55 Allowed Glycine 0 N--CA 1.5 2.966 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.8 mt -117.02 -62.14 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.392 0 CA-C-O 122.221 1.01 . . . . 0.0 109.38 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.525 ' O ' ' N ' ' A' ' 87' ' ' HIS . 32.4 mm -118.36 86.45 27.83 Favored Pre-proline 0 N--CA 1.506 2.358 0 CA-C-N 113.071 -1.877 . . . . 0.0 112.63 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -65.47 -175.61 0.45 Allowed 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 121.845 1.696 . . . . 0.0 108.037 172.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.407 ' O ' ' C ' ' A' ' 94' ' ' HIS . 89.2 Cg_exo -54.25 170.22 0.56 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.8 1.667 . . . . 0.0 110.015 174.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.412 ' O ' ' CG ' ' A' ' 94' ' ' HIS . 21.3 t-160 9.55 66.98 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.208 0 O-C-N 125.448 1.718 . . . . 0.0 115.097 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -119.35 65.23 0.79 Allowed 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 66.3 m -29.06 134.57 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 125.216 1.572 . . . . 0.0 111.317 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 16.7 mt -101.54 143.3 31.71 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.8 t -131.6 112.65 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -106.25 163.3 12.92 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 122.519 1.152 . . . . 0.0 109.399 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -129.1 90.27 3.0 Favored 'General case' 0 N--CA 1.492 1.649 1 N-CA-C 98.222 -4.733 . . . . 0.0 98.222 179.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 16.1 t -105.68 151.43 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.51 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -127.13 103.35 7.39 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 111.806 -2.452 . . . . 0.0 107.979 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 42.4 tp -72.74 120.86 18.94 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 102.177 -3.268 . . . . 0.0 102.177 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 15.8 mt -90.22 -55.57 3.55 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -165.29 175.54 9.12 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.045 -1.062 . . . . 0.0 111.483 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.429 ' O ' ' OE1' ' A' ' 107' ' ' GLU . 18.2 mt -117.26 146.31 43.38 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.429 ' OE1' ' O ' ' A' ' 106' ' ' LEU . 5.7 mm-40 . . . . . 0 N--CA 1.505 2.32 0 CA-C-O 116.087 -1.911 . . . . 0.0 109.9 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.628 ' N ' ' CE1' ' A' ' 80' ' ' TYR . . . . . . . . 0 N--CA 1.485 1.951 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.5 p -109.18 140.59 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.253 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.527 HE22 ' C ' ' A' ' 4' ' ' VAL . 4.7 tm0? -117.87 149.7 40.42 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.527 ' C ' HE22 ' A' ' 3' ' ' GLN . 40.5 t -123.51 101.73 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.524 ' OE2' ' NZ ' ' A' ' 73' ' ' LYS . 39.1 tt0 -103.24 107.88 18.87 Favored 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 93.9 m -83.65 154.14 23.86 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 122.229 1.014 . . . . 0.0 112.51 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 56.3 mt -124.15 -50.29 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 CA-C-N 113.313 -1.767 . . . . 0.0 107.282 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 9' ' ' PRO . 48.1 t -122.14 79.97 43.63 Favored Pre-proline 0 N--CA 1.507 2.384 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.498 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 8' ' ' SER . 5.8 Cg_exo -37.3 165.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.735 2.29 . . . . 0.0 113.528 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.43 -169.83 13.52 Favored Glycine 0 N--CA 1.5 2.914 0 N-CA-C 106.234 -2.746 . . . . 0.0 106.234 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.521 ' N ' ' OD1' ' A' ' 11' ' ' ASP . 13.0 p-10 -39.76 -60.68 0.95 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.518 -0.873 . . . . 0.0 112.678 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.22 14.32 18.85 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 106.844 -2.502 . . . . 0.0 106.844 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 45.6 mtm180 -128.9 -36.32 1.8 Allowed 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 114.468 -0.866 . . . . 0.0 113.324 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 36.6 m -107.65 138.36 44.01 Favored 'General case' 0 N--CA 1.508 2.468 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.457 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 61.7 m-85 -130.91 176.25 3.03 Favored Pre-proline 0 N--CA 1.497 1.916 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -69.84 133.61 25.85 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 CA-C-N 119.63 0.904 . . . . 0.0 111.149 164.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.0 mtmp? -119.48 162.32 19.07 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 122.313 1.054 . . . . 0.0 108.653 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 58.4 mtt-85 -61.86 144.28 55.12 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 114.39 -1.277 . . . . 0.0 107.714 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 107.17 -31.31 8.25 Favored Glycine 0 N--CA 1.498 2.781 0 C-N-CA 119.564 -1.303 . . . . 0.0 110.589 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.413 HE21 ' HB3' ' A' ' 106' ' ' LEU . 26.4 mt-30 -109.33 176.86 4.93 Favored 'General case' 0 N--CA 1.506 2.369 0 CA-C-O 121.781 0.801 . . . . 0.0 112.881 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 63.7 m -114.71 124.82 52.77 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 114.387 -1.279 . . . . 0.0 109.828 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 22.3 m -69.53 152.14 45.17 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.2 t -128.07 106.49 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 102.117 -3.29 . . . . 0.0 102.117 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.0 m -125.52 148.32 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.423 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -122.82 140.41 52.96 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 101.856 -3.387 . . . . 0.0 101.856 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -160.13 174.73 13.85 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 117.696 -1.602 . . . . 0.0 113.674 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.5 m -136.64 118.84 15.53 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 104.57 -2.382 . . . . 0.0 104.57 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.64 135.33 12.45 Favored Glycine 0 N--CA 1.503 3.112 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 63.9 mtp -140.28 178.75 7.07 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 122.102 0.953 . . . . 0.0 110.233 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 24.6 mt -116.08 175.77 5.4 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -33.78 -63.5 0.26 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 124.934 1.396 . . . . 0.0 113.179 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -160.93 38.4 0.15 Allowed 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 114.369 -1.287 . . . . 0.0 109.447 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -119.25 -82.47 0.78 Allowed Glycine 0 N--CA 1.499 2.881 0 C-N-CA 118.684 -1.722 . . . . 0.0 114.896 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.24 174.1 10.91 Favored 'General case' 0 N--CA 1.505 2.292 0 N-CA-C 116.536 2.05 . . . . 0.0 116.536 -179.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -91.72 137.06 32.67 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 112.109 -2.314 . . . . 0.0 105.191 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -118.84 -33.97 4.07 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -141.76 107.6 5.14 Favored 'General case' 0 N--CA 1.511 2.607 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.7 m -120.39 168.08 11.67 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 68.3 p -118.32 63.18 0.76 Allowed 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 19.0 ttm180 -116.41 -70.46 0.79 Allowed 'General case' 0 N--CA 1.504 2.257 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.172 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -19.71 -61.03 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.387 0 O-C-N 125.18 1.55 . . . . 0.0 113.163 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.48 ' HE ' ' HA ' ' A' ' 42' ' ' ARG . 1.4 mmp_? -91.02 71.66 6.39 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 103.45 -2.796 . . . . 0.0 103.45 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.4 ' C ' ' O ' ' A' ' 42' ' ' ARG . 5.1 m120 -8.47 -57.13 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.13 0 O-C-N 126.239 2.212 . . . . 0.0 114.248 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.466 ' N ' ' O ' ' A' ' 42' ' ' ARG . 4.5 mptp? -52.08 158.71 1.69 Allowed Pre-proline 0 N--CA 1.495 1.781 0 C-N-CA 119.073 -1.051 . . . . 0.0 108.341 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.22 -162.02 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 121.663 1.575 . . . . 0.0 110.717 171.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -114.37 152.66 31.13 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-N 114.73 -1.123 . . . . 0.0 112.843 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -140.9 133.22 28.25 Favored 'General case' 0 N--CA 1.514 2.731 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -139.04 174.92 10.01 Favored 'General case' 0 N--CA 1.515 2.779 0 CA-C-N 119.508 1.049 . . . . 0.0 111.771 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 44.6 ttm -115.24 134.66 54.94 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.3 tp -91.02 139.1 31.08 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 113.496 -1.684 . . . . 0.0 109.82 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 127.99 -36.26 2.55 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.284 -1.527 . . . . 0.0 109.284 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.411 ' O ' ' C ' ' A' ' 53' ' ' GLN . 19.7 tptp -130.38 42.67 3.23 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 119.147 -0.454 . . . . 0.0 112.087 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.411 ' C ' ' O ' ' A' ' 52' ' ' LYS . 8.4 tt0 23.98 77.32 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 124.578 1.173 . . . . 0.0 112.991 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.417 ' O ' ' OE1' ' A' ' 54' ' ' GLU . 8.1 tm-20 -84.3 -27.2 27.98 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.436 ' O ' ' O ' ' A' ' 56' ' ' ILE . 16.3 m -119.4 154.44 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.439 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.588 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.436 ' O ' ' O ' ' A' ' 55' ' ' VAL . 3.1 pt -45.8 174.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 C-N-CA 118.653 -1.219 . . . . 0.0 111.913 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.54 ' O ' ' N ' ' A' ' 59' ' ' TRP . 5.0 tpt180 -71.01 -58.96 3.06 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.883 -1.053 . . . . 0.0 113.171 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -32.52 -30.53 0.01 OUTLIER Glycine 0 N--CA 1.5 2.947 0 CA-C-O 122.825 1.236 . . . . 0.0 111.531 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.54 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.8 OUTLIER -92.2 -76.2 0.46 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 112.924 -1.638 . . . . 0.0 109.557 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.514 ' OE1' ' NH1' ' A' ' 57' ' ' ARG . 3.8 tm-20 -32.02 -50.3 0.21 Allowed 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.1 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -73.65 -56.39 5.06 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -51.35 -77.55 0.13 Allowed Glycine 0 N--CA 1.481 1.637 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.526 ' N ' ' O ' ' A' ' 59' ' ' TRP . 40.2 t -36.05 -45.87 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.435 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -50.09 -53.48 26.92 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 123.715 1.721 . . . . 0.0 109.618 179.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -61.97 0.29 0.41 Allowed 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 110.399 -3.091 . . . . 0.0 110.692 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.435 ' H ' ' C ' ' A' ' 64' ' ' ALA . 50.8 ttm -110.09 151.8 26.77 Favored 'General case' 0 N--CA 1.51 2.534 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 80.4 p -115.85 153.57 31.26 Favored 'General case' 0 N--CA 1.509 2.512 0 CA-C-O 122.832 1.301 . . . . 0.0 113.922 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 79.6 t -45.23 98.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-N 112.324 -2.216 . . . . 0.0 114.967 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.46 10.5 21.63 Favored Glycine 0 N--CA 1.498 2.795 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -108.58 152.13 25.18 Favored 'General case' 0 N--CA 1.509 2.517 0 CA-C-O 122.384 1.088 . . . . 0.0 111.249 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 -131.83 141.25 49.38 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 113.027 -1.897 . . . . 0.0 108.357 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -148.07 177.91 8.98 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 112.888 -1.96 . . . . 0.0 114.223 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.573 ' HZ3' ' HB3' ' A' ' 73' ' ' LYS . 6.3 ttpm? -122.8 103.55 8.71 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 102.986 -2.968 . . . . 0.0 102.986 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.7 mt -96.49 145.06 26.02 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 90.7 m -117.45 107.62 14.54 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 104.349 -2.463 . . . . 0.0 104.349 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 35.8 mt -101.55 140.05 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.665 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.454 ' HG ' ' CG ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -114.24 160.42 32.76 Favored Pre-proline 0 N--CA 1.497 1.887 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -45.09 -52.69 6.11 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.39 2.06 . . . . 0.0 112.736 -172.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.454 ' CG ' ' HG ' ' A' ' 77' ' ' SER . 24.5 p30 -39.66 -29.85 0.06 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.628 ' CE1' ' N ' ' A' ' 1' ' ' GLY . 6.0 m-85 -105.52 18.67 21.85 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 115.089 1.515 . . . . 0.0 115.089 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -166.1 -84.09 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.412 ' CD2' HD11 ' A' ' 97' ' ' LEU . 7.9 m-30 -107.76 60.07 0.62 Allowed 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 114.419 -1.264 . . . . 0.0 111.355 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -8.9 -90.04 0.01 OUTLIER Glycine 0 N--CA 1.499 2.844 0 N-CA-C 116.697 1.439 . . . . 0.0 116.697 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -130.88 -55.95 1.05 Allowed 'General case' 0 N--CA 1.505 2.299 0 O-C-N 122.045 -0.679 . . . . 0.0 112.612 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 97.6 m -112.73 97.24 6.43 Favored 'General case' 0 N--CA 1.502 2.142 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.913 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -109.25 -83.01 1.43 Allowed Glycine 0 N--CA 1.501 2.988 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 29.1 t60 -144.19 75.62 15.35 Favored Pre-proline 0 N--CA 1.506 2.34 0 CA-C-N 118.033 0.916 . . . . 0.0 111.411 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -37.84 140.5 0.28 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.22 1.947 . . . . 0.0 110.796 177.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 113.92 -42.62 1.89 Allowed Glycine 0 N--CA 1.501 3.029 0 N-CA-C 107.491 -2.244 . . . . 0.0 107.491 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.6 mt -108.08 -52.84 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 37.6 mm -117.88 85.62 23.23 Favored Pre-proline 0 N--CA 1.502 2.151 0 CA-C-N 112.193 -2.276 . . . . 0.0 110.27 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -45.36 154.78 0.47 Allowed 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 122.234 1.956 . . . . 0.0 108.378 167.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -49.19 160.8 0.73 Allowed 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 121.657 1.571 . . . . 0.0 112.498 -174.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 8.9 p80 9.42 70.78 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 116.868 2.173 . . . . 0.0 116.868 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -111.96 154.67 24.92 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 25.5 m -91.12 140.42 29.83 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.412 HD11 ' CD2' ' A' ' 82' ' ' TYR . 29.7 mt -109.17 151.65 26.19 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 104.929 -2.248 . . . . 0.0 104.929 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.4 t -134.81 102.7 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -96.49 163.38 13.07 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 117.83 -1.548 . . . . 0.0 107.812 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -125.41 87.7 2.74 Favored 'General case' 0 N--CA 1.492 1.633 1 N-CA-C 95.559 -5.719 . . . . 0.0 95.559 179.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 16.8 t -100.07 147.98 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.423 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -127.18 103.75 7.59 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 112.463 -2.153 . . . . 0.0 107.538 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 37.5 tp -74.39 114.37 12.68 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 102.866 -3.013 . . . . 0.0 102.866 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.1 mt -77.11 -53.97 7.11 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.187 -179.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 9.0 mtpt -174.5 -167.21 0.3 Allowed 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.64 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.413 ' HB3' HE21 ' A' ' 20' ' ' GLN . 22.5 mt -117.53 154.28 31.74 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 . . . . . 0 N--CA 1.501 2.123 0 CA-C-O 116.156 -1.878 . . . . 0.0 108.528 179.84 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.353 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.4 p -110.88 150.26 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -122.3 154.7 37.25 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 57.2 t -126.52 109.11 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 CA-C-N 115.197 -0.91 . . . . 0.0 108.567 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -109.9 96.0 5.96 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 89.7 m -69.89 156.33 39.24 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 118.813 -1.155 . . . . 0.0 113.106 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 69.1 mt -122.49 -54.72 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-N 113.361 -1.745 . . . . 0.0 107.356 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.416 ' O ' ' O ' ' A' ' 9' ' ' PRO . 48.6 m -123.85 82.43 55.26 Favored Pre-proline 0 N--CA 1.506 2.372 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.574 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.416 ' O ' ' O ' ' A' ' 8' ' ' SER . 5.3 Cg_exo -36.36 163.91 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.447 2.098 . . . . 0.0 113.176 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -118.02 -172.51 15.77 Favored Glycine 0 N--CA 1.5 2.961 0 N-CA-C 104.88 -3.288 . . . . 0.0 104.88 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.464 ' CG ' ' H ' ' A' ' 12' ' ' GLY . 10.6 p-10 -45.88 -58.46 3.51 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 118.635 1.218 . . . . 0.0 111.108 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.464 ' H ' ' CG ' ' A' ' 11' ' ' ASP . . . 106.5 27.02 5.68 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 107.246 -2.341 . . . . 0.0 107.246 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 57.7 mtt85 -132.39 -35.32 1.17 Allowed 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 114.457 -0.871 . . . . 0.0 111.871 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.8 m -111.28 136.8 49.86 Favored 'General case' 0 N--CA 1.506 2.326 0 CA-C-O 121.703 0.763 . . . . 0.0 112.848 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.448 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 59.0 m-85 -132.14 176.11 3.16 Favored Pre-proline 0 N--CA 1.496 1.851 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -70.91 140.24 37.92 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 CA-C-N 119.508 0.86 . . . . 0.0 111.484 163.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -122.74 169.95 10.55 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 121.716 0.77 . . . . 0.0 109.009 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.1 mtp-105 -70.23 126.34 29.37 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.078 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.42 -19.3 13.04 Favored Glycine 0 N--CA 1.498 2.775 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -108.56 174.12 6.02 Favored 'General case' 0 N--CA 1.504 2.225 0 CA-C-O 121.847 0.832 . . . . 0.0 111.391 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 42.5 m -118.82 129.93 55.49 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 114.039 -1.437 . . . . 0.0 107.753 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 59.3 m -78.75 149.45 32.69 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.5 t -121.85 101.6 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 103.12 -2.918 . . . . 0.0 103.12 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.0 m -121.59 150.69 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.49 0 N-CA-C 117.248 2.314 . . . . 0.0 117.248 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.483 ' ND1' ' CG ' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -123.31 107.04 11.22 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 179.346 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -127.59 170.15 12.95 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-O 123.237 1.494 . . . . 0.0 114.589 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 98.1 m -139.29 119.5 13.68 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 102.754 -3.054 . . . . 0.0 102.754 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.53 137.63 14.23 Favored Glycine 0 N--CA 1.501 3.001 0 C-N-CA 120.073 -1.06 . . . . 0.0 110.995 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 40.5 ttm -136.05 168.54 19.18 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.1 mt -112.59 173.45 6.37 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 107.994 -1.114 . . . . 0.0 107.994 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.434 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -32.66 -63.33 0.21 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 124.792 1.308 . . . . 0.0 111.943 179.857 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.425 ' OD1' ' OE2' ' A' ' 31' ' ' GLU . 12.3 p-10 -160.29 42.69 0.19 Allowed 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.303 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -118.49 -80.22 0.7 Allowed Glycine 0 N--CA 1.5 2.938 0 C-N-CA 119.222 -1.466 . . . . 0.0 112.979 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.9 pttp -161.11 -168.01 1.94 Allowed 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.402 ' HG2' ' H ' ' A' ' 35' ' ' LYS . 60.8 pttt -90.7 137.7 32.15 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.528 ' CE2' ' OD2' ' A' ' 37' ' ' ASP . 6.5 p90 -127.87 -38.31 1.86 Allowed 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 113.098 -1.865 . . . . 0.0 107.111 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.528 ' OD2' ' CE2' ' A' ' 36' ' ' PHE . 29.6 m-20 -129.88 80.78 1.98 Allowed 'General case' 0 N--CA 1.508 2.444 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 56.4 m -113.62 164.56 13.52 Favored 'General case' 0 N--CA 1.492 1.635 1 N-CA-C 99.391 -4.3 . . . . 0.0 99.391 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 92.9 p -120.4 -141.24 0.34 Allowed 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 103.265 -2.865 . . . . 0.0 103.265 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 26.6 ttt85 -130.76 74.03 1.57 Allowed 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 111.893 -2.412 . . . . 0.0 104.872 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.483 ' CG ' ' ND1' ' A' ' 25' ' ' HIS . 32.0 m-20 -80.69 40.17 0.51 Allowed 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.008 -1.077 . . . . 0.0 110.909 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.35 -69.71 0.72 Allowed 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -111.01 -56.5 2.36 Favored 'General case' 0 N--CA 1.504 2.26 0 CA-C-N 115.054 -0.975 . . . . 0.0 113.522 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.428 ' O ' ' O ' ' A' ' 45' ' ' PRO . 4.5 mmpt? -114.22 87.5 13.49 Favored Pre-proline 0 N--CA 1.507 2.412 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -179.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 44' ' ' LYS . 33.2 Cg_exo -42.81 -156.95 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 123.148 2.565 . . . . 0.0 114.94 168.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -106.66 145.32 32.11 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 113.519 -1.673 . . . . 0.0 111.76 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.49 116.29 14.03 Favored 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -132.92 172.63 12.35 Favored 'General case' 0 N--CA 1.512 2.63 0 C-N-CA 119.797 -0.761 . . . . 0.0 111.298 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.9 ttm -119.89 153.65 35.55 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.4 tp -90.93 125.27 35.72 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.822 -1.535 . . . . 0.0 110.491 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.18 -24.57 7.33 Favored Glycine 0 N--CA 1.501 2.983 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 54' ' ' GLU . 52.8 tttp -116.11 39.35 3.1 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' ' 52' ' ' LYS . 86.5 mt-30 1.49 61.77 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 125.794 1.934 . . . . 0.0 114.384 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 52' ' ' LYS . 43.7 tt0 -75.21 -23.38 57.61 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 113.715 -1.584 . . . . 0.0 107.406 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.5 m -113.15 -178.45 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 18.6 pt -90.26 167.04 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 C-N-CA 118.998 -1.081 . . . . 0.0 110.868 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.531 ' O ' ' N ' ' A' ' 59' ' ' TRP . 0.7 OUTLIER -45.69 -70.22 0.11 Allowed 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 114.311 -1.313 . . . . 0.0 111.138 -179.774 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -26.47 -36.66 0.01 OUTLIER Glycine 0 N--CA 1.496 2.654 0 O-C-N 125.175 1.547 . . . . 0.0 112.799 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.531 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.8 OUTLIER -83.59 -68.36 0.72 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.819 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.463 ' OE1' ' N ' ' A' ' 61' ' ' GLU . 10.1 tm-20 -33.73 -53.45 0.44 Allowed 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 113.934 -1.485 . . . . 0.0 110.721 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.503 ' OE2' ' NE2' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -73.71 -57.42 4.0 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 104.777 -2.305 . . . . 0.0 104.777 179.707 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -46.46 -78.57 0.08 OUTLIER Glycine 0 N--CA 1.485 1.963 0 C-N-CA 119.554 -1.307 . . . . 0.0 111.061 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 59' ' ' TRP . 32.3 t -39.63 -47.32 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 114.948 -0.626 . . . . 0.0 111.932 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.404 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -50.1 -51.27 44.32 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 123.265 1.507 . . . . 0.0 110.499 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.503 ' NE2' ' OE2' ' A' ' 61' ' ' GLU . 7.3 tt0 -65.94 2.98 0.9 Allowed 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 111.216 -2.72 . . . . 0.0 111.507 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.404 ' H ' ' C ' ' A' ' 64' ' ' ALA . 60.0 ttm -106.61 151.99 24.32 Favored 'General case' 0 N--CA 1.509 2.493 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 179.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 92.0 p -116.49 151.98 35.0 Favored 'General case' 0 N--CA 1.51 2.566 0 CA-C-O 122.69 1.233 . . . . 0.0 113.541 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 86.0 t -45.0 97.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 112.597 -2.092 . . . . 0.0 114.755 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.35 8.42 23.27 Favored Glycine 0 N--CA 1.5 2.937 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -105.4 145.31 30.97 Favored 'General case' 0 N--CA 1.506 2.361 0 CA-C-O 121.648 0.737 . . . . 0.0 111.566 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.9 ttt85 -126.17 141.45 51.93 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.261 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -149.54 177.52 9.66 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 113.007 -1.906 . . . . 0.0 115.507 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -127.03 105.14 8.39 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 103.07 -2.937 . . . . 0.0 103.07 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.41 HD12 ' N ' ' A' ' 74' ' ' LEU . 5.1 mp -101.67 151.55 21.89 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 119.766 -0.774 . . . . 0.0 109.882 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 86.3 m -121.61 121.73 38.05 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 25.6 mt -111.41 139.92 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.429 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 66.8 p -113.87 154.35 45.92 Favored Pre-proline 0 N--CA 1.503 2.22 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.435 ' O ' ' O ' ' A' ' 81' ' ' ALA . 9.5 Cg_endo -37.55 -54.11 1.28 Allowed 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 121.784 1.656 . . . . 0.0 113.192 -174.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.52 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 0.9 OUTLIER -34.66 -35.87 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.445 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -104.53 -25.36 12.8 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 114.685 -1.143 . . . . 0.0 112.049 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 83' ' ' GLY . . . -105.1 164.9 11.46 Favored 'General case' 0 N--CA 1.505 2.315 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.119 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -11.43 71.4 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 126.515 2.384 . . . . 0.0 113.799 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 81' ' ' ALA . . . -82.95 53.66 4.89 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 119.26 -1.448 . . . . 0.0 111.487 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.488 ' CB ' ' O ' ' A' ' 83' ' ' GLY . . . 114.81 22.26 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 O-C-N 126.348 1.852 . . . . 0.0 109.531 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 48.2 m -128.26 46.59 2.56 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-O 121.096 0.474 . . . . 0.0 109.992 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -126.0 173.91 17.78 Favored Glycine 0 N--CA 1.5 2.947 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -125.93 150.3 68.63 Favored Pre-proline 0 N--CA 1.504 2.239 0 N-CA-C 103.469 -2.789 . . . . 0.0 103.469 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.526 ' O ' ' N ' ' A' ' 90' ' ' ILE . 36.6 Cg_endo -54.43 -77.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 120.978 1.119 . . . . 0.0 109.436 -177.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -21.25 -40.76 0.01 OUTLIER Glycine 0 N--CA 1.493 2.462 0 O-C-N 124.896 1.372 . . . . 0.0 114.973 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.526 ' N ' ' O ' ' A' ' 88' ' ' PRO . 6.1 mt -109.03 -65.27 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.321 0 CA-C-O 122.396 1.093 . . . . 0.0 111.44 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 35.5 mm -116.26 90.9 30.87 Favored Pre-proline 0 N--CA 1.505 2.311 0 CA-C-N 113.123 -1.853 . . . . 0.0 112.639 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -55.12 -179.29 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.17 1.913 . . . . 0.0 108.286 162.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -64.44 165.72 19.36 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 121.915 1.743 . . . . 0.0 112.881 -176.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 17.9 m80 9.33 76.0 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -115.93 156.71 25.71 Favored 'General case' 0 N--CA 1.505 2.298 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 68.9 m -91.1 139.49 30.7 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 31.5 mt -116.82 149.59 39.74 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.6 t -132.37 123.03 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -115.77 157.13 24.8 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 122.023 0.916 . . . . 0.0 110.166 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -127.72 90.82 3.17 Favored 'General case' 0 N--CA 1.493 1.689 1 N-CA-C 99.194 -4.372 . . . . 0.0 99.194 179.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.4 t -105.32 151.34 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.54 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -127.92 98.09 5.03 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 112.327 -2.215 . . . . 0.0 107.838 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 56.0 tp -69.87 119.44 14.1 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 11.4 mt -82.35 -55.97 4.18 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 113.902 -1.499 . . . . 0.0 110.639 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -173.95 -168.09 0.39 Allowed 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 114.71 -1.132 . . . . 0.0 111.065 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 25.7 mt -114.82 160.02 19.94 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 . . . . . 0 N--CA 1.504 2.251 0 CA-C-O 116.241 -1.838 . . . . 0.0 108.236 179.705 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.7 p -115.45 150.23 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -124.31 151.89 43.74 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.0 t -123.09 115.79 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -117.78 97.67 5.96 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 94.7 m -69.75 156.52 38.87 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.154 -1.018 . . . . 0.0 112.734 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.1 mt -121.38 -58.52 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.531 ' CB ' ' NH1' ' A' ' 71' ' ' ARG . 48.3 m -121.64 84.6 43.07 Favored Pre-proline 0 N--CA 1.501 2.086 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.877 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 8' ' ' SER . 6.8 Cg_exo -36.23 163.79 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.397 2.065 . . . . 0.0 113.264 178.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.2 -173.63 14.7 Favored Glycine 0 N--CA 1.499 2.885 0 N-CA-C 105.555 -3.018 . . . . 0.0 105.555 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.506 ' N ' ' OD1' ' A' ' 11' ' ' ASP . 13.0 p-10 -39.71 -59.87 1.08 Allowed 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.809 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.15 20.06 11.76 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 105.356 -3.098 . . . . 0.0 105.356 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 46.4 mtm180 -128.21 -38.5 1.78 Allowed 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 113.699 -1.251 . . . . 0.0 112.733 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.0 m -108.18 135.29 49.77 Favored 'General case' 0 N--CA 1.505 2.315 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.441 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 67.6 m-85 -130.94 177.16 2.37 Favored Pre-proline 0 N--CA 1.495 1.796 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -66.22 153.27 78.7 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 CA-C-N 119.408 0.824 . . . . 0.0 110.806 160.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -122.65 170.88 9.58 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 121.759 0.79 . . . . 0.0 109.361 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 42.4 mtp-105 -78.22 96.63 5.27 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.096 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.73 10.56 3.92 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -114.74 172.09 7.25 Favored 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 74.7 m -121.86 112.27 18.13 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.25 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 22.5 m -69.54 147.35 50.92 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.758 0.789 . . . . 0.0 109.518 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.1 t -123.09 112.31 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 101.592 -3.484 . . . . 0.0 101.592 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.0 m -122.44 151.62 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -120.38 99.21 6.44 Favored 'General case' 0 N--CA 1.508 2.463 0 CA-C-N 112.71 -2.041 . . . . 0.0 106.473 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.41 ' CD2' ' CD2' ' A' ' 99' ' ' PHE . 28.0 p90 -132.29 173.8 10.89 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.6 m -134.7 117.92 16.56 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 102.628 -3.101 . . . . 0.0 102.628 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 37' ' ' ASP . . . -104.57 120.8 6.73 Favored Glycine 0 N--CA 1.503 3.157 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.434 ' SD ' ' C ' ' A' ' 34' ' ' LYS . 37.4 tpp -141.05 151.0 43.69 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.52 ' H ' HD12 ' A' ' 30' ' ' LEU . 3.2 mp -93.02 151.92 19.61 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -90.51 34.64 0.88 Allowed 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 33' ' ' GLY . 32.7 p30 -121.05 -26.58 5.11 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 113.463 -1.699 . . . . 0.0 111.106 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.538 ' N ' ' OD1' ' A' ' 32' ' ' ASP . . . 161.35 -43.66 0.4 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 120.55 2.98 . . . . 0.0 120.55 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.486 ' O ' HD12 ' A' ' 30' ' ' LEU . 32.5 mmtp -129.34 176.87 7.6 Favored 'General case' 0 N--CA 1.523 3.198 0 CA-C-N 121.734 2.767 . . . . 0.0 113.025 -178.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.418 ' H ' ' HG2' ' A' ' 35' ' ' LYS . 53.8 pttt -93.07 148.43 22.01 Favored 'General case' 0 N--CA 1.513 2.721 0 O-C-N 124.781 1.3 . . . . 0.0 111.717 179.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -136.21 -32.79 0.85 Allowed 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.25 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.463 ' O ' ' N ' ' A' ' 28' ' ' GLY . 7.5 t0 -137.75 121.47 17.46 Favored 'General case' 0 N--CA 1.526 3.336 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.5 m -130.68 162.45 29.4 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.479 ' O ' ' N ' ' A' ' 41' ' ' ASP . 88.4 p -100.73 46.21 0.95 Allowed 'General case' 0 N--CA 1.504 2.275 0 C-N-CA 121.061 -0.256 . . . . 0.0 111.45 179.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.486 ' C ' ' H ' ' A' ' 42' ' ' ARG . 10.1 tpp85 -29.85 -36.09 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 124.242 0.964 . . . . 0.0 112.949 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.479 ' N ' ' O ' ' A' ' 39' ' ' SER . 54.5 m-20 -54.98 15.43 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 116.652 2.093 . . . . 0.0 116.652 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.486 ' H ' ' C ' ' A' ' 40' ' ' ARG . 64.8 mtt85 -19.55 -58.12 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.568 HD22 ' N ' ' A' ' 43' ' ' ASN . 2.0 m120 -43.79 -64.44 0.66 Allowed 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.867 0.842 . . . . 0.0 110.838 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.454 ' O ' ' O ' ' A' ' 45' ' ' PRO . 46.1 pttt -122.61 73.25 42.24 Favored Pre-proline 0 N--CA 1.498 1.939 0 CA-C-N 113.996 -1.456 . . . . 0.0 110.168 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.454 ' O ' ' O ' ' A' ' 44' ' ' LYS . 21.6 Cg_exo -41.45 -154.3 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 125.099 3.866 . . . . 0.0 119.229 -163.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -91.35 135.61 33.7 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 112.468 -2.151 . . . . 0.0 107.882 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -133.05 143.9 49.67 Favored 'General case' 0 N--CA 1.514 2.753 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -149.07 174.64 12.1 Favored 'General case' 0 N--CA 1.504 2.242 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.156 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 41.6 ttm -118.04 142.74 47.06 Favored 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.3 tp -91.02 120.63 32.16 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.953 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.08 24.18 9.95 Favored Glycine 0 N--CA 1.5 2.903 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.48 ' O ' ' CB ' ' A' ' 53' ' ' GLN . 15.6 tppt? -125.29 -55.94 1.54 Allowed 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.48 ' CB ' ' O ' ' A' ' 52' ' ' LYS . 46.3 tt0 100.81 68.85 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 O-C-N 126.0 2.063 . . . . 0.0 108.29 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -109.12 -36.24 6.11 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 113.939 -1.482 . . . . 0.0 107.459 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.415 ' O ' ' O ' ' A' ' 56' ' ' ILE . 15.8 m -111.05 151.77 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.415 ' O ' ' O ' ' A' ' 55' ' ' VAL . 15.7 pt -48.48 174.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 C-N-CA 118.276 -1.37 . . . . 0.0 111.038 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.544 ' O ' ' N ' ' A' ' 59' ' ' TRP . 46.5 ttm180 -69.59 -63.28 1.1 Allowed 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -28.78 -34.73 0.01 OUTLIER Glycine 0 N--CA 1.499 2.837 0 O-C-N 124.472 1.107 . . . . 0.0 112.356 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.544 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.5 OUTLIER -81.42 -74.53 0.33 Allowed 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 113.177 -1.511 . . . . 0.0 107.553 179.877 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.518 ' OE1' ' N ' ' A' ' 61' ' ' GLU . 10.9 tm-20 -33.86 -51.37 0.4 Allowed 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.742 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.518 ' N ' ' OE1' ' A' ' 60' ' ' GLU . 17.7 tp10 -72.7 -55.48 6.73 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 112.544 -2.116 . . . . 0.0 108.095 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -55.29 -72.74 0.51 Allowed Glycine 0 N--CA 1.477 1.408 0 C-N-CA 119.246 -1.454 . . . . 0.0 110.17 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.498 ' N ' ' O ' ' A' ' 59' ' ' TRP . 40.6 t -39.56 -49.56 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 120.126 -0.629 . . . . 0.0 112.308 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.477 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -47.22 -62.09 1.58 Allowed 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 124.037 1.875 . . . . 0.0 110.139 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -48.43 -12.7 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 109.654 -3.43 . . . . 0.0 108.764 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.477 ' H ' ' C ' ' A' ' 64' ' ' ALA . 52.1 ttp -108.95 156.01 20.21 Favored 'General case' 0 N--CA 1.509 2.479 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.4 p -110.94 161.76 15.52 Favored 'General case' 0 N--CA 1.509 2.519 0 N-CA-C 116.338 1.977 . . . . 0.0 116.338 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 86.2 t -56.32 102.58 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-N 110.727 -2.942 . . . . 0.0 113.482 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.56 6.61 23.27 Favored Glycine 0 N--CA 1.499 2.867 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -107.12 148.86 28.29 Favored 'General case' 0 N--CA 1.504 2.27 0 CA-C-O 122.097 0.951 . . . . 0.0 110.29 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.531 ' NH1' ' CB ' ' A' ' 8' ' ' SER . 34.8 mtm-85 -122.35 128.35 50.89 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 113.577 -1.647 . . . . 0.0 107.977 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -134.91 172.02 13.58 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -124.57 103.17 8.0 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 102.766 -3.05 . . . . 0.0 102.766 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.8 mt -98.46 146.93 25.25 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.1 m -117.52 111.06 18.73 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 102.473 -3.158 . . . . 0.0 102.473 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 27.2 mt -109.41 137.79 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-O 121.462 0.649 . . . . 0.0 111.53 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 27.1 p -104.63 152.51 39.44 Favored Pre-proline 0 N--CA 1.504 2.27 0 CA-C-N 113.804 -1.543 . . . . 0.0 110.082 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -47.86 -38.83 31.2 Favored 'Trans proline' 0 N--CA 1.488 1.177 0 C-N-CA 122.574 2.183 . . . . 0.0 113.332 -173.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.521 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 7.0 p-10 -48.81 -40.44 29.22 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.101 -0.64 . . . . 0.0 110.943 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.7 m-30 -102.06 19.81 17.79 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.884 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -143.89 -96.79 0.11 Allowed 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.424 ' CD2' ' CG1' ' A' ' 91' ' ' ILE . 15.1 m-85 -120.08 99.29 6.52 Favored 'General case' 0 N--CA 1.504 2.238 0 CA-C-O 120.8 0.333 . . . . 0.0 110.331 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -108.68 34.84 5.32 Favored Glycine 0 N--CA 1.498 2.83 0 N-CA-C 107.61 -2.196 . . . . 0.0 107.61 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -132.79 -175.59 3.82 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 93.5 m -121.98 119.21 30.8 Favored 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.423 ' H ' HG22 ' A' ' 91' ' ' ILE . . . -115.82 -81.73 0.94 Allowed Glycine 0 N--CA 1.503 3.125 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 -123.02 145.85 47.03 Favored Pre-proline 0 N--CA 1.508 2.435 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -84.55 117.7 2.09 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 C-N-CA 121.918 1.745 . . . . 0.0 109.937 176.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 119.63 -26.18 7.36 Favored Glycine 0 N--CA 1.5 2.926 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.0 mt -108.57 -59.34 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.487 ' O ' ' CG2' ' A' ' 91' ' ' ILE . 0.8 OUTLIER -124.18 85.55 54.92 Favored Pre-proline 0 N--CA 1.503 2.224 0 CA-C-N 112.465 -2.152 . . . . 0.0 110.204 179.983 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -69.4 162.34 42.28 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 N-CA-C 107.019 -1.954 . . . . 0.0 107.019 170.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 94' ' ' HIS . 73.5 Cg_endo -61.78 166.0 12.83 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.048 1.832 . . . . 0.0 109.373 176.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.406 ' C ' ' O ' ' A' ' 93' ' ' PRO . 20.3 m80 9.71 66.23 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.252 0 O-C-N 125.702 1.876 . . . . 0.0 114.576 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -111.52 158.4 19.22 Favored 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 122.423 1.106 . . . . 0.0 112.307 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 87.3 m -91.19 120.31 32.01 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 112.851 -1.977 . . . . 0.0 108.601 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 20.7 mt -97.75 147.19 24.63 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 103.893 -2.632 . . . . 0.0 103.893 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 56.5 t -132.71 124.11 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.41 ' CD2' ' CD2' ' A' ' 26' ' ' TYR . 2.0 m-85 -115.5 167.82 10.55 Favored 'General case' 0 N--CA 1.507 2.387 0 CA-C-O 123.264 1.507 . . . . 0.0 110.477 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -130.28 88.7 2.68 Favored 'General case' 0 N--CA 1.49 1.544 1 N-CA-C 98.222 -4.733 . . . . 0.0 98.222 179.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.5 t -100.95 151.46 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.442 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 -179.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 72.8 tt0 -127.27 97.36 4.88 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 112.377 -2.192 . . . . 0.0 106.806 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 43.8 tp -68.25 122.72 18.92 Favored 'General case' 0 N--CA 1.506 2.373 0 C-N-CA 115.591 -2.444 . . . . 0.0 104.936 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 11.4 mt -85.42 -62.29 1.56 Allowed 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.92 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.469 ' HG2' ' H ' ' A' ' 106' ' ' LEU . 34.1 ttpt -170.77 -175.24 1.76 Allowed 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 118.892 -1.123 . . . . 0.0 109.826 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.469 ' H ' ' HG2' ' A' ' 105' ' ' LYS . 24.2 mt -108.94 156.31 19.86 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 . . . . . 0 N--CA 1.504 2.271 0 CA-C-O 116.037 -1.935 . . . . 0.0 109.686 179.955 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.2 p -116.87 150.14 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -119.51 151.25 38.9 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 86.6 t -129.41 98.11 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.142 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -102.0 117.16 34.23 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 104.879 -2.267 . . . . 0.0 104.879 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 92.8 m -91.7 154.86 18.71 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 122.054 0.93 . . . . 0.0 111.729 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 62.5 mt -123.53 -51.11 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 9' ' ' PRO . 33.8 m -121.46 81.26 38.79 Favored Pre-proline 0 N--CA 1.509 2.516 0 C-N-CA 120.271 -0.572 . . . . 0.0 112.038 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 8' ' ' SER . 5.3 Cg_exo -37.33 164.75 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.373 2.049 . . . . 0.0 112.578 178.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.11 -171.97 14.37 Favored Glycine 0 N--CA 1.5 2.926 0 N-CA-C 107.048 -2.421 . . . . 0.0 107.048 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 12' ' ' GLY . 1.1 p30 -39.55 -52.29 2.18 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.707 -0.797 . . . . 0.0 112.689 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.476 ' N ' ' OD1' ' A' ' 11' ' ' ASP . . . 100.51 5.14 54.45 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 108.44 -1.864 . . . . 0.0 108.44 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 32.3 mtp85 -121.45 -35.76 3.2 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 42.4 m -107.7 138.43 43.94 Favored 'General case' 0 N--CA 1.509 2.488 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 35.0 m-85 -133.09 175.41 3.73 Favored Pre-proline 0 N--CA 1.498 1.952 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -66.27 145.63 78.58 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 CA-C-N 119.769 0.953 . . . . 0.0 109.967 165.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -118.96 169.89 9.5 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 122.373 1.083 . . . . 0.0 111.969 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 25.3 ttt85 -79.2 103.18 8.96 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 113.805 -1.543 . . . . 0.0 109.89 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.44 -10.09 6.49 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 108.353 -1.899 . . . . 0.0 108.353 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -114.93 176.1 5.2 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 89.2 m -112.62 163.2 14.81 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 2.2 m -114.27 143.26 45.14 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 104.613 -2.366 . . . . 0.0 104.613 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.8 t -117.72 102.5 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 103.397 -2.816 . . . . 0.0 103.397 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.8 m -122.46 152.0 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.363 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.525 ' NE2' ' O ' ' A' ' 40' ' ' ARG . 4.3 t-80 -129.63 128.12 41.98 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 102.721 -3.066 . . . . 0.0 102.721 178.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -139.77 176.23 8.91 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 115.335 1.605 . . . . 0.0 115.335 -179.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 91.7 m -132.87 121.55 23.08 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 103.246 -2.872 . . . . 0.0 103.246 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.84 123.15 7.55 Favored Glycine 0 N--CA 1.503 3.138 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 45.3 ttp -142.85 176.83 8.77 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.0 mt -115.78 170.2 8.64 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -27.56 -61.07 0.1 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 125.262 1.601 . . . . 0.0 114.061 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -160.48 43.81 0.19 Allowed 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 114.592 -1.186 . . . . 0.0 109.23 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -117.04 -78.4 0.67 Allowed Glycine 0 N--CA 1.502 3.051 0 C-N-CA 119.279 -1.439 . . . . 0.0 113.399 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.3 pttt -160.95 -177.13 5.91 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -90.99 135.54 33.67 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 114.055 -1.43 . . . . 0.0 110.39 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -118.65 -34.68 3.91 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -139.63 90.0 2.37 Favored 'General case' 0 N--CA 1.511 2.593 0 CA-C-O 120.866 0.365 . . . . 0.0 111.65 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 70.7 m -111.74 129.57 56.07 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 61.8 p -116.61 37.15 3.86 Favored 'General case' 0 N--CA 1.502 2.164 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.655 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.683 HH21 ' NH1' ' A' ' 42' ' ' ARG . 8.2 tpt180 -32.74 -63.97 0.2 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 124.029 0.831 . . . . 0.0 112.045 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.426 ' C ' ' H ' ' A' ' 43' ' ' ASN . 36.1 t70 -19.52 88.68 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 125.358 1.661 . . . . 0.0 114.165 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.683 ' NH1' HH21 ' A' ' 40' ' ' ARG . 26.4 mtm180 -82.58 38.03 0.54 Allowed 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 118.975 -1.09 . . . . 0.0 109.146 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.426 ' H ' ' C ' ' A' ' 41' ' ' ASP . 44.3 t30 -110.85 50.27 0.82 Allowed 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.442 ' O ' ' O ' ' A' ' 45' ' ' PRO . 55.2 mtmt 98.38 72.98 0.01 OUTLIER Pre-proline 0 N--CA 1.504 2.255 0 O-C-N 126.166 2.166 . . . . 0.0 108.889 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.442 ' O ' ' O ' ' A' ' 44' ' ' LYS . 33.3 Cg_exo -43.4 -160.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 124.248 3.299 . . . . 0.0 116.548 -178.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -85.01 142.3 29.7 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 113.596 -1.638 . . . . 0.0 109.5 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm -131.48 119.92 22.25 Favored 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -138.83 170.94 15.09 Favored 'General case' 0 N--CA 1.513 2.688 0 C-N-CA 119.306 -0.958 . . . . 0.0 112.402 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 43.1 ttm -115.75 154.6 29.29 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.1 tp -90.92 120.71 32.15 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.86 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.89 12.84 48.66 Favored Glycine 0 N--CA 1.499 2.84 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.303 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.427 ' O ' ' OE2' ' A' ' 54' ' ' GLU . 59.3 tttm -121.85 23.06 10.24 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 23.5 69.4 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 114.617 -1.174 . . . . 0.0 113.782 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.427 ' OE2' ' O ' ' A' ' 52' ' ' LYS . 66.6 mm-40 -106.28 -35.86 7.04 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 56' ' ' ILE . 18.6 m -116.59 152.56 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 CA-C-O 121.513 0.673 . . . . 0.0 110.543 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.425 ' O ' ' O ' ' A' ' 55' ' ' VAL . 4.8 pt -48.98 177.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.706 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.541 ' O ' ' N ' ' A' ' 59' ' ' TRP . 18.2 ttm180 -71.4 -61.01 1.93 Allowed 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -24.05 -39.16 0.01 OUTLIER Glycine 0 N--CA 1.495 2.622 0 O-C-N 124.929 1.393 . . . . 0.0 112.497 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.541 ' N ' ' O ' ' A' ' 57' ' ' ARG . 1.1 m95 -83.01 -70.01 0.59 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.412 ' O ' ' OE1' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -30.4 -59.82 0.19 Allowed 'General case' 0 N--CA 1.504 2.243 0 O-C-N 124.95 1.406 . . . . 0.0 110.05 -179.899 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -67.72 -52.66 35.03 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -49.77 -89.11 0.01 OUTLIER Glycine 0 N--CA 1.478 1.451 0 CA-C-N 114.363 -1.29 . . . . 0.0 111.282 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' A' ' 59' ' ' TRP . 40.0 t -31.76 -48.43 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.478 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -46.32 -59.79 2.72 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 124.169 1.937 . . . . 0.0 110.648 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -48.18 -11.77 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 109.305 -3.588 . . . . 0.0 109.276 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.478 ' H ' ' C ' ' A' ' 64' ' ' ALA . 85.2 mtp -97.53 156.12 16.65 Favored 'General case' 0 N--CA 1.513 2.691 0 C-N-CA 118.753 -1.179 . . . . 0.0 108.123 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 70' ' ' GLN . 73.1 p -120.11 147.66 44.58 Favored 'General case' 0 N--CA 1.51 2.544 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 59.1 t -36.8 96.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 CA-C-N 113.131 -1.849 . . . . 0.0 114.139 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.05 13.75 16.99 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 108.539 -1.824 . . . . 0.0 108.539 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 67' ' ' SER . 44.6 tt0 -109.68 138.17 46.43 Favored 'General case' 0 N--CA 1.503 2.225 0 CA-C-O 121.602 0.715 . . . . 0.0 109.795 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -126.83 138.99 53.42 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -144.43 178.01 8.24 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-N 112.006 -2.361 . . . . 0.0 114.6 -179.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.5 ttmp? -124.55 104.22 8.59 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 111.406 -2.634 . . . . 0.0 104.021 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.3 mp -100.42 146.0 27.54 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 119.676 -0.81 . . . . 0.0 108.878 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 90.2 m -121.72 104.47 9.62 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.512 ' H ' HD12 ' A' ' 76' ' ' ILE . 2.7 mp -95.41 141.71 14.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.206 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.3 p -112.97 153.59 45.2 Favored Pre-proline 0 N--CA 1.503 2.204 0 CA-C-N 114.631 -1.168 . . . . 0.0 108.011 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -40.25 -47.13 4.2 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.01 1.807 . . . . 0.0 112.964 -172.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.526 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 4.0 p-10 -43.88 -35.3 1.92 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -103.78 23.93 12.02 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -169.74 -88.87 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 117.36 2.356 . . . . 0.0 117.36 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.495 ' CE2' HD11 ' A' ' 97' ' ' LEU . 5.4 m-30 -108.0 104.41 13.86 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 113.769 -1.56 . . . . 0.0 110.665 -179.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -111.32 -64.84 0.51 Allowed Glycine 0 N--CA 1.501 3.009 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -125.43 46.31 2.4 Favored 'General case' 0 N--CA 1.503 2.215 0 CA-C-O 121.486 0.66 . . . . 0.0 110.821 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.445 ' O ' ' O ' ' A' ' 86' ' ' GLY . 97.5 m -127.54 -66.97 0.85 Allowed 'General case' 0 N--CA 1.501 2.119 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.566 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 85' ' ' THR . . . 35.98 176.98 0.01 OUTLIER Glycine 0 N--CA 1.498 2.819 0 N-CA-C 116.934 1.533 . . . . 0.0 116.934 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -129.42 157.85 75.05 Favored Pre-proline 0 N--CA 1.505 2.314 0 CA-C-N 114.529 -0.836 . . . . 0.0 109.786 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -82.43 66.66 8.15 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 C-N-CA 122.936 2.424 . . . . 0.0 116.571 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 121.41 27.97 1.71 Allowed Glycine 0 N--CA 1.509 3.55 0 C-N-CA 121.251 -0.499 . . . . 0.0 114.22 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 28.4 mt -139.63 -58.81 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 N-CA-C 103.853 -2.647 . . . . 0.0 103.853 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.482 HD13 ' CE2' ' A' ' 82' ' ' TYR . 14.6 mt -126.54 91.47 47.41 Favored Pre-proline 0 N--CA 1.492 1.643 0 CA-C-N 109.189 -3.641 . . . . 0.0 107.931 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -61.93 156.93 46.14 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.031 1.821 . . . . 0.0 107.769 167.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -53.5 175.43 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.602 2.201 . . . . 0.0 113.192 -175.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 9.58 64.22 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 116.301 1.963 . . . . 0.0 116.301 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -120.59 155.44 33.71 Favored 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 93.0 m -91.16 142.7 27.45 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.495 HD11 ' CE2' ' A' ' 82' ' ' TYR . 22.2 mt -113.35 157.91 21.25 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 53.4 t -135.28 98.39 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -93.36 155.42 17.4 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -122.66 89.99 3.21 Favored 'General case' 0 N--CA 1.491 1.606 1 N-CA-C 95.466 -5.753 . . . . 0.0 95.466 179.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 12.5 t -100.7 148.32 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 C-N-CA 118.817 -1.153 . . . . 0.0 113.793 -178.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -124.94 109.12 12.61 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 112.429 -2.169 . . . . 0.0 107.49 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 55.5 tp -79.68 116.73 20.04 Favored 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 102.396 -3.187 . . . . 0.0 102.396 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.479 ' O ' ' NZ ' ' A' ' 105' ' ' LYS . 15.4 mt -88.13 -54.57 4.15 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -178.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.479 ' NZ ' ' O ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -164.58 177.82 7.81 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.326 -179.722 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 28.6 mt -118.07 153.58 33.5 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 . . . . . 0 N--CA 1.503 2.206 0 CA-C-O 115.733 -2.08 . . . . 0.0 108.63 179.849 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 110.079 -1.209 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.466 ' C ' ' NE2' ' A' ' 3' ' ' GLN . 9.2 p -117.0 150.16 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.478 ' CD ' ' N ' ' A' ' 3' ' ' GLN . 16.0 mp0 -121.59 148.11 44.95 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 59.6 t -124.66 109.36 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.026 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -109.98 97.03 6.62 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 88.6 m -69.91 156.72 38.67 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 118.961 -1.095 . . . . 0.0 112.643 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -121.84 -54.77 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-N 113.569 -1.65 . . . . 0.0 107.213 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.422 ' O ' ' O ' ' A' ' 9' ' ' PRO . 37.0 t -124.1 82.66 56.46 Favored Pre-proline 0 N--CA 1.506 2.345 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.821 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 8' ' ' SER . 2.0 Cg_exo -35.84 161.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.336 2.024 . . . . 0.0 112.574 178.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.52 -171.25 14.74 Favored Glycine 0 N--CA 1.502 3.036 0 N-CA-C 107.426 -2.269 . . . . 0.0 107.426 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 68' ' ' VAL . 0.7 OUTLIER -39.92 -65.18 0.42 Allowed 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.589 0.709 . . . . 0.0 112.351 -179.969 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.95 16.16 16.14 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 105.809 -2.916 . . . . 0.0 105.809 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.0 mtp85 -125.47 -44.18 1.86 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 114.028 -1.086 . . . . 0.0 111.963 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.0 m -103.96 133.23 49.27 Favored 'General case' 0 N--CA 1.504 2.247 0 CA-C-O 121.522 0.677 . . . . 0.0 112.085 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.43 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 41.9 m-85 -130.97 175.21 3.86 Favored Pre-proline 0 N--CA 1.501 2.085 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -71.44 150.66 58.4 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 N-CA-C 109.485 -1.006 . . . . 0.0 109.485 164.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -120.24 172.39 7.82 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-O 121.929 0.871 . . . . 0.0 110.84 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 19.6 ttp180 -81.23 96.67 7.33 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.382 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.16 -1.24 5.77 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 108.597 -1.801 . . . . 0.0 108.597 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.5 ' O ' ' SD ' ' A' ' 49' ' ' MET . 82.0 mt-30 -114.63 172.56 6.95 Favored 'General case' 0 N--CA 1.503 2.209 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.2 m -108.67 153.08 23.93 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.3 m -111.27 141.5 44.72 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 104.972 -2.233 . . . . 0.0 104.972 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.6 t -118.8 109.16 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 100.689 -3.819 . . . . 0.0 100.689 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.444 HG21 ' CH2' ' A' ' 59' ' ' TRP . 5.4 m -124.36 155.46 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 125.751 1.907 . . . . 0.0 113.058 -179.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 -130.76 107.3 9.05 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 104.197 -2.52 . . . . 0.0 104.197 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.419 ' CD2' ' CD2' ' A' ' 99' ' ' PHE . 27.2 p90 -132.59 177.29 7.73 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 95.9 m -137.49 116.41 12.36 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 111.444 -2.616 . . . . 0.0 104.959 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -111.5 114.5 3.65 Favored Glycine 0 N--CA 1.501 2.992 0 N-CA-C 107.642 -2.183 . . . . 0.0 107.642 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 38.9 ttm -123.36 174.38 7.37 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 32.6 mt -120.51 172.7 7.65 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -33.12 -62.56 0.26 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 124.74 1.275 . . . . 0.0 113.12 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 55.8 p30 -160.57 44.79 0.2 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 114.462 -1.244 . . . . 0.0 108.7 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -114.55 -81.55 1.0 Allowed Glycine 0 N--CA 1.498 2.777 0 C-N-CA 118.987 -1.578 . . . . 0.0 112.193 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.01 -176.32 5.42 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -91.12 94.87 9.79 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 112.935 -1.939 . . . . 0.0 106.181 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.526 ' CE2' ' OD2' ' A' ' 37' ' ' ASP . 6.4 p90 -89.71 -41.04 12.14 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 112.422 -2.172 . . . . 0.0 109.072 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.526 ' OD2' ' CE2' ' A' ' 36' ' ' PHE . 24.3 m-20 -135.08 95.45 3.31 Favored 'General case' 0 N--CA 1.51 2.575 0 CA-C-O 121.419 0.628 . . . . 0.0 112.597 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 52.0 m -119.56 168.6 10.85 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.58 ' O ' ' N ' ' A' ' 41' ' ' ASP . 93.5 p -111.63 72.24 0.77 Allowed 'General case' 0 N--CA 1.505 2.299 0 CA-C-O 119.115 -0.469 . . . . 0.0 110.283 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 12.5 ptm85 -28.66 61.69 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.106 0 O-C-N 126.95 2.656 . . . . 0.0 116.899 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.58 ' N ' ' O ' ' A' ' 39' ' ' SER . 30.7 m-20 -19.58 -74.81 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 111.927 -2.397 . . . . 0.0 113.628 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.6 mtt180 -19.89 -47.41 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.039 0 O-C-N 125.331 1.645 . . . . 0.0 114.117 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.441 ' N ' ' O ' ' A' ' 41' ' ' ASP . 5.6 m120 -110.17 67.31 0.64 Allowed 'General case' 0 N--CA 1.501 2.124 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.767 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.42 ' O ' ' O ' ' A' ' 43' ' ' ASN . 13.0 mmmm 57.86 155.62 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.725 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.574 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -84.44 -158.45 0.09 OUTLIER 'Trans proline' 0 C--N 1.315 -1.193 0 C-N-CA 122.863 2.376 . . . . 0.0 112.54 175.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -96.61 145.81 25.4 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 114.43 -1.259 . . . . 0.0 112.774 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 31.9 mtmm -142.51 122.89 13.94 Favored 'General case' 0 N--CA 1.504 2.247 0 CA-C-O 118.782 -0.628 . . . . 0.0 110.667 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -133.17 167.07 21.02 Favored 'General case' 0 N--CA 1.513 2.678 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.5 ' SD ' ' O ' ' A' ' 20' ' ' GLN . 47.3 tpp -107.37 129.39 54.92 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 113.492 -1.685 . . . . 0.0 111.824 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.7 tp -90.66 146.39 24.07 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.157 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 129.51 -42.28 1.44 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 107.317 -2.313 . . . . 0.0 107.317 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 54' ' ' GLU . 6.2 tmtt? -120.39 43.57 2.69 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 3.63 58.65 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.094 0 O-C-N 125.64 1.838 . . . . 0.0 114.807 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.534 ' N ' ' O ' ' A' ' 52' ' ' LYS . 11.3 pt-20 -64.01 -6.29 6.01 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 118.759 -1.176 . . . . 0.0 110.738 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 56' ' ' ILE . 33.7 m -116.38 158.94 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.425 ' O ' ' O ' ' A' ' 55' ' ' VAL . 17.3 pt -49.31 174.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 C-N-CA 117.83 -1.548 . . . . 0.0 110.118 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.541 ' O ' ' N ' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -70.55 -60.53 2.21 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 57' ' ' ARG . . . -20.52 -44.17 0.01 OUTLIER Glycine 0 N--CA 1.502 3.046 0 O-C-N 125.407 1.692 . . . . 0.0 112.495 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.541 ' N ' ' O ' ' A' ' 57' ' ' ARG . 1.5 m95 -73.99 -75.78 0.15 Allowed 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 111.668 -2.266 . . . . 0.0 108.813 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 59' ' ' TRP . 4.1 tm-20 -22.54 -55.66 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 126.303 2.252 . . . . 0.0 110.898 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -78.72 -53.07 7.52 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 113.219 -1.81 . . . . 0.0 106.592 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -51.35 -73.24 0.4 Allowed Glycine 0 N--CA 1.482 1.709 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.526 ' N ' ' O ' ' A' ' 59' ' ' TRP . 24.9 t -44.14 -49.76 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 119.258 -0.977 . . . . 0.0 111.503 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.471 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -45.22 -61.88 1.48 Allowed 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 123.864 1.793 . . . . 0.0 111.181 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -46.63 -13.63 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 109.913 -3.312 . . . . 0.0 109.244 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.471 ' H ' ' C ' ' A' ' 64' ' ' ALA . 41.9 mtm -103.32 154.8 18.99 Favored 'General case' 0 N--CA 1.513 2.717 0 C-N-CA 118.847 -1.141 . . . . 0.0 109.098 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 82.7 p -116.41 153.59 31.79 Favored 'General case' 0 N--CA 1.505 2.286 0 CA-C-O 122.624 1.202 . . . . 0.0 113.428 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.417 ' O ' ' OD1' ' A' ' 11' ' ' ASP . 85.8 t -43.07 95.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 112.416 -2.175 . . . . 0.0 114.388 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.04 16.42 7.88 Favored Glycine 0 N--CA 1.497 2.759 0 N-CA-C 108.816 -1.714 . . . . 0.0 108.816 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -108.38 142.81 38.17 Favored 'General case' 0 N--CA 1.506 2.356 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.741 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 24.2 ttt85 -126.72 141.65 51.78 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -149.46 177.4 9.74 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 116.334 1.976 . . . . 0.0 116.334 -179.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -127.81 104.5 7.86 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 103.326 -2.842 . . . . 0.0 103.326 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.407 HD12 ' N ' ' A' ' 74' ' ' LEU . 5.2 mp -101.8 146.65 27.5 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 119.606 -0.838 . . . . 0.0 109.194 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 73.2 m -117.05 104.0 10.81 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 102.309 -3.219 . . . . 0.0 102.309 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 21.4 mt -102.86 138.73 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.14 163.7 20.62 Favored Pre-proline 0 N--CA 1.503 2.219 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.865 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -37.74 -50.94 1.87 Allowed 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 122.561 2.174 . . . . 0.0 113.184 -175.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 80' ' ' TYR . 1.7 p30 -44.24 -42.72 6.76 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 120.191 -0.603 . . . . 0.0 111.608 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.476 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 6.8 m-85 -108.0 13.27 26.25 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.674 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.69 -111.48 0.23 Allowed 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -119.5 114.71 22.69 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 84' ' ' ALA . . . -90.55 -172.18 44.12 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 109.104 -1.599 . . . . 0.0 109.104 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.418 ' O ' ' O ' ' A' ' 83' ' ' GLY . . . 33.57 -156.21 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 74.7 m -101.59 56.53 0.83 Allowed 'General case' 0 N--CA 1.501 2.076 0 CA-C-O 120.926 0.393 . . . . 0.0 110.268 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -31.08 -86.27 0.01 OUTLIER Glycine 0 N--CA 1.494 2.533 0 CA-C-N 114.808 -1.087 . . . . 0.0 113.779 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 67.3 t60 -132.44 102.16 14.21 Favored Pre-proline 0 N--CA 1.504 2.26 0 CA-C-O 117.841 -1.076 . . . . 0.0 108.829 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -78.22 51.78 3.83 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 CA-C-N 120.778 1.314 . . . . 0.0 112.823 -173.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -128.91 -47.31 0.17 Allowed Glycine 0 N--CA 1.5 2.964 0 N-CA-C 109.036 -1.626 . . . . 0.0 109.036 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 20.7 mt -108.34 -46.03 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.6 mm -104.92 96.58 11.07 Favored Pre-proline 0 N--CA 1.499 2.006 0 CA-C-N 110.419 -3.082 . . . . 0.0 111.158 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -84.92 154.17 11.35 Favored 'Trans proline' 0 C--N 1.315 -1.209 0 C-N-CA 121.469 1.446 . . . . 0.0 108.614 176.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.401 ' O ' ' C ' ' A' ' 94' ' ' HIS . 26.7 Cg_endo -48.65 169.99 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.483 2.122 . . . . 0.0 112.182 -171.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.401 ' C ' ' O ' ' A' ' 93' ' ' PRO . 17.8 m80 9.56 61.97 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 O-C-N 125.787 1.929 . . . . 0.0 114.616 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -119.9 74.06 1.0 Allowed 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.388 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 99.9 m -29.46 131.46 0.07 Allowed 'General case' 0 N--CA 1.506 2.343 0 O-C-N 124.831 1.332 . . . . 0.0 110.544 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.8 mt -96.72 152.61 18.5 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.5 t -134.78 115.12 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.419 ' CD2' ' CD2' ' A' ' 26' ' ' TYR . 2.0 m-85 -108.15 163.09 13.46 Favored 'General case' 0 N--CA 1.504 2.232 0 CA-C-O 122.968 1.366 . . . . 0.0 109.477 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -128.78 90.03 2.98 Favored 'General case' 0 N--CA 1.492 1.664 1 N-CA-C 98.186 -4.746 . . . . 0.0 98.186 179.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.3 t -102.21 148.31 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.558 0 N-CA-C 116.89 2.181 . . . . 0.0 116.89 -178.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -129.72 99.7 5.23 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 112.922 -1.944 . . . . 0.0 108.626 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 50.4 tp -73.28 119.39 17.45 Favored 'General case' 0 N--CA 1.504 2.253 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.2 mt -85.66 -60.07 2.13 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.643 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.473 ' HG2' ' H ' ' A' ' 106' ' ' LEU . 60.4 tttm -168.72 -175.89 2.57 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.813 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.473 ' H ' ' HG2' ' A' ' 105' ' ' LYS . 20.9 mt -109.03 160.6 15.91 Favored 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 . . . . . 0 N--CA 1.503 2.216 0 CA-C-O 115.827 -2.035 . . . . 0.0 109.4 179.838 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.615 ' N ' ' CE1' ' A' ' 80' ' ' TYR . . . . . . . . 0 N--CA 1.486 2.031 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.5 p -114.96 147.81 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -121.87 154.53 36.96 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.6 t -126.98 114.12 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-N 112.929 -1.941 . . . . 0.0 109.3 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.528 ' OE2' ' NZ ' ' A' ' 73' ' ' LYS . 37.7 tt0 -118.06 101.52 8.31 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 42.0 m -70.04 150.73 46.32 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 118.938 -1.105 . . . . 0.0 113.623 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 77.2 mt -110.99 -55.35 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.9 t -129.65 90.78 42.57 Favored Pre-proline 0 N--CA 1.504 2.232 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.235 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -37.75 165.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 122.189 1.926 . . . . 0.0 112.54 174.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.6 -113.78 2.47 Favored Glycine 0 N--CA 1.5 2.938 0 N-CA-C 106.344 -2.702 . . . . 0.0 106.344 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.507 ' CG ' ' H ' ' A' ' 12' ' ' GLY . 9.8 p-10 -100.61 -62.5 1.23 Allowed 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.507 ' H ' ' CG ' ' A' ' 11' ' ' ASP . . . 104.88 28.05 5.76 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 42.4 mtp-105 -133.61 -39.0 0.9 Allowed 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.4 m -107.53 131.3 54.48 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.425 0.631 . . . . 0.0 112.279 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.461 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 23.1 m-85 -129.73 174.18 4.89 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -71.48 139.15 33.94 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 CA-C-N 119.857 0.985 . . . . 0.0 111.801 166.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -120.07 171.98 8.08 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 122.205 1.003 . . . . 0.0 111.271 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.9 ttt85 -71.28 104.31 3.1 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.189 -1.369 . . . . 0.0 111.588 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.33 8.84 5.77 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -121.97 174.15 7.08 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 57.5 m -119.44 114.56 22.5 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.544 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 58.5 m -69.26 153.28 43.9 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.537 HG13 ' HZ2' ' A' ' 47' ' ' LYS . 24.6 t -128.06 102.46 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 103.677 -2.712 . . . . 0.0 103.677 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.9 m -122.48 149.66 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.465 0 N-CA-C 116.662 2.097 . . . . 0.0 116.662 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -128.35 112.19 14.17 Favored 'General case' 0 N--CA 1.51 2.528 0 N-CA-C 103.996 -2.594 . . . . 0.0 103.996 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' A' ' 26' ' ' TYR . 36.1 p90 -133.7 -175.07 3.7 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 90.8 m -140.17 123.25 16.72 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 102.06 -3.311 . . . . 0.0 102.06 179.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -114.41 125.09 6.68 Favored Glycine 0 N--CA 1.507 3.392 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.483 ' SD ' ' O ' ' A' ' 34' ' ' LYS . 1.8 tmm? -144.19 177.81 8.34 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.0 mt -117.11 170.51 8.6 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -26.66 -60.34 0.09 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 125.335 1.647 . . . . 0.0 114.139 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 54.8 p-10 -160.27 46.08 0.23 Allowed 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.035 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -114.68 -85.19 1.28 Allowed Glycine 0 N--CA 1.497 2.71 0 C-N-CA 119.022 -1.561 . . . . 0.0 112.474 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.483 ' O ' ' SD ' ' A' ' 29' ' ' MET . 0.0 OUTLIER -161.03 -175.01 4.66 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 112.697 -1.751 . . . . 0.0 114.252 -179.478 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.458 ' H ' ' HD3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -91.41 136.79 32.86 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 113.999 -1.455 . . . . 0.0 109.507 179.663 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -115.72 -37.37 3.95 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -139.19 109.61 6.55 Favored 'General case' 0 N--CA 1.505 2.313 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.194 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.2 m -121.2 167.58 12.53 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 87.9 p -118.32 28.68 8.21 Favored 'General case' 0 N--CA 1.505 2.298 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.552 ' O ' ' N ' ' A' ' 42' ' ' ARG . 36.1 mtp85 -30.03 -62.88 0.14 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 124.603 1.189 . . . . 0.0 113.347 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -19.01 69.44 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.552 ' N ' ' O ' ' A' ' 40' ' ' ARG . 41.6 mtp180 -25.53 -74.4 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 124.592 1.183 . . . . 0.0 113.669 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -22.44 -73.18 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 113.213 -1.812 . . . . 0.0 115.515 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' A' ' 45' ' ' PRO . 2.1 tpmt? -125.5 114.81 25.28 Favored Pre-proline 0 N--CA 1.496 1.827 0 CA-C-N 114.541 -1.208 . . . . 0.0 112.089 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 44' ' ' LYS . 21.5 Cg_exo -42.12 -155.16 0.0 OUTLIER 'Trans proline' 0 N--CA 1.488 1.173 0 C-N-CA 122.355 2.037 . . . . 0.0 115.849 165.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -110.29 149.84 29.59 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 112.632 -2.076 . . . . 0.0 111.157 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.537 ' HZ2' HG13 ' A' ' 23' ' ' VAL . 31.2 mttm -145.08 137.4 25.95 Favored 'General case' 0 N--CA 1.512 2.659 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -136.45 165.72 25.15 Favored 'General case' 0 N--CA 1.516 2.85 0 CA-C-N 119.972 1.26 . . . . 0.0 110.85 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 47.8 ttp -117.15 86.84 2.58 Favored 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 116.867 2.173 . . . . 0.0 116.867 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.4 tp -32.14 125.12 0.29 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 124.215 0.947 . . . . 0.0 112.867 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 129.48 -30.77 3.55 Favored Glycine 0 N--CA 1.499 2.84 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.48 ' O ' ' N ' ' A' ' 54' ' ' GLU . 80.1 tttt -121.03 43.76 2.7 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 52' ' ' LYS . 46.0 tt0 3.19 62.68 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.163 0 O-C-N 126.031 2.082 . . . . 0.0 113.306 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' A' ' 52' ' ' LYS . 43.8 tt0 -72.36 -24.77 61.32 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 113.541 -1.663 . . . . 0.0 106.686 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.4 m -113.8 156.5 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.818 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.7 pt -60.2 172.69 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 118.153 -1.419 . . . . 0.0 110.03 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.559 ' O ' ' N ' ' A' ' 59' ' ' TRP . 24.2 ttt85 -65.56 -59.99 3.39 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 118.214 -0.898 . . . . 0.0 112.624 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -28.13 -34.91 0.01 OUTLIER Glycine 0 N--CA 1.506 3.336 0 CA-C-O 122.916 1.287 . . . . 0.0 111.444 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.559 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.5 OUTLIER -83.01 -79.84 0.18 Allowed 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 112.24 -1.98 . . . . 0.0 107.746 179.829 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -28.48 -49.39 0.07 Allowed 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 113.347 -1.752 . . . . 0.0 110.692 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -77.33 -54.54 6.34 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -52.64 -74.95 0.25 Allowed Glycine 0 N--CA 1.482 1.752 0 N-CA-C 108.553 -1.819 . . . . 0.0 108.553 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.518 ' N ' ' O ' ' A' ' 59' ' ' TRP . 25.9 t -38.32 -45.47 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.612 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.8 -44.2 66.45 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 122.799 1.285 . . . . 0.0 109.445 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.443 ' N ' ' O ' ' A' ' 62' ' ' GLY . 6.7 tt0 -74.6 8.79 2.1 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 111.966 -2.379 . . . . 0.0 111.463 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 94.4 mtp -116.61 149.66 39.34 Favored 'General case' 0 N--CA 1.507 2.389 0 N-CA-C 104.664 -2.347 . . . . 0.0 104.664 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 80.3 p -116.52 153.87 31.4 Favored 'General case' 0 N--CA 1.51 2.571 0 CA-C-O 122.934 1.349 . . . . 0.0 113.899 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 63.0 t -43.03 100.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 112.04 -2.345 . . . . 0.0 116.15 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.26 4.52 28.97 Favored Glycine 0 N--CA 1.5 2.909 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.401 ' OE1' ' C ' ' A' ' 70' ' ' GLN . 0.8 OUTLIER -110.17 145.16 37.72 Favored 'General case' 0 N--CA 1.507 2.42 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.977 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -128.16 145.48 51.01 Favored 'General case' 0 N--CA 1.508 2.435 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.611 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -144.11 -177.72 5.59 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-N 112.776 -2.011 . . . . 0.0 115.538 -179.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.55 ' HZ3' ' HB3' ' A' ' 73' ' ' LYS . 6.6 ttpm? -125.49 106.79 10.04 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 101.767 -3.42 . . . . 0.0 101.767 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.1 mt -101.25 143.54 31.2 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 59.0 m -115.17 117.01 29.31 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 102.021 -3.326 . . . . 0.0 102.021 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 30.0 mt -110.82 142.4 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.422 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 32.7 p -114.31 158.32 40.09 Favored Pre-proline 0 N--CA 1.506 2.341 0 CA-C-N 114.427 -1.26 . . . . 0.0 108.141 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -35.0 -55.31 0.57 Allowed 'Trans proline' 0 C--N 1.315 -1.202 0 C-N-CA 121.871 1.714 . . . . 0.0 113.852 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.524 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 3.9 p-10 -42.15 -41.97 2.84 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.332 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.615 ' CE1' ' N ' ' A' ' 1' ' ' GLY . 7.5 m-85 -108.02 22.13 16.38 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -179.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -121.62 -103.49 0.4 Allowed 'General case' 0 N--CA 1.505 2.298 0 CA-C-N 118.683 0.674 . . . . 0.0 111.067 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.556 ' CE2' ' CD1' ' A' ' 91' ' ' ILE . 96.8 m-85 -118.66 -55.48 2.2 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.18 162.81 14.52 Favored Glycine 0 N--CA 1.505 3.281 0 C-N-CA 121.29 -0.481 . . . . 0.0 113.925 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -17.62 -53.34 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.049 0 O-C-N 125.639 1.435 . . . . 0.0 113.442 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 97.7 m -121.5 91.23 3.47 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -88.27 -102.05 0.94 Allowed Glycine 0 N--CA 1.492 2.414 0 C-N-CA 118.998 -1.573 . . . . 0.0 111.741 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -128.21 74.06 79.54 Favored Pre-proline 0 N--CA 1.503 2.185 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.177 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -30.2 100.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 123.347 2.698 . . . . 0.0 112.862 -178.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.44 -25.11 3.65 Favored Glycine 0 N--CA 1.498 2.809 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.9 mt -110.19 -66.04 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.556 ' CD1' ' CE2' ' A' ' 82' ' ' TYR . 2.4 mp -112.29 91.4 16.23 Favored Pre-proline 0 N--CA 1.502 2.159 0 CA-C-N 114.075 -1.421 . . . . 0.0 108.8 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_exo -39.39 153.62 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 122.635 2.224 . . . . 0.0 109.812 166.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -51.37 169.01 0.23 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.071 1.847 . . . . 0.0 113.447 -172.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 7.9 p80 9.4 65.12 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -118.29 149.76 40.6 Favored 'General case' 0 N--CA 1.505 2.32 0 CA-C-O 121.366 0.603 . . . . 0.0 110.901 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 29.5 m -91.28 144.57 25.46 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.2 mt -115.13 155.75 26.52 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 59.0 t -139.43 97.72 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -92.07 167.04 12.36 Favored 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 117.586 -1.646 . . . . 0.0 108.992 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -130.04 86.87 2.45 Favored 'General case' 0 N--CA 1.493 1.678 1 N-CA-C 97.387 -5.042 . . . . 0.0 97.387 178.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.401 HG12 ' N ' ' A' ' 102' ' ' GLU . 14.7 t -100.8 149.82 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.401 ' N ' HG12 ' A' ' 101' ' ' VAL . 87.9 tt0 -125.81 101.58 6.91 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 112.04 -2.345 . . . . 0.0 107.406 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 50.4 tp -74.83 113.8 12.53 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 103.35 -2.833 . . . . 0.0 103.35 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 9.3 mt -76.71 -55.19 5.72 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 113.315 -1.766 . . . . 0.0 111.479 -179.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -176.24 -168.18 0.25 Allowed 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 118.622 -1.231 . . . . 0.0 110.423 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.4 mt -115.21 150.25 36.42 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 . . . . . 0 N--CA 1.502 2.132 0 CA-C-O 115.79 -2.052 . . . . 0.0 109.24 179.892 . . . . . . . . 0 0 . 1 stop_ save_